Citrus Sinensis ID: 039565
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 188 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.675 | 0.141 | 0.465 | 2e-30 | |
| Q9SI06 | 892 | Putative leucine-rich rep | no | no | 0.675 | 0.142 | 0.465 | 6e-29 | |
| C0LGG3 | 885 | Probable LRR receptor-lik | no | no | 0.675 | 0.143 | 0.471 | 9e-29 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.707 | 0.149 | 0.428 | 9e-29 | |
| C0LGL4 | 880 | Probable LRR receptor-lik | no | no | 0.670 | 0.143 | 0.468 | 3e-28 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.675 | 0.144 | 0.446 | 7e-28 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.670 | 0.144 | 0.443 | 2e-27 | |
| Q9FN93 | 887 | Probable LRR receptor-lik | no | no | 0.675 | 0.143 | 0.427 | 1e-26 | |
| C0LGQ7 | 898 | Probable LRR receptor-lik | no | no | 0.670 | 0.140 | 0.462 | 3e-26 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.675 | 0.145 | 0.446 | 3e-26 |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 132 bits (331), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 74/159 (46%), Positives = 95/159 (59%), Gaps = 32/159 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K P++ RD+K+TNILLNE + AKLADFG SR P+EG TH+ST +AGT G+
Sbjct: 701 GLEYLHNGCKPPMVHRDVKTTNILLNEHLHAKLADFGLSRSFPIEGETHVSTVVAGTPGY 760
Query: 109 LNTE------LTEKSDVDSFEIVILEIITGILTV-------------------------- 136
L+ E L EKSDV SF IV+LEIIT L +
Sbjct: 761 LDPEYYRTNWLNEKSDVYSFGIVLLEIITNQLVINQSREKPHIAEWVGLMLTKGDIQNIM 820
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175
D G++D SV +AVE+AM+ ++ RRP M+QVV+
Sbjct: 821 DPKLYGDYDSGSVWRAVELAMSCLNPSSARRPTMSQVVI 859
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SI06|Y5573_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g04300 OS=Arabidopsis thaliana GN=At2g04300 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 127 bits (318), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 74/159 (46%), Positives = 95/159 (59%), Gaps = 32/159 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K P++ RD+K+TNILL+E QAKLADFG SR P+EG T + T +AGT G+
Sbjct: 691 GLEYLHNGCKPPMVHRDVKTTNILLDEHFQAKLADFGLSRSFPLEGETRVDTVVAGTPGY 750
Query: 109 LNTE------LTEKSDVDSFEIVILEIITG-------------------ILT-------V 136
L+ E L EKSDV SF IV+LEIIT +LT +
Sbjct: 751 LDPEYYRTNWLNEKSDVYSFGIVLLEIITNQHVINQSREKPHIAEWVGVMLTKGDIKSII 810
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175
D F G++D SV +AVE+AM+ V+ RP M+QVV+
Sbjct: 811 DPKFSGDYDAGSVWRAVELAMSCVNPSSTGRPTMSQVVI 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG3|Y5182_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51820 OS=Arabidopsis thaliana GN=At1g51820 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 126 bits (316), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 75/159 (47%), Positives = 97/159 (61%), Gaps = 32/159 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K P++ RD+K+TNILLNE +AKLADFG SR +EG TH+ST +AGT G+
Sbjct: 687 GLEYLHNGCKPPMVHRDVKTTNILLNEHFEAKLADFGLSRSFLIEGETHVSTVVAGTPGY 746
Query: 109 LNTE------LTEKSDVDSFEIVILEIITG-------------------ILT-------V 136
L+ E LTEKSDV SF I++LEIIT +LT +
Sbjct: 747 LDPEYHRTNWLTEKSDVYSFGILLLEIITNRHVIDQSREKPHIGEWVGVMLTKGDIQSIM 806
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175
D S ++D SV KAVE+AM+ ++ RRP M+QVV+
Sbjct: 807 DPSLNEDYDSGSVWKAVELAMSCLNHSSARRPTMSQVVI 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 126 bits (316), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 75/175 (42%), Positives = 97/175 (55%), Gaps = 42/175 (24%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G + P++ RD+K+TNILLNE+ AKLADFG SR P++G H+ST +AGT G+
Sbjct: 692 GLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGY 751
Query: 109 LNTE------LTEKSDVDSFEIVILEIITG-------------------ILT-------V 136
L+ E L+EKSDV SF +V+LEI+T +LT V
Sbjct: 752 LDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTRERPHINDWVGFMLTKGDIKSIV 811
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM----------VREQGS 181
D G++D K VE+A+A V+ NRRP M VVM R QGS
Sbjct: 812 DPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALENARRQGS 866
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGL4|Y2289_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g28960 OS=Arabidopsis thaliana GN=At2g28960 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 124 bits (311), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 74/158 (46%), Positives = 93/158 (58%), Gaps = 32/158 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K P++ RD+K+TNILL+E QAKLADFG SR PV G TH+ST +AGT G+
Sbjct: 682 GLEYLHTGCKPPMVHRDVKTTNILLDEHFQAKLADFGLSRSFPVGGETHVSTAVAGTPGY 741
Query: 109 LNTE------LTEKSDVDSFEIVILEIITG-------------------ILT-------V 136
L+ E L EKSDV SF IV+LEIIT +LT V
Sbjct: 742 LDPEYYRTNRLNEKSDVYSFGIVLLEIITSRPVIQQTREKPHIAAWVGYMLTKGDIENVV 801
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174
D +++ SV KA+EIAM+ V+ +RP M+QV
Sbjct: 802 DPRLNRDYEPTSVWKALEIAMSCVNPSSEKRPTMSQVT 839
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 123 bits (309), Expect = 7e-28, Method: Compositional matrix adjust.
Identities = 71/159 (44%), Positives = 93/159 (58%), Gaps = 32/159 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G + P++ RD+K TNILLNE+ QAKLADFG SR PV+G +H+ T +AGT G+
Sbjct: 678 GLEYLHNGCRPPMVHRDVKPTNILLNERSQAKLADFGLSRSFPVDGESHVMTVVAGTPGY 737
Query: 109 LNTE------LTEKSDVDSFEIVILEIITG-------------------ILT-------V 136
L+ E L+EKSDV SF +V+LEI+T +LT V
Sbjct: 738 LDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVMNKNRERPHINEWVMFMLTNGDIKSIV 797
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175
D ++D V K VE+A+A V+ +RRP M VVM
Sbjct: 798 DPKLNEDYDTNGVWKVVELALACVNPSSSRRPTMPHVVM 836
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 122 bits (305), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 70/158 (44%), Positives = 92/158 (58%), Gaps = 32/158 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G P++ RD+K+TNILLNE+ AKLADFG SR PV+G +H+ST +AGT G+
Sbjct: 674 GLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPVDGESHVSTVVAGTPGY 733
Query: 109 LNTE------LTEKSDVDSFEIVILEIIT-------------------GILT-------V 136
L+ E L+EKSDV SF +V+LEI+T +LT +
Sbjct: 734 LDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKTRERTHINEWVGSMLTKGDIKSIL 793
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174
D G++D K VE+A+A V+ NRRP M VV
Sbjct: 794 DPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVV 831
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN93|Y5596_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g59680 OS=Arabidopsis thaliana GN=At5g59680 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 119 bits (299), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 68/159 (42%), Positives = 90/159 (56%), Gaps = 32/159 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G P++ RD+K+TNILL+E +AKLADFG SR PV G +H+ST IAGT G+
Sbjct: 689 GLEYLHIGCTPPMVHRDVKTTNILLDEHYKAKLADFGLSRSFPVGGESHVSTVIAGTPGY 748
Query: 109 LNTE------LTEKSDVDSFEIVILEIITGILTV-------------------------- 136
L+ E L+EKSDV SF IV+LE+IT +
Sbjct: 749 LDPEYYHTSRLSEKSDVYSFGIVLLEMITNQAVIDRNRRKSHITQWVGSELNGGDIAKIM 808
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175
DL G++D S +A+E+AM+ RRP M+ VV+
Sbjct: 809 DLKLNGDYDSRSAWRALELAMSCADPTSARRPTMSHVVI 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ7|Y4245_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g20450 OS=Arabidopsis thaliana GN=At4g20450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 118 bits (295), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 73/158 (46%), Positives = 91/158 (57%), Gaps = 32/158 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K P+I RD+KS NILL+ QAKL DFG SR PV TH+ST +AG+ G+
Sbjct: 700 GLEYLHIGCKPPMIHRDIKSMNILLDNNFQAKLGDFGLSRSFPVGSETHVSTNVAGSPGY 759
Query: 109 LNTE------LTEKSDVDSFEIVILEIITG-------------------ILT-------V 136
L+ E LTEKSDV SF +V+LEIIT LT V
Sbjct: 760 LDPEYYRTNWLTEKSDVFSFGVVLLEIITSQPVIDQTREKSHIGEWVGFKLTNGDIKNIV 819
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174
D S G++D S+ KA+E+AM+ VS + RP M+QV
Sbjct: 820 DPSMNGDYDSSSLWKALELAMSCVSPSSSGRPNMSQVA 857
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 117 bits (294), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 71/159 (44%), Positives = 93/159 (58%), Gaps = 32/159 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K ++ RD+K+TNILLNE KLADFG SR P+EG TH+ST +AGT G+
Sbjct: 686 GLEYLHNGCKPLMVHRDVKTTNILLNEHFDTKLADFGLSRSFPIEGETHVSTVVAGTIGY 745
Query: 109 LNTE------LTEKSDVDSFEIVILEIIT-------------------GILT-------V 136
L+ E LTEKSDV SF +V+L +IT G+LT
Sbjct: 746 LDPEYYRTNWLTEKSDVYSFGVVLLVMITNQPVIDQNREKRHIAEWVGGMLTKGDIKSIT 805
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175
D + G+++ SV KAVE+AM+ ++ RP M+QVV
Sbjct: 806 DPNLLGDYNSGSVWKAVELAMSCMNPSSMTRPTMSQVVF 844
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 188 | ||||||
| 255549708 | 883 | Nodulation receptor kinase precursor, pu | 0.675 | 0.143 | 0.521 | 8e-32 | |
| 147797614 | 757 | hypothetical protein VITISV_023487 [Viti | 0.696 | 0.173 | 0.496 | 3e-31 | |
| 9837280 | 904 | leaf senescence-associated receptor-like | 0.675 | 0.140 | 0.503 | 3e-31 | |
| 255549706 | 886 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.760 | 0.161 | 0.443 | 4e-31 | |
| 255549714 | 915 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.670 | 0.137 | 0.509 | 5e-31 | |
| 255549700 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.675 | 0.143 | 0.496 | 6e-31 | |
| 297743130 | 1242 | unnamed protein product [Vitis vinifera] | 0.664 | 0.100 | 0.515 | 4e-30 | |
| 356556621 | 892 | PREDICTED: probable LRR receptor-like se | 0.670 | 0.141 | 0.506 | 7e-30 | |
| 255549716 | 892 | Nodulation receptor kinase precursor, pu | 0.760 | 0.160 | 0.432 | 9e-30 | |
| 255549712 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.675 | 0.143 | 0.465 | 2e-29 |
| >gi|255549708|ref|XP_002515905.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544810|gb|EEF46325.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 142 bits (357), Expect = 8e-32, Method: Compositional matrix adjust.
Identities = 84/161 (52%), Positives = 98/161 (60%), Gaps = 34/161 (21%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K PII RD+K TNILLN K QAKLADFG SRI PVEGG+H+ST +AGT G+
Sbjct: 689 GLEYLHNGCKPPIIHRDVKPTNILLNNKFQAKLADFGLSRICPVEGGSHVSTIVAGTPGY 748
Query: 109 LNTE------LTEKSDVDSFEIVILEIIT----------GILT----------------- 135
L+ E LTEKSDV SF +V+LEIIT G T
Sbjct: 749 LDPEYYATNWLTEKSDVFSFGVVLLEIITSGPVISKTRDGDTTHLSQWFSSMVEKGDIQS 808
Query: 136 -VDLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175
VD +FDI S+ K VE+AMA VS+ +RP MNQVV+
Sbjct: 809 IVDPRLGDDFDINSLWKVVELAMACVSATSAQRPTMNQVVI 849
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147797614|emb|CAN65001.1| hypothetical protein VITISV_023487 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 140 bits (353), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 81/163 (49%), Positives = 98/163 (60%), Gaps = 32/163 (19%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL+YLH G K PII RD+KSTNILLNE+ QAKLADFG SR P+EG +H+ST + GT G+
Sbjct: 559 GLDYLHDGCKPPIIHRDIKSTNILLNERFQAKLADFGLSRAFPIEGSSHVSTAVVGTPGY 618
Query: 109 LNTE------LTEKSDVDSFEIVILEIITG------------IL--------------TV 136
L+ E LTEKSDV S+ +V+LEIIT I+ TV
Sbjct: 619 LDPEYYVSNRLTEKSDVFSYGVVLLEIITSQPAISKDREKTHIIEWVSCMLANGDIKNTV 678
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179
D +GEFDI S KAVE+AM VS RP M+ VVM +Q
Sbjct: 679 DPRLQGEFDINSAWKAVEVAMCCVSPTSTERPAMHYVVMELKQ 721
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|9837280|gb|AAG00510.1| leaf senescence-associated receptor-like protein kinase [Phaseolus vulgaris] | Back alignment and taxonomy information |
|---|
Score = 140 bits (352), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 80/159 (50%), Positives = 97/159 (61%), Gaps = 32/159 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYL G K PII RD+KS+NILLNE QAKL+DFG S+I P +G +H+ST +AGT G+
Sbjct: 708 GLEYLQNGCKPPIIHRDVKSSNILLNEHFQAKLSDFGLSKIIPDDGASHLSTVVAGTPGY 767
Query: 109 L------NTELTEKSDVDSFEIVILEIITGILT--------------------------V 136
L N LTEKSDV SF +V+LEIITG L V
Sbjct: 768 LDPDYYTNNRLTEKSDVYSFGVVLLEIITGQLVIARNEERSHIIEWVRSLVAIGDIKAIV 827
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175
D +G+FDI S KAVEIAMA VS + N+RP+M+ VV
Sbjct: 828 DSRLEGDFDINSAWKAVEIAMACVSLRPNQRPIMSVVVF 866
|
Source: Phaseolus vulgaris Species: Phaseolus vulgaris Genus: Phaseolus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549706|ref|XP_002515904.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544809|gb|EEF46324.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 139 bits (351), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 79/178 (44%), Positives = 107/178 (60%), Gaps = 35/178 (19%)
Query: 33 NPELVDQQGKEEVC---CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89
+P+++ +G+ ++ GLEYLH G K PI+ RD+K+ NILL++K QAKLADFG SR+
Sbjct: 666 HPDILSWEGRLKIALETAQGLEYLHNGCKPPIVHRDVKTANILLDDKFQAKLADFGLSRM 725
Query: 90 SPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT--GILT------ 135
P EGGTH+ST +AGT G+L+ E LTEKSDV SF +V+LEIIT +++
Sbjct: 726 FPAEGGTHVSTIVAGTPGYLDPEYYVRNWLTEKSDVYSFGVVLLEIITSRSVISQTSEKT 785
Query: 136 ------------------VDLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175
VD G+FD + KA E+AMA VS+ RP M+QVVM
Sbjct: 786 HVSQWVKPMLERGDIKNIVDSRLCGDFDTNTAWKAAELAMACVSATSTERPSMSQVVM 843
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549714|ref|XP_002515908.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544813|gb|EEF46328.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 139 bits (350), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 81/159 (50%), Positives = 97/159 (61%), Gaps = 33/159 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K PI+ RD+K+ NILLN++ QA+LADFG S+ PVEGGTH+ST +AGT G+
Sbjct: 706 GLEYLHNGCKPPIVHRDIKTANILLNDQFQARLADFGLSKSFPVEGGTHVSTVVAGTPGY 765
Query: 109 LNTE------LTEKSDVDSFEIVILEIITG--------------------------ILTV 136
L+ E LTEKSDV SF +V+L+IITG I TV
Sbjct: 766 LDPEYSMTNWLTEKSDVYSFGVVLLKIITGRPVIAVIDERSIHISHWVSSLVANGDIKTV 825
Query: 137 -DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174
D G+FDI SV KAVE+AMA S RP MNQVV
Sbjct: 826 IDPCLGGDFDINSVWKAVEVAMACTSPTSAGRPTMNQVV 864
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549700|ref|XP_002515901.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544806|gb|EEF46321.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 139 bits (349), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 79/159 (49%), Positives = 96/159 (60%), Gaps = 32/159 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K I+ RD+K+TNILLN+K QAKLADFG SRI PV+G TH+ST +AGT G+
Sbjct: 683 GLEYLHNGCKPQIVHRDVKTTNILLNDKFQAKLADFGLSRIFPVDGSTHISTVVAGTPGY 742
Query: 109 LNTE------LTEKSDVDSFEIVILEIITGILT--------------------------V 136
L+ E LT+KSDV SF +V+LEIITG V
Sbjct: 743 LDPEYYVNNWLTDKSDVFSFGVVLLEIITGRPAIAQTRERTHISQWVSSMLEKGDIHGIV 802
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175
D G+F+I SV KA E+AM VS+ RRP MNQ V+
Sbjct: 803 DPRLNGDFEINSVWKAAELAMGCVSASSARRPTMNQAVV 841
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297743130|emb|CBI35997.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 136 bits (342), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 81/157 (51%), Positives = 94/157 (59%), Gaps = 32/157 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K PII RD+KSTNILLNEK QAKLADF SR P EG TH+ST +AGT G+
Sbjct: 288 GLEYLHNGCKPPIIHRDIKSTNILLNEKFQAKLADFRLSRAFPNEGSTHVSTIVAGTRGY 347
Query: 109 LNTE------LTEKSDVDSFEIVILEIITG-------------------ILT-------V 136
L+ E LTEKSDV SF +V+LEIIT +L V
Sbjct: 348 LDPEYHASNRLTEKSDVFSFGVVLLEIITSQSPVPGNHEETHIIQWVSSMLANGDIKNIV 407
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQV 173
D +G+FDI S KAVE+AM+ V+S RP MN V
Sbjct: 408 DPRLQGDFDINSAWKAVEVAMSCVASTSTERPAMNYV 444
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556621|ref|XP_003546622.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g51880-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 135 bits (340), Expect = 7e-30, Method: Compositional matrix adjust.
Identities = 80/158 (50%), Positives = 97/158 (61%), Gaps = 32/158 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYL G K PII RD+KSTNILLNE QAKL+DFG S+I P +G TH+ST IAGT G+
Sbjct: 694 GLEYLQNGCKPPIIHRDVKSTNILLNEHFQAKLSDFGLSKIIPTDGSTHVSTVIAGTPGY 753
Query: 109 LNTE------LTEKSDVDSFEIVILEIITG--ILT------------------------V 136
L+ E LTEKSDV SF +V+LEIIT ++T V
Sbjct: 754 LDPEYYITNRLTEKSDVYSFGVVLLEIITSKPVITKNQEKTHISQWVSSLVAKGDIKSIV 813
Query: 137 DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174
D +G+FD SV KAVEIA A VS NRRP+++ +V
Sbjct: 814 DSRLEGDFDNNSVWKAVEIAAACVSPNPNRRPIISVIV 851
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549716|ref|XP_002515909.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544814|gb|EEF46329.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 135 bits (339), Expect = 9e-30, Method: Compositional matrix adjust.
Identities = 77/178 (43%), Positives = 106/178 (59%), Gaps = 35/178 (19%)
Query: 33 NPELVDQQGKEEVC---CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89
+P ++ +G+ ++ GL+YLH G K PI+ RD+K+TNILLN++ QAKLADFG SR
Sbjct: 674 HPSILSWEGRLQIALEAAQGLDYLHNGCKPPIVHRDVKTTNILLNDRFQAKLADFGLSRT 733
Query: 90 SPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT------------ 131
PVE G+H+ST +AGT G+L+ + LTEKSDV S+ +V+LEIIT
Sbjct: 734 FPVEDGSHVSTVVAGTPGYLDPDYYVTNWLTEKSDVYSYGVVLLEIITSRPVIARTRDKT 793
Query: 132 -------GILT-------VDLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175
+L VD +G+FD SV K E+AMA +S+ RP M+QVVM
Sbjct: 794 HVSQWVKAMLDKGDIKNIVDPRLRGDFDNNSVWKVTELAMACLSTTSGERPSMSQVVM 851
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549712|ref|XP_002515907.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544812|gb|EEF46327.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 134 bits (337), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 75/161 (46%), Positives = 97/161 (60%), Gaps = 34/161 (21%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K PI+ RD+K+TNILLN+K QAK++DFG SRI P +GGTH+ST +AGT G+
Sbjct: 683 GLEYLHGGCKLPIVHRDVKTTNILLNDKFQAKISDFGLSRIFPADGGTHVSTIVAGTPGY 742
Query: 109 LNTE------LTEKSDVDSFEIVILEIITGILTV-------------------------- 136
L+ E LT+KSDV SF +V+LEIIT +
Sbjct: 743 LDPEYYVTNWLTDKSDVYSFGVVLLEIITCRPVIAQNRNHENSHISQWVSSMIENGDVNS 802
Query: 137 --DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175
D GE+++ SV K VE+AM +S+ RRP MNQVV+
Sbjct: 803 IADPRLNGEYEVNSVWKIVELAMECLSTTSARRPTMNQVVI 843
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 188 | ||||||
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.446 | 0.095 | 0.588 | 4e-32 | |
| TAIR|locus:2017527 | 693 | AT1G51830 [Arabidopsis thalian | 0.473 | 0.128 | 0.589 | 1.9e-31 | |
| TAIR|locus:2066133 | 880 | AT2G28960 [Arabidopsis thalian | 0.441 | 0.094 | 0.629 | 1.5e-30 | |
| TAIR|locus:2017557 | 894 | IOS1 "IMPAIRED OOMYCETE SUSCEP | 0.579 | 0.121 | 0.504 | 1.5e-30 | |
| TAIR|locus:2824870 | 884 | AT1G51805 [Arabidopsis thalian | 0.484 | 0.102 | 0.577 | 8.7e-29 | |
| TAIR|locus:2066143 | 786 | AT2G28970 [Arabidopsis thalian | 0.441 | 0.105 | 0.640 | 3.1e-28 | |
| TAIR|locus:2195825 | 865 | AT1G51850 [Arabidopsis thalian | 0.484 | 0.105 | 0.608 | 3.2e-28 | |
| TAIR|locus:2028446 | 888 | AT1G49100 [Arabidopsis thalian | 0.441 | 0.093 | 0.595 | 1.3e-27 | |
| TAIR|locus:2195855 | 876 | AT1G51910 [Arabidopsis thalian | 0.473 | 0.101 | 0.586 | 5.1e-27 | |
| TAIR|locus:2017647 | 885 | AT1G51820 [Arabidopsis thalian | 0.484 | 0.102 | 0.587 | 5.3e-27 |
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 258 (95.9 bits), Expect = 4.0e-32, Sum P(3) = 4.0e-32
Identities = 53/90 (58%), Positives = 66/90 (73%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K PI+ RD+K NILLNE +QAK+ADFG SR PVEG + +ST +AGT G+
Sbjct: 681 GLEYLHYGCKPPIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAGTIGY 740
Query: 109 LNTE------LTEKSDVDSFEIVILEIITG 132
L+ E + EKSDV SF +V+LE+ITG
Sbjct: 741 LDPEYYATRQMNEKSDVYSFGVVLLEVITG 770
|
|
| TAIR|locus:2017527 AT1G51830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 263 (97.6 bits), Expect = 1.9e-31, Sum P(3) = 1.9e-31
Identities = 56/95 (58%), Positives = 69/95 (72%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K ++ RD+K+TNILLNE+ AKLADFG SR P+EG TH+ST +AGT G+
Sbjct: 495 GLEYLHNGCKPLMVHRDIKTTNILLNEQFDAKLADFGLSRSFPIEGETHVSTAVAGTPGY 554
Query: 109 LNTE------LTEKSDVDSFEIVILEIITGILTVD 137
L+ E LTEKSDV SF +V+LEIIT +D
Sbjct: 555 LDPEYYRTNWLTEKSDVYSFGVVLLEIITNQPVID 589
|
|
| TAIR|locus:2066133 AT2G28960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 257 (95.5 bits), Expect = 1.5e-30, Sum P(3) = 1.5e-30
Identities = 56/89 (62%), Positives = 66/89 (74%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K P++ RD+K+TNILL+E QAKLADFG SR PV G TH+ST +AGT G+
Sbjct: 682 GLEYLHTGCKPPMVHRDVKTTNILLDEHFQAKLADFGLSRSFPVGGETHVSTAVAGTPGY 741
Query: 109 LNTE------LTEKSDVDSFEIVILEIIT 131
L+ E L EKSDV SF IV+LEIIT
Sbjct: 742 LDPEYYRTNRLNEKSDVYSFGIVLLEIIT 770
|
|
| TAIR|locus:2017557 IOS1 "IMPAIRED OOMYCETE SUSCEPTIBILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 266 (98.7 bits), Expect = 1.5e-30, Sum P(3) = 1.5e-30
Identities = 60/119 (50%), Positives = 79/119 (66%)
Query: 29 GFRGNPELVDQQGKEEVCCP---GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG 85
G RG P ++ +G+ + GLEYLH G K I+ RD+K+TNILLNEK QAKLADFG
Sbjct: 672 GKRG-PSILTWEGRLRIAAESAQGLEYLHNGCKPQIVHRDIKTTNILLNEKFQAKLADFG 730
Query: 86 QSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDL 138
SR P+ TH+ST +AGT G+L+ E LTEKSDV SF +V+LE++T +D+
Sbjct: 731 LSRSFPLGTETHVSTIVAGTPGYLDPEYYRTNWLTEKSDVFSFGVVLLELVTNQPVIDM 789
|
|
| TAIR|locus:2824870 AT1G51805 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 256 (95.2 bits), Expect = 8.7e-29, Sum P(3) = 8.7e-29
Identities = 56/97 (57%), Positives = 69/97 (71%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K ++ RD+K+TNILLNE +AKLADFG SR P+ G TH+ST +AGT G+
Sbjct: 686 GLEYLHNGCKPLMVHRDVKTTNILLNEHFEAKLADFGLSRSFPIGGETHVSTVVAGTPGY 745
Query: 109 LNTE------LTEKSDVDSFEIVILEIITGILTVDLS 139
L+ E LTEKSDV SF IV+LE+IT +D S
Sbjct: 746 LDPEYYKTNRLTEKSDVYSFGIVLLEMITNRPVIDQS 782
|
|
| TAIR|locus:2066143 AT2G28970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 265 (98.3 bits), Expect = 3.1e-28, Sum P(2) = 3.1e-28
Identities = 57/89 (64%), Positives = 67/89 (75%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K P++ RD+KSTNILL+E+ QAKLADFG SR P E TH+ST +AGT G+
Sbjct: 588 GLEYLHTGCKPPMVHRDIKSTNILLDERFQAKLADFGLSRSFPTENETHVSTVVAGTPGY 647
Query: 109 LNTE------LTEKSDVDSFEIVILEIIT 131
L+ E LTEKSDV SF IV+LEIIT
Sbjct: 648 LDPEYYQTNWLTEKSDVYSFGIVLLEIIT 676
|
|
| TAIR|locus:2195825 AT1G51850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 277 (102.6 bits), Expect = 3.2e-28, Sum P(2) = 3.2e-28
Identities = 59/97 (60%), Positives = 71/97 (73%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K P++ RD+K+TNILLNE QAKLADFG SR P+EG TH+ST +AGT G+
Sbjct: 667 GLEYLHNGCKPPMVHRDVKTTNILLNEHFQAKLADFGLSRSFPIEGETHVSTVVAGTPGY 726
Query: 109 LNTE------LTEKSDVDSFEIVILEIITGILTVDLS 139
L+ E LTEKSDV SF IV+LE+IT +D S
Sbjct: 727 LDPEYYKTNWLTEKSDVYSFGIVLLELITNRPVIDKS 763
|
|
| TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 244 (91.0 bits), Expect = 1.3e-27, Sum P(3) = 1.3e-27
Identities = 53/89 (59%), Positives = 66/89 (74%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH+G + PI+ RD+K+ NILL+E QAKLADFG SR EG +H+ST +AGT G+
Sbjct: 690 GLEYLHKGCRPPIVHRDVKTANILLDEHFQAKLADFGLSRSFLNEGESHVSTVVAGTIGY 749
Query: 109 LNTE------LTEKSDVDSFEIVILEIIT 131
L+ E LTEKSDV SF +V+LEIIT
Sbjct: 750 LDPEYYRTNWLTEKSDVYSFGVVLLEIIT 778
|
|
| TAIR|locus:2195855 AT1G51910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 263 (97.6 bits), Expect = 5.1e-27, Sum P(2) = 5.1e-27
Identities = 54/92 (58%), Positives = 71/92 (77%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G + P++ RD+K+TNILLNE QAKLADFG SR SPV+G +++ST +AGT G+
Sbjct: 682 GLEYLHNGSRPPMVHRDVKTTNILLNELYQAKLADFGLSRSSPVDGESYVSTIVAGTPGY 741
Query: 109 LNTE---LTEKSDVDSFEIVILEIITGILTVD 137
L+ E L+EK+DV SF +V+LEIIT +D
Sbjct: 742 LDPETNLLSEKTDVYSFGVVLLEIITNQPVID 773
|
|
| TAIR|locus:2017647 AT1G51820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 263 (97.6 bits), Expect = 5.3e-27, Sum P(2) = 5.3e-27
Identities = 57/97 (58%), Positives = 70/97 (72%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH G K P++ RD+K+TNILLNE +AKLADFG SR +EG TH+ST +AGT G+
Sbjct: 687 GLEYLHNGCKPPMVHRDVKTTNILLNEHFEAKLADFGLSRSFLIEGETHVSTVVAGTPGY 746
Query: 109 LNTE------LTEKSDVDSFEIVILEIITGILTVDLS 139
L+ E LTEKSDV SF I++LEIIT +D S
Sbjct: 747 LDPEYHRTNWLTEKSDVYSFGILLLEIITNRHVIDQS 783
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00034228001 | SubName- Full=Chromosome chr9 scaffold_7, whole genome shotgun sequence; (853 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 188 | |||
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-15 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-14 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-14 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-13 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-11 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-11 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-10 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-10 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-10 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-10 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-10 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-09 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-07 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-06 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-06 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-05 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-04 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-04 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-04 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-04 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 0.001 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.001 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 0.001 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.001 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.001 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 0.001 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 0.001 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.001 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.002 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.002 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.002 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.002 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.002 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.002 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.002 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 0.002 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.002 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 0.002 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.002 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.002 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.002 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 0.002 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.003 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.003 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 0.003 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 0.004 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 0.004 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.004 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.004 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.004 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 0.004 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.004 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 3e-15
Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 9/90 (10%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YLH + I+ RD+K NIL++ KLADFG ++ + ++ GT +
Sbjct: 113 GLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 109 L------NTELTEKSDVDSFEIVILEIITG 132
+ E +D+ S ++E+ TG
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-14
Identities = 37/121 (30%), Positives = 56/121 (46%), Gaps = 16/121 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH + II RD+K NILL+E K+ADFG ++ + TT GT +
Sbjct: 110 GLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWY 164
Query: 109 LNTEL-------TEKSDVDSFEIVILEIITGILTVDLSFKGEFDIISVEKAVEIAMASVS 161
+ E+ K DV S +++ E++TG F GE + ++ I +
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTG----KPPFSGENILDQLQLIRRILGPPLE 220
Query: 162 S 162
Sbjct: 221 F 221
|
Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 4e-14
Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 14/91 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS-RISPVEGGTHMSTTIAGTAG 107
GLEYLH + II RD+K+ NILL + KL DFG S ++S T T+ GT
Sbjct: 110 GLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD----TKARNTMVGTPY 162
Query: 108 FLNTEL------TEKSDVDSFEIVILEIITG 132
++ E+ K+D+ S I +E+ G
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 2e-13
Identities = 31/95 (32%), Positives = 45/95 (47%), Gaps = 13/95 (13%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
++ LEYLH I+ RD+K NILL+E KLADFG +R TT
Sbjct: 105 QILS-ALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFV 157
Query: 104 GTAGF------LNTELTEKSDVDSFEIVILEIITG 132
GT + L + D+ S +++ E++TG
Sbjct: 158 GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTG 192
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-13
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 13/89 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKV-QAKLADFGQSRISPVEGGTHMSTTIAGTAG 107
GLEYLH + II RD+K NILL+ + KLADFG S++ + + TI GT
Sbjct: 104 GLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPA 158
Query: 108 FL-------NTELTEKSDVDSFEIVILEI 129
++ +EKSD+ S +++ E+
Sbjct: 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 4e-12
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL+YLH II RD+K +N+L+N K + K+ADFG S++ +E T GT +
Sbjct: 111 GLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTY 166
Query: 109 LNTELTE------KSDVDSFEIVILEIITG 132
++ E + +D+ S + +LE G
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALG 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-11
Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 12/90 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YLH+ KH II RD+K +NIL+N + Q KL DFG S + ++ T GT+ +
Sbjct: 112 GLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSY 165
Query: 109 LNTE------LTEKSDVDSFEIVILEIITG 132
+ E + KSD+ S + ++E+ TG
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 5e-11
Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 11/90 (12%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLEYLH + I RD+K+ NILLNE+ QAKLADFG S + T+ GT +
Sbjct: 111 GLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQ--LTDTMAKRNTVIGTPFW 165
Query: 109 LNTELTE------KSDVDSFEIVILEIITG 132
+ E+ + K+D+ S I +E+ G
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 5e-11
Identities = 36/94 (38%), Positives = 48/94 (51%), Gaps = 14/94 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMS---TTIAGT 105
GLEYLH + I RD+K+ NILL E K+ADFG S S +GG T GT
Sbjct: 114 GLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSA-SLADGGDRTRKVRKTFVGT 169
Query: 106 AGFLNTEL-------TEKSDVDSFEIVILEIITG 132
++ E+ K+D+ SF I +E+ TG
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 1e-10
Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 15/92 (16%)
Query: 49 GLEYLH-QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS-RISPVEGGTHMSTTIAGTA 106
GL YLH QG +I RD+K+ NIL + KLADFG + +++ V ++ GT
Sbjct: 111 GLAYLHEQG----VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA---SVVGTP 163
Query: 107 GFLNTE------LTEKSDVDSFEIVILEIITG 132
++ E + SD+ S ++E++TG
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 2e-10
Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 11/92 (11%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
C L+YLH I+ RD+K NI L KL DFG S++ + ++ T+ GT
Sbjct: 113 CLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTP 167
Query: 107 GFLNTEL------TEKSDVDSFEIVILEIITG 132
+L+ EL KSD+ S V+ E+ T
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTL 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-10
Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 11/90 (12%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL +LH I+ RD+KS N+ L+ K+ D G +++ + T+ + TI GT +
Sbjct: 113 GLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYY 167
Query: 109 LNTEL------TEKSDVDSFEIVILEIITG 132
L+ EL EKSDV + +V+ E TG
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTG 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-10
Identities = 43/131 (32%), Positives = 61/131 (46%), Gaps = 33/131 (25%)
Query: 8 KLTGPLLVELIGKQKNNALELGFRGNPELVDQQGKEEVCCPGLEYLHQGLKHPIIQRDMK 67
K GP+ VE++GK +E GL YL+ H I+ RD+K
Sbjct: 95 KKGGPIPVEILGKIAVAVVE---------------------GLTYLYN--VHRIMHRDIK 131
Query: 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDS 121
+NIL+N + Q KL DFG S E ++ T GT+ +++ E T KSDV S
Sbjct: 132 PSNILVNSRGQIKLCDFGVSG----ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWS 187
Query: 122 FEIVILEIITG 132
I I+E+ G
Sbjct: 188 LGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (138), Expect = 4e-10
Identities = 27/95 (28%), Positives = 43/95 (45%), Gaps = 10/95 (10%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT-- 101
++ G+EYL + RD+ + N L+ E + K++DFG SR +
Sbjct: 110 QIAK-GMEYLES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGK 165
Query: 102 --IAGTA--GFLNTELTEKSDVDSFEIVILEIITG 132
I A + + T KSDV SF +++ EI T
Sbjct: 166 LPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 5e-10
Identities = 28/94 (29%), Positives = 43/94 (45%), Gaps = 10/94 (10%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT-- 101
++ G+EYL + RD+ + N L+ E + K++DFG SR + T
Sbjct: 113 QIAK-GMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGK 168
Query: 102 --IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I A + T KSDV SF +++ EI T
Sbjct: 169 LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-10
Identities = 33/87 (37%), Positives = 44/87 (50%), Gaps = 13/87 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YLH II RD+K +NILL K Q KL DFG S E ++ T GT+ +
Sbjct: 117 GLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSG----ELVNSLAGTFTGTSFY 169
Query: 109 LNTE------LTEKSDVDSFEIVILEI 129
+ E + SDV S + +LE+
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 7e-10
Identities = 30/108 (27%), Positives = 50/108 (46%), Gaps = 27/108 (25%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI------------------S 90
LEYLH II RD+K NILL++ + K+ DFG +++ S
Sbjct: 114 ALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 91 PVEGGTHMSTTIAGTAGFLNTEL------TEKSDVDSFEIVILEIITG 132
+E + GTA +++ EL + SD+ + +I +++TG
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 8e-10
Identities = 28/92 (30%), Positives = 41/92 (44%), Gaps = 9/92 (9%)
Query: 45 VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT--- 101
+ G+EYL I RD+ + N L+ E + K++DFG SR +
Sbjct: 111 IAR-GMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLP 166
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I A + T KSDV SF +++ EI T
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 8e-10
Identities = 25/69 (36%), Positives = 37/69 (53%), Gaps = 7/69 (10%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ LEYLH II RD+K NILL+E+ + DF + V T ++T+ +
Sbjct: 108 EIVL-ALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATK--VTPDT-LTTSTS 160
Query: 104 GTAGFLNTE 112
GT G++ E
Sbjct: 161 GTPGYMAPE 169
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 8e-10
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 13/94 (13%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS-RISPVEGGTHMSTTIAG 104
GLEYLH +I RD+KS NILL++ KLADFG + +++ ++ G
Sbjct: 125 VLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK---EKSKRNSVVG 178
Query: 105 TAGFLNTEL------TEKSDVDSFEIVILEIITG 132
T ++ E+ K D+ S I+ +E+ G
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 8e-10
Identities = 28/92 (30%), Positives = 42/92 (45%), Gaps = 9/92 (9%)
Query: 45 VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT--- 101
+ G+EYL I RD+ + N L+ E + K++DFG SR + +
Sbjct: 112 IAR-GMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I A + T KSDV SF +++ EI T
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 9e-10
Identities = 33/97 (34%), Positives = 46/97 (47%), Gaps = 12/97 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ LEYLH II RD+K NILL+ KL DFG ++ EG + T
Sbjct: 101 EIVL-ALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFC 154
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITGIL 134
GT +L E+ VD S +++ E++TG
Sbjct: 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-09
Identities = 29/96 (30%), Positives = 39/96 (40%), Gaps = 16/96 (16%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAG- 107
GL YLH H I+ RD+K NI L+ KL DFG + T M + AG
Sbjct: 111 GLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL-KNNTTTMGEEVQSLAGT 166
Query: 108 --------FLNTELTEK---SDVDSFEIVILEIITG 132
+ +D+ S V+LE+ TG
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 54.0 bits (128), Expect = 7e-09
Identities = 38/134 (28%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEK-VQAKLADFGQSRISPVEGGT----HMSTT 101
LEYLH II RD+K NILL+ KL DFG +++ P G T + +T
Sbjct: 111 LSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167
Query: 102 IAGTAGFLNTEL---------TEKSDVDSFEIVILEIITGILTVDLSFKGEFDIISVEKA 152
GT G++ E+ + SD+ S I + E++TG+ F+GE + + +
Sbjct: 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL----PPFEGEKNSSATSQT 223
Query: 153 VEIAMASVSSKVNR 166
++I + + +
Sbjct: 224 LKIILELPTPSLAS 237
|
Length = 384 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 9e-09
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 23/96 (23%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTI------ 102
GLEYLH+ K I RD+K+ NILL+E+ KLADFG S +++T+
Sbjct: 110 GLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVS--------GQLTSTMSKRNTF 158
Query: 103 AGTAGFL------NTELTEKSDVDSFEIVILEIITG 132
GT ++ + EK+D+ S I +E+ G
Sbjct: 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 1e-08
Identities = 20/40 (50%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL+YLH + I+ RD+K +NIL+N KLADFG +R
Sbjct: 112 GLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 1e-08
Identities = 20/40 (50%), Positives = 24/40 (60%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL Y H H I+ RD+K NIL+N KLADFG +R
Sbjct: 110 GLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 1e-08
Identities = 29/97 (29%), Positives = 40/97 (41%), Gaps = 15/97 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG------QSRISPVEGGTHMSTTI 102
LEYLH + II RD+K NIL++ KL DFG R + I
Sbjct: 105 ALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 103 AGTAGFLNTELTEKSD----VD--SFEIVILEIITGI 133
GT ++ E+ VD S ++ E + GI
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGI 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-08
Identities = 24/56 (42%), Positives = 30/56 (53%), Gaps = 5/56 (8%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTHMSTTI 102
GLEYLH + I+ RD+K N+L+ KLADFG +R SP TH T
Sbjct: 114 GLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTR 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-08
Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 18/110 (16%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS-RISPVEGGTHMSTTIAGTAGF 108
L YL + KH +I RD+K +NILL+ KL DFG S R+ V+ T AG A +
Sbjct: 127 LHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAK--TRSAGCAAY 180
Query: 109 LNTELTE----------KSDVDSFEIVILEIITGILTVDLSFKGEFDIIS 148
+ E + ++DV S I ++E+ TG K EF++++
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC-KTEFEVLT 229
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-08
Identities = 36/99 (36%), Positives = 50/99 (50%), Gaps = 25/99 (25%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT--A 106
LEYLH L +I RD+K +N+L+N Q KL DFG S ++ ++A T A
Sbjct: 115 ALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--------GYLVDSVAKTIDA 164
Query: 107 GF--------LNTELTE-----KSDVDSFEIVILEIITG 132
G +N EL + KSDV S I ++E+ TG
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-08
Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 24/114 (21%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMST--TIAG 104
GL+YLH+ + I+ RD+K N+LL+ + K+ADFG + EG T G
Sbjct: 111 VLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCG 163
Query: 105 TAGFLNTE-LTEKS---DVD--SFEIVILEIITGILTVDLSFKGE-----FDII 147
T FL E LTE S VD ++I E++ G + F G+ FD I
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG----ESPFPGDDEEEVFDSI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-08
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 12/90 (13%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
L+Y+H K +I RD+K+ NIL+ KL DFG + + + + +T GT ++
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFVGTPYWM 168
Query: 110 NTE-LTE------KSDVDSFEIVILEIITG 132
E +TE K+D+ S I I E+ TG
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-07
Identities = 24/46 (52%), Positives = 26/46 (56%), Gaps = 6/46 (13%)
Query: 45 VCCP---GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS 87
VC GL YLH+ K I RD+K NILL E KLADFG S
Sbjct: 106 VCRETLKGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-07
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 10/88 (11%)
Query: 50 LEYLHQGL--KHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAG 107
L H + ++ RD+K NI L+ KL DFG ++I + + + T GT
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGTPY 175
Query: 108 FLNTEL------TEKSDVDSFEIVILEI 129
+++ E EKSD+ S +I E+
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-07
Identities = 24/57 (42%), Positives = 31/57 (54%), Gaps = 5/57 (8%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTHMSTT 101
GL + H H I+ RD+K N+L+N + KLADFG +R SPV TH T
Sbjct: 108 LQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT 161
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-07
Identities = 19/41 (46%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89
G+++LH H I+ RD+K NIL+ Q K+ADFG +RI
Sbjct: 119 GVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-07
Identities = 38/123 (30%), Positives = 56/123 (45%), Gaps = 16/123 (13%)
Query: 14 LVELIGKQKNNALELGFRGNPELVDQQGKEEVCCPGLEYLHQGLKHPIIQRDMKSTNILL 73
L+E + AL+L P+L+D + G+ YL I RD+ + N+L+
Sbjct: 88 LLEYLQGGAGRALKL-----PQLIDMAAQ---VASGMAYLEA---QNYIHRDLAARNVLV 136
Query: 74 NEKVQAKLADFGQSRI---SPVEGGTHMSTTIAGTA--GFLNTELTEKSDVDSFEIVILE 128
E K+ADFG +R+ E I TA L + KSDV SF I++ E
Sbjct: 137 GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTE 196
Query: 129 IIT 131
I+T
Sbjct: 197 IVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-07
Identities = 36/103 (34%), Positives = 48/103 (46%), Gaps = 11/103 (10%)
Query: 34 PELVDQQGKEEVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR-ISPV 92
P+LVD + G+ YL I RD+ + NIL+ E + K+ADFG +R I
Sbjct: 103 PQLVDMAAQ---IAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156
Query: 93 EGGTHMSTT--IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
E I TA T KSDV SF I++ EI+T
Sbjct: 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 3e-07
Identities = 19/40 (47%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL YLH+ + +I RD+K NILL + + KL DFG S
Sbjct: 125 GLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-07
Identities = 32/91 (35%), Positives = 43/91 (47%), Gaps = 20/91 (21%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI-SPVEGGTHMSTTIAGTAG 107
GL YLH H I RD+K+ NILL E KLADFG + + SP + + GT
Sbjct: 127 GLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTPY 176
Query: 108 FLNTEL---------TEKSDVDSFEIVILEI 129
++ E+ K DV S I +E+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-07
Identities = 30/90 (33%), Positives = 40/90 (44%), Gaps = 15/90 (16%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G+E LHQ II RD+K N+L+++ KL DFG SR + GT +
Sbjct: 109 GVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDY 159
Query: 109 LNTEL------TEKSDVDSFEIVILEIITG 132
L E + SD S VI E + G
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-07
Identities = 21/58 (36%), Positives = 34/58 (58%), Gaps = 6/58 (10%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI---SPVEGGTHMSTTIA 103
GL+Y+H +I RD+K +N+L+NE + ++ DFG +R SP E M+ +A
Sbjct: 119 GLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-07
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 16/92 (17%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH--MSTTIAGTA 106
GL YL + KH I+ RD+K +NIL+N + + KL DFG V G M+ + GT
Sbjct: 111 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG------VSGQLIDSMANSFVGTR 162
Query: 107 GFLNTE------LTEKSDVDSFEIVILEIITG 132
+++ E T +SD+ S + ++E+ G
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 5e-07
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 15/96 (15%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
+V LEYLH I+ RD+K N+LL+ K+ DFG ++ V+G T+ T+
Sbjct: 109 QVVL-ALEYLHS--LD-IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTY---TLC 159
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITGI 133
GT +L E+ VD + I+I E++ G
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-07
Identities = 39/146 (26%), Positives = 61/146 (41%), Gaps = 24/146 (16%)
Query: 8 KLTGPLLVELIG---KQK----------NNALELGFRGNPELVDQQGKEEVC---CPGLE 51
KL+ P LV+L G KQ+ N L R + + ++C C +E
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME 114
Query: 52 YLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRIS-----PVEGGTHMSTTIAGTA 106
YL + I RD+ + N L+ E K++DFG +R GT A
Sbjct: 115 YLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPE 171
Query: 107 GFLNTELTEKSDVDSFEIVILEIITG 132
F + + KSDV SF +++ E+ +
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 6e-07
Identities = 18/41 (43%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89
G+ YLH+ H I+ RD+K+ NIL++ + K+ADFG +R
Sbjct: 127 GINYLHE--NH-ILHRDIKAANILIDNQGILKIADFGLARP 164
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-07
Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 24/111 (21%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI---------SPVEGGTHMS 99
G+ YLH + I+ RD+K +N+L+N K+ADFG SRI S V +MS
Sbjct: 180 GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMS 236
Query: 100 TTIAGTAGFLNTELTE------KSDVDSFEIVILEIITGILTVDLSFKGEF 144
+NT+L D+ S + ILE G + +G++
Sbjct: 237 PE------RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW 281
|
Length = 353 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 1e-06
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 12/89 (13%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
EYLH II RD+K N+LL+ KL DFG ++ T T GT ++
Sbjct: 106 FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYV 159
Query: 110 NTELTEK------SDVDSFEIVILEIITG 132
E+ D S I++ E++TG
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-06
Identities = 27/92 (29%), Positives = 41/92 (44%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG---------QSRISPVEGGTH 97
L +LH H +I RD+K+ NILL KLADFG Q R + +
Sbjct: 113 LEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYW 169
Query: 98 MSTTIAGTAGFLNTELTEKSDVDSFEIVILEI 129
M+ + F + K+D+ S I ++E+
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-06
Identities = 23/42 (54%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRIS 90
GL YLH H +I RD+K+ NILL E Q KLADFG + S
Sbjct: 133 GLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-06
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 15/93 (16%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTHMSTTIAG 104
C G++++H + ++ RD+KS NI L + + KL DFG +R+ SP + T G
Sbjct: 110 CLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA----YACTYVG 162
Query: 105 TAGFLNTELTE------KSDVDSFEIVILEIIT 131
T ++ E+ E KSD+ S ++ E+ T
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-06
Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 24/97 (24%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT--AG 107
L YL + LK II RD+K +NILL+ KL DFG IS + +IA T AG
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFG---IS-----GQLVDSIAKTRDAG 169
Query: 108 F--------LNTELTE----KSDVDSFEIVILEIITG 132
++ + +SDV S I + E+ TG
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-06
Identities = 16/40 (40%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
G+ +LH + I+ RD+K++N+LLN + K+ DFG +R
Sbjct: 118 GVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-06
Identities = 27/75 (36%), Positives = 42/75 (56%), Gaps = 6/75 (8%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
EV L +LH+ H +I RD+K NILL+ + KLADFG + + G T +TT
Sbjct: 104 EVTL-ALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFC 157
Query: 104 GTAGFLNTELTEKSD 118
GT ++ E+ ++ +
Sbjct: 158 GTPDYIAPEILQELE 172
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-06
Identities = 22/41 (53%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89
GL Y H K + RD+K +NILLN K Q KLADFG +R+
Sbjct: 128 GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-06
Identities = 20/40 (50%), Positives = 29/40 (72%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL+YLH+ + II RD+K +N+LL +K K+ADFG +R
Sbjct: 120 GLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-06
Identities = 27/87 (31%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISP--VEGGTHMSTTIAG 104
C G+EYL + + RD+ + N+L++E + AK++DFG ++ + + G +
Sbjct: 112 CEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG---KLPVKW 165
Query: 105 TA--GFLNTELTEKSDVDSFEIVILEI 129
TA + + KSDV SF I++ EI
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-06
Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 11/92 (11%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YLH I+ RD+K+ N+L++ K++DFG S+ S + ++ G+ +
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 109 LNTEL--------TEKSDVDSFEIVILEIITG 132
+ E+ + K D+ S V+LE+ G
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 3e-06
Identities = 20/39 (51%), Positives = 27/39 (69%), Gaps = 3/39 (7%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
L+Y+H G +I RD+K +NILLN + KLADFG +R
Sbjct: 120 LKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-06
Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 13/89 (14%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNE-KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
L ++H I+ RD+K+ NILL++ K+ K+ DFG IS + + T+ GT +
Sbjct: 114 LHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFG---ISKILSSKSKAYTVVGTPCY 167
Query: 109 LNTELTE------KSDVDSFEIVILEIIT 131
++ EL E KSD+ + V+ E+ +
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-06
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 15/93 (16%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTHMSTTIAG 104
C L+++H I+ RD+KS NI L + KL DFG +R+ S VE ++ T G
Sbjct: 111 CLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE----LARTCIG 163
Query: 105 TAGFLNTELTE------KSDVDSFEIVILEIIT 131
T +L+ E+ E KSD+ + V+ E+ T
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-06
Identities = 28/90 (31%), Positives = 50/90 (55%), Gaps = 11/90 (12%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL++LH+ II RD+K N+LL+ + K+ADFG + + G T ++T GT +
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDY 162
Query: 109 LNTE-LTEKS---DVD--SFEIVILEIITG 132
+ E L+ + VD + +++ E++ G
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 4e-06
Identities = 25/44 (56%), Positives = 29/44 (65%), Gaps = 4/44 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI-SP 91
GL YLH H +I RD+K+ NILL E Q KLADFG + I SP
Sbjct: 137 GLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-06
Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ C GL++LH K II RD+K N+LL++ K+ADFG + + G ++T
Sbjct: 104 EIIC-GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFC 157
Query: 104 GTAGFLNTEL------TEKSDVDSFEIVILEIITG 132
GT ++ E+ E D SF +++ E++ G
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-06
Identities = 32/88 (36%), Positives = 46/88 (52%), Gaps = 15/88 (17%)
Query: 56 GLKH----PIIQRDMKSTNILL--NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
GLKH I+ RD+KS NI L N V AKL DFG +R + ++ T GT +L
Sbjct: 113 GLKHIHDRKILHRDIKSQNIFLSKNGMV-AKLGDFGIARQ--LNDSMELAYTCVGTPYYL 169
Query: 110 NTELTE------KSDVDSFEIVILEIIT 131
+ E+ + K+D+ S V+ E+ T
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-06
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 18/91 (19%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YLH II RD+K+ NI +N+ Q + D G ++ V G AG
Sbjct: 169 GLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA------PAFLGLAGT 219
Query: 109 LNTELTE---------KSDVDSFEIVILEII 130
+ T E K+D+ S IV+ E++
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-06
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS-RISPVEGGTHMSTTIAGTAG 107
G+EYLH + I+ RD+K NIL + KL DFG S R+ + ++ GT
Sbjct: 116 GVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 108 FLNTELT------EKSDVDSFEIVILEIIT 131
+++ E+ K+DV S ++E++T
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-06
Identities = 18/40 (45%), Positives = 24/40 (60%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GLEYLH + RD+K NIL++ KLADFG ++
Sbjct: 114 GLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-06
Identities = 23/49 (46%), Positives = 30/49 (61%), Gaps = 3/49 (6%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH 97
GL Y H K I+ RD+K N+L+NEK + KLADFG +R V T+
Sbjct: 115 GLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-06
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 11/91 (12%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
+ Y+H K I+ RD+K+ NI L + KL DFG S+I E M+ T+ GT
Sbjct: 111 VSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE--YSMAETVVGTP 165
Query: 107 GFLNTELTE------KSDVDSFEIVILEIIT 131
+++ EL + KSD+ + V+ E++T
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-06
Identities = 29/76 (38%), Positives = 42/76 (55%), Gaps = 7/76 (9%)
Query: 62 IQRDMKSTNILLNEKVQAKLADFGQSRI------SPVEGGTHMSTTIAGTAGFLNTELTE 115
I RD+++ NIL++E + K+ADFG +R+ + EG A A T T
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTI 182
Query: 116 KSDVDSFEIVILEIIT 131
KSDV SF I++ EI+T
Sbjct: 183 KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-06
Identities = 18/41 (43%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRIS 90
L+YLH+ H II RD+K N+L++ + KL DFG S+++
Sbjct: 117 LDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-06
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 13/95 (13%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
++ C GLE+LHQ I+ RD+K N+LL++ +++D G + A
Sbjct: 103 QIIC-GLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---A 155
Query: 104 GTAGFLNTELTEK----SDVDSFEI--VILEIITG 132
GT G++ E+ + VD F + + E+I G
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-06
Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 11/88 (12%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
L+YLH+ KH I+ RD+K+ N+ L K+ D G +R+ +E M++T+ GT ++
Sbjct: 115 LQYLHE--KH-ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYM 169
Query: 110 NTEL------TEKSDVDSFEIVILEIIT 131
+ EL KSDV + + E+ T
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-06
Identities = 25/87 (28%), Positives = 47/87 (54%), Gaps = 6/87 (6%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
G+EYL ++ RD+ + NIL++E AK++DFG +R+ G + + TA
Sbjct: 110 AEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGS-MGVDNSKLPVKWTA 165
Query: 107 --GFLNTELTEKSDVDSFEIVILEIIT 131
+ + + KSDV S+ +++ E+ +
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-05
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 13/94 (13%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG-QSRISPVEGGTHMSTTIAG 104
C LE+LH + +I RD+KS NILL KL DFG ++I+P + +T+ G
Sbjct: 124 CLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVG 177
Query: 105 TAGFLNTELTE------KSDVDSFEIVILEIITG 132
T ++ E+ K D+ S I+ +E++ G
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-05
Identities = 34/90 (37%), Positives = 48/90 (53%), Gaps = 13/90 (14%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGG-THMSTTIAGTAGF 108
LE+LHQ II RD+K NILL+ + KL DFG + S EG TH T GT +
Sbjct: 113 LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH---TFCGTIEY 166
Query: 109 LNTELTEKS----DVD--SFEIVILEIITG 132
+ E+ +S VD S ++ +++TG
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-05
Identities = 18/57 (31%), Positives = 30/57 (52%), Gaps = 3/57 (5%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
G+ Y+H + I+ RD+K N+L++ K+ADFG +R+ E S +A
Sbjct: 109 LKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-05
Identities = 25/72 (34%), Positives = 39/72 (54%), Gaps = 5/72 (6%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GLE+LHQ II RD+K N+LL+ +++D G + ++ G + AGT GF
Sbjct: 109 GLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGF 163
Query: 109 LNTELTEKSDVD 120
+ EL + + D
Sbjct: 164 MAPELLQGEEYD 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-05
Identities = 18/41 (43%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89
GL+Y+H ++ RD+K +NIL+NE K+ DFG +RI
Sbjct: 120 GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-05
Identities = 20/53 (37%), Positives = 29/53 (54%), Gaps = 5/53 (9%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTH 97
G+ Y H H ++ RD+K N+L++ + KLADFG +R PV TH
Sbjct: 109 LQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-05
Identities = 31/95 (32%), Positives = 45/95 (47%), Gaps = 16/95 (16%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL +LHQ H +I RD+K N+LL E + KL DFG S + ++ T GT +
Sbjct: 123 GLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYW 177
Query: 109 LNTELTE-----------KSDVDSFEIVILEIITG 132
+ E+ KSD+ S I +E+ G
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 2e-05
Identities = 16/40 (40%), Positives = 24/40 (60%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL ++H KH RD+K N+L++ K+ADFG +R
Sbjct: 111 GLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-05
Identities = 27/73 (36%), Positives = 40/73 (54%), Gaps = 5/73 (6%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL+YLH K I RD+K+ N+LL+E+ KLADFG + + T GT +
Sbjct: 113 GLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFW 167
Query: 109 LNTELTEKSDVDS 121
+ E+ ++S DS
Sbjct: 168 MAPEVIQQSAYDS 180
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-05
Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 12/90 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YL + KH I+ RD+K +NIL+N + + KL DFG S + M+ + GT +
Sbjct: 115 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSY 168
Query: 109 LN------TELTEKSDVDSFEIVILEIITG 132
++ T + +SD+ S + ++E+ G
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-05
Identities = 18/40 (45%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL Y HQ ++ RD+K N+L++E+ + KLADFG +R
Sbjct: 115 GLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-05
Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 12/90 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YL + KH I+ RD+K +NIL+N + + KL DFG S + M+ + GT +
Sbjct: 115 GLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSY 168
Query: 109 LN------TELTEKSDVDSFEIVILEIITG 132
++ T + +SD+ S + ++E+ G
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 17/96 (17%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT------I 102
GL YLH II RD+K NIL++ K K++DFG S+ +E + + T +
Sbjct: 118 GLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGARPSL 172
Query: 103 AGTAGFLNTEL------TEKSDVDSFEIVILEIITG 132
G+ ++ E+ T K+D+ S +++E++TG
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 33/91 (36%), Positives = 45/91 (49%), Gaps = 13/91 (14%)
Query: 55 QGLK-----HPIIQRDMKSTNILLNEKVQAKLADFGQS-----RISPVEGG--THMSTT- 101
+GLK H II RD+K TN+L+N Q KL DFG S ++ G ++M+
Sbjct: 113 KGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPER 172
Query: 102 IAGTAGFLNTELTEKSDVDSFEIVILEIITG 132
I N T +SDV S + ILE+ G
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-05
Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 15/101 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
L++LH L II RD+K NILL+E+ KL DFG S+ S + + GT +
Sbjct: 110 ALDHLH-SLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEY 164
Query: 109 LNTEL------TEKSDVDSFEIVILEIITGILTVDLSFKGE 143
+ E+ T+ +D SF +++ E++TG L F+G+
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG----SLPFQGK 201
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-05
Identities = 28/92 (30%), Positives = 38/92 (41%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEG-----GTHMSTT 101
G+ YL K I RD+ + NILL + K+ DFG R P H+
Sbjct: 107 ANGMRYLES--KR-FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP 163
Query: 102 IAGTA-GFLNT-ELTEKSDVDSFEIVILEIIT 131
A A L T + SDV F + + E+ T
Sbjct: 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-05
Identities = 20/41 (48%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89
GL++LH H ++ RD+K NIL+ Q KLADFG +RI
Sbjct: 122 GLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-05
Identities = 21/41 (51%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89
GL YLH H +I RD+K+ NILL+E KL DFG + I
Sbjct: 127 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-05
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 13/91 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G++YL + + RD+ + NIL+N + K++DFG SR T+ TT G
Sbjct: 118 GMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY--TTKGGKIPI 172
Query: 109 LNT--------ELTEKSDVDSFEIVILEIIT 131
T + T SDV SF IV+ E+++
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-05
Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 11/103 (10%)
Query: 34 PELVDQQGKEEVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI---- 89
P LVD + G+ Y+ + I RD++S NIL+ + + K+ADFG +R+
Sbjct: 102 PNLVDMAAQ---VAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155
Query: 90 -SPVEGGTHMSTTIAGTAGFLNTELTEKSDVDSFEIVILEIIT 131
G L T KSDV SF I++ E++T
Sbjct: 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-05
Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 12/87 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G+ Y+HQ I+ RD+K+ NI L + K+ DFG SR+ + G ++TT GT +
Sbjct: 118 GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYY 171
Query: 109 LNTELTE------KSDVDSFEIVILEI 129
++ E + KSD+ S ++ E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-05
Identities = 20/54 (37%), Positives = 32/54 (59%), Gaps = 3/54 (5%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTI 102
GL Y H + ++ RD+K N+L+NE+ + KLADFG +R V T+ + +
Sbjct: 116 GLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV 166
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-05
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ C GL++LH II RD+K N++L+ K+ADFG + + G + ++T
Sbjct: 104 EIVC-GLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFC 157
Query: 104 GTAGFLNTEL------TEKSDVDSFEIVILEIITG 132
GT ++ E+ T D SF +++ E++ G
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-05
Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 13/90 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YL LK I+ RD+K +N+L+N + Q KL DFG S + ++ T GT +
Sbjct: 107 GLTYL-WSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAY 159
Query: 109 LNTE--LTEK----SDVDSFEIVILEIITG 132
+ E E+ SDV S I +E+ G
Sbjct: 160 MAPERISGEQYGIHSDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-05
Identities = 20/41 (48%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89
GL++LH I+ RD+K NIL+ Q KLADFG +RI
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-05
Identities = 31/93 (33%), Positives = 42/93 (45%), Gaps = 11/93 (11%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR-----ISPVEGGTHMSTT 101
G+EYL I RD+ + N L+ E K++DFG SR I V G
Sbjct: 103 AAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK-QIP 158
Query: 102 IAGTA-GFLNT-ELTEKSDVDSFEIVILEIITG 132
I TA LN T +SDV S+ I++ E +
Sbjct: 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-05
Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 11/91 (12%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
L YLH ++ RD+K N++L++ K+ DFG + +G T T GT +L
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 162
Query: 110 NTELTEKSD----VD--SFEIVILEIITGIL 134
E+ E +D VD +V+ E++ G L
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-05
Identities = 40/145 (27%), Positives = 63/145 (43%), Gaps = 24/145 (16%)
Query: 8 KLTGPLLVELIGKQKNNA---LELGFRGNPELVD----QQGK------EEVC---CPGLE 51
KL+ P LV+L G + L F + L D Q+GK +C C G+
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA 114
Query: 52 YLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRIS-----PVEGGTHMSTTIAGTA 106
YL +I RD+ + N L+ E K++DFG +R GT +
Sbjct: 115 YLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE 171
Query: 107 GFLNTELTEKSDVDSFEIVILEIIT 131
F ++ + KSDV SF +++ E+ +
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-05
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 11/103 (10%)
Query: 34 PELVDQQGKEEVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI---- 89
P+LVD + G+ Y+ + I RD+++ NIL+ + + K+ADFG +R+
Sbjct: 102 PQLVDMAAQ---IADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155
Query: 90 -SPVEGGTHMSTTIAGTAGFLNTELTEKSDVDSFEIVILEIIT 131
G L T KSDV SF I++ E++T
Sbjct: 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-05
Identities = 17/40 (42%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL + H H ++ RD+K N+L+N+ + KLADFG +R
Sbjct: 111 GLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 5e-05
Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 9/89 (10%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR------ISPVEGGTHMSTTI 102
G+ YL + RD+ + N L+ + K+ADFG SR V+G +
Sbjct: 142 GMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRW 198
Query: 103 AGTAGFLNTELTEKSDVDSFEIVILEIIT 131
L + T KSDV +F + + EI+T
Sbjct: 199 MAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-05
Identities = 27/98 (27%), Positives = 48/98 (48%), Gaps = 15/98 (15%)
Query: 44 EVC---CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR-------ISPVE 93
E+C C G+ YL I RD+ + N L++++ K++DFG SR S V
Sbjct: 104 EMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV- 159
Query: 94 GGTHMSTTIAGTAGFLNTELTEKSDVDSFEIVILEIIT 131
G+ + L ++ + KSDV +F +++ E+ +
Sbjct: 160 -GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-05
Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 16/99 (16%)
Query: 41 GKEEVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMST 100
E VC LEYLH I+ RD+K NILL+++ KL DFG ++ + T
Sbjct: 107 ASEIVC--ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTW--- 156
Query: 101 TIAGTAGFLNTELTEKSD----VD--SFEIVILEIITGI 133
T+ GT +L E+ + VD + I+I E++ G
Sbjct: 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-05
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL+YLH K I RD+K+ N+LL+E+ KLADFG + + T GT +
Sbjct: 113 GLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFW 167
Query: 109 LNTELTEKSDVDSFEIVILEIITGILTVDLSFKGE 143
+ E+ ++S D F+ I + GI ++L+ KGE
Sbjct: 168 MAPEVIKQSAYD-FKADIWSL--GITAIELA-KGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-05
Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 28/147 (19%)
Query: 8 KLTGPLLVELIG---KQKNNALELGFRGNPELVD----QQGK------EEVC---CPGLE 51
KL+ P LV+L G +QK + F N L++ +QGK +C C G+E
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME 114
Query: 52 YLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR-------ISPVEGGTHMSTTIAG 104
YL + + I RD+ + N L++ K++DFG +R S G +
Sbjct: 115 YLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS--SSGAKFPVKWSP 169
Query: 105 TAGFLNTELTEKSDVDSFEIVILEIIT 131
F ++ + KSDV SF +++ E+ T
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-05
Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 34 PELVDQQGKEEVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI---- 89
P+L+D + G+ Y+ + I RD+++ N+L++E + K+ADFG +R+
Sbjct: 103 PKLIDFSAQ---IAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156
Query: 90 --SPVEGGTHMSTTIAGTAGFLNTELTEKSDVDSFEIVILEIIT 131
+ EG A A + T KSDV SF I++ EI+T
Sbjct: 157 EYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-05
Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 16/92 (17%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAG---- 104
+EYL K I RD+ + N L+ E K+ADFG SR+ + G T+ T AG
Sbjct: 116 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTY--TAHAGAKFP 168
Query: 105 ---TA--GFLNTELTEKSDVDSFEIVILEIIT 131
TA + + KSDV +F +++ EI T
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-05
Identities = 33/123 (26%), Positives = 54/123 (43%), Gaps = 16/123 (13%)
Query: 14 LVELIGKQKNNALELGFRGNPELVDQQGKEEVCCPGLEYLHQGLKHPIIQRDMKSTNILL 73
L++ + + L L P+LVD + G+ Y+ + + RD+++ NIL+
Sbjct: 87 LLDFLKGEMGKYLRL-----PQLVDMAAQ---IASGMAYVE---RMNYVHRDLRAANILV 135
Query: 74 NEKVQAKLADFGQSRI-----SPVEGGTHMSTTIAGTAGFLNTELTEKSDVDSFEIVILE 128
E + K+ADFG +R+ G L T KSDV SF I++ E
Sbjct: 136 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 195
Query: 129 IIT 131
+ T
Sbjct: 196 LTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-05
Identities = 19/54 (35%), Positives = 32/54 (59%), Gaps = 3/54 (5%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTI 102
GL Y H + ++ RD+K N+L+NE+ + KLADFG +R + T+ + +
Sbjct: 116 GLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV 166
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-05
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 9/60 (15%)
Query: 52 YLHQGLK-------HPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTHMSTTI 102
YL Q L+ H ++ RD+K N+L+N + KLADFG +R PV TH T+
Sbjct: 105 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 7e-05
Identities = 19/51 (37%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMS 99
GL+YLH I+ RD+K N+L+N K+ DFG +R+ + HM+
Sbjct: 115 GLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-05
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ C GL++LH I+ RD+K NILL+ K+ADFG + + + G + T
Sbjct: 104 EIIC-GLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFC 157
Query: 104 GTAGFLNTE--LTEK--SDVD--SFEIVILEIITG 132
GT ++ E L +K + VD SF +++ E++ G
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 7e-05
Identities = 19/57 (33%), Positives = 28/57 (49%), Gaps = 3/57 (5%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
+ Y H H II RD+K NIL++E KL DFG +R + ++ +A
Sbjct: 110 LQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA 163
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-05
Identities = 31/123 (25%), Positives = 55/123 (44%), Gaps = 16/123 (13%)
Query: 14 LVELIGKQKNNALELGFRGNPELVDQQGKEEVCCPGLEYLHQGLKHPIIQRDMKSTNILL 73
L++ + + + L P+L+D + G+ ++ Q I RD+++ NIL+
Sbjct: 87 LLDFLKSDEGSKQPL-----PKLIDFSAQ---IAEGMAFIEQ---RNYIHRDLRAANILV 135
Query: 74 NEKVQAKLADFGQSRI-----SPVEGGTHMSTTIAGTAGFLNTELTEKSDVDSFEIVILE 128
+ + K+ADFG +R+ G T KSDV SF I+++E
Sbjct: 136 SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLME 195
Query: 129 IIT 131
I+T
Sbjct: 196 IVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-05
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 12/90 (13%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
LE+LH K+ I+ RD+K NILL+ L DFG S+ + + T + T GT +L
Sbjct: 109 LEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 110 NTEL-------TEKSDVDSFEIVILEIITG 132
E+ T+ D S +++ E+ G
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 9e-05
Identities = 33/107 (30%), Positives = 49/107 (45%), Gaps = 11/107 (10%)
Query: 33 NPELVDQQGKEEVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR---- 88
NP + D G G+EYL + RD+ + N +L+E K+ADFG +R
Sbjct: 94 NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYD 150
Query: 89 --ISPVEGGTHMSTTIAGTA-GFLNTE-LTEKSDVDSFEIVILEIIT 131
V T + A L T+ T KSDV SF +++ E++T
Sbjct: 151 KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 9e-05
Identities = 34/101 (33%), Positives = 47/101 (46%), Gaps = 17/101 (16%)
Query: 44 EVCCPGLEYLH-QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTI 102
EV LEYLH G I+ RD+K NILL+E L+DF S+ S VE
Sbjct: 111 EVLL-ALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165
Query: 103 AGTAG-FLNTELTE-KSDVDSF---------EIVILEIITG 132
G+ +N+ +E S+ SF E + E+I+G
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 1e-04
Identities = 19/39 (48%), Positives = 24/39 (61%), Gaps = 3/39 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS 87
GL +LH H +I RD+K N+LL E + KL DFG S
Sbjct: 133 GLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 1e-04
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 14/93 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQA-KLADFGQSRISPVEGGTHMSTTIAGTAG 107
GL+YLH + I+ RD+K N+L+N K++DFG S+ + G + T GT
Sbjct: 120 GLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTGTLQ 174
Query: 108 FLNTELTEK--------SDVDSFEIVILEIITG 132
++ E+ +K +D+ S I+E+ TG
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 30/79 (37%), Positives = 37/79 (46%), Gaps = 10/79 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMST--T 101
E+ L YLH L II RD+K NILL+ + L DFG + EG H T T
Sbjct: 104 EIAS-ALGYLH-SLN--IIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTST 155
Query: 102 IAGTAGFLNTELTEKSDVD 120
GT +L E+ K D
Sbjct: 156 FCGTPEYLAPEVLRKQPYD 174
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 1e-04
Identities = 23/65 (35%), Positives = 37/65 (56%), Gaps = 5/65 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL +LH + II RD+K N++L+ + K+ADFG + V+G T + T GT +
Sbjct: 113 GLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDY 167
Query: 109 LNTEL 113
+ E+
Sbjct: 168 IAPEI 172
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 1e-04
Identities = 19/40 (47%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL Y+H ++ I+ RDMK+ NIL+ + KLADFG +R
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 1e-04
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 12/91 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS-RISPV-EGGTHMSTTIAGTA 106
G+ YLH + I+ RD+K NIL + KL DFG S RI + GT + ++ GT
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK-SVTGTP 173
Query: 107 GFLNTELT------EKSDVDSFEIVILEIIT 131
+++ E+ K+DV S ++E++T
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 1e-04
Identities = 20/53 (37%), Positives = 30/53 (56%), Gaps = 4/53 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRIS-PVEGGTHMST 100
GL+Y+H ++ RD+K +N+LLN K+ DFG +RI+ P T T
Sbjct: 118 GLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 1e-04
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 12/91 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS-RISPV-EGGTHMSTTIAGTA 106
G+ YLH + I+ RD+K NIL + KL DFG S R+ + GT + ++ GT
Sbjct: 118 GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR-SVTGTP 173
Query: 107 GFLNTELT------EKSDVDSFEIVILEIIT 131
+++ E+ K+DV S ++E++T
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 1e-04
Identities = 17/47 (36%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGG 95
GL+Y+H ++ RD+K +N+LLN K+ DFG +R + +G
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 1e-04
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 15/94 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMST--TIAGTA 106
L+YLH G I+ RD+K N++L++ K+ DFG + EG T +T T GT
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTP 159
Query: 107 GFLNTELTEKSD----VD--SFEIVILEIITGIL 134
+L E+ E +D VD +V+ E++ G L
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
C G+EYL ++ + RD+ + NIL+ + + K+ DFG +++ P + + +
Sbjct: 118 CKGMEYL-GSKRY--VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174
Query: 107 GFLNT--ELTE-----KSDVDSFEIVILEIIT 131
F LTE SDV SF +V+ E+ T
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 2e-04
Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 44/155 (28%)
Query: 50 LEYLH-QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQ------SRISPVEGGTHMSTTI 102
++Y+H +G II RD+K+ N+L+N L DFG S +P G I
Sbjct: 273 IDYIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG------I 322
Query: 103 AGTAGFLNTELTEKSDVDSFEIVILEIITGILTVDLSFKGEFDIISVEKAVEIA-MASVS 161
AGT D ++ E++ + T +VD+ G ++ E AV A + S S
Sbjct: 323 AGTV-----------DTNAPEVLAGDPYTP--SVDIWSAG---LVIFEAAVHTASLFSAS 366
Query: 162 SKVNRRPLMNQVVMVREQG----------SGSRIT 186
RRP Q++ + Q +GSR+
Sbjct: 367 RGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV 401
|
Length = 461 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 2e-04
Identities = 20/54 (37%), Positives = 32/54 (59%), Gaps = 3/54 (5%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTI 102
GL Y+HQ I+ RD+K N+L+++ + KLADFG +R V T+ + +
Sbjct: 115 GLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 2e-04
Identities = 30/86 (34%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G++YL Q I RD+ + NIL+ E AK+ADFG SR V M
Sbjct: 124 GMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 180
Query: 109 --LNTEL-TEKSDVDSFEIVILEIIT 131
LN + T SDV S+ +++ EI++
Sbjct: 181 ESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 2e-04
Identities = 18/41 (43%), Positives = 25/41 (60%), Gaps = 3/41 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89
GL+YLH +I RD+K +NIL+N K+ DFG +R
Sbjct: 115 GLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 2e-04
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 13/94 (13%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG-QSRISPVEGGTHMSTTIAG 104
C LE+LH + +I RD+KS N+LL KL DFG ++I+P + +T+ G
Sbjct: 124 CLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---KRSTMVG 177
Query: 105 TAGFLNTELTE------KSDVDSFEIVILEIITG 132
T ++ E+ K D+ S I+ +E++ G
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 2e-04
Identities = 24/84 (28%), Positives = 42/84 (50%), Gaps = 4/84 (4%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR-ISPVEGGTHMSTTIAGT 105
C +EYL + + RD+ + N+L++E AK++DFG ++ S + +
Sbjct: 112 CEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAP 168
Query: 106 AGFLNTELTEKSDVDSFEIVILEI 129
+ + KSDV SF I++ EI
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 19/58 (32%), Positives = 32/58 (55%), Gaps = 6/58 (10%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR---ISPVEGGTHMSTTIA 103
GL+Y+H ++ RD+K N+L+N + K+ DFG +R +P E M+ +A
Sbjct: 117 GLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 18/41 (43%), Positives = 25/41 (60%), Gaps = 3/41 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89
+ + H KH I RD+K NIL+ ++ Q KL DFG +RI
Sbjct: 112 AVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 21/134 (15%)
Query: 54 HQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL 113
H KH +I RD+KS NILL KL DFG S++ + T GT ++ E+
Sbjct: 158 HVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216
Query: 114 ------TEKSDVDSFEIVILEIIT------GILTVDLSFK---GEFD----IISVEKAVE 154
++K+D+ S +++ E++T G ++ K G +D IS E E
Sbjct: 217 WRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQ-E 275
Query: 155 IAMASVSSKVNRRP 168
I A +SS RRP
Sbjct: 276 IVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 15/40 (37%), Positives = 28/40 (70%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
G+ + H+ + ++ RD+K N+L+N++ + KLADFG +R
Sbjct: 112 GIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 2e-04
Identities = 27/72 (37%), Positives = 40/72 (55%), Gaps = 7/72 (9%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+CC GLE LHQ I+ RD+K NILL++ +++D G + P EG T
Sbjct: 110 EICC-GLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKGRV-- 162
Query: 104 GTAGFLNTELTE 115
GT G++ E+ +
Sbjct: 163 GTVGYMAPEVVK 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 2e-04
Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQ-AKLADFGQS--RISPVEGGTHMSTTIA 103
GL YLH+ + II RD+K N+L++ Q ++ADFG + + G +
Sbjct: 113 LRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169
Query: 104 GTAGFLNTELT------EKSDVDSFEIVILEIITG 132
GT F+ E+ DV S VI+E+ T
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 2e-04
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 6/86 (6%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G++YL + I RD+ + N+L+ E + +K+ADFG SR V M
Sbjct: 131 GMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAI 187
Query: 109 --LNTEL-TEKSDVDSFEIVILEIIT 131
LN + T KSDV SF +++ EI++
Sbjct: 188 ESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 2e-04
Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 10/85 (11%)
Query: 32 GNPELVDQQG---KEEVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GNP +Q+ E+CC GLE L + I+ RD+K NILL+++ +++D G +
Sbjct: 95 GNPGFDEQRAIFYAAELCC-GLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAV 150
Query: 89 ISPVEGGTHMSTTIAGTAGFLNTEL 113
P EG T GT G++ E+
Sbjct: 151 QIP-EGETVRGRV--GTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 3e-04
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 13/94 (13%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG-QSRISPVEGGTHMSTTIAG 104
C L++LH + +I RD+KS NILL KL DFG ++I+P + +T+ G
Sbjct: 124 CLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVG 177
Query: 105 TAGFLNTELTE------KSDVDSFEIVILEIITG 132
T ++ E+ K D+ S I+ +E++ G
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 16/40 (40%), Positives = 22/40 (55%), Gaps = 3/40 (7%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG 85
L +LH +I RD+KS +ILL + KL+DFG
Sbjct: 124 VLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 13/91 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL +LH II RD+K N++L+ + K+ADFG + + G T + T GT +
Sbjct: 113 GLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDY 167
Query: 109 LNTELT-----EKSDVD--SFEIVILEIITG 132
+ E+ KS VD +F +++ E++ G
Sbjct: 168 IAPEIIAYQPYGKS-VDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 3e-04
Identities = 27/75 (36%), Positives = 35/75 (46%), Gaps = 11/75 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YLH K + RD+K NILL + KLADFG S ++ TIA F
Sbjct: 118 GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS--------AQITATIAKRKSF 166
Query: 109 LNTELTEKSDVDSFE 123
+ T +V + E
Sbjct: 167 IGTPYWMAPEVAAVE 181
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 12/93 (12%)
Query: 47 CPGLEYLH-QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
C G++YL Q H RD+ + NIL+ + K++DFG +++ P + + +
Sbjct: 119 CKGMDYLGSQRYIH----RDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 106 AGF------LNT-ELTEKSDVDSFEIVILEIIT 131
F L T + + SDV SF + + E+ T
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 3e-04
Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTHMSTTIAGTA 106
G+ YL + I RD+ + NIL+ E + K+ADFG +R+ V + TA
Sbjct: 116 GMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA 172
Query: 107 --GFLNTELTEKSDVDSFEIVILEIIT 131
+ + KSDV SF I++ E+ T
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 4e-04
Identities = 20/37 (54%), Positives = 26/37 (70%), Gaps = 3/37 (8%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG 85
GL+YLH K I RD+K+ N+LL+E + KLADFG
Sbjct: 113 GLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFG 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 4e-04
Identities = 16/42 (38%), Positives = 25/42 (59%), Gaps = 4/42 (9%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
L+++H+ + I RD+K NIL+ + + KLADFG R
Sbjct: 110 LKSLDHMHR---NGIFHRDIKPENILIKDDI-LKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 4e-04
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 13/94 (13%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG-QSRISPVEGGTHMSTTIAG 104
C LE+LH + +I RD+KS NILL KL DFG ++I+P + +T+ G
Sbjct: 125 CLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVG 178
Query: 105 TAGFLNTELTE------KSDVDSFEIVILEIITG 132
T ++ E+ K D+ S I+ +E+I G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 4e-04
Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 13/92 (14%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
GL+ LH+ I+ RD+KS NILL K+ D G IS V M+ T GT
Sbjct: 113 LRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLG---ISKVLKKN-MAKTQIGTP 165
Query: 107 GFLNTEL------TEKSDVDSFEIVILEIITG 132
++ E+ + KSD+ S ++ E+ T
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 4e-04
Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 12/91 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR--ISPVEGGTHMSTTIAGTA 106
G+ YLH + I+ RD+K NIL + KL DFG S+ + GT M ++ GT
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK-SVTGTP 173
Query: 107 GFLNTELT------EKSDVDSFEIVILEIIT 131
+++ E+ K+D+ S ++E++T
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 4e-04
Identities = 30/108 (27%), Positives = 51/108 (47%), Gaps = 19/108 (17%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
C L +LH+ II RD+K N+LL+ KL D+G + G T ++T GT
Sbjct: 106 CIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTP 160
Query: 107 GFLNTELTEKSD----VD--SFEIVILEIITGILTVDLSFKGEFDIIS 148
++ E+ + VD + +++ E++ G + FDII+
Sbjct: 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAG--------RSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 4e-04
Identities = 22/78 (28%), Positives = 37/78 (47%), Gaps = 9/78 (11%)
Query: 31 RGNPELVDQQGKEEVC---CPGLEYLHQGLKHPIIQRDMKSTNILLN-EKVQAKLADFGQ 86
RG + + + G+ + H KH ++ RD+K N+L++ +K K+AD G
Sbjct: 101 RGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157
Query: 87 SR--ISPVEGGTHMSTTI 102
R PV+ TH T+
Sbjct: 158 GRAFSIPVKSYTHEIVTL 175
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 5e-04
Identities = 30/86 (34%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G++YL Q I RD+ + NIL+ E AK+ADFG SR V M
Sbjct: 136 GMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 192
Query: 109 --LNTEL-TEKSDVDSFEIVILEIIT 131
LN + T SDV S+ +++ EI++
Sbjct: 193 ESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 5e-04
Identities = 18/40 (45%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL+Y+H II RD+K +NI +NE + K+ DFG +R
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 6e-04
Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 11/89 (12%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
L +LH II RD+K N+LL+ + KLADFG + G T ++T GT ++
Sbjct: 109 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYI 163
Query: 110 NTELTEKS----DVD--SFEIVILEIITG 132
E+ ++ VD + +++ E++ G
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 6e-04
Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 12/91 (13%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
L++LHQ L II RD+K NILL+ + L DFG S+ + + + GT ++
Sbjct: 118 LDHLHQ-LG--IIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYM 173
Query: 110 NTELTEKSD------VD--SFEIVILEIITG 132
E+ VD S ++ E++TG
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 6e-04
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 14/92 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAG---- 104
G++YL + RD+ + NIL+N ++ K++DFG SR+ +E + T +G
Sbjct: 119 GMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRV--LEDDPEGTYTTSGGKIP 173
Query: 105 ---TA--GFLNTELTEKSDVDSFEIVILEIIT 131
TA + T SDV SF IV+ E+++
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 6e-04
Identities = 19/52 (36%), Positives = 32/52 (61%), Gaps = 3/52 (5%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMST 100
GL+Y+H II RD+K +N+ +NE + K+ DFG +R + E +++T
Sbjct: 132 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 180
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 7e-04
Identities = 36/144 (25%), Positives = 56/144 (38%), Gaps = 24/144 (16%)
Query: 9 LTGPLLVELIGKQKNNALE--------------LGFRGNPELVDQQGKEEVCCPGLEYLH 54
+ P +++L G N L + N + D E ++YLH
Sbjct: 140 INHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLH 199
Query: 55 QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTELT 114
+ + II RD+K+ NI +N L DFG + PV+ + AGT EL
Sbjct: 200 E---NRIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWAGTIATNAPELL 255
Query: 115 EKS------DVDSFEIVILEIITG 132
+ D+ S IV+ E+ T
Sbjct: 256 ARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 7e-04
Identities = 25/91 (27%), Positives = 44/91 (48%), Gaps = 11/91 (12%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
L YLH+ + I+ RD+ NI+L E + + DFG ++ E T++ GT
Sbjct: 123 VLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTI 177
Query: 107 GFLNTEL------TEKSDVDSFEIVILEIIT 131
+ E+ EK+DV +F ++ ++ T
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 8e-04
Identities = 22/57 (38%), Positives = 32/57 (56%), Gaps = 6/57 (10%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQA-KLADFGQSRI--SPVEGGTHMSTTI 102
G+ Y H H ++ RD+K N+L++ + A KLADFG +R PV TH T+
Sbjct: 114 GIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL 167
|
Length = 294 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 8e-04
Identities = 18/45 (40%), Positives = 27/45 (60%), Gaps = 3/45 (6%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVE 93
GL+Y+H II RD+K N+ +NE + K+ DFG +R + E
Sbjct: 129 GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 9e-04
Identities = 17/40 (42%), Positives = 22/40 (55%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL LH K + RD+ NI +N K K+ADFG +R
Sbjct: 131 GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.001
Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 12/93 (12%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAG-- 104
C G+ YLH +H I RD+ + N+LL+ K+ DFG ++ P EG + G
Sbjct: 117 CEGMAYLHS--QH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDGDS 172
Query: 105 ------TAGFLNTELTEKSDVDSFEIVILEIIT 131
+ + SDV SF + + E++T
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.001
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 15/93 (16%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMST--TIAGTAG 107
LEYLH ++ RD+K N++L++ K+ DFG + EG + +T T GT
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPE 160
Query: 108 FLNTELTEKSD----VD--SFEIVILEIITGIL 134
+L E+ E +D VD +V+ E++ G L
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.001
Identities = 24/63 (38%), Positives = 31/63 (49%), Gaps = 11/63 (17%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YLH K + RD+K NILL + KLADFG + ++ TIA F
Sbjct: 118 GLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA--------AKITATIAKRKSF 166
Query: 109 LNT 111
+ T
Sbjct: 167 IGT 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.001
Identities = 18/40 (45%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
G+E+ H H II RD+K NIL+++ KL DFG +R
Sbjct: 112 GIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.001
Identities = 30/96 (31%), Positives = 43/96 (44%), Gaps = 23/96 (23%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH-----MSTT-- 101
G+E+L I RD+ + N+L+ E K+ADFG +R H TT
Sbjct: 144 GMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR------DIHHIDYYRKTTNG 194
Query: 102 ------IAGTAGFLNTELTEKSDVDSFEIVILEIIT 131
+A A F T +SDV SF +++ EI T
Sbjct: 195 RLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.001
Identities = 26/92 (28%), Positives = 44/92 (47%), Gaps = 15/92 (16%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPV-------EGGTHMSTT 101
G+ YL + ++ RD+ + N+L+ K+ DFG +++ V EGG
Sbjct: 121 GMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG---KVP 174
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I A L+ T KSDV S+ + + E++T
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.001
Identities = 28/95 (29%), Positives = 40/95 (42%), Gaps = 21/95 (22%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH----------- 97
G+EYL I RD+ + N+L+ E K+ADFG +R G H
Sbjct: 146 GMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLAR------GVHDIDYYKKTSNG 196
Query: 98 -MSTTIAGTAGFLNTELTEKSDVDSFEIVILEIIT 131
+ + T +SDV SF I++ EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.001
Identities = 29/95 (30%), Positives = 39/95 (41%), Gaps = 21/95 (22%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG------------QSRISPVEGGT 96
G+EYL I RD+ + N +LNE + +ADFG Q RI+
Sbjct: 124 GMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA------ 174
Query: 97 HMSTTIAGTAGFLNTELTEKSDVDSFEIVILEIIT 131
M + T KSDV SF + + EI T
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.001
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 10/85 (11%)
Query: 32 GNPELVDQQG---KEEVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GNP +++ E+ C GLE LH+ + RD+K NILL++ +++D G +
Sbjct: 95 GNPGFEEERALFYAAEILC-GLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAV 150
Query: 89 ISPVEGGTHMSTTIAGTAGFLNTEL 113
P EG + GT G++ E+
Sbjct: 151 KIP-EGESIRGRV--GTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 10/92 (10%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
L+YLH + ++ RD+K N++L++ K+ DFG + +G T T GT +
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEY 162
Query: 109 LNTELTEKSD----VD--SFEIVILEIITGIL 134
L E+ E +D VD +V+ E++ G L
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.002
Identities = 26/77 (33%), Positives = 35/77 (45%), Gaps = 6/77 (7%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
EV + YLH II RD+K NILL+ + L DFG + T ++T
Sbjct: 104 EVAS-AIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFC 157
Query: 104 GTAGFLNTELTEKSDVD 120
GT +L E+ K D
Sbjct: 158 GTPEYLAPEVLRKEPYD 174
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.002
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
LE LH K +I RD+K NILL+ + L DFG +++ + + T GT +L
Sbjct: 106 LENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYL 160
Query: 110 NTEL------TEKSDVDSFEIVILEIITGI 133
EL T+ D + +++ E++TG+
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGL 190
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.002
Identities = 23/89 (25%), Positives = 43/89 (48%), Gaps = 9/89 (10%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR------ISPVEGGTHMSTTI 102
G+EYL H + +D+ + NIL+ E++ K++D G SR V+ + +
Sbjct: 136 GMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRW 192
Query: 103 AGTAGFLNTELTEKSDVDSFEIVILEIIT 131
+ + + SD+ SF +V+ EI +
Sbjct: 193 MPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.002
Identities = 17/40 (42%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL+Y+H II RD+K N+ +NE + K+ DFG +R
Sbjct: 130 GLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.002
Identities = 16/40 (40%), Positives = 24/40 (60%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
G+EYL H + RD+ + N L+ E + K++DFG SR
Sbjct: 136 GMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.002
Identities = 16/42 (38%), Positives = 26/42 (61%), Gaps = 4/42 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLN-EKVQAKLADFGQSRI 89
GL+Y+H ++ RD+K N+ +N E + K+ DFG +RI
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.002
Identities = 22/60 (36%), Positives = 31/60 (51%), Gaps = 9/60 (15%)
Query: 52 YLHQGL-------KHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTHMSTTI 102
YL+Q L ++ RD+K N+L++ K KLADFG +R PV TH T+
Sbjct: 106 YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.002
Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 61 IIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTELTE----- 115
++ RD+KS NI L KL DFG S+ ++++ GT +L EL E
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 116 -KSDVDSFEIVILEIITGILTVDLSFKG 142
K+D+ S +++ E +LT+ FKG
Sbjct: 250 KKADMWSLGVILYE----LLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.002
Identities = 18/40 (45%), Positives = 24/40 (60%), Gaps = 3/40 (7%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89
LEYLH + I+ RD+K N+L+ KL DFG S+I
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 37.3 bits (87), Expect = 0.002
Identities = 28/78 (35%), Positives = 40/78 (51%), Gaps = 14/78 (17%)
Query: 11 GPLLVELIGKQKNNALELGFRGNPELVDQQGKEEVCCPGLEYLHQGLKHPIIQRDMKSTN 70
GPLL L +++ +L EL Q V G+ YL KH + RD+ + N
Sbjct: 80 GPLLKYLKKRREIPVSDL-----KELAHQ-----VAM-GMAYLE--SKH-FVHRDLAARN 125
Query: 71 ILLNEKVQAKLADFGQSR 88
+LL + QAK++DFG SR
Sbjct: 126 VLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.002
Identities = 20/54 (37%), Positives = 32/54 (59%), Gaps = 3/54 (5%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTI 102
GL Y+H +H I+ RD+K N+L++ + KLADFG +R + T+ S +
Sbjct: 115 GLAYIHG--QH-ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV 165
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.002
Identities = 32/99 (32%), Positives = 47/99 (47%), Gaps = 14/99 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
LE+LH K II RD+K NILL+ L DFG S+ E + + GT +
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIEY 172
Query: 109 LNTELTEKSD------VD--SFEIVILEIITGI--LTVD 137
+ ++ D VD S +++ E++TG TVD
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.002
Identities = 28/94 (29%), Positives = 41/94 (43%), Gaps = 9/94 (9%)
Query: 45 VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG---------QSRISPVEGG 95
+C LE L II RD+K+ N+LL KLADFG Q R S +
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174
Query: 96 THMSTTIAGTAGFLNTELTEKSDVDSFEIVILEI 129
M+ + +T K+D+ S I ++E+
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.002
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 13/94 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEG--GTH--MSTTIAG 104
G+ YLH + ++ RD+K N++L KL DFG +R G GTH M ++ G
Sbjct: 114 GVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 105 TAGFLNTELT------EKSDVDSFEIVILEIITG 132
T ++ E+ KSD+ S + E+ TG
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.003
Identities = 23/76 (30%), Positives = 36/76 (47%), Gaps = 6/76 (7%)
Query: 62 IQRDMKSTNILLNEKVQAKLADFGQSR------ISPVEGGTHMSTTIAGTAGFLNTELTE 115
+ RD+ + N L+ + + K+ DFG SR V G T + L + T
Sbjct: 144 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT 203
Query: 116 KSDVDSFEIVILEIIT 131
+SD+ SF +V+ EI T
Sbjct: 204 ESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.003
Identities = 18/52 (34%), Positives = 32/52 (61%), Gaps = 3/52 (5%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMST 100
GL+Y+H II RD+K +N+ +NE + ++ DFG +R + E +++T
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVAT 178
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 37.4 bits (86), Expect = 0.003
Identities = 19/54 (35%), Positives = 32/54 (59%), Gaps = 1/54 (1%)
Query: 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTELTE 115
+ RD+K NIL++ +LADFG S + +E GT S+ GT +++ E+ +
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 36.7 bits (85), Expect = 0.003
Identities = 26/75 (34%), Positives = 37/75 (49%), Gaps = 17/75 (22%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHM--STT 101
E+ C GLE LH + I+ RD+K NILL+ D+G RIS + + T
Sbjct: 110 EITC-GLEDLH---RERIVYRDLKPENILLD--------DYGHIRISDLGLAVEIPEGET 157
Query: 102 I---AGTAGFLNTEL 113
I GT G++ E+
Sbjct: 158 IRGRVGTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 36.5 bits (84), Expect = 0.004
Identities = 34/88 (38%), Positives = 46/88 (52%), Gaps = 13/88 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMST------TI 102
G+EYL KH I RD+ + N L+ EK K++DFG SR E G + ST +
Sbjct: 106 GMEYLES--KH-CIHRDLAARNCLVTEKNVLKISDFGMSREE--EDGVYASTGGMKQIPV 160
Query: 103 AGTA-GFLN-TELTEKSDVDSFEIVILE 128
TA LN + +SDV SF I++ E
Sbjct: 161 KWTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 36.9 bits (85), Expect = 0.004
Identities = 25/72 (34%), Positives = 35/72 (48%), Gaps = 5/72 (6%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
L YLH + I+ RD+K NILL+ + L DFG + + T +TT GT +
Sbjct: 108 ALGYLHS-IN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEY 162
Query: 109 LNTELTEKSDVD 120
L E+ K D
Sbjct: 163 LAPEVIRKQPYD 174
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 36.5 bits (84), Expect = 0.004
Identities = 19/39 (48%), Positives = 24/39 (61%), Gaps = 3/39 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS 87
GL++LH + II RD+K NILL + KL DFG S
Sbjct: 140 GLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 36.7 bits (85), Expect = 0.004
Identities = 27/107 (25%), Positives = 48/107 (44%), Gaps = 19/107 (17%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
L +LH+ II RD+K N+LL+ + KL D+G + G T ++T GT
Sbjct: 106 SLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTP 160
Query: 107 GFLNTELTEKSDVD------SFEIVILEIITGILTVDLSFKGEFDII 147
++ E+ D + +++ E++ G + FDI+
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAG--------RSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 36.5 bits (84), Expect = 0.004
Identities = 23/72 (31%), Positives = 37/72 (51%), Gaps = 15/72 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQ----SRISPVEGGTHMSTTIAG 104
GLE++H ++ RD+K NILL+E +++D G S+ P H S G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---G 157
Query: 105 TAGFLNTELTEK 116
T G++ E+ +K
Sbjct: 158 THGYMAPEVLQK 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 36.5 bits (85), Expect = 0.004
Identities = 18/46 (39%), Positives = 24/46 (52%), Gaps = 7/46 (15%)
Query: 43 EEVCCPGLEYLHQ-GLKHPIIQRDMKSTNILLNEKVQAKLADFGQS 87
E V L+ +H+ G H RD+K NIL++ KLADFG
Sbjct: 109 ELVLA--LDSVHKLGFIH----RDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 36.5 bits (84), Expect = 0.004
Identities = 29/101 (28%), Positives = 51/101 (50%), Gaps = 15/101 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL +LH II RD+K N++L+ + K+ADFG + + +G T + T GT +
Sbjct: 113 GLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDY 167
Query: 109 LNTELT------EKSDVDSFEIVILEIITGILTVDLSFKGE 143
+ E+ + D +F +++ E++ G F+GE
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAG----QAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 188 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.98 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.98 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.98 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.98 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.98 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.98 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.95 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.91 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.91 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.88 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.88 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.88 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.88 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.88 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.85 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.84 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.83 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.78 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.73 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.66 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.62 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.6 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.6 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.58 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.56 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.55 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.54 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.49 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.4 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.4 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.39 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.38 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.36 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.31 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.26 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.25 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.24 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.21 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.2 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.18 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.15 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.11 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.88 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.66 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.63 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.56 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.47 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.23 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.16 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.1 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.02 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.95 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.62 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.51 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.2 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.85 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.26 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.26 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.09 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.48 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 95.16 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 94.27 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.22 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 93.75 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 93.41 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 93.39 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 92.79 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 92.73 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 91.98 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 91.83 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 91.83 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 91.7 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 91.68 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 91.49 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 91.21 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 91.16 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 89.96 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 89.14 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 88.78 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 88.63 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 88.47 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 88.39 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 87.9 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 85.81 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 85.15 | |
| PLN02236 | 344 | choline kinase | 85.13 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 85.07 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 82.78 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 82.76 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 82.05 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 80.32 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=260.06 Aligned_cols=164 Identities=23% Similarity=0.346 Sum_probs=142.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++|||||++.++ ++..|+||||++||.|.+++ .+.. |++.|+.|||+ .||+||||||+|
T Consensus 230 LkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeN 306 (475)
T KOG0615|consen 230 LKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPEN 306 (475)
T ss_pred HHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcce
Confidence 678999999999999 78889999999999999999 3222 99999999999 999999999999
Q ss_pred EEEccC---CceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 71 ILLNEK---VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 71 ill~~~---~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||++.+ ..+|++|||+++... ......+++||+.|.||| +..++|+||+||++|-+++|.+||..
T Consensus 307 ILl~~~~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 307 ILLSNDAEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred EEeccCCcceEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 999866 688999999999753 344566789999999999 34588999999999999999999976
Q ss_pred cCCCC----------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKGE----------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~~----------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..... .-...+++..+++.++|..||++|||++++++
T Consensus 384 ~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 384 EYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 54433 22356778999999999999999999999876
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=257.54 Aligned_cols=172 Identities=30% Similarity=0.361 Sum_probs=145.0
Q ss_pred cccccCCCeeeeccc--CC--ccEEEEecCCCCChhhhcCC--cc------------cHHHHHHHHhcCCCCC-cEEeCC
Q 039565 6 RNKLTGPLLVELIGK--QK--NNALELGFRGNPELVDQQGK--EE------------VCCPGLEYLHQGLKHP-IIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~--~~~lv~e~~~~~~L~~~~~~--~~------------~i~~~l~~Lh~~~~~~-i~h~dl 66 (188)
|++++|||||+++|+ .. .+++||||+++|+|..++.. .. |+|.||.|||+ .+ ||||||
T Consensus 93 l~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDL 169 (362)
T KOG0192|consen 93 LSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDL 169 (362)
T ss_pred HHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeeccc
Confidence 567999999999999 33 58999999999999999933 22 99999999999 78 999999
Q ss_pred CCCcEEEccCC-ceEEecccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 67 KSTNILLNEKV-QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 67 ~~~nill~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
|++|+|++.++ .+||+|||+++...... .......||+.||||| ++.++||||||+++||++||+.||.
T Consensus 170 K~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~ 247 (362)
T KOG0192|consen 170 KSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE 247 (362)
T ss_pred ChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC
Confidence 99999999997 99999999998543111 1222368999999998 5788999999999999999999985
Q ss_pred ccC-------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 138 LSF-------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 138 ~~~-------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
... ....+......+..++..||+.+|..||++.+|+..|+.+..
T Consensus 248 ~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 248 DLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 422 233455578899999999999999999999999999986644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=252.37 Aligned_cols=164 Identities=24% Similarity=0.359 Sum_probs=142.3
Q ss_pred cccccCCCeeeeccc---CC-ccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QK-NNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~-~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+.+||+||+++|. .. ...++||||++|+|+.++...+ ++++||.|||+. ++|+|||+||+
T Consensus 131 l~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPs 208 (364)
T KOG0581|consen 131 LRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPS 208 (364)
T ss_pred HhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHH
Confidence 456799999999999 45 4899999999999999994322 999999999963 89999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccccc----
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLS---- 139 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~---- 139 (188)
|+|++..|.+||+|||+++... .+ ...++.||..||+|| ++.++||||||+.++|+..|+.|+.+.
T Consensus 209 NlLvNskGeVKicDFGVS~~lv--nS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~ 284 (364)
T KOG0581|consen 209 NLLVNSKGEVKICDFGVSGILV--NS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY 284 (364)
T ss_pred HeeeccCCCEEeccccccHHhh--hh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC
Confidence 9999999999999999998653 22 567899999999999 789999999999999999999988764
Q ss_pred -------------CCCCcCHH-HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 140 -------------FKGEFDII-SVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 140 -------------~~~~~~~~-~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+...+.. .++++.+++..|+++||.+|||++|+++
T Consensus 285 ~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 285 LDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12234443 7888999999999999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=259.62 Aligned_cols=175 Identities=24% Similarity=0.279 Sum_probs=146.2
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
.|++|+|+|||+++++ +..++|||||++.|+|.++++. .+ |||+||+||.+ .++|||||.
T Consensus 254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLA 330 (468)
T KOG0197|consen 254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLA 330 (468)
T ss_pred HHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhh
Confidence 4789999999999999 4669999999999999999943 22 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccc--
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDL-- 138 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~-- 138 (188)
+.|||++++..+||+|||+++... ...........-+..|.||| ++.+|||||||+++||++| |+.|+..
T Consensus 331 ARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms 409 (468)
T KOG0197|consen 331 ARNILVDEDLVVKISDFGLARLIG-DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS 409 (468)
T ss_pred hhheeeccCceEEEcccccccccC-CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence 999999999999999999999432 11111122223345688998 8999999999999999996 7777643
Q ss_pred ----------cCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 139 ----------SFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 139 ----------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
....+.|..++..+.+++..||..+|++||||+.+...|+.+...
T Consensus 410 n~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 410 NEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 233446667889999999999999999999999999999887654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=254.03 Aligned_cols=173 Identities=25% Similarity=0.359 Sum_probs=150.2
Q ss_pred CCcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 4 PNRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 4 ~~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
.+|++|+||||+.+.|+ ...+++|||||+.|.|...++... +||.|+.|||. +.|||||||.
T Consensus 164 KHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKS 240 (904)
T KOG4721|consen 164 KHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKS 240 (904)
T ss_pred HHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCC
Confidence 46889999999999999 677889999999999999993322 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccccc---
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLS--- 139 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~--- 139 (188)
.||||+.+..+||+|||-++... .....-.+.||..||||| .+.++|||||||++|||+||..||...
T Consensus 241 PNiLIs~~d~VKIsDFGTS~e~~---~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss 317 (904)
T KOG4721|consen 241 PNILISYDDVVKISDFGTSKELS---DKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS 317 (904)
T ss_pred CceEeeccceEEeccccchHhhh---hhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh
Confidence 99999999999999999887432 112234589999999999 588999999999999999999998542
Q ss_pred ----------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 140 ----------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 140 ----------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
+....+..+++.++=++.+||+..|.+||+|++|+..|+-..+
T Consensus 318 AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 318 AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred eeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 3344677889999999999999999999999999999976554
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=249.76 Aligned_cols=165 Identities=23% Similarity=0.270 Sum_probs=143.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
|+..+|+|||++++. .+.+|+||||+++|+|.+.+.... +++.||+|||. .+|+|||||.+||
T Consensus 324 m~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnI 400 (550)
T KOG0578|consen 324 MRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNI 400 (550)
T ss_pred HHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHh---cceeeecccccee
Confidence 677899999999998 899999999999999999993331 88899999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccc-------
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDL------- 138 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~------- 138 (188)
|++.+|.+||+|||++..+. .......+..||++||||| |+.+.||||||++++||+.|.+||=-
T Consensus 401 LL~~~g~vKltDFGFcaqi~--~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl 478 (550)
T KOG0578|consen 401 LLTMDGSVKLTDFGFCAQIS--EEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 478 (550)
T ss_pred EeccCCcEEEeeeeeeeccc--cccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH
Confidence 99999999999999987653 2233567789999999999 79999999999999999999998721
Q ss_pred -------cCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 -------SFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 -------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
......+...+..+.+++.+||+.|+++|+++.++|+
T Consensus 479 yLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 479 YLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 1122244567889999999999999999999999997
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=242.50 Aligned_cols=176 Identities=42% Similarity=0.593 Sum_probs=145.4
Q ss_pred CcccccCCCeeeeccc---CC-ccEEEEecCCCCChhhhc-C-Cc-c-----------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 5 NRNKLTGPLLVELIGK---QK-NNALELGFRGNPELVDQQ-G-KE-E-----------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~-~~~lv~e~~~~~~L~~~~-~-~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
.+++++|||+|+++|+ .+ +..||+||+++|+|.+++ . .. . ++|.||+|||+.+...|+|||+
T Consensus 124 ~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDi 203 (361)
T KOG1187|consen 124 ILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDI 203 (361)
T ss_pred HHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCC
Confidence 4678999999999999 44 489999999999999999 3 22 2 9999999999987778999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeee-cccccccCCC------CCCccchHHHHHHHHHHHhCCccccc-
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTI-AGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDL- 138 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~-~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~- 138 (188)
|++|||+|++...|++|||+++..+.. ....... .|+.+|++|| .+.++||||||+++.|+++|+.+.+.
T Consensus 204 KssNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 204 KSSNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CHHHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 999999999999999999999754311 1111222 7999999999 47899999999999999999975542
Q ss_pred ---------------------------cCC-CCcCH-HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 139 ---------------------------SFK-GEFDI-ISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 139 ---------------------------~~~-~~~~~-~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
.+. .+++. .+..++..++..|++.+|..||+|.+|+++|+.+..
T Consensus 282 ~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 282 RPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 222 23343 578889999999999999999999999999976553
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=240.40 Aligned_cols=163 Identities=23% Similarity=0.326 Sum_probs=135.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++|||||+++++ ++..|+|||||.+|+|.+|+++.+ |+|.||++||+ .+||||||||+|
T Consensus 63 Lkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQN 139 (429)
T KOG0595|consen 63 LKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQN 139 (429)
T ss_pred HHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcce
Confidence 578999999999999 899999999999999999993332 99999999999 999999999999
Q ss_pred EEEccC------CceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 71 ILLNEK------VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 71 ill~~~------~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||++.+ ..+||+|||+++... ......+.+|++.||||| |+.++|+||.|+++|++++|..||+.
T Consensus 140 iLLs~~~~~~~~~~LKIADFGfAR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 140 ILLSTTARNDTSPVLKIADFGFARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred EEeccCCCCCCCceEEecccchhhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 999865 468999999999654 334566789999999999 79999999999999999999999984
Q ss_pred cCCC--------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 039565 139 SFKG--------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174 (188)
Q Consensus 139 ~~~~--------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~ 174 (188)
.... ..+......+.+++...++.++..|-++.+-+
T Consensus 217 ~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 217 ETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred cCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 4322 22333444556777777888888887766533
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=249.10 Aligned_cols=164 Identities=22% Similarity=0.317 Sum_probs=144.1
Q ss_pred ccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 7 NKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 7 ~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
++|+|||||+++++ .++.|+|+|+|..++|..++++ .. |++.||.|||+ .+|+|||||..|+
T Consensus 73 r~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNl 149 (592)
T KOG0575|consen 73 RSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNL 149 (592)
T ss_pred HhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhhe
Confidence 46899999999999 8899999999999999999943 32 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK---- 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~---- 141 (188)
+++++..+||+|||++.... .......+.+||+-|.||| .+-.+||||+||++|.++.|++||....-
T Consensus 150 fL~~~~~VKIgDFGLAt~le--~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety 227 (592)
T KOG0575|consen 150 FLNENMNVKIGDFGLATQLE--YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY 227 (592)
T ss_pred eecCcCcEEecccceeeeec--CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH
Confidence 99999999999999998653 2334456789999999999 57889999999999999999999976421
Q ss_pred -------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 -------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 -------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
-..|...+....+++..+|+.+|.+|||+++|+.
T Consensus 228 ~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 228 NKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1244567778999999999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=230.98 Aligned_cols=171 Identities=20% Similarity=0.256 Sum_probs=141.0
Q ss_pred CcccccCCCeeeeccc----C-CccEEEEecCCCCChhhhcC---Ccc-------------cHHHHHHHHhcCCCC-CcE
Q 039565 5 NRNKLTGPLLVELIGK----Q-KNNALELGFRGNPELVDQQG---KEE-------------VCCPGLEYLHQGLKH-PII 62 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~----~-~~~~lv~e~~~~~~L~~~~~---~~~-------------~i~~~l~~Lh~~~~~-~i~ 62 (188)
-|++|+|||||+.+++ + +-++++||+|+.|+|...++ +.. |+|.||..+|....+ .|.
T Consensus 71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm 150 (375)
T KOG0591|consen 71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM 150 (375)
T ss_pred HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence 3678999999999996 3 44899999999999999982 221 999999999973323 489
Q ss_pred EeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccc
Q 039565 63 QRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 63 h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
|||+||.||+++.+|.+||+|||+++.+. .......+..|||+||+|| ++.++||||+||++|||+.-..||
T Consensus 151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 151 HRDIKPANIFLTANGVVKLGDFGLGRFLS--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred eccCcchheEEcCCCceeeccchhHhHhc--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 99999999999999999999999999753 3334566789999999999 799999999999999999999998
Q ss_pred cccC---------CCC---cC-HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 039565 137 DLSF---------KGE---FD-IISVEKAVEIAMASVSSKVNRRPLMNQVVMVR 177 (188)
Q Consensus 137 ~~~~---------~~~---~~-~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l 177 (188)
.... ..+ .+ ...+..+..++..|+..||+.||+...+++.+
T Consensus 229 ~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 229 YGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred ccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 5321 112 23 67889999999999999999999854444443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=237.53 Aligned_cols=177 Identities=23% Similarity=0.259 Sum_probs=145.8
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+|+.++||||++.+.. +..+|+||.||.+|++.+++ ...+ +++.||.|||. .|.||||+|
T Consensus 77 ~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvK 153 (516)
T KOG0582|consen 77 TMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVK 153 (516)
T ss_pred HhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccc
Confidence 5788999999999888 99999999999999999999 2222 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCc-ce-eeecccccccCCC--------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTH-MS-TTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~-~~-~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
+.|||++.+|.+||+|||++--+...+... .. .++.|+++||||| |+.++||||||++..|+.+|..||.
T Consensus 154 AgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~ 233 (516)
T KOG0582|consen 154 AGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS 233 (516)
T ss_pred cccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence 999999999999999999865433222221 12 5678999999999 7899999999999999999999984
Q ss_pred ccC---------------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhhccCcc
Q 039565 138 LSF---------------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM--VREQGSGSR 184 (188)
Q Consensus 138 ~~~---------------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~--~l~~~~~~~ 184 (188)
... +.+........+.+++..|++.||.+|||++++++ .+++.+...
T Consensus 234 k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 234 KYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred cCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 321 12222345667889999999999999999999987 455555443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=236.44 Aligned_cols=169 Identities=22% Similarity=0.339 Sum_probs=140.7
Q ss_pred cccccCCCeeeeccc---CC--ccEEEEecCCCCChhhhcCC----cc---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK---QK--NNALELGFRGNPELVDQQGK----EE---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~--~~~lv~e~~~~~~L~~~~~~----~~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
|.+++|||||+.+|. .+ .+++.|||+++|+|.+++.+ .+ |++.||+|||+ ++++|||||
T Consensus 68 L~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK 144 (313)
T KOG0198|consen 68 LSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIK 144 (313)
T ss_pred HHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcc
Confidence 567889999999996 33 58999999999999999922 22 99999999999 999999999
Q ss_pred CCcEEEcc-CCceEEecccCcccccCCCC-CcceeeecccccccCCCC-----CC--ccchHHHHHHHHHHHhCCccccc
Q 039565 68 STNILLNE-KVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTEL-----TE--KSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 68 ~~nill~~-~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe~-----~~--~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|+|||++. ++.+||+|||+++....... ........||+.||+||. .. ++||||+||++.||+||..||..
T Consensus 145 ~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 145 PANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 99999999 79999999998875432111 122345789999999992 23 89999999999999999988865
Q ss_pred c--------------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 039565 139 S--------------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVR 177 (188)
Q Consensus 139 ~--------------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l 177 (188)
. ..++++...+....+++..|+..+|+.|||++++++.-
T Consensus 225 ~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 225 FFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred hcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1 11356666788999999999999999999999999843
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=234.72 Aligned_cols=174 Identities=21% Similarity=0.217 Sum_probs=138.0
Q ss_pred ccc-cCCCeeeeccc----CCccEEEEecCCCCChhhhcCC-c-------------------------------------
Q 039565 7 NKL-TGPLLVELIGK----QKNNALELGFRGNPELVDQQGK-E------------------------------------- 43 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~~~-~------------------------------------- 43 (188)
.++ +||||+++++. ....+++|||+++|+|.+++.. .
T Consensus 65 ~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (338)
T cd05102 65 IHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASV 144 (338)
T ss_pred HHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCc
Confidence 345 89999999997 4467899999999999988821 0
Q ss_pred ------------------------------------ccHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCc
Q 039565 44 ------------------------------------EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS 87 (188)
Q Consensus 44 ------------------------------------~~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~ 87 (188)
.|++.||+|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a 221 (338)
T cd05102 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLA 221 (338)
T ss_pred cccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccc
Confidence 089999999999 99999999999999999999999999998
Q ss_pred ccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCCC-------------CcCHH
Q 039565 88 RISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFKG-------------EFDII 147 (188)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~~-------------~~~~~ 147 (188)
+...............++..|++|| ++.++||||||+++|++++ |..||...... ..+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (338)
T cd05102 222 RDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPEN 301 (338)
T ss_pred cccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCC
Confidence 7542111111112234556799999 5889999999999999997 88888643211 11223
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 148 SVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 148 ~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
.+..+.+++..||+.+|.+|||+.++++.|+.+.+.
T Consensus 302 ~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 456789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=236.54 Aligned_cols=165 Identities=22% Similarity=0.326 Sum_probs=142.9
Q ss_pred ccccc-CCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLT-GPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~-Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++ ||||++++++ ....++||||+.+|+|.+++.+.+ |++.|++|||+ .+|+||||||+
T Consensus 73 ~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~E 149 (370)
T KOG0583|consen 73 LRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPE 149 (370)
T ss_pred HHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHH
Confidence 56777 9999999999 777999999999999999992222 99999999999 99999999999
Q ss_pred cEEEccC-CceEEecccCcccccCCCCCcceeeecccccccCCC-------C-CCccchHHHHHHHHHHHhCCccccccC
Q 039565 70 NILLNEK-VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------L-TEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 70 nill~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~-~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|++++.+ +.+||+|||++.... .......+.+|++.|+||| + ..++|+||+|+++|.|++|..||+...
T Consensus 150 Nilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 150 NILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred HEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 9999999 999999999998653 3344567789999999999 2 578999999999999999999998643
Q ss_pred C-----------CCcCHHH-HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 K-----------GEFDIIS-VEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~-----------~~~~~~~-~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. -.++... +..+..++..|+..+|.+|+|+.+|++
T Consensus 228 ~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 228 VPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 1234444 889999999999999999999999983
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=235.94 Aligned_cols=167 Identities=25% Similarity=0.318 Sum_probs=142.0
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|.+| .||.|++++-- ...+|+|+||+++|+|.+++++.+ +++.||+|||+ .|||||||||+
T Consensus 127 l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPE 203 (604)
T KOG0592|consen 127 LTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPE 203 (604)
T ss_pred HHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChh
Confidence 4456 89999999777 889999999999999999995555 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCC---------cc--eeeecccccccCCC------CCCccchHHHHHHHHHHHhC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGT---------HM--STTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~---------~~--~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g 132 (188)
|||++++++++|+|||.++.+...... .. ...+.||..|++|| .+..+|+|+|||++|+|+.|
T Consensus 204 NILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG 283 (604)
T KOG0592|consen 204 NILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAG 283 (604)
T ss_pred heeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcC
Confidence 999999999999999999876422111 11 24589999999999 47899999999999999999
Q ss_pred CccccccC-----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 133 ILTVDLSF-----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 133 ~~p~~~~~-----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+||.... .-+++...++.+.+++...|..||.+|++.++|-+
T Consensus 284 ~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 284 QPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred CCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 99996532 22345555678899999999999999999998876
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=227.90 Aligned_cols=158 Identities=27% Similarity=0.316 Sum_probs=136.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|.+++||.||++.-. .+++|+|+||+.||.|...+++.+ +++.||.|||+ .+|+|||+||+|
T Consensus 79 L~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPEN 155 (357)
T KOG0598|consen 79 LSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPEN 155 (357)
T ss_pred HHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHH
Confidence 567999999999655 899999999999999999995444 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
||++..|+++|+|||+++... .......+++||+.||||| ++.++|.||+|+++|+|++|..||.....
T Consensus 156 ILLd~~GHi~LtDFgL~k~~~--~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~ 233 (357)
T KOG0598|consen 156 ILLDEQGHIKLTDFGLCKEDL--KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM 233 (357)
T ss_pred eeecCCCcEEEeccccchhcc--cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH
Confidence 999999999999999998532 2223455689999999999 79999999999999999999999965432
Q ss_pred ---------CCcCHHHHHHHHHHHHHccCcCCCCCC
Q 039565 142 ---------GEFDIISVEKAVEIAMASVSSKVNRRP 168 (188)
Q Consensus 142 ---------~~~~~~~~~~~~~l~~~cl~~~p~~Rp 168 (188)
...+...+....+++...+..+|++|.
T Consensus 234 ~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 234 YDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 223334677889999999999999995
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=227.34 Aligned_cols=170 Identities=19% Similarity=0.220 Sum_probs=139.5
Q ss_pred CcccccCCCeeeeccc--C-----CccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeC
Q 039565 5 NRNKLTGPLLVELIGK--Q-----KNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~--~-----~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
.|.+++||||++++++ . ...+++|||+++|+|.+++.+.. |++.||.|||+. .+++|||
T Consensus 71 ~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrd 148 (283)
T PHA02988 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKN 148 (283)
T ss_pred HHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCc
Confidence 4678999999999987 2 36789999999999999993322 899999999972 4888999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
+||+||+++.++.+|++|||+++..... .....++..|+||| ++.++|+||||+++|++++|..||+
T Consensus 149 lkp~nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 149 LTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred CChhhEEECCCCcEEEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 9999999999999999999998754311 11234667788888 4678999999999999999999996
Q ss_pred ccCC-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 138 LSFK-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 138 ~~~~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
.... ...+...+..+.+++.+||+.+|++|||++++++.|++..
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 224 NLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 4321 1123346778999999999999999999999999998764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=246.73 Aligned_cols=174 Identities=21% Similarity=0.263 Sum_probs=141.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Ccc-------------------------cHHHHHHHHhcC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KEE-------------------------VCCPGLEYLHQG 56 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~~-------------------------~i~~~l~~Lh~~ 56 (188)
|..++|||||+++|+ ++.+++|||||++|+|.+|+. ..+ |||.||+||.+
T Consensus 543 la~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~- 621 (774)
T KOG1026|consen 543 LAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS- 621 (774)
T ss_pred HHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence 467999999999999 899999999999999999992 111 99999999999
Q ss_pred CCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHH
Q 039565 57 LKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEII 130 (188)
Q Consensus 57 ~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~ 130 (188)
..++||||..+|.||+++..+||+|||+++-.-..+-........-+.+||+|| |+++||||||||++||++
T Consensus 622 --~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIF 699 (774)
T KOG1026|consen 622 --HHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIF 699 (774)
T ss_pred --CcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhh
Confidence 999999999999999999999999999997421111000111112345788888 899999999999999999
Q ss_pred h-CCccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 131 T-GILTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 131 ~-g~~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
+ |..|+-.-. .-+.+..++.++.+++..||+.+|.+||++.+|-..|+....
T Consensus 700 syG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 700 SYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 6 666763322 134667788999999999999999999999999998876543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=249.53 Aligned_cols=175 Identities=23% Similarity=0.289 Sum_probs=144.0
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc------c-------------cHHHHHHHHhcCCCCCcE
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE------E-------------VCCPGLEYLHQGLKHPII 62 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~------~-------------~i~~~l~~Lh~~~~~~i~ 62 (188)
.|++++|||||+++|+ ....++++|||.+|+|..|++.. + |+|.|+.||++ ...|
T Consensus 748 ~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fv 824 (1025)
T KOG1095|consen 748 LMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFV 824 (1025)
T ss_pred HHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCc
Confidence 3789999999999999 88899999999999999999433 1 99999999999 9999
Q ss_pred EeCCCCCcEEEccCCceEEecccCcccccCCCCCcc-eeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCc
Q 039565 63 QRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHM-STTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GIL 134 (188)
Q Consensus 63 h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~-~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~ 134 (188)
||||..+|+|++....+|++|||+++-.- ...... ...-.-+..||+|| |+.++|||||||++||++| |..
T Consensus 825 HRDLAaRNCLL~~~r~VKIaDFGlArDiy-~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~ 903 (1025)
T KOG1095|consen 825 HRDLAARNCLLDERRVVKIADFGLARDIY-DKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGAT 903 (1025)
T ss_pred CcchhhhheeecccCcEEEcccchhHhhh-hchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCC
Confidence 99999999999999999999999998221 111101 11112335799998 8999999999999999997 667
Q ss_pred cccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 135 TVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 135 p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
||.... .-+.+..++.++.+++.+||+.+|++||++..|++.++.+...
T Consensus 904 PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 904 PYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 875422 2345667889999999999999999999999999988776543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=234.70 Aligned_cols=167 Identities=20% Similarity=0.225 Sum_probs=137.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC----cc-----------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK----EE-----------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~----~~-----------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
++.++||||+++++. .+..++||||+++|+|.+++ +. .. |++.||.|||+ .+|+||||
T Consensus 119 l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDl 195 (478)
T PTZ00267 119 LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDL 195 (478)
T ss_pred HHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCc
Confidence 567899999999998 88999999999999998876 21 11 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+||+++.++.+||+|||+++...............|++.|++|| ++.++|+|||||++|+|++|..||....
T Consensus 196 kp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred CHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987643222222234467899999998 6788999999999999999999986432
Q ss_pred C------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 K------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ...+...+..+.+++..||+.+|++||++++++.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 276 QREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1 1122345568999999999999999999999875
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=218.02 Aligned_cols=171 Identities=20% Similarity=0.280 Sum_probs=139.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc----------------c------------cHHHHHHHHh
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE----------------E------------VCCPGLEYLH 54 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~----------------~------------~i~~~l~~Lh 54 (188)
+.+++||||++++++ ....++++||+++++|.+++... . |++.||.|||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred HHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 567899999999998 67789999999999999998221 0 8999999999
Q ss_pred cCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHH
Q 039565 55 QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILE 128 (188)
Q Consensus 55 ~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~ 128 (188)
+ .+++|+|+||+||+++.++.++|+|||++................++..|+||| ++.++|+||||+++|+
T Consensus 142 ~---~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~e 218 (283)
T cd05048 142 S---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218 (283)
T ss_pred h---CCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHH
Confidence 9 999999999999999999999999999987532111111222334567799998 4788999999999999
Q ss_pred HHh-CCccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 129 IIT-GILTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 129 ~~~-g~~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
+++ |..||.... ....+...+..+.+++..||+.+|.+||++++|++.|+.
T Consensus 219 l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 219 IFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 997 888875321 122334567889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=232.74 Aligned_cols=172 Identities=24% Similarity=0.275 Sum_probs=142.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|.+++|||||+++|+ ...+++|||+|.||+|.+++++.+ +.|.||+|||+ .+++||||.++
T Consensus 215 Mr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAAR 291 (474)
T KOG0194|consen 215 MRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAAR 291 (474)
T ss_pred HHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHH
Confidence 567999999999999 899999999999999999993332 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCccee-eecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMST-TIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~-~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~- 140 (188)
|+|++.++.+|++|||+++... ...... ....+..|+||| ++.++|||||||++||+.+ |..||....
T Consensus 292 NcL~~~~~~vKISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 292 NCLYSKKGVVKISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred HheecCCCeEEeCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 9999999999999999987432 111111 123456789999 7999999999999999997 777875432
Q ss_pred ------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 141 ------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 141 ------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
....+...+..+..++.+||..+|++||||.++.+.|+.+...
T Consensus 369 ~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 369 YEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred HHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 2234446677888999999999999999999999999876544
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=215.07 Aligned_cols=171 Identities=16% Similarity=0.178 Sum_probs=136.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ .+..++||||+++|+|.+++ .... |++.||+|||+ .+++|+|+||+
T Consensus 60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~ 136 (266)
T cd05064 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAH 136 (266)
T ss_pred HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHh
Confidence 567899999999998 78899999999999999998 3221 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
||+++.++.++++|||.+...... .........++..|++|| ++.++|+||||+++|++++ |..||....
T Consensus 137 nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~ 215 (266)
T cd05064 137 KVLVNSDLVCKISGFRRLQEDKSE-AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ 215 (266)
T ss_pred hEEEcCCCcEEECCCccccccccc-chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 999999999999999976532111 111111223445788998 5789999999999999875 888885321
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
....+...+..+.+++..||+.+|.+||++++|++.|+..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 216 DVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1123344567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=225.74 Aligned_cols=171 Identities=22% Similarity=0.230 Sum_probs=135.8
Q ss_pred ccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc--------------------------------------
Q 039565 7 NKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-------------------------------------- 43 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-------------------------------------- 43 (188)
..+ +||||+++++. ....++||||+++|+|.+++ .+.
T Consensus 93 ~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (375)
T cd05104 93 SYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMK 172 (375)
T ss_pred HHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcC
Confidence 345 79999999998 78889999999999999888 211
Q ss_pred ------------------------------------------------ccHHHHHHHHhcCCCCCcEEeCCCCCcEEEcc
Q 039565 44 ------------------------------------------------EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNE 75 (188)
Q Consensus 44 ------------------------------------------------~~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~ 75 (188)
.|++.||.|||+ .+++|||+||+||+++.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~ 249 (375)
T cd05104 173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTH 249 (375)
T ss_pred CCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEEC
Confidence 089999999999 99999999999999999
Q ss_pred CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-------
Q 039565 76 KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK------- 141 (188)
Q Consensus 76 ~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~------- 141 (188)
++.++++|||++................++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 250 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~ 329 (375)
T cd05104 250 GRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329 (375)
T ss_pred CCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH
Confidence 9999999999987543221111111233455699999 5789999999999999998 7788754221
Q ss_pred ------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 142 ------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 142 ------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
...+...+..+.+++..||+.+|++|||+.+|++.|++.
T Consensus 330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 330 IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111223456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=219.78 Aligned_cols=171 Identities=19% Similarity=0.248 Sum_probs=134.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc---------------------c---------cHHHHHH
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE---------------------E---------VCCPGLE 51 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~---------------------~---------~i~~~l~ 51 (188)
+.+++||||++++++ .+..+++|||+++++|.+++ ... . |++.||.
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 152 (304)
T cd05096 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152 (304)
T ss_pred HhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 567899999999998 77889999999999999987 210 0 8999999
Q ss_pred HHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHH
Q 039565 52 YLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIV 125 (188)
Q Consensus 52 ~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~ 125 (188)
|||+ .+++|+||||+||+++.++.+||+|||+++...............++..|++|| ++.++|+||||++
T Consensus 153 ~lH~---~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 229 (304)
T cd05096 153 YLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVT 229 (304)
T ss_pred HHHH---CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHH
Confidence 9999 999999999999999999999999999987542111111122234466789988 5788999999999
Q ss_pred HHHHHh--CCccccccCCC-------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 126 ILEIIT--GILTVDLSFKG-------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 126 l~~~~~--g~~p~~~~~~~-------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
+|++++ +..||...... ..+...+..+.+++.+||+.+|++|||+++|.+.|++
T Consensus 230 l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 230 LWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred HHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 999986 44566432111 1122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=224.97 Aligned_cols=169 Identities=24% Similarity=0.305 Sum_probs=145.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++++||.+.++. +..+|++||||.+|++.+.++... ++..|+.|||+ .+.+|||+|+.|
T Consensus 65 Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaan 141 (467)
T KOG0201|consen 65 LSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAAN 141 (467)
T ss_pred HHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhh---cceecccccccc
Confidence 567889999999998 999999999999999999993222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccc------
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDL------ 138 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~------ 138 (188)
|++...|.+|++|||++.... .......++.||++||||| |+.++||||||++.+||.+|.+|+..
T Consensus 142 il~s~~g~vkl~DfgVa~ql~--~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv 219 (467)
T KOG0201|consen 142 ILLSESGDVKLADFGVAGQLT--NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV 219 (467)
T ss_pred eeEeccCcEEEEecceeeeee--chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE
Confidence 999999999999999987653 2333457899999999999 79999999999999999999998743
Q ss_pred ------cCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhh
Q 039565 139 ------SFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM--VREQ 179 (188)
Q Consensus 139 ------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~--~l~~ 179 (188)
..++..+...+..+.+++..|+.++|+.|||+.++++ .++.
T Consensus 220 lflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 220 LFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred EEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 1222334467788999999999999999999999987 3444
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=240.46 Aligned_cols=176 Identities=22% Similarity=0.286 Sum_probs=147.4
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
=|.+++||||+++.|+ ....++|.|||++|+|..|+ .+.+ .||+||.||.+ .+++||||.+
T Consensus 683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAA 759 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAA 759 (996)
T ss_pred hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhh
Confidence 3789999999999999 88899999999999999999 3333 88999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeee--cccccccCCC------CCCccchHHHHHHHHHHHh-CCccccc-
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTI--AGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDL- 138 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~--~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~- 138 (188)
.|||++.+..||++|||+++... .+......+. .-+..|.||| ++.++|+||||+++||.++ |..|+.+
T Consensus 760 RNILVNsnLvCKVsDFGLSRvle-dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 760 RNILVNSNLVCKVSDFGLSRVLE-DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred hheeeccceEEEeccccceeecc-cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 99999999999999999998653 2221112222 2234799999 8999999999999999885 7788743
Q ss_pred -----------cCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcc
Q 039565 139 -----------SFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSR 184 (188)
Q Consensus 139 -----------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 184 (188)
....+-+.+++..+.+++..||++|-.+||.+.||+.+|+++..+-
T Consensus 839 SNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 839 SNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred chHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 2333455678899999999999999999999999999999987663
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=215.18 Aligned_cols=175 Identities=18% Similarity=0.240 Sum_probs=139.6
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++||||++++++ ....++++||+++|+|.+++ .... |++.||+|||+ .+++|+|+||+|
T Consensus 63 l~~l~h~~iv~~~~~~~~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~n 139 (279)
T cd05111 63 MGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARN 139 (279)
T ss_pred HhcCCCCCcceEEEEECCCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcce
Confidence 467899999999999 66788999999999999999 2221 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFKG- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~~- 142 (188)
|+++.++.+|++|||.++...............++..|++|| ++.++|+||||+++|++++ |..||......
T Consensus 140 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~ 219 (279)
T cd05111 140 ILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219 (279)
T ss_pred EEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999987543222211222334556788888 5778999999999999998 88888543211
Q ss_pred -----------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 143 -----------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 143 -----------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
..+......+.+++..||..+|++|||+.++++.|+.+.+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 220 VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11122345678899999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=217.00 Aligned_cols=174 Identities=18% Similarity=0.213 Sum_probs=141.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc------------------c---------cHHHHHHHHh
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------------------E---------VCCPGLEYLH 54 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------------------~---------~i~~~l~~Lh 54 (188)
+++++||||++++++ ....+++|||+++++|.+++ ... + |++.|++|||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 567899999999999 77889999999999999998 211 1 8999999999
Q ss_pred cCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHH
Q 039565 55 QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILE 128 (188)
Q Consensus 55 ~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~ 128 (188)
+ .+++|+|+||+||+++.++.++++|||++................++..|++|| ++.++|+||||+++|+
T Consensus 141 ~---~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 217 (291)
T cd05094 141 S---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217 (291)
T ss_pred h---CCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence 9 999999999999999999999999999986432211111122334566789999 4778999999999999
Q ss_pred HHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 129 IIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 129 ~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
+++ |..||..... ...+...+..+.+++.+||+.+|++|||+++++++|+.+..
T Consensus 218 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 218 IFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 998 8888743211 12233456789999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=231.00 Aligned_cols=165 Identities=24% Similarity=0.307 Sum_probs=143.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|+-|.||||++++++ ..++|+++||+++|.|.+++ .+.+ |+..|+.|||. .+|.|||+||+|
T Consensus 66 MkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpEN 142 (786)
T KOG0588|consen 66 MKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPEN 142 (786)
T ss_pred HHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchh
Confidence 566899999999999 89999999999999999999 4433 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
++++..+.+||+|||.+.+.. ......+.+|++-|.+|| -+.++||||+||++|.+++|.+|||+...
T Consensus 143 lLLd~~~nIKIADFGMAsLe~---~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~ 219 (786)
T KOG0588|consen 143 LLLDVKNNIKIADFGMASLEV---PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV 219 (786)
T ss_pred hhhhcccCEeeeccceeeccc---CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH
Confidence 999999999999999987532 334566789999999999 37889999999999999999999985421
Q ss_pred -------C--CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 -------G--EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 -------~--~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
+ +.+...+..+.+++..++..||++|.|+++|++.
T Consensus 220 LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 220 LLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1 1334556788899999999999999999999873
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=225.52 Aligned_cols=173 Identities=20% Similarity=0.237 Sum_probs=137.3
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-------------------------------------
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------------------------------------- 43 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------------------------------------- 43 (188)
+.++ +||||+++++. ....+++|||+++|+|.+++ .+.
T Consensus 95 l~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred HHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 3456 79999999998 77899999999999999887 210
Q ss_pred --------------------------------------------ccHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCce
Q 039565 44 --------------------------------------------EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQA 79 (188)
Q Consensus 44 --------------------------------------------~~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~ 79 (188)
.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~ 251 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVA 251 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeE
Confidence 189999999999 999999999999999999999
Q ss_pred EEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCCC----------
Q 039565 80 KLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFKG---------- 142 (188)
Q Consensus 80 kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~~---------- 142 (188)
+|+|||++................++..|+||| ++.++|+||||+++|++++ |..||......
T Consensus 252 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~ 331 (374)
T cd05106 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG 331 (374)
T ss_pred EEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc
Confidence 999999987542111111111223445699998 5889999999999999997 99888543221
Q ss_pred ---CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 143 ---EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 143 ---~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
..+...+..+.+++..||+.+|.+|||+++|+++|+++.
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 332 YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 111223578899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=220.81 Aligned_cols=175 Identities=18% Similarity=0.254 Sum_probs=139.7
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||+++++. ....++++||+++|+|.+++ .... |++.||+|||+ .+++||||||+|
T Consensus 63 l~~l~h~niv~~~g~~~~~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~N 139 (316)
T cd05108 63 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARN 139 (316)
T ss_pred HHhCCCCCCCeEEEEEcCCCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhh
Confidence 567899999999998 67788999999999999998 3221 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFKG- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~~- 142 (188)
|+++.++.+||+|||+++...............++..|++|| ++.++|+||||+++|++++ |..||+.....
T Consensus 140 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~ 219 (316)
T cd05108 140 VLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219 (316)
T ss_pred eEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999998653222111112223345688988 5788999999999999997 88888642211
Q ss_pred -----------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 143 -----------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 143 -----------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
..+......+.+++..||+.+|++||++.+++..|......
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 220 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 11223456788999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=225.98 Aligned_cols=166 Identities=22% Similarity=0.319 Sum_probs=145.4
Q ss_pred cccccCCCeeeeccc---CCc-cEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK---QKN-NALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~-~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+++++|||||.+.+. ++. .+++|+||+||++.+.+ ++.+ |++.|+.|||+ ..|+|||+|
T Consensus 57 is~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK 133 (426)
T KOG0589|consen 57 LSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLK 133 (426)
T ss_pred HHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccch
Confidence 578999999999999 555 89999999999999999 3333 99999999998 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
+.||+++.++.++++|||+++...... ....+..||+.|++|| +..++|||||||++|||++-+.+|+....
T Consensus 134 ~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 134 CANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred hhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 999999999999999999999764222 2456789999999999 79999999999999999999988865432
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
...+...+..+..++..|++.+|..||++.+++.+
T Consensus 212 ~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 212 SELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33566778899999999999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=210.95 Aligned_cols=154 Identities=25% Similarity=0.351 Sum_probs=133.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|+.+.||.++++++. ..++++||||+++|.|.+++++.+ |++.||+|||+ .+|++|||||+|
T Consensus 98 L~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPEN 174 (355)
T KOG0616|consen 98 LKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPEN 174 (355)
T ss_pred HhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHH
Confidence 567889999999987 889999999999999999994432 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
||+|.+|.+|++|||+++... ....+.+||+.|+||| +..++|.||||+++|||+.|.+||-....
T Consensus 175 iLlD~~G~iKitDFGFAK~v~-----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i 249 (355)
T KOG0616|consen 175 LLLDQNGHIKITDFGFAKRVS-----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI 249 (355)
T ss_pred eeeccCCcEEEEeccceEEec-----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH
Confidence 999999999999999998643 2366789999999999 68899999999999999999999954332
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCC
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
-.++......+.+++...++.|-.+|
T Consensus 250 Y~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 YEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 12455566778889999999888888
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=211.73 Aligned_cols=171 Identities=24% Similarity=0.253 Sum_probs=137.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++||||++++++ ....++++||+++++|.+++ ... . |++.||+|||+ .+++|+|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp 132 (263)
T cd05052 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAA 132 (263)
T ss_pred HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCc
Confidence 567899999999998 77889999999999999998 221 1 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC-
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF- 140 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~- 140 (188)
+||+++.++.++++|||.+...... .........++..|++|| ++.++|+||||+++|++++ |..||+...
T Consensus 133 ~nil~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 211 (263)
T cd05052 133 RNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 211 (263)
T ss_pred ceEEEcCCCcEEeCCCccccccccc-eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999999998754311 111111122345688888 5678999999999999998 888875321
Q ss_pred -----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 141 -----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 141 -----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
..+.+...+..+.+++.+||+.+|++|||+.+++++|+.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 212 SQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2223344567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=220.15 Aligned_cols=166 Identities=21% Similarity=0.300 Sum_probs=135.1
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
.+.+++||||++++++ .+..+++|||+++++|.+++.. .. |++.||.|||+. .+++|+|+||+
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~ 133 (331)
T cd06649 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPS 133 (331)
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChh
Confidence 3578899999999998 7789999999999999999822 21 899999999971 36999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE 143 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~ 143 (188)
||+++.++.++|+|||++..... .......|+..|++|| ++.++|+||||+++|++++|+.||......+
T Consensus 134 Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 209 (331)
T cd06649 134 NILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209 (331)
T ss_pred hEEEcCCCcEEEccCcccccccc----cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999998864321 1223456888999999 5788999999999999999999985321100
Q ss_pred -----------------------------------------------------------cCHHHHHHHHHHHHHccCcCC
Q 039565 144 -----------------------------------------------------------FDIISVEKAVEIAMASVSSKV 164 (188)
Q Consensus 144 -----------------------------------------------------------~~~~~~~~~~~l~~~cl~~~p 164 (188)
.....+..+.+++.+||+.+|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P 289 (331)
T cd06649 210 LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNP 289 (331)
T ss_pred HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCc
Confidence 001234678899999999999
Q ss_pred CCCCCHHHHHHH
Q 039565 165 NRRPLMNQVVMV 176 (188)
Q Consensus 165 ~~Rps~~~i~~~ 176 (188)
++|||++++++.
T Consensus 290 ~~Rpt~~ell~h 301 (331)
T cd06649 290 AERADLKMLMNH 301 (331)
T ss_pred ccCCCHHHHhcC
Confidence 999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=210.77 Aligned_cols=171 Identities=22% Similarity=0.253 Sum_probs=138.3
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+.+++||||++++++ .+..++++||+++++|.+++.+. . |++.|++|||+ .+++|+|+||.||
T Consensus 50 l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~ni 126 (257)
T cd05116 50 MQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNV 126 (257)
T ss_pred HHhCCCCCcceEEEEEcCCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhE
Confidence 567899999999998 77889999999999999998322 1 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcc-eeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC--
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHM-STTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK-- 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~-~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~-- 141 (188)
+++.++.++++|||.+........... .....++..|++|| .+.++|+||||+++|++++ |..||.....
T Consensus 127 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 206 (257)
T cd05116 127 LLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206 (257)
T ss_pred EEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999875432211111 11122345788998 4668999999999999998 8888864321
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
.+.+...+..+.+++.+||+.+|++||++++|.+.|++
T Consensus 207 ~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 207 VTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 22344567789999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=217.16 Aligned_cols=169 Identities=27% Similarity=0.317 Sum_probs=129.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC--cc-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK--EE-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~--~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||++++|+ .+..++|+||+++|+|.+++ .. .. |++.||.|||+ .+++|+++++
T Consensus 55 l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~ 131 (259)
T PF07714_consen 55 LRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSP 131 (259)
T ss_dssp HHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SG
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccc
Confidence 567899999999999 66789999999999999999 33 12 99999999999 8999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~ 141 (188)
.||+++.++.+||+|||++....................|++|| ++.++||||||+++||+++ |..|+.....
T Consensus 132 ~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~ 211 (259)
T PF07714_consen 132 SNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN 211 (259)
T ss_dssp GGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999887542111111122234556788998 5889999999999999999 6788753211
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVR 177 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l 177 (188)
...+...+..+.+++..||..+|++|||+++|++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 212 EEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 123334567899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=221.33 Aligned_cols=165 Identities=19% Similarity=0.246 Sum_probs=136.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. .+..++||||+++++|..++ .... |++.||+|||+ .+++||||||+|
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~N 125 (323)
T cd05571 49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLEN 125 (323)
T ss_pred HHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHH
Confidence 467899999999887 78899999999999999988 3221 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.+||+|||+++.... .........|+..|+||| ++.++|+|||||++|+|++|..||.....
T Consensus 126 Ill~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 203 (323)
T cd05571 126 LMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203 (323)
T ss_pred EEECCCCCEEEeeCCCCccccc--CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH
Confidence 9999999999999999864221 112233467899999999 57889999999999999999999854321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
..++...+..+.+++..||+.||++|| ++.++++
T Consensus 204 ~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 204 FELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 123344567889999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=215.08 Aligned_cols=175 Identities=17% Similarity=0.197 Sum_probs=140.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Cc---------------c---------cHHHHHHHHhcCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KE---------------E---------VCCPGLEYLHQGL 57 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~---------------~---------~i~~~l~~Lh~~~ 57 (188)
+.+++||||+++++. ....++++||+++++|.+++. .. . |++.||+|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-- 138 (288)
T cd05093 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-- 138 (288)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--
Confidence 567899999999988 788999999999999999882 11 1 89999999999
Q ss_pred CCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh
Q 039565 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~ 131 (188)
.+++|||+||+||+++.++.++++|||.+................++..|++|| ++.++|+||||+++|+|++
T Consensus 139 -~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 139 -QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred -CCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999987442111111112233456789998 5778999999999999998
Q ss_pred -CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 132 -GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 132 -g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
|..||..... ...+...+..+.+++.+||+.+|.+|||++++++.|+++...
T Consensus 218 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 218 YGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 8888753221 112223456899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=209.48 Aligned_cols=171 Identities=20% Similarity=0.235 Sum_probs=134.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++++||+++++|.+++ .... |++.||.|||+ .+++|+|++|.
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~ 123 (252)
T cd05084 47 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAAR 123 (252)
T ss_pred HHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchh
Confidence 467899999999988 77889999999999999998 2221 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
||+++.++.++++|||.+.................+..|++|| ++.++|+||||+++|++++ |..||+...
T Consensus 124 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~ 203 (252)
T cd05084 124 NCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ 203 (252)
T ss_pred eEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH
Confidence 9999999999999999886432110000001112234588888 4678999999999999997 777774321
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
....+...+..+.+++.+|++.+|++|||++++.++|+.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 204 QTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 122334456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=221.40 Aligned_cols=165 Identities=24% Similarity=0.281 Sum_probs=134.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. .+..+++|||+++|+|.+++ .+.. |++.||.|||+ .+++||||||+|
T Consensus 47 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~N 123 (312)
T cd05585 47 LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPEN 123 (312)
T ss_pred HHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHH
Confidence 567899999999887 78899999999999999998 3222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++++|||+++.... .........|+..|+||| ++.++|+|||||++|+|++|..||.....
T Consensus 124 ili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~ 201 (312)
T cd05585 124 ILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM 201 (312)
T ss_pred eEECCCCcEEEEECcccccCcc--CCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH
Confidence 9999999999999999874321 112233457889999999 57889999999999999999999854221
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCC---HHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPL---MNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps---~~~i~~ 175 (188)
..++...+..+.+++..||+.+|.+||+ +.+++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 202 YRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 1233345567889999999999999985 555544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=212.02 Aligned_cols=165 Identities=19% Similarity=0.195 Sum_probs=133.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++|||+|.++++ ...++||+|||+..-|.+.-.. .+ |++.|+.|+|+ .+++|||+||+|
T Consensus 55 LKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPEN 131 (396)
T KOG0593|consen 55 LKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPEN 131 (396)
T ss_pred HHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhh
Confidence 568999999999999 8899999999997444443322 12 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF--- 140 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~--- 140 (188)
|+++.+|.+|++|||+++.... ....-+.+.+|.+|.||| |+..+|||++||++.||++|.+.|....
T Consensus 132 ILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD 209 (396)
T KOG0593|consen 132 ILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID 209 (396)
T ss_pred eEEecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence 9999999999999999997542 333455678899999999 7899999999999999999997442111
Q ss_pred ------------------------------------CCCc---CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 ------------------------------------KGEF---DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ------------------------------------~~~~---~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+.. -...+..+.+++..|++.||.+|++-+|++.
T Consensus 210 QLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 210 QLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0001 1123446789999999999999999999875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=210.38 Aligned_cols=172 Identities=22% Similarity=0.253 Sum_probs=138.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c---c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E---E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||+++++. ....++++||+++++|.+++.. . . |++.|+.|||+ .+++|+|++|.
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~ 135 (266)
T cd05033 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAAR 135 (266)
T ss_pred HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcc
Confidence 567899999999998 7788999999999999999822 1 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
||+++.++.++++|||++................++..|++|| ++.++|+||||+++|++++ |..||....
T Consensus 136 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~ 215 (266)
T cd05033 136 NILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215 (266)
T ss_pred eEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence 9999999999999999987653111111111223345688888 4778999999999999997 888874321
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
..+.+...+..+.+++.+||+.+|++||++++|+++|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 216 DVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1122334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=211.54 Aligned_cols=172 Identities=22% Similarity=0.240 Sum_probs=134.7
Q ss_pred cccccCCCeeeeccc---------CCccEEEEecCCCCChhhhc--CC----c---c---------cHHHHHHHHhcCCC
Q 039565 6 RNKLTGPLLVELIGK---------QKNNALELGFRGNPELVDQQ--GK----E---E---------VCCPGLEYLHQGLK 58 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~--~~----~---~---------~i~~~l~~Lh~~~~ 58 (188)
+.+++||||+++++. ....++++||+++|+|.+++ .. . . |++.||+|||+
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--- 130 (272)
T cd05075 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--- 130 (272)
T ss_pred HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---
Confidence 567899999999886 12468999999999999887 11 1 1 89999999999
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT- 131 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~- 131 (188)
.+++|+|+||+||+++.++.++++|||+++...............++..|++|| ++.++|+||||+++|++++
T Consensus 131 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~ 210 (272)
T cd05075 131 KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210 (272)
T ss_pred CCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcC
Confidence 999999999999999999999999999987543211111112234456688887 5788999999999999998
Q ss_pred CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 132 GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 132 g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
|..||..... ...+...+..+.+++..||+.+|++|||++++++.|+++
T Consensus 211 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 211 GQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 7788853211 112233456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=220.43 Aligned_cols=166 Identities=23% Similarity=0.312 Sum_probs=135.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+.+++|+||++++++ ....++++||+++++|...... .. |++.||.|||+ .+++||||||+||+++
T Consensus 126 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 202 (353)
T PLN00034 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLIN 202 (353)
T ss_pred HHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEc
Confidence 567899999999998 7788999999999999776521 11 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCCC-----------CCccchHHHHHHHHHHHhCCccccccCCC-
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-----------TEKSDVDSFEIVILEIITGILTVDLSFKG- 142 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-----------~~~~di~s~G~~l~~~~~g~~p~~~~~~~- 142 (188)
.++.+||+|||++..... .........|+..|++||. +.++|||||||++|+|++|..||......
T Consensus 203 ~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~ 280 (353)
T PLN00034 203 SAKNVKIADFGVSRILAQ--TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280 (353)
T ss_pred CCCCEEEcccccceeccc--ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 999999999999875421 1112234568889999993 24799999999999999999999632211
Q ss_pred --------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 143 --------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 143 --------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
+.+...+..+.+++..||+.+|++|||++++++.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 281 WASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223345688999999999999999999999874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=219.95 Aligned_cols=168 Identities=26% Similarity=0.317 Sum_probs=137.1
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhc-CCc--c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQ-GKE--E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~-~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
|++++|||||+++++ .++.|||+|||..|.+...= +.. . ++..||+|||. .+||||||||
T Consensus 162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKP 238 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKP 238 (576)
T ss_pred HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccch
Confidence 678999999999999 78999999999988775443 222 1 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCC---CCCcceeeecccccccCCC----------CCCccchHHHHHHHHHHHhCCcc
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVE---GGTHMSTTIAGTAGFLNTE----------LTEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~---~~~~~~~~~~~~~~~~~pe----------~~~~~di~s~G~~l~~~~~g~~p 135 (188)
+|+|++++|++||+|||++...... +.........||+.++||| .+.+.||||+||++|-++-|+.|
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 9999999999999999998754322 1222233478999999999 25689999999999999999999
Q ss_pred ccccCC-----------CCcC--HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 136 VDLSFK-----------GEFD--IISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 136 ~~~~~~-----------~~~~--~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
|-.... -+++ .+..+.+.+++..+|.+||++|.+..+|...
T Consensus 319 F~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 319 FFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred cccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 854221 1122 2457789999999999999999999988654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=220.97 Aligned_cols=163 Identities=20% Similarity=0.227 Sum_probs=136.5
Q ss_pred ccccc-CCCeeeeccc---CC-ccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLT-GPLLVELIGK---QK-NNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~-Hpniv~~~~~---~~-~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
|.+|+ |||||++.++ .+ ++++|||||+. +|.+.+ ++.. |+++||+|+|. +|+.|||+|
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlK 137 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLK 137 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCC
Confidence 56788 9999999999 34 89999999994 999999 4433 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+|||+..+..+||+|||+++... +...-+.+..|.+|+||| |+.+.|+|++||+++|+.+-++.|....
T Consensus 138 PENiLi~~~~~iKiaDFGLARev~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 138 PENILISGNDVIKIADFGLAREVR---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred hhheEecccceeEecccccccccc---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 999999999999999999998543 344456678889999999 7999999999999999999887553210
Q ss_pred ----------------CCC--------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 141 ----------------KGE--------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 141 ----------------~~~--------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
..+ .+ .++..+.+++..|+.-||.+|||+++.+++
T Consensus 215 E~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 215 EIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000 12 256678899999999999999999999874
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=212.35 Aligned_cols=173 Identities=20% Similarity=0.244 Sum_probs=136.5
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCC--cc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGK--EE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||++++++ ....+++|||+++++|.+++.. .. |++.||.|||+ .+++|+|+||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~ 136 (283)
T cd05080 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAAR 136 (283)
T ss_pred HHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChh
Confidence 567899999999987 3457899999999999999832 22 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCc-ceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTH-MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.++++|||++.......... ......++..|++|| .+.++|+||||+++|++++|..|+......
T Consensus 137 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 216 (283)
T cd05080 137 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK 216 (283)
T ss_pred eEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch
Confidence 9999999999999999987543211111 111223445678887 578899999999999999999876432110
Q ss_pred ---------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 143 ---------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 143 ---------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
..+...+..+.+++..||+.+|++|||+++++++|+.+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 217 FEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 011223568999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=209.08 Aligned_cols=173 Identities=21% Similarity=0.260 Sum_probs=139.1
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+++++||||++++++ .+..++++||+.+++|.+++ +... |++.||+|||+ .+++|+|++|+||
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~ni 126 (257)
T cd05060 50 MAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNV 126 (257)
T ss_pred HHhcCCCCeeeEEEEEcCCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceE
Confidence 567899999999999 77789999999999999999 2221 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCc-ceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC--
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTH-MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK-- 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~-- 141 (188)
+++.++.++++|||.+.......... ......++..|++|| ++.++|+||||+++|++++ |..||+....
T Consensus 127 li~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~ 206 (257)
T cd05060 127 LLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206 (257)
T ss_pred EEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999999987543221111 011122334688888 5778999999999999998 8899864321
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
.+.+...+..+.+++.+||+.+|++||++.++++.|++..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 207 VIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1223345578899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=210.66 Aligned_cols=175 Identities=19% Similarity=0.240 Sum_probs=139.7
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||++++++ ....++++||+++|+|.+++ .... |++.||.|||+ .+++|+|+||+|
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~N 139 (279)
T cd05109 63 MAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARN 139 (279)
T ss_pred HHhcCCCCCceEEEEEcCCCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence 456889999999998 66788999999999999999 3221 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~-- 141 (188)
|+++.++.++|+|||+++...............++..|++|| ++.++|+||||+++|++++ |..||+....
T Consensus 140 il~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 219 (279)
T cd05109 140 VLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219 (279)
T ss_pred EEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999987553222111111223455788998 5778999999999999998 8888864221
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
...+...+..+.+++..||+.+|++||++.++++.|+.....
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 220 IPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 112234566888999999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=209.39 Aligned_cols=169 Identities=25% Similarity=0.321 Sum_probs=135.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Ccc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....+++|||+++|+|.+++. ... |++.||+|||+ .+++|+|++|+
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ 129 (256)
T cd05114 53 MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAAR 129 (256)
T ss_pred HHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcc
Confidence 567899999999988 778899999999999999983 221 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~~ 142 (188)
||+++.++.++++|||.+..... ..........++..|++|| ++.++|+||||+++|++++ |..||......
T Consensus 130 ni~i~~~~~~kl~d~g~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05114 130 NCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208 (256)
T ss_pred eEEEcCCCeEEECCCCCccccCC-CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999998864321 1111111223445688888 4678999999999999999 88888543211
Q ss_pred ------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 143 ------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 143 ------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
..+...+..+.+++..||+.+|++|||++++++.|.
T Consensus 209 ~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 209 EVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 122334567899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=212.67 Aligned_cols=171 Identities=18% Similarity=0.189 Sum_probs=135.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c------------c---------cHHHHHHHHhcCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E------------E---------VCCPGLEYLHQGLKHP 60 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~------------~---------~i~~~l~~Lh~~~~~~ 60 (188)
+.+++||||++++++ ....++++||+++++|.+++.+ . . |++.||.|||+ .+
T Consensus 63 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~ 139 (277)
T cd05062 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NK 139 (277)
T ss_pred HHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CC
Confidence 456889999999998 6788999999999999998821 1 0 89999999999 99
Q ss_pred cEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CC
Q 039565 61 IIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GI 133 (188)
Q Consensus 61 i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~ 133 (188)
++|+|+||+||+++.++.++++|||++................++..|++|| ++.++|+||||+++|++++ |.
T Consensus 140 ~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~ 219 (277)
T cd05062 140 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 219 (277)
T ss_pred cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999886432111111111223456789998 5788999999999999998 67
Q ss_pred ccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 134 LTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 134 ~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
.||..... ...+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 220 QPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 77753221 11223345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=209.27 Aligned_cols=170 Identities=23% Similarity=0.285 Sum_probs=136.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++||||+++++. .+..++++||+++++|.+++ .... |++.||+|||+ .+++|+|++|
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p 131 (261)
T cd05072 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRA 131 (261)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccch
Confidence 467899999999888 77889999999999999998 2211 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~ 141 (188)
+||+++.++.++++|||++...... .........++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 132 ~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 132 ANVLVSESLMCKIADFGLARVIEDN-EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred hhEEecCCCcEEECCCccceecCCC-ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 9999999999999999998754311 111112223455688888 4678999999999999998 8888853211
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
.+.....+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 211 SDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11222345688999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=217.28 Aligned_cols=163 Identities=24% Similarity=0.259 Sum_probs=135.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. ....+++|||+++++|.+++.+ .. |++.||.|||+ .+++||||||+|
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~N 131 (291)
T cd05612 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPEN 131 (291)
T ss_pred HHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHH
Confidence 567899999999988 7788999999999999999822 21 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++++|||++..... ......|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 132 Ili~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~ 206 (291)
T cd05612 132 ILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI 206 (291)
T ss_pred eEECCCCCEEEEecCcchhccC-----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999875421 122346888999999 57889999999999999999999865321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPL-----MNQVVMV 176 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~i~~~ 176 (188)
..++......+.+++..||+.||.+||+ ++++++.
T Consensus 207 ~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 207 YEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1233344667899999999999999995 8887763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=221.29 Aligned_cols=135 Identities=21% Similarity=0.233 Sum_probs=107.8
Q ss_pred cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccc
Q 039565 45 VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSD 118 (188)
Q Consensus 45 ~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~d 118 (188)
|++.||.|||+ .+++|+|+||+||+++.++.+|++|||+++...............++..|++|| ++.++|
T Consensus 245 qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 321 (400)
T cd05105 245 QVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSD 321 (400)
T ss_pred HHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhh
Confidence 78999999999 999999999999999999999999999987543221111122334566799998 578899
Q ss_pred hHHHHHHHHHHHh-CCccccccCC-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 119 VDSFEIVILEIIT-GILTVDLSFK-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 119 i~s~G~~l~~~~~-g~~p~~~~~~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
+||||+++|++++ |..||..... ...+...+..+.+++..||+.+|++||++.+|.++|+.+.+
T Consensus 322 iwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 322 VWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 9999999999997 8888754221 12233456789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=207.84 Aligned_cols=172 Identities=20% Similarity=0.237 Sum_probs=137.5
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcC-Cc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQG-KE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~-~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++++||+++++|.+++. +. . |++.||.|||+ .+++|+||||+|
T Consensus 49 l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~n 125 (257)
T cd05115 49 MHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARN 125 (257)
T ss_pred HHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchhe
Confidence 567899999999999 677899999999999999982 22 1 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcc-eeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHM-STTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~-~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
|+++.++.++++|||++........... .....++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 126 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 205 (257)
T cd05115 126 VLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205 (257)
T ss_pred EEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 9999999999999999875432211111 11122245688888 4678999999999999996 8888854321
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
...+...+..+.+++..||+.+|++||++.+|.+.|+..
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 206 EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 123334567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=208.78 Aligned_cols=172 Identities=22% Similarity=0.231 Sum_probs=135.8
Q ss_pred cccccCCCeeeeccc---CC------ccEEEEecCCCCChhhhc-CC--------cc---------cHHHHHHHHhcCCC
Q 039565 6 RNKLTGPLLVELIGK---QK------NNALELGFRGNPELVDQQ-GK--------EE---------VCCPGLEYLHQGLK 58 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~------~~~lv~e~~~~~~L~~~~-~~--------~~---------~i~~~l~~Lh~~~~ 58 (188)
+.+++||||++++++ .. ..++++||+++++|..++ .. .. |++.||+|||+
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--- 131 (273)
T cd05035 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--- 131 (273)
T ss_pred HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---
Confidence 456889999999987 22 368999999999999887 11 11 99999999999
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT- 131 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~- 131 (188)
.+++|+|+||+||++++++.++++|||+++...............++..|++|| ++.++|+||||+++|++++
T Consensus 132 ~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~ 211 (273)
T cd05035 132 RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211 (273)
T ss_pred CCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhC
Confidence 999999999999999999999999999987543222111122223455678888 5788999999999999998
Q ss_pred CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 132 GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 132 g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
|..||..... ...+...+..+.+++..||+.+|++|||+.++++.|+++
T Consensus 212 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 212 GQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 7788753221 122334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=220.49 Aligned_cols=165 Identities=20% Similarity=0.242 Sum_probs=135.5
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCCcc-------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGKEE-------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
|++++||||+++.++ ...+|||||||++ +|..++...+ |++.||+|||+ .+|.|||||
T Consensus 170 Lr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK 245 (560)
T KOG0600|consen 170 LRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIK 245 (560)
T ss_pred HHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeecccc
Confidence 678999999999999 4689999999996 8999884432 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
.+|||++.+|.+||+|||+++++... .....+....|.+|.+|| |+.+.|+||.||++.||+.|++.|....
T Consensus 246 ~SNiLidn~G~LKiaDFGLAr~y~~~-~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 246 GSNILIDNNGVLKIADFGLARFYTPS-GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred ccceEEcCCCCEEeccccceeeccCC-CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 99999999999999999999976532 323355567888999999 7999999999999999999997442111
Q ss_pred -------------------C--------------CCcC-------HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 -------------------K--------------GEFD-------IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 -------------------~--------------~~~~-------~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+ ..+. ...+....+++..+|..||.+|.|+.+.++
T Consensus 325 EveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 325 EVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 0011 122346779999999999999999998875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=223.70 Aligned_cols=176 Identities=23% Similarity=0.317 Sum_probs=147.8
Q ss_pred CcccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCCc-c------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 5 NRNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGKE-E------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
.+++=+|-||+-+.|+ ...+++|+.+|.+.+|..+++.. . |+|+|+.|||. ++|||+|||..
T Consensus 441 ~lkkTRH~NIlLFMG~~~~p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSn 517 (678)
T KOG0193|consen 441 VLKKTRHENILLFMGACMNPPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSN 517 (678)
T ss_pred HHhhcchhhheeeehhhcCCceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhcccc
Confidence 4567789999999999 66669999999999999999222 2 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||++.+++.+||+|||++.....-..........|...||||| |+..+||||||+++|||++|..||....
T Consensus 518 NIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~ 597 (678)
T KOG0193|consen 518 NIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN 597 (678)
T ss_pred ceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC
Confidence 9999999999999999987533222333344567888899999 7999999999999999999999996332
Q ss_pred CCC----------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 141 KGE----------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 141 ~~~----------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
.+. ....+.+.+.+++..||..++++||++.+|+..|+.+..+
T Consensus 598 ~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 598 RDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred hhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 211 2335677899999999999999999999999988887763
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=223.77 Aligned_cols=164 Identities=23% Similarity=0.270 Sum_probs=141.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE---E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++|||||.++++ ..+.|+|+||+.+ +|..++... + |+..||.|||+ .+|+|||+||+|
T Consensus 55 ~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqn 130 (808)
T KOG0597|consen 55 LRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQN 130 (808)
T ss_pred HHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcce
Confidence 467999999999999 8999999999996 999999332 2 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccccc-----
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLS----- 139 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~----- 139 (188)
|+++.++.+|++|||+++.+.. .........||+.||||| ++..+|.||+||++||+.+|++||-..
T Consensus 131 iLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~L 208 (808)
T KOG0597|consen 131 ILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQL 208 (808)
T ss_pred eeecCCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHH
Confidence 9999999999999999997642 333455678999999999 789999999999999999999998321
Q ss_pred ------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 140 ------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 140 ------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+...+...+..+.+++...+++||.+|.|+.+++.
T Consensus 209 v~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 209 VKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 112234467788999999999999999999999876
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=218.02 Aligned_cols=165 Identities=24% Similarity=0.277 Sum_probs=136.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. .+..+++|||+++++|.+++.+.+ |++.||.|||+ .+++||||||+|
T Consensus 54 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~N 130 (323)
T cd05584 54 LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPEN 130 (323)
T ss_pred HHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHH
Confidence 567899999999888 778899999999999999982222 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.+||+|||+++.... .........|+..|++|| ++.++|+||||+++|+|++|..||.....
T Consensus 131 il~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~ 208 (323)
T cd05584 131 ILLDAQGHVKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT 208 (323)
T ss_pred eEECCCCCEEEeeCcCCeeccc--CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999998864321 111233456889999999 46789999999999999999999864321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
...+...+..+.+++..||+.+|++|| +++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 209 IDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 123334466789999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=218.96 Aligned_cols=165 Identities=20% Similarity=0.268 Sum_probs=135.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. .+..++||||+++|+|..++ +... |++.||.|||+ .+++||||||+|
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~N 125 (323)
T cd05595 49 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLEN 125 (323)
T ss_pred HHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHH
Confidence 467899999999887 78899999999999999888 2221 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG-- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~-- 142 (188)
|+++.++.+||+|||++.... ..........|+..|++|| ++.++|+|||||++|++++|..||......
T Consensus 126 Ill~~~~~~kL~Dfg~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~ 203 (323)
T cd05595 126 LMLDKDGHIKITDFGLCKEGI--SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 203 (323)
T ss_pred EEEcCCCCEEecccHHhcccc--CCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999876421 1111223456889999999 478899999999999999999998543211
Q ss_pred ---------CcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 143 ---------EFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 143 ---------~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
.++...+..+.+++..||+.+|.+|| ++.++++
T Consensus 204 ~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 204 FELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 12334567889999999999999998 7888775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=209.81 Aligned_cols=171 Identities=18% Similarity=0.191 Sum_probs=137.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-----------------c---------cHHHHHHHHhcC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-----------------E---------VCCPGLEYLHQG 56 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-----------------~---------~i~~~l~~Lh~~ 56 (188)
+.+++||||++++++ ....+++|||+++++|.+++... . |++.|+.|||+
T Consensus 62 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~- 140 (280)
T cd05049 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS- 140 (280)
T ss_pred HHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-
Confidence 567899999999999 78899999999999999998211 0 89999999999
Q ss_pred CCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHH
Q 039565 57 LKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEII 130 (188)
Q Consensus 57 ~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~ 130 (188)
.+++|+|++|+||+++.++.++++|||.+................++..|+||| ++.++|+||||+++|+++
T Consensus 141 --~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~ 218 (280)
T cd05049 141 --QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIF 218 (280)
T ss_pred --CCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHH
Confidence 999999999999999999999999999886432111111122234456789998 578899999999999999
Q ss_pred h-CCccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 131 T-GILTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 131 ~-g~~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
+ |..||.... ....+...+..+.+++..||+.+|++||++.++++.|++
T Consensus 219 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 219 TYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 8 988874321 112233456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=211.73 Aligned_cols=175 Identities=21% Similarity=0.238 Sum_probs=140.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc---------------------------c---------cH
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE---------------------------E---------VC 46 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~---------------------------~---------~i 46 (188)
+.+++||||+++++. ....++++||+.+++|.+++... . |+
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 567899999999988 77889999999999999987210 0 89
Q ss_pred HHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchH
Q 039565 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVD 120 (188)
Q Consensus 47 ~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~ 120 (188)
+.||.|||+ .+++|||++|+||++++++.++++|||+++...............++..|++|| .+.++|+|
T Consensus 137 ~~~l~~LH~---~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 137 SRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred HHHHHHHHH---CCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 999999999 999999999999999999999999999987542222111122233455788888 57889999
Q ss_pred HHHHHHHHHHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 121 SFEIVILEIIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 121 s~G~~l~~~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
|||+++|++++ |..||+.... ...+...+..+.+++..||+.+|++||++.++++.|+++..+
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 99999999998 8888854321 112334556899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=208.68 Aligned_cols=164 Identities=19% Similarity=0.208 Sum_probs=130.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Ccc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+..++||||++++++ ....++++||+++++|..++. +.. |++.||+|||+ .+++|+|+||+
T Consensus 58 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~ 134 (262)
T cd05077 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTK 134 (262)
T ss_pred HHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcc
Confidence 457899999999998 677899999999999998882 221 99999999999 99999999999
Q ss_pred cEEEccCCc-------eEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHH-hCCc
Q 039565 70 NILLNEKVQ-------AKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEII-TGIL 134 (188)
Q Consensus 70 nill~~~~~-------~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~-~g~~ 134 (188)
||+++.++. ++++|||++..... .....++..|++|| ++.++|+||||+++|+++ .|..
T Consensus 135 Nill~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~ 208 (262)
T cd05077 135 NILLAREGIDGECGPFIKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEI 208 (262)
T ss_pred cEEEecCCccCCCCceeEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 999986653 89999998764321 12234566789998 356799999999999997 5777
Q ss_pred cccccCCCC----------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 135 TVDLSFKGE----------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 135 p~~~~~~~~----------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
|+......+ ........+.+++..||+.+|++||++.+|++.|+
T Consensus 209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 209 PLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred CCCCcchhHHHHHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 775432111 11123467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=209.78 Aligned_cols=171 Identities=19% Similarity=0.222 Sum_probs=137.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c------------c---------cHHHHHHHHhcCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E------------E---------VCCPGLEYLHQGLKHP 60 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~------------~---------~i~~~l~~Lh~~~~~~ 60 (188)
+..++||||++++++ ....++++||+++++|.+++.. . . |++.||.|||+ .+
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~ 139 (277)
T cd05032 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KK 139 (277)
T ss_pred HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence 467899999999998 7889999999999999998821 0 1 89999999999 99
Q ss_pred cEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CC
Q 039565 61 IIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GI 133 (188)
Q Consensus 61 i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~ 133 (188)
++|+|++|+||+++.++.++++|||.++...............++..|++|| .+.++|+||||+++|++++ |.
T Consensus 140 i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 219 (277)
T cd05032 140 FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAE 219 (277)
T ss_pred ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCC
Confidence 9999999999999999999999999887532111111122234556788888 5788999999999999998 88
Q ss_pred ccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 134 LTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 134 ~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
.||.... ....+...+..+.+++..||+.+|++|||+.++++.|+.
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 220 QPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 8874321 112233456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=207.26 Aligned_cols=170 Identities=22% Similarity=0.273 Sum_probs=137.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++||||++++++ .+..++++||+++++|.+++ ...+ |++.|+.|||+ .+++|+|++|
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p 131 (261)
T cd05068 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAA 131 (261)
T ss_pred HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCc
Confidence 567899999999988 77889999999999999998 3321 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~ 141 (188)
+||+++.++.++++|||++...... ..........+..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 132 ~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 132 RNVLVGENNICKVADFGLARVIKED-IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred ceEEEcCCCCEEECCcceEEEccCC-cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999998754311 111111122234688898 4778999999999999999 8888854221
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
...+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 211 AEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11233456789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=207.68 Aligned_cols=169 Identities=24% Similarity=0.309 Sum_probs=135.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....+++|||+.+++|.+++.. . . |++.||.|||+ .+++|+|++|.
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ 129 (256)
T cd05113 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAAR 129 (256)
T ss_pred HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcc
Confidence 677899999999998 6678999999999999999822 1 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
||+++.++.+|++|||.+...... .........++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 130 nili~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 208 (256)
T cd05113 130 NCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS 208 (256)
T ss_pred eEEEcCCCCEEECCCccceecCCC-ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 999999999999999988754211 111111223445688888 4778999999999999998 8888753221
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
...+...+..+.+++..||+.+|++||++.+|++.|+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 209 ETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1122234578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=212.39 Aligned_cols=164 Identities=23% Similarity=0.270 Sum_probs=135.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C-Cc-c-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G-KE-E-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~-~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++||||+++.+. .+..++++||+++|+|..++ . .. . |++.||+|||+ .+++||||||
T Consensus 54 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp 130 (285)
T cd05631 54 LEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKP 130 (285)
T ss_pred HHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCH
Confidence 467889999999887 77899999999999998877 2 11 1 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
+||+++.++.++++|||++..... ........|+..|+||| ++.++|+|||||++|++++|..||.....
T Consensus 131 ~Nill~~~~~~kl~Dfg~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 207 (285)
T cd05631 131 ENILLDDRGHIRISDLGLAVQIPE---GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207 (285)
T ss_pred HHEEECCCCCEEEeeCCCcEEcCC---CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence 999999999999999999875421 11223456888999999 57889999999999999999999964322
Q ss_pred --------------CCcCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 039565 142 --------------GEFDIISVEKAVEIAMASVSSKVNRRPL-----MNQVVM 175 (188)
Q Consensus 142 --------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~i~~ 175 (188)
..++...+..+.+++..||+.+|.+||+ ++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 208 VKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred hhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1123345567889999999999999997 788887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=215.53 Aligned_cols=165 Identities=24% Similarity=0.315 Sum_probs=135.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+++++||||++++++ .+..++||||+++++|..++.... |++.||.|||+ .+++||||||+||
T Consensus 56 ~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Ni 132 (324)
T cd05589 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNL 132 (324)
T ss_pred ccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHe
Confidence 356789999999998 788999999999999998883322 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK---- 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~---- 141 (188)
+++.++.+||+|||++..... .........|+..|++|| ++.++|+||||+++|+|++|..||.....
T Consensus 133 ll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~ 210 (324)
T cd05589 133 LLDTEGFVKIADFGLCKEGMG--FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210 (324)
T ss_pred EECCCCcEEeCcccCCccCCC--CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999998764321 112233467889999999 57789999999999999999999864321
Q ss_pred -------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 142 -------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 142 -------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
...+...+..+.+++.+||+.+|.+|| ++.++++
T Consensus 211 ~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 211 DSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 112333466788999999999999999 5666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=218.66 Aligned_cols=166 Identities=20% Similarity=0.266 Sum_probs=135.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++.+. .+..++||||+++|+|..++ .... |++.||+|||+ .+++||||||+|
T Consensus 49 l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~N 125 (328)
T cd05593 49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLEN 125 (328)
T ss_pred HHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHH
Confidence 467899999999887 78899999999999999888 2221 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG-- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~-- 142 (188)
|+++.++.+||+|||+++.... .........|+..|++|| ++.++|+|||||++|++++|..||......
T Consensus 126 Ill~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~ 203 (328)
T cd05593 126 LMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203 (328)
T ss_pred eEECCCCcEEEecCcCCccCCC--cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH
Confidence 9999999999999999864221 111223456889999999 578899999999999999999998543211
Q ss_pred ---------CcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 039565 143 ---------EFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVMV 176 (188)
Q Consensus 143 ---------~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~~ 176 (188)
.++...+..+.+++..||+.+|++|| ++.++++.
T Consensus 204 ~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 204 FELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 12333456789999999999999997 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=212.57 Aligned_cols=166 Identities=19% Similarity=0.154 Sum_probs=132.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. .+..++||||++++.+..+.... . |++.||.|||+ .+++|+||||+|
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~N 130 (287)
T cd07848 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPEN 130 (287)
T ss_pred HHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHH
Confidence 567899999999988 78899999999987776655221 1 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG-- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~-- 142 (188)
|+++.++.+||+|||++..... ..........|+..|++|| ++.++|+|||||++|++++|..||......
T Consensus 131 ill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~ 209 (287)
T cd07848 131 LLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209 (287)
T ss_pred EEEcCCCcEEEeeccCcccccc-cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999875431 1111223456788899998 578899999999999999999988532110
Q ss_pred ---------Cc--------------------------------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 ---------EF--------------------------------DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ---------~~--------------------------------~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.. ....+..+.+++.+||+.+|++|||++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 210 LFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 0013456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=207.22 Aligned_cols=174 Identities=22% Similarity=0.257 Sum_probs=135.5
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhcCC-cc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQGK-EE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~~~-~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
++.++||||+++++. +...++++||+.+++|.+++.+ .. |++.||.|||+ .+++|+|++|
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~ 126 (262)
T cd05058 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAA 126 (262)
T ss_pred HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCc
Confidence 467899999999996 4457899999999999999822 21 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCC--cceeeecccccccCCC------CCCccchHHHHHHHHHHHhC-Ccccccc
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGT--HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITG-ILTVDLS 139 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~--~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g-~~p~~~~ 139 (188)
+||+++.++.++++|||++......... .......++..|++|| ++.++|+||||+++|++++| ..||...
T Consensus 127 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 206 (262)
T cd05058 127 RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206 (262)
T ss_pred ceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999988743211110 0111233455788888 47789999999999999995 4555421
Q ss_pred CC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 140 FK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 140 ~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
.. ...+...+..+.+++..||+.+|++||++.++++.|+++..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 207 DSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 11 11122345688999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=215.95 Aligned_cols=173 Identities=20% Similarity=0.207 Sum_probs=137.8
Q ss_pred ccc-cCCCeeeeccc----CCccEEEEecCCCCChhhhcCC-c-------------------------------------
Q 039565 7 NKL-TGPLLVELIGK----QKNNALELGFRGNPELVDQQGK-E------------------------------------- 43 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~~~-~------------------------------------- 43 (188)
.++ +||||+++++. ....++++||+++++|.+++.. .
T Consensus 65 ~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (337)
T cd05054 65 IHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSAS 144 (337)
T ss_pred HhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccc
Confidence 455 79999999987 5678899999999999988711 0
Q ss_pred -----------------------------------ccHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 44 -----------------------------------EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 44 -----------------------------------~~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
.|++.||+|||+ .+++|||+||.||+++.++.++|+|||++.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~ 221 (337)
T cd05054 145 SGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLAR 221 (337)
T ss_pred cccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccch
Confidence 189999999999 999999999999999999999999999987
Q ss_pred cccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCCC-------------CcCHHH
Q 039565 89 ISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFKG-------------EFDIIS 148 (188)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~~-------------~~~~~~ 148 (188)
...............++..|++|| ++.++|+|||||++|++++ |..||...... ..+...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (337)
T cd05054 222 DIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYA 301 (337)
T ss_pred hcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence 543222111122334556799999 5788999999999999997 88888542211 112234
Q ss_pred HHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 149 VEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 149 ~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
+..+.+++..||+.+|++||++++++++|+.+.+
T Consensus 302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=210.05 Aligned_cols=171 Identities=19% Similarity=0.271 Sum_probs=136.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Cc-------------------c---------cHHHHHHHH
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KE-------------------E---------VCCPGLEYL 53 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~-------------------~---------~i~~~l~~L 53 (188)
+.+++||||++++++ ....+++|||+++++|.+++. +. . |++.||.||
T Consensus 61 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 140 (283)
T cd05090 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140 (283)
T ss_pred HhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 567899999999998 778899999999999999871 10 0 899999999
Q ss_pred hcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHH
Q 039565 54 HQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 54 h~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~ 127 (188)
|+ .+++|+|+||+||+++.++.++++|||++................++..|++|| ++.++|+||||+++|
T Consensus 141 H~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 217 (283)
T cd05090 141 SS---HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLW 217 (283)
T ss_pred Hh---cCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHH
Confidence 99 999999999999999999999999999987543222111222334456688888 478899999999999
Q ss_pred HHHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 128 EIIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 128 ~~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
++++ |..||..... ...+...+..+.+++..||+.+|++||++.+|.+.|..
T Consensus 218 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 218 EIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 9998 8888743211 11223456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=207.58 Aligned_cols=170 Identities=21% Similarity=0.263 Sum_probs=137.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+..++||||++++++ ....+++|||+++++|.+++.. .+ |++.|+.|||+ .+++|+|++|
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~ 132 (261)
T cd05148 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAA 132 (261)
T ss_pred HhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCc
Confidence 567899999999988 7788999999999999999832 21 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~ 141 (188)
+||+++.++.++++|||.+...... ........++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 133 ~nilv~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~ 210 (261)
T cd05148 133 RNILVGEDLVCKVADFGLARLIKED--VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210 (261)
T ss_pred ceEEEcCCceEEEccccchhhcCCc--cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999999988754211 11112233455688887 5778999999999999998 7888853221
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
...+...+..+.+++.+||+.+|.+|||++++++.|+.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 211 HEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 122334567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=220.11 Aligned_cols=162 Identities=24% Similarity=0.312 Sum_probs=134.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. .+..+++|||+.+++|.+++.+. . |++.||.|||+ .+++||||||+|
T Consensus 72 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~N 148 (329)
T PTZ00263 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPEN 148 (329)
T ss_pred HHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHH
Confidence 567899999999988 78899999999999999998222 1 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.+||+|||++..... ......|++.|+||| ++.++|+|||||++|+|++|..||.....
T Consensus 149 Ill~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 223 (329)
T PTZ00263 149 LLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223 (329)
T ss_pred EEECCCCCEEEeeccCceEcCC-----CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH
Confidence 9999999999999999875421 122457888999999 57889999999999999999999854321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPL-----MNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~i~~ 175 (188)
...+...+..+.+++..||+.||.+||+ +++++.
T Consensus 224 ~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 224 YEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1122334567889999999999999996 677764
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=209.33 Aligned_cols=169 Identities=20% Similarity=0.214 Sum_probs=131.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Cc-------c---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KE-------E---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~-------~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+.+++||||+++++. ....+++|||+++|+|.+++. .. . |++.|+.|||+ .+++|+|
T Consensus 49 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d 125 (269)
T cd05087 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSD 125 (269)
T ss_pred HHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccc
Confidence 467899999999998 677899999999999999882 11 0 89999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC-------------CCccchHHHHHHHHHHHh-
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-------------TEKSDVDSFEIVILEIIT- 131 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-------------~~~~di~s~G~~l~~~~~- 131 (188)
+||.||+++.++.++++|||.+................++..|++||. +.++|+||||+++|++++
T Consensus 126 lkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05087 126 LALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFEL 205 (269)
T ss_pred cCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhC
Confidence 999999999999999999998864321111111223445667899982 568999999999999996
Q ss_pred CCccccccCCC-----------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 132 GILTVDLSFKG-----------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 132 g~~p~~~~~~~-----------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
|..||...... .........+.+++..|| .+|++|||+++|++.|+
T Consensus 206 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 206 GSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 98888532111 111123456788999999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=208.82 Aligned_cols=169 Identities=20% Similarity=0.209 Sum_probs=130.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc----------------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE----------------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~----------------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
++.++||||+++++. ....+++|||+++|+|.+++ .... |++.|++|||+ .+++|||
T Consensus 49 ~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~d 125 (269)
T cd05042 49 YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSD 125 (269)
T ss_pred HHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEeccc
Confidence 456789999999988 77899999999999999998 2110 89999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------------CCCccchHHHHHHHHHHHh-
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------------LTEKSDVDSFEIVILEIIT- 131 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------------~~~~~di~s~G~~l~~~~~- 131 (188)
+||+||+++.++.+|++|||++................++..|++|| .+.++|+||||+++|++++
T Consensus 126 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05042 126 LALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205 (269)
T ss_pred ccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhC
Confidence 99999999999999999999886432111111112223445688887 2568999999999999998
Q ss_pred CCccccccCC-----------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 132 GILTVDLSFK-----------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 132 g~~p~~~~~~-----------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
|..||..... ...+...+..+.+++..|| .+|++|||+++|++.|.
T Consensus 206 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 206 ADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 6777743211 1122244566778889998 49999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=211.60 Aligned_cols=174 Identities=20% Similarity=0.204 Sum_probs=137.9
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc---------------------------ccHHHHHHHH
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE---------------------------EVCCPGLEYL 53 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~---------------------------~~i~~~l~~L 53 (188)
+..+ +||||+++++. ....+++|||+.+++|.+++ .+. .|++.||.||
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L 153 (304)
T cd05101 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL 153 (304)
T ss_pred HHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH
Confidence 3456 79999999998 77889999999999999998 221 0899999999
Q ss_pred hcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHH
Q 039565 54 HQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 54 h~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~ 127 (188)
|+ .+++|+|+||+||+++.++.++++|||+++...............++..|++|| ++.++|+||||+++|
T Consensus 154 H~---~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 230 (304)
T cd05101 154 AS---QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230 (304)
T ss_pred HH---CCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHH
Confidence 99 999999999999999999999999999987543222211222233456789998 577899999999999
Q ss_pred HHHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 128 EIIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 128 ~~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
++++ |..||..... ...+...+..+.+++..||+.+|.+|||+.++++.|+++..
T Consensus 231 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 231 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 9998 6677643211 11223345788999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=210.75 Aligned_cols=171 Identities=20% Similarity=0.289 Sum_probs=135.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc--------------c---------cHHHHHHHHhcCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE--------------E---------VCCPGLEYLHQGLK 58 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~--------------~---------~i~~~l~~Lh~~~~ 58 (188)
+++++|||+++++++ ....+++|||+++++|.+++ ... . |++.||.|||+
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--- 147 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--- 147 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---
Confidence 577999999999998 78899999999999999988 211 1 89999999999
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT- 131 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~- 131 (188)
.+++|+|+||+||+++.++.+|++|||++................++..|++|| ++.++|+||||+++|++++
T Consensus 148 ~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 148 LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred cCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 999999999999999999999999999887542111111112233456788888 4789999999999999988
Q ss_pred -CCccccccCCC-------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 132 -GILTVDLSFKG-------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 132 -g~~p~~~~~~~-------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
+..||...... ..+...+..+.+++..||+.+|++|||+++|++.|++
T Consensus 228 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 228 CKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 44566432110 1122235679999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=210.90 Aligned_cols=172 Identities=22% Similarity=0.220 Sum_probs=136.6
Q ss_pred ccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c--------------c-------------cHHHHHHHHh
Q 039565 7 NKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E--------------E-------------VCCPGLEYLH 54 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~--------------~-------------~i~~~l~~Lh 54 (188)
.++ +||||+++++. ....+++|||+++|+|..++.. . . |++.||+|||
T Consensus 70 ~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 149 (293)
T cd05053 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA 149 (293)
T ss_pred HhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 355 79999999998 7788999999999999999821 1 0 8999999999
Q ss_pred cCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHH
Q 039565 55 QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILE 128 (188)
Q Consensus 55 ~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~ 128 (188)
+ .+++|+|+||.||+++.++.++++|||.+................++..|++|| ++.++|+||||+++|+
T Consensus 150 ~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 226 (293)
T cd05053 150 S---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE 226 (293)
T ss_pred H---CCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHH
Confidence 9 999999999999999999999999999987543211111111223445688998 5778999999999999
Q ss_pred HHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 129 IIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 129 ~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
+++ |..||..... .+.+...+..+.+++..|+..+|++|||+.++++.|+.+.
T Consensus 227 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 227 IFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 997 8777743211 1223344568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=209.51 Aligned_cols=171 Identities=18% Similarity=0.262 Sum_probs=136.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-C------------------cc---------cHHHHHHHHh
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-K------------------EE---------VCCPGLEYLH 54 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~------------------~~---------~i~~~l~~Lh 54 (188)
+.+++||||++++++ ....++++||+++++|..++. . .. |++.||.|||
T Consensus 62 ~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH 141 (283)
T cd05091 62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141 (283)
T ss_pred HhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 356889999999998 678899999999999999872 1 01 8999999999
Q ss_pred cCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHH
Q 039565 55 QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILE 128 (188)
Q Consensus 55 ~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~ 128 (188)
+ .+++|||+||.||+++.++.+|++|||+++...............++..|++|| ++.++|+||||+++|+
T Consensus 142 ~---~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 218 (283)
T cd05091 142 S---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWE 218 (283)
T ss_pred H---cCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHH
Confidence 9 999999999999999999999999999887543221111122234456799998 5778999999999999
Q ss_pred HHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 129 IIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 129 ~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
+++ |..||..... ...+...+..+.+++..||+.+|.+||++.+|++.|+.
T Consensus 219 l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 219 VFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 998 7777643211 11233456678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=211.07 Aligned_cols=172 Identities=20% Similarity=0.218 Sum_probs=137.3
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.++ +||||+++++. .+..++++||+++++|.+++ ... . |++.||.|||+ .+++|+|++
T Consensus 92 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlk 168 (302)
T cd05055 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLA 168 (302)
T ss_pred HHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhc
Confidence 3466 79999999988 77899999999999999998 321 1 89999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~ 140 (188)
|+||+++.++.++++|||++................++..|++|| ++.++|+||||+++|++++ |..||....
T Consensus 169 p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 169 ARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred cceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 999999999999999999987543221111112234556799999 4778999999999999998 888874322
Q ss_pred C-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 141 K-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 141 ~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
. ...+...+..+.+++..|++.+|++|||+.++++.|++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 249 VDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred chHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1 111223456889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=207.59 Aligned_cols=164 Identities=15% Similarity=0.132 Sum_probs=130.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+..++||||+++++. +...++||||+++|+|..++ .+.. |++.||+|||+ .+++|||+||+
T Consensus 53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~ 129 (258)
T cd05078 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAK 129 (258)
T ss_pred HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccc
Confidence 456889999999999 68899999999999999999 3221 99999999999 99999999999
Q ss_pred cEEEccCCc--------eEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCC-
Q 039565 70 NILLNEKVQ--------AKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGI- 133 (188)
Q Consensus 70 nill~~~~~--------~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~- 133 (188)
||+++.++. ++++|||++.... ......++..|++|| ++.++|+||||+++|++++|.
T Consensus 130 nili~~~~~~~~~~~~~~~l~d~g~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 203 (258)
T cd05078 130 NVLLIREEDRKTGNPPFIKLSDPGISITVL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGD 203 (258)
T ss_pred eEEEecccccccCCCceEEecccccccccC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999987654 6899999876432 112245667789998 366799999999999999985
Q ss_pred ccccccCC----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 134 LTVDLSFK----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 134 ~p~~~~~~----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
.|+..... ...+.....++.+++..||+.+|++|||+++|++.|+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 204 KPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CChhhccHHHHHHHHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 55533211 1122233467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=204.87 Aligned_cols=170 Identities=24% Similarity=0.282 Sum_probs=137.1
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++|||+++++++ ....+++|||+++++|.+++ .... |++.||.|||+ .+++|+|++|.
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~ 131 (260)
T cd05069 55 MKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAA 131 (260)
T ss_pred HHhCCCCCeeeEEEEEcCCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcc
Confidence 567899999999988 67789999999999999998 2221 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
||++++++.++++|||.+....... ........++..|++|| .+.++|+||||+++|++++ |..||.....
T Consensus 132 Nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 210 (260)
T cd05069 132 NILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210 (260)
T ss_pred eEEEcCCCeEEECCCccceEccCCc-ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987542111 11111223456688888 4678999999999999998 8888854221
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
...+...+..+.+++.+||..+|++||+++++++.|+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 211 EVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 12233456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=215.63 Aligned_cols=164 Identities=22% Similarity=0.328 Sum_probs=132.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..+++|||+++++|.+++.+.. |++.||.|||+. .+++|+||||+|
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~N 134 (333)
T cd06650 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSN 134 (333)
T ss_pred HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhh
Confidence 567899999999998 788999999999999999983221 899999999971 479999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCCc
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGEF 144 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~~ 144 (188)
|+++.++.+|++|||++..... .......|+..|++|| ++.++|+|||||++|++++|..||+.......
T Consensus 135 ili~~~~~~kL~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 210 (333)
T cd06650 135 ILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210 (333)
T ss_pred EEEcCCCCEEEeeCCcchhhhh----hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 9999999999999998864321 1122346788899999 57789999999999999999988853211000
Q ss_pred ---------------------------------------------------------CHHHHHHHHHHHHHccCcCCCCC
Q 039565 145 ---------------------------------------------------------DIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 145 ---------------------------------------------------------~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
....+..+.+++.+||+.+|++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 290 (333)
T cd06650 211 ELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAER 290 (333)
T ss_pred HHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccC
Confidence 00123467899999999999999
Q ss_pred CCHHHHHH
Q 039565 168 PLMNQVVM 175 (188)
Q Consensus 168 ps~~~i~~ 175 (188)
||++++++
T Consensus 291 pt~~ell~ 298 (333)
T cd06650 291 ADLKQLMV 298 (333)
T ss_pred cCHHHHhh
Confidence 99999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=209.93 Aligned_cols=171 Identities=18% Similarity=0.251 Sum_probs=134.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----------------------ccHHHHHHHHhcCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----------------------EVCCPGLEYLHQGLKH 59 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----------------------~~i~~~l~~Lh~~~~~ 59 (188)
+.+++||||++++++ .+..++++||+++++|.+++ ... .|++.|++|||+ .
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~ 149 (296)
T cd05095 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---L 149 (296)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---C
Confidence 567899999999998 77889999999999999998 211 089999999999 9
Q ss_pred CcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh--
Q 039565 60 PIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-- 131 (188)
Q Consensus 60 ~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-- 131 (188)
+++|+|+||+||+++.++.++++|||++................++..|++|| ++.++|+||||+++|++++
T Consensus 150 ~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~ 229 (296)
T cd05095 150 NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229 (296)
T ss_pred CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhC
Confidence 99999999999999999999999999987542111111111223345677876 5789999999999999998
Q ss_pred CCccccccCCC-------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 132 GILTVDLSFKG-------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 132 g~~p~~~~~~~-------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
|..||...... +.+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 230 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 230 KEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 55676432110 1122345788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=209.70 Aligned_cols=175 Identities=17% Similarity=0.187 Sum_probs=138.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c---------c------------cHHHHHHHHhcCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E---------E------------VCCPGLEYLHQGLKHP 60 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~---------~------------~i~~~l~~Lh~~~~~~ 60 (188)
+.+++||||++++++ +...+++|||+++|+|.+++.+ . . |++.||.|||+ .+
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~ 139 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KK 139 (288)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence 567899999999998 7788999999999999999921 0 0 89999999999 99
Q ss_pred cEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CC
Q 039565 61 IIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GI 133 (188)
Q Consensus 61 i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~ 133 (188)
++|+|+||+||+++.++.++++|||+++...............++..|++|| ++.++|+||||+++|++++ |.
T Consensus 140 i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~ 219 (288)
T cd05061 140 FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 219 (288)
T ss_pred CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999887532211111112223455688888 4788999999999999998 67
Q ss_pred ccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 134 LTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 134 ~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
.||..... ...+...+..+.+++.+|++.+|++|||+.++++.|+.....
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 220 QPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 77753221 112223457899999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=208.37 Aligned_cols=171 Identities=22% Similarity=0.218 Sum_probs=133.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc---------c---------cHHHHHHHHhcCCCCCcEE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE---------E---------VCCPGLEYLHQGLKHPIIQ 63 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~---------~---------~i~~~l~~Lh~~~~~~i~h 63 (188)
+.+++||||++++++ ....++++||+++++|.+++ ... . |++.||.|||+ .+++|
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH 139 (277)
T cd05036 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIH 139 (277)
T ss_pred HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEee
Confidence 567899999999997 67789999999999999998 211 1 89999999999 89999
Q ss_pred eCCCCCcEEEccCC---ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CC
Q 039565 64 RDMKSTNILLNEKV---QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GI 133 (188)
Q Consensus 64 ~dl~~~nill~~~~---~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~ 133 (188)
+|++|+||+++.++ .++++|||.++................+..|++|| ++.++|+|||||++|++++ |.
T Consensus 140 ~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~ 219 (277)
T cd05036 140 RDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219 (277)
T ss_pred cccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 99999999998754 58999999987542111111111222335688888 6889999999999999996 88
Q ss_pred ccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 134 LTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 134 ~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
.||+.... .+.+...+..+.+++.+|++.+|++|||+.++++.|++
T Consensus 220 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 220 MPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 88864321 12233445688999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-33 Score=227.54 Aligned_cols=164 Identities=22% Similarity=0.285 Sum_probs=145.1
Q ss_pred ccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc--------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 7 NKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE--------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 7 ~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~--------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
++++|+|||+.+|. +...-+.||-.+||+|.+.+ .+++ |+++||.|||+ ..|+|||+|-
T Consensus 627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKG 703 (1226)
T KOG4279|consen 627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKG 703 (1226)
T ss_pred HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccC
Confidence 46899999999999 66677899999999999999 5554 99999999999 9999999999
Q ss_pred CcEEEcc-CCceEEecccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCccccc-
Q 039565 69 TNILLNE-KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTVDL- 138 (188)
Q Consensus 69 ~nill~~-~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~~- 138 (188)
+|++++. .|.+||+|||-+++. .+-.....+++||..||||| ++.++|||||||++.||.||++||-+
T Consensus 704 DNVLvNTySGvlKISDFGTsKRL--AginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 704 DNVLVNTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred CcEEEeeccceEEecccccchhh--ccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 9999975 689999999988864 34445677899999999999 78999999999999999999999843
Q ss_pred -------------cCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 -------------SFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 -------------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...++.+...+.+...++..|...+|..||++.++++
T Consensus 782 gspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 782 GSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1235678889999999999999999999999999986
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=208.47 Aligned_cols=164 Identities=19% Similarity=0.191 Sum_probs=129.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||++++++ ....++||||+++|+|..++.+ .+ |++.||+|||+ .+++||||||+
T Consensus 70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~ 146 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAK 146 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcc
Confidence 467899999999999 7788999999999999999822 21 99999999999 99999999999
Q ss_pred cEEEccCC-------ceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHH-hCCc
Q 039565 70 NILLNEKV-------QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEII-TGIL 134 (188)
Q Consensus 70 nill~~~~-------~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~-~g~~ 134 (188)
||+++..+ .++++|||.+...... ....++..|++|| ++.++|+||||+++|+++ +|..
T Consensus 147 Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 220 (274)
T cd05076 147 NILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV 220 (274)
T ss_pred cEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99997643 3799999987543211 1123556688888 467899999999999985 7888
Q ss_pred cccccCCCC----------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 135 TVDLSFKGE----------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 135 p~~~~~~~~----------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
||......+ .+......+.+++..||+.+|++|||+.+|++.|.
T Consensus 221 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 221 PLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred CccccChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 886432211 12222357899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=209.25 Aligned_cols=171 Identities=18% Similarity=0.196 Sum_probs=136.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-----------------c---------cHHHHHHHHhc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-----------------E---------VCCPGLEYLHQ 55 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-----------------~---------~i~~~l~~Lh~ 55 (188)
+.+++||||+++++. ....++++||+++++|.+++ ... . |++.|++|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 567899999999988 67789999999999999988 211 1 89999999999
Q ss_pred CCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHH
Q 039565 56 GLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEI 129 (188)
Q Consensus 56 ~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~ 129 (188)
.+++|+|+||+||++++++.++++|||++................++..|++|| ++.++|+||||+++|++
T Consensus 141 ---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 217 (280)
T cd05092 141 ---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217 (280)
T ss_pred ---CCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 999999999999999999999999999886442111111112223456789998 57889999999999999
Q ss_pred Hh-CCccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 130 IT-GILTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 130 ~~-g~~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
++ |..||.... ....+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 218 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 218 FTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 98 888874321 112233456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=207.07 Aligned_cols=171 Identities=19% Similarity=0.259 Sum_probs=139.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC----Ccc------------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG----KEE------------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~----~~~------------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+++++||||+++++. .+..++++||+++++|.+++. ... |++.||+|||+ .+++|+|+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl 132 (267)
T cd08228 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDI 132 (267)
T ss_pred HHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCC
Confidence 467899999999988 778899999999999998772 111 89999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
+|+||+++.++.++++|||.+...... ........++..|++|| .+.++|+||||+++|++++|..||....
T Consensus 133 ~~~nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 133 KPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CHHHEEEcCCCCEEECccccceeccch--hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 999999999999999999988754311 11122345777899998 4678999999999999999998874321
Q ss_pred C---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 141 K---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 141 ~---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
. .......+..+.+++.+||..+|++||++.++++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 211 MNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1 1112345578999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=205.31 Aligned_cols=171 Identities=22% Similarity=0.246 Sum_probs=138.1
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCC-c----c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGK-E----E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||+++++. ....+++|||+++++|.+++.+ . . |++.||+|||+ .+++|+|++|.
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ 131 (262)
T cd05071 55 MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAA 131 (262)
T ss_pred HHhCCCCCcceEEEEECCCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcc
Confidence 467899999999987 6678999999999999999832 1 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
||+++.++.++++|||.+....... ........++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 132 Nill~~~~~~~L~dfg~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~ 210 (262)
T cd05071 132 NILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210 (262)
T ss_pred cEEEcCCCcEEeccCCceeeccccc-cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence 9999999999999999887543111 11111233455688998 4778999999999999999 7788754321
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
...+...+..+.+++..|++.+|++||++.++++.|+..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 211 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 122334567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-33 Score=219.04 Aligned_cols=163 Identities=23% Similarity=0.265 Sum_probs=136.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||++++++ ....+++|||+.+|+|.+++.. .. |++.||.|||+ .+++||||||+|
T Consensus 85 l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~N 161 (340)
T PTZ00426 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPEN 161 (340)
T ss_pred HHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHH
Confidence 467899999999998 7788999999999999999922 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++|+|||++..... ......|++.|+||| ++.++|+|||||++|+|++|..||.....
T Consensus 162 ILl~~~~~ikL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 236 (340)
T PTZ00426 162 LLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236 (340)
T ss_pred EEECCCCCEEEecCCCCeecCC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999999875421 123457889999999 57889999999999999999999864321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVMV 176 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~~ 176 (188)
...+...+..+.+++..|++.+|++|+ +++++++.
T Consensus 237 ~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 237 YQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 112334456788999999999999995 88888763
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=206.88 Aligned_cols=169 Identities=16% Similarity=0.204 Sum_probs=130.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc----c------------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE----E------------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~----~------------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+..++||||+++++. ....+++|||+++|+|.+++.+. . |++.||.|||+ .+++|+|+
T Consensus 49 ~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~di 125 (268)
T cd05086 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDL 125 (268)
T ss_pred HhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence 456899999999998 67889999999999999988221 1 89999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC-------------CCccchHHHHHHHHHHHhC-
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-------------TEKSDVDSFEIVILEIITG- 132 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-------------~~~~di~s~G~~l~~~~~g- 132 (188)
||+||+++.++.++++|||++................++..|++||. +.++|+||||+++|+++++
T Consensus 126 kp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 205 (268)
T cd05086 126 ALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205 (268)
T ss_pred ccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC
Confidence 99999999999999999998753211111111223456777888983 4679999999999999974
Q ss_pred CccccccCC-----------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 133 ILTVDLSFK-----------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 133 ~~p~~~~~~-----------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
..||+.... ..........+.+++..|| .+|++||++++|++.|.
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 206 AQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 567642211 1112234567788999999 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-33 Score=217.18 Aligned_cols=163 Identities=17% Similarity=0.213 Sum_probs=136.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||+++++. .+..+++|||+++++|.+++.+.. |++.||.|||+ .+++||||||+|
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~N 131 (333)
T cd05600 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPEN 131 (333)
T ss_pred HHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHH
Confidence 456789999999988 778999999999999999983221 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE- 143 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~- 143 (188)
|+++.++.+||+|||++..... ......|++.|++|| ++.++|+|||||++|+|++|..||+.....+
T Consensus 132 il~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~ 206 (333)
T cd05600 132 FLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206 (333)
T ss_pred EEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH
Confidence 9999999999999999875321 233456888999999 5788999999999999999999986432111
Q ss_pred ------------cC------HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 144 ------------FD------IISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 144 ------------~~------~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
.+ ...+..+.+++..||..+|.+||+++++++.
T Consensus 207 ~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 207 WENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01 1236788999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=204.97 Aligned_cols=170 Identities=23% Similarity=0.265 Sum_probs=136.8
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCC-c----c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGK-E----E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++|||++++++. ....+++|||+++++|.+++.. . . |++.||.|||+ .+++|+|++|.
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~ 131 (260)
T cd05070 55 MKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSA 131 (260)
T ss_pred HHhcCCCceEEEEeEECCCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccc
Confidence 567899999999988 6778999999999999999822 1 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
||+++.++.++++|||.+........ .......++..|++|| .+.++|+||||+++|++++ |..||.....
T Consensus 132 Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 132 NILVGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred eEEEeCCceEEeCCceeeeeccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999875431111 1111223445688998 4678999999999999998 8888854221
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
.+.+...+..+.+++.+|+..+|++|||++++.+.|++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 211 EVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=222.11 Aligned_cols=173 Identities=20% Similarity=0.251 Sum_probs=145.2
Q ss_pred CcccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCCcc-------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 5 NRNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGKEE-------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
.|..++|||||+++|+ ....|+|||.++-|.|..|+++.. |++.||+|||+ ...+|||+...
T Consensus 444 iMrnfdHphIikLIGv~~e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaR 520 (974)
T KOG4257|consen 444 IMRNFDHPHIIKLIGVCVEQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAAR 520 (974)
T ss_pred HHHhCCCcchhheeeeeeccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhh
Confidence 4788999999999999 899999999999999999993333 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCcccccc---
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLS--- 139 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~--- 139 (188)
|||++++..+|++|||+++.+.. ..........-+.-||+|| ++.++|+|-|||++||++. |..||..-
T Consensus 521 NiLVsSp~CVKLaDFGLSR~~ed-~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 521 NILVSSPQCVKLADFGLSRYLED-DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred heeecCcceeeecccchhhhccc-cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence 99999999999999999986532 2212222333345799999 7999999999999999984 77888432
Q ss_pred ---------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 140 ---------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 140 ---------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
...+.+..++..+..++.+||..+|.+||++.+|...|..+.
T Consensus 600 DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 600 DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 223456788999999999999999999999999998886554
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=207.90 Aligned_cols=174 Identities=17% Similarity=0.158 Sum_probs=139.3
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhcCCc--------c------------cHHHHHHHHhcCCCCCc
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQGKE--------E------------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~~~~--------~------------~i~~~l~~Lh~~~~~~i 61 (188)
+.+++||||++++++ +...+++++|+++++|.+++... . |++.||+|||+ .++
T Consensus 62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i 138 (280)
T cd05043 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGV 138 (280)
T ss_pred HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCE
Confidence 567899999999997 57789999999999999998221 1 89999999999 999
Q ss_pred EEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCc
Q 039565 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GIL 134 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~ 134 (188)
+|+|++|+||+++.++.++++|||+++.+.............++..|++|| ++.++|+||||+++|++++ |..
T Consensus 139 ~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 218 (280)
T cd05043 139 IHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQT 218 (280)
T ss_pred eecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCC
Confidence 999999999999999999999999987543211111112233455688998 5788999999999999998 888
Q ss_pred cccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 135 TVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 135 p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
||+.... ...+...+..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 219 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 219 PYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 8864211 11222345689999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=204.73 Aligned_cols=171 Identities=20% Similarity=0.256 Sum_probs=135.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC------c---c---------cHHHHHHHHhcCCCCCcEE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK------E---E---------VCCPGLEYLHQGLKHPIIQ 63 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~------~---~---------~i~~~l~~Lh~~~~~~i~h 63 (188)
+++++||||++++++ ....++++||+++++|.+++ +. . . |++.||.|||+ .+++|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H 129 (269)
T cd05044 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIH 129 (269)
T ss_pred HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCccc
Confidence 567899999999998 77889999999999999998 21 0 0 89999999999 89999
Q ss_pred eCCCCCcEEEccCC-----ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-
Q 039565 64 RDMKSTNILLNEKV-----QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT- 131 (188)
Q Consensus 64 ~dl~~~nill~~~~-----~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~- 131 (188)
+|++|+||+++.++ .++++|||++................++..|++|| ++.++|+||||+++|+|++
T Consensus 130 ~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~ 209 (269)
T cd05044 130 RDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTL 209 (269)
T ss_pred CCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHc
Confidence 99999999999877 89999999886442111111112223455688888 5788999999999999998
Q ss_pred CCccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 132 GILTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 132 g~~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
|..||.... ....+...+..+.+++.+||+.+|.+||+++++++.|++
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 210 GQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 888875321 112233456788999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=215.50 Aligned_cols=166 Identities=20% Similarity=0.219 Sum_probs=129.7
Q ss_pred cccccCCCeeeeccc---C-----CccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---Q-----KNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~-----~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+++++||||++++++ . ...+++|||++ ++|.+++... . |++.||.|||+ .+++|||
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~d 128 (338)
T cd07859 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRD 128 (338)
T ss_pred HHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCC
Confidence 567899999999987 1 24799999997 6898888322 1 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCC-CcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
|||+||+++.++.+||+|||+++....... ........|+..|+||| ++.++|+|||||++|+|++|..||
T Consensus 129 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf 208 (338)
T cd07859 129 LKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208 (338)
T ss_pred CCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999875321111 11123356888999998 356899999999999999999988
Q ss_pred cccCCCC-------------------------------------cC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 039565 137 DLSFKGE-------------------------------------FD-----IISVEKAVEIAMASVSSKVNRRPLMNQVV 174 (188)
Q Consensus 137 ~~~~~~~-------------------------------------~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~ 174 (188)
....... .+ ......+.+++..||+.+|++|||+++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 209 PGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 5321100 00 01134567999999999999999999998
Q ss_pred H
Q 039565 175 M 175 (188)
Q Consensus 175 ~ 175 (188)
+
T Consensus 289 ~ 289 (338)
T cd07859 289 A 289 (338)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=211.14 Aligned_cols=164 Identities=21% Similarity=0.245 Sum_probs=129.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||++++++ ....++||||+. ++|.+++ .... |++.||.|||+ .+++||||||+
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~ 132 (303)
T cd07869 57 LKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQ 132 (303)
T ss_pred HhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHH
Confidence 467899999999998 788999999997 5787777 3221 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.+||+|||++....... .......++..|+||| ++.++|+||+||++|+|++|..||......
T Consensus 133 Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 210 (303)
T cd07869 133 NLLISDTGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210 (303)
T ss_pred HEEECCCCCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 9999999999999999886432111 1122345778899998 356789999999999999999998542110
Q ss_pred -----------------Cc------------------CH---------HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 -----------------EF------------------DI---------ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 -----------------~~------------------~~---------~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+ +. ..+..+.+++..|++.+|.+|||++++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 211 QDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 00 01245779999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=204.69 Aligned_cols=168 Identities=23% Similarity=0.310 Sum_probs=133.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++++||+++++|.+++ .+.. |++.|++|||+ .+++|+|++|+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ 129 (256)
T cd05059 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAAR 129 (256)
T ss_pred HHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHh
Confidence 567899999999988 77889999999999999998 2221 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
||+++.++.++++|||.++... ...........++..|++|| ++.++|+||||+++|++++ |..||+....
T Consensus 130 ni~i~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 208 (256)
T cd05059 130 NCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS 208 (256)
T ss_pred hEEECCCCcEEECCcccceecc-cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH
Confidence 9999999999999999886432 11111111122334688888 5678999999999999998 7888853221
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVR 177 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l 177 (188)
...+...+..+.+++.+||+.+|++|||++++++.|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 209 EVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 122234567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=226.49 Aligned_cols=179 Identities=21% Similarity=0.200 Sum_probs=143.9
Q ss_pred Cccccc-CCCeeeeccc----------CCccEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHhcCCCC
Q 039565 5 NRNKLT-GPLLVELIGK----------QKNNALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLHQGLKH 59 (188)
Q Consensus 5 ~l~~l~-Hpniv~~~~~----------~~~~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~ 59 (188)
.|++|+ |||||.+++. .....|+||||.+|.|.+++ ++.. |+|+|+++||. ...
T Consensus 87 ~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~p 165 (738)
T KOG1989|consen 87 IMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKP 165 (738)
T ss_pred HHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCC
Confidence 467777 9999999993 24567999999999999999 3332 99999999996 234
Q ss_pred CcEEeCCCCCcEEEccCCceEEecccCcccccCCC-CCcce------eeecccccccCCC---------CCCccchHHHH
Q 039565 60 PIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEG-GTHMS------TTIAGTAGFLNTE---------LTEKSDVDSFE 123 (188)
Q Consensus 60 ~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~-~~~~~------~~~~~~~~~~~pe---------~~~~~di~s~G 123 (188)
.+||||||.+|+|++.++.+||+|||.+....... ..... -...-|+.|++|| +++++|||+||
T Consensus 166 PiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALG 245 (738)
T KOG1989|consen 166 PIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALG 245 (738)
T ss_pred ccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHH
Confidence 59999999999999999999999999876432222 11111 1245678899999 68999999999
Q ss_pred HHHHHHHhCCccccccCC---------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcc
Q 039565 124 IVILEIITGILTVDLSFK---------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSR 184 (188)
Q Consensus 124 ~~l~~~~~g~~p~~~~~~---------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 184 (188)
|++|.++-...||+..-. -.-...++..+.+||..||+.+|++||++-|++..+..+....
T Consensus 246 clLYkLCy~t~PFe~sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 246 CLLYKLCYFTTPFEESGKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred HHHHHHHHhCCCcCcCcceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 999999999999986511 1122478999999999999999999999999999887776653
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=208.28 Aligned_cols=171 Identities=19% Similarity=0.256 Sum_probs=136.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-------------c---------cHHHHHHHHhcCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-------------E---------VCCPGLEYLHQGLKH 59 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-------------~---------~i~~~l~~Lh~~~~~ 59 (188)
+.+++||||++++++ ....++++||+++++|.+++ ... . |++.||+|||+ .
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~ 149 (296)
T cd05051 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---L 149 (296)
T ss_pred HHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---c
Confidence 577899999999998 68899999999999999998 222 1 89999999999 9
Q ss_pred CcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh--
Q 039565 60 PIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-- 131 (188)
Q Consensus 60 ~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-- 131 (188)
+++|+|+||+||+++.++.++++|||++................++..|++|| ++.++|+||||+++|++++
T Consensus 150 ~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 229 (296)
T cd05051 150 NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229 (296)
T ss_pred CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence 99999999999999999999999999987542222112222344566799998 4788999999999999998
Q ss_pred CCccccccCC-------------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 132 GILTVDLSFK-------------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 132 g~~p~~~~~~-------------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
+..||..... ...+...+..+.+++..||+.+|++|||+++|++.|++
T Consensus 230 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 230 REQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred CCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 5566643211 01112234689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=207.47 Aligned_cols=172 Identities=20% Similarity=0.251 Sum_probs=132.6
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||+++.++ ....++++||+++++|.+++ +.. . |++.||.|||+ .+++|+|+|
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlk 135 (284)
T cd05081 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLA 135 (284)
T ss_pred HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCC
Confidence 567899999999886 45689999999999999998 221 1 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcce-eeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMS-TTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~-~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+||+++.++.++++|||++............ ....++..|++|| ++.++|+||||+++|++++|..++....
T Consensus 136 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 215 (284)
T cd05081 136 TRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP 215 (284)
T ss_pred HhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc
Confidence 99999999999999999998764322111111 1112233578888 5778999999999999999765432110
Q ss_pred C-------C---------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 141 K-------G---------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 141 ~-------~---------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
. . ..+...+..+.+++..||..+|++|||+.+|++.|+.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 216 AEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 0 01112345799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=209.64 Aligned_cols=172 Identities=24% Similarity=0.290 Sum_probs=135.7
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c------------------c---------cHHHHHHHH
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E------------------E---------VCCPGLEYL 53 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~------------------~---------~i~~~l~~L 53 (188)
+.++ +||||+++++. ....++++||+++++|.+++.+ . . |++.||+||
T Consensus 56 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l 135 (297)
T cd05089 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL 135 (297)
T ss_pred HHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456 79999999998 6778999999999999999821 1 1 899999999
Q ss_pred hcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHH
Q 039565 54 HQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 54 h~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~ 127 (188)
|+ .+++|+|+||+||+++.++.+|++|||++..... .........+..|++|| ++.++|+||||+++|
T Consensus 136 H~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 209 (297)
T cd05089 136 SE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW 209 (297)
T ss_pred HH---CCcccCcCCcceEEECCCCeEEECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHH
Confidence 99 9999999999999999999999999998763211 00111112234688888 478899999999999
Q ss_pred HHHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 128 EIIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 128 ~~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
+|++ |..||..... ...+...+..+.+++..||+.+|.+|||++++++.|+.+...
T Consensus 210 el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 210 EIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 9997 8888854321 112234567889999999999999999999999998876653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=205.40 Aligned_cols=174 Identities=19% Similarity=0.210 Sum_probs=139.7
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCC-c---c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGK-E---E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....+++|||+++++|.+++.+ . . |++.||.|||+ .+++|+|++|+|
T Consensus 61 l~~~~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~n 137 (270)
T cd05056 61 MRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARN 137 (270)
T ss_pred HHhCCCCchhceeEEEcCCCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChhe
Confidence 467899999999998 7778999999999999999822 1 1 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~-- 141 (188)
|+++.++.++++|||++...... .........++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 138 ili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~ 216 (270)
T cd05056 138 VLVSSPDCVKLGDFGLSRYLEDE-SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216 (270)
T ss_pred EEEecCCCeEEccCceeeecccc-cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 99999999999999988754321 111111223345688888 5778999999999999986 9988854321
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
...+...+..+.+++.+|+..+|.+|||+.++++.|+++...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 217 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 112334567899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=204.64 Aligned_cols=167 Identities=23% Similarity=0.265 Sum_probs=134.7
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+++++|+|++++++. .+..++++||+++++|.+++ .+.. |++.||.|||+ .+++|+|++
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk 129 (256)
T cd05082 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLA 129 (256)
T ss_pred HHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccc
Confidence 567899999999986 56789999999999999998 2211 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~ 140 (188)
|+||+++.++.++++|||++....... ....++..|++|| ++.++|+||||+++|++++ |..||....
T Consensus 130 p~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 130 ARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred hheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999887432111 1122344688887 5778999999999999997 888875322
Q ss_pred C------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 141 K------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 141 ~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
. ...+...+..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 205 LKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1 112233467889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=211.01 Aligned_cols=173 Identities=25% Similarity=0.300 Sum_probs=136.8
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Cc------------------c---------cHHHHHHHH
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KE------------------E---------VCCPGLEYL 53 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~------------------~---------~i~~~l~~L 53 (188)
+.++ +||||++++++ .+..++++||+++++|.+++. .. . |++.|++||
T Consensus 61 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 140 (303)
T cd05088 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 140 (303)
T ss_pred HHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH
Confidence 4466 89999999998 778999999999999999882 11 1 899999999
Q ss_pred hcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHH
Q 039565 54 HQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 54 h~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~ 127 (188)
|+ .+++|||+||+||+++.++.++++|||++.... .........++..|++|| ++.++|+||||+++|
T Consensus 141 H~---~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 214 (303)
T cd05088 141 SQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214 (303)
T ss_pred Hh---CCccccccchheEEecCCCcEEeCccccCcccc---hhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence 99 999999999999999999999999999876321 101111122345688888 578899999999999
Q ss_pred HHHh-CCccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcc
Q 039565 128 EIIT-GILTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSR 184 (188)
Q Consensus 128 ~~~~-g~~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 184 (188)
++++ |..||.... ..+.+...+..+.+++.+||+.+|+.||+++++++.|+.+...+
T Consensus 215 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 215 EIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHhcCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 9998 888874321 11122234567889999999999999999999999988765544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=198.86 Aligned_cols=173 Identities=21% Similarity=0.330 Sum_probs=139.1
Q ss_pred ccccCCCeeeeccc--------CCccEEEEecCCCCChhhhcCCc---c-------------cHHHHHHHHhcCCCCCcE
Q 039565 7 NKLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQGKE---E-------------VCCPGLEYLHQGLKHPII 62 (188)
Q Consensus 7 ~~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~---~-------------~i~~~l~~Lh~~~~~~i~ 62 (188)
++++||||+++++. ....|+++.|...|+|.+.+... + ++++||++||+. ...+.
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yA 151 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYA 151 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCccc
Confidence 57899999999888 45589999999999999999222 1 899999999982 12499
Q ss_pred EeCCCCCcEEEccCCceEEecccCcccccCC--CCC-----cceeeecccccccCCC---------CCCccchHHHHHHH
Q 039565 63 QRDMKSTNILLNEKVQAKLADFGQSRISPVE--GGT-----HMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVI 126 (188)
Q Consensus 63 h~dl~~~nill~~~~~~kl~d~~~~~~~~~~--~~~-----~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l 126 (188)
|+|+||.||++++++.+++.|||.+...+.. +.. +....-..|-.|.||| ++++.|||||||++
T Consensus 152 H~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL 231 (302)
T KOG2345|consen 152 HRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL 231 (302)
T ss_pred ccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence 9999999999999999999999987654311 111 1112245677899999 58999999999999
Q ss_pred HHHHhCCccccccCC---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 127 LEIITGILTVDLSFK---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 127 ~~~~~g~~p~~~~~~---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
|.|+-|..||+.... -......++.+.+++..|++.||.+||++.+++..++.+
T Consensus 232 Ya~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 232 YAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred HHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 999999999964322 112234788999999999999999999999999988765
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=214.75 Aligned_cols=165 Identities=23% Similarity=0.288 Sum_probs=133.1
Q ss_pred ccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 7 NKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
.++ +||||+++++. ....+++|||+++|+|.+++ .+.. |++.||.|||+ .+++||||||+|
T Consensus 59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~N 135 (332)
T cd05614 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLEN 135 (332)
T ss_pred HhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHH
Confidence 345 59999999887 77789999999999999988 3222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~- 142 (188)
|+++.++.++|+|||++..... ..........|+..|++|| .+.++|+|||||++|+|++|..||......
T Consensus 136 ili~~~~~~kl~DfG~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 214 (332)
T cd05614 136 ILLDSEGHVVLTDFGLSKEFLS-EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214 (332)
T ss_pred eEECCCCCEEEeeCcCCccccc-cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC
Confidence 9999999999999999875421 1122233457899999998 356899999999999999999999632211
Q ss_pred --------------CcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 143 --------------EFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 143 --------------~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
..+...+..+.+++..||+.+|++|| +++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 215 TQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 12223456788999999999999999 7778775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=205.74 Aligned_cols=170 Identities=25% Similarity=0.297 Sum_probs=134.5
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc------------------c---------cHHHHHHHH
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------------------E---------VCCPGLEYL 53 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------------------~---------~i~~~l~~L 53 (188)
+.++ +||||++++++ ....+++|||+++++|.+++ ... . |++.|++||
T Consensus 49 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l 128 (270)
T cd05047 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 128 (270)
T ss_pred HHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456 79999999998 67789999999999999988 211 1 899999999
Q ss_pred hcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHH
Q 039565 54 HQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 54 h~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~ 127 (188)
|+ .+++|+|+||+||+++.++.++++|||++.... ..........+..|++|| ++.++|+||||+++|
T Consensus 129 H~---~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 202 (270)
T cd05047 129 SQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 202 (270)
T ss_pred HH---CCEeecccccceEEEcCCCeEEECCCCCccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHH
Confidence 99 999999999999999999999999999875321 000111122344688888 577899999999999
Q ss_pred HHHh-CCccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 128 EIIT-GILTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 128 ~~~~-g~~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
++++ |..||.... ..+.+...+..+.+++.+||+.+|.+|||++++++.|+++.
T Consensus 203 el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 203 EIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 9997 888884321 11222334567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=209.83 Aligned_cols=164 Identities=21% Similarity=0.242 Sum_probs=130.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....+++|||+++ +|.+++ ... . |++.||+|||+ .+++||||||+
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~ 132 (288)
T cd07871 57 LKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQ 132 (288)
T ss_pred HHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHH
Confidence 567899999999998 6678999999984 898887 221 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.+||+|||++....... .......++..|+||| ++.++|+||+|+++|+|++|..||......
T Consensus 133 Nil~~~~~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~ 210 (288)
T cd07871 133 NLLINEKGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK 210 (288)
T ss_pred HEEECCCCCEEECcCcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999986432111 1122345678899998 467799999999999999999888432110
Q ss_pred C------------------------------c-----------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 E------------------------------F-----------DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ~------------------------------~-----------~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+ + .......+.+++..|++.||.+|||++|+++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 211 EELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 0 0012356789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=212.54 Aligned_cols=162 Identities=21% Similarity=0.300 Sum_probs=132.8
Q ss_pred ccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 9 LTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 9 l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
.+||||+++++. ....++||||+++|+|..++... . |++.||.|||+ .+++||||||+||++
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill 129 (316)
T cd05592 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLL 129 (316)
T ss_pred cCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEE
Confidence 589999999988 77899999999999999988222 1 99999999999 999999999999999
Q ss_pred ccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC------
Q 039565 74 NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------ 141 (188)
Q Consensus 74 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------ 141 (188)
+.++.+||+|||++...... ........|+..|++|| ++.++|+|||||++|+|++|..||.....
T Consensus 130 ~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~ 207 (316)
T cd05592 130 DKDGHIKIADFGMCKENMNG--EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS 207 (316)
T ss_pred CCCCCEEEccCcCCeECCCC--CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999998743211 12234467899999999 57889999999999999999999864321
Q ss_pred -----CCcCHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 039565 142 -----GEFDIISVEKAVEIAMASVSSKVNRRPLMN-QVVM 175 (188)
Q Consensus 142 -----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-~i~~ 175 (188)
...+...+..+.+++..||+.+|.+||++. ++++
T Consensus 208 i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 208 ILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 122334556788999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=217.54 Aligned_cols=167 Identities=20% Similarity=0.238 Sum_probs=135.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+..++||||+++++. ....++||||+++|+|.+++.+. . |++.||+|||+ .+++||||||+||
T Consensus 97 l~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NI 173 (370)
T cd05596 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNM 173 (370)
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHE
Confidence 467899999999987 77889999999999999998322 2 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC----------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE----------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe----------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
+++.++.+||+|||++..... ..........|++.|+||| ++.++|+|||||++|+|++|..||.....
T Consensus 174 Ll~~~~~~kL~DfG~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 174 LLDKSGHLKLADFGTCMKMDA-NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred EEcCCCCEEEEeccceeeccC-CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 999999999999999875421 1111223456889999998 35689999999999999999999864321
Q ss_pred -------------CCcCH--HHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 039565 142 -------------GEFDI--ISVEKAVEIAMASVSSKVNR--RPLMNQVVMV 176 (188)
Q Consensus 142 -------------~~~~~--~~~~~~~~l~~~cl~~~p~~--Rps~~~i~~~ 176 (188)
..++. ..+..+.+++..|++.+|.+ |++++++++.
T Consensus 253 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 253 VGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111 34678899999999999988 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=203.88 Aligned_cols=172 Identities=20% Similarity=0.247 Sum_probs=136.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||+++.++ .+..+++|||+++++|.+++ ...+ |++.|++|||+ .+++|+|++|+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~ 136 (268)
T cd05063 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAAR 136 (268)
T ss_pred HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchh
Confidence 467899999999999 77889999999999999998 3221 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcc-eeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHM-STTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~-~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~ 141 (188)
||+++.++.++++|||++........... ......+..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 137 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 137 NILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred hEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 99999999999999998875431111111 11112234588888 4778999999999999997 8988853221
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
.+.....+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 217 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 217 HEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112233466889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=202.77 Aligned_cols=170 Identities=26% Similarity=0.305 Sum_probs=139.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc---------c------------cHHHHHHHHhcCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE---------E------------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~---------~------------~i~~~l~~Lh~~~~~~i 61 (188)
+.+++|+||++++++ ....++++||+++++|.+++... . |++.||.|||+ .++
T Consensus 50 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i 126 (262)
T cd00192 50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKF 126 (262)
T ss_pred HhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCc
Confidence 567889999999998 78899999999999999999332 2 99999999999 999
Q ss_pred EEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCc
Q 039565 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GIL 134 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~ 134 (188)
+|+|++|+||+++.++.++++|||.+................++..|++|| ++.++|+||+|+++|++++ |..
T Consensus 127 ~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 206 (262)
T cd00192 127 VHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206 (262)
T ss_pred ccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999987654222212233345667889998 5778999999999999998 588
Q ss_pred cccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 135 TVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 135 p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
||+.... ...+...+..+.+++..||+.+|.+|||++++++.|+
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 207 PYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 8854321 1223344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=202.89 Aligned_cols=166 Identities=23% Similarity=0.328 Sum_probs=137.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc---c-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE---E-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~---~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||+++++. .+..++++||+++++|.+++... . |++.||.|||+ .+++|+|++|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~ 129 (256)
T cd08529 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKS 129 (256)
T ss_pred HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCc
Confidence 578899999999988 77899999999999999998221 1 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
+||+++.++.++++|||.+...... ........++..|++|| ++.++|+||||++++++++|..||.....
T Consensus 130 ~nili~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 207 (256)
T cd08529 130 LNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG 207 (256)
T ss_pred ceEEEeCCCCEEEcccccceeccCc--cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999988754321 11223346778899999 47789999999999999999999864321
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
...+......+.+++..||+.+|++||++.++++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 208 ALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 12233456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=204.64 Aligned_cols=172 Identities=22% Similarity=0.256 Sum_probs=135.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||+++.++ ....++++||+++++|.+++.. .+ |++.|+.|||+ .+++|+|++|+
T Consensus 59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~ 135 (269)
T cd05065 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAAR 135 (269)
T ss_pred HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChh
Confidence 467899999999998 7778999999999999999832 22 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeec---ccccccCCC------CCCccchHHHHHHHHHHHh-CCcccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA---GTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLS 139 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~---~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~ 139 (188)
||+++.++.++++|||++................ .+..|++|| ++.++|+||||+++|++++ |..||...
T Consensus 136 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 136 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred eEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999886543211111111111 133588888 4778999999999999886 88888542
Q ss_pred CC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 140 FK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 140 ~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
.. ...+...+..+.+++..||+.+|.+||++++|+..|+++
T Consensus 216 ~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 216 SNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 21 112233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=203.30 Aligned_cols=170 Identities=26% Similarity=0.292 Sum_probs=137.2
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||++++++ .+..++++||+.+++|.+++ ...+ |++.||+|||+ .+++|+|++|+
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ 131 (260)
T cd05067 55 MKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAA 131 (260)
T ss_pred HHhcCCcCeeeEEEEEccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHH
Confidence 467899999999999 77889999999999999988 2211 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
||+++.++.++++|||++..... ..........++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 132 ni~i~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 210 (260)
T cd05067 132 NILVSETLCCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210 (260)
T ss_pred hEEEcCCCCEEEccCcceeecCC-CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence 99999999999999998865431 1111112233456788888 4778999999999999998 8998853321
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
.+.+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 211 EVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 12223345689999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=214.14 Aligned_cols=160 Identities=23% Similarity=0.263 Sum_probs=131.8
Q ss_pred ccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 7 NKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 7 ~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
..++||||+++++. .+..++||||+.+|+|..++.+. . |++.||.|||+ .+++||||||+||
T Consensus 51 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NI 127 (323)
T cd05575 51 KNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENI 127 (323)
T ss_pred hhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHe
Confidence 56899999999887 77899999999999999988222 1 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK---- 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~---- 141 (188)
+++.++.+||+|||++.... ..........|+..|++|| ++.++|+||||+++|+|++|..||.....
T Consensus 128 ll~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 205 (323)
T cd05575 128 LLDSQGHVVLTDFGLCKEGI--EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY 205 (323)
T ss_pred EECCCCcEEEeccCCCcccc--cCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH
Confidence 99999999999999886422 1112233456888999999 57889999999999999999999854321
Q ss_pred -------CCcCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 039565 142 -------GEFDIISVEKAVEIAMASVSSKVNRRPLMN 171 (188)
Q Consensus 142 -------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ 171 (188)
...+...+..+.+++..|++.+|.+||++.
T Consensus 206 ~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 206 DNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 112233467889999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=215.32 Aligned_cols=164 Identities=21% Similarity=0.238 Sum_probs=134.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||+++++. .+..+++|||+++++|..++.+ .. |++.||.|||+ .+++||||||+|
T Consensus 50 l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~N 126 (325)
T cd05602 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPEN 126 (325)
T ss_pred HHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHH
Confidence 356899999999888 7889999999999999998822 21 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++|+|||+++.... .........|+..|++|| ++.++|+|||||++|+|++|..||.....
T Consensus 127 ili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 204 (325)
T cd05602 127 ILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204 (325)
T ss_pred eEECCCCCEEEccCCCCccccc--CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999999864321 112233457889999999 57899999999999999999999854221
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~ 174 (188)
...+...+..+.+++..|++.+|.+||++.+.+
T Consensus 205 ~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 205 YDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 122234566789999999999999999876433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=202.03 Aligned_cols=169 Identities=20% Similarity=0.263 Sum_probs=134.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....+++|||+++++|.+++ .... |++.||.|+|+ .+++|+|++|+
T Consensus 46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~ 122 (250)
T cd05085 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAAR 122 (250)
T ss_pred HHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChh
Confidence 457889999999999 77889999999999999988 2221 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
||+++.++.++++|||++.... ...........++..|++|| ++.++|+||||+++|++++ |..||....
T Consensus 123 nili~~~~~~~l~d~g~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~ 201 (250)
T cd05085 123 NCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ 201 (250)
T ss_pred eEEEcCCCeEEECCCccceecc-ccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999999886432 11111111123345688888 4678999999999999998 888885321
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
....+...+..+.+++..|++.+|++||++.++++.|.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 202 QAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=209.45 Aligned_cols=163 Identities=21% Similarity=0.251 Sum_probs=130.1
Q ss_pred cccccCCCeeeeccc--------CCccEEEEecCCCCChhhhcCC-c----c---------cHHHHHHHHhcCCCCCcEE
Q 039565 6 RNKLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQGK-E----E---------VCCPGLEYLHQGLKHPIIQ 63 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~~~-~----~---------~i~~~l~~Lh~~~~~~i~h 63 (188)
+.+++||||++++++ ....++++||++ ++|.+++.. . . |++.||.|||+ .+++|
T Consensus 58 l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH 133 (290)
T cd07862 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVH 133 (290)
T ss_pred hcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeee
Confidence 445689999999886 345789999997 589888822 1 1 99999999999 99999
Q ss_pred eCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 64 RDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 64 ~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
||+||+||+++.++.++++|||++...... .......|+..|+||| ++.++|+||||+++|++++|..||.
T Consensus 134 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 134 RDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred CCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 999999999999999999999998754311 2233456788999998 5788999999999999999999885
Q ss_pred ccCCC----------------Cc----------------------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LSFKG----------------EF----------------------DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~~~~----------------~~----------------------~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..... .+ ....+..+.+++..|++.+|++|||+.++++
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 211 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 42210 00 0113446789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=206.58 Aligned_cols=175 Identities=18% Similarity=0.247 Sum_probs=139.7
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCC-cc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGK-EE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++++||+++|+|.+++.+ .. |++.|++|||+ .+++|+|++|+|
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~n 139 (279)
T cd05057 63 MASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARN 139 (279)
T ss_pred HHhCCCCCcceEEEEEecCceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcce
Confidence 567899999999998 7889999999999999999832 21 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFKG- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~~- 142 (188)
|+++.++.++|+|||.++...............++..|++|| ++.++|+||||+++|++++ |..||+.....
T Consensus 140 il~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 219 (279)
T cd05057 140 VLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219 (279)
T ss_pred EEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 999999999999999987543221111111122345688888 4778999999999999998 99888643221
Q ss_pred -----------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 143 -----------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 143 -----------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
..+......+.+++..||..+|+.||++.++++.|+.....
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 220 IPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11223446788999999999999999999999999986443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=204.01 Aligned_cols=168 Identities=21% Similarity=0.261 Sum_probs=136.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++++||+++++|.+++.+.. |++.||.|||+ .+++|+|++|+|
T Consensus 58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~n 134 (263)
T cd06625 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGAN 134 (263)
T ss_pred HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHH
Confidence 567899999999998 789999999999999999882211 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcc-eeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHM-STTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF--- 140 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~-~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~--- 140 (188)
|+++.++.++++|||.+........... .....++..|++|| .+.++|+||||+++|++++|..||....
T Consensus 135 ilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 214 (263)
T cd06625 135 ILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214 (263)
T ss_pred EEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH
Confidence 9999999999999999875431111110 12345677899999 5688999999999999999999985321
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
....+......+.+++..||..+|++|||+.++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 215 AIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 122334556788999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=215.74 Aligned_cols=134 Identities=24% Similarity=0.235 Sum_probs=106.0
Q ss_pred cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccc
Q 039565 45 VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSD 118 (188)
Q Consensus 45 ~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~d 118 (188)
|++.||+|||+ .+++|+|+||+||+++.++.++++|||+++...............++..|++|| ++.++|
T Consensus 247 qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 323 (401)
T cd05107 247 QVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSD 323 (401)
T ss_pred HHHHHHHHHhc---CCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhH
Confidence 78999999999 999999999999999999999999999987542111111112234567799998 578899
Q ss_pred hHHHHHHHHHHHh-CCccccccCC-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 119 VDSFEIVILEIIT-GILTVDLSFK-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 119 i~s~G~~l~~~~~-g~~p~~~~~~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
+||||+++|++++ |..||..... ...+...+..+.+++..||+.+|+.||++++|++.|+++.
T Consensus 324 vwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 324 VWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 9999999999998 7788753221 1122234578899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=213.63 Aligned_cols=157 Identities=20% Similarity=0.268 Sum_probs=128.5
Q ss_pred ccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 9 LTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 9 l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
.+||||++++++ ....++||||+++|+|..++ .... |++.||.|||+ .+++||||||+||++
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili 129 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLL 129 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEE
Confidence 379999999998 78899999999999999888 2222 99999999999 999999999999999
Q ss_pred ccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC------
Q 039565 74 NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------ 141 (188)
Q Consensus 74 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------ 141 (188)
+.++.++|+|||+++.... .........|+..|+||| ++.++|+||||+++|+|++|..||+....
T Consensus 130 ~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 207 (329)
T cd05618 130 DSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207 (329)
T ss_pred CCCCCEEEeeCCccccccC--CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc
Confidence 9999999999999864221 112233467889999999 57789999999999999999999852110
Q ss_pred --------------CCcCHHHHHHHHHHHHHccCcCCCCCCCH
Q 039565 142 --------------GEFDIISVEKAVEIAMASVSSKVNRRPLM 170 (188)
Q Consensus 142 --------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 170 (188)
...+...+..+.+++..||+.+|.+||++
T Consensus 208 ~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 208 NTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11233345678899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=207.30 Aligned_cols=165 Identities=19% Similarity=0.225 Sum_probs=134.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C---Ccc------------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G---KEE------------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~---~~~------------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||+++.+. ....+++|||+++|+|..++ . ... |++.||.|||+ .+++||||
T Consensus 47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl 123 (280)
T cd05608 47 LAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDL 123 (280)
T ss_pred HHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCC
Confidence 567899999999887 67789999999999998776 1 111 89999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+||+++.++.++++|||.+...... ........|+..|++|| ++.++|+||||+++|++++|..||....
T Consensus 124 kp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 124 KPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred CHHHEEECCCCCEEEeeCccceecCCC--CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999988654311 11233456888999999 5778999999999999999999986432
Q ss_pred CC---------------CcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 141 KG---------------EFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 141 ~~---------------~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
.. ..+...+..+.+++..||+.+|++|| +++++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 202 EKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11 12233566889999999999999999 6777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=214.53 Aligned_cols=157 Identities=22% Similarity=0.299 Sum_probs=129.9
Q ss_pred ccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 9 LTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 9 l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
.+||||++++++ .+..++||||+++|+|..++ .... |++.||+|||+ .+++||||||+||++
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli 129 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLL 129 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEE
Confidence 369999999988 77889999999999999888 2222 99999999999 999999999999999
Q ss_pred ccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC-----
Q 039565 74 NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG----- 142 (188)
Q Consensus 74 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~----- 142 (188)
+.++.++|+|||++..... .........|++.|+||| ++.++|+||||+++|++++|..||......
T Consensus 130 ~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 207 (320)
T cd05590 130 DHEGHCKLADFGMCKEGIF--NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 207 (320)
T ss_pred CCCCcEEEeeCCCCeecCc--CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 9999999999998764321 112233457889999999 577899999999999999999999643211
Q ss_pred ------CcCHHHHHHHHHHHHHccCcCCCCCCCH
Q 039565 143 ------EFDIISVEKAVEIAMASVSSKVNRRPLM 170 (188)
Q Consensus 143 ------~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 170 (188)
..+...+..+.+++..|++.+|.+||++
T Consensus 208 i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 208 ILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1223356678999999999999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=208.70 Aligned_cols=172 Identities=20% Similarity=0.218 Sum_probs=135.5
Q ss_pred ccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc------------------c---------cHHHHHHHHh
Q 039565 7 NKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------------------E---------VCCPGLEYLH 54 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------------------~---------~i~~~l~~Lh 54 (188)
.++ +||||++++++ ....++++||+++|+|.+++ ... . |++.||.|||
T Consensus 72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH 151 (314)
T cd05099 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE 151 (314)
T ss_pred HhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH
Confidence 345 59999999998 67789999999999999998 211 0 8999999999
Q ss_pred cCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHH
Q 039565 55 QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILE 128 (188)
Q Consensus 55 ~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~ 128 (188)
+ .+++|+|+||+||+++.++.++++|||.++...............++..|++|| ++.++|+||||+++|+
T Consensus 152 ~---~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~e 228 (314)
T cd05099 152 S---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWE 228 (314)
T ss_pred H---CCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHH
Confidence 9 999999999999999999999999999987543111111111223345689998 5778999999999999
Q ss_pred HHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 129 IIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 129 ~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
+++ |..||..... .+.+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 229 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 229 IFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 998 7777743211 1122334567889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=213.43 Aligned_cols=161 Identities=20% Similarity=0.276 Sum_probs=131.1
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+||||++++++ ....++||||+++|+|..++ .... |++.||.|||+ .+++||||||+||+++
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~ 130 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLD 130 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEC
Confidence 79999999998 77889999999999999888 2222 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC------
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG------ 142 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~------ 142 (188)
.++.++|+|||+++... ..........|+..|++|| ++.++|+||||+++|++++|..||+.....
T Consensus 131 ~~~~~kL~Dfg~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~ 208 (329)
T cd05588 131 AEGHIKLTDYGMCKEGI--RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208 (329)
T ss_pred CCCCEEECcCccccccc--cCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccccc
Confidence 99999999999886421 1112233467889999999 577899999999999999999999632111
Q ss_pred --------------CcCHHHHHHHHHHHHHccCcCCCCCCC------HHHHHH
Q 039565 143 --------------EFDIISVEKAVEIAMASVSSKVNRRPL------MNQVVM 175 (188)
Q Consensus 143 --------------~~~~~~~~~~~~l~~~cl~~~p~~Rps------~~~i~~ 175 (188)
..+...+..+.+++..|++.+|.+||+ ++++++
T Consensus 209 ~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 209 TEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred chHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 122234457889999999999999997 667764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=206.53 Aligned_cols=172 Identities=17% Similarity=0.228 Sum_probs=134.9
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+++++||||+++.++ ....++++||+++++|.+++ ... . |++.||.|||+ .+++|+|+|
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlk 136 (284)
T cd05079 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLA 136 (284)
T ss_pred HHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccc
Confidence 567899999999987 25678999999999999998 221 1 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCC-cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+||+++.++.++++|||++......... .......++..|++|| ++.++|+||||+++|+++++..|.....
T Consensus 137 p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~ 216 (284)
T cd05079 137 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPM 216 (284)
T ss_pred hheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcccc
Confidence 99999999999999999998754322211 1112344556788888 5778999999999999999765432110
Q ss_pred ---------------------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 141 ---------------------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 141 ---------------------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
....+...+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 217 TLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred chhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0011223457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=212.02 Aligned_cols=162 Identities=22% Similarity=0.319 Sum_probs=132.9
Q ss_pred ccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 9 LTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 9 l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
++||||++++++ .+..++||||+++|+|..++.. .. |++.||.|||+ .+++|||+||+||++
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~ 129 (316)
T cd05619 53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILL 129 (316)
T ss_pred cCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEE
Confidence 589999999988 7788999999999999999822 21 99999999999 999999999999999
Q ss_pred ccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC------
Q 039565 74 NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------ 141 (188)
Q Consensus 74 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------ 141 (188)
+.++.++++|||++..... .........|+..|+||| ++.++|+|||||++|++++|..||.....
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (316)
T cd05619 130 DTDGHIKIADFGMCKENML--GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207 (316)
T ss_pred CCCCCEEEccCCcceECCC--CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999998864221 112234567889999998 57889999999999999999999864321
Q ss_pred -----CCcCHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 039565 142 -----GEFDIISVEKAVEIAMASVSSKVNRRPLMN-QVVM 175 (188)
Q Consensus 142 -----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-~i~~ 175 (188)
...+......+.+++..||+.+|++||++. ++.+
T Consensus 208 i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 208 IRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 112233456788999999999999999986 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=204.48 Aligned_cols=172 Identities=21% Similarity=0.258 Sum_probs=136.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ .+..+++|||+++++|.+++ .... |++.|++|||+ .+++|+|+||+
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~ 135 (267)
T cd05066 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAAR 135 (267)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchh
Confidence 467899999999998 77889999999999999998 3221 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcc-eeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHM-STTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~-~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~ 141 (188)
||+++.++.++++|||.+........... .....++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 136 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~ 215 (267)
T cd05066 136 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215 (267)
T ss_pred cEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence 99999999999999999875432211110 11112234688888 4778999999999999886 9988853221
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
...+...+..+.+++..|++.+|++||++.++++.|+.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 216 QDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 112223456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=240.24 Aligned_cols=169 Identities=22% Similarity=0.247 Sum_probs=142.8
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
.+..++|||+|+.+|+ .+..++.||||++|+|++.++... |++.|++|||+ .||+|||+||.
T Consensus 1287 vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~a 1363 (1509)
T KOG4645|consen 1287 VLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPA 1363 (1509)
T ss_pred HHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCcc
Confidence 4677899999999999 888999999999999999993332 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCC--CCcceeeecccccccCCCC---------CCccchHHHHHHHHHHHhCCccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEG--GTHMSTTIAGTAGFLNTEL---------TEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~~~~~~~pe~---------~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+++.+|.+|++|||.+....... -........||+.|||||. ..++||||+||++.||+||+.||..
T Consensus 1364 NI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~ 1443 (1509)
T KOG4645|consen 1364 NILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE 1443 (1509)
T ss_pred ceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh
Confidence 9999999999999999987543221 1123446789999999992 4578999999999999999999843
Q ss_pred -------------cCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 139 -------------SFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 139 -------------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
.-.+.++...+..-.+++..|++.||++|.++.|+++.
T Consensus 1444 ~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1444 LDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 12244666788889999999999999999999988874
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=211.54 Aligned_cols=161 Identities=22% Similarity=0.314 Sum_probs=132.0
Q ss_pred ccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 9 LTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 9 l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
.+||||+++++. .+..++||||+.+|+|..++ .... |++.||+|||+ .+++||||||+||++
T Consensus 53 ~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~ 129 (316)
T cd05620 53 WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVML 129 (316)
T ss_pred cCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEE
Confidence 589999999988 77899999999999999888 2221 99999999999 999999999999999
Q ss_pred ccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC------
Q 039565 74 NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------ 141 (188)
Q Consensus 74 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------ 141 (188)
+.++.++|+|||+++... ..........|+..|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 130 ~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~ 207 (316)
T cd05620 130 DRDGHIKIADFGMCKENV--FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES 207 (316)
T ss_pred CCCCCEEeCccCCCeecc--cCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999876421 1112234467889999999 57789999999999999999999864321
Q ss_pred -----CCcCHHHHHHHHHHHHHccCcCCCCCCCHH-HHH
Q 039565 142 -----GEFDIISVEKAVEIAMASVSSKVNRRPLMN-QVV 174 (188)
Q Consensus 142 -----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-~i~ 174 (188)
...+...+..+.+++..||+.+|++||++. ++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 208 IRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 112233456788999999999999999974 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=201.91 Aligned_cols=171 Identities=20% Similarity=0.227 Sum_probs=138.2
Q ss_pred CcccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCc--c-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 5 NRNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKE--E-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~--~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
.+++++||||+++++. ....++++||+++++|.+++ +.. . |++.||.|||+ .+++|+|++|
T Consensus 49 ~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p 125 (257)
T cd05040 49 IMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAA 125 (257)
T ss_pred HHhhcCCCCccceeEEEcCCeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCc
Confidence 3678899999999998 77789999999999999999 332 1 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCc-ceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTH-MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF 140 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~ 140 (188)
+||+++.++.++++|||++.......... ......++..|++|| ++.++|+||||+++|+|++ |..||+...
T Consensus 126 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 205 (257)
T cd05040 126 RNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205 (257)
T ss_pred ccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999987653222111 112244566789998 4778999999999999998 998884321
Q ss_pred C-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 141 K-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 141 ~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
. ...+...+..+.+++..|++.+|++|||+.++++.|.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 206 GSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1 1122234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=221.88 Aligned_cols=168 Identities=23% Similarity=0.264 Sum_probs=136.1
Q ss_pred cccccCCCeeeeccc---CC--------ccEEEEecCCCCChhhhcC-Cc------c---------cHHHHHHHHhcCCC
Q 039565 6 RNKLTGPLLVELIGK---QK--------NNALELGFRGNPELVDQQG-KE------E---------VCCPGLEYLHQGLK 58 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~--------~~~lv~e~~~~~~L~~~~~-~~------~---------~i~~~l~~Lh~~~~ 58 (188)
+..++|+||+++.+. .. ..+++|||+++|+|.+++. +. . |++.||.|||+
T Consensus 85 l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~--- 161 (496)
T PTZ00283 85 LLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS--- 161 (496)
T ss_pred HhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---
Confidence 456789999998765 11 2679999999999999882 11 1 99999999999
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhC
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g 132 (188)
.+++||||||+||+++.++.+||+|||+++...............|++.|++|| ++.++|+||||+++|++++|
T Consensus 162 ~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG 241 (496)
T PTZ00283 162 KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241 (496)
T ss_pred CCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999999999999999999999999987643222222334567899999999 57889999999999999999
Q ss_pred CccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 133 ILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 133 ~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
..||+.... ...+...+..+.+++..||+.+|.+||++.++++.
T Consensus 242 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 242 KRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 999864321 12334456789999999999999999999998763
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=206.37 Aligned_cols=163 Identities=21% Similarity=0.237 Sum_probs=132.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc--c-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE--E-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~--~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++||||+++.+. ....+++|||+++++|..++ ... . |++.||+|||+ .+++|+|+||
T Consensus 47 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp 123 (277)
T cd05607 47 LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKP 123 (277)
T ss_pred HHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCCh
Confidence 567899999999887 77889999999999998887 211 1 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
+||+++.++.++++|||++..... ........|+..|++|| ++.++|+||+||++|++++|..||......
T Consensus 124 ~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~ 200 (277)
T cd05607 124 ENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200 (277)
T ss_pred HhEEEcCCCCEEEeeceeeeecCC---CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch
Confidence 999999999999999998875431 11223346788899998 578899999999999999999998542110
Q ss_pred -------------Cc---CHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 039565 143 -------------EF---DIISVEKAVEIAMASVSSKVNRRPLMNQVV 174 (188)
Q Consensus 143 -------------~~---~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~ 174 (188)
.. ....+..+.+++..||+.+|++||++.+++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 201 VAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred hhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 00 012356789999999999999999996654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=201.75 Aligned_cols=171 Identities=19% Similarity=0.283 Sum_probs=139.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC--c-----c---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK--E-----E---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~--~-----~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++|+|++++++. .+..++++||+++++|.+++.. . . +++.||.|||+ .+++|+|+
T Consensus 56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl 132 (267)
T cd08224 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDI 132 (267)
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCc
Confidence 567899999999998 7788999999999999988721 1 1 89999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
+|+||+++.++.++++|||.+...... ........++..|.+|| ++.++|+||||+++|++++|..||....
T Consensus 133 ~p~nil~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 133 KPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ChhhEEECCCCcEEEeccceeeeccCC--CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 999999999999999999987653211 11223345777888998 5678999999999999999998884321
Q ss_pred C--------------CCcCH-HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 141 K--------------GEFDI-ISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 141 ~--------------~~~~~-~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
. ...+. ..+..+.+++.+||..+|++|||+.+|+++|+++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 211 MNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1 11222 45568999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-33 Score=217.32 Aligned_cols=162 Identities=27% Similarity=0.300 Sum_probs=133.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. ....++||||+.+++|.+++.+. . |++.||.|||+ .+++||||||+|
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~N 128 (318)
T cd05582 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPEN 128 (318)
T ss_pred HHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHH
Confidence 567899999999888 77889999999999999998322 1 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++|+|||++..... .........|+..|++|| ++.++|+||||+++|+|++|..||.....
T Consensus 129 il~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 206 (318)
T cd05582 129 ILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET 206 (318)
T ss_pred eEECCCCcEEEeeccCCcccCC--CCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH
Confidence 9999999999999999875321 112233457888999999 57789999999999999999999864321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQ 172 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~ 172 (188)
...+...+..+.+++..||+.+|++||++.+
T Consensus 207 ~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 207 MTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1123334667889999999999999999543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-33 Score=216.47 Aligned_cols=166 Identities=19% Similarity=0.280 Sum_probs=134.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||+++.+. ....++||||+++|+|..++.+. . |++.||.|||+ ..+++||||||+|
T Consensus 49 l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~N 126 (325)
T cd05594 49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLEN 126 (325)
T ss_pred HHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCe
Confidence 456889999999877 77899999999999999888222 1 99999999996 1699999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG-- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~-- 142 (188)
|+++.++.+||+|||+++..... ........|+..|+||| ++.++|+||||+++|+|++|..||......
T Consensus 127 Ill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~ 204 (325)
T cd05594 127 LMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 204 (325)
T ss_pred EEECCCCCEEEecCCCCeecCCC--CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH
Confidence 99999999999999988643211 11223456889999998 578999999999999999999998543211
Q ss_pred ---------CcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 143 ---------EFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 143 ---------~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
.++...+..+.+++.+||+.+|++|+ ++.++++
T Consensus 205 ~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 205 FELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 12333466789999999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=208.56 Aligned_cols=174 Identities=20% Similarity=0.236 Sum_probs=137.1
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++++||+++|+|.+++ ... . |++.||.|||+ .+++|+|+||+|
T Consensus 63 ~~~l~h~niv~~~~~~~~~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~N 139 (303)
T cd05110 63 MASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARN 139 (303)
T ss_pred HHhCCCCCcccEEEEEcCCCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccce
Confidence 467899999999998 66678999999999999998 221 1 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~-- 141 (188)
|+++.++.+|++|||++................++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 140 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~ 219 (303)
T cd05110 140 VLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219 (303)
T ss_pred eeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999987543211111112233455788888 4678999999999999997 8888753211
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
...+...+..+.+++..||..+|++||+++++++.|+.+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 220 IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11112345678899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=213.67 Aligned_cols=165 Identities=22% Similarity=0.233 Sum_probs=130.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++||||++++++ ....++++|++. ++|..++ .... |++.||.|||+ .+|+||||||+|
T Consensus 137 l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~N 212 (391)
T PHA03212 137 LRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAEN 212 (391)
T ss_pred HHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHh
Confidence 567899999999998 778899999996 6888887 3222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC----
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF---- 140 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~---- 140 (188)
|+++.++.++|+|||++.... ...........|++.|++|| ++.++|+|||||++|++++|..|+-...
T Consensus 213 Ill~~~~~vkL~DFG~a~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~ 291 (391)
T PHA03212 213 IFINHPGDVCLGDFGAACFPV-DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDG 291 (391)
T ss_pred EEEcCCCCEEEEeCCcccccc-cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccc
Confidence 999999999999999986432 11112233467899999999 5788999999999999999986542110
Q ss_pred ------------------CCCcC-------------------------------HHHHHHHHHHHHHccCcCCCCCCCHH
Q 039565 141 ------------------KGEFD-------------------------------IISVEKAVEIAMASVSSKVNRRPLMN 171 (188)
Q Consensus 141 ------------------~~~~~-------------------------------~~~~~~~~~l~~~cl~~~p~~Rps~~ 171 (188)
+.+++ ...+..+.+++..||+.||.+|||++
T Consensus 292 ~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~ 371 (391)
T PHA03212 292 DCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAE 371 (391)
T ss_pred cCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHH
Confidence 00000 01244688999999999999999999
Q ss_pred HHHH
Q 039565 172 QVVM 175 (188)
Q Consensus 172 ~i~~ 175 (188)
++++
T Consensus 372 elL~ 375 (391)
T PHA03212 372 ALLD 375 (391)
T ss_pred HHhc
Confidence 9986
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=203.16 Aligned_cols=171 Identities=18% Similarity=0.237 Sum_probs=138.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC----cc------------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK----EE------------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~----~~------------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+..++||||+++++. .+..++++||+.+++|.+++.. .. |++.|+.|||+ .+++|+|+
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl 132 (267)
T cd08229 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDI 132 (267)
T ss_pred HHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCC
Confidence 467889999999998 7788999999999999988721 11 89999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
+|+||+++.++.++++|||.+....... .......++..|++|| .+.++|+||||+++|++++|..||....
T Consensus 133 ~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 133 KPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CHHHEEEcCCCCEEECcchhhhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9999999999999999999876543111 1122345777889998 4678999999999999999999885321
Q ss_pred C---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 141 K---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 141 ~---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
. .......+..+.+++..||..+|++|||+.+|++++++..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 211 MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred chHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1 0111235678999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=208.43 Aligned_cols=174 Identities=20% Similarity=0.205 Sum_probs=137.3
Q ss_pred ccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC------------------cc---------cHHHHHHHHh
Q 039565 7 NKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK------------------EE---------VCCPGLEYLH 54 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~------------------~~---------~i~~~l~~Lh 54 (188)
.++ +||||+++++. ....++++||+++++|.+++ .+ .. |++.||+|||
T Consensus 78 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH 157 (307)
T cd05098 78 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA 157 (307)
T ss_pred HHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence 345 79999999998 77889999999999999998 21 01 8999999999
Q ss_pred cCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHH
Q 039565 55 QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILE 128 (188)
Q Consensus 55 ~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~ 128 (188)
+ .+++|+|+||+||+++.++.++++|||.+................++..|++|| ++.++|+||||+++|+
T Consensus 158 ~---~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~e 234 (307)
T cd05098 158 S---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 234 (307)
T ss_pred H---CCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHH
Confidence 9 999999999999999999999999999886543111111111223345789998 5788999999999999
Q ss_pred HHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 129 IIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 129 ~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
|++ |..||..... .+.+...+..+.+++..||+.+|++|||+.++++.|+.+...
T Consensus 235 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 235 IFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 998 7777643211 122334567888999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=196.66 Aligned_cols=162 Identities=25% Similarity=0.339 Sum_probs=141.3
Q ss_pred ccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC--Ccc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 7 NKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG--KEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 7 ~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~--~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.|+||||++++++ ....||++||.+.|++...+. +.. |+|.|+.|+|. .+|+|||+||+
T Consensus 77 s~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpe 153 (281)
T KOG0580|consen 77 SHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPE 153 (281)
T ss_pred cccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHH
Confidence 56899999999999 778899999999999999883 222 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE 143 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~ 143 (188)
|+|++..+.+|++|||-+...+ .....+.+||.-|.+|| .+..+|+|++|++.||++.|..||......+
T Consensus 154 nlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e 229 (281)
T KOG0580|consen 154 NLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE 229 (281)
T ss_pred HhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH
Confidence 9999999999999999887432 34566789999999999 5889999999999999999999997654322
Q ss_pred -----------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 -----------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 -----------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
++...+....++++.|+..+|.+|.+..|+++
T Consensus 230 tYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 230 TYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 44556778999999999999999999999876
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=219.82 Aligned_cols=174 Identities=24% Similarity=0.263 Sum_probs=144.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc--------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE--------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~--------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
|+.|+|||+|+++|+ ....|+|+|||.+|+|.+|++... ||+.|++||.. +..|||||.+
T Consensus 317 MKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAA 393 (1157)
T KOG4278|consen 317 MKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAA 393 (1157)
T ss_pred HHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhh
Confidence 678999999999999 788999999999999999993322 99999999998 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccc---
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDL--- 138 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~--- 138 (188)
.|.|+.++..+|++|||+++++. .+.......-.-+.-|.||| ++.++|+|+|||++||+.| |..|+..
T Consensus 394 RNCLVgEnhiVKvADFGLsRlMt-gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl 472 (1157)
T KOG4278|consen 394 RNCLVGENHIVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 472 (1157)
T ss_pred hhccccccceEEeeccchhhhhc-CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH
Confidence 99999999999999999999874 22211111112234578888 7999999999999999986 6666643
Q ss_pred ---------cCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 139 ---------SFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 139 ---------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
.+..+-+..++.++++++..||+-.|.+||++.+|-+.||.....
T Consensus 473 SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 473 SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 233445667889999999999999999999999999999876543
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=205.33 Aligned_cols=166 Identities=19% Similarity=0.211 Sum_probs=133.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. .+..++++||+++++|.+++. +.. |++.|+.|||+ .+++|+|++|.|
T Consensus 60 l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~n 136 (267)
T cd06646 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGAN 136 (267)
T ss_pred HHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHH
Confidence 567899999999988 788899999999999999882 222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+++.++.++++|||++....... .......++..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 137 ill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 137 ILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred EEECCCCCEEECcCccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 999999999999999987543111 1122345777888988 24579999999999999999988742211
Q ss_pred C-------------C---cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 G-------------E---FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 ~-------------~---~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
. . .....+..+.+++..||+.+|++|||++++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 215 MRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred hhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0 0 011245789999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=213.04 Aligned_cols=162 Identities=23% Similarity=0.319 Sum_probs=133.0
Q ss_pred ccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 9 LTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 9 l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
.+||||++++++ .+..++||||+++++|..++ +... |++.||.|||+ .+++||||||+||++
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill 129 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILL 129 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEE
Confidence 379999999988 77899999999999999888 2221 89999999999 999999999999999
Q ss_pred ccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC-----
Q 039565 74 NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG----- 142 (188)
Q Consensus 74 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~----- 142 (188)
+.++.++|+|||++..... .........|+..|+||| ++.++|+||||+++|+|++|..||+.....
T Consensus 130 ~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~ 207 (321)
T cd05591 130 DAEGHCKLADFGMCKEGIL--NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES 207 (321)
T ss_pred CCCCCEEEeecccceeccc--CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 9999999999998864321 112233456888999998 578899999999999999999999643221
Q ss_pred ------CcCHHHHHHHHHHHHHccCcCCCCCC-------CHHHHHH
Q 039565 143 ------EFDIISVEKAVEIAMASVSSKVNRRP-------LMNQVVM 175 (188)
Q Consensus 143 ------~~~~~~~~~~~~l~~~cl~~~p~~Rp-------s~~~i~~ 175 (188)
..+...+..+.+++..|++.+|++|| +++++++
T Consensus 208 i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 208 ILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 12223457888999999999999999 7888775
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=210.40 Aligned_cols=175 Identities=20% Similarity=0.196 Sum_probs=135.8
Q ss_pred cccc-cCCCeeeeccc----CCccEEEEecCCCCChhhhc-CCc------------------------------------
Q 039565 6 RNKL-TGPLLVELIGK----QKNNALELGFRGNPELVDQQ-GKE------------------------------------ 43 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~-~~~------------------------------------ 43 (188)
+.++ +||||+++++. ....+++|||+++|+|.+++ ...
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (343)
T cd05103 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITS 143 (343)
T ss_pred HHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccc
Confidence 3455 68999999987 45678999999999999887 210
Q ss_pred ---------------------------------c---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEE
Q 039565 44 ---------------------------------E---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKL 81 (188)
Q Consensus 44 ---------------------------------~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl 81 (188)
. |++.||+|||+ .+++|+|+||.||+++.++.+++
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl 220 (343)
T cd05103 144 SQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKI 220 (343)
T ss_pred ccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEE
Confidence 0 89999999999 99999999999999999999999
Q ss_pred ecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-------------
Q 039565 82 ADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK------------- 141 (188)
Q Consensus 82 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~------------- 141 (188)
+|||++................++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 221 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 300 (343)
T cd05103 221 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 300 (343)
T ss_pred EecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC
Confidence 9999887542111111111223445688988 5788999999999999997 8888753221
Q ss_pred CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 142 GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 142 ~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
...+...+..+.+++..||+.+|++|||+++|++.|+.+.+.
T Consensus 301 ~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 301 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111222345789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=202.65 Aligned_cols=167 Identities=22% Similarity=0.322 Sum_probs=136.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++||||+++++. ....++++||+++++|.+++.+.. |++.||+|||+ .+++|+|++|+|
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~n 136 (267)
T cd06628 60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGAN 136 (267)
T ss_pred HHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHH
Confidence 567899999999998 788899999999999999993222 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCC----CcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGG----THMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~----~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+++.++.++++|||.++....... ........++..|++|| ++.++|+||||+++|++++|..||....
T Consensus 137 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 137 ILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred EEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 9999999999999998875431111 11112345777899998 4678999999999999999999986421
Q ss_pred ------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 ------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+...+..+.+++..||+.+|++||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 217 QLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 12333456678899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=206.31 Aligned_cols=165 Identities=22% Similarity=0.277 Sum_probs=135.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+.+++||||+++++. ....++|+||+++++|.+++.+. . |++.||+|||+ .+++|+||+|+||
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Ni 147 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNI 147 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHE
Confidence 456789999999988 78899999999999999998322 2 89999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC---
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG--- 142 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~--- 142 (188)
+++.++.++++|||.+...... ........++..|++|| .+.++|+||||+++|++++|..||......
T Consensus 148 ll~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~ 225 (296)
T cd06654 148 LLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (296)
T ss_pred EEcCCCCEEECccccchhcccc--ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH
Confidence 9999999999999987753211 11122346778899998 568899999999999999999998543211
Q ss_pred -----------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 -----------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 -----------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+......+.+++.+||..+|++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 122344567899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=206.80 Aligned_cols=171 Identities=21% Similarity=0.255 Sum_probs=134.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Cc------------------------c---------cHHH
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KE------------------------E---------VCCP 48 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~------------------------~---------~i~~ 48 (188)
+.+++||||++++++ +...++++||+++++|.+++. .. . |++.
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred HHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 467899999999998 778999999999999999982 10 0 8999
Q ss_pred HHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHH
Q 039565 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSF 122 (188)
Q Consensus 49 ~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~ 122 (188)
||+|||+ .+++|+|++|.||+++.++.++++|||.+.................+..|++|| ++.++|+|||
T Consensus 142 aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (288)
T cd05050 142 GMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAY 218 (288)
T ss_pred HHHHHHh---CCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHH
Confidence 9999999 999999999999999999999999999886432111111111223345688888 5778999999
Q ss_pred HHHHHHHHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 123 EIVILEIIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 123 G~~l~~~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
|+++|++++ |..||..... ...+...+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus 219 G~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 219 GVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 999999997 7667632211 11123345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=200.57 Aligned_cols=167 Identities=23% Similarity=0.295 Sum_probs=135.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++|+||++++++ ....++++||+++++|.+++ ... . |++.|+.|||+ .+++|+|++|
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p 130 (256)
T cd05039 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAA 130 (256)
T ss_pred HHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhccc
Confidence 467899999999998 78889999999999999998 222 1 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~ 141 (188)
.||+++.++.++++|||.+........ ....+..|.+|| ++.++|+||||+++|++++ |..||.....
T Consensus 131 ~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 205 (256)
T cd05039 131 RNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred ceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999998875421111 122344577887 4668999999999999997 8888754321
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
.+.+...+..+.+++.+||..+|++|||+++++++|+.+
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 206 KDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 122233467899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=211.59 Aligned_cols=161 Identities=20% Similarity=0.296 Sum_probs=132.8
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+||||++++++ .+..++||||+++++|..++ +... |++.||.|||+ .+++|+||||+||+++
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~ 130 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLD 130 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEEC
Confidence 79999999998 77899999999999999888 2222 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-------
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------- 141 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------- 141 (188)
.++.++|+|||++..... .........|+..|++|| ++.++|+|||||++|++++|..||.....
T Consensus 131 ~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i 208 (318)
T cd05570 131 SEGHIKIADFGMCKEGIL--GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208 (318)
T ss_pred CCCcEEecccCCCeecCc--CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 999999999998864211 111223456888999999 57889999999999999999999864321
Q ss_pred ----CCcCHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHH
Q 039565 142 ----GEFDIISVEKAVEIAMASVSSKVNRRPLM-----NQVVM 175 (188)
Q Consensus 142 ----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~-----~~i~~ 175 (188)
...+...+..+.+++..||+.+|.+||++ .++++
T Consensus 209 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 209 LEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11233456788999999999999999998 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=203.47 Aligned_cols=165 Identities=22% Similarity=0.277 Sum_probs=135.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+++++||||+++++. ....++|+||+++++|.+++.... |++.|+.|||+ .+++|+|++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni 132 (277)
T cd06642 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANV 132 (277)
T ss_pred HHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheE
Confidence 567899999999998 778999999999999999883222 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK---- 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~---- 141 (188)
+++.++.++++|||++..... .........++..|++|| ++.++|+||||+++|++++|..|+.....
T Consensus 133 ~i~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 210 (277)
T cd06642 133 LLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL 210 (277)
T ss_pred EEeCCCCEEEccccccccccC--cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH
Confidence 999999999999998875431 111222345677788888 57789999999999999999998753221
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+..+.+++..||+.+|++||++.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 211 FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred hhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1122345667899999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=212.04 Aligned_cols=161 Identities=22% Similarity=0.258 Sum_probs=131.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||+++++. .+..++||||+++++|..++ .... |++.||.|||+ .+++||||||+|
T Consensus 50 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~N 126 (321)
T cd05603 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPEN 126 (321)
T ss_pred HHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHH
Confidence 456899999999887 78899999999999998888 2221 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.+||+|||++.... ..........|+..|++|| ++.++|+|||||++|+|++|..||.....
T Consensus 127 Ill~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 204 (321)
T cd05603 127 ILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM 204 (321)
T ss_pred eEECCCCCEEEccCCCCccCC--CCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH
Confidence 999999999999999886421 1112233456888999999 57789999999999999999999854321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLMN 171 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ 171 (188)
...+......+.+++.+|++.+|.+||++.
T Consensus 205 ~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 205 YDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 122333456788999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=209.70 Aligned_cols=164 Identities=19% Similarity=0.320 Sum_probs=142.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE---E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|+.++||||++++++ .+...+||||..+|.|.+|+... . |+..|+.|||. .+++|||||.+|
T Consensus 107 MSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLEN 183 (668)
T KOG0611|consen 107 MSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLEN 183 (668)
T ss_pred HhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhh
Confidence 678999999999999 88999999999999999999222 2 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
||++.++..||+|||++-.+. ......+++|++-|.+|| -.+.+|-||+|+++|.++.|.+|||....
T Consensus 184 ILLD~N~NiKIADFGLSNly~---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~ 260 (668)
T KOG0611|consen 184 ILLDQNNNIKIADFGLSNLYA---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR 260 (668)
T ss_pred eeecCCCCeeeeccchhhhhc---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH
Confidence 999999999999999987653 334567899999999999 37889999999999999999999986432
Q ss_pred -------CC-cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 -------GE-FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 -------~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+. .....+....-++.++|-.+|++|.|+++|..
T Consensus 261 lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 261 LVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred HHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 11 22344557788999999999999999999875
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=203.44 Aligned_cols=165 Identities=22% Similarity=0.220 Sum_probs=134.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C-Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G-KEE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~-~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||+++++. ++..++++||+++++|..++ + ... |++.||.|||+ .+++|+|++|+
T Consensus 56 l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~ 132 (282)
T cd06643 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAG 132 (282)
T ss_pred HHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcc
Confidence 467899999999988 78899999999999999887 2 111 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC-----------CCccchHHHHHHHHHHHhCCccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-----------TEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-----------~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+++.++.++++|||++..... .........++..|++||. +.++|+||||+++|++++|..||..
T Consensus 133 nili~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 133 NILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred cEEEccCCCEEEccccccccccc--cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 99999999999999998865321 1112233467788999982 3579999999999999999998853
Q ss_pred cCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFK--------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... ...+...+..+.+++..||+.+|.+||+++++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 211 LNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred cCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 221 1122345678999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=208.26 Aligned_cols=174 Identities=21% Similarity=0.224 Sum_probs=137.1
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc------------------c---------cHHHHHHHH
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------------------E---------VCCPGLEYL 53 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------------------~---------~i~~~l~~L 53 (188)
+.++ +||||+++++. ....++++||+++|+|.+++ .+. . |++.||.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred HHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 3456 79999999998 67789999999999999998 211 0 899999999
Q ss_pred hcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHH
Q 039565 54 HQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 54 h~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~ 127 (188)
|+ .+++|+|+||+||+++.++.++|+|||+++...............++..|++|| ++.++|+||||+++|
T Consensus 151 H~---~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 227 (334)
T cd05100 151 AS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 227 (334)
T ss_pred HH---CCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHH
Confidence 99 999999999999999999999999999887542111111111223345688998 577899999999999
Q ss_pred HHHh-CCccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 128 EIIT-GILTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 128 ~~~~-g~~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
+|++ |..||.... ..+.+...+..+.+++..||+.+|++|||+.++++.|+++..
T Consensus 228 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 228 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 9998 777774321 112233445688999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=205.29 Aligned_cols=165 Identities=23% Similarity=0.243 Sum_probs=135.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC--c--c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK--E--E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~--~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++||||+++++. ++..+++|||+++++|.+++ .. . . |++.||.|||+ .+++|+|++|
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp 130 (285)
T cd05605 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKP 130 (285)
T ss_pred HHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCH
Confidence 567899999999887 67899999999999999887 21 1 1 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
+||+++.++.++++|||++...... .......|+..|++|| ++.++|+||+|+++|++++|..||.....
T Consensus 131 ~Nil~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~ 207 (285)
T cd05605 131 ENILLDDYGHIRISDLGLAVEIPEG---ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207 (285)
T ss_pred HHEEECCCCCEEEeeCCCceecCCC---CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh
Confidence 9999999999999999998754211 1122346788899999 57789999999999999999999965322
Q ss_pred --------------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 039565 142 --------------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVMV 176 (188)
Q Consensus 142 --------------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~~ 176 (188)
...+...+..+.+++..||+.||++|| +++++++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 208 VKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred hHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 122334567789999999999999999 88888663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=196.27 Aligned_cols=165 Identities=21% Similarity=0.239 Sum_probs=134.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|..++||||+.++++ ..+..+|+||++ .+|+..+ ++.. +++.|++|||+ ..|.|||+||.
T Consensus 55 Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPn 130 (318)
T KOG0659|consen 55 LQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPN 130 (318)
T ss_pred HHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCcc
Confidence 667899999999999 889999999999 4999999 3332 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~-- 140 (188)
|+|++.+|.+|++|||+++.+..+... ......|.+|.||| |+...|+||.||++.|++-+.+.|....
T Consensus 131 NLLis~~g~lKiADFGLAr~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi 208 (318)
T KOG0659|consen 131 NLLISSDGQLKIADFGLARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI 208 (318)
T ss_pred ceEEcCCCcEEeecccchhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH
Confidence 999999999999999999987543332 22236778899999 7889999999999999998876332110
Q ss_pred -----------------C--------------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 141 -----------------K--------------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 141 -----------------~--------------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
+ ...-...+....+++..++..||.+|.|++|.+++
T Consensus 209 dQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 209 DQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 00112334567899999999999999999999874
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=204.68 Aligned_cols=172 Identities=18% Similarity=0.253 Sum_probs=136.1
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+++++||||++++++ ....++++||+++++|.+++ ... . |++.||.|||+ .+++|+|++
T Consensus 60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~ 136 (284)
T cd05038 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLA 136 (284)
T ss_pred HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 567899999999888 44689999999999999999 322 1 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCc-ceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTH-MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|.||+++.++.++++|||.+.......... ......++..|++|| ++.++|+||||++++++++|..|+....
T Consensus 137 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 137 ARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred HHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 999999999999999999987643111111 111123344577887 5778999999999999999998775432
Q ss_pred CCC---------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 141 KGE---------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 141 ~~~---------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
... .+...+..+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 217 AEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred chhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111 1122346788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=214.88 Aligned_cols=161 Identities=24% Similarity=0.263 Sum_probs=131.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
++.++||||+++++. .+..++||||+++|+|..++ .... |++.||.|||+ .+++||||||+|
T Consensus 50 l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~N 126 (325)
T cd05604 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPEN 126 (325)
T ss_pred HHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHH
Confidence 356899999999887 78899999999999999888 2222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG-- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~-- 142 (188)
|+++.++.++|+|||++.... ..........|+..|++|| ++.++|+|||||++|+|++|..||......
T Consensus 127 Ill~~~~~~kL~DfG~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~ 204 (325)
T cd05604 127 ILLDSQGHVVLTDFGLCKEGI--AQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204 (325)
T ss_pred eEECCCCCEEEeecCCcccCC--CCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH
Confidence 999999999999999986422 1112233457889999999 578899999999999999999998543211
Q ss_pred ---------CcCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 039565 143 ---------EFDIISVEKAVEIAMASVSSKVNRRPLMN 171 (188)
Q Consensus 143 ---------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ 171 (188)
......+..+.+++..|++.+|.+||++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 205 YDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 11223456788999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=199.22 Aligned_cols=170 Identities=21% Similarity=0.231 Sum_probs=134.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||++++++ ....++++||+++++|.+++ +... +++.|+.|||+ .+++|+|++|+
T Consensus 46 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~ 122 (251)
T cd05041 46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAAR 122 (251)
T ss_pred HHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcc
Confidence 567899999999988 77889999999999999998 2221 88999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
||+++.++.++++|||.+.................+..|++|| ++.++|+||||+++|++++ |..||....
T Consensus 123 nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~ 202 (251)
T cd05041 123 NCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ 202 (251)
T ss_pred eEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH
Confidence 9999999999999999887432111111111122344588888 5778999999999999998 777774321
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
....+...+..+.+++.+|++.+|.+|||++++++.|+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 203 QTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11123345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=201.19 Aligned_cols=166 Identities=22% Similarity=0.272 Sum_probs=137.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+++++||||+++++. ....++++||+++++|.+++.... |++.|++|||+ .+++|+|++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Ni 132 (277)
T cd06640 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANV 132 (277)
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhE
Confidence 457899999999999 788999999999999999883222 89999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC-----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF----- 140 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~----- 140 (188)
+++.++.++++|||.+...... ........++..|++|| .+.++|+||||+++|++++|..||....
T Consensus 133 l~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 210 (277)
T cd06640 133 LLSEQGDVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL 210 (277)
T ss_pred EEcCCCCEEEcccccceeccCC--ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh
Confidence 9999999999999998754321 11222345667788988 4778999999999999999999986432
Q ss_pred -------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 141 -------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 141 -------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
........+..+.+++..||+.+|++||+++++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 211 FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 223344567889999999999999999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=231.09 Aligned_cols=172 Identities=22% Similarity=0.334 Sum_probs=138.5
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEE
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTNIL 72 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nil 72 (188)
.+++++|||||+++++ +...++||||+++|+|.++++... |++.||+|||..+..+++|||+||+||+
T Consensus 736 ~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil 815 (968)
T PLN00113 736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII 815 (968)
T ss_pred HHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEE
Confidence 4678899999999999 778899999999999999994433 9999999999544479999999999999
Q ss_pred EccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC----
Q 039565 73 LNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG---- 142 (188)
Q Consensus 73 l~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~---- 142 (188)
++.++..++. ++...... ......++..|+||| ++.++|||||||++||+++|+.||+.....
T Consensus 816 ~~~~~~~~~~-~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~ 888 (968)
T PLN00113 816 IDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI 888 (968)
T ss_pred ECCCCceEEE-eccccccc------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcH
Confidence 9988877765 55433211 111235678899999 588999999999999999999997543210
Q ss_pred -------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 143 -------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 143 -------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
..+..+..++.+++.+||+.+|++||||++++++|+++...
T Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 12334566788999999999999999999999999988653
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=199.17 Aligned_cols=160 Identities=21% Similarity=0.320 Sum_probs=135.8
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
-||+|+++.++ +...++|+|.|+.|.|.+++ ..-. |+..|++|||. ..|+||||||+|||++
T Consensus 81 GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILld 157 (411)
T KOG0599|consen 81 GHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLD 157 (411)
T ss_pred CCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeec
Confidence 49999999999 77788999999999999999 2222 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC------------CCCccchHHHHHHHHHHHhCCcccccc---
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------------LTEKSDVDSFEIVILEIITGILTVDLS--- 139 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------------~~~~~di~s~G~~l~~~~~g~~p~~~~--- 139 (188)
++..++++|||+++... ++ ......+||++|+||| ++...|+|++|+++|.++.|..||...
T Consensus 158 dn~~i~isDFGFa~~l~-~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm 234 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQLE-PG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM 234 (411)
T ss_pred cccceEEeccceeeccC-Cc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH
Confidence 99999999999998654 22 2345678999999999 688999999999999999999998432
Q ss_pred ------------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 140 ------------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 140 ------------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+..+-=...+....+++.+|++.||++|.|+++.++
T Consensus 235 lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 235 LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 111111245668899999999999999999999876
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=218.15 Aligned_cols=156 Identities=23% Similarity=0.333 Sum_probs=135.3
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcC--Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEcc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQG--KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNE 75 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~--~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~ 75 (188)
+||.+++++.. .+++++||||+.||++..+.+ +.. .++.||.|||+ ++|||||||.+|||+|.
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~ 503 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDT 503 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcc
Confidence 79999999999 899999999999999655552 222 89999999999 99999999999999999
Q ss_pred CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC--------
Q 039565 76 KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK-------- 141 (188)
Q Consensus 76 ~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-------- 141 (188)
.|.+||+|||+++--. .....+.+++||+.|+||| |+..+|.|||||++|+|+.|+.||.....
T Consensus 504 eGh~kiADFGlcKe~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~ 581 (694)
T KOG0694|consen 504 EGHVKIADFGLCKEGM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV 581 (694)
T ss_pred cCcEEecccccccccC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 9999999999998532 2333677899999999999 79999999999999999999999964332
Q ss_pred ---CCcCHHHHHHHHHHHHHccCcCCCCCCCH
Q 039565 142 ---GEFDIISVEKAVEIAMASVSSKVNRRPLM 170 (188)
Q Consensus 142 ---~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 170 (188)
..++...+.+..+++...+..+|++|.-+
T Consensus 582 ~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22667788899999999999999999844
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=213.68 Aligned_cols=167 Identities=21% Similarity=0.265 Sum_probs=133.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+..++||||+++++. +...++||||+++|+|.+++... . |++.||+|||+ .+|+||||||+||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NI 173 (370)
T cd05621 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNM 173 (370)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHE
Confidence 456789999999988 77899999999999999998322 2 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC----------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE----------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe----------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
+++.++.+||+|||++..... ..........|++.|+||| ++.++|+||+||++|+|++|..||.....
T Consensus 174 Ll~~~~~~kL~DFG~a~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 174 LLDKHGHLKLADFGTCMKMDE-TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred EECCCCCEEEEecccceeccc-CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 999999999999999875431 1111223457899999998 35789999999999999999999854321
Q ss_pred -------------CCcC--HHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 039565 142 -------------GEFD--IISVEKAVEIAMASVSSKVNR--RPLMNQVVMV 176 (188)
Q Consensus 142 -------------~~~~--~~~~~~~~~l~~~cl~~~p~~--Rps~~~i~~~ 176 (188)
..++ ...+..+.+++..|+..++.+ |++++++++.
T Consensus 253 ~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 253 VGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111 134667889999999865554 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=217.39 Aligned_cols=165 Identities=21% Similarity=0.221 Sum_probs=140.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|..++||+||++++. .+++|++.|||+||....++-..+ |++.||.|||+ ..|||||||+.
T Consensus 83 La~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAG 159 (1187)
T KOG0579|consen 83 LAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAG 159 (1187)
T ss_pred hhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhcccc
Confidence 567899999999988 899999999999999998882211 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|||++-+|.++|+|||++--. .........+.||++||||| |+.++||||||+++.+|..+.+|-..
T Consensus 160 NiL~TldGdirLADFGVSAKn--~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 160 NILLTLDGDIRLADFGVSAKN--KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred ceEEEecCcEeeecccccccc--hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 999999999999999987532 22334566799999999999 68899999999999999999876532
Q ss_pred c--------------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 S--------------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~--------------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
- ...-.+..+...+.+++..||.+||..||++.++++
T Consensus 238 lnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 238 LNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1 111245678889999999999999999999999987
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=201.51 Aligned_cols=166 Identities=20% Similarity=0.296 Sum_probs=136.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||+++.+. ....++++||+++++|.+++ .... |++.||.|||+ .+++|+|++|
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p 128 (255)
T cd08219 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKS 128 (255)
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCc
Confidence 567899999999988 78899999999999999887 2111 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
.||+++.++.++++|||.+....... .......++..|++|| .+.++|+||||+++|+|++|..||+....
T Consensus 129 ~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~ 206 (255)
T cd08219 129 KNIFLTQNGKVKLGDFGSARLLTSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK 206 (255)
T ss_pred ceEEECCCCcEEEcccCcceeecccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH
Confidence 99999999999999999887543211 1223356777899998 57789999999999999999999864321
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
...+...+..+.+++..||+.+|++|||+.+++..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 207 NLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11333456678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=208.00 Aligned_cols=167 Identities=14% Similarity=0.160 Sum_probs=128.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---c--c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---E--E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
++.++||||++++++ ++..++|+||+++++|.+++.. . . |++.||+|||+ .+++|+|+||
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp 129 (327)
T cd08227 53 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKA 129 (327)
T ss_pred HHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCh
Confidence 345799999999988 7889999999999999998822 1 1 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCc-----ceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCcc
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTH-----MSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p 135 (188)
+||+++.++.+++.||+............ ......++..|++|| ++.++|+|||||++|++++|..|
T Consensus 130 ~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 209 (327)
T cd08227 130 SHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209 (327)
T ss_pred hhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999999999987543221111100 011123455688888 45789999999999999999999
Q ss_pred ccccCCC---------------------------------------------------------CcCHHHHHHHHHHHHH
Q 039565 136 VDLSFKG---------------------------------------------------------EFDIISVEKAVEIAMA 158 (188)
Q Consensus 136 ~~~~~~~---------------------------------------------------------~~~~~~~~~~~~l~~~ 158 (188)
|+..... .........+.+++.+
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 289 (327)
T cd08227 210 FKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQ 289 (327)
T ss_pred CCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHH
Confidence 8531100 0111234578899999
Q ss_pred ccCcCCCCCCCHHHHHH
Q 039565 159 SVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 159 cl~~~p~~Rps~~~i~~ 175 (188)
||+.||++|||++++++
T Consensus 290 ~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 290 CLQRNPDARPSASTLLN 306 (327)
T ss_pred HHhhCchhcCCHHHHhc
Confidence 99999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=209.35 Aligned_cols=163 Identities=19% Similarity=0.242 Sum_probs=128.7
Q ss_pred cccccCCCeeeeccc---C------CccEEEEecCCCCChhhhc-CCcc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---Q------KNNALELGFRGNPELVDQQ-GKEE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~------~~~~lv~e~~~~~~L~~~~-~~~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ . ...+++|||+++ +|...+ .... |++.||.|||+ .+++||||
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDl 149 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDL 149 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 467899999999987 1 246999999985 566555 2222 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+||+++.++.++|+|||+++... .........++..|+||| ++.++|+||||+++|+|++|..||....
T Consensus 150 kp~NIl~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 150 KPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred CHHHEEECCCCCEEEecCCCccccc---cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987432 111223356788899999 5788999999999999999999885321
Q ss_pred CCC-----------------------------------------------------cCHHHHHHHHHHHHHccCcCCCCC
Q 039565 141 KGE-----------------------------------------------------FDIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 141 ~~~-----------------------------------------------------~~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
... ........+.+++.+||+.||++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 306 (359)
T cd07876 227 HIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306 (359)
T ss_pred HHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccC
Confidence 100 000123467899999999999999
Q ss_pred CCHHHHHH
Q 039565 168 PLMNQVVM 175 (188)
Q Consensus 168 ps~~~i~~ 175 (188)
||+.++++
T Consensus 307 ~t~~e~l~ 314 (359)
T cd07876 307 ISVDEALR 314 (359)
T ss_pred CCHHHHhc
Confidence 99999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=199.18 Aligned_cols=166 Identities=22% Similarity=0.297 Sum_probs=134.1
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++|||++++++. .+..++++||+++++|.+++ ... . |++.|+.|||+ .+++|||++|+
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~ 129 (254)
T cd05083 53 MTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAAR 129 (254)
T ss_pred HHhCCCCCcCeEEEEEcCCCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcc
Confidence 567899999999998 67789999999999999998 221 1 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
||+++.++.++++|||.+...... ......+..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 130 nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 204 (254)
T cd05083 130 NILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK 204 (254)
T ss_pred eEEEcCCCcEEECCCccceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 999999999999999988643211 11122334577777 5678999999999999997 8888854321
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
...+...+..+.+++.+||+.+|+.||+++++++.|+.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 205 EVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11222345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=210.69 Aligned_cols=164 Identities=18% Similarity=0.202 Sum_probs=129.3
Q ss_pred cccccCCCeeeeccc---------CCccEEEEecCCCCChhhhc-CCcc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---------QKNNALELGFRGNPELVDQQ-GKEE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~-~~~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
++.++||||++++++ ....+++|||+++ +|...+ .... |++.||.|||+ .+++|||+
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDi 145 (355)
T cd07874 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDL 145 (355)
T ss_pred HHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 456899999999987 1346899999985 666666 2222 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+||+++.++.+||+|||+++... .........++..|+||| ++.++|+|||||++|+|++|..||....
T Consensus 146 kp~Nill~~~~~~kl~Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 146 KPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred ChHHEEECCCCCEEEeeCcccccCC---CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987532 111223456788899998 5788999999999999999998885321
Q ss_pred CC-----------------------------------------------------CcCHHHHHHHHHHHHHccCcCCCCC
Q 039565 141 KG-----------------------------------------------------EFDIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 141 ~~-----------------------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
.. .........+.+++.+|++.||++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 302 (355)
T cd07874 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhc
Confidence 00 0001123467899999999999999
Q ss_pred CCHHHHHHH
Q 039565 168 PLMNQVVMV 176 (188)
Q Consensus 168 ps~~~i~~~ 176 (188)
||++++++.
T Consensus 303 ps~~ell~h 311 (355)
T cd07874 303 ISVDEALQH 311 (355)
T ss_pred CCHHHHhcC
Confidence 999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=218.80 Aligned_cols=160 Identities=25% Similarity=0.277 Sum_probs=137.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc--CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ--GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~--~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|.+++|||+|.+.|+ ....|||||||- |+-.+++ .+.+ +.+.||+|||+ .+.||||+|+.
T Consensus 80 L~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAG 155 (948)
T KOG0577|consen 80 LRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAG 155 (948)
T ss_pred HHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhcccc
Confidence 568999999999999 778899999998 5777877 3333 88899999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccc-c--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTV-D-- 137 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~-~-- 137 (188)
|||++++|.+|++|||.+.+.. ..+.+.|||+||||| |+-++||||+|+++.++...++|+ +
T Consensus 156 NILLse~g~VKLaDFGSAsi~~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN 229 (948)
T KOG0577|consen 156 NILLSEPGLVKLADFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 229 (948)
T ss_pred ceEecCCCeeeeccccchhhcC------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch
Confidence 9999999999999999887643 356789999999999 789999999999999999988764 1
Q ss_pred ----------ccCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 ----------LSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ----------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+.-....++..+.+++..|+++-|..|||.++++.
T Consensus 230 AMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 230 AMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 01111124678899999999999999999999999876
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=199.18 Aligned_cols=169 Identities=24% Similarity=0.321 Sum_probs=134.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++|||++++++. ....++++||+++++|.+++ .+.. |++.|++|||+ .+++|+|++|+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ 129 (256)
T cd05112 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAAR 129 (256)
T ss_pred HHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccc
Confidence 567899999999988 67889999999999999998 2221 88999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~~ 142 (188)
||+++.++.++++|||.+...... .........++..|++|| ++.++|+||||+++|++++ |..||+.....
T Consensus 130 ni~i~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05112 130 NCLVGENQVVKVSDFGMTRFVLDD-QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208 (256)
T ss_pred eEEEcCCCeEEECCCcceeecccC-cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 999999999999999987643211 111111223345688888 4678999999999999998 88888643211
Q ss_pred ------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 143 ------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 143 ------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 209 EVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112234677999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=198.67 Aligned_cols=170 Identities=24% Similarity=0.290 Sum_probs=136.8
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++|+||+++.+. ....++++||+++++|.+++ .... |++.||.|||+ .+++|+|++|+
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ 131 (260)
T cd05073 55 MKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAA 131 (260)
T ss_pred HHhcCCCCcceEEEEEcCCCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcc
Confidence 567899999999888 77789999999999999998 3221 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
|++++.++.++++|||.+..... ..........++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 132 ni~i~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 210 (260)
T cd05073 132 NILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210 (260)
T ss_pred eEEEcCCCcEEECCCcceeeccC-CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999998865421 1111122233455688888 4778999999999999998 8888853211
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
.+.....+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 211 EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12223455689999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=208.03 Aligned_cols=172 Identities=20% Similarity=0.227 Sum_probs=136.3
Q ss_pred CcccccCCCeeeeccc-----CC---ccEEEEecCCCCChhhhcCC-----cc-----------cHHHHHHHHhcCCCCC
Q 039565 5 NRNKLTGPLLVELIGK-----QK---NNALELGFRGNPELVDQQGK-----EE-----------VCCPGLEYLHQGLKHP 60 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~-----~~---~~~lv~e~~~~~~L~~~~~~-----~~-----------~i~~~l~~Lh~~~~~~ 60 (188)
-|++++|||||++.-+ .. .+.+||||++. +|...++. .. |+.+||+|||+ .+
T Consensus 70 im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~ 145 (364)
T KOG0658|consen 70 IMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HG 145 (364)
T ss_pred HHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cC
Confidence 3678999999999777 22 45699999995 99988842 11 99999999999 99
Q ss_pred cEEeCCCCCcEEEccC-CceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhC
Q 039565 61 IIQRDMKSTNILLNEK-VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 61 i~h~dl~~~nill~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g 132 (188)
|.|||+||+|+|+|.. |.+||+|||.++... .+ ........+.+|.||| ++.+.||||.||++.||+-|
T Consensus 146 IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~-~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g 222 (364)
T KOG0658|consen 146 ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV-KG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKG 222 (364)
T ss_pred cccCCCChheEEEcCCCCeEEeccCCcceeec-cC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcC
Confidence 9999999999999976 899999999998753 22 2345667788999999 79999999999999999999
Q ss_pred CccccccCC---------------------------------------CC-cCHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 039565 133 ILTVDLSFK---------------------------------------GE-FDIISVEKAVEIAMASVSSKVNRRPLMNQ 172 (188)
Q Consensus 133 ~~p~~~~~~---------------------------------------~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~~ 172 (188)
+..|..... .. +.........+++..+++.+|++|.++.+
T Consensus 223 ~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~ 302 (364)
T KOG0658|consen 223 QPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALE 302 (364)
T ss_pred CcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHH
Confidence 975532110 00 22344567889999999999999999998
Q ss_pred HHH--HHhhccCc
Q 039565 173 VVM--VREQGSGS 183 (188)
Q Consensus 173 i~~--~l~~~~~~ 183 (188)
++. .++.+.+.
T Consensus 303 ~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 303 ALAHPFFDELRDP 315 (364)
T ss_pred HhcchhhHHhhCc
Confidence 876 44444443
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=199.11 Aligned_cols=170 Identities=24% Similarity=0.277 Sum_probs=136.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||+++++. ....++++||+++++|.+++ ... . |++.|+.|||+ .+++|+|++|
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p 131 (261)
T cd05034 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAA 131 (261)
T ss_pred HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcch
Confidence 568899999999998 57889999999999999998 322 1 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~ 141 (188)
+||+++.++.++++|||.+..... ..........++..|++|| .+.++|+||||+++|++++ |..||.....
T Consensus 132 ~nili~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 132 RNILVGENLVCKIADFGLARLIED-DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred heEEEcCCCCEEECccccceeccc-hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999998875431 1111111223345688887 5778999999999999998 8888854221
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
...+...+..+.+++.+|++.+|.+||+++++++.|+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 211 REVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11222345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=212.30 Aligned_cols=167 Identities=19% Similarity=0.250 Sum_probs=135.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||+++++. .+..++||||+++++|.+++ .... |++.||+|||+ .+++||||||+|
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~N 131 (350)
T cd05573 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDN 131 (350)
T ss_pred HHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHH
Confidence 567889999999888 78899999999999999999 3222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCC---------------------------CCcceeeecccccccCCC------CCCcc
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEG---------------------------GTHMSTTIAGTAGFLNTE------LTEKS 117 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~pe------~~~~~ 117 (188)
|+++.++.++|+|||++....... .........|+..|+||| ++.++
T Consensus 132 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 211 (350)
T cd05573 132 ILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC 211 (350)
T ss_pred eEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCce
Confidence 999999999999999987543211 001123456888999999 57899
Q ss_pred chHHHHHHHHHHHhCCccccccCCC-------------CcCH--HHHHHHHHHHHHccCcCCCCCCC-HHHHHHH
Q 039565 118 DVDSFEIVILEIITGILTVDLSFKG-------------EFDI--ISVEKAVEIAMASVSSKVNRRPL-MNQVVMV 176 (188)
Q Consensus 118 di~s~G~~l~~~~~g~~p~~~~~~~-------------~~~~--~~~~~~~~l~~~cl~~~p~~Rps-~~~i~~~ 176 (188)
|+|||||++|+|++|..||...... ..+. ..+..+.+++..|+. +|.+||+ ++++++.
T Consensus 212 DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 212 DWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred eeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9999999999999999998643211 1111 236788999999997 9999999 9999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=199.27 Aligned_cols=165 Identities=18% Similarity=0.184 Sum_probs=131.2
Q ss_pred CcccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 5 NRNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
.+++++||||+++++. ....++++||+++++|.+++ ... . |++.||.|||+ .+++|+|+||+
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~ 130 (259)
T cd05037 54 LMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGK 130 (259)
T ss_pred HHHcCCCcchhheeeEEecCCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccc
Confidence 3578899999999998 66789999999999999998 222 1 99999999999 99999999999
Q ss_pred cEEEccCC-------ceEEecccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHh-CC
Q 039565 70 NILLNEKV-------QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIIT-GI 133 (188)
Q Consensus 70 nill~~~~-------~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~-g~ 133 (188)
||+++.++ .++++|||++..... .....++..|++|| ++.++|+||||+++|++++ |.
T Consensus 131 Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~ 204 (259)
T cd05037 131 NILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204 (259)
T ss_pred eEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCC
Confidence 99999877 799999998875321 11223445677777 3567999999999999998 46
Q ss_pred ccccccCCCC----------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 134 LTVDLSFKGE----------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 134 ~p~~~~~~~~----------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
.|+......+ .+......+.+++.+||..+|.+|||+.++++.|+
T Consensus 205 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 205 EPLSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCcccCCchhHHHHHhcCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 6664432111 11122368889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=211.85 Aligned_cols=167 Identities=21% Similarity=0.251 Sum_probs=133.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+..++||||+++++. +...++||||+++|+|.+++.... |++.||.|||+ .+++||||||+||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NI 173 (371)
T cd05622 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNM 173 (371)
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHE
Confidence 456789999999988 778999999999999999983222 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC----------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE----------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe----------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
+++.++.+||+|||++...... .........|++.|+||| ++.++|+|||||++|+|++|..||.....
T Consensus 174 ll~~~~~ikL~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 174 LLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred EECCCCCEEEEeCCceeEcCcC-CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 9999999999999998754311 111223457899999998 45789999999999999999999964321
Q ss_pred -------------CCcC--HHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 039565 142 -------------GEFD--IISVEKAVEIAMASVSSKVNR--RPLMNQVVMV 176 (188)
Q Consensus 142 -------------~~~~--~~~~~~~~~l~~~cl~~~p~~--Rps~~~i~~~ 176 (188)
..++ ...+..+.+++..|++..+.+ |++++++++.
T Consensus 253 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 253 VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0111 235677889999999854443 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=210.93 Aligned_cols=166 Identities=21% Similarity=0.205 Sum_probs=132.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Cc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. ....+++||++. ++|..++. .. . |++.||.|||+ .+|+||||||+|
T Consensus 140 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~N 215 (392)
T PHA03207 140 LKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTEN 215 (392)
T ss_pred HHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHH
Confidence 678899999999988 778899999997 58888872 22 1 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG-- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~-- 142 (188)
|+++.++.++|+|||++................|+..|++|| ++.++|+|||||++|+|++|..||......
T Consensus 216 ill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 295 (392)
T PHA03207 216 IFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295 (392)
T ss_pred EEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc
Confidence 999999999999999987543222222233467899999999 578899999999999999999887432110
Q ss_pred ----------------CcC------------------------------HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 ----------------EFD------------------------------IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ----------------~~~------------------------------~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+++ ......+.+++..|+..+|++|||+.+++.
T Consensus 296 ~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 296 SSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred HHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 011345678899999999999999999987
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=211.87 Aligned_cols=167 Identities=18% Similarity=0.228 Sum_probs=130.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. .+..+++|||+++|+|.+++.+ .. |++.||.|||+ .+|+||||||+|
T Consensus 55 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~N 131 (381)
T cd05626 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDN 131 (381)
T ss_pred HHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHH
Confidence 567899999999988 7889999999999999999822 21 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCC---------------------------------------------Ccceeeeccc
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGG---------------------------------------------THMSTTIAGT 105 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~ 105 (188)
|+++.++.++|+|||++........ ........|+
T Consensus 132 ili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 211 (381)
T cd05626 132 ILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGT 211 (381)
T ss_pred EEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCC
Confidence 9999999999999998753210000 0001234688
Q ss_pred ccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC-------------cC--HHHHHHHHHHHHH--ccCc
Q 039565 106 AGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE-------------FD--IISVEKAVEIAMA--SVSS 162 (188)
Q Consensus 106 ~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~-------------~~--~~~~~~~~~l~~~--cl~~ 162 (188)
..|+||| ++.++|+|||||++|+|++|..||......+ .+ ...+..+.+++.+ |+..
T Consensus 212 ~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~ 291 (381)
T cd05626 212 PNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE 291 (381)
T ss_pred ccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcc
Confidence 9999999 5788999999999999999999996432211 11 1235677788877 5566
Q ss_pred CCCCCCCHHHHHH
Q 039565 163 KVNRRPLMNQVVM 175 (188)
Q Consensus 163 ~p~~Rps~~~i~~ 175 (188)
++..||++++++.
T Consensus 292 ~~~~R~~~~~~l~ 304 (381)
T cd05626 292 ERLGRNGADDIKA 304 (381)
T ss_pred cccCCCCHHHHhc
Confidence 6667999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=204.75 Aligned_cols=165 Identities=22% Similarity=0.326 Sum_probs=133.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. ++..++++||+++++|.+++.+.. |++.||.|||+ ..+++|+|++|.|
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~n 130 (308)
T cd06615 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSN 130 (308)
T ss_pred HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHH
Confidence 567899999999988 889999999999999999983221 99999999997 1589999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCCc
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGEF 144 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~~ 144 (188)
|+++.++.++++|||++...... ......++..|++|| ++.++|+||||+++|++++|..||........
T Consensus 131 il~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 206 (308)
T cd06615 131 ILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206 (308)
T ss_pred EEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH
Confidence 99999999999999987643211 123346777888998 56789999999999999999988753211000
Q ss_pred ------------------------------------------------C-HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 145 ------------------------------------------------D-IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 145 ------------------------------------------------~-~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+ ......+.+++.+||+.+|++|||+.++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 207 EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred HHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 013456889999999999999999999987
Q ss_pred H
Q 039565 176 V 176 (188)
Q Consensus 176 ~ 176 (188)
.
T Consensus 287 ~ 287 (308)
T cd06615 287 H 287 (308)
T ss_pred C
Confidence 5
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=201.06 Aligned_cols=165 Identities=21% Similarity=0.223 Sum_probs=133.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||+++++. +...+++|||+++++|..++ +... |++.|+.|||+ .+++|+|++|+
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~ 139 (292)
T cd06644 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAG 139 (292)
T ss_pred HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcc
Confidence 567899999999998 78899999999999998877 2211 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC-----------CCccchHHHHHHHHHHHhCCccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-----------TEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-----------~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+++.++.++|+|||.+..... .........++..|++||. +.++|+||||+++|++++|..||..
T Consensus 140 Nili~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 140 NVLLTLDGDIKLADFGVSAKNVK--TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred eEEEcCCCCEEEccCccceeccc--cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 99999999999999998764321 1112234557778899982 4579999999999999999998854
Q ss_pred cCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFK--------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... ...+...+..+.+++..||+.+|++||+++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 218 LNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 211 0112234567899999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=201.08 Aligned_cols=164 Identities=25% Similarity=0.313 Sum_probs=133.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc--------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE--------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~--------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+.+++||||+++++. .+..++++||+++++|..+..... |++.||.|||+ .+++|+|+||+||+++
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~ 129 (279)
T cd06619 53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVN 129 (279)
T ss_pred HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEEC
Confidence 457899999999998 778899999999999976652222 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC-----
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE----- 143 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~----- 143 (188)
.++.++++|||++..... .......++..|++|| ++.++|+||||+++|++++|..||.......
T Consensus 130 ~~~~~~l~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 205 (279)
T cd06619 130 TRGQVKLCDFGVSTQLVN----SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP 205 (279)
T ss_pred CCCCEEEeeCCcceeccc----ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch
Confidence 999999999998875321 1223356778899998 5788999999999999999999985422110
Q ss_pred --------------c-CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 144 --------------F-DIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 144 --------------~-~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
. ....+..+.+++..|++.+|++||+++++++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 206 LQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0 11234578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=198.19 Aligned_cols=165 Identities=26% Similarity=0.297 Sum_probs=134.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||+++++. ....++++||+++++|.+++.. . . |++.|+.|||+ .+++|+|++|.
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ 128 (256)
T cd06612 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAG 128 (256)
T ss_pred HHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcc
Confidence 567799999999998 7889999999999999999822 1 1 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG- 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~- 142 (188)
||+++.++.++++|||++....... .......++..|++|| ++.++|+||||+++|++++|..||......
T Consensus 129 ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~ 206 (256)
T cd06612 129 NILLNEEGQAKLADFGVSGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206 (256)
T ss_pred eEEECCCCcEEEcccccchhcccCc--cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 9999999999999999887543211 1223345677889998 567899999999999999999988543211
Q ss_pred -------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 -------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 -------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+......+.+++..||+.+|++|||++++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 207 AIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 112234567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=207.62 Aligned_cols=156 Identities=21% Similarity=0.313 Sum_probs=128.1
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+||||++++++ .+..++||||+++|+|..++ .... |++.||+|||+ .+++||||||+||+++
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~ 130 (327)
T cd05617 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLD 130 (327)
T ss_pred CCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEe
Confidence 69999999988 77899999999999999887 2221 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC------
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG------ 142 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~------ 142 (188)
.++.++|+|||++..... .........|+..|+||| ++.++|+||||+++|+|++|..||+.....
T Consensus 131 ~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~ 208 (327)
T cd05617 131 ADGHIKLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTE 208 (327)
T ss_pred CCCCEEEeccccceeccC--CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccH
Confidence 999999999998864221 112233467889999999 578999999999999999999999532111
Q ss_pred ------------CcCHHHHHHHHHHHHHccCcCCCCCCCH
Q 039565 143 ------------EFDIISVEKAVEIAMASVSSKVNRRPLM 170 (188)
Q Consensus 143 ------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 170 (188)
..+...+..+.+++..||+.+|.+|+++
T Consensus 209 ~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 209 DYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1223345678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=210.76 Aligned_cols=165 Identities=18% Similarity=0.213 Sum_probs=133.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+..++||||+++++. ....++||||+++|+|.+++.+. . |++.||.|||+ .+++||||||+
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~ 131 (330)
T cd05601 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPE 131 (330)
T ss_pred HHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchH
Confidence 456789999999887 77889999999999999999322 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC------------CCccchHHHHHHHHHHHhCCcccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL------------TEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~------------~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
||+++.++.+||+|||++...... .........|++.|+|||. +.++|+||||+++|+|++|..||.
T Consensus 132 NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 132 NVLIDRTGHIKLADFGSAARLTAN-KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred heEECCCCCEEeccCCCCeECCCC-CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 999999999999999998754321 1112233568889999982 467999999999999999999986
Q ss_pred ccCC-------------CCcC--HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LSFK-------------GEFD--IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~~~-------------~~~~--~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.... ..++ ...+..+.+++..|++ +|.+||+++++++
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 211 EGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 4321 0111 1346678899999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=211.51 Aligned_cols=165 Identities=17% Similarity=0.195 Sum_probs=129.7
Q ss_pred cccccCCCeeeeccc---CC-----ccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---QK-----NNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~-----~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+..++||||++++++ .. ..++++||+. ++|..++ .... |++.||.|||+ .+++|||
T Consensus 53 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~d 128 (372)
T cd07853 53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRD 128 (372)
T ss_pred HHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCC
Confidence 467899999999998 33 6799999997 5788777 2222 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|||+||+++.++.+||+|||++...... .........++..|++|| ++.++|+|||||++|+|++|..||..
T Consensus 129 lkp~Nili~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 207 (372)
T cd07853 129 IKPGNLLVNSNCVLKICDFGLARVEEPD-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207 (372)
T ss_pred CChHHEEECCCCCEEeccccceeecccC-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999998754311 111222345677899998 46789999999999999999998854
Q ss_pred cCCC-------------------------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKG-------------------------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~-------------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.... ......+..+.+++.+|++.||++|||++++++
T Consensus 208 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 208 QSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 3210 001112456789999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=199.95 Aligned_cols=164 Identities=25% Similarity=0.281 Sum_probs=130.9
Q ss_pred ccc-cCCCeeeeccc---------CCccEEEEecCCCCChhhhcCC-c----c---------cHHHHHHHHhcCCCCCcE
Q 039565 7 NKL-TGPLLVELIGK---------QKNNALELGFRGNPELVDQQGK-E----E---------VCCPGLEYLHQGLKHPII 62 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~~~-~----~---------~i~~~l~~Lh~~~~~~i~ 62 (188)
.++ +||||+++.+. ....++++||+++++|.+++.. . . |++.|++|||+ .+++
T Consensus 57 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~iv 133 (272)
T cd06637 57 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVI 133 (272)
T ss_pred HHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCc
Confidence 345 69999999988 1357899999999999999822 1 1 99999999999 9999
Q ss_pred EeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHh
Q 039565 63 QRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 63 h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~ 131 (188)
|+|++|+||+++.++.++++|||++..... .........|+..|++|| ++.++|+||||+++|++++
T Consensus 134 h~dl~~~nili~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~ 211 (272)
T cd06637 134 HRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 211 (272)
T ss_pred cCCCCHHHEEECCCCCEEEccCCCceeccc--ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999875321 111233456778899988 3457999999999999999
Q ss_pred CCccccccCC-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 132 GILTVDLSFK-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 132 g~~p~~~~~~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|..||+.... .......+..+.+++..||+.+|++|||++++++
T Consensus 212 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 212 GAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 9998853211 1111234568899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=204.61 Aligned_cols=169 Identities=20% Similarity=0.234 Sum_probs=132.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ .+..+++|||+++ +|.+++ ... . |++.||.|||+ .+++|||+||+
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~ 133 (309)
T cd07872 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQ 133 (309)
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHH
Confidence 567899999999999 7889999999985 888877 221 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.++|+|||++....... .......++..|++|| ++.++|+||||+++|+|++|..||......
T Consensus 134 Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 211 (309)
T cd07872 134 NLLINERGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE 211 (309)
T ss_pred HEEECCCCCEEECccccceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999999999999999987532111 1122345677899998 467899999999999999999988532210
Q ss_pred C------------------------------c-----------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhh
Q 039565 143 E------------------------------F-----------DIISVEKAVEIAMASVSSKVNRRPLMNQVVM--VREQ 179 (188)
Q Consensus 143 ~------------------------------~-----------~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~--~l~~ 179 (188)
+ . ....+..+.+++..|++.+|.+|||++++++ .++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 212 DELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred HHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 0 0 0012456789999999999999999999987 4444
Q ss_pred c
Q 039565 180 G 180 (188)
Q Consensus 180 ~ 180 (188)
.
T Consensus 292 ~ 292 (309)
T cd07872 292 L 292 (309)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=197.02 Aligned_cols=165 Identities=22% Similarity=0.251 Sum_probs=133.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||+++++. ....+++|||+++++|.+++ .. .. |++.||.|||+ .+++|+|++|+
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ 130 (262)
T cd06613 54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGA 130 (262)
T ss_pred HHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChh
Confidence 567899999999988 78899999999999999988 32 22 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+++.++.++++|||.+...... ........++..|++|| ++.++|+||||+++|+|++|..||....
T Consensus 131 ni~i~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 131 NILLTEDGDVKLADFGVSAQLTAT--IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred hEEECCCCCEEECccccchhhhhh--hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999988653211 11223345667788888 2346899999999999999999985432
Q ss_pred C-------------C---CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 K-------------G---EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~-------------~---~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. . ......+..+.+++.+||..+|.+|||+++|+.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 209 PMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 0 112344678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=199.96 Aligned_cols=165 Identities=20% Similarity=0.250 Sum_probs=132.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||+++++. .+..++++||+++++|.+++...+ |++.|+.|||+ .+++|+|++|+|
T Consensus 60 ~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~n 136 (267)
T cd06645 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGAN 136 (267)
T ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHH
Confidence 456799999999998 788999999999999999882221 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+++.++.++++|||++..... .........|+..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 137 ili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 137 ILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred EEECCCCCEEECcceeeeEccC--cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 9999999999999998764421 111223456788899998 34579999999999999999988732111
Q ss_pred --------------CCc--CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 --------------GEF--DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 --------------~~~--~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... ....+..+.+++..|++.+|++||++++|++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 215 MRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred hhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000 0123457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=204.47 Aligned_cols=166 Identities=19% Similarity=0.215 Sum_probs=126.6
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcC--C----------cc---------cHHHHHHHHhcCCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQG--K----------EE---------VCCPGLEYLHQGLKH 59 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~--~----------~~---------~i~~~l~~Lh~~~~~ 59 (188)
+++++||||+++++. +...++++||+.+ +|..++. . .. |++.||.|||+ .
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~ 127 (317)
T cd07868 52 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---N 127 (317)
T ss_pred HHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---C
Confidence 567899999999887 4567899999974 7777651 1 11 99999999999 9
Q ss_pred CcEEeCCCCCcEEE----ccCCceEEecccCcccccCCCCC-cceeeecccccccCCC-------CCCccchHHHHHHHH
Q 039565 60 PIIQRDMKSTNILL----NEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 60 ~i~h~dl~~~nill----~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~ 127 (188)
+++||||||+||++ +.++.+||+|||+++........ .......++..|+||| ++.++|+||+||++|
T Consensus 128 ~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 207 (317)
T cd07868 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207 (317)
T ss_pred CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHH
Confidence 99999999999999 45578999999998764322111 1123456788899999 466799999999999
Q ss_pred HHHhCCccccccCCCC-----c--------------------------C---H------------------------HHH
Q 039565 128 EIITGILTVDLSFKGE-----F--------------------------D---I------------------------ISV 149 (188)
Q Consensus 128 ~~~~g~~p~~~~~~~~-----~--------------------------~---~------------------------~~~ 149 (188)
+|++|..||....... . + . ...
T Consensus 208 el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (317)
T cd07868 208 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 287 (317)
T ss_pred HHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCC
Confidence 9999999885321100 0 0 0 001
Q ss_pred HHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 150 EKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 150 ~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+.+++..|++.||.+|||++++++
T Consensus 288 ~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 288 SKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred hHHHHHHHHHhccCcccCCCHHHHhc
Confidence 24678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=208.97 Aligned_cols=164 Identities=18% Similarity=0.223 Sum_probs=129.1
Q ss_pred cccccCCCeeeeccc---------CCccEEEEecCCCCChhhhc-CCcc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---------QKNNALELGFRGNPELVDQQ-GKEE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~-~~~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
++.++||||++++++ ....++||||+++ +|..++ .... |++.||.|||+ .+++||||
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dl 152 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDL 152 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCC
Confidence 456899999999887 1346999999985 777766 2222 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+||+++.++.+||+|||+++... .........++..|+||| ++.++|+|||||++|+|++|..||....
T Consensus 153 kp~NIll~~~~~~kL~DfG~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 153 KPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred CHHHEEECCCCcEEEEeCCCccccC---CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987532 111223356788899998 5789999999999999999999885321
Q ss_pred CCC-----------------------------------------------------cCHHHHHHHHHHHHHccCcCCCCC
Q 039565 141 KGE-----------------------------------------------------FDIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 141 ~~~-----------------------------------------------------~~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
..+ ........+.+++.+|++.||.+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 309 (364)
T cd07875 230 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309 (364)
T ss_pred HHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccC
Confidence 000 000112467899999999999999
Q ss_pred CCHHHHHHH
Q 039565 168 PLMNQVVMV 176 (188)
Q Consensus 168 ps~~~i~~~ 176 (188)
||++++++.
T Consensus 310 ~t~~e~L~h 318 (364)
T cd07875 310 ISVDEALQH 318 (364)
T ss_pred CCHHHHhcC
Confidence 999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=198.45 Aligned_cols=168 Identities=20% Similarity=0.268 Sum_probs=135.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++|||++++++. .+..++++||+++++|.+++.+.. |++.||.|||+ .+++|+|++|+|
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~n 138 (272)
T cd06629 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADN 138 (272)
T ss_pred HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhh
Confidence 667899999999998 788899999999999999983322 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
|+++.++.++++|||.+................++..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 139 il~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 218 (272)
T cd06629 139 LLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218 (272)
T ss_pred EEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH
Confidence 999999999999999887543221222233445777888888 36679999999999999999998853211
Q ss_pred ----------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 ----------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 ----------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
.......+..+.+++..||..+|.+|||++++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 219 AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11112335789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=198.18 Aligned_cols=167 Identities=23% Similarity=0.330 Sum_probs=137.0
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
.+++++|+||++++++ ....++++||+++++|.+++.+. . |++.|+.|||+ .+++|+|++
T Consensus 52 ~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~ 128 (256)
T cd08221 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIK 128 (256)
T ss_pred HHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCC
Confidence 3567899999999998 77889999999999999999222 1 89999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+||+++.++.+|++|||.+....... .......++..|.+|| .+.++|+||||+++|++++|..||+....
T Consensus 129 p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08221 129 TLNIFLTKAGLIKLGDFGISKILGSEY--SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206 (256)
T ss_pred hHhEEEeCCCCEEECcCcceEEccccc--ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999999999999999887543222 1233456778899998 46789999999999999999998865322
Q ss_pred CC------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 GE------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 ~~------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
.+ .+...+..+.+++.+||+.+|.+||+++++++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 207 LNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11 122345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=202.47 Aligned_cols=166 Identities=20% Similarity=0.236 Sum_probs=133.8
Q ss_pred cccccCCCeeeeccc--------CCccEEEEecCCCCChhhhcCCc---c---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQGKE---E---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~---~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
|.+++|+||+.+.++ -+..|+|+|+|+ .+|...++.. . |++.||.|+|+ .+|+|||
T Consensus 75 Lr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRD 150 (359)
T KOG0660|consen 75 LRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRD 150 (359)
T ss_pred HHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhc---ccccccc
Confidence 567889999999999 356799999996 5999999322 2 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|||.|++++.+..+|++|||+++...........+....|.+|.||| ++.+.||||.||++.||++|+..|..
T Consensus 151 LKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 151 LKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred cchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 99999999999999999999999754222233345678889999999 79999999999999999999976632
Q ss_pred cCC--------------CC-------------------------cC---HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFK--------------GE-------------------------FD---IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~--------------~~-------------------------~~---~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... .+ +. ........+++..+|..||.+|+|++|.++
T Consensus 231 ~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 231 KDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 110 00 00 012235679999999999999999999887
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=199.13 Aligned_cols=169 Identities=18% Similarity=0.175 Sum_probs=134.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-----------c---------cHHHHHHHHhcCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-----------E---------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-----------~---------~i~~~l~~Lh~~~~~~i 61 (188)
+.+++||||++++++ ....+++|||+++++|.+++ ... . |++.||.|||+ .++
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i 138 (275)
T cd05046 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARF 138 (275)
T ss_pred HHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCc
Confidence 567899999999998 67889999999999999998 222 1 99999999999 999
Q ss_pred EEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCc
Q 039565 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GIL 134 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~ 134 (188)
+|+|+||+||+++.++.++++|||++...... .........++..|++|| .+.++|+||||+++|++++ |..
T Consensus 139 ~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~ 217 (275)
T cd05046 139 VHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGEL 217 (275)
T ss_pred ccCcCccceEEEeCCCcEEEcccccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987643211 111112223455688888 4677999999999999998 777
Q ss_pred cccccCC-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 135 TVDLSFK-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 135 p~~~~~~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
||..... ...+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 218 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 218 PFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 7743211 1122334568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=215.18 Aligned_cols=169 Identities=18% Similarity=0.184 Sum_probs=129.1
Q ss_pred cccccCCCeeeeccc-----------CCccEEEEecCCCCChhhhcC----Ccc------------cHHHHHHHHhcCCC
Q 039565 6 RNKLTGPLLVELIGK-----------QKNNALELGFRGNPELVDQQG----KEE------------VCCPGLEYLHQGLK 58 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----------~~~~~lv~e~~~~~~L~~~~~----~~~------------~i~~~l~~Lh~~~~ 58 (188)
|.+++||||+++.++ ....+++|||+++ +|..++. ... |++.||.|||+
T Consensus 113 l~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~--- 188 (440)
T PTZ00036 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS--- 188 (440)
T ss_pred HHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---
Confidence 567899999998765 1236689999985 6766651 111 89999999999
Q ss_pred CCcEEeCCCCCcEEEccCC-ceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHH
Q 039565 59 HPIIQRDMKSTNILLNEKV-QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEII 130 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~ 130 (188)
.+|+||||||+||+++.++ .+||+|||+++..... .......|++.|+||| ++.++|+|||||++|+|+
T Consensus 189 ~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell 265 (440)
T PTZ00036 189 KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265 (440)
T ss_pred CCEecCCcCHHHEEEcCCCCceeeeccccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999999765 6999999999754311 1223456788899999 467799999999999999
Q ss_pred hCCccccccCCCC----------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCH
Q 039565 131 TGILTVDLSFKGE----------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLM 170 (188)
Q Consensus 131 ~g~~p~~~~~~~~----------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~ 170 (188)
+|..||......+ ++...+..+.+++.+||+.+|.+|||+
T Consensus 266 tG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta 345 (440)
T PTZ00036 266 LGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP 345 (440)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH
Confidence 9999985432100 011123578899999999999999999
Q ss_pred HHHHH--HHhhcc
Q 039565 171 NQVVM--VREQGS 181 (188)
Q Consensus 171 ~~i~~--~l~~~~ 181 (188)
.++++ .++.+.
T Consensus 346 ~e~l~hp~f~~~~ 358 (440)
T PTZ00036 346 IEALADPFFDDLR 358 (440)
T ss_pred HHHhCChhHHhhh
Confidence 99985 444443
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=202.11 Aligned_cols=163 Identities=21% Similarity=0.235 Sum_probs=128.2
Q ss_pred cccccCCCeeeeccc--------CCccEEEEecCCCCChhhhcCC-c----c---------cHHHHHHHHhcCCCCCcEE
Q 039565 6 RNKLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQGK-E----E---------VCCPGLEYLHQGLKHPIIQ 63 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~~~-~----~---------~i~~~l~~Lh~~~~~~i~h 63 (188)
+.+++||||++++++ ....++++||+++ +|.+++.. . . |++.||.|||+ .+++|
T Consensus 56 l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH 131 (288)
T cd07863 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVH 131 (288)
T ss_pred hhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 445689999999987 2347899999984 88888722 1 1 99999999999 99999
Q ss_pred eCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 64 RDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 64 ~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
+|+||+||+++.++.++|+|||++..... ........++..|++|| ++.++|+||+||++|++++|..||.
T Consensus 132 ~dikp~Nili~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 132 RDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred CCCCHHHEEECCCCCEEECccCccccccC---cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 99999999999999999999999875431 11122345678899999 5788999999999999999998874
Q ss_pred ccCCC----------------C----------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LSFKG----------------E----------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~~~~----------------~----------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..... . ........+.+++..|++.||++|||+.+++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 209 GNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 32110 0 00123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=207.25 Aligned_cols=159 Identities=21% Similarity=0.304 Sum_probs=127.8
Q ss_pred ccccCC-Ceeeeccc---CCccEEEEecCCCCChhhhcCC-c--c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 7 NKLTGP-LLVELIGK---QKNNALELGFRGNPELVDQQGK-E--E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 7 ~~l~Hp-niv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
..++|+ +|++++++ .+..++||||+++|+|..++.+ . . |++.||.|||+ .+++||||||+|
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~N 131 (324)
T cd05587 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDN 131 (324)
T ss_pred HhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHH
Confidence 345554 57788776 7789999999999999998822 1 1 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++|+|||++..... .........|+..|++|| ++.++|+||+||++|+|++|..||+....
T Consensus 132 ill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~ 209 (324)
T cd05587 132 VMLDAEGHIKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209 (324)
T ss_pred eEEcCCCCEEEeecCcceecCC--CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999998764221 112233457889999999 57789999999999999999999964321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLM 170 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 170 (188)
..++...+..+.+++..||..+|.+|++.
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 210 FQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 12233456678899999999999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=200.67 Aligned_cols=164 Identities=20% Similarity=0.191 Sum_probs=132.9
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCCcc-------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGKEE-------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
|.+++|||||.+.++ -+..++|||||+. +|.+.+++.+ |+++|++|||+ ..|+|||||
T Consensus 129 Ll~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK 204 (419)
T KOG0663|consen 129 LLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLK 204 (419)
T ss_pred HHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccc
Confidence 567899999999888 5678999999996 8988883222 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
++|+|++..|.+|++|||+++.+..+. ...+....|.+|.||| +++..|+||+||++.|++.+.+.|....
T Consensus 205 ~SNLLm~~~G~lKiaDFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 205 TSNLLLSHKGILKIADFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred hhheeeccCCcEEecccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 999999999999999999999765332 2344567788899998 7999999999999999999986442100
Q ss_pred -------------------C-----------------------CCcCHH-HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 -------------------K-----------------------GEFDII-SVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 -------------------~-----------------------~~~~~~-~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+ ..+... ..+.-.+++...+..||.+|-|+++.++
T Consensus 283 E~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 283 EIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0 001111 3356789999999999999999999875
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=200.19 Aligned_cols=166 Identities=22% Similarity=0.226 Sum_probs=134.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c---c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E---E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||+++++. +...+++|||+++++|..++.. . . |++.||.|||+ .+++|+|++|+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ 132 (280)
T cd06611 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAG 132 (280)
T ss_pred HHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChh
Confidence 567899999999998 7888999999999999999822 1 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+++.++.++++|||++...... ........++..|++|| ++.++|+||||+++|++++|..||..
T Consensus 133 nili~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 133 NILLTLDGDVKLADFGVSAKNKST--LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred hEEECCCCCEEEccCccchhhccc--ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 999999999999999987643211 11223456777888888 24579999999999999999999864
Q ss_pred cCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 139 SFK--------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 139 ~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
... ...+...+..+.+++..||+.+|.+||+++++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 211 LNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 321 01122345688999999999999999999999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=197.76 Aligned_cols=165 Identities=21% Similarity=0.255 Sum_probs=133.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC---c--c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK---E--E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~---~--~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||++++++ ++..++++||+++++|.+++ .. . . |++.||+|||+ .+++|+|++
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~ 135 (268)
T cd06624 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIK 135 (268)
T ss_pred HHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCC
Confidence 467899999999998 77889999999999999998 22 1 1 89999999999 999999999
Q ss_pred CCcEEEcc-CCceEEecccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 68 STNILLNE-KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 68 ~~nill~~-~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|.||+++. ++.++++|||.+..... .........++..|++|| ++.++|+||||+++|++++|..||..
T Consensus 136 p~nil~~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 136 GDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred HHHEEEcCCCCeEEEecchhheeccc--CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999976 67899999998865321 111222345777899998 45789999999999999999998853
Q ss_pred cCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFK--------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... ...+......+.+++.+||+.+|++|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 214 LGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 211 1223345568899999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=201.81 Aligned_cols=165 Identities=22% Similarity=0.291 Sum_probs=134.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
++.++||||+++++. .+..++++||+++++|..++... . |++.|++|||+ .+++|+|++|+||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Ni 146 (296)
T cd06655 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNV 146 (296)
T ss_pred HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHE
Confidence 467899999999998 78899999999999999988322 2 89999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC---
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG--- 142 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~--- 142 (188)
+++.++.++++|||++....... .......++..|++|| ++.++|+||||+++|++++|..||......
T Consensus 147 li~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~ 224 (296)
T cd06655 147 LLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (296)
T ss_pred EECCCCCEEEccCccchhccccc--ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999876532111 1122345777899999 567899999999999999999998643210
Q ss_pred -----------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 -----------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 -----------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+...+..+.+++.+||..+|++||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 225 YLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 112234567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=207.32 Aligned_cols=156 Identities=21% Similarity=0.299 Sum_probs=128.7
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+||+|+++.++ .+..++||||+++|+|..++.+ .. |++.||+|||+ .+++||||||+||+++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~ 135 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLD 135 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEEC
Confidence 68999999887 7788999999999999988822 21 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-------
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------- 141 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------- 141 (188)
.++.+||+|||+++.... .........|++.|+||| ++.++|+|||||++|+|++|..||.....
T Consensus 136 ~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i 213 (323)
T cd05616 136 SEGHIKIADFGMCKENMW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213 (323)
T ss_pred CCCcEEEccCCCceecCC--CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999864321 111233456889999999 57899999999999999999999965321
Q ss_pred ----CCcCHHHHHHHHHHHHHccCcCCCCCCCH
Q 039565 142 ----GEFDIISVEKAVEIAMASVSSKVNRRPLM 170 (188)
Q Consensus 142 ----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 170 (188)
..++...+..+.+++..|++.+|++|++.
T Consensus 214 ~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 214 MEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11233456788999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=213.36 Aligned_cols=173 Identities=19% Similarity=0.245 Sum_probs=141.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
|.+++||||++++|+ ++.+++|+||+++|+|.+|+... + |+++||+||.+ .+++|||+.+
T Consensus 589 LsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~ 665 (807)
T KOG1094|consen 589 LSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLAT 665 (807)
T ss_pred HhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccc
Confidence 678999999999999 99999999999999999999222 2 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh--CCccccccC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT--GILTVDLSF 140 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~--g~~p~~~~~ 140 (188)
.|+|+++++.+|++|||.++..-........-...-+..|||+| ++.++|+|+||+++||+++ ...||.+-.
T Consensus 666 rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 666 RNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred cceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 99999999999999999988432222222222234445788888 8999999999999999864 345663211
Q ss_pred C-------------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 141 K-------------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 141 ~-------------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
. ...+..++.++.+++..||+.+..+||+++++...|.+..
T Consensus 746 ~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 746 DEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred HHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1 1245567889999999999999999999999999887654
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=204.20 Aligned_cols=166 Identities=18% Similarity=0.218 Sum_probs=126.3
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcC--C----------cc---------cHHHHHHHHhcCCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQG--K----------EE---------VCCPGLEYLHQGLKH 59 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~--~----------~~---------~i~~~l~~Lh~~~~~ 59 (188)
+++++||||++++++ +...++++||+.+ +|.+++. . .. |++.||.|||+ .
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~ 127 (317)
T cd07867 52 LRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---N 127 (317)
T ss_pred HHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---C
Confidence 567899999999887 5677899999985 6666651 0 01 99999999999 9
Q ss_pred CcEEeCCCCCcEEE----ccCCceEEecccCcccccCCCCC-cceeeecccccccCCC-------CCCccchHHHHHHHH
Q 039565 60 PIIQRDMKSTNILL----NEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 60 ~i~h~dl~~~nill----~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~ 127 (188)
+++|||+||+||++ +.++.+||+|||+++........ .......++..|+||| ++.++|+||||+++|
T Consensus 128 ~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 207 (317)
T cd07867 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207 (317)
T ss_pred CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHH
Confidence 99999999999999 45678999999998754322111 1123456788899999 367799999999999
Q ss_pred HHHhCCccccccCCCC----------------------------------cC------------------------HHHH
Q 039565 128 EIITGILTVDLSFKGE----------------------------------FD------------------------IISV 149 (188)
Q Consensus 128 ~~~~g~~p~~~~~~~~----------------------------------~~------------------------~~~~ 149 (188)
+|++|..||....... ++ ....
T Consensus 208 el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (317)
T cd07867 208 ELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPD 287 (317)
T ss_pred HHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCC
Confidence 9999999885321100 00 0012
Q ss_pred HHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 150 EKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 150 ~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+.+++..|++.||.+|||++|+++
T Consensus 288 ~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 288 SKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred hHHHHHHHHHhccCcccccCHHHHhc
Confidence 34678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=210.84 Aligned_cols=166 Identities=19% Similarity=0.281 Sum_probs=132.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||+++++. ....++||||+++|+|.+++ .... |++.||+|||+ .+++||||||+|
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~N 131 (364)
T cd05599 55 LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDN 131 (364)
T ss_pred HHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHH
Confidence 567889999999988 78899999999999999998 3222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCc------------------------------------ceeeecccccccCCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTH------------------------------------MSTTIAGTAGFLNTE-- 112 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~pe-- 112 (188)
|+++.++.++++|||++.......... ......|++.|+|||
T Consensus 132 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 211 (364)
T cd05599 132 LLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF 211 (364)
T ss_pred eEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH
Confidence 999999999999999886432111000 011235889999999
Q ss_pred ----CCCccchHHHHHHHHHHHhCCccccccCCC-------------Cc--CHHHHHHHHHHHHHccCcCCCCCCC---H
Q 039565 113 ----LTEKSDVDSFEIVILEIITGILTVDLSFKG-------------EF--DIISVEKAVEIAMASVSSKVNRRPL---M 170 (188)
Q Consensus 113 ----~~~~~di~s~G~~l~~~~~g~~p~~~~~~~-------------~~--~~~~~~~~~~l~~~cl~~~p~~Rps---~ 170 (188)
++.++|+|||||++|+|++|..||...... .. ....+..+.+++..|+. +|.+|++ +
T Consensus 212 ~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 212 LQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred cCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 578899999999999999999998643210 01 11235678899999986 8999998 8
Q ss_pred HHHHH
Q 039565 171 NQVVM 175 (188)
Q Consensus 171 ~~i~~ 175 (188)
+++++
T Consensus 291 ~~ll~ 295 (364)
T cd05599 291 NEIKS 295 (364)
T ss_pred HHHhc
Confidence 88876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=198.99 Aligned_cols=165 Identities=24% Similarity=0.312 Sum_probs=136.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+++++||||+++.+. +...++++||+++++|.+++... . |++.|+.|||+ .+++|+|++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni 129 (274)
T cd06609 53 LSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANI 129 (274)
T ss_pred HHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHE
Confidence 467889999999998 78889999999999999999332 2 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK---- 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~---- 141 (188)
+++.++.++++|||++....... .......++..|++|| ++.++|+||||+++|++++|..||+....
T Consensus 130 ~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~ 207 (274)
T cd06609 130 LLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL 207 (274)
T ss_pred EECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH
Confidence 99999999999999987643221 1233456777899999 47889999999999999999999864221
Q ss_pred --------CCcCHH-HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 --------GEFDII-SVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~-~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...... .+..+.+++..||..+|++|||++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 208 FLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111112 5567899999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=199.04 Aligned_cols=173 Identities=24% Similarity=0.244 Sum_probs=133.7
Q ss_pred CcccccCCCeeeeccc---C------CccEEEEecCCCCChhhhc--CC---c----c---------cHHHHHHHHhcCC
Q 039565 5 NRNKLTGPLLVELIGK---Q------KNNALELGFRGNPELVDQQ--GK---E----E---------VCCPGLEYLHQGL 57 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~------~~~~lv~e~~~~~~L~~~~--~~---~----~---------~i~~~l~~Lh~~~ 57 (188)
.+++++||||+++++. . ...+++++|+.+|+|..++ .. . . |++.||+|||+
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-- 131 (273)
T cd05074 54 CMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-- 131 (273)
T ss_pred HHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--
Confidence 3677899999999997 1 1236889999999998876 11 0 1 99999999999
Q ss_pred CCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh
Q 039565 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~ 131 (188)
.+++|+|+||+||+++.++.++++|||.++...............++..|++|| ++.++|+||||+++|++++
T Consensus 132 -~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~ 210 (273)
T cd05074 132 -KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210 (273)
T ss_pred -CCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhh
Confidence 999999999999999999999999999887543211111122233445677787 4788999999999999998
Q ss_pred -CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 132 -GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 132 -g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
|..||..... ...+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 211 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 211 RGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 7777743221 111223457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=195.70 Aligned_cols=165 Identities=21% Similarity=0.300 Sum_probs=134.6
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhc-CC-c---c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQ-GK-E---E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~-~~-~---~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+++++|||++++.+. ....++++||+++++|.+++ .. . . +++.|++|||+ .+++|+|++
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~ 129 (257)
T cd08223 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLK 129 (257)
T ss_pred HHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCC
Confidence 567899999999877 33578999999999999988 21 1 1 89999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+||+++.++.++++|||++...... ........++..|++|| .+.++|+||||++++++++|..||+....
T Consensus 130 p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~ 207 (257)
T cd08223 130 TQNVFLTRTNIIKVGDLGIARVLENQ--CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM 207 (257)
T ss_pred chhEEEecCCcEEEecccceEEeccc--CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 99999999999999999998754321 12233456778899999 46789999999999999999988864321
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+...+..+.+++..|++.+|++||++.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 208 NSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1233345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=198.39 Aligned_cols=167 Identities=21% Similarity=0.294 Sum_probs=135.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++|+||+++.++ ....++++||+++++|.+++.+ .. |++.||+|||+ .+++|+|++|.|
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~n 132 (265)
T cd06631 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNN 132 (265)
T ss_pred HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHh
Confidence 567899999999998 7788999999999999999822 22 89999999999 899999999999
Q ss_pred EEEccCCceEEecccCcccccCCC----CCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEG----GTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~----~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+++.++.++++|||.+....... .........++..|++|| ++.++|+||||+++|++++|..||....
T Consensus 133 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 133 VMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred EEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 999999999999999876432111 111122356778899999 4688999999999999999999985321
Q ss_pred --------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 --------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 --------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+.+...+..+.+++..||+.+|.+||++.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 213 RLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11233345678899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=191.93 Aligned_cols=163 Identities=21% Similarity=0.297 Sum_probs=135.0
Q ss_pred ccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 7 NKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 7 ~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
..++||||+++... ...+++|+|+++|+.|-.=+ ++.- |++.||.|+|. .+|+|||+||+|+
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nl 141 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENL 141 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhhe
Confidence 35899999999888 77889999999999886555 3321 99999999999 9999999999999
Q ss_pred EEcc---CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 72 LLNE---KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 72 ll~~---~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
++.+ ...+|++|||++.... .......+.|+|.|++|| ++..+|||+.|+++|-++.|.+||......
T Consensus 142 lLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~ 218 (355)
T KOG0033|consen 142 LLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 218 (355)
T ss_pred eeeeccCCCceeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH
Confidence 9975 3468999999998653 444566789999999999 789999999999999999999999652210
Q ss_pred -----------CcC----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 -----------EFD----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 -----------~~~----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.++ ....++..+++..|+..||.+|.|+.+.+.
T Consensus 219 rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 219 RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111 234568899999999999999999988664
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=206.62 Aligned_cols=164 Identities=20% Similarity=0.269 Sum_probs=142.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|+-.+|||||++|++ +..+|||+|.-++|+|.+|+ +. .+ |++.|+.|+|. ..++||||||+
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPE 147 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPE 147 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcc
Confidence 455789999999999 88999999999999999999 33 32 99999999999 99999999999
Q ss_pred cEEEcc-CCceEEecccCcccccCCCCCcceeeecccccccCCCC-------CCccchHHHHHHHHHHHhCCccccccCC
Q 039565 70 NILLNE-KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-------TEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 70 nill~~-~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-------~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+.+-+ -|.+||.|||++-.+. ......+.+|+..|.|||+ .+++||||+||++|-+++|+.||.....
T Consensus 148 NVVFFEKlGlVKLTDFGFSNkf~---PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND 224 (864)
T KOG4717|consen 148 NVVFFEKLGLVKLTDFGFSNKFQ---PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND 224 (864)
T ss_pred eeEEeeecCceEeeeccccccCC---CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence 998754 5899999999986543 2234667899999999993 6889999999999999999999976544
Q ss_pred CC-----------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 GE-----------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ~~-----------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+ .+...+.++.+++..||..||.+|.+.++|+.
T Consensus 225 SETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 225 SETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 33 56778899999999999999999999999875
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=202.58 Aligned_cols=165 Identities=22% Similarity=0.278 Sum_probs=135.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+..++||||+++++. +...++++||+++++|.+++.+. . |++.||.|||+ .+++|+||+|+||
T Consensus 70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Ni 146 (297)
T cd06656 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNI 146 (297)
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHE
Confidence 456899999999988 77899999999999999998322 2 89999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC---
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG--- 142 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~--- 142 (188)
+++.++.++++|||.+....... .......++..|++|| ++.++|+||||+++|++++|..||......
T Consensus 147 li~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~ 224 (297)
T cd06656 147 LLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (297)
T ss_pred EECCCCCEEECcCccceEccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe
Confidence 99999999999999886542111 1222345777888888 567899999999999999999998543210
Q ss_pred -----------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 -----------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 -----------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+......+.+++..||+.+|++||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 225 YLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred eeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122334567889999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=201.96 Aligned_cols=166 Identities=19% Similarity=0.211 Sum_probs=135.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+++++||||+++++. .+..++++||+++++|.+++.. .. |++.||+|||+ .+++|+|++|.||
T Consensus 73 l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Ni 149 (292)
T cd06658 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSI 149 (292)
T ss_pred HHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHE
Confidence 467899999999988 7889999999999999998822 22 89999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK---- 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~---- 141 (188)
+++.++.++++|||++...... ........++..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 150 ll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~ 227 (292)
T cd06658 150 LLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 227 (292)
T ss_pred EEcCCCCEEEccCcchhhcccc--cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999988654211 11223356778899999 47889999999999999999998853221
Q ss_pred --------CC--cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 --------GE--FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 --------~~--~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
.. ........+.+++..|+..+|++|||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 228 RRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11 111345578899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=208.06 Aligned_cols=168 Identities=20% Similarity=0.238 Sum_probs=128.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. ....++||||+++|+|.+++ ++.. |++.||+|||+ .+|+||||||+|
T Consensus 55 l~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~N 131 (363)
T cd05628 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDN 131 (363)
T ss_pred HHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHH
Confidence 457899999999988 77889999999999999998 3222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCC---------------------------------CcceeeecccccccCCC-----
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGG---------------------------------THMSTTIAGTAGFLNTE----- 112 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~~pe----- 112 (188)
|+++.++.++|+|||+++....... ........|+..|+|||
T Consensus 132 ILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 211 (363)
T cd05628 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT 211 (363)
T ss_pred eEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC
Confidence 9999999999999999864321100 00012357899999999
Q ss_pred -CCCccchHHHHHHHHHHHhCCccccccCCCC-------------cCH--HHHHHHHHHHHHcc--CcCCCCCCCHHHHH
Q 039565 113 -LTEKSDVDSFEIVILEIITGILTVDLSFKGE-------------FDI--ISVEKAVEIAMASV--SSKVNRRPLMNQVV 174 (188)
Q Consensus 113 -~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~-------------~~~--~~~~~~~~l~~~cl--~~~p~~Rps~~~i~ 174 (188)
++.++|+|||||++|+|++|..||......+ ++. ..+..+.+++..++ ..++..||++++|+
T Consensus 212 ~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~ 291 (363)
T cd05628 212 GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHh
Confidence 5788999999999999999999996432111 111 13456667776633 33444678999998
Q ss_pred HH
Q 039565 175 MV 176 (188)
Q Consensus 175 ~~ 176 (188)
+.
T Consensus 292 ~h 293 (363)
T cd05628 292 TN 293 (363)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=197.34 Aligned_cols=166 Identities=22% Similarity=0.270 Sum_probs=130.7
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCC-c--c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGK-E--E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||++++++ ....++++||+++++|.+++.. . . |++.||.|||+ .+++|+|++|
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p 134 (266)
T cd06651 58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKG 134 (266)
T ss_pred HHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCH
Confidence 567899999999987 3567899999999999999822 1 1 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCC-CcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC-
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF- 140 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~- 140 (188)
+||+++.++.++++|||++........ ........++..|++|| ++.++|+||||+++|++++|..||....
T Consensus 135 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~ 214 (266)
T cd06651 135 ANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214 (266)
T ss_pred HHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch
Confidence 999999999999999998875421111 11112345777899998 4778999999999999999999985432
Q ss_pred ------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 ------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+......+.+++ .||..+|++||++++|++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 215 MAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1223334455666766 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=200.48 Aligned_cols=164 Identities=19% Similarity=0.175 Sum_probs=129.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c--c------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E--E------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~--~------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||+++++. +...++++||+. ++|.+++.. . . |++.||.|||+ .+++|+|++
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~ 128 (285)
T cd07861 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLK 128 (285)
T ss_pred HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCC
Confidence 456889999999999 788999999998 688888721 1 1 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+||+++.++.++|+|||++....... .......++..|++|| ++.++|+||||+++|++++|..||....
T Consensus 129 p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 129 PQNLLIDNKGVIKLADFGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred HHHEEEcCCCcEEECcccceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999887542111 1112234567789998 3567999999999999999998885321
Q ss_pred CCC----------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 KGE----------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~~~----------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... .....+.++.+++..||+.+|.+|||+.++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 207 EIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 100 00012456779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=209.66 Aligned_cols=161 Identities=23% Similarity=0.286 Sum_probs=130.5
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+||||+++++. ....++||||+++|+|..++.+.. |++.||+|||+ .+++||||||+||+++
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~ 130 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLD 130 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEEC
Confidence 69999999887 778999999999999998882221 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCCC----
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKGE---- 143 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~---- 143 (188)
.++.++|+|||++..... .........|+..|++|| ++.++|+|||||++|+|++|..||......+
T Consensus 131 ~~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~ 208 (330)
T cd05586 131 ATGHIALCDFGLSKANLT--DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN 208 (330)
T ss_pred CCCCEEEecCCcCcCCCC--CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH
Confidence 999999999999864321 112233457889999998 4678999999999999999999985432111
Q ss_pred -------cC-HHHHHHHHHHHHHccCcCCCCCC----CHHHHHH
Q 039565 144 -------FD-IISVEKAVEIAMASVSSKVNRRP----LMNQVVM 175 (188)
Q Consensus 144 -------~~-~~~~~~~~~l~~~cl~~~p~~Rp----s~~~i~~ 175 (188)
.+ ...+..+.+++..||+.+|.+|| +++++++
T Consensus 209 i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 209 IAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11 12456788999999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=211.02 Aligned_cols=167 Identities=23% Similarity=0.254 Sum_probs=129.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||++++++ ....++++|++. ++|..++ ... . |++.||.|||+ .+|+||||||+
T Consensus 214 L~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~ 289 (461)
T PHA03211 214 LRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTE 289 (461)
T ss_pred HHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHH
Confidence 567899999999998 778899999996 6888887 321 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccc-cccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTV-DLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~-~~~~~- 141 (188)
||+++.++.++|+|||+++...............|+..|++|| ++.++|+|||||++|++++|..++ .....
T Consensus 290 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~ 369 (461)
T PHA03211 290 NVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369 (461)
T ss_pred HEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCccc
Confidence 9999999999999999987543222222223456899999999 578899999999999999876322 11000
Q ss_pred --------------------CCcCH-------------------------------HHHHHHHHHHHHccCcCCCCCCCH
Q 039565 142 --------------------GEFDI-------------------------------ISVEKAVEIAMASVSSKVNRRPLM 170 (188)
Q Consensus 142 --------------------~~~~~-------------------------------~~~~~~~~l~~~cl~~~p~~Rps~ 170 (188)
.+++. .....+.+++..||+.||.+|||+
T Consensus 370 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa 449 (461)
T PHA03211 370 ERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA 449 (461)
T ss_pred ccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH
Confidence 00000 112357789999999999999999
Q ss_pred HHHHHH
Q 039565 171 NQVVMV 176 (188)
Q Consensus 171 ~~i~~~ 176 (188)
.|+++.
T Consensus 450 ~elL~h 455 (461)
T PHA03211 450 AELLRL 455 (461)
T ss_pred HHHhhC
Confidence 999874
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=201.64 Aligned_cols=165 Identities=19% Similarity=0.218 Sum_probs=134.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+.+++||||+++++. .+..++++||+++++|..++... . |++.||.|||+ .+++|+|++|+||
T Consensus 72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Ni 148 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSI 148 (297)
T ss_pred HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHe
Confidence 466899999999998 78899999999999999988322 2 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC---
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG--- 142 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~--- 142 (188)
+++.++.++|+|||++...... ........++..|++|| ++.++|+||||+++|++++|..||......
T Consensus 149 ll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 226 (297)
T cd06659 149 LLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226 (297)
T ss_pred EEccCCcEEEeechhHhhcccc--cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999988643211 11223356778899998 477899999999999999999988532110
Q ss_pred -----------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 -----------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 -----------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.........+.+++..||+.+|++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 227 KRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 011123457889999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=196.64 Aligned_cols=166 Identities=21% Similarity=0.294 Sum_probs=135.1
Q ss_pred cccCCCeeeeccc---CCccEEEEecCCCCChhhhcC----Cc---c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 8 KLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG----KE---E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 8 ~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~----~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
.++||||+++++. .+..++++||+++++|.+++. .. . |++.||.|||+ ..+++|+|++|
T Consensus 65 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~ 142 (269)
T cd08528 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTP 142 (269)
T ss_pred cCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCH
Confidence 4789999999998 788999999999999988761 11 1 89999999995 16799999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
.||+++.++.++++|||.+....... ......++..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 143 ~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~ 219 (269)
T cd08528 143 NNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219 (269)
T ss_pred HHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH
Confidence 99999999999999999987543211 233456777889998 57889999999999999999999854321
Q ss_pred -----------CC-cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 142 -----------GE-FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 142 -----------~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
.. .....+..+.+++.+||+.+|++||++.++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11 11134578999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=200.12 Aligned_cols=167 Identities=17% Similarity=0.187 Sum_probs=131.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||+++++. .+..++++||+++++|.+++.+ .. |++.||.|||+ .+++|+|++|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~ 129 (314)
T cd08216 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKA 129 (314)
T ss_pred HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCc
Confidence 567899999999988 7788999999999999999832 11 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCC-----cceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCcc
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGT-----HMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p 135 (188)
+||+++.++.++++||+.+......... .......++..|++|| ++.++|+||||+++|++++|..|
T Consensus 130 ~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~p 209 (314)
T cd08216 130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209 (314)
T ss_pred ceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999987643211110 1112234556788888 45789999999999999999998
Q ss_pred ccccCCC---------------------------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCH
Q 039565 136 VDLSFKG---------------------------------------------EFDIISVEKAVEIAMASVSSKVNRRPLM 170 (188)
Q Consensus 136 ~~~~~~~---------------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 170 (188)
|...... .........+.+++..||+.+|++|||+
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 289 (314)
T cd08216 210 FKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA 289 (314)
T ss_pred CCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCH
Confidence 8532100 0111234578899999999999999999
Q ss_pred HHHHH
Q 039565 171 NQVVM 175 (188)
Q Consensus 171 ~~i~~ 175 (188)
+++++
T Consensus 290 ~~ll~ 294 (314)
T cd08216 290 SQLLN 294 (314)
T ss_pred HHHhc
Confidence 99987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=198.86 Aligned_cols=166 Identities=23% Similarity=0.252 Sum_probs=131.3
Q ss_pred cccc-cCCCeeeeccc--------CCccEEEEecCCCCChhhhcC----Ccc------------cHHHHHHHHhcCCCCC
Q 039565 6 RNKL-TGPLLVELIGK--------QKNNALELGFRGNPELVDQQG----KEE------------VCCPGLEYLHQGLKHP 60 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~~----~~~------------~i~~~l~~Lh~~~~~~ 60 (188)
+.++ +||||+++++. ....+++|||+++++|.+++. ... |++.||.|||+ .+
T Consensus 68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~ 144 (286)
T cd06638 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NK 144 (286)
T ss_pred HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 4456 69999999886 346799999999999998761 111 88999999999 99
Q ss_pred cEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHH
Q 039565 61 IIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEI 129 (188)
Q Consensus 61 i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~ 129 (188)
++|+|++|+||+++.++.++++|||.+...... ........|+..|++|| ++.++|+||||+++|++
T Consensus 145 i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el 222 (286)
T cd06638 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222 (286)
T ss_pred ccccCCCHHhEEECCCCCEEEccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHH
Confidence 999999999999999999999999998754311 11223345778899998 35689999999999999
Q ss_pred HhCCccccccCCC--------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 130 ITGILTVDLSFKG--------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 130 ~~g~~p~~~~~~~--------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
++|..|+...... ..+......+.+++..||+.+|++|||+.++++.
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 223 GDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 9999887532110 0112234579999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=209.66 Aligned_cols=167 Identities=20% Similarity=0.238 Sum_probs=130.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. ....++||||+++|+|.+++.+.. |++.||+|||+ .+++||||||+|
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~N 131 (377)
T cd05629 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDN 131 (377)
T ss_pred HHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHH
Confidence 456899999999988 778999999999999999982221 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCC-----------c----------------------------------ceeeeccc
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGT-----------H----------------------------------MSTTIAGT 105 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~-----------~----------------------------------~~~~~~~~ 105 (188)
|+++.++.++++|||+++.+...... . ......|+
T Consensus 132 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 211 (377)
T cd05629 132 ILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGT 211 (377)
T ss_pred EEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCC
Confidence 99999999999999988532110000 0 00123588
Q ss_pred ccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC-------------CcCH--HHHHHHHHHHHHccCcCC
Q 039565 106 AGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG-------------EFDI--ISVEKAVEIAMASVSSKV 164 (188)
Q Consensus 106 ~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~-------------~~~~--~~~~~~~~l~~~cl~~~p 164 (188)
+.|+||| ++.++|+|||||++|+|++|..||...... .++. ..+..+.+++..|+. +|
T Consensus 212 ~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 212 PDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred ccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CH
Confidence 8999998 588999999999999999999998543211 1111 235678899999997 66
Q ss_pred CCC---CCHHHHHHH
Q 039565 165 NRR---PLMNQVVMV 176 (188)
Q Consensus 165 ~~R---ps~~~i~~~ 176 (188)
.+| ++++++++.
T Consensus 291 ~~r~~r~~~~~~l~h 305 (377)
T cd05629 291 ENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCHHHHhcC
Confidence 654 599998873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=215.78 Aligned_cols=170 Identities=20% Similarity=0.243 Sum_probs=141.7
Q ss_pred CCcccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCCcc--------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 4 PNRNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGKEE--------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 4 ~~l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~--------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.|.+++|||++++||+ +....+|+|.++.|+|.+.+++.. |+|.||.||.+ +++|||||.
T Consensus 163 s~M~~L~H~hliRLyGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLA 239 (1039)
T KOG0199|consen 163 SHMLKLQHPHLIRLYGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLA 239 (1039)
T ss_pred HHHHhccCcceeEEeeeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhh
Confidence 45789999999999999 899999999999999999994422 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCc-ceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCcccc--
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTH-MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVD-- 137 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~-- 137 (188)
..|+++.....+||+|||+.+......... ......-...|.+|| |+.++|+|+|||++|||++ |..||.
T Consensus 240 ARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 240 ARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred hhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 999999999999999999988654222221 111234456788998 8999999999999999997 557763
Q ss_pred ----------ccCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 138 ----------LSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 138 ----------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
..-.-+.++.+++.+++++..||..+|++||||..|.+.
T Consensus 320 ~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 320 RGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 222334667899999999999999999999999999743
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=199.45 Aligned_cols=164 Identities=17% Similarity=0.162 Sum_probs=128.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||+++++. ....++++||++ ++|.+++ .... |++.||.|||+ .+++|+|++|+
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~ 128 (284)
T cd07839 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQ 128 (284)
T ss_pred HHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHH
Confidence 466899999999999 778899999998 5788777 2211 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.++++|||++....... .......++..|++|| ++.++|+||||+++|+|++|..|+.+....
T Consensus 129 nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~ 206 (284)
T cd07839 129 NLLINKNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 206 (284)
T ss_pred HEEEcCCCcEEECccchhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH
Confidence 9999999999999999887542111 1122234567788998 467899999999999999998775321110
Q ss_pred -----------------------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 -----------------------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 -----------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
......+..+.+++.+||+.+|.+|||++++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 207 DDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=209.33 Aligned_cols=166 Identities=16% Similarity=0.193 Sum_probs=128.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++||||+++++. ....++||||+++|+|.+++.+.. |++.||.|||+ .+|+||||||+|
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~N 131 (382)
T cd05625 55 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDN 131 (382)
T ss_pred HHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHH
Confidence 467899999999988 778999999999999999982221 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCC---------------------------------------------CCcceeeeccc
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEG---------------------------------------------GTHMSTTIAGT 105 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~ 105 (188)
|+++.++.+||+|||++....... .........|+
T Consensus 132 ILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 211 (382)
T cd05625 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGT 211 (382)
T ss_pred EEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccC
Confidence 999999999999999864221000 00001124688
Q ss_pred ccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC-------------Cc--CHHHHHHHHHHHHHccCcCC
Q 039565 106 AGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG-------------EF--DIISVEKAVEIAMASVSSKV 164 (188)
Q Consensus 106 ~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~-------------~~--~~~~~~~~~~l~~~cl~~~p 164 (188)
+.|+||| ++.++|+|||||++|+|++|..||...... .. ....+..+.+++..++ .+|
T Consensus 212 ~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p 290 (382)
T cd05625 212 PNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGP 290 (382)
T ss_pred cccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCH
Confidence 9999999 578899999999999999999999643211 01 1123556777777765 489
Q ss_pred CCCCC---HHHHHH
Q 039565 165 NRRPL---MNQVVM 175 (188)
Q Consensus 165 ~~Rps---~~~i~~ 175 (188)
.+|++ ++++++
T Consensus 291 ~~R~~~~~~~ei~~ 304 (382)
T cd05625 291 EDRLGKNGADEIKA 304 (382)
T ss_pred hHcCCCCCHHHHhc
Confidence 99997 877765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=200.59 Aligned_cols=164 Identities=24% Similarity=0.282 Sum_probs=133.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++|+||+++.+. .+..+++|||+.+++|.+++ ... . |++.||.|||+ .+++|+|+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp 130 (285)
T cd05630 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKP 130 (285)
T ss_pred HHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCH
Confidence 457899999999887 78899999999999999887 211 1 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
+||+++.++.++++|||++...... .......|+..|++|| ++.++|+||||+++|++++|..||......
T Consensus 131 ~Nil~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~ 207 (285)
T cd05630 131 ENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207 (285)
T ss_pred HHEEECCCCCEEEeeccceeecCCC---ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc
Confidence 9999999999999999988643211 1122346788899999 578899999999999999999999753221
Q ss_pred ---------------CcCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 039565 143 ---------------EFDIISVEKAVEIAMASVSSKVNRRPL-----MNQVVM 175 (188)
Q Consensus 143 ---------------~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~i~~ 175 (188)
..+...+..+.+++..||+.+|++||| ++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 208 IKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred chHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111224456889999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=201.75 Aligned_cols=170 Identities=19% Similarity=0.202 Sum_probs=133.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++++||++ ++|..++ +... |++.||.|||+ .+++|+|++|+
T Consensus 58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~ 133 (301)
T cd07873 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQ 133 (301)
T ss_pred HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHH
Confidence 467899999999999 778899999998 5888887 2211 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.++++|||++....... .......++..|++|| ++.++|+||||+++|+|++|..||......
T Consensus 134 Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~ 211 (301)
T cd07873 134 NLLINERGELKLADFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE 211 (301)
T ss_pred HEEECCCCcEEECcCcchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999886532111 1122234567889998 356799999999999999999888532110
Q ss_pred ------------------------------Cc-----------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhh
Q 039565 143 ------------------------------EF-----------DIISVEKAVEIAMASVSSKVNRRPLMNQVVM--VREQ 179 (188)
Q Consensus 143 ------------------------------~~-----------~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~--~l~~ 179 (188)
.. ....+..+.+++.+|++.+|.+|||++++++ .++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 212 EQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred HHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00 0113456789999999999999999999987 4444
Q ss_pred cc
Q 039565 180 GS 181 (188)
Q Consensus 180 ~~ 181 (188)
+.
T Consensus 292 ~~ 293 (301)
T cd07873 292 LG 293 (301)
T ss_pred cc
Confidence 44
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=195.85 Aligned_cols=167 Identities=20% Similarity=0.261 Sum_probs=135.7
Q ss_pred CcccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCCc-----c-----------cHHHHHHHHh-----cCCC
Q 039565 5 NRNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGKE-----E-----------VCCPGLEYLH-----QGLK 58 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~-----~-----------~i~~~l~~Lh-----~~~~ 58 (188)
.+++++||||+++++. ....++++||+++++|.+++... . |++.||.||| +
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--- 128 (265)
T cd08217 52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG--- 128 (265)
T ss_pred HHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc---
Confidence 3567899999999886 45578999999999999998221 1 8999999999 6
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhC
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g 132 (188)
.+++|+|++|+||+++.++.++++|||.+....... .......++..|++|| .+.++|+||||++++++++|
T Consensus 129 ~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g 206 (265)
T cd08217 129 NTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL 206 (265)
T ss_pred CcceecCCCHHHEEEecCCCEEEecccccccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHC
Confidence 899999999999999999999999999887543211 1123346778899998 46789999999999999999
Q ss_pred CccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 133 ILTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 133 ~~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
..||+... ....+...+..+.+++..|++.+|.+||++.+|++.
T Consensus 207 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 207 SPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 99986432 112334556789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=197.73 Aligned_cols=165 Identities=22% Similarity=0.231 Sum_probs=131.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE---E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++|||++++++. ....++++||+++++|..+.... . |++.||.|||+ .+++|+|++|+|
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~n 130 (286)
T cd07847 54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPEN 130 (286)
T ss_pred HHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhh
Confidence 467889999999998 77889999999998888877222 1 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKGE 143 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~ 143 (188)
|+++.++.++++|||++........ ......++..|++|| ++.++|+||||+++|++++|..||......+
T Consensus 131 il~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~ 208 (286)
T cd07847 131 ILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD 208 (286)
T ss_pred EEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9999999999999999875432111 122334666788887 3568999999999999999999885322100
Q ss_pred -------------------------------------c-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 -------------------------------------F-----DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 -------------------------------------~-----~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ....+..+.+++.+||+.+|++||++.+++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 209 QLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 0112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=203.18 Aligned_cols=163 Identities=20% Similarity=0.249 Sum_probs=125.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||++++++ ....++++|++. ++|..++ .+.. |++.||.|||+ .+++||||||+
T Consensus 111 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~ 186 (357)
T PHA03209 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTE 186 (357)
T ss_pred HHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHH
Confidence 567899999999998 778899999996 5888887 2221 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCc-cccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGIL-TVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~-p~~~~~~~ 142 (188)
||+++.++.++|+|||.++... .........|+..|++|| ++.++|+|||||++|+++++.. +|+.....
T Consensus 187 Nill~~~~~~kl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~ 263 (357)
T PHA03209 187 NIFINDVDQVCIGDLGAAQFPV---VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263 (357)
T ss_pred HEEECCCCCEEEecCccccccc---cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCc
Confidence 9999999999999999886422 111223456888999999 5788999999999999998543 33211100
Q ss_pred ------------------------CcC----H--------------------------HHHHHHHHHHHHccCcCCCCCC
Q 039565 143 ------------------------EFD----I--------------------------ISVEKAVEIAMASVSSKVNRRP 168 (188)
Q Consensus 143 ------------------------~~~----~--------------------------~~~~~~~~l~~~cl~~~p~~Rp 168 (188)
+++ . ..+..+.+++..||+.||.+||
T Consensus 264 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp 343 (357)
T PHA03209 264 PEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRP 343 (357)
T ss_pred HHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCc
Confidence 000 0 0122344689999999999999
Q ss_pred CHHHHHH
Q 039565 169 LMNQVVM 175 (188)
Q Consensus 169 s~~~i~~ 175 (188)
|+.++++
T Consensus 344 ta~e~l~ 350 (357)
T PHA03209 344 SAEEILN 350 (357)
T ss_pred CHHHHhc
Confidence 9999986
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=198.59 Aligned_cols=166 Identities=22% Similarity=0.261 Sum_probs=135.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+.+++||||+++++. .+..++|+||+++++|.+++.+. . |++.|+.|||+ .+++|+|++|+||
T Consensus 70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Ni 146 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNI 146 (293)
T ss_pred HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHE
Confidence 467899999999988 77899999999999999998322 2 89999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC--
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE-- 143 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~-- 143 (188)
+++.++.++++|||++....... .......++..|++|| ++.++|+||||+++|++++|..||.......
T Consensus 147 li~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~ 224 (293)
T cd06647 147 LLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (293)
T ss_pred EEcCCCCEEEccCcceecccccc--cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe
Confidence 99999999999999876443111 1223345777899998 4678999999999999999999986432110
Q ss_pred ------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 144 ------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 144 ------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
.+......+.+++..||..+|++||++++++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 225 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred eehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112345678899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=197.78 Aligned_cols=167 Identities=25% Similarity=0.291 Sum_probs=135.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
|+.++||.++.+|.. ++..+++||||+||+|.... ++.+ +++.||+|||- .|||+|||||
T Consensus 131 L~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKP 207 (459)
T KOG0610|consen 131 LSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKP 207 (459)
T ss_pred HHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCc
Confidence 567999999999999 88899999999999999998 3333 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCC--------------------------------CCC--------------------
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVE--------------------------------GGT-------------------- 96 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~--------------------------------~~~-------------------- 96 (188)
+|||+-++|++.|+||.++...... ...
T Consensus 208 ENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep 287 (459)
T KOG0610|consen 208 ENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEP 287 (459)
T ss_pred ceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCC
Confidence 9999999999999999876432100 000
Q ss_pred --cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC-----------cC--HHHHHHHHHH
Q 039565 97 --HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE-----------FD--IISVEKAVEI 155 (188)
Q Consensus 97 --~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~-----------~~--~~~~~~~~~l 155 (188)
.....+.||-.|+||| .+.++|.|+||+++|||+.|..||......+ ++ ...+..+.++
T Consensus 288 ~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDL 367 (459)
T KOG0610|consen 288 TGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDL 367 (459)
T ss_pred CCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHH
Confidence 0112367888999999 4889999999999999999999996543322 11 2456789999
Q ss_pred HHHccCcCCCCCCC----HHHHHH
Q 039565 156 AMASVSSKVNRRPL----MNQVVM 175 (188)
Q Consensus 156 ~~~cl~~~p~~Rps----~~~i~~ 175 (188)
|.+.|.+||.+|.- +.+|.+
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHhccChhhhhccccchHHhhc
Confidence 99999999999997 666654
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=206.27 Aligned_cols=160 Identities=19% Similarity=0.284 Sum_probs=132.8
Q ss_pred CCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 11 GPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 11 Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
|.+||+++++ ++.+|+|||+-+ -+|..++++.. |++.|+.++|. .||||.||||.|.++-
T Consensus 419 ~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV 494 (677)
T KOG0596|consen 419 HDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV 494 (677)
T ss_pred CceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE
Confidence 7899999999 889999999987 58999993332 99999999999 9999999999999987
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
+ |.+||.|||++..+......-......||+.||+|| .+.++||||+||++|+|+-|+.||.
T Consensus 495 k-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 495 K-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred e-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 6 599999999998776444444556789999999999 4678999999999999999999985
Q ss_pred cc--------------CCCCcCHHH-HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LS--------------FKGEFDIIS-VEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~--------------~~~~~~~~~-~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.. ...+++..- ...+.+++..||..||.+|||+.++++
T Consensus 574 ~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 574 QIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 32 112333211 223999999999999999999999987
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=198.52 Aligned_cols=166 Identities=28% Similarity=0.359 Sum_probs=134.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||+++++. ....++++||+++++|..++.+.+ +++.||.|||+. .+++|+|++|+|
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~n 134 (284)
T cd06620 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSN 134 (284)
T ss_pred HHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHH
Confidence 456899999999998 788999999999999999883221 899999999962 589999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG-- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~-- 142 (188)
|+++.++.++++|||++...... ......++..|++|| ++.++|+|||||++|++++|..||+.....
T Consensus 135 il~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~ 210 (284)
T cd06620 135 ILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210 (284)
T ss_pred EEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh
Confidence 99999999999999987643211 122346777888888 467899999999999999999998743321
Q ss_pred ---------------------CcC-HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 039565 143 ---------------------EFD-IISVEKAVEIAMASVSSKVNRRPLMNQVVMVR 177 (188)
Q Consensus 143 ---------------------~~~-~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l 177 (188)
..+ ...+..+.+++..|++.+|++|||+++++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 211 GQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 011 12456788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=197.19 Aligned_cols=164 Identities=26% Similarity=0.343 Sum_probs=133.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc------c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE------E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~------~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||+++++. ....++++||+++++|..++... . |++.||.|||+. .+++|+||+
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~ 130 (286)
T cd06622 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVK 130 (286)
T ss_pred HHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCC
Confidence 567899999999998 88899999999999999988321 1 899999999961 599999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC------------CCccchHHHHHHHHHHHhCCcc
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL------------TEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~------------~~~~di~s~G~~l~~~~~g~~p 135 (188)
|+||+++.++.++++|||.+...... ......++..|++||. +.++|+||||+++|++++|..|
T Consensus 131 p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p 206 (286)
T cd06622 131 PTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206 (286)
T ss_pred HHHEEECCCCCEEEeecCCcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCC
Confidence 99999999999999999988643211 1222346677888882 5689999999999999999999
Q ss_pred ccccCC---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 136 VDLSFK---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 136 ~~~~~~---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|..... ...+...+..+.+++..||+.+|.+||++++++.
T Consensus 207 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 207 YPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 854221 1233345678899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=196.92 Aligned_cols=163 Identities=26% Similarity=0.321 Sum_probs=131.1
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcC---C-c---c---------cHHHHHHHHhcCCCCCcEEe
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQG---K-E---E---------VCCPGLEYLHQGLKHPIIQR 64 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~---~-~---~---------~i~~~l~~Lh~~~~~~i~h~ 64 (188)
+++++||||+++++. ....+++|||+++++|.+++. . . . |++.||.|||+ .+++|+
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~ 129 (287)
T cd06621 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHR 129 (287)
T ss_pred HHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccC
Confidence 567899999999986 446899999999999988761 1 1 1 89999999999 999999
Q ss_pred CCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 65 DMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 65 dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|++|.||+++.++.++++|||++....... .....++..|++|| ++.++|+||||+++|++++|..||+.
T Consensus 130 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (287)
T cd06621 130 DIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205 (287)
T ss_pred CCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999999876432111 11334566788888 57789999999999999999999875
Q ss_pred cCCC-----------------C----c--CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKG-----------------E----F--DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~-----------------~----~--~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.... . . ....+..+.+++.+||+.+|.+|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 206 EGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 4210 0 0 0123567889999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=209.78 Aligned_cols=167 Identities=17% Similarity=0.205 Sum_probs=130.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. .+..++||||+++|+|.+++.+.+ |++.||+|||+ .+|+||||||+|
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~N 131 (376)
T cd05598 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDN 131 (376)
T ss_pred HHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHH
Confidence 467899999999988 788999999999999999982222 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCC-----------------------------------------CCcceeeeccccccc
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEG-----------------------------------------GTHMSTTIAGTAGFL 109 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~ 109 (188)
|+++.++.++|+|||++..+.... .........|++.|+
T Consensus 132 ill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 211 (376)
T cd05598 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYI 211 (376)
T ss_pred EEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcccc
Confidence 999999999999999874221000 000011246889999
Q ss_pred CCC------CCCccchHHHHHHHHHHHhCCccccccCCCC---------------cCHHHHHHHHHHHHHccCcCCCCCC
Q 039565 110 NTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE---------------FDIISVEKAVEIAMASVSSKVNRRP 168 (188)
Q Consensus 110 ~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~---------------~~~~~~~~~~~l~~~cl~~~p~~Rp 168 (188)
||| ++.++|+|||||++|+|++|..||......+ .....+..+.+++..|+ .+|.+|+
T Consensus 212 aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 212 APEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred CHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence 999 5788999999999999999999986432111 11123456778888866 4999999
Q ss_pred ---CHHHHHHH
Q 039565 169 ---LMNQVVMV 176 (188)
Q Consensus 169 ---s~~~i~~~ 176 (188)
+++++++.
T Consensus 291 ~~~t~~ell~h 301 (376)
T cd05598 291 GKNGADEIKAH 301 (376)
T ss_pred CCCCHHHHhCC
Confidence 88888763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=195.32 Aligned_cols=166 Identities=22% Similarity=0.290 Sum_probs=135.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+.+++||||+++++. ....++++||+++++|..++.... |++.|+.|||+ .+++|+|++|.||
T Consensus 56 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni 132 (277)
T cd06641 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANV 132 (277)
T ss_pred HHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhE
Confidence 467899999999988 788999999999999999983222 89999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK---- 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~---- 141 (188)
+++.++.++++|||++....... .......++..|++|| .+.++|+||||+++|++++|..||.....
T Consensus 133 ~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 210 (277)
T cd06641 133 LLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL 210 (277)
T ss_pred EECCCCCEEEeecccceecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH
Confidence 99999999999999876542111 1122345667788888 46789999999999999999999864221
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
...+...+..+.+++..||+.+|.+||++.++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 211 FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 12233456678999999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=193.42 Aligned_cols=168 Identities=23% Similarity=0.291 Sum_probs=134.7
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE---E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
.+.+++|+||+++++. .+..++++||+++++|.+++.+. . +++.|+.|||+ .+++|+|++|.
T Consensus 52 ~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~ 128 (264)
T cd06626 52 VLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPA 128 (264)
T ss_pred HHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHH
Confidence 3567899999999998 77889999999999999998332 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcc--eeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHM--STTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~--~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+++.++.++++|||.+........... .....++..|++|| .+.++|+||||++++++++|..||..
T Consensus 129 nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~ 208 (264)
T cd06626 129 NIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208 (264)
T ss_pred HEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence 99999999999999998875432211110 11245667888888 46679999999999999999999864
Q ss_pred cCC-------------CCcCHH--HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFK-------------GEFDII--SVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~-------------~~~~~~--~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... ...+.. ....+.+++..||+.+|++|||+++++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 209 LDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 311 112222 2667889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=202.42 Aligned_cols=161 Identities=17% Similarity=0.199 Sum_probs=127.9
Q ss_pred cccccCCCeeeeccc---------CCccEEEEecCCCCChhhhcCC--cc---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---------QKNNALELGFRGNPELVDQQGK--EE---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~~~--~~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+++++||||++++++ ....+++++++ +++|..++.. .. |++.||.|||+ .+++|||
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrd 143 (343)
T cd07878 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRD 143 (343)
T ss_pred HHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccc
Confidence 567899999999887 14568999988 5789888732 22 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|||+||+++.++.+||+|||++..... ......|+..|+||| ++.++|+|||||++|+|++|..||..
T Consensus 144 ikp~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 144 LKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CChhhEEECCCCCEEEcCCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999875321 123356788899999 36689999999999999999998853
Q ss_pred cCCC------------C----------------------cCH--------HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKG------------E----------------------FDI--------ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~------------~----------------------~~~--------~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.... . .+. .....+.+++.+|++.+|++|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2110 0 000 01224679999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=196.89 Aligned_cols=164 Identities=23% Similarity=0.220 Sum_probs=129.7
Q ss_pred ccc-cCCCeeeeccc--------CCccEEEEecCCCCChhhhcCC----c---c---------cHHHHHHHHhcCCCCCc
Q 039565 7 NKL-TGPLLVELIGK--------QKNNALELGFRGNPELVDQQGK----E---E---------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~~~----~---~---------~i~~~l~~Lh~~~~~~i 61 (188)
.++ +|||++++++. ....++++||+++++|.++++. . . |++.||.|||+ .++
T Consensus 73 ~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i 149 (291)
T cd06639 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRI 149 (291)
T ss_pred HHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 445 79999999987 2358999999999999987621 1 1 89999999999 999
Q ss_pred EEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHH
Q 039565 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEII 130 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~ 130 (188)
+|+|++|+||+++.++.++++|||++....... .......++..|++|| ++.++|+||||+++|+++
T Consensus 150 vH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~ 227 (291)
T cd06639 150 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227 (291)
T ss_pred eccCCCHHHEEEcCCCCEEEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence 999999999999999999999999887532111 1122345677789998 367899999999999999
Q ss_pred hCCccccccCCC--------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 131 TGILTVDLSFKG--------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 131 ~g~~p~~~~~~~--------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+|+.||...... ..+......+.+++..||+.+|++||++.++++
T Consensus 228 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 228 DGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 999887532110 112234457899999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=193.92 Aligned_cols=165 Identities=21% Similarity=0.294 Sum_probs=134.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||+++.+. .+..++++||+++++|.+++ ... . |++.|+.|||+ .+++|+|++|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~ 129 (256)
T cd08218 53 LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKS 129 (256)
T ss_pred HHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCH
Confidence 567899999999988 77899999999999999988 211 1 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
+||+++.++.++++|||.+....... .......++..|++|| .+.++|+||||++++++++|..||.....
T Consensus 130 ~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~ 207 (256)
T cd08218 130 QNIFLTKDGTIKLGDFGIARVLNSTV--ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK 207 (256)
T ss_pred HHEEEcCCCCEEEeeccceeecCcch--hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH
Confidence 99999999999999999887543111 1122234667788888 46789999999999999999988854321
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+......+.+++.+||+.+|.+||+++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 208 NLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1123344667899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-30 Score=192.41 Aligned_cols=168 Identities=23% Similarity=0.284 Sum_probs=134.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC----cc---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK----EE---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~----~~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++||||++++++ .+..+++|||+++++|.+++ .. .. |++.|+.|||+ .+++|+|++|
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~ 131 (258)
T smart00219 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAA 131 (258)
T ss_pred HHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeeccccc
Confidence 456799999999998 67899999999999999998 22 22 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~ 141 (188)
+||+++.++.++++|||.+......... ......++..|++|| .+.++|+||+|++++++++ |..||+....
T Consensus 132 ~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~ 210 (258)
T smart00219 132 RNCLVGENLVVKISDFGLSRDLYDDDYY-KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN 210 (258)
T ss_pred ceEEEccCCeEEEcccCCceeccccccc-ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999998754322111 111223567788888 5788999999999999998 7777753211
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVR 177 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l 177 (188)
...+...+..+.+++.+|+..+|++|||+.++++.|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 211 EEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 122233567899999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=196.52 Aligned_cols=161 Identities=24% Similarity=0.280 Sum_probs=129.0
Q ss_pred cCCCeeeeccc---------CCccEEEEecCCCCChhhhcCC-c-c------------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 10 TGPLLVELIGK---------QKNNALELGFRGNPELVDQQGK-E-E------------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 10 ~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~~~-~-~------------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+||||+++++. ....+++|||+++++|.+++.. . . |++.|+.|||+ .+++|+|+
T Consensus 71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl 147 (282)
T cd06636 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDI 147 (282)
T ss_pred CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCC
Confidence 69999999888 2467899999999999998822 1 1 89999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCcc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~p 135 (188)
+|+||+++.++.++++|||.+...... ........++..|++|| ++.++|+||||+++|++++|..|
T Consensus 148 ~~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p 225 (282)
T cd06636 148 KGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225 (282)
T ss_pred CHHHEEECCCCCEEEeeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCC
Confidence 999999999999999999987643211 11223456777889988 24479999999999999999999
Q ss_pred ccccCC-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 136 VDLSFK-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 136 ~~~~~~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|..... .......+..+.+++..||+.+|.+||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 226 LCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 854221 0111234668999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=192.84 Aligned_cols=164 Identities=20% Similarity=0.321 Sum_probs=133.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||+++++. .+..++++||+++++|.+++ ... . +++.|+.|||+ .+++|+|++|
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~ 129 (256)
T cd08220 53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKT 129 (256)
T ss_pred HhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 567899999999988 77889999999999999998 221 1 89999999999 9999999999
Q ss_pred CcEEEccC-CceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 69 TNILLNEK-VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
.||+++.+ +.++++|||.+...... .......++..|++|| .+.++|+||||+++|++++|..||+....
T Consensus 130 ~nil~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 206 (256)
T cd08220 130 QNILLDKHKMVVKIGDFGISKILSSK---SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206 (256)
T ss_pred HHEEEcCCCCEEEEccCCCceecCCC---ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch
Confidence 99999865 46799999988754321 1122345777899999 47789999999999999999998865321
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+...+..+.+++.+||+.+|++|||++++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 207 PALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1122335667899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=196.88 Aligned_cols=165 Identities=19% Similarity=0.232 Sum_probs=134.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+..++||||+++++. .+..++++||+++++|.+++.... |++.|++|||+ .+++|+|++|+||
T Consensus 70 l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Ni 146 (285)
T cd06648 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSI 146 (285)
T ss_pred HHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhE
Confidence 456789999999997 788999999999999999983222 89999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK---- 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~---- 141 (188)
+++.++.++++|||.+...... ........|+..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 147 l~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~ 224 (285)
T cd06648 147 LLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM 224 (285)
T ss_pred EEcCCCcEEEcccccchhhccC--CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence 9999999999999987643211 11222345778899998 57789999999999999999988753211
Q ss_pred --------CC--cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 --------GE--FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 --------~~--~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.. .....+..+.+++.+||+.+|++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 225 KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01 11124568999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=195.37 Aligned_cols=169 Identities=21% Similarity=0.201 Sum_probs=133.1
Q ss_pred cccccCCC-eeeeccc---CC------ccEEEEecCCCCChhhhc-CCc----c-----------cHHHHHHHHhcCCCC
Q 039565 6 RNKLTGPL-LVELIGK---QK------NNALELGFRGNPELVDQQ-GKE----E-----------VCCPGLEYLHQGLKH 59 (188)
Q Consensus 6 l~~l~Hpn-iv~~~~~---~~------~~~lv~e~~~~~~L~~~~-~~~----~-----------~i~~~l~~Lh~~~~~ 59 (188)
|.+++|+| |++++++ .+ .+++|+||++. +|..++ ... + |++.||+|||+ +
T Consensus 64 lk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~ 139 (323)
T KOG0594|consen 64 LKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---H 139 (323)
T ss_pred HHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence 56789999 9999999 33 78899999984 899999 222 2 99999999999 9
Q ss_pred CcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhC
Q 039565 60 PIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 60 ~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g 132 (188)
+|+||||||+||++++.|.+|++|||+++....+... -....+|.+|.+|| ++...||||+||++.||+++
T Consensus 140 ~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~ 217 (323)
T KOG0594|consen 140 GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTR 217 (323)
T ss_pred CeecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhC
Confidence 9999999999999999999999999999865433222 33345667789998 78999999999999999999
Q ss_pred CccccccC-------------------C-------------------CCcCHHHH---HHHHHHHHHccCcCCCCCCCHH
Q 039565 133 ILTVDLSF-------------------K-------------------GEFDIISV---EKAVEIAMASVSSKVNRRPLMN 171 (188)
Q Consensus 133 ~~p~~~~~-------------------~-------------------~~~~~~~~---~~~~~l~~~cl~~~p~~Rps~~ 171 (188)
+..|+... + ........ ....+++.+|++.+|.+|.|++
T Consensus 218 ~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~ 297 (323)
T KOG0594|consen 218 RPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAK 297 (323)
T ss_pred CCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHH
Confidence 87552110 0 00111111 3678999999999999999999
Q ss_pred HHHHH--Hhhc
Q 039565 172 QVVMV--REQG 180 (188)
Q Consensus 172 ~i~~~--l~~~ 180 (188)
..+++ +...
T Consensus 298 ~al~h~yf~~~ 308 (323)
T KOG0594|consen 298 GALTHPYFSEL 308 (323)
T ss_pred HHhcChhhccc
Confidence 99885 5444
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=193.55 Aligned_cols=164 Identities=23% Similarity=0.299 Sum_probs=134.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c--c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E--E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. ....++++||+++++|.+++.+ . . |++.|+.|||+ .+++|+|++|+|
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~n 132 (258)
T cd06632 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGAN 132 (258)
T ss_pred HHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHH
Confidence 467899999999998 7788999999999999999822 2 1 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
|+++.++.+|++|||.+....... ......++..|++|| ++.++|+||||+++|++++|..||+....
T Consensus 133 i~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~ 209 (258)
T cd06632 133 ILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA 209 (258)
T ss_pred EEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH
Confidence 999999999999999876532111 223345677788888 46679999999999999999999865321
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+......+.+++.+||+.+|.+||++++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 210 AVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1122334567889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=209.75 Aligned_cols=164 Identities=24% Similarity=0.323 Sum_probs=144.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|..++|||||+++++ ...+++||||+.+|.+.+++.+.+ |+..|++|||+ ..++|||||++|
T Consensus 109 mk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eN 185 (596)
T KOG0586|consen 109 MKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAEN 185 (596)
T ss_pred HHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhh
Confidence 677999999999999 899999999999999999993333 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKGE 143 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~ 143 (188)
++++.+..+||+|||++..+. ......+++|++.|.+|| ..+++|+||+|+++|.++.|.+|||.....+
T Consensus 186 ilL~~~mnikIaDfgfS~~~~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~ 262 (596)
T KOG0586|consen 186 ILLDENMNIKIADFGFSTFFD---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE 262 (596)
T ss_pred cccccccceeeeccccceeec---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc
Confidence 999999999999999998654 334566789999999999 4789999999999999999999999765544
Q ss_pred -----------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 -----------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 -----------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+......+.+++...+..+|.+|++.++|-+
T Consensus 263 Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 263 LRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 33445668889999999999999999999865
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=195.32 Aligned_cols=165 Identities=25% Similarity=0.325 Sum_probs=130.7
Q ss_pred cccc-cCCCeeeeccc---CC------ccEEEEecCCCCChhhhc-CCc----c-----------cHHHHHHHHhcCCCC
Q 039565 6 RNKL-TGPLLVELIGK---QK------NNALELGFRGNPELVDQQ-GKE----E-----------VCCPGLEYLHQGLKH 59 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~------~~~lv~e~~~~~~L~~~~-~~~----~-----------~i~~~l~~Lh~~~~~ 59 (188)
++++ +||||++++++ .. ..++++||+++++|.+++ ... . |++.||.|||+ .
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~ 132 (275)
T cd06608 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---N 132 (275)
T ss_pred HHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---C
Confidence 3455 69999999998 22 379999999999999987 211 1 89999999999 9
Q ss_pred CcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHH
Q 039565 60 PIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILE 128 (188)
Q Consensus 60 ~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~ 128 (188)
+++|+|++|+||+++.++.++++|||.+..... .........++..|++|| ++.++|+||||+++|+
T Consensus 133 ~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~ 210 (275)
T cd06608 133 KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS--TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210 (275)
T ss_pred CcccCCCCHHHEEEccCCeEEECCCccceeccc--chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHH
Confidence 999999999999999999999999998764321 112223345777888888 3567999999999999
Q ss_pred HHhCCccccccCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 129 IITGILTVDLSFK--------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 129 ~~~g~~p~~~~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+++|..||..... ...+...+..+.+++.+||..+|++|||++++++
T Consensus 211 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 211 LADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 9999999864221 0111224568899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=197.59 Aligned_cols=164 Identities=22% Similarity=0.233 Sum_probs=133.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc--c-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE--E-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~--~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++|+||+++.+. .+..++++||+.+++|..++ ... . |++.||.|||+ .+++|+|++|
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp 130 (285)
T cd05632 54 LEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKP 130 (285)
T ss_pred HHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCH
Confidence 567899999999877 77889999999999999887 211 1 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
.||+++.++.++++|||++...... .......|+..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 131 ~Nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~ 207 (285)
T cd05632 131 ENILLDDYGHIRISDLGLAVKIPEG---ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207 (285)
T ss_pred HHEEECCCCCEEEecCCcceecCCC---CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999988653211 1122346788899999 57789999999999999999999864321
Q ss_pred --------------CCcCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 039565 142 --------------GEFDIISVEKAVEIAMASVSSKVNRRPL-----MNQVVM 175 (188)
Q Consensus 142 --------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~i~~ 175 (188)
..++...+..+.+++..|++.+|++||+ +++++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 208 VKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1122334567889999999999999999 677776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=193.54 Aligned_cols=164 Identities=23% Similarity=0.257 Sum_probs=135.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. +...++++||+++++|.+++.+. . |++.||.|||+ .+++|+|++|.|
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~n 123 (262)
T cd05572 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPEN 123 (262)
T ss_pred HHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHH
Confidence 467899999999988 78899999999999999998322 1 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++++|||.+....... ......++..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 124 ilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 200 (262)
T cd05572 124 LLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200 (262)
T ss_pred EEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH
Confidence 999999999999999887543211 222345677899998 47789999999999999999999864431
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPL-----MNQVVM 175 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~i~~ 175 (188)
...+...+..+.+++.+||+.+|++||+ +.++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 201 EIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1122233578899999999999999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=219.48 Aligned_cols=174 Identities=17% Similarity=0.230 Sum_probs=137.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-----------------------ccHHHHHHHHhcCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-----------------------EVCCPGLEYLHQGLKH 59 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-----------------------~~i~~~l~~Lh~~~~~ 59 (188)
+++++||||++++++ .+..+++|||+++++|.+++.+. .|++.||+|||+ .
T Consensus 56 Ls~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~ 132 (932)
T PRK13184 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---K 132 (932)
T ss_pred HHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---C
Confidence 467899999999998 77889999999999999887210 089999999999 9
Q ss_pred CcEEeCCCCCcEEEccCCceEEecccCcccccCCCCC----------------cceeeecccccccCCC------CCCcc
Q 039565 60 PIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGT----------------HMSTTIAGTAGFLNTE------LTEKS 117 (188)
Q Consensus 60 ~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~pe------~~~~~ 117 (188)
+++|||+||+||+++.++.++++|||+++........ .......|++.|+||| .+.++
T Consensus 133 GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kS 212 (932)
T PRK13184 133 GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST 212 (932)
T ss_pred CccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHh
Confidence 9999999999999999999999999998754111000 0111246899999999 57889
Q ss_pred chHHHHHHHHHHHhCCccccccCCCCc--------------CHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHhhccC
Q 039565 118 DVDSFEIVILEIITGILTVDLSFKGEF--------------DIISVEKAVEIAMASVSSKVNRRP-LMNQVVMVREQGSG 182 (188)
Q Consensus 118 di~s~G~~l~~~~~g~~p~~~~~~~~~--------------~~~~~~~~~~l~~~cl~~~p~~Rp-s~~~i~~~l~~~~~ 182 (188)
|+|||||++|+|++|..||........ ....+..+.+++.+|++.+|++|| +++++.+.|+....
T Consensus 213 DIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 213 DIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred HHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999864322110 012345688999999999999997 57778777766533
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=196.96 Aligned_cols=162 Identities=25% Similarity=0.328 Sum_probs=133.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++||||+++++. ....++++||+++++|.+++.+ .. |++.||.|||+ .+++|+|++|.|
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~n 131 (290)
T cd05580 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPEN 131 (290)
T ss_pred HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHH
Confidence 567889999999998 7788999999999999999822 22 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++++|||++...... .....++..|++|| .+.++|+||||+++|++++|..||.....
T Consensus 132 ili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 206 (290)
T cd05580 132 LLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI 206 (290)
T ss_pred EEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999988754311 22345778899998 36789999999999999999999864321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
...+...+..+.+++..||..+|.+|+ +++++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 207 YEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 112333467889999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=196.85 Aligned_cols=161 Identities=24% Similarity=0.252 Sum_probs=130.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC--Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG--KEE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~--~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||+++.++ ....++++||+. |++.+++. ... |++.||.|||+ .+++|+|++|.
T Consensus 69 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~ 144 (307)
T cd06607 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAG 144 (307)
T ss_pred HHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcc
Confidence 567899999999998 778899999998 57767662 111 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+++.++.++++|||++..... .....++..|++|| ++.++|+||||+++|++++|..||....
T Consensus 145 nIl~~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 145 NILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (307)
T ss_pred cEEECCCCCEEEeecCcceecCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence 99999999999999998865321 12345667788888 3568999999999999999998875321
Q ss_pred -------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 141 -------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 141 -------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
........+..+.+++..||+.+|++||++.+|+..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 219 AMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111123456789999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=193.39 Aligned_cols=167 Identities=25% Similarity=0.327 Sum_probs=135.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC-c----c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK-E----E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~-~----~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
++.++|+||+++++. .+..++++|++++++|.+++ .. . . |++.|++|||+ .+++|+|++
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~ 129 (267)
T cd06610 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIK 129 (267)
T ss_pred HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 567899999999988 88899999999999999998 21 1 1 89999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCC--cceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGT--HMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~--~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|+||++++++.++++|||++......... .......++..|++|| .+.++|+||||+++|+|++|..||..
T Consensus 130 p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 209 (267)
T cd06610 130 AGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209 (267)
T ss_pred HHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence 99999999999999999988754322221 1223346778899998 46679999999999999999999864
Q ss_pred cCCCC------------cC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKGE------------FD-----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~~------------~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..... .. ...+..+.+++..||+.+|++||+++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 210 YPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 32110 10 134577899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=201.75 Aligned_cols=156 Identities=21% Similarity=0.308 Sum_probs=126.9
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c--c---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E--E---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+|++|+++.++ .+..++||||+++|+|..++.+ . . |++.||.|||+ .+++|||+||+||+++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~ 135 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLD 135 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEEC
Confidence 46778888877 6789999999999999998822 2 1 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-------
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------- 141 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------- 141 (188)
.++.++|+|||++..... .........|+..|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 136 ~~~~ikL~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (323)
T cd05615 136 SEGHIKIADFGMCKEHMV--DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213 (323)
T ss_pred CCCCEEEeccccccccCC--CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999998874321 111233456888999999 57889999999999999999999865321
Q ss_pred ----CCcCHHHHHHHHHHHHHccCcCCCCCCCH
Q 039565 142 ----GEFDIISVEKAVEIAMASVSSKVNRRPLM 170 (188)
Q Consensus 142 ----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 170 (188)
...+...+..+.+++..|++.+|.+|++.
T Consensus 214 ~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 214 MEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HhCCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11233456678899999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=193.73 Aligned_cols=157 Identities=22% Similarity=0.318 Sum_probs=130.4
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+||||+++++. .+..+++|||+++++|.+++.+. . |++.||.|||+ .+++|+|++|+||+++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~ 143 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYD 143 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEe
Confidence 69999999988 78899999999999999999222 2 99999999999 8999999999999999
Q ss_pred cCC-ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC----
Q 039565 75 EKV-QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE---- 143 (188)
Q Consensus 75 ~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~---- 143 (188)
.++ .++++|||.+..... .....++..|++|| ++.++|+||||+++|++++|..||......+
T Consensus 144 ~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~ 217 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217 (267)
T ss_pred CCCCeEEEecCccceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH
Confidence 988 999999998765321 11235677889998 5778999999999999999999986432221
Q ss_pred -----------cCHHHHHHHHHHHHHccCcCCCCCCC-HHHHHH
Q 039565 144 -----------FDIISVEKAVEIAMASVSSKVNRRPL-MNQVVM 175 (188)
Q Consensus 144 -----------~~~~~~~~~~~l~~~cl~~~p~~Rps-~~~i~~ 175 (188)
.....+..+.+++..||+.+|.+||+ ++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 218 SLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 12235678899999999999999996 688874
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=199.31 Aligned_cols=171 Identities=19% Similarity=0.275 Sum_probs=132.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||+++++. +...++++||+++++|.+++.. .. |++.||.|||+ .+++|+|++|.|
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~N 131 (305)
T cd05609 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDN 131 (305)
T ss_pred HHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHH
Confidence 456889999999988 6778999999999999999822 21 88999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCC-------------CCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEG-------------GTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~ 131 (188)
|+++.++.++++|||.++...... .........++..|++|| ++.++|+||||+++|++++
T Consensus 132 Ill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~ 211 (305)
T cd05609 132 LLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV 211 (305)
T ss_pred EEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999876311000 000111234667789998 5788999999999999999
Q ss_pred CCccccccCCCC-----------c---CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 132 GILTVDLSFKGE-----------F---DIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 132 g~~p~~~~~~~~-----------~---~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
|..||......+ . ....+..+.+++..||+.+|++||++.++.+.|+.
T Consensus 212 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 212 GCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 999885432111 0 11245678999999999999999997666666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=198.18 Aligned_cols=165 Identities=24% Similarity=0.282 Sum_probs=131.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE---E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ +...++++||+++++|..+.... . |++.||+|||+ .+++|+|++|+|
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~n 130 (286)
T cd07846 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPEN 130 (286)
T ss_pred HHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHH
Confidence 467889999999999 77899999999998888877221 1 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKGE 143 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~ 143 (188)
|+++.++.++++|||++....... .......++..|++|| ++.++|+||||+++|++++|..||......+
T Consensus 131 i~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~ 208 (286)
T cd07846 131 ILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID 208 (286)
T ss_pred EEECCCCcEEEEeeeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 999999999999999887543211 1222345677788998 3567999999999999999998774221100
Q ss_pred ---------------------------------c---------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 ---------------------------------F---------DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 ---------------------------------~---------~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ....+..+.+++..||+.+|++||++.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 209 QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 0122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=192.36 Aligned_cols=166 Identities=19% Similarity=0.228 Sum_probs=132.3
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCC-c--c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGK-E--E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++||||++++++ ....++++||+++++|.+++.+ . . |++.||.|||+ .+++|+|++|
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p 134 (265)
T cd06652 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKG 134 (265)
T ss_pred HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCH
Confidence 567899999999997 2457799999999999999822 1 1 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCC-CcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccccc--
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLS-- 139 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~-- 139 (188)
+||+++.++.++++|||.+........ ........++..|++|| .+.++|+||||+++|++++|..||...
T Consensus 135 ~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 214 (265)
T cd06652 135 ANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214 (265)
T ss_pred HHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch
Confidence 999999999999999998875321111 11122345777899999 467899999999999999999998531
Q ss_pred -----------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 140 -----------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 140 -----------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.....+......+.+++..|+. +|++||++++|++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 215 MAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1122444566778899999995 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=200.49 Aligned_cols=165 Identities=23% Similarity=0.267 Sum_probs=141.5
Q ss_pred ccccc-CCCeeeeccc---CCccEEEEecCCCCChhhhc-CC-cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLT-GPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK-EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~-Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~-~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|.++. |||||++.+. ....++|||++.+|.|.+.+ .. .. |++.|+.|||+ .+++|||+||+|
T Consensus 89 l~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN 165 (382)
T KOG0032|consen 89 LQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPEN 165 (382)
T ss_pred HHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHH
Confidence 55677 9999999999 78889999999999999999 43 33 99999999999 999999999999
Q ss_pred EEEccC----CceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 71 ILLNEK----VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 71 ill~~~----~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
+++... +.+|++|||++..... .......+|++.|+||| ++..+|+||+|+++|.|++|..||....
T Consensus 166 ~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 166 LLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred eeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 999643 4799999999986542 44566789999999999 6889999999999999999999996543
Q ss_pred ---------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 141 ---------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 141 ---------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
..+.-...+..+.+++..++..||.+|+|+.++++.
T Consensus 243 ~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 243 EFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred hhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 112223457789999999999999999999999984
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=195.70 Aligned_cols=166 Identities=20% Similarity=0.203 Sum_probs=131.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++||||++++++ .+..++++||++++.+..+..+ .. |++.|+.|||+ .+++|+|++|+|
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~n 130 (288)
T cd07833 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPEN 130 (288)
T ss_pred HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHH
Confidence 457889999999999 7789999999998777665532 21 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
|+++.++.++++|||.+........ .......++..|++|| .+.++|+||||+++|++++|..||.....
T Consensus 131 i~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~ 209 (288)
T cd07833 131 ILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID 209 (288)
T ss_pred eEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999875432211 1223345677889998 45789999999999999999988753210
Q ss_pred --------------------------------C---------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 --------------------------------G---------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 --------------------------------~---------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. .++...+..+.+++..||+.+|++|||++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 210 QLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 011123677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=198.60 Aligned_cols=166 Identities=16% Similarity=0.143 Sum_probs=128.6
Q ss_pred ccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-----c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 7 NKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-----E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 7 ~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-----~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
..++||||++++++ .+..++++||+.+++|.+++.+. . |++.||+|||+ .+++|||+||+
T Consensus 54 ~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~ 130 (328)
T cd08226 54 HFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKAS 130 (328)
T ss_pred HhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHH
Confidence 34789999999999 78889999999999999988321 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcc-----eeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHM-----STTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~-----~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
||+++.++.+++.||+............. .....++..|++|| ++.++|+||||+++|++++|..||
T Consensus 131 Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 210 (328)
T cd08226 131 HILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210 (328)
T ss_pred HEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999875432211111100 11123445688998 357899999999999999999988
Q ss_pred cccCC----------------------------------------------------------CCcCHHHHHHHHHHHHH
Q 039565 137 DLSFK----------------------------------------------------------GEFDIISVEKAVEIAMA 158 (188)
Q Consensus 137 ~~~~~----------------------------------------------------------~~~~~~~~~~~~~l~~~ 158 (188)
..... ..........+.+++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 290 (328)
T cd08226 211 QDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVEL 290 (328)
T ss_pred CCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHH
Confidence 53211 00112345678999999
Q ss_pred ccCcCCCCCCCHHHHHH
Q 039565 159 SVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 159 cl~~~p~~Rps~~~i~~ 175 (188)
||+.+|++|||++++++
T Consensus 291 ~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 291 CLQQDPEKRPSASSLLS 307 (328)
T ss_pred HccCCcccCCCHHHHhh
Confidence 99999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=193.75 Aligned_cols=162 Identities=20% Similarity=0.243 Sum_probs=132.4
Q ss_pred ccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 9 LTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 9 l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
..|||++++++. ....++++||+++++|.+++.... |++.||.|||+ .+++|+|++|+||+++
T Consensus 59 ~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~ 135 (277)
T cd06917 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVT 135 (277)
T ss_pred CCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEc
Confidence 359999999988 777899999999999999983222 89999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC------
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK------ 141 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------ 141 (188)
.++.++++|||.+....... .......|+..|++|| ++.++|+||||+++|++++|..||+....
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~ 213 (277)
T cd06917 136 NTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213 (277)
T ss_pred CCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc
Confidence 99999999999887543222 2223346777899998 36789999999999999999999854321
Q ss_pred ------CCcCH-HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ------GEFDI-ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ------~~~~~-~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+. ..+..+.+++..||+.+|++||++.+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 214 IPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred cccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111 24568899999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=221.53 Aligned_cols=172 Identities=20% Similarity=0.252 Sum_probs=132.4
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCC-------cc---------cHHHHHHHHhcCC----CCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGK-------EE---------VCCPGLEYLHQGL----KHP 60 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-------~~---------~i~~~l~~Lh~~~----~~~ 60 (188)
+.+++||||++++++ ....++||||+++++|..++.. .. |++.||.|||+.. ..+
T Consensus 66 L~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~ 145 (1021)
T PTZ00266 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER 145 (1021)
T ss_pred HHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence 567899999999986 4568999999999999998821 11 9999999999721 134
Q ss_pred cEEeCCCCCcEEEccC-----------------CceEEecccCcccccCCCCCcceeeecccccccCCC--------CCC
Q 039565 61 IIQRDMKSTNILLNEK-----------------VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTE 115 (188)
Q Consensus 61 i~h~dl~~~nill~~~-----------------~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~ 115 (188)
|+|+||||+|||++.. +.+||+|||++..... ........|++.|+||| ++.
T Consensus 146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~ 222 (1021)
T PTZ00266 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDD 222 (1021)
T ss_pred ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCc
Confidence 9999999999999642 3489999999875431 11223456888999998 467
Q ss_pred ccchHHHHHHHHHHHhCCccccccCC-----------CCcC-HHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhhc
Q 039565 116 KSDVDSFEIVILEIITGILTVDLSFK-----------GEFD-IISVEKAVEIAMASVSSKVNRRPLMNQVVM--VREQG 180 (188)
Q Consensus 116 ~~di~s~G~~l~~~~~g~~p~~~~~~-----------~~~~-~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~--~l~~~ 180 (188)
++|||||||++|+|++|..||..... ...+ ...+..+.+++..||+.+|.+||++.++++ .+...
T Consensus 223 KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 223 KSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred hhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 89999999999999999999964221 0011 123567899999999999999999999984 45433
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-31 Score=197.72 Aligned_cols=165 Identities=22% Similarity=0.256 Sum_probs=143.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc--CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ--GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~--~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|.+++.|+||+.||. +..+|+|||||.-|+..+++ ++.. +.+.||+|||. ..-+|||+|+.
T Consensus 82 MQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAG 158 (502)
T KOG0574|consen 82 MQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAG 158 (502)
T ss_pred HHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccc
Confidence 567889999999999 88999999999999999999 3333 77899999999 89999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC---
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF--- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~--- 140 (188)
|||++.+|..|++|||++.... ......++..||+.||||| +..++||||+|++..||..|++|+.+.-
T Consensus 159 NILLNT~G~AKLADFGVAGQLT--DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR 236 (502)
T KOG0574|consen 159 NILLNTDGIAKLADFGVAGQLT--DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR 236 (502)
T ss_pred cEEEcccchhhhhhccccchhh--hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc
Confidence 9999999999999999987543 3334567789999999999 7899999999999999999999884311
Q ss_pred ---------CC--CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 ---------KG--EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ---------~~--~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+. ..+..++..+.+++..|+.++|++|-|+-++++
T Consensus 237 AIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 237 AIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred eeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 11 245678899999999999999999999999887
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=195.31 Aligned_cols=161 Identities=18% Similarity=0.209 Sum_probs=130.9
Q ss_pred ccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 9 LTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 9 l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
.+||||+.+.+. .+..++||||+++++|..++ .+.. |++.||.|||+ .+++|+|+||+||++
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~ 130 (279)
T cd05633 54 GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILL 130 (279)
T ss_pred CCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEE
Confidence 479999999887 67889999999999999888 2221 89999999999 999999999999999
Q ss_pred ccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC----
Q 039565 74 NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG---- 142 (188)
Q Consensus 74 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~---- 142 (188)
+.++.++++|||++...... ......|+..|++|| ++.++|+||||+++|++++|..||......
T Consensus 131 ~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 206 (279)
T cd05633 131 DEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206 (279)
T ss_pred CCCCCEEEccCCcceecccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH
Confidence 99999999999988643211 122345778899998 356799999999999999999998643211
Q ss_pred ----------CcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 039565 143 ----------EFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVMV 176 (188)
Q Consensus 143 ----------~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~~ 176 (188)
..+...+..+.+++..|++.+|.+|| ++.++++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 207 IDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12233456888999999999999999 59888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=207.76 Aligned_cols=164 Identities=21% Similarity=0.325 Sum_probs=137.3
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
|+.|+||||++++.. ....-+|+|.+..|+|..|.++.. ||+.||.|||+ ....|||||||-
T Consensus 95 LKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKC 173 (632)
T KOG0584|consen 95 LKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKC 173 (632)
T ss_pred HccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhc-CCCCcccccccc
Confidence 567999999999998 455789999999999999994433 99999999997 235899999999
Q ss_pred CcEEEccC-CceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccccc----
Q 039565 69 TNILLNEK-VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDL---- 138 (188)
Q Consensus 69 ~nill~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~---- 138 (188)
+||+++.+ |.+||+|+|++.... .+ ......|||.+|||| |...+||||||.++.||+|+..||..
T Consensus 174 DNIFinG~~G~VKIGDLGLAtl~r--~s--~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~ 249 (632)
T KOG0584|consen 174 DNIFVNGNLGEVKIGDLGLATLLR--KS--HAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNP 249 (632)
T ss_pred ceEEEcCCcCceeecchhHHHHhh--cc--ccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCH
Confidence 99999986 899999999998653 12 233478999999999 89999999999999999999999843
Q ss_pred ----------cCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 ----------SFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ----------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+..+.......+.+++..|+.. ...|||+.++++
T Consensus 250 AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 250 AQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 122223334456889999999999 999999999987
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=204.25 Aligned_cols=166 Identities=18% Similarity=0.232 Sum_probs=131.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|..-++|+||+++-. .+++||||||.+||++..++.+.+ +++-|++-+|. .|+|||||||+|
T Consensus 195 L~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdN 271 (550)
T KOG0605|consen 195 LAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDN 271 (550)
T ss_pred hhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhh
Confidence 445679999999777 899999999999999999993322 88999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccC---------------------CCCCc-----c-------------------eeeeccc
Q 039565 71 ILLNEKVQAKLADFGQSRISPV---------------------EGGTH-----M-------------------STTIAGT 105 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~---------------------~~~~~-----~-------------------~~~~~~~ 105 (188)
+|||..|++||+|||++..... ..... . .....||
T Consensus 272 lLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGT 351 (550)
T KOG0605|consen 272 LLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGT 351 (550)
T ss_pred eeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCC
Confidence 9999999999999999853210 00000 0 0125699
Q ss_pred ccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC---------------cCHHHHHHHHHHHHHccCcCC
Q 039565 106 AGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE---------------FDIISVEKAVEIAMASVSSKV 164 (188)
Q Consensus 106 ~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~---------------~~~~~~~~~~~l~~~cl~~~p 164 (188)
|-|+||| ++..+|.||+||++|||+.|.+||-...+.+ .......+..++|..|+. ||
T Consensus 352 PDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 352 PDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred ccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CH
Confidence 9999999 6899999999999999999999996544322 223445788899999998 99
Q ss_pred CCCCC---HHHHHH
Q 039565 165 NRRPL---MNQVVM 175 (188)
Q Consensus 165 ~~Rps---~~~i~~ 175 (188)
++|.- ++||-+
T Consensus 431 ~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 431 ENRLGSKGAEEIKK 444 (550)
T ss_pred HHhcCcccHHHHhc
Confidence 99974 555543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=190.48 Aligned_cols=163 Identities=20% Similarity=0.240 Sum_probs=133.4
Q ss_pred ccccCCCeeeeccc-------CCccEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHhcCCCCCcEEeC
Q 039565 7 NKLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 7 ~~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
..-.|||||+++++ ...+.+|||.++||.|.+.+ ++.. |++.|+.|||+ .+|.|||
T Consensus 110 ~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRD 186 (400)
T KOG0604|consen 110 MASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRD 186 (400)
T ss_pred hhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhcc
Confidence 34469999999999 56778999999999999999 2222 99999999999 9999999
Q ss_pred CCCCcEEEcc---CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccc
Q 039565 66 MKSTNILLNE---KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 66 l~~~nill~~---~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
+||+|+|.+. +..+||+|||+++... ......+.+.|++|.+|| ++..+|+||+||++|-++.|.+||
T Consensus 187 lKpENLLyt~t~~na~lKLtDfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPF 263 (400)
T KOG0604|consen 187 LKPENLLYTTTSPNAPLKLTDFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_pred CChhheeeecCCCCcceEecccccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcc
Confidence 9999999965 4578999999998532 223345667889999998 789999999999999999999998
Q ss_pred cccCC---------------CCcCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 137 DLSFK---------------GEFDI----ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 137 ~~~~~---------------~~~~~----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
-..-. -+++. ..++...+++...|..+|++|.|++++..
T Consensus 264 YS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 264 YSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 32111 11222 35678889999999999999999999865
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=200.38 Aligned_cols=167 Identities=20% Similarity=0.224 Sum_probs=129.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+..++||||+++++. .++.++||||+++|+|.+++.+ .. |++.||+|||+ .+++||||||+
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~ 131 (331)
T cd05597 55 LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPD 131 (331)
T ss_pred HHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHH
Confidence 345789999999888 7889999999999999999832 21 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+++.++.++|+|||++..... ..........|+..|++|| ++.++|+|||||++|+|++|..||..
T Consensus 132 Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 132 NVLLDKNGHIRLADFGSCLRLLA-DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred HEEECCCCCEEEEECCceeecCC-CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 99999999999999998864321 1111222346888999998 24679999999999999999999854
Q ss_pred cCCC-------------CcC---HHHHHHHHHHHHHccCcCCC--CCCCHHHHHHH
Q 039565 139 SFKG-------------EFD---IISVEKAVEIAMASVSSKVN--RRPLMNQVVMV 176 (188)
Q Consensus 139 ~~~~-------------~~~---~~~~~~~~~l~~~cl~~~p~--~Rps~~~i~~~ 176 (188)
.... ..+ ...+..+.+++.+|+...++ .|++++++++.
T Consensus 211 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 211 ESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 2110 011 12456788888887754333 37899888874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=196.37 Aligned_cols=165 Identities=25% Similarity=0.378 Sum_probs=134.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....+++|||+++++|.+++. ... |++.||.+||+ .+++|+||||+|
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~N 128 (260)
T PF00069_consen 52 LRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPEN 128 (260)
T ss_dssp HHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGG
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccc
Confidence 456789999999999 788899999999999999884 222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKGE 143 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~ 143 (188)
|+++.++.++++|||.+... ...........++..|.+|| .+.++|+||+|+++++|++|..||.......
T Consensus 129 Il~~~~~~~~l~Dfg~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~ 206 (260)
T PF00069_consen 129 ILLDENGEVKLIDFGSSVKL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD 206 (260)
T ss_dssp EEESTTSEEEESSGTTTEES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH
T ss_pred cccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence 99999999999999998643 11222333456777888887 5788999999999999999999887641100
Q ss_pred ------------cC------HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 ------------FD------IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 ------------~~------~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.. ......+.+++..||+.+|++|||++++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 207 QLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 001368999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=191.58 Aligned_cols=167 Identities=20% Similarity=0.320 Sum_probs=134.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++||||+++++. .+..++++||+.+++|.+++ +... |++.||.|||+ .+++|+|++|.|
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~n 133 (268)
T cd06630 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGAN 133 (268)
T ss_pred HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHH
Confidence 456899999999999 77889999999999999998 2221 99999999999 999999999999
Q ss_pred EEEccCC-ceEEecccCcccccCCCC--CcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILLNEKV-QAKLADFGQSRISPVEGG--THMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill~~~~-~~kl~d~~~~~~~~~~~~--~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+++.++ .++++|||.+........ ........++..|++|| ++.++|+||+|++++++++|..||.....
T Consensus 134 il~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 134 LLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred EEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 9998776 589999998875432211 11122345677889988 47789999999999999999999853221
Q ss_pred ----------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ----------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ----------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+.+......+.+++.+|++.+|.+||++.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 214 SNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred cchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 2233345678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=192.82 Aligned_cols=161 Identities=24% Similarity=0.271 Sum_probs=130.7
Q ss_pred cccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCcEE
Q 039565 8 KLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTNIL 72 (188)
Q Consensus 8 ~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~nil 72 (188)
..+|||++++++. .+..++++||+++++|.+++.... |++.||.|||+ .+++|+|++|.||+
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil 129 (260)
T cd05611 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLL 129 (260)
T ss_pred cCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeE
Confidence 4589999999988 778999999999999999983221 99999999999 99999999999999
Q ss_pred EccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC----
Q 039565 73 LNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG---- 142 (188)
Q Consensus 73 l~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~---- 142 (188)
++.++.++++|||++..... .....++..|++|| ++.++|+||||+++|++++|..||......
T Consensus 130 ~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 203 (260)
T cd05611 130 IDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD 203 (260)
T ss_pred ECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99999999999998764321 22345667788888 477899999999999999999998543211
Q ss_pred -----------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 039565 143 -----------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVR 177 (188)
Q Consensus 143 -----------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l 177 (188)
......+..+.+++.+||+.+|++||++.++.+.|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 204 NILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 11123467899999999999999999776554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=194.98 Aligned_cols=166 Identities=18% Similarity=0.243 Sum_probs=132.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||++++++ +...++|+||+ +++|.+++ .... |++.||.|||+ .+++|+|++|+
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ 128 (286)
T cd07832 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPA 128 (286)
T ss_pred HHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHH
Confidence 456789999999998 77889999999 89999988 2211 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.++++|||.+........ .......++..|++|| ++.++|+||+|++++++++|..+|......
T Consensus 129 ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~ 207 (286)
T cd07832 129 NLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI 207 (286)
T ss_pred HEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH
Confidence 99999999999999998875432211 1122345777899998 367899999999999999998776432100
Q ss_pred -----------------------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 143 -----------------------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 143 -----------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
+........+.+++..|++.+|++|||++++++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 208 EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0001234788899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=195.31 Aligned_cols=165 Identities=22% Similarity=0.249 Sum_probs=131.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ .+..++|+||+ +++|.+++ ... . |++.||.|||+ .+++|+|++|+
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~ 131 (298)
T cd07841 56 LQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPN 131 (298)
T ss_pred HhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChh
Confidence 567899999999999 67889999999 78999999 333 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.++++|||++....... .......++..|++|| ++.++|+||||+++|++++|..+|......
T Consensus 132 nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~ 209 (298)
T cd07841 132 NLLIASDGVLKLADFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI 209 (298)
T ss_pred hEEEcCCCCEEEccceeeeeccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH
Confidence 9999999999999999987543211 1122234556788887 367899999999999999997666422110
Q ss_pred C---------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 143 E---------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 143 ~---------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
+ .....+..+.+++..||+.+|++|||+.++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 210 DQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 001224678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=200.21 Aligned_cols=167 Identities=21% Similarity=0.240 Sum_probs=131.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+..++||||+++++. ....++||||+++|+|.+++.+ .. |++.||.|||+ .+++||||||+
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~ 131 (332)
T cd05623 55 LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPD 131 (332)
T ss_pred HhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHH
Confidence 456789999999888 7889999999999999999932 11 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+++.++.++|+|||++.... ...........|+..|++|| ++.++|+|||||++|+|++|..||..
T Consensus 132 Nili~~~~~~kL~DfG~a~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 132 NILMDMNGHIRLADFGSCLKLM-EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred HEEECCCCCEEEeecchheecc-cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 9999999999999999886432 11112223356889999998 35689999999999999999999854
Q ss_pred cCC-------------CCcC---HHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 039565 139 SFK-------------GEFD---IISVEKAVEIAMASVSSKVNR--RPLMNQVVMV 176 (188)
Q Consensus 139 ~~~-------------~~~~---~~~~~~~~~l~~~cl~~~p~~--Rps~~~i~~~ 176 (188)
... ..++ ...+..+.+++..|+..++.+ |++++++++.
T Consensus 211 ~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 211 ESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 221 0111 134667888898888655444 6889988764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=193.34 Aligned_cols=161 Identities=19% Similarity=0.226 Sum_probs=132.3
Q ss_pred cccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCcEE
Q 039565 8 KLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTNIL 72 (188)
Q Consensus 8 ~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~nil 72 (188)
..+||||+++.+. .+..++++||+.+++|..++.+.. |++.|+.|||+ .+++|+|++|+||+
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nil 129 (278)
T cd05606 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANIL 129 (278)
T ss_pred hCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEE
Confidence 3579999999887 778899999999999999882221 89999999999 99999999999999
Q ss_pred EccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC----
Q 039565 73 LNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK---- 141 (188)
Q Consensus 73 l~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~---- 141 (188)
++.++.++++|||.+...... ......|+..|++|| ++.++|+||+|+++|++++|..||+....
T Consensus 130 i~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~ 205 (278)
T cd05606 130 LDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205 (278)
T ss_pred ECCCCCEEEccCcCccccCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH
Confidence 999999999999988643211 122346788899998 46779999999999999999999865421
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
.+.+...+..+.+++..|+..+|.+|| ++.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 206 EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 112223467899999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=194.21 Aligned_cols=164 Identities=21% Similarity=0.244 Sum_probs=128.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||++++++ .+..++|+||+++ +|.+++ +.. . |++.||.|||+ .+++|+|++|+
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~ 132 (291)
T cd07844 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQ 132 (291)
T ss_pred HhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHH
Confidence 567899999999998 7789999999984 899888 221 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.++++|||.++....... ......++..|++|| ++.++|+||+|+++|+|++|..||......
T Consensus 133 nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~ 210 (291)
T cd07844 133 NLLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV 210 (291)
T ss_pred HEEEcCCCCEEECccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 99999999999999998764321111 111223566788888 356799999999999999999888533200
Q ss_pred -----------------C-----------------c-CH-------HH--HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 -----------------E-----------------F-DI-------IS--VEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 -----------------~-----------------~-~~-------~~--~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. . +. .. ...+.+++..|++.+|++|||++++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 211 EDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0 00 01 156779999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=190.48 Aligned_cols=167 Identities=23% Similarity=0.334 Sum_probs=137.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++|||++++++. ....++++||+++++|.+++.+ .. |++.|+.|||+. .+++|+|++|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~n 130 (264)
T cd06623 53 LRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSN 130 (264)
T ss_pred HHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHH
Confidence 567889999999998 7889999999999999999932 22 999999999973 799999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC----
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF---- 140 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~---- 140 (188)
|+++.++.++++|||.+....... .......++..|++|| .+.++|+||||+++|++++|..||....
T Consensus 131 i~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~ 208 (264)
T cd06623 131 LLINSKGEVKIADFGISKVLENTL--DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF 208 (264)
T ss_pred EEECCCCCEEEccCccceecccCC--CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH
Confidence 999999999999999887543111 1222345677888988 4778999999999999999999986552
Q ss_pred -----------CCCcCHH-HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 141 -----------KGEFDII-SVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 141 -----------~~~~~~~-~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
....+.. .+..+.+++..|++.+|+.||++.++++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 209 FELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1122333 56789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=194.85 Aligned_cols=164 Identities=21% Similarity=0.223 Sum_probs=128.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||++++++ ....++++||+. ++|..++.. .. |++.||+|||+ .+++|+|++|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p 128 (284)
T cd07860 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKP 128 (284)
T ss_pred HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCH
Confidence 567899999999999 788999999996 588888721 11 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
+||+++.++.++++|||++........ ......++..|++|| .+.++|+||||+++|++++|..||.....
T Consensus 129 ~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~ 206 (284)
T cd07860 129 QNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 206 (284)
T ss_pred HHEEECCCCCEEEeeccchhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999999999999998865431111 112234566788998 36679999999999999999988743211
Q ss_pred CC----------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 GE----------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ~~----------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+ ........+.+++.+|++.+|.+|||++++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 207 IDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 00012356778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=189.21 Aligned_cols=168 Identities=23% Similarity=0.278 Sum_probs=137.7
Q ss_pred CcccccCCCeeeeccc---C--CccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 5 NRNKLTGPLLVELIGK---Q--KNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~--~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
.+++++||||+++++. . ...++++||+++++|.+++.+. . |++.|+.|||+ .+++|+|++
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~ 128 (260)
T cd06606 52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIK 128 (260)
T ss_pred HHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCC
Confidence 3567889999999988 4 6789999999999999998222 2 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC-
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF- 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~- 140 (188)
|+||+++.++.++++|||.+................++..|.+|| .+.++|+||||++++++++|..||+...
T Consensus 129 p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 208 (260)
T cd06606 129 GANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN 208 (260)
T ss_pred HHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999887543222111123456777888998 5778999999999999999999986542
Q ss_pred -------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 -------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 -------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+...+..+.+++.+|++.+|.+||++.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 209 PMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred hHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 12234455778999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=194.46 Aligned_cols=164 Identities=18% Similarity=0.191 Sum_probs=130.0
Q ss_pred cccccCCCeeeeccc---C--CccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK---Q--KNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~--~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||+++.++ . ...++++||++ ++|.+++ ... . |++.||.|||+ .+++|+|++
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~ 133 (293)
T cd07843 58 LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLK 133 (293)
T ss_pred HHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCC
Confidence 567899999999987 4 78999999998 4898887 221 1 89999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+||+++.++.++++|||++....... .......++..|++|| .+.++|+||||+++|++++|..||....
T Consensus 134 p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 134 TSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred HHHEEECCCCcEEEeecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999887543221 1122234567789998 3567999999999999999998775321
Q ss_pred C------------------------------------------CCcCHH-HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 K------------------------------------------GEFDII-SVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~------------------------------------------~~~~~~-~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ..++.. ....+.+++.+||+.+|++|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 212 EIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 001111 3567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=206.54 Aligned_cols=165 Identities=18% Similarity=0.176 Sum_probs=126.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-c---------------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-E---------------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-~---------------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
|.+++||||++++++ .+..+++++++. ++|..++ ... . |++.||.|||+ .+|+|||
T Consensus 217 l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrD 292 (501)
T PHA03210 217 LGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRD 292 (501)
T ss_pred HHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 567899999999998 778899999987 4666665 211 0 89999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCc-cccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGIL-TVDL 138 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~-p~~~ 138 (188)
|||+||+++.++.+||+|||++..+... .........|+..|++|| ++.++|||||||++|+|++|.. |+..
T Consensus 293 LKP~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 293 IKLENIFLNCDGKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred CCHHHEEECCCCCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 9999999999999999999998754321 111223467889999999 5788999999999999999874 3321
Q ss_pred cCC-----------------CCcCH----------------------------HHHHHHHHHHHHccCcCCCCCCCHHHH
Q 039565 139 SFK-----------------GEFDI----------------------------ISVEKAVEIAMASVSSKVNRRPLMNQV 173 (188)
Q Consensus 139 ~~~-----------------~~~~~----------------------------~~~~~~~~l~~~cl~~~p~~Rps~~~i 173 (188)
... .+++. .....+.+++.+|++.||.+|||+.++
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el 451 (501)
T PHA03210 372 GGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL 451 (501)
T ss_pred CCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence 110 00000 011235567889999999999999999
Q ss_pred HH
Q 039565 174 VM 175 (188)
Q Consensus 174 ~~ 175 (188)
++
T Consensus 452 L~ 453 (501)
T PHA03210 452 LA 453 (501)
T ss_pred hh
Confidence 87
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=192.78 Aligned_cols=163 Identities=22% Similarity=0.283 Sum_probs=135.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++||||+++++. ....++++||+.+++|..++.+. . |++.||.|||+ .+++|+|++|+|
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~n 130 (258)
T cd05578 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDN 130 (258)
T ss_pred HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHH
Confidence 567899999999888 78899999999999999999322 2 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++++|||.+....... ......++..|++|| .+.++|+||||+++|++++|..||+....
T Consensus 131 il~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 207 (258)
T cd05578 131 ILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR 207 (258)
T ss_pred eEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH
Confidence 999999999999999877543111 223345677788998 47899999999999999999999875442
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCH--HHHH
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLM--NQVV 174 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~--~~i~ 174 (188)
...+...+..+.+++..||+.+|.+||++ ++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 208 DQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 22334456789999999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=204.15 Aligned_cols=166 Identities=20% Similarity=0.282 Sum_probs=129.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. ....++||||+++|+|.+++ .... |++.||.|||+ .+++||||||+|
T Consensus 55 l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~N 131 (360)
T cd05627 55 LVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDN 131 (360)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHH
Confidence 457899999999988 77899999999999999998 3222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCC---------------------------------CcceeeecccccccCCC-----
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGG---------------------------------THMSTTIAGTAGFLNTE----- 112 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~~pe----- 112 (188)
|+++.++.++|+|||++........ ........|+..|+|||
T Consensus 132 Ili~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~ 211 (360)
T cd05627 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT 211 (360)
T ss_pred EEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC
Confidence 9999999999999998764321100 00012346889999998
Q ss_pred -CCCccchHHHHHHHHHHHhCCccccccCCCC-------------cCH--HHHHHHHHHHHHccCcCCCCCCC---HHHH
Q 039565 113 -LTEKSDVDSFEIVILEIITGILTVDLSFKGE-------------FDI--ISVEKAVEIAMASVSSKVNRRPL---MNQV 173 (188)
Q Consensus 113 -~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~-------------~~~--~~~~~~~~l~~~cl~~~p~~Rps---~~~i 173 (188)
++.++|+|||||++|+|++|..||......+ ++. ..+..+.+++..++. +|.+|++ ++++
T Consensus 212 ~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei 290 (360)
T cd05627 212 GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEI 290 (360)
T ss_pred CCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHH
Confidence 5789999999999999999999985432211 111 135677888888664 9999985 6666
Q ss_pred HH
Q 039565 174 VM 175 (188)
Q Consensus 174 ~~ 175 (188)
++
T Consensus 291 ~~ 292 (360)
T cd05627 291 KS 292 (360)
T ss_pred hc
Confidence 65
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=192.21 Aligned_cols=164 Identities=24% Similarity=0.337 Sum_probs=133.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||+++++. ....++++||+++++|.+++... . |++.|++|||+. .+++|+|++|.
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ 130 (265)
T cd06605 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPS 130 (265)
T ss_pred HHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHH
Confidence 467889999999988 78899999999999999999322 1 899999999973 69999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
||+++.++.++++|||.+....... .....++..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 131 ni~~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 206 (265)
T cd06605 131 NILVNSRGQIKLCDFGVSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP 206 (265)
T ss_pred HEEECCCCCEEEeecccchhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc
Confidence 9999999999999999876432111 11256777889998 57889999999999999999998864310
Q ss_pred ---------------CCcCHH-HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ---------------GEFDII-SVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ---------------~~~~~~-~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+.. .+..+.+++..||..+|++|||+.+++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 207 DGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 011112 4667899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=187.07 Aligned_cols=164 Identities=25% Similarity=0.309 Sum_probs=134.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++|||++++.+. ....++++||+++++|.+++... . |++.|+.|||+ .+++|+|++|.
T Consensus 51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ 127 (253)
T cd05122 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAA 127 (253)
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHH
Confidence 467889999999998 77889999999999999998222 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC---
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF--- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~--- 140 (188)
||+++.++.++|+|||.+........ .....++..|++|| .+.++|+||||+++|++++|..||+...
T Consensus 128 ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 204 (253)
T cd05122 128 NILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK 204 (253)
T ss_pred HEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 99999999999999998875432111 33456777889998 4778999999999999999999886541
Q ss_pred ---------CCCcCHH--HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 ---------KGEFDII--SVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ---------~~~~~~~--~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....... .+..+.+++.+||+.+|++|||+.++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 205 ALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111 2578999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=197.99 Aligned_cols=167 Identities=22% Similarity=0.250 Sum_probs=131.0
Q ss_pred cccc-cCCCeeeeccc-----CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKL-TGPLLVELIGK-----QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.++ +||||++++++ ....++|+||++ ++|..++.... |++.||.|||+ .+++|+|++|
T Consensus 60 l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p 135 (337)
T cd07852 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKP 135 (337)
T ss_pred HHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCH
Confidence 3567 99999999997 335799999998 59988882212 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCC---cceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGT---HMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~---~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
.||+++.++.++++|||++......... .......++..|++|| .+.++|+||||+++|++++|+.||..
T Consensus 136 ~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 136 SNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred HHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999988754322211 1223456788899999 35689999999999999999988853
Q ss_pred cCCCC------------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 139 SFKGE------------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 139 ~~~~~------------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
....+ .....+..+.+++..||+.+|.+|||+.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 216 TSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 21100 000124567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=192.95 Aligned_cols=170 Identities=23% Similarity=0.331 Sum_probs=134.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. ....++++||+++++|.+++.+. . |++.||+|||+ .+++|+|++|.|
T Consensus 47 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~n 123 (265)
T cd05579 47 LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDN 123 (265)
T ss_pred HHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHH
Confidence 456789999999888 77889999999999999988221 2 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCC------CcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGG------THMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~------~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|+++.++.++++|||++........ ........++..|++|| .+.++|+||||+++|++++|..||+.
T Consensus 124 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred eEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999998765322211 11222345667788888 46789999999999999999999864
Q ss_pred cCCC-----------CcCHHH--HHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 139 SFKG-----------EFDIIS--VEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 139 ~~~~-----------~~~~~~--~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
.... ..+... +..+.+++..||+.+|.+|||+..+.+.|+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 204 ETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 3211 112222 678899999999999999999955555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=191.62 Aligned_cols=165 Identities=22% Similarity=0.261 Sum_probs=134.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++|||++++++. ....++++||+++++|.+++ ... . |++.||.|||+ .+++|+|++|+
T Consensus 69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ 145 (286)
T cd06614 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSD 145 (286)
T ss_pred HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChh
Confidence 567899999999988 88899999999999999999 322 2 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG- 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~- 142 (188)
||+++.++.++++|||.+....... .......++..|++|| ++.++|+||||+++|++++|..||......
T Consensus 146 ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~ 223 (286)
T cd06614 146 NILLSKDGSVKLADFGFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223 (286)
T ss_pred hEEEcCCCCEEECccchhhhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999876432111 1223345667788888 478899999999999999999887542210
Q ss_pred -------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 -------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 -------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
......+..+.+++.+|++.+|.+|||++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 224 ALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111124567999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=210.21 Aligned_cols=167 Identities=24% Similarity=0.315 Sum_probs=137.4
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc------------------c---------cHHHHHHHHhcCCC
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------------------E---------VCCPGLEYLHQGLK 58 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------------------~---------~i~~~l~~Lh~~~~ 58 (188)
+||||+.++|. ....++|.||+..|+|..++ ++. . |+|.|++||++
T Consensus 360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--- 436 (609)
T KOG0200|consen 360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--- 436 (609)
T ss_pred CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---
Confidence 59999999998 68899999999999999999 333 1 99999999999
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeec--ccccccCCC------CCCccchHHHHHHHHHHH
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA--GTAGFLNTE------LTEKSDVDSFEIVILEII 130 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~--~~~~~~~pe------~~~~~di~s~G~~l~~~~ 130 (188)
.+++|||+..+||++..+..+|++|||+++........ ...... -+..||||| ++.++|+||||+++||++
T Consensus 437 ~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eif 515 (609)
T KOG0200|consen 437 VPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIF 515 (609)
T ss_pred CCccchhhhhhhEEecCCCEEEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHh
Confidence 99999999999999999999999999999853211111 111111 244699998 799999999999999999
Q ss_pred h-CCccccc-------------cCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 131 T-GILTVDL-------------SFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 131 ~-g~~p~~~-------------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
| |..|+.. ....+.+..+..++.+++..||+.+|+.||++.++++.|+..
T Consensus 516 sLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 516 TLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred hCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 7 5567653 122345667788999999999999999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=203.26 Aligned_cols=160 Identities=23% Similarity=0.252 Sum_probs=132.7
Q ss_pred cccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 8 KLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE----------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 8 ~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
.-+||||+++.+. ..+.|+|||.+.++-+.+.+ .+.. +++.|+.|||+ .+++|||+||.|||+
T Consensus 372 ~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~ 448 (612)
T KOG0603|consen 372 VRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILL 448 (612)
T ss_pred hcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheee
Confidence 3469999999999 88999999999988777777 2221 88999999999 999999999999999
Q ss_pred -ccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC----
Q 039565 74 -NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG---- 142 (188)
Q Consensus 74 -~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~---- 142 (188)
+..+.++++|||.++..... ..+.+-+..|.||| ++.++|+||||+++|+|++|+.||.....+
T Consensus 449 ~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~ 523 (612)
T KOG0603|consen 449 DGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH 523 (612)
T ss_pred cCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH
Confidence 58889999999998754321 22334456678887 799999999999999999999998654332
Q ss_pred ------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 ------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+....+....+++.+||+.+|.+||+++++..
T Consensus 524 ~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 524 TRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 233566788999999999999999999999875
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=191.64 Aligned_cols=164 Identities=21% Similarity=0.240 Sum_probs=132.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc--c-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE--E-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~--~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++||||+++.+. .+..++++||+++++|.+++ ... . |++.|+.|||+ .+++|+|++|
T Consensus 47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p 123 (277)
T cd05577 47 LEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKP 123 (277)
T ss_pred HHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCH
Confidence 567889999999887 77899999999999999988 322 1 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
.||+++.++.++++|||.+..... ........++..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 124 ~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 200 (277)
T cd05577 124 ENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK 200 (277)
T ss_pred HHEEECCCCCEEEccCcchhhhcc---CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc
Confidence 999999999999999998765321 11122334566788888 46789999999999999999999865322
Q ss_pred --------------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 142 --------------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 142 --------------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
...+...+..+.+++.+||+.+|.+|| ++.+++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 201 VEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 112233466889999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=189.29 Aligned_cols=165 Identities=21% Similarity=0.280 Sum_probs=132.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||+++++. ....++++||+++++|.+++ ... . |++.||.|||+ .+++|+|++|
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~ 129 (257)
T cd08225 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKS 129 (257)
T ss_pred HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCH
Confidence 467889999999988 77889999999999999998 221 1 89999999999 9999999999
Q ss_pred CcEEEccCC-ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 69 TNILLNEKV-QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
.||+++.++ .++++|||.+..... .........|+..|++|| .+.++|+||||++++++++|..||.....
T Consensus 130 ~nil~~~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 207 (257)
T cd08225 130 QNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207 (257)
T ss_pred HHEEEcCCCCeEEecccccchhccC--CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 999999885 469999998865431 111222345777899998 46789999999999999999998864321
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+..+.+++.+|++.+|++|||++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 208 HQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1122234567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=193.52 Aligned_cols=169 Identities=14% Similarity=0.133 Sum_probs=129.1
Q ss_pred cccccCCCeeeeccc---C----CccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---Q----KNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~----~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+..++|+|++++++. . ...+++++++.. ++.+.+.. .+ |++.||.|||+ .+++||||
T Consensus 77 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDi 152 (294)
T PHA02882 77 IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDI 152 (294)
T ss_pred hccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 456789999999987 1 134677777653 55555511 11 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCC-----cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGT-----HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p 135 (188)
||+||+++.++.++++|||+++........ .......|++.|++|| ++.++|+|||||++|++++|..|
T Consensus 153 Kp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P 232 (294)
T PHA02882 153 KPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232 (294)
T ss_pred CHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999998754321111 1122346889999988 68899999999999999999999
Q ss_pred ccccCCCC-------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 136 VDLSFKGE-------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 136 ~~~~~~~~-------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
|....... .....+..+.+++..|++.+|++||++++|++.|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 233 WKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred CCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 96442110 01123456889999999999999999999998764
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=194.45 Aligned_cols=167 Identities=24% Similarity=0.273 Sum_probs=133.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c-c------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E-E------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~-~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++||||+++++. ....++++||+.+++|.+++.+ . . |++.||+|||+ .+++|+||||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp 131 (316)
T cd05574 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKP 131 (316)
T ss_pred HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCh
Confidence 567889999999988 7788999999999999999832 1 1 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCC---------------------------cceeeecccccccCCC------CCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGT---------------------------HMSTTIAGTAGFLNTE------LTE 115 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~pe------~~~ 115 (188)
+||+++.++.++++|||++......... .......|+..|++|| .+.
T Consensus 132 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 211 (316)
T cd05574 132 ENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS 211 (316)
T ss_pred HHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc
Confidence 9999999999999999987643211100 0111245677899998 577
Q ss_pred ccchHHHHHHHHHHHhCCccccccCC-----------CCcCH--HHHHHHHHHHHHccCcCCCCCCC----HHHHHH
Q 039565 116 KSDVDSFEIVILEIITGILTVDLSFK-----------GEFDI--ISVEKAVEIAMASVSSKVNRRPL----MNQVVM 175 (188)
Q Consensus 116 ~~di~s~G~~l~~~~~g~~p~~~~~~-----------~~~~~--~~~~~~~~l~~~cl~~~p~~Rps----~~~i~~ 175 (188)
++|+||||+++|++++|..||..... ...+. ..+..+.+++.+||..+|++||| +++++.
T Consensus 212 ~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 212 AVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 89999999999999999999853321 11111 24678999999999999999999 777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=191.70 Aligned_cols=164 Identities=18% Similarity=0.221 Sum_probs=127.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++|+||+++.++ ....++++||+. +++.+++ .+.. |++.||.|||+ .+++|+||||+
T Consensus 57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~ 132 (291)
T cd07870 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQ 132 (291)
T ss_pred HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChH
Confidence 567899999999998 678899999997 6777766 3211 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.++|+|||+++....... ......++..|++|| ++.++|+||||+++|++++|..||+.....
T Consensus 133 Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~ 210 (291)
T cd07870 133 NLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210 (291)
T ss_pred HEEEcCCCcEEEeccccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH
Confidence 99999999999999998864321111 122234567788998 255789999999999999999988532110
Q ss_pred ------------------------------C---------c-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 ------------------------------E---------F-----DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ------------------------------~---------~-----~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+ . .......+.+++..|+..+|.+|||+++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 211 FEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 0 0011346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=189.19 Aligned_cols=163 Identities=21% Similarity=0.277 Sum_probs=135.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-----cc-----------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-----EE-----------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-----~~-----------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+++++||||+++.+. ....++++||+++++|..++.+ .. |++.||+|||+ .+++|+|+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l 129 (256)
T cd08530 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDL 129 (256)
T ss_pred HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCC
Confidence 567889999999888 7889999999999999998822 11 89999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
+|.||+++.++.++++|||++...... ......++..|++|| ++.++|+||||++++++++|..||+...
T Consensus 130 ~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 130 KSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred CcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998764322 122244667788888 5678999999999999999999986433
Q ss_pred C------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 K------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ...+......+.+++..|++.+|++|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 206 MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 2 2233456678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=198.00 Aligned_cols=166 Identities=17% Similarity=0.195 Sum_probs=131.2
Q ss_pred cccccCCCeeeeccc-------CCccEEEEecCCCCChhhhcC-Ccc-----------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQG-KEE-----------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~~-~~~-----------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||+++.++ ....++++||+. ++|.+++. ... |++.||.|||+ .+++|+|+
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dl 133 (334)
T cd07855 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDL 133 (334)
T ss_pred HHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCC
Confidence 567889999999886 346799999997 68988882 222 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCC--cceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGT--HMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~--~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
+|+||+++.++.++++|||++......... .......++..|++|| .+.++|+||||+++|++++|..||.
T Consensus 134 kp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 213 (334)
T cd07855 134 KPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP 213 (334)
T ss_pred CHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC
Confidence 999999999999999999998754322111 1122346777888998 3578999999999999999999985
Q ss_pred ccCC-------------------------------------CCcC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LSFK-------------------------------------GEFD-----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~~~-------------------------------------~~~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.... ...+ ...+..+.+++.+|++.+|++|||+++++.
T Consensus 214 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 214 GKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred CCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 4211 0000 123567899999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=192.37 Aligned_cols=163 Identities=25% Similarity=0.261 Sum_probs=131.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc--CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ--GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~--~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++|||+++++++ ....++++||+. |+|.+.+ .... |++.|+.|||+ .+++|+|++|.
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~ 154 (317)
T cd06635 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAG 154 (317)
T ss_pred HHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcc
Confidence 467899999999998 778899999998 4777766 2221 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+++.++.++++|||++.... ......++..|++|| .+.++|+||||+++|++++|..||....
T Consensus 155 Nil~~~~~~~kl~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 155 NILLTEPGQVKLADFGSASIAS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred cEEECCCCCEEEecCCCccccC------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999999999999876432 122345677788888 3567999999999999999998875422
Q ss_pred C-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 141 K-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 141 ~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
. .......+..+.+++.+||+.+|.+||++.++++..-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 229 AMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 1 1112245567899999999999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=192.91 Aligned_cols=165 Identities=19% Similarity=0.189 Sum_probs=134.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+++++||||+++++. .+..++++||+++++|.+++... . |++.|++|||+ .+++|+|++|.||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Ni 147 (292)
T cd06657 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSI 147 (292)
T ss_pred HHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHE
Confidence 567899999999988 88999999999999999988222 2 99999999999 8999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK---- 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~---- 141 (188)
+++.++.++++|||.+....... .......++..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 148 lv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~ 225 (292)
T cd06657 148 LLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 225 (292)
T ss_pred EECCCCCEEEcccccceeccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999876443111 1123345777889998 46789999999999999999998753211
Q ss_pred --------CC--cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 --------GE--FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 --------~~--~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.. .....+..+.+++.+||+.+|.+||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 226 KMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11 11124567889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=204.41 Aligned_cols=159 Identities=20% Similarity=0.238 Sum_probs=122.1
Q ss_pred ccCCCeeeeccc----CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEE
Q 039565 9 LTGPLLVELIGK----QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNIL 72 (188)
Q Consensus 9 l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nil 72 (188)
.+|+++++++++ ..+.++++|++. ++|.+++ +... |++.||.|||+ +.+|+||||||+||+
T Consensus 188 ~~~~~i~~i~~~~~~~~~~~~iv~~~~g-~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NIL 264 (467)
T PTZ00284 188 ADRFPLMKIQRYFQNETGHMCIVMPKYG-PCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENIL 264 (467)
T ss_pred ccCcceeeeEEEEEcCCceEEEEEeccC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEE
Confidence 345668888777 457889999884 6888887 3221 99999999997 149999999999999
Q ss_pred EccCC----------------ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHH
Q 039565 73 LNEKV----------------QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEII 130 (188)
Q Consensus 73 l~~~~----------------~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~ 130 (188)
++.++ .+||+|||.+.... .......|+..|+||| ++.++|||||||++|+|+
T Consensus 265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell 339 (467)
T PTZ00284 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339 (467)
T ss_pred EecCCcccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence 98765 48999999875321 1233467889999999 678899999999999999
Q ss_pred hCCccccccCCCC-----------cC---------------------------H---------------HHHHHHHHHHH
Q 039565 131 TGILTVDLSFKGE-----------FD---------------------------I---------------ISVEKAVEIAM 157 (188)
Q Consensus 131 ~g~~p~~~~~~~~-----------~~---------------------------~---------------~~~~~~~~l~~ 157 (188)
+|+.||+.....+ .+ . .....+.+++.
T Consensus 340 tG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 419 (467)
T PTZ00284 340 TGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIY 419 (467)
T ss_pred hCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHH
Confidence 9999996422100 00 0 01234679999
Q ss_pred HccCcCCCCCCCHHHHHH
Q 039565 158 ASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 158 ~cl~~~p~~Rps~~~i~~ 175 (188)
.||+.||++|||++|+++
T Consensus 420 ~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 420 GLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HhCCcChhhCCCHHHHhc
Confidence 999999999999999987
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=198.20 Aligned_cols=166 Identities=20% Similarity=0.219 Sum_probs=129.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+..++||||+++++. .+..++||||+++|+|.+++.+ . . |++.||.|||+ .+++||||||+
T Consensus 55 l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~ 131 (331)
T cd05624 55 LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPD 131 (331)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchH
Confidence 345789999999888 7888999999999999999922 1 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+++.++.+||+|||++..... ..........|+..|+||| ++.++|+||||+++|+|++|..||..
T Consensus 132 Nill~~~~~~kl~DfG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 132 NVLLDMNGHIRLADFGSCLKMNQ-DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred HEEEcCCCCEEEEeccceeeccC-CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 99999999999999999875431 1111223356889999998 34679999999999999999999854
Q ss_pred cCC-------------CCcC---HHHHHHHHHHHHHccCcCCCC--CCCHHHHHH
Q 039565 139 SFK-------------GEFD---IISVEKAVEIAMASVSSKVNR--RPLMNQVVM 175 (188)
Q Consensus 139 ~~~-------------~~~~---~~~~~~~~~l~~~cl~~~p~~--Rps~~~i~~ 175 (188)
... ...+ ...+..+.+++..|+...+.+ |++++++++
T Consensus 211 ~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 211 ESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 211 0111 123578889999988865544 467888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=191.16 Aligned_cols=162 Identities=24% Similarity=0.296 Sum_probs=129.0
Q ss_pred ccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC--c----c---------cHHHHHHHHhcCCCC-CcEEeCC
Q 039565 7 NKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK--E----E---------VCCPGLEYLHQGLKH-PIIQRDM 66 (188)
Q Consensus 7 ~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~--~----~---------~i~~~l~~Lh~~~~~-~i~h~dl 66 (188)
+..+||||+++++. ....++++||++ ++|.+++ .. . . |++.||.|||+ . +++|+|+
T Consensus 55 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dl 130 (283)
T cd06617 55 RSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDV 130 (283)
T ss_pred HHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCC
Confidence 45689999999998 778999999997 6887776 21 1 1 99999999998 6 9999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC----------CCCccchHHHHHHHHHHHhCCccc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE----------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe----------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
+|+||+++.++.+|++|||.+...... .......++..|++|| ++.++|+||||+++|++++|..||
T Consensus 131 kp~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 207 (283)
T cd06617 131 KPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207 (283)
T ss_pred CHHHEEECCCCCEEEeecccccccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCC
Confidence 999999999999999999998754211 1122245677788888 256799999999999999999998
Q ss_pred cccCC-------------CCcC-HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 137 DLSFK-------------GEFD-IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 137 ~~~~~-------------~~~~-~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+.... ...+ ...+..+.+++..||..+|.+||+++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 208 DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 63211 1111 234578899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=194.51 Aligned_cols=166 Identities=17% Similarity=0.175 Sum_probs=128.4
Q ss_pred cccccCCCeeeeccc---C--CccEEEEecCCCCChhhhcC-----Cc---c---------cHHHHHHHHhcCCCCCcEE
Q 039565 6 RNKLTGPLLVELIGK---Q--KNNALELGFRGNPELVDQQG-----KE---E---------VCCPGLEYLHQGLKHPIIQ 63 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~--~~~~lv~e~~~~~~L~~~~~-----~~---~---------~i~~~l~~Lh~~~~~~i~h 63 (188)
+.+++||||++++++ . ...++|+||+++ +|.+++. .. . |++.||.|||+ .+++|
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h 131 (316)
T cd07842 56 LRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLH 131 (316)
T ss_pred HHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEee
Confidence 467899999999998 4 678999999985 6666551 11 1 89999999999 99999
Q ss_pred eCCCCCcEEEcc----CCceEEecccCcccccCCCC-CcceeeecccccccCCC-------CCCccchHHHHHHHHHHHh
Q 039565 64 RDMKSTNILLNE----KVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 64 ~dl~~~nill~~----~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~ 131 (188)
+|++|+||+++. ++.+|++|||++........ ........++..|++|| ++.++|+||||++++++++
T Consensus 132 ~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 211 (316)
T cd07842 132 RDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (316)
T ss_pred CCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999 89999999998875432211 11122345677889998 3677999999999999999
Q ss_pred CCccccccCCCC----------------------------------------------cC-----H------HHHHHHHH
Q 039565 132 GILTVDLSFKGE----------------------------------------------FD-----I------ISVEKAVE 154 (188)
Q Consensus 132 g~~p~~~~~~~~----------------------------------------------~~-----~------~~~~~~~~ 154 (188)
|..||....... .+ . ..+..+.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (316)
T cd07842 212 LEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291 (316)
T ss_pred cCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHH
Confidence 998885322111 00 0 12346889
Q ss_pred HHHHccCcCCCCCCCHHHHHH
Q 039565 155 IAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 155 l~~~cl~~~p~~Rps~~~i~~ 175 (188)
++.+|++.+|++|||++++++
T Consensus 292 ~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 292 LLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhcCCcccCcCHHHHhc
Confidence 999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=187.43 Aligned_cols=154 Identities=20% Similarity=0.138 Sum_probs=124.7
Q ss_pred ccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 9 LTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 9 l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
..||||+++++. .+..+++|||+++++|.+++ +... |++.||.|||+ .+++|+|+||+||++
T Consensus 42 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~ 118 (237)
T cd05576 42 HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILL 118 (237)
T ss_pred cCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEE
Confidence 469999999998 77889999999999999988 2211 89999999999 999999999999999
Q ss_pred ccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC------
Q 039565 74 NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------ 141 (188)
Q Consensus 74 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------ 141 (188)
+.++.++++|||.+...... .....++..|++|| ++.++|+||+|+++|++++|..|++....
T Consensus 119 ~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~ 193 (237)
T cd05576 119 DDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHT 193 (237)
T ss_pred cCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccccc
Confidence 99999999999976543211 12233455688888 46789999999999999999977653221
Q ss_pred -CCcCHHHHHHHHHHHHHccCcCCCCCCCH
Q 039565 142 -GEFDIISVEKAVEIAMASVSSKVNRRPLM 170 (188)
Q Consensus 142 -~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 170 (188)
...+...+..+.+++.+|++.||.+||++
T Consensus 194 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 194 TLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 12334456789999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=191.79 Aligned_cols=164 Identities=20% Similarity=0.214 Sum_probs=129.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++|||++++++. ....++++||++ ++|.+++ ... . |++.||.|||+ .+++|+|++|
T Consensus 52 l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p 127 (283)
T cd07835 52 LKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKP 127 (283)
T ss_pred HHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCH
Confidence 567889999999999 788899999996 6899988 322 1 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
+||+++.++.++++|||.+........ ......++..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 128 ~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 205 (283)
T cd07835 128 QNLLIDREGALKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE 205 (283)
T ss_pred HHEEEcCCCcEEEeecccccccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999875432111 112224567788998 36679999999999999999988742210
Q ss_pred C----------------------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 G----------------------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ~----------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ......+..+.+++.+|++.+|++|||++++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 206 IDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000112357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=188.28 Aligned_cols=164 Identities=21% Similarity=0.301 Sum_probs=132.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC----cc------------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK----EE------------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~----~~------------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||+++++. ....++++||+++++|..++.. .. |++.|+.|||+ .+++|+|+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l 132 (260)
T cd08222 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDL 132 (260)
T ss_pred HHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCC
Confidence 457789999999988 7788999999999999987721 11 89999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
+|+|++++. +.++++|||++..... .........++..|++|| ++.++|+||||+++|++++|..||+...
T Consensus 133 ~~~nili~~-~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~ 209 (260)
T cd08222 133 KAKNIFLKN-NLLKIGDFGVSRLLMG--SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN 209 (260)
T ss_pred ChhheEeec-CCEeecccCceeecCC--CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999975 5699999998875421 111223345677788888 4678999999999999999998885321
Q ss_pred ------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 ------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+...+..+.+++.+||+.+|++||++.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 210 FLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 12234456678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=188.78 Aligned_cols=161 Identities=22% Similarity=0.238 Sum_probs=127.3
Q ss_pred ccc-cCCCeeeeccc---C--CccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 7 NKL-TGPLLVELIGK---Q--KNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~--~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
.++ +|||+++++++ . +..++|+||+. ++|.+++ .+. . |++.||.|||+ .+++|+|++
T Consensus 52 ~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~ 127 (282)
T cd07831 52 RRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIK 127 (282)
T ss_pred hhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccC
Confidence 345 49999999998 4 78899999998 5787777 322 1 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|.||+++. +.++++|||++....... ......++..|++|| .+.++|+||||+++|+|++|..||....
T Consensus 128 p~ni~l~~-~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 128 PENILIKD-DILKLADFGSCRGIYSKP---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred HHHEEEcC-CCeEEEecccccccccCC---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 99999999 999999999987542111 112245677888998 3678999999999999999998885321
Q ss_pred CC-----------------------------Cc-----------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 KG-----------------------------EF-----------DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~~-----------------------------~~-----------~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.. .+ ....+..+.+++..||+.+|++||+++++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 204 ELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 10 00 0123578999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=194.56 Aligned_cols=163 Identities=19% Similarity=0.247 Sum_probs=128.7
Q ss_pred cccccCCCeeeeccc---C------CccEEEEecCCCCChhhhc-CCcc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---Q------KNNALELGFRGNPELVDQQ-GKEE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~------~~~~lv~e~~~~~~L~~~~-~~~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ . ...++|+||+. ++|...+ .... |++.||+|||+ .+++|+||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dl 144 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDL 144 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCC
Confidence 567899999999987 1 34699999997 4888877 2222 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+||+++.++.++++|||.+..... ........++..|++|| ++.++|+||||+++|+|++|..||....
T Consensus 145 kp~Nil~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 145 KPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred CHHHEEECCCCCEEEccCccceeCCC---CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999875421 11122345677899998 6788999999999999999998874221
Q ss_pred C------------CC------------------------------------------cCHHHHHHHHHHHHHccCcCCCC
Q 039565 141 K------------GE------------------------------------------FDIISVEKAVEIAMASVSSKVNR 166 (188)
Q Consensus 141 ~------------~~------------------------------------------~~~~~~~~~~~l~~~cl~~~p~~ 166 (188)
. .. .....+..+.+++..||+.+|.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 301 (353)
T cd07850 222 HIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301 (353)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhh
Confidence 0 00 00123456789999999999999
Q ss_pred CCCHHHHHH
Q 039565 167 RPLMNQVVM 175 (188)
Q Consensus 167 Rps~~~i~~ 175 (188)
|||+.++++
T Consensus 302 R~t~~eiL~ 310 (353)
T cd07850 302 RISVDDALQ 310 (353)
T ss_pred CcCHHHHhc
Confidence 999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=195.85 Aligned_cols=171 Identities=17% Similarity=0.186 Sum_probs=133.4
Q ss_pred cccccCCCeeeeccc---C-----CccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---Q-----KNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~-----~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+++++||||++++++ . ...++++||+. ++|.+++... . |++.||.|||+ .+++|+|
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~d 133 (337)
T cd07858 58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRD 133 (337)
T ss_pred HHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCC
Confidence 457899999999987 1 34799999997 6888888322 2 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
++|+||+++.++.++|+|||++....... .......++..|++|| ++.++|+||||+++|++++|..||..
T Consensus 134 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 134 LKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred CCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999987543211 1223345677888888 45789999999999999999988853
Q ss_pred cCC----------------C--------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 139 SFK----------------G--------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 139 ~~~----------------~--------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
... . ......+..+.+++.+||+.+|++|||++++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 212 KDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 210 0 0011234567899999999999999999999985
Q ss_pred --HhhccC
Q 039565 177 --REQGSG 182 (188)
Q Consensus 177 --l~~~~~ 182 (188)
++...+
T Consensus 292 ~~~~~~~~ 299 (337)
T cd07858 292 PYLASLHD 299 (337)
T ss_pred cchhhhcC
Confidence 655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=191.12 Aligned_cols=164 Identities=18% Similarity=0.196 Sum_probs=127.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||++++++ ....++|+||++ ++|..++ .... |++.||.|||+ .+++|+|++|
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p 130 (294)
T PLN00009 55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKP 130 (294)
T ss_pred HHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCc
Confidence 567899999999999 788999999997 5787776 2111 89999999999 9999999999
Q ss_pred CcEEEcc-CCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 69 TNILLNE-KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 69 ~nill~~-~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
+||+++. ++.+|++|||++...... ........++..|++|| ++.++|+||||+++|++++|..||....
T Consensus 131 ~nill~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 131 QNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred ceEEEECCCCEEEEcccccccccCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999985 457899999998754211 11112234566788887 3668999999999999999998884321
Q ss_pred CC------------------------------------C----cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 KG------------------------------------E----FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~~------------------------------------~----~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.. . .....+..+.+++.+|++.+|++||+++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 209 EIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred HHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0 00123456789999999999999999999986
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=188.98 Aligned_cols=164 Identities=20% Similarity=0.240 Sum_probs=130.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++||||++++++ +...++++||+++ +|.+++ ... . |++.||.|||+ .+++|+|++|.
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~ 127 (283)
T cd05118 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPE 127 (283)
T ss_pred HHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHH
Confidence 567889999999998 7888999999985 888887 321 2 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
||+++.++.++++|||.+....... .......++..|++|| .+.++|+||||+++|++++|..||.....
T Consensus 128 nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~ 205 (283)
T cd05118 128 NLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI 205 (283)
T ss_pred HEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999887543221 1122234666788888 46789999999999999999988743211
Q ss_pred ------------------C----------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ------------------G----------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ------------------~----------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. +.....+.++.+++..||+.+|.+||++++++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 206 DQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 011124568899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=192.43 Aligned_cols=166 Identities=21% Similarity=0.211 Sum_probs=127.3
Q ss_pred cccccCCCeeeeccc---C--------CccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---Q--------KNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~--------~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i 61 (188)
+++++||||++++++ . ...++++||+.+ +|.+++ ... . |++.||.|||+ .++
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i 140 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKI 140 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCe
Confidence 467899999999987 2 345999999984 788777 221 1 99999999999 999
Q ss_pred EEeCCCCCcEEEccCCceEEecccCcccccCCCCC--cceeeecccccccCCC-------CCCccchHHHHHHHHHHHhC
Q 039565 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGT--HMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~--~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g 132 (188)
+|+|++|+||+++.++.++++|||++......... .......++..|++|| ++.++|+||||+++|++++|
T Consensus 141 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~ 220 (310)
T cd07865 141 LHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220 (310)
T ss_pred eccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhC
Confidence 99999999999999999999999998754322211 1122345667799999 35689999999999999999
Q ss_pred CccccccCCC----------------------------------Cc---------CHHHHHHHHHHHHHccCcCCCCCCC
Q 039565 133 ILTVDLSFKG----------------------------------EF---------DIISVEKAVEIAMASVSSKVNRRPL 169 (188)
Q Consensus 133 ~~p~~~~~~~----------------------------------~~---------~~~~~~~~~~l~~~cl~~~p~~Rps 169 (188)
..||...... .. +......+.+++.+||+.+|.+|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t 300 (310)
T cd07865 221 SPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID 300 (310)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC
Confidence 9877432110 00 0011345678999999999999999
Q ss_pred HHHHHH
Q 039565 170 MNQVVM 175 (188)
Q Consensus 170 ~~~i~~ 175 (188)
++++++
T Consensus 301 ~~e~l~ 306 (310)
T cd07865 301 ADTALN 306 (310)
T ss_pred HHHHhc
Confidence 999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=189.44 Aligned_cols=164 Identities=17% Similarity=0.217 Sum_probs=129.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-----c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-----E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-----~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||+++++. .+..++++||+++ +|.+++ ... . |++.||.|||+ .+++|+|++
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~ 127 (284)
T cd07836 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLK 127 (284)
T ss_pred HHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCC
Confidence 567899999999998 7788999999995 888877 221 1 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+||++++++.++++|||.+....... .......++..|++|| ++.++|+||||+++|++++|..||....
T Consensus 128 p~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 128 PQNLLINKRGELKLADFGLARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred HHHEEECCCCcEEEeecchhhhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999886432111 1112234566788888 3678999999999999999998885432
Q ss_pred CCC----------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 KGE----------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~~~----------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+ .....+..+.+++..|++.+|.+||++.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 206 NEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 110 00122456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=189.99 Aligned_cols=170 Identities=24% Similarity=0.280 Sum_probs=134.4
Q ss_pred ccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 7 NKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
.++ +||||+++.+. +...++++||+++++|.+++ .+.. |++.||.|||+ .+++|+|++|.|
T Consensus 59 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~n 135 (288)
T cd05583 59 EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLEN 135 (288)
T ss_pred HhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHH
Confidence 445 59999999887 77888999999999999998 2222 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
|+++.++.++++|||++...... .........++..|++|| .+.++|+||||+++|++++|..||.....
T Consensus 136 il~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 136 ILLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred eEECCCCCEEEEECccccccccc-cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 99999999999999988754322 111222345777888888 35689999999999999999999853211
Q ss_pred --------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 142 --------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 142 --------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
...+......+.+++..||+.+|++|||+.++.+.|+-.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 215 NSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred chHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 111222346788999999999999999998887777544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=195.85 Aligned_cols=172 Identities=19% Similarity=0.237 Sum_probs=131.9
Q ss_pred cccccCCCeeeeccc--------CCccEEEEecCCCCChhhhcCCc--c---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQGKE--E---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ ....++++||+++ +|...+... . |++.||.|||+ .+++|+|+
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dl 132 (336)
T cd07849 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDL 132 (336)
T ss_pred HHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCC
Confidence 467889999999987 2347899999984 888777322 2 89999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCC-CcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+||+++.++.++++|||++........ ........++..|+||| ++.++|+||+|+++|+|++|..||..
T Consensus 133 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 133 KPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred CHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999998875432111 11122346778899998 35679999999999999999988843
Q ss_pred cCC----------------CC---------------------cC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 139 SFK----------------GE---------------------FD-----IISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 139 ~~~----------------~~---------------------~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
... .. .+ ...+..+.+++.+||+.+|++|||+.++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 213 KDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 210 00 00 0123568899999999999999999999985
Q ss_pred --Hhhcc
Q 039565 177 --REQGS 181 (188)
Q Consensus 177 --l~~~~ 181 (188)
++...
T Consensus 293 p~~~~~~ 299 (336)
T cd07849 293 PYLEQYH 299 (336)
T ss_pred ccccccC
Confidence 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=184.70 Aligned_cols=165 Identities=25% Similarity=0.296 Sum_probs=134.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++|||++++.++ .+..++++||+++++|.+++.... |++.|+.|||+ .+++|+|++|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~n 129 (254)
T cd06627 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAAN 129 (254)
T ss_pred HHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHH
Confidence 567899999999988 778899999999999999983222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++++|||.+....... .......++..|++|| .+.++|+||+|+++|++++|..||.....
T Consensus 130 i~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~ 207 (254)
T cd06627 130 ILTTKDGVVKLADFGVATKLNDVS--KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA 207 (254)
T ss_pred EEECCCCCEEEeccccceecCCCc--ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 999999999999999887543211 1123345677889998 46789999999999999999998854221
Q ss_pred ---------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ---------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ---------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+...+..+.+++.+||..+|++|||+.+++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 208 LFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122334578899999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=188.20 Aligned_cols=165 Identities=23% Similarity=0.259 Sum_probs=130.3
Q ss_pred cccccCCCeeeeccc---C--CccEEEEecCCCCChhhhcCCc--c-----------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK---Q--KNNALELGFRGNPELVDQQGKE--E-----------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~--~~~~lv~e~~~~~~L~~~~~~~--~-----------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++|||+++++++ . ...++++||+++ +|.+++.+. . |++.||+|||+ .+++|+|++
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~ 127 (287)
T cd07840 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIK 127 (287)
T ss_pred HHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCc
Confidence 567889999999999 4 689999999984 888888222 1 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|.||+++.++.++++|||.+........ .......++..|++|| ++.++|+||||+++|++++|..||....
T Consensus 128 p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 128 GSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred HHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999998875432211 1122234566789998 3678999999999999999998875322
Q ss_pred CC----------------C--------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 KG----------------E--------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~~----------------~--------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.. . ....++..+.+++.+||+.+|.+||+++++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 207 ELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 10 0 00012567889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=186.95 Aligned_cols=163 Identities=20% Similarity=0.219 Sum_probs=129.5
Q ss_pred ccccc-CCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc--c-----------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLT-GPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE--E-----------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~-Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~--~-----------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++ |||+++++++ ++..+++|||+ +++|.+++ .+. . |++.||.|||+ .+++|+|++
T Consensus 51 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~ 126 (283)
T cd07830 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLK 126 (283)
T ss_pred HHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCC
Confidence 44677 9999999999 78899999999 67998888 322 1 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|.||+++.++.++++|||.+...... .......++..|++|| .+.++|+||||++++++++|..||....
T Consensus 127 ~~ni~i~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 127 PENLLVSGPEVVKIADFGLAREIRSR---PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred hhhEEEcCCCCEEEeecccceeccCC---CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 99999999999999999988754211 1122345667788888 3678999999999999999998774321
Q ss_pred CCC------------------------------------c-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 KGE------------------------------------F-----DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~~~------------------------------------~-----~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... . .......+.+++..||+.+|++|||+++++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 204 EIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 100 0 0011367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=189.99 Aligned_cols=161 Identities=25% Similarity=0.244 Sum_probs=129.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc--CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ--GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~--~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++|||++++.++ ....++++||+. |++.+++ .... |++.|+.|||+ .+++|+|++|.
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~ 144 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAG 144 (308)
T ss_pred HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHH
Confidence 567899999999988 778899999997 5777766 2211 88999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+++.++.++++|||++..... .....++..|++|| .+.++|+||||+++|++++|..||....
T Consensus 145 nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 145 NILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred hEEECCCCcEEECCcccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 99999999999999998765321 12345667788887 3557999999999999999998874321
Q ss_pred C-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 141 K-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 141 ~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
. .......+..+.+++.+||+.+|++||+++++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 219 AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 1 11122456678999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=185.32 Aligned_cols=166 Identities=22% Similarity=0.244 Sum_probs=133.4
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||+++++. ....++++||+++++|.+++ .... |++.||.|||+ .+++|+|++|
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p 134 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKG 134 (264)
T ss_pred HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCH
Confidence 567899999999988 24578999999999999988 2221 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCC-CcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccccc--
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLS-- 139 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~-- 139 (188)
+||+++.++.++++|||++........ ........++..|++|| .+.++|+||||+++|++++|..||...
T Consensus 135 ~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 214 (264)
T cd06653 135 ANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214 (264)
T ss_pred HHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH
Confidence 999999999999999999875421111 11122345778899999 467899999999999999999998532
Q ss_pred -----------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 140 -----------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 140 -----------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.....+......+.+++.+|++ +|..||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 215 MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1233455667789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=186.15 Aligned_cols=163 Identities=21% Similarity=0.284 Sum_probs=127.9
Q ss_pred cccccCCCeeeeccc---CCc-----cEEEEecCCCCChhhhcCC--c---c---------cHHHHHHHHhcCCCCCcEE
Q 039565 6 RNKLTGPLLVELIGK---QKN-----NALELGFRGNPELVDQQGK--E---E---------VCCPGLEYLHQGLKHPIIQ 63 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~-----~~lv~e~~~~~~L~~~~~~--~---~---------~i~~~l~~Lh~~~~~~i~h 63 (188)
+.+++|||++++++. .+. .++++||+.+ +|.+++.+ . . |++.||.|||+ .+++|
T Consensus 55 l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h 130 (287)
T cd07838 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVH 130 (287)
T ss_pred hhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeee
Confidence 455679999999999 344 8999999984 88888721 1 1 99999999999 99999
Q ss_pred eCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 64 RDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 64 ~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
+|++|+||+++.++.++++|||.+....... ......++..|++|| ++.++|+||||+++|+|++|..||+
T Consensus 131 ~~l~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 131 RDLKPQNILVTSDGQVKIADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred ccCChhhEEEccCCCEEEeccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCccc
Confidence 9999999999999999999999887543211 112234567788888 5778999999999999999998875
Q ss_pred ccCCCC--------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LSFKGE--------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~~~~~--------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.....+ ........+.+++.+||+.+|.+||+++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 208 GTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 432100 01123467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=204.71 Aligned_cols=163 Identities=23% Similarity=0.277 Sum_probs=141.2
Q ss_pred cccCCCeeeeccc--------CCccEEEEecCCCCChhhhcCCc-c-------------cHHHHHHHHhcCCCCCcEEeC
Q 039565 8 KLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQGKE-E-------------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 8 ~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~-~-------------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
..+|||++.++|+ ++.+|||||||.+||..+.+++. + .++.|+.+||. ..++|||
T Consensus 72 ~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRD 148 (953)
T KOG0587|consen 72 YSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRD 148 (953)
T ss_pred ccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeec
Confidence 4579999999999 89999999999999999999222 2 88999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGIL 134 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~ 134 (188)
+|-.|||++.++.+|+.|||++.... .+.....+..||++||||| ++.++|+||+|++-.||..|.+
T Consensus 149 ikG~NiLLT~e~~VKLvDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 149 IKGQNVLLTENAEVKLVDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred ccCceEEEeccCcEEEeeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 99999999999999999999987543 3444567789999999999 6889999999999999999998
Q ss_pred ccc--------------ccCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 135 TVD--------------LSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 135 p~~--------------~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|+- +....-.+....+++-+++..|+.+|-++||++.++++
T Consensus 227 Pl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 227 PLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 762 22222346788999999999999999999999988875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=190.85 Aligned_cols=164 Identities=22% Similarity=0.232 Sum_probs=127.7
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCCc-c------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGKE-E------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~-~------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||++++++ .+..++|+||+.+ +|.+++... . |++.||.|||+ .+++|+||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~ 135 (309)
T cd07845 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLK 135 (309)
T ss_pred HHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 457899999999988 2467999999984 788887221 1 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+||+++.++.++|+|||.+........ ......++..|++|| ++.++|+||+|+++|++++|..||....
T Consensus 136 p~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 136 VSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred HHHEEECCCCCEEECccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999875432211 111223456788888 3678999999999999999998874221
Q ss_pred CCC-----------------------------------cC------HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 KGE-----------------------------------FD------IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~~~-----------------------------------~~------~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+ .. ...+..+.+++..|++.||++|||++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 214 EIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred HHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 100 00 012567789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=183.76 Aligned_cols=165 Identities=22% Similarity=0.340 Sum_probs=135.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc---c------------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE---E------------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~---~------------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++|||++++.+. ....++++||+++++|.+++ ... . +++.||.|||+ .+++|+|+
T Consensus 53 l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl 129 (258)
T cd08215 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDI 129 (258)
T ss_pred HHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccC
Confidence 467789999999988 78889999999999999998 321 1 99999999999 89999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
+|+||+++.++.++++|||.+....... .......++..|++|| .+.++|+||+|++++++++|..||+...
T Consensus 130 ~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 130 KPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred ChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999999999999999999887543221 1233346777889988 5788999999999999999999986542
Q ss_pred C------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 K------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ...+......+.+++.+||..+|++|||+.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 208 LLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 1122244568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=189.29 Aligned_cols=160 Identities=26% Similarity=0.264 Sum_probs=128.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C-Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G-KEE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~-~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++|||++++.++ ....++++||+. +++.+++ . ... |++.|+.|||+ .+++|+|++|+
T Consensus 75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~ 150 (313)
T cd06633 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAG 150 (313)
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChh
Confidence 567899999999998 778899999997 5777776 2 211 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+++.++.++++|||.+.... ......++..|++|| ++.++|+||||+++|++++|..||....
T Consensus 151 nili~~~~~~kL~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 151 NILLTEPGQVKLADFGSASKSS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred hEEECCCCCEEEeecCCCcccC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999875321 122345677788888 3556899999999999999999875421
Q ss_pred -------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 -------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 -------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
........+..+.+++.+||+.+|++||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 225 AMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred hHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11112234457899999999999999999999886
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=188.83 Aligned_cols=165 Identities=22% Similarity=0.240 Sum_probs=126.0
Q ss_pred ccccc-CCCeeeeccc---CCccEEEEecCCCCChhhhc-----CC-c--c---------cHHHHHHHHhcCCCCCcEEe
Q 039565 6 RNKLT-GPLLVELIGK---QKNNALELGFRGNPELVDQQ-----GK-E--E---------VCCPGLEYLHQGLKHPIIQR 64 (188)
Q Consensus 6 l~~l~-Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-----~~-~--~---------~i~~~l~~Lh~~~~~~i~h~ 64 (188)
+.++. ||||+++++. ....++++||+.. ++.++. .. . + +++.||+|||+. .+++||
T Consensus 56 l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~ 132 (288)
T cd06616 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHR 132 (288)
T ss_pred HHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecc
Confidence 44564 9999999998 7788999999874 554432 11 1 1 899999999971 499999
Q ss_pred CCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCcc
Q 039565 65 DMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 65 dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p 135 (188)
|++|+||+++.++.++++|||++...... .......++..|++|| ++.++|+||||+++|++++|..|
T Consensus 133 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 209 (288)
T cd06616 133 DVKPSNILLDRNGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209 (288)
T ss_pred CCCHHHEEEccCCcEEEeecchhHHhccC---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCC
Confidence 99999999999999999999988643211 1112235667788887 35689999999999999999999
Q ss_pred ccccC-----------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 136 VDLSF-----------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 136 ~~~~~-----------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
|.... ........+..+.+++..||+.+|++|||+++|++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 210 YPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred chhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 85321 001112356789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=188.84 Aligned_cols=165 Identities=22% Similarity=0.201 Sum_probs=127.1
Q ss_pred cccccCCCeeeeccc---CC----------ccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCC
Q 039565 6 RNKLTGPLLVELIGK---QK----------NNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKH 59 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~----------~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~ 59 (188)
+++++||||++++++ .. ..++++||+++ ++...+ ... . |++.||.|||+ .
T Consensus 60 ~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~ 135 (302)
T cd07864 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---K 135 (302)
T ss_pred HHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence 467899999999987 22 68999999986 676666 222 1 99999999999 9
Q ss_pred CcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhC
Q 039565 60 PIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 60 ~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g 132 (188)
+++|+|++|.||+++.++.++++|||.+........ .......++..|++|| .+.++|+||||++++++++|
T Consensus 136 ~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g 214 (302)
T cd07864 136 NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK 214 (302)
T ss_pred CeecCCCCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 999999999999999999999999998875432211 1111223456688887 36779999999999999999
Q ss_pred CccccccCCC----------------C-------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 039565 133 ILTVDLSFKG----------------E-------------------------FDIISVEKAVEIAMASVSSKVNRRPLMN 171 (188)
Q Consensus 133 ~~p~~~~~~~----------------~-------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~ 171 (188)
+.||...... . .....+..+.+++..||+.+|.+||+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 294 (302)
T cd07864 215 KPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294 (302)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 9888532100 0 0011356889999999999999999999
Q ss_pred HHHH
Q 039565 172 QVVM 175 (188)
Q Consensus 172 ~i~~ 175 (188)
++++
T Consensus 295 ~il~ 298 (302)
T cd07864 295 EALN 298 (302)
T ss_pred HHhc
Confidence 9875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=189.06 Aligned_cols=163 Identities=16% Similarity=0.137 Sum_probs=124.7
Q ss_pred ccc-cCCCeeeeccc---CCc-----cEEEEecCCCCChhhhc-CC--c-----c---------cHHHHHHHHhcCCCCC
Q 039565 7 NKL-TGPLLVELIGK---QKN-----NALELGFRGNPELVDQQ-GK--E-----E---------VCCPGLEYLHQGLKHP 60 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~~~-----~~lv~e~~~~~~L~~~~-~~--~-----~---------~i~~~l~~Lh~~~~~~ 60 (188)
.++ +||||++++++ .+. .++++||+++ +|.+++ .. . . |++.||.|||+ .+
T Consensus 55 ~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ 130 (295)
T cd07837 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HG 130 (295)
T ss_pred HHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CC
Confidence 445 46999999988 333 7999999995 788877 21 1 1 99999999999 99
Q ss_pred cEEeCCCCCcEEEcc-CCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhC
Q 039565 61 IIQRDMKSTNILLNE-KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 61 i~h~dl~~~nill~~-~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g 132 (188)
++|+|++|+||+++. ++.++++|||.+........ ......+++.|++|| ++.++|+||||+++|++++|
T Consensus 131 i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 208 (295)
T cd07837 131 VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208 (295)
T ss_pred eeecCCChHHEEEecCCCeEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcC
Confidence 999999999999998 88999999998875422111 112224566788888 36789999999999999999
Q ss_pred CccccccCCC----------------C-----------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 039565 133 ILTVDLSFKG----------------E-----------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQV 173 (188)
Q Consensus 133 ~~p~~~~~~~----------------~-----------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i 173 (188)
..||...... . .....+.++.+++..||+.+|.+||+++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei 288 (295)
T cd07837 209 QPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA 288 (295)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH
Confidence 9887432100 0 001235678899999999999999999998
Q ss_pred HH
Q 039565 174 VM 175 (188)
Q Consensus 174 ~~ 175 (188)
+.
T Consensus 289 l~ 290 (295)
T cd07837 289 LT 290 (295)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=187.20 Aligned_cols=166 Identities=22% Similarity=0.270 Sum_probs=130.6
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.++ +||||+++++. +...++++||+++++|.+++ .... |++.||.|||+ .+++|+|++|+
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~ 134 (290)
T cd05613 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLE 134 (290)
T ss_pred HHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHH
Confidence 3445 59999999877 66778999999999999998 2222 89999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
||+++.++.++++|||++..... ..........|+..|++|| .+.++|+||||+++|++++|..||+....
T Consensus 135 nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 213 (290)
T cd05613 135 NILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213 (290)
T ss_pred HeEECCCCCEEEeeCccceeccc-ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc
Confidence 99999999999999998875421 1111222355777899998 24679999999999999999999853211
Q ss_pred ---------------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 142 ---------------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 142 ---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
...+......+.+++..||+.+|++|| ++++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 214 KNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 112223456788999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=187.20 Aligned_cols=167 Identities=24% Similarity=0.316 Sum_probs=134.6
Q ss_pred ccccc-CCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLT-GPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~-Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++ ||||++++++ .+..+++||++.+++|.+++.+. . |++.||.|||+ .+++|+|++|+
T Consensus 55 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ 131 (280)
T cd05581 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPE 131 (280)
T ss_pred HHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHH
Confidence 34666 9999999988 77899999999999999999333 2 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCC------------------CcceeeecccccccCCC------CCCccchHHHHHH
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGG------------------THMSTTIAGTAGFLNTE------LTEKSDVDSFEIV 125 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~ 125 (188)
||+++.++.++++|||.+........ ........++..|++|| .+.++|+||||++
T Consensus 132 ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~ 211 (280)
T cd05581 132 NILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCI 211 (280)
T ss_pred HeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHH
Confidence 99999999999999998875432111 01222345677888888 5778999999999
Q ss_pred HHHHHhCCccccccCC-----------CCcCHHHHHHHHHHHHHccCcCCCCCCCH----HHHHH
Q 039565 126 ILEIITGILTVDLSFK-----------GEFDIISVEKAVEIAMASVSSKVNRRPLM----NQVVM 175 (188)
Q Consensus 126 l~~~~~g~~p~~~~~~-----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~----~~i~~ 175 (188)
++++++|..||..... ...+...+..+.+++..||+.+|.+||++ +++++
T Consensus 212 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 212 IYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHhCCCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 9999999999864321 12333446788999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-29 Score=207.84 Aligned_cols=175 Identities=19% Similarity=0.240 Sum_probs=143.2
Q ss_pred CcccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCCc--c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 5 NRNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGKE--E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~~--~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
.|.+++|||+++++++ .....||++|++.|+|.++++.+ . |||+||.|||+ .+++||||..+
T Consensus 751 ~masldHpnl~RLLgvc~~s~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaR 827 (1177)
T KOG1025|consen 751 RMASLDHPNLLRLLGVCMLSTLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAAR 827 (1177)
T ss_pred HHhcCCCchHHHHhhhcccchHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhh
Confidence 3788999999999999 67799999999999999999322 2 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
|+|+.....+|+.|||+++...............-..-|++-| ++.++|||||||++||++| |..|++....
T Consensus 828 NVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~ 907 (1177)
T KOG1025|consen 828 NVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE 907 (1177)
T ss_pred heeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence 9999999999999999999765333332222223334566655 7999999999999999997 6677754322
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
-..+..+...+..++..||..|+..||+++++...+.....
T Consensus 908 eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 908 EIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 23455677789999999999999999999999998876554
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=190.13 Aligned_cols=166 Identities=18% Similarity=0.171 Sum_probs=129.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..++++||++ ++|.+++.. .. |++.||.|||+ .+++|+|++|+|
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~n 149 (335)
T PTZ00024 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPAN 149 (335)
T ss_pred HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHH
Confidence 567899999999998 788899999998 689988822 21 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCC------------CCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHh
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEG------------GTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~------------~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~ 131 (188)
|+++.++.++++|||.+....... .........++..|++|| ++.++|+||||+++|++++
T Consensus 150 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t 229 (335)
T PTZ00024 150 IFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229 (335)
T ss_pred eEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999999886532100 001111234566789998 3678999999999999999
Q ss_pred CCccccccCCCC----------------c-----------------------CHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 039565 132 GILTVDLSFKGE----------------F-----------------------DIISVEKAVEIAMASVSSKVNRRPLMNQ 172 (188)
Q Consensus 132 g~~p~~~~~~~~----------------~-----------------------~~~~~~~~~~l~~~cl~~~p~~Rps~~~ 172 (188)
|..||......+ + ....+..+.+++..|++.+|++|||+++
T Consensus 230 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 309 (335)
T PTZ00024 230 GKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309 (335)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence 998874321000 0 0112467889999999999999999999
Q ss_pred HHH
Q 039565 173 VVM 175 (188)
Q Consensus 173 i~~ 175 (188)
++.
T Consensus 310 ~l~ 312 (335)
T PTZ00024 310 ALK 312 (335)
T ss_pred Hhc
Confidence 986
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=181.66 Aligned_cols=162 Identities=27% Similarity=0.345 Sum_probs=132.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE---E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++++. +...+++|||+++++|.+++.+. . |++.|+.|||+ .+++|+|++|.|
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~n 123 (250)
T cd05123 47 LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPEN 123 (250)
T ss_pred HHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcce
Confidence 567889999999888 77889999999999999999322 2 89999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++++|||.+....... .......++..|++|| .+.++|+||||+++|++++|..||+....
T Consensus 124 i~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~ 201 (250)
T cd05123 124 ILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI 201 (250)
T ss_pred EEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999999999999999887542111 1233445677788888 46789999999999999999999854331
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQ 172 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~ 172 (188)
...+...+..+.+++..||..+|++||++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 202 YEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1233344678899999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=195.93 Aligned_cols=169 Identities=22% Similarity=0.242 Sum_probs=131.5
Q ss_pred cccccCCCeeeeccc---------CCccEEEEecCCCCChhhhcCCcc---------------cHHHHHHHHhcCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---------QKNNALELGFRGNPELVDQQGKEE---------------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~~~~~---------------~i~~~l~~Lh~~~~~~i 61 (188)
|++++|||||+++++ ...-.++||||.+|+|...+++.. +++.||.|||+ .+|
T Consensus 65 lkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~I 141 (732)
T KOG4250|consen 65 LKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGI 141 (732)
T ss_pred HHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCc
Confidence 678999999999999 234579999999999999994433 89999999999 999
Q ss_pred EEeCCCCCcEEEcc--CC--ceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHH
Q 039565 62 IQRDMKSTNILLNE--KV--QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEII 130 (188)
Q Consensus 62 ~h~dl~~~nill~~--~~--~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~ 130 (188)
+||||||.||++-. +| ..||+|||.++-.. .........||+.|.+|+ ++..+|.|||||++|+..
T Consensus 142 vHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~ca 218 (732)
T KOG4250|consen 142 VHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECA 218 (732)
T ss_pred eeccCCCCcEEEeecCCCceEEeeecccccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHh
Confidence 99999999999843 34 46999999998643 223567789999999998 688899999999999999
Q ss_pred hCCccccccCCCC----------------------------------------cCHHHHHHHHHHHHHccCcCCCCCC--
Q 039565 131 TGILTVDLSFKGE----------------------------------------FDIISVEKAVEIAMASVSSKVNRRP-- 168 (188)
Q Consensus 131 ~g~~p~~~~~~~~----------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rp-- 168 (188)
||..||-+....- ........+...+...+.-+|.+|-
T Consensus 219 TG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~ 298 (732)
T KOG4250|consen 219 TGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHE 298 (732)
T ss_pred ccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCC
Confidence 9999884322110 1122333566777777888888887
Q ss_pred CHHHHHHHHhhc
Q 039565 169 LMNQVVMVREQG 180 (188)
Q Consensus 169 s~~~i~~~l~~~ 180 (188)
.+.+....+..+
T Consensus 299 ~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 299 GFDRFFAEVDDI 310 (732)
T ss_pred CcchHHHHHHHH
Confidence 565555555443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=188.41 Aligned_cols=162 Identities=19% Similarity=0.221 Sum_probs=128.1
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||+++.++ ....++++||+. ++|..++.... |++.||.|||+ .+++|+|++|.|
T Consensus 63 l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~N 138 (328)
T cd07856 63 LKHLRHENIISLSDIFISPLEDIYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSN 138 (328)
T ss_pred HHhcCCCCeeeEeeeEecCCCcEEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHH
Confidence 457899999999987 456889999985 58988883222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
|+++.++.++++|||.+..... ......++..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 139 ili~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~ 213 (328)
T cd07856 139 ILINENCDLKICDFGLARIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213 (328)
T ss_pred EeECCCCCEEeCccccccccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999998764321 112234566788887 46789999999999999999988853211
Q ss_pred -----------------------------------CCcC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 -----------------------------------GEFD-----IISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 -----------------------------------~~~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
...+ ......+.+++..|++.+|++|||+++++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0124678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=184.91 Aligned_cols=166 Identities=20% Similarity=0.219 Sum_probs=126.2
Q ss_pred cccccCCCeeeeccc---C--------CccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---Q--------KNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~--------~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i 61 (188)
+++++||||++++++ . ...++++||+.+ +|...+ .... |++.||.|||+ .++
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i 136 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHI 136 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 567899999999887 2 236899999985 677666 2221 99999999999 999
Q ss_pred EEeCCCCCcEEEccCCceEEecccCcccccCCCCCc---------ceeeecccccccCCC-------CCCccchHHHHHH
Q 039565 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH---------MSTTIAGTAGFLNTE-------LTEKSDVDSFEIV 125 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~---------~~~~~~~~~~~~~pe-------~~~~~di~s~G~~ 125 (188)
+|+|++|+||+++.++.++++|||++.......... ......++..|++|| ++.++|+||||++
T Consensus 137 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~i 216 (311)
T cd07866 137 LHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCV 216 (311)
T ss_pred ecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHH
Confidence 999999999999999999999999887543211110 112234567799998 3678999999999
Q ss_pred HHHHHhCCccccccCCCC----------------------------------cC-------HHHHHHHHHHHHHccCcCC
Q 039565 126 ILEIITGILTVDLSFKGE----------------------------------FD-------IISVEKAVEIAMASVSSKV 164 (188)
Q Consensus 126 l~~~~~g~~p~~~~~~~~----------------------------------~~-------~~~~~~~~~l~~~cl~~~p 164 (188)
+|++++|..||....... .+ ......+.+++.+|++.+|
T Consensus 217 l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 296 (311)
T cd07866 217 FAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296 (311)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCc
Confidence 999999998875321100 00 0122567899999999999
Q ss_pred CCCCCHHHHHH
Q 039565 165 NRRPLMNQVVM 175 (188)
Q Consensus 165 ~~Rps~~~i~~ 175 (188)
.+|||+.+++.
T Consensus 297 ~~R~t~~ell~ 307 (311)
T cd07866 297 YKRLTASDALE 307 (311)
T ss_pred ccCcCHHHHhc
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=182.18 Aligned_cols=160 Identities=24% Similarity=0.319 Sum_probs=124.5
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhc----CCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQ----GKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~----~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
+.|.||+.+|+ +...++.||.|.. =+...+ +.-+ .+..||.||-+ +++|+|||+||+|||+
T Consensus 149 dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILl 225 (391)
T KOG0983|consen 149 DCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILL 225 (391)
T ss_pred CCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEE
Confidence 36999999998 6777788887642 222222 1111 67899999998 4899999999999999
Q ss_pred ccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccC----
Q 039565 74 NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSF---- 140 (188)
Q Consensus 74 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~---- 140 (188)
+..|.+|++|||++..+. .........|++.||+|| ++.++|+||||+.++|+.||+.||..-.
T Consensus 226 De~GniKlCDFGIsGrlv---dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe 302 (391)
T KOG0983|consen 226 DERGNIKLCDFGISGRLV---DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE 302 (391)
T ss_pred ccCCCEEeecccccceee---cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH
Confidence 999999999999987653 222344567899999999 6788999999999999999999985311
Q ss_pred ---------CCCcC--HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 ---------KGEFD--IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ---------~~~~~--~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+...+ ...+..+.+++..||++|+.+||...++++
T Consensus 303 ~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 303 VLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11111 125778999999999999999999998876
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=187.90 Aligned_cols=165 Identities=18% Similarity=0.159 Sum_probs=127.0
Q ss_pred ccc-cCCCeeeeccc-------CCccEEEEecCCCCChhhhcC-Ccc-----------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 7 NKL-TGPLLVELIGK-------QKNNALELGFRGNPELVDQQG-KEE-----------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~~-~~~-----------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
.++ +||||+++++. ....+++++|+. ++|.+++. ... |++.||.|||+ .+++|+|+
T Consensus 56 ~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dl 131 (332)
T cd07857 56 RHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDL 131 (332)
T ss_pred HHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 345 59999999886 245678888887 58988882 222 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCC--cceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGT--HMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~--~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
||+||+++.++.++|+|||.+......... .......|+..|++|| .+.++|+||+|+++|++++|..||.
T Consensus 132 kp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 132 KPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred CHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 999999999999999999998754321111 1122346788899999 3567999999999999999998885
Q ss_pred ccCCC-------------------------------------CcC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LSFKG-------------------------------------EFD-----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~~~~-------------------------------------~~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..... ... ......+.+++..|++.+|++|||++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 212 GKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 42100 000 012357889999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=188.23 Aligned_cols=173 Identities=18% Similarity=0.176 Sum_probs=134.1
Q ss_pred cccccCCCeeeeccc---C-----CccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---Q-----KNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~-----~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+.+++||||+++.++ . ...++++||+. ++|..++.+. . |++.||+|||+ .+++|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~d 128 (330)
T cd07834 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRD 128 (330)
T ss_pred HHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 567889999999998 3 26899999998 5888888332 2 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCC-CcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
+||.||+++.++.++++|||.+........ ........++..|++|| .+.++|+||||+++|++++|..||.
T Consensus 129 lkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 129 LKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred CCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 999999999999999999999875432211 01123345677889998 4668999999999999999998885
Q ss_pred ccCCCC------------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LSFKGE------------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~~~~~------------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.....+ .....+..+.+++..||+.+|.+|||++++++
T Consensus 209 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 209 GRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred CCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 322100 00112456789999999999999999999998
Q ss_pred H--HhhccC
Q 039565 176 V--REQGSG 182 (188)
Q Consensus 176 ~--l~~~~~ 182 (188)
. +++..+
T Consensus 289 ~~~~~~~~~ 297 (330)
T cd07834 289 HPYLAQLHD 297 (330)
T ss_pred CccHHhhcc
Confidence 3 555444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=184.55 Aligned_cols=161 Identities=22% Similarity=0.276 Sum_probs=125.0
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhc-C-C--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G-K--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~-~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
.||||+++++. ....++++||+. +++..++ . . .. |++.|+.|||+. .+++|+|++|+||++
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill 148 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILL 148 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEE
Confidence 59999999998 778999999986 4676666 2 1 11 999999999961 589999999999999
Q ss_pred ccCCceEEecccCcccccCCCCCcceeeecccccccCCC----------CCCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 74 NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE----------LTEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 74 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe----------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
+.++.++|+|||.+....... ......++..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 149 ~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 225 (296)
T cd06618 149 DASGNVKLCDFGISGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF 225 (296)
T ss_pred cCCCCEEECccccchhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH
Confidence 999999999999886542111 112234566788887 35679999999999999999999854111
Q ss_pred -----------CCcC--HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 -----------GEFD--IISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 -----------~~~~--~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
...+ ...+..+.+++.+||+.+|.+||+++++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 226 EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111 1245678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=187.66 Aligned_cols=168 Identities=20% Similarity=0.237 Sum_probs=129.7
Q ss_pred cccccCCCeeeeccc---C------CccEEEEecCCCCChhhhcC-Ccc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---Q------KNNALELGFRGNPELVDQQG-KEE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~------~~~~lv~e~~~~~~L~~~~~-~~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ . ...++++||+.. +|..+.. ... |++.||+|||+ .+++|||+
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl 143 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDL 143 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCC
Confidence 457889999999987 1 345899999974 7777663 222 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcccccc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLS 139 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~ 139 (188)
+|+||+++.++.++++|||+++.... ......++..|++|| ++.++|+||||+++|++++|+.||...
T Consensus 144 kp~NIll~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 144 KPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred CHHHEEECCCCCEEEeeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999998874321 112335567788888 356799999999999999999988642
Q ss_pred CCC----------------------------------CcC--------HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH-
Q 039565 140 FKG----------------------------------EFD--------IISVEKAVEIAMASVSSKVNRRPLMNQVVMV- 176 (188)
Q Consensus 140 ~~~----------------------------------~~~--------~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~- 176 (188)
... ..+ ......+.+++.+||+.+|++||++++++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~ 298 (342)
T cd07879 219 DYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHP 298 (342)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 200 000 0123467899999999999999999999953
Q ss_pred -HhhccC
Q 039565 177 -REQGSG 182 (188)
Q Consensus 177 -l~~~~~ 182 (188)
+++..+
T Consensus 299 ~f~~~~~ 305 (342)
T cd07879 299 YFDSFRD 305 (342)
T ss_pred chhhccc
Confidence 655543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=189.62 Aligned_cols=161 Identities=22% Similarity=0.259 Sum_probs=127.9
Q ss_pred cccccCCCeeeeccc---CC------ccEEEEecCCCCChhhhcCCc--c---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---QK------NNALELGFRGNPELVDQQGKE--E---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~------~~~lv~e~~~~~~L~~~~~~~--~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+++++|||++++.++ .+ ..++++||+. ++|.+++... . |++.||.|||+ .+++|+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~d 143 (343)
T cd07851 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRD 143 (343)
T ss_pred HHhccCCCHHHHHHHhhccccccccccEEEEEecCC-CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCC
Confidence 467899999999887 33 3799999995 6999988332 2 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
++|+||+++.++.++++|||++...... .....++..|++|| .+.++|+||||+++|++++|..||..
T Consensus 144 lkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 144 LKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred CCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998754211 22335667788888 35789999999999999999998853
Q ss_pred cCCCC---------------------------------------c---CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKGE---------------------------------------F---DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~~---------------------------------------~---~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..... + ....+..+.+++..|++.+|++|||+.+|++
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 21100 0 0012567889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=179.82 Aligned_cols=127 Identities=22% Similarity=0.266 Sum_probs=107.3
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhc--CCcc---------------cHHHHHHHHhcCCCCCcEEe
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQ--GKEE---------------VCCPGLEYLHQGLKHPIIQR 64 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~--~~~~---------------~i~~~l~~Lh~~~~~~i~h~ 64 (188)
++.++||||+.+..+ +...|+++||++. +|..++ ++.. |++.|+.|||+ .=|+||
T Consensus 81 ~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHR 156 (438)
T KOG0666|consen 81 LRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHR 156 (438)
T ss_pred HHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeec
Confidence 457899999999888 7889999999996 888888 2222 99999999999 899999
Q ss_pred CCCCCcEEEccC----CceEEecccCcccccCCCCCc-ceeeecccccccCCC-------CCCccchHHHHHHHHHHHhC
Q 039565 65 DMKSTNILLNEK----VQAKLADFGQSRISPVEGGTH-MSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 65 dl~~~nill~~~----~~~kl~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g 132 (188)
||||.||++..+ |++||+|+|+++.+..+-... .......|.+|.||| ++++.|+|+.||++.|+++-
T Consensus 157 DLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl 236 (438)
T KOG0666|consen 157 DLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTL 236 (438)
T ss_pred cCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHcc
Confidence 999999999876 899999999999875332222 334567788999999 79999999999999999998
Q ss_pred Cccc
Q 039565 133 ILTV 136 (188)
Q Consensus 133 ~~p~ 136 (188)
.+.|
T Consensus 237 ~PlF 240 (438)
T KOG0666|consen 237 EPLF 240 (438)
T ss_pred Cccc
Confidence 7644
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=181.84 Aligned_cols=164 Identities=23% Similarity=0.234 Sum_probs=129.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++|||++++.++ ....++++||++ ++|.+++.+. . |++.||.|||+ .+++|+|++|+
T Consensus 52 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ 127 (282)
T cd07829 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQ 127 (282)
T ss_pred HHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChh
Confidence 456789999999998 778999999998 5899999332 2 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.++++|||.+........ ......++..|++|| .+.++|+||||+++|++++|..||......
T Consensus 128 ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 205 (282)
T cd07829 128 NILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205 (282)
T ss_pred eEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence 99999999999999998875432111 112233455688887 467899999999999999999887432100
Q ss_pred -----------------------------C-----------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 -----------------------------E-----------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 -----------------------------~-----------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ........+.+++..||+.+|++||++++++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 206 DQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 00012457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=193.27 Aligned_cols=114 Identities=22% Similarity=0.292 Sum_probs=98.8
Q ss_pred CCeeeeccc---CCccEEEEecCCCCChhhhcCCcc--------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 12 PLLVELIGK---QKNNALELGFRGNPELVDQQGKEE--------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 12 pniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~--------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
-|+|+++++ .+++|||+|.++ .+|.+++++.. |++.||.+||+ .+||||||||+|||+.
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~ 323 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLK 323 (586)
T ss_pred eeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeec
Confidence 479999999 999999999998 49999994333 99999999999 9999999999999997
Q ss_pred cCC--ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCc
Q 039565 75 EKV--QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGIL 134 (188)
Q Consensus 75 ~~~--~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~ 134 (188)
..+ .+||+|||.++... ....+..-+.+|.||| ++.+.|+|||||++.||.+|.+
T Consensus 324 ~~~r~~vKVIDFGSSc~~~-----q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~P 386 (586)
T KOG0667|consen 324 DPKRSRIKVIDFGSSCFES-----QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEP 386 (586)
T ss_pred cCCcCceeEEecccccccC-----CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcc
Confidence 654 68999999987532 1233667778899999 7999999999999999999986
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=183.55 Aligned_cols=158 Identities=22% Similarity=0.281 Sum_probs=133.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|...+||.+..+.-. ++.+|+||||+-||.|.-++.+.. ++..||.|||+ .+|++||+|.+|
T Consensus 222 L~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLEN 298 (516)
T KOG0690|consen 222 LQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLEN 298 (516)
T ss_pred HHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhh
Confidence 456789998877444 899999999999999998884433 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
.+++.+|++|++|||+++--.. ......+++||+.|+||| +..++|.|.+|+++|||++|++||-....
T Consensus 299 LlLDkDGHIKitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL 376 (516)
T KOG0690|consen 299 LLLDKDGHIKITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL 376 (516)
T ss_pred heeccCCceEeeecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH
Confidence 9999999999999999985321 223466799999999999 78999999999999999999999954322
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCC
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRP 168 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rp 168 (188)
..++...+.+...++...+.++|.+|.
T Consensus 377 FeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 377 FELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 125566677888999999999999997
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=186.80 Aligned_cols=157 Identities=23% Similarity=0.300 Sum_probs=133.1
Q ss_pred cccccCCCeeee-ccc--CCccEEEEecCCCCChhhhc-CCc--c-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVEL-IGK--QKNNALELGFRGNPELVDQQ-GKE--E-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~-~~~--~~~~~lv~e~~~~~~L~~~~-~~~--~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
|++++.|.||.+ |.+ .+.+++|+..|-||+|..++ +.. + +++-||++||. .+|++||+||
T Consensus 239 L~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKP 315 (591)
T KOG0986|consen 239 LEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKP 315 (591)
T ss_pred HHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCCh
Confidence 567788999988 555 89999999999999999999 322 2 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC--
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF-- 140 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~-- 140 (188)
+|||+|+.|+++|+|+|++.-+. .........||.+||||| |+...|.||+||++|+|+.|..||....
T Consensus 316 eNILLDd~GhvRISDLGLAvei~---~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 316 ENILLDDHGHVRISDLGLAVEIP---EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred hheeeccCCCeEeeccceEEecC---CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 99999999999999999998653 222233458999999999 7889999999999999999999995432
Q ss_pred -------------CCCcCHHHHHHHHHHHHHccCcCCCCCC
Q 039565 141 -------------KGEFDIISVEKAVEIAMASVSSKVNRRP 168 (188)
Q Consensus 141 -------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rp 168 (188)
..+++...++.+.++..+.|..||++|.
T Consensus 393 vk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 393 VKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred hhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhc
Confidence 2345566677888999999999999986
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=185.81 Aligned_cols=161 Identities=20% Similarity=0.233 Sum_probs=125.3
Q ss_pred cccccCCCeeeeccc---------CCccEEEEecCCCCChhhhcCC--cc---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---------QKNNALELGFRGNPELVDQQGK--EE---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~~~--~~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+.+++||||++++++ ....+++++++ +++|.+++.. .. |++.||.|||+ .+++|+|
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~d 145 (345)
T cd07877 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRD 145 (345)
T ss_pred HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecC
Confidence 567899999999887 13467777776 5799887732 22 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
++|+||+++.++.++++|||++..... ......++..|++|| ++.++|+||||+++|++++|..||..
T Consensus 146 lkp~NIll~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 146 LKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred CChHHEEEcCCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998864321 122345677788888 36789999999999999999988843
Q ss_pred cCCCC-------------------cC-----------------------HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKGE-------------------FD-----------------------IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~~-------------------~~-----------------------~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..... .+ ......+.+++..|++.+|.+||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 21100 00 012346789999999999999999999886
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-28 Score=191.69 Aligned_cols=158 Identities=23% Similarity=0.239 Sum_probs=136.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|.+.+.|.||++|.- ....|++||-|-||.|...+ ++.. -+.+|++|||+ ++||+|||||+|
T Consensus 474 m~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPEN 550 (732)
T KOG0614|consen 474 MMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPEN 550 (732)
T ss_pred HHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhh
Confidence 456788999999988 77889999999999999999 3333 67899999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
++++.+|-+||.|||+++... ....+.+++||+.|.||| .+.++|.||+|+++||+++|.+||....+
T Consensus 551 llLd~~Gy~KLVDFGFAKki~---~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt 627 (732)
T KOG0614|consen 551 LLLDNRGYLKLVDFGFAKKIG---SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT 627 (732)
T ss_pred eeeccCCceEEeehhhHHHhc---cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence 999999999999999998643 445678899999999999 47889999999999999999999975433
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCC
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPL 169 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps 169 (188)
.+++........+++......+|..|.-
T Consensus 628 Yn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 628 YNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 2356666777888888888889999874
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=187.39 Aligned_cols=166 Identities=16% Similarity=0.183 Sum_probs=125.4
Q ss_pred cccccCCCeeeeccc--C---------------CccEEEEecCCCCChhhhcCCc--c---------cHHHHHHHHhcCC
Q 039565 6 RNKLTGPLLVELIGK--Q---------------KNNALELGFRGNPELVDQQGKE--E---------VCCPGLEYLHQGL 57 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~---------------~~~~lv~e~~~~~~L~~~~~~~--~---------~i~~~l~~Lh~~~ 57 (188)
+.+++||||+++++. . ...++++||++ ++|.+++... . |++.||.|||+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-- 132 (342)
T cd07854 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS-- 132 (342)
T ss_pred HHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--
Confidence 567899999999877 1 24689999998 5898887322 2 99999999999
Q ss_pred CCCcEEeCCCCCcEEEcc-CCceEEecccCcccccCCCCC-cceeeecccccccCCC-------CCCccchHHHHHHHHH
Q 039565 58 KHPIIQRDMKSTNILLNE-KVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILE 128 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~-~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~ 128 (188)
.+++|+|+||+||+++. ++.++++|||.+......... .......++..|+||| ++.++|+|||||++|+
T Consensus 133 -~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~e 211 (342)
T cd07854 133 -ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 211 (342)
T ss_pred -CCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHH
Confidence 99999999999999975 567899999988653211111 1111234566788888 3568999999999999
Q ss_pred HHhCCccccccCC------------------------------------CCc-----CHHHHHHHHHHHHHccCcCCCCC
Q 039565 129 IITGILTVDLSFK------------------------------------GEF-----DIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 129 ~~~g~~p~~~~~~------------------------------------~~~-----~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
+++|..||..... ... ....+..+.+++.+|++.+|++|
T Consensus 212 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 291 (342)
T cd07854 212 MLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDR 291 (342)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhc
Confidence 9999998853210 000 00123567799999999999999
Q ss_pred CCHHHHHH
Q 039565 168 PLMNQVVM 175 (188)
Q Consensus 168 ps~~~i~~ 175 (188)
||+++++.
T Consensus 292 ~t~~ell~ 299 (342)
T cd07854 292 LTAEEALM 299 (342)
T ss_pred cCHHHHhC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=185.65 Aligned_cols=161 Identities=20% Similarity=0.222 Sum_probs=126.4
Q ss_pred cccccCCCeeeeccc---C------CccEEEEecCCCCChhhhcCC--cc---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---Q------KNNALELGFRGNPELVDQQGK--EE---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~------~~~~lv~e~~~~~~L~~~~~~--~~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+++++||||++++++ . ...++++||+ +++|..++.. .. |++.||+|||+ .+++|+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~d 143 (343)
T cd07880 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRD 143 (343)
T ss_pred HHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 567899999999987 2 2358999999 5689888732 22 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
++|+||+++.++.++++|||++..... ......++..|++|| .+.++|+||||+++|++++|..||..
T Consensus 144 lkp~Nill~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 144 LKPGNLAVNEDCELKILDFGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred CCHHHEEEcCCCCEEEeeccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998875321 112234566788888 45689999999999999999998863
Q ss_pred cCCCC------------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKGE------------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~~------------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..... ........+.+++.+|++.+|.+|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 219 HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 21100 00012335789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=182.44 Aligned_cols=152 Identities=23% Similarity=0.331 Sum_probs=129.4
Q ss_pred CCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccC
Q 039565 12 PLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEK 76 (188)
Q Consensus 12 pniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~ 76 (188)
|.++++..+ -+.+++||||+.+|+|-..+++.+ ++|.||-|||+ .+|++||||..|++++..
T Consensus 410 pFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~e 486 (683)
T KOG0696|consen 410 PFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSE 486 (683)
T ss_pred chHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccC
Confidence 444555444 678999999999999988885544 99999999999 999999999999999999
Q ss_pred CceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC-------
Q 039565 77 VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE------- 143 (188)
Q Consensus 77 ~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~------- 143 (188)
|++||+|||.++.-. .......+++||+.|+||| ++.++|.||||+++|||+.|+.||+.....+
T Consensus 487 GHiKi~DFGmcKEni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e 564 (683)
T KOG0696|consen 487 GHIKIADFGMCKENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME 564 (683)
T ss_pred CceEeeecccccccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 999999999987432 2233466799999999999 6899999999999999999999998765433
Q ss_pred ----cCHHHHHHHHHHHHHccCcCCCCCC
Q 039565 144 ----FDIISVEKAVEIAMASVSSKVNRRP 168 (188)
Q Consensus 144 ----~~~~~~~~~~~l~~~cl~~~p~~Rp 168 (188)
++...+.+..++....+.+.|.+|.
T Consensus 565 hnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 HNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 5667788889999999999999996
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-28 Score=181.56 Aligned_cols=164 Identities=23% Similarity=0.260 Sum_probs=129.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC------Ccc-----------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG------KEE-----------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~------~~~-----------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
|+.-+-||||+++|. ..-.|+-||.|+ .||..+.. +.. -...||.||-+ +..|||||
T Consensus 117 mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRD 193 (361)
T KOG1006|consen 117 MKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRD 193 (361)
T ss_pred HhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--Hhhhhhcc
Confidence 455678999999999 788999999998 47766541 111 45689999987 48999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
+||+|||++..|.+||+|||++.... .+ -..+.-.|+..||||| ++.++|+||+|+++||+.||..|+.
T Consensus 194 vKPSNILldr~G~vKLCDFGIcGqLv--~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr 270 (361)
T KOG1006|consen 194 VKPSNILLDRHGDVKLCDFGICGQLV--DS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR 270 (361)
T ss_pred CChhheEEecCCCEeeecccchHhHH--HH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence 99999999999999999999986432 11 1122346888899999 6788999999999999999999873
Q ss_pred c-----------------cCCCC-cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 L-----------------SFKGE-FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~-----------------~~~~~-~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. .+..+ ........+..++..|+.+|...||..+++.+
T Consensus 271 ~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 271 KWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred hHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 2 11111 11346778999999999999999999998875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=177.34 Aligned_cols=163 Identities=20% Similarity=0.222 Sum_probs=131.4
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
.|+||++++++ +...|||||-+.||+|...+.+.. +++.||.|||. ++|.|||+||+|||-.
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCE 210 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeec
Confidence 49999999999 888999999999999999982222 99999999999 9999999999999997
Q ss_pred cCC---ceEEecccCcccccC-----CCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCcc
Q 039565 75 EKV---QAKLADFGQSRISPV-----EGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 75 ~~~---~~kl~d~~~~~~~~~-----~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~p 135 (188)
+.. -+||+||.+...+.. +.......+..|+..||||| |+.++|.||+|+++|-|++|..|
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 764 479999987653221 22233345678999999999 68999999999999999999999
Q ss_pred ccccCC--------------------------CCcCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 136 VDLSFK--------------------------GEFDI----ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 136 ~~~~~~--------------------------~~~~~----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|...-. -+++. ..+....+++...+..++.+|.++.+++.
T Consensus 291 FvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 291 FVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 843211 11232 34556778889999999999999988876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=180.68 Aligned_cols=176 Identities=19% Similarity=0.185 Sum_probs=140.2
Q ss_pred cccCCCeeeeccc-------CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcC-----CCCCcEEe
Q 039565 8 KLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQG-----LKHPIIQR 64 (188)
Q Consensus 8 ~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~-----~~~~i~h~ 64 (188)
.|+|+||+.+++. -.++|||++|=+.|||.+|+.+.. .+|.||++||.. .+..|.||
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHR 340 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHR 340 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcc
Confidence 3899999999998 356899999999999999995544 889999999942 25689999
Q ss_pred CCCCCcEEEccCCceEEecccCcccccCCCC--CcceeeecccccccCCCC------------CCccchHHHHHHHHHHH
Q 039565 65 DMKSTNILLNEKVQAKLADFGQSRISPVEGG--THMSTTIAGTAGFLNTEL------------TEKSDVDSFEIVILEII 130 (188)
Q Consensus 65 dl~~~nill~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~~~~~~pe~------------~~~~di~s~G~~l~~~~ 130 (188)
|||+.|||+.+++.+-|+|+|++........ ....+...||.+|||||. =..+||||||.++||+.
T Consensus 341 DlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia 420 (513)
T KOG2052|consen 341 DLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA 420 (513)
T ss_pred ccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence 9999999999999999999999986542211 122346799999999992 25699999999999987
Q ss_pred hCC----------ccccccCC------------------CC-----cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 039565 131 TGI----------LTVDLSFK------------------GE-----FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVR 177 (188)
Q Consensus 131 ~g~----------~p~~~~~~------------------~~-----~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l 177 (188)
..- .||.+-.+ +. .+...+..+.+++..||..+|.-|-|+-.|.+.|
T Consensus 421 rRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 421 RRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred HHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 422 35422111 11 2335677899999999999999999999999999
Q ss_pred hhccCc
Q 039565 178 EQGSGS 183 (188)
Q Consensus 178 ~~~~~~ 183 (188)
.++...
T Consensus 501 ~~l~~~ 506 (513)
T KOG2052|consen 501 AKLSNS 506 (513)
T ss_pred HHHhcC
Confidence 887754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=172.68 Aligned_cols=164 Identities=27% Similarity=0.364 Sum_probs=133.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++|+||+++.+. ....++++||+++++|.+++ ... . +++.++.|||+ .+++|+|++|.|
T Consensus 41 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~n 117 (244)
T smart00220 41 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPEN 117 (244)
T ss_pred HHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHH
Confidence 456799999999998 68899999999999999998 322 2 89999999999 899999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG-- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~-- 142 (188)
|+++.++.++++|||.+....... ......++..|++|| ++.++|+||||++++++++|..||+.....
T Consensus 118 i~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~ 194 (244)
T smart00220 118 ILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE 194 (244)
T ss_pred eEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999887543211 223345667788888 577999999999999999999888651110
Q ss_pred ----------CcCHH---HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 ----------EFDII---SVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ----------~~~~~---~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..... .+..+.+++.+|+..+|++||++.++++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 195 LFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 01111 5578999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=178.37 Aligned_cols=170 Identities=20% Similarity=0.231 Sum_probs=136.9
Q ss_pred cccCCCeeeeccc----CCccEEEEecCCCCChhhhcCCcc--------------------cHHHHHHHHhcCCCCCcEE
Q 039565 8 KLTGPLLVELIGK----QKNNALELGFRGNPELVDQQGKEE--------------------VCCPGLEYLHQGLKHPIIQ 63 (188)
Q Consensus 8 ~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~--------------------~i~~~l~~Lh~~~~~~i~h 63 (188)
.+.|||+..+.++ ...-++++.++..|+|..++.... |++.|++|||. .+++|
T Consensus 343 ~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViH 419 (563)
T KOG1024|consen 343 GASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIH 419 (563)
T ss_pred cCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCccc
Confidence 3579999999998 778889999999999999993111 99999999999 99999
Q ss_pred eCCCCCcEEEccCCceEEecccCcccccCCCCCc-ceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCcc
Q 039565 64 RDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH-MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILT 135 (188)
Q Consensus 64 ~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p 135 (188)
.|+..+|.++++.-++|++|-.+++-.- +..-. .-.....+..||++| ++.++|+||||+++||++| |+.|
T Consensus 420 kDiAaRNCvIdd~LqVkltDsaLSRDLF-P~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~P 498 (563)
T KOG1024|consen 420 KDIAARNCVIDDQLQVKLTDSALSRDLF-PGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLP 498 (563)
T ss_pred chhhhhcceehhheeEEeccchhccccC-cccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999988887432 11111 111122345688888 8999999999999999986 6677
Q ss_pred ccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 136 VDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 136 ~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
+.+..+ ...+..++.+++.++.-||...|++||+++|++.-|.+..
T Consensus 499 yaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 499 YAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 644322 2244568889999999999999999999999999887654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=199.30 Aligned_cols=166 Identities=12% Similarity=0.168 Sum_probs=118.2
Q ss_pred cccccC-CCeeeeccc----------CCccEEEEecCCCCChhhhcCC-cc------------cHHHHHHHHhcCCCCCc
Q 039565 6 RNKLTG-PLLVELIGK----------QKNNALELGFRGNPELVDQQGK-EE------------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 6 l~~l~H-pniv~~~~~----------~~~~~lv~e~~~~~~L~~~~~~-~~------------~i~~~l~~Lh~~~~~~i 61 (188)
.+.++| +||.++++. +.....++|+++ ++|.++++. .. |++.||+|||+ .+|
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 456778 688877775 346678888875 699999932 21 99999999999 999
Q ss_pred EEeCCCCCcEEEccCCc-------------------eEEecccCcccccCCCC--------------Ccceeeecccccc
Q 039565 62 IQRDMKSTNILLNEKVQ-------------------AKLADFGQSRISPVEGG--------------THMSTTIAGTAGF 108 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~-------------------~kl~d~~~~~~~~~~~~--------------~~~~~~~~~~~~~ 108 (188)
+||||||+|||++..+. +|++|||+++....... ........|++.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965444 55556665542110000 0000113577889
Q ss_pred cCCC------CCCccchHHHHHHHHHHHhCCccccccCC-------CCcCH---HHHHHHHHHHHHccCcCCCCCCCHHH
Q 039565 109 LNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK-------GEFDI---ISVEKAVEIAMASVSSKVNRRPLMNQ 172 (188)
Q Consensus 109 ~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-------~~~~~---~~~~~~~~l~~~cl~~~p~~Rps~~~ 172 (188)
+||| ++.++|||||||++|||+++..|+..... ...+. .......+++.+||+.+|.+||++.+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHH
Confidence 9999 58899999999999999999877653210 00111 12345668888999999999999999
Q ss_pred HHH
Q 039565 173 VVM 175 (188)
Q Consensus 173 i~~ 175 (188)
+++
T Consensus 262 il~ 264 (793)
T PLN00181 262 LLQ 264 (793)
T ss_pred Hhh
Confidence 986
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=178.46 Aligned_cols=174 Identities=22% Similarity=0.235 Sum_probs=136.7
Q ss_pred cccCCCeeeeccc-------CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCC------CCCcEE
Q 039565 8 KLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGL------KHPIIQ 63 (188)
Q Consensus 8 ~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~------~~~i~h 63 (188)
.++|+||+++++. ...+|||++|-+.|+|.+|++.+. .+++||+|||+.. +.+|+|
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaH 339 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAH 339 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccc
Confidence 5899999999999 348899999999999999994443 8899999999654 457999
Q ss_pred eCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CC-----CccchHHHHHHHHHHHh
Q 039565 64 RDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LT-----EKSDVDSFEIVILEIIT 131 (188)
Q Consensus 64 ~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~-----~~~di~s~G~~l~~~~~ 131 (188)
||+|..|||+-.++.+-|+|||++..+.............||.+||||| +. .+.||||+|.++||+++
T Consensus 340 RDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~S 419 (534)
T KOG3653|consen 340 RDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIAS 419 (534)
T ss_pred ccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999998776444444455689999999999 22 46899999999999998
Q ss_pred CCccccccCCCC------------------------------cCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 132 GILTVDLSFKGE------------------------------FDI-----ISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 132 g~~p~~~~~~~~------------------------------~~~-----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
...-+++...++ ++. ..+..+++.+..||..|++-|.|+.=+-+.
T Consensus 420 RC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR 499 (534)
T KOG3653|consen 420 RCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEER 499 (534)
T ss_pred hcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence 653221110000 111 234468899999999999999998776666
Q ss_pred Hhhcc
Q 039565 177 REQGS 181 (188)
Q Consensus 177 l~~~~ 181 (188)
+.++.
T Consensus 500 ~~~l~ 504 (534)
T KOG3653|consen 500 MAELM 504 (534)
T ss_pred HHHHh
Confidence 65543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-27 Score=193.51 Aligned_cols=163 Identities=22% Similarity=0.300 Sum_probs=131.4
Q ss_pred ccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c--------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 9 LTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E--------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 9 l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~--------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
=+|||||+.++. ++.+|+.+|.|. -+|.+++... . |++.||++||+ .+|+||||||+
T Consensus 560 D~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQ 635 (903)
T KOG1027|consen 560 DEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQ 635 (903)
T ss_pred cCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCc
Confidence 369999999999 888999999998 5999999431 1 99999999999 99999999999
Q ss_pred cEEEccC-----CceEEecccCcccccCCCCC-cceeeecccccccCCC------CCCccchHHHHHHHHHHHhC-Cccc
Q 039565 70 NILLNEK-----VQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITG-ILTV 136 (188)
Q Consensus 70 nill~~~-----~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g-~~p~ 136 (188)
||||+.+ .+.+|+|||+++......+. .......|+.+|+||| -+.++||+|+||++|+.++| .-||
T Consensus 636 NILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpF 715 (903)
T KOG1027|consen 636 NILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPF 715 (903)
T ss_pred eEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCC
Confidence 9999862 46899999999876533332 2234578999999999 46789999999999999887 5788
Q ss_pred cccCCCC-------cCH---HHHH--HHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 137 DLSFKGE-------FDI---ISVE--KAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 137 ~~~~~~~-------~~~---~~~~--~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
......+ ... .... ...+++.++++.+|..||++.+|+.
T Consensus 716 Gd~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 716 GDSLERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred CchHHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 7654332 100 1111 7889999999999999999999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=179.59 Aligned_cols=167 Identities=24% Similarity=0.323 Sum_probs=134.8
Q ss_pred ccccCCCeeeeccc----CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 7 NKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 7 ~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.|+||.||++|++ .+..|-|+|||+|.+|..|+++.. |+..||.||.+ .+..|||.||||.|
T Consensus 522 KeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgN 600 (775)
T KOG1151|consen 522 KELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGN 600 (775)
T ss_pred hccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCcc
Confidence 46899999999999 788899999999999999994443 99999999986 45689999999999
Q ss_pred EEEcc---CCceEEecccCcccccCCC-----CCcceeeecccccccCCC----------CCCccchHHHHHHHHHHHhC
Q 039565 71 ILLNE---KVQAKLADFGQSRISPVEG-----GTHMSTTIAGTAGFLNTE----------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 71 ill~~---~~~~kl~d~~~~~~~~~~~-----~~~~~~~~~~~~~~~~pe----------~~~~~di~s~G~~l~~~~~g 132 (188)
||+.. .|.+||.|||+++++.... .........||++|++|| ++.++|+||.||++|.++.|
T Consensus 601 ILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYG 680 (775)
T KOG1151|consen 601 ILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYG 680 (775)
T ss_pred EEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhcc
Confidence 99964 4678999999999875321 222334578999999888 68999999999999999999
Q ss_pred CccccccCCCC---------------cC--HHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 039565 133 ILTVDLSFKGE---------------FD--IISVEKAVEIAMASVSSKVNRRPLMNQVV 174 (188)
Q Consensus 133 ~~p~~~~~~~~---------------~~--~~~~~~~~~l~~~cl~~~p~~Rps~~~i~ 174 (188)
+.||....... ++ +..+.....++..||...-++|....++.
T Consensus 681 rKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 681 RKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred CCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 99996432211 11 23456788999999999999988766654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=186.76 Aligned_cols=152 Identities=19% Similarity=0.190 Sum_probs=113.7
Q ss_pred CCccEEEEecCCCCChhhhc-CCc-------------------------------ccHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 21 QKNNALELGFRGNPELVDQQ-GKE-------------------------------EVCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 21 ~~~~~lv~e~~~~~~L~~~~-~~~-------------------------------~~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
....++++||+.+++|.+++ ... .|++.||.|||+ .+|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCH
Confidence 56789999999999999887 221 078999999999 9999999999
Q ss_pred CcEEEcc-CCceEEecccCcccccCCCCCcceeeecccccccCCCC----------------------------CCccch
Q 039565 69 TNILLNE-KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL----------------------------TEKSDV 119 (188)
Q Consensus 69 ~nill~~-~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~----------------------------~~~~di 119 (188)
+|||++. ++.+||+|||+++... ...........+++.|++||. ..++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~-~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLR-VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccc-cccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999986 5789999999997543 122223345677888999981 124599
Q ss_pred HHHHHHHHHHHhCCccccccCC---------------------CCcCHH----------HHHHHHHHHHHccCcCCCCCC
Q 039565 120 DSFEIVILEIITGILTVDLSFK---------------------GEFDII----------SVEKAVEIAMASVSSKVNRRP 168 (188)
Q Consensus 120 ~s~G~~l~~~~~g~~p~~~~~~---------------------~~~~~~----------~~~~~~~l~~~cl~~~p~~Rp 168 (188)
|||||++|+|+++..+.+.... ...... ......+++..|++.||++||
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 9999999999987765442110 000000 011234899999999999999
Q ss_pred CHHHHHHH
Q 039565 169 LMNQVVMV 176 (188)
Q Consensus 169 s~~~i~~~ 176 (188)
|++++++.
T Consensus 443 ta~e~L~H 450 (566)
T PLN03225 443 SAKAALAH 450 (566)
T ss_pred CHHHHhCC
Confidence 99999873
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=194.61 Aligned_cols=160 Identities=22% Similarity=0.269 Sum_probs=126.8
Q ss_pred CCCeeee-ccc--CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEcc
Q 039565 11 GPLLVEL-IGK--QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNE 75 (188)
Q Consensus 11 Hpniv~~-~~~--~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~ 75 (188)
.+.|+++ |.+ ..++|+||||++||+|-..+.+.. .+..||.-+|+ .|+||||+||+|||++.
T Consensus 134 s~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 134 SEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDK 210 (1317)
T ss_pred cHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecc
Confidence 3446666 333 889999999999999999993332 88999999999 99999999999999999
Q ss_pred CCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCccccccC----
Q 039565 76 KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGILTVDLSF---- 140 (188)
Q Consensus 76 ~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~p~~~~~---- 140 (188)
.|++||+|||.+-.+. ..+.-......|||-|.+|| |+..+|.||+||++|||+.|..||-...
T Consensus 211 ~GHikLADFGsClkm~-~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT 289 (1317)
T KOG0612|consen 211 SGHIKLADFGSCLKMD-ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET 289 (1317)
T ss_pred cCcEeeccchhHHhcC-CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH
Confidence 9999999999887654 33344455679999999998 6899999999999999999999983210
Q ss_pred ---------CCCcC--HHHHHHHHHHHHHccCcCCCCCCC---HHHHHH
Q 039565 141 ---------KGEFD--IISVEKAVEIAMASVSSKVNRRPL---MNQVVM 175 (188)
Q Consensus 141 ---------~~~~~--~~~~~~~~~l~~~cl~~~p~~Rps---~~~i~~ 175 (188)
.-.+| ...++...++|...+. +|+.|.. ++++-.
T Consensus 290 Y~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 290 YGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 11122 3467788888887766 6777776 777654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=156.63 Aligned_cols=164 Identities=18% Similarity=0.180 Sum_probs=125.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
++.++|+|||+++++ ++.+.+|+|||+. +|..+.+.. + |++.||.|+|+ +.+.|||+||+
T Consensus 55 lkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpq 130 (292)
T KOG0662|consen 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQ 130 (292)
T ss_pred HHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcc
Confidence 467899999999999 8899999999985 888888332 2 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHh-CCccccccC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIIT-GILTVDLSF- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~-g~~p~~~~~- 140 (188)
|.+++.+|.+|++|||+++.+..+- ..-.....|.+|.+|. ++...|+||-||++.|+.. |++.|....
T Consensus 131 nllin~ngelkladfglarafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv 208 (292)
T KOG0662|consen 131 NLLINRNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_pred eEEeccCCcEEecccchhhhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence 9999999999999999998764221 1222334566777777 7899999999999999984 555442110
Q ss_pred -------------------------CC-----Cc---------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 -------------------------KG-----EF---------DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 -------------------------~~-----~~---------~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
++ .+ -+.....-.++++..+.-+|.+|.+++..++
T Consensus 209 ddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 209 DDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred HHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 00 00 0111223457888888889999999988765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=184.24 Aligned_cols=80 Identities=29% Similarity=0.412 Sum_probs=71.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||+++++. ....++||||+.+++|.+++.... |++.||.|||. .+|+||||||+|
T Consensus 58 l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~N 134 (669)
T cd05610 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDN 134 (669)
T ss_pred HHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHH
Confidence 456799999999887 788999999999999999983221 89999999999 899999999999
Q ss_pred EEEccCCceEEecccCcc
Q 039565 71 ILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~ 88 (188)
|+++.++.++|+|||+++
T Consensus 135 ILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 135 MLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEcCCCCEEEEeCCCCc
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=168.15 Aligned_cols=163 Identities=20% Similarity=0.206 Sum_probs=129.4
Q ss_pred cccccCCCeeeeccc---------CCccEEEEecCCCCChhhhcCCcc----------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---------QKNNALELGFRGNPELVDQQGKEE----------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~~~~~----------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+..++|+||++++.+ -...|+|||+++ ++|...+.... |++.|+.|||+ .+|+||||
T Consensus 69 ~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs---~~IihRdL 144 (369)
T KOG0665|consen 69 MKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILMELDHETISYILYQMLCGIKHLHS---AGIIHRDL 144 (369)
T ss_pred hhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHHhcchHHHHHHHHHHHHHHHHHHh---cceeeccc
Confidence 567899999999999 356799999998 58888873222 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+||++..++.+|+.|||+++.-. ..........+..|.||| +.+.+||||.||++.||++|...|....
T Consensus 145 kPsnivv~~~~~lKi~dfg~ar~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 145 KPSNIVVNSDCTLKILDFGLARTED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred CcccceecchhheeeccchhhcccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence 9999999999999999999987432 222344566777899999 6889999999999999999986442111
Q ss_pred C-----------------------------------------------------CCcCHHHHHHHHHHHHHccCcCCCCC
Q 039565 141 K-----------------------------------------------------GEFDIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 141 ~-----------------------------------------------------~~~~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
. .+.+......+.+++..+|-.+|++|
T Consensus 222 ~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~R 301 (369)
T KOG0665|consen 222 HIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKR 301 (369)
T ss_pred HHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhc
Confidence 0 00111223356689999999999999
Q ss_pred CCHHHHHH
Q 039565 168 PLMNQVVM 175 (188)
Q Consensus 168 ps~~~i~~ 175 (188)
-|++++++
T Consensus 302 isv~daL~ 309 (369)
T KOG0665|consen 302 ISVDDALR 309 (369)
T ss_pred ccHHHHhc
Confidence 99999886
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=154.64 Aligned_cols=122 Identities=23% Similarity=0.159 Sum_probs=96.8
Q ss_pred cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccc
Q 039565 45 VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSD 118 (188)
Q Consensus 45 ~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~d 118 (188)
|++.||.|||+ .+ ||+||+++.++.+++ ||.+...... ...|+..|+||| ++.++|
T Consensus 25 qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~g~~~y~aPE~~~~~~~~~~~D 86 (176)
T smart00750 25 QCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSRVDPYFMAPEVIQGQSYTEKAD 86 (176)
T ss_pred HHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc-------cCCCcccccChHHhcCCCCcchhh
Confidence 99999999998 55 999999999999998 9988754311 125788999999 578999
Q ss_pred hHHHHHHHHHHHhCCccccccCCC-------------C------cCHHHHH--HHHHHHHHccCcCCCCCCCHHHHHHHH
Q 039565 119 VDSFEIVILEIITGILTVDLSFKG-------------E------FDIISVE--KAVEIAMASVSSKVNRRPLMNQVVMVR 177 (188)
Q Consensus 119 i~s~G~~l~~~~~g~~p~~~~~~~-------------~------~~~~~~~--~~~~l~~~cl~~~p~~Rps~~~i~~~l 177 (188)
|||||+++|+|++|..||...... . ....... .+.+++..||+.+|.+||++.++++.+
T Consensus 87 iwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~ 166 (176)
T smart00750 87 IYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHC 166 (176)
T ss_pred HHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHH
Confidence 999999999999999988532210 0 1112222 589999999999999999999999988
Q ss_pred hhccCcc
Q 039565 178 EQGSGSR 184 (188)
Q Consensus 178 ~~~~~~~ 184 (188)
.......
T Consensus 167 ~~~~~~~ 173 (176)
T smart00750 167 RALFAET 173 (176)
T ss_pred HHHHHHH
Confidence 7665443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=184.53 Aligned_cols=152 Identities=23% Similarity=0.289 Sum_probs=115.9
Q ss_pred CCccEEEEecCCCCChhhhcCCcc-------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCc
Q 039565 21 QKNNALELGFRGNPELVDQQGKEE-------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS 87 (188)
Q Consensus 21 ~~~~~lv~e~~~~~~L~~~~~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~ 87 (188)
...+|+-||||+..+|.++++++. +++.||.|+|+ .++||||+||.||+++++..+||+|||++
T Consensus 668 ~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLA 744 (1351)
T KOG1035|consen 668 PLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLA 744 (1351)
T ss_pred ceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---CceeeccCCcceeEEcCCCCeeecccccc
Confidence 456799999999877777773222 99999999999 99999999999999999999999999998
Q ss_pred cccc------C----------CCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccc------
Q 039565 88 RISP------V----------EGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTV------ 136 (188)
Q Consensus 88 ~~~~------~----------~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~------ 136 (188)
.... . .......+...||..|+||| ++.++|+||+|++++||+.-..+-
T Consensus 745 t~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~i 824 (1351)
T KOG1035|consen 745 TDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYPFGTSMERASI 824 (1351)
T ss_pred hhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhccCCchHHHHHH
Confidence 7510 0 01111234578999999999 678999999999999998642100
Q ss_pred -----cccCC--CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 137 -----DLSFK--GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 137 -----~~~~~--~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+...+ ..+.......-.+++.++++.||.+|||+.+++.
T Consensus 825 L~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 825 LTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 11111 1122334456678999999999999999999886
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=159.30 Aligned_cols=166 Identities=20% Similarity=0.194 Sum_probs=127.0
Q ss_pred cccccCCCeeeeccc-----------CCccEEEEecCCCCChhhhcCCc-c------------cHHHHHHHHhcCCCCCc
Q 039565 6 RNKLTGPLLVELIGK-----------QKNNALELGFRGNPELVDQQGKE-E------------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----------~~~~~lv~e~~~~~~L~~~~~~~-~------------~i~~~l~~Lh~~~~~~i 61 (188)
|..++|+|+++++++ ....++||++|+. +|..++... . ++..||.|+|. ..|
T Consensus 70 L~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~ki 145 (376)
T KOG0669|consen 70 LQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKI 145 (376)
T ss_pred HHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhH
Confidence 456789999999988 3457999999995 888888332 1 88999999999 999
Q ss_pred EEeCCCCCcEEEccCCceEEecccCcccccCCCCC--cceeeecccccccCCC-------CCCccchHHHHHHHHHHHhC
Q 039565 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGT--HMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~--~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g 132 (188)
+|||+|+.|++++.+|.+|++|||+++.+...... ..-+....|.+|.+|| +++..|+|+.||++.+|.++
T Consensus 146 lHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtr 225 (376)
T KOG0669|consen 146 LHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTR 225 (376)
T ss_pred HhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHcc
Confidence 99999999999999999999999999765322211 1123345677888888 79999999999999999998
Q ss_pred Cccccc-------------------cCCCC--------------cCH-------H------HHHHHHHHHHHccCcCCCC
Q 039565 133 ILTVDL-------------------SFKGE--------------FDI-------I------SVEKAVEIAMASVSSKVNR 166 (188)
Q Consensus 133 ~~p~~~-------------------~~~~~--------------~~~-------~------~~~~~~~l~~~cl~~~p~~ 166 (188)
...+.. ..+++ .+. . -.....+++..++..||.+
T Consensus 226 spimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~k 305 (376)
T KOG0669|consen 226 SPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTK 305 (376)
T ss_pred CccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCccc
Confidence 863311 11111 000 0 0125678999999999999
Q ss_pred CCCHHHHHH
Q 039565 167 RPLMNQVVM 175 (188)
Q Consensus 167 Rps~~~i~~ 175 (188)
|+.+++++.
T Consensus 306 R~~ad~aln 314 (376)
T KOG0669|consen 306 RIDADQALN 314 (376)
T ss_pred CcchHhhhc
Confidence 999988765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=154.65 Aligned_cols=127 Identities=28% Similarity=0.347 Sum_probs=105.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc----CCcc------------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ----GKEE------------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~----~~~~------------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
++....|.+|.++|. ....|+.||.++ .||..+. ++.. .+..||.|||+ +..++|||+
T Consensus 99 ~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDv 175 (282)
T KOG0984|consen 99 MRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDV 175 (282)
T ss_pred ccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccC
Confidence 345568999999998 788999999998 4887776 2222 77899999998 489999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC----------CCCccchHHHHHHHHHHHhCCccc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE----------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe----------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
||+|||++..|++|++|||++.... ++ -..+.-.|+..|+||| ++.++||||+|+++.||.+++.|+
T Consensus 176 KPsNiLIn~~GqVKiCDFGIsG~L~--dS-iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY 252 (282)
T KOG0984|consen 176 KPSNILINYDGQVKICDFGISGYLV--DS-IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY 252 (282)
T ss_pred CcceEEEccCCcEEEcccccceeeh--hh-hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence 9999999999999999999987542 11 1122256888999998 688999999999999999999998
Q ss_pred cc
Q 039565 137 DL 138 (188)
Q Consensus 137 ~~ 138 (188)
+.
T Consensus 253 ~~ 254 (282)
T KOG0984|consen 253 ES 254 (282)
T ss_pred cc
Confidence 64
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=160.28 Aligned_cols=155 Identities=21% Similarity=0.316 Sum_probs=127.7
Q ss_pred ccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 9 LTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 9 l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
-+||.+|-+..+ ...+++|.||..+|+|--.+ ++ .+ +++-||.|||+ +|||+||+|..|+++
T Consensus 308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvll 384 (593)
T KOG0695|consen 308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLL 384 (593)
T ss_pred cCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEE
Confidence 468888888777 77889999999999998877 22 22 89999999999 999999999999999
Q ss_pred ccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC----
Q 039565 74 NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE---- 143 (188)
Q Consensus 74 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~---- 143 (188)
+..|++|+.|||.++.- ........+++||+.|.||| +.-..|.|++|++++||+.|+.|||-.-.++
T Consensus 385 daeghikltdygmcke~--l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n 462 (593)
T KOG0695|consen 385 DAEGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN 462 (593)
T ss_pred ccCCceeecccchhhcC--CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc
Confidence 99999999999998742 22334567899999999999 6888999999999999999999997432211
Q ss_pred ---------------cCHHHHHHHHHHHHHccCcCCCCCC
Q 039565 144 ---------------FDIISVEKAVEIAMASVSSKVNRRP 168 (188)
Q Consensus 144 ---------------~~~~~~~~~~~l~~~cl~~~p~~Rp 168 (188)
.+...+.+...++..-+++||..|.
T Consensus 463 tedylfqvilekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 463 TEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 2333444677888899999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=174.11 Aligned_cols=164 Identities=21% Similarity=0.264 Sum_probs=134.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+...+|||||.++|. .+.+|+.||||.+|+|++...--+ +.+.|+.|||+ .+-+|||+|-.|
T Consensus 66 ~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGan 142 (829)
T KOG0576|consen 66 LRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGAN 142 (829)
T ss_pred eecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhc---CCcccccccccc
Confidence 567899999999999 899999999999999999882222 77899999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCcc-c----
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILT-V---- 136 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p-~---- 136 (188)
|++++.|.+|++|||++-.++ ..-.....+.|+++||+|| +...+|+|+.|+...|+-.-+.| |
T Consensus 143 illtd~gDvklaDfgvsaqit--ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp 220 (829)
T KOG0576|consen 143 ILLTDEGDVKLADFGVSAQIT--ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP 220 (829)
T ss_pred eeecccCceeecccCchhhhh--hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch
Confidence 999999999999999876432 2333456789999999999 68899999999998888666543 2
Q ss_pred ------------cccCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 137 ------------DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 137 ------------~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
++... +......+-+-+++..|+.++|.+||+++.+++
T Consensus 221 mr~l~LmTkS~~qpp~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 221 MRALFLMTKSGFQPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHhhccCCCCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22211 122356677889999999999999999987654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-23 Score=165.71 Aligned_cols=133 Identities=20% Similarity=0.281 Sum_probs=108.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|..-+.+.||++|-. .+++|+||+|++||++-.++ +..- ++.-|+++.|. .|.|||||||+|
T Consensus 683 LAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDN 759 (1034)
T KOG0608|consen 683 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDN 759 (1034)
T ss_pred HhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccc
Confidence 345567889999776 89999999999999999888 3322 78889999999 999999999999
Q ss_pred EEEccCCceEEecccCccccc-C-------CCCC--------------------------------cceeeecccccccC
Q 039565 71 ILLNEKVQAKLADFGQSRISP-V-------EGGT--------------------------------HMSTTIAGTAGFLN 110 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~-~-------~~~~--------------------------------~~~~~~~~~~~~~~ 110 (188)
||||.+|++||.|||++..+. . .+.. -......||+.|++
T Consensus 760 ILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyia 839 (1034)
T KOG0608|consen 760 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIA 839 (1034)
T ss_pred eEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccC
Confidence 999999999999999986431 0 0000 00012569999999
Q ss_pred CC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 111 TE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 111 pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|| ++..+|.||.||++|+|+.|+.||-...+
T Consensus 840 pevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 840 PEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred hHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence 99 68889999999999999999999965444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=146.50 Aligned_cols=147 Identities=30% Similarity=0.478 Sum_probs=121.9
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc----c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE----E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
.+..++|++|+++++. ....++++|++++++|.+++... . +++.++.+||+ .+++|+|++|
T Consensus 44 ~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~ 120 (215)
T cd00180 44 ILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKP 120 (215)
T ss_pred HHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCH
Confidence 3567889999999999 56899999999999999999332 1 99999999999 8999999999
Q ss_pred CcEEEcc-CCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 69 TNILLNE-KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 69 ~nill~~-~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
.||+++. ++.++++||+.+........ ......+...|.+|| .+.+.|+|++|++++++
T Consensus 121 ~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------- 187 (215)
T cd00180 121 ENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------- 187 (215)
T ss_pred hhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------
Confidence 9999999 89999999998875432111 122234555667776 45779999999999998
Q ss_pred CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 141 KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 141 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
..+.+++..|++.+|.+||+++++++.
T Consensus 188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 788999999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-24 Score=169.55 Aligned_cols=163 Identities=21% Similarity=0.254 Sum_probs=132.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|.+++||.||.+..- ++..++|||-+-|.-|+.++ ...+ |++.||.|||. .+|+|+||||+
T Consensus 617 Lq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPE 693 (888)
T KOG4236|consen 617 LQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPE 693 (888)
T ss_pred HHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCch
Confidence 457899999999666 88999999999876666666 2222 99999999999 99999999999
Q ss_pred cEEEccC---CceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 70 NILLNEK---VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 70 nill~~~---~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+|+++. ..+|++|||++++.+ .........||+.|++|| +...-|+||.|+++|.-++|-.||++.-
T Consensus 694 NVLLas~~~FPQvKlCDFGfARiIg---EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 694 NVLLASASPFPQVKLCDFGFARIIG---EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred heeeccCCCCCceeeccccceeecc---hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 9999865 378999999999754 444566789999999999 7888999999999999999999996532
Q ss_pred CCC------------cC-HHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 039565 141 KGE------------FD-IISVEKAVEIAMASVSSKVNRRPLMNQVV 174 (188)
Q Consensus 141 ~~~------------~~-~~~~~~~~~l~~~cl~~~p~~Rps~~~i~ 174 (188)
... -+ .+.+....++++..++..-.+|.|.++-+
T Consensus 771 dIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 771 DINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred chhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 211 11 23456788999999999999999887654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-23 Score=148.53 Aligned_cols=159 Identities=16% Similarity=0.231 Sum_probs=124.2
Q ss_pred CCCeeeeccc-----CCccEEEEecCCCCChhhhcCCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccC
Q 039565 11 GPLLVELIGK-----QKNNALELGFRGNPELVDQQGKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEK 76 (188)
Q Consensus 11 Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~ 76 (188)
||||++++++ .....||+||+.+.+......... +++.||.|||+ .||.|||+||.|++++..
T Consensus 92 g~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~ 168 (338)
T KOG0668|consen 92 GPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHE 168 (338)
T ss_pred CCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechh
Confidence 9999999999 567789999999888777764444 99999999999 999999999999999975
Q ss_pred -CceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcccccc---------
Q 039565 77 -VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLS--------- 139 (188)
Q Consensus 77 -~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~--------- 139 (188)
-.+++.|+|++..+. ++ ..-+...++.++-.|| ++-.-|+|||||++..|+-.+.||=..
T Consensus 169 ~rkLrlIDWGLAEFYH-p~--~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk 245 (338)
T KOG0668|consen 169 LRKLRLIDWGLAEFYH-PG--KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK 245 (338)
T ss_pred hceeeeeecchHhhcC-CC--ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence 468999999998754 22 2233445666677777 688899999999999999888776110
Q ss_pred --------------------CCCC--------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 140 --------------------FKGE--------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 140 --------------------~~~~--------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
++.. -..-...+..+++...+..|-.+|+|+.+...
T Consensus 246 IakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 246 IAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0000 01112357789999999999999999988654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=163.39 Aligned_cols=150 Identities=19% Similarity=0.185 Sum_probs=110.4
Q ss_pred CccEEEEecCCCCChhhhcCC-c-----------------------------------ccHHHHHHHHhcCCCCCcEEeC
Q 039565 22 KNNALELGFRGNPELVDQQGK-E-----------------------------------EVCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 22 ~~~~lv~e~~~~~~L~~~~~~-~-----------------------------------~~i~~~l~~Lh~~~~~~i~h~d 65 (188)
...++|+||+++++|.++++. . .|++.||.|||+ .+++|||
T Consensus 258 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrD 334 (507)
T PLN03224 258 GSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRD 334 (507)
T ss_pred CceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCC
Confidence 467999999999999988721 0 078899999999 8999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCCC----------------------------Ccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTELT----------------------------EKS 117 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~----------------------------~~~ 117 (188)
+||+||+++.++.++++|||++...... .........+++.|++||.- ...
T Consensus 335 LKp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~ 413 (507)
T PLN03224 335 IKPENLLVTVDGQVKIIDFGAAVDMCTG-INFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLF 413 (507)
T ss_pred CchHhEEECCCCcEEEEeCcCccccccC-CccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCcc
Confidence 9999999999999999999998643211 11111122346788998821 236
Q ss_pred chHHHHHHHHHHHhCCc-ccccc------CCC----------------CcC--HHHHHHHHHHHHHccCcCC---CCCCC
Q 039565 118 DVDSFEIVILEIITGIL-TVDLS------FKG----------------EFD--IISVEKAVEIAMASVSSKV---NRRPL 169 (188)
Q Consensus 118 di~s~G~~l~~~~~g~~-p~~~~------~~~----------------~~~--~~~~~~~~~l~~~cl~~~p---~~Rps 169 (188)
|+||+||++++|+++.. |+... ... .++ ........+++..++..+| .+|+|
T Consensus 414 DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlS 493 (507)
T PLN03224 414 DSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLS 493 (507)
T ss_pred chhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCC
Confidence 99999999999999874 55321 000 011 1234567899999999766 68999
Q ss_pred HHHHHH
Q 039565 170 MNQVVM 175 (188)
Q Consensus 170 ~~~i~~ 175 (188)
++++++
T Consensus 494 a~eaL~ 499 (507)
T PLN03224 494 VGQALS 499 (507)
T ss_pred HHHHhC
Confidence 999886
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-23 Score=156.47 Aligned_cols=153 Identities=18% Similarity=0.239 Sum_probs=118.6
Q ss_pred eeeeccc---CCccEEEEecCCCCChhhhcCCcc--------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEcc-
Q 039565 14 LVELIGK---QKNNALELGFRGNPELVDQQGKEE--------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNE- 75 (188)
Q Consensus 14 iv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~--------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~- 75 (188)
+|++.++ .++.++|+|.++ .|+.+++..+. |++.+++|||+ .+++|-||||+||++.+
T Consensus 153 cv~m~~wFdyrghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSS 228 (415)
T ss_pred EEeeehhhhccCceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEecc
Confidence 5777566 889999999996 49999994433 99999999999 99999999999999842
Q ss_pred -------------------CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHH
Q 039565 76 -------------------KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEII 130 (188)
Q Consensus 76 -------------------~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~ 130 (188)
+..++++|||.+.... . -......|.-|.||| ++..+|+||+||++.|+.
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~---e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH---E--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceec---c--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 2357899999887421 1 124456677899999 799999999999999999
Q ss_pred hCCccccccCC-----------------------------------CC----------------------cCHHHHHHHH
Q 039565 131 TGILTVDLSFK-----------------------------------GE----------------------FDIISVEKAV 153 (188)
Q Consensus 131 ~g~~p~~~~~~-----------------------------------~~----------------------~~~~~~~~~~ 153 (188)
+|...|..... ++ ....+-..+.
T Consensus 304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 99875421100 00 0112334688
Q ss_pred HHHHHccCcCCCCCCCHHHHHH
Q 039565 154 EIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 154 ~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+++..++..||.+|+|+.+++.
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHccCccccccHHHHhc
Confidence 9999999999999999999876
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.5e-22 Score=146.24 Aligned_cols=171 Identities=15% Similarity=0.203 Sum_probs=131.7
Q ss_pred CCCcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc-------------cHHHHHHHHhcCCCCCcEEeC
Q 039565 3 FPNRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE-------------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 3 ~~~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~-------------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
||.|+-+.||||+.+++. +.++.+|..|++.|+|...++. .+ +++.|++|||+- +.-|.-.-
T Consensus 238 fp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~ 316 (448)
T KOG0195|consen 238 FPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFY 316 (448)
T ss_pred CcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhh
Confidence 788999999999999998 8899999999999999999933 32 899999999972 12344456
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
+++..++++++...+++- +-.+.. .......-.+.|++|| .-.++|+|||.+++||+.|...||
T Consensus 317 lns~hvmidedltarism-ad~kfs------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf 389 (448)
T KOG0195|consen 317 LNSKHVMIDEDLTARISM-ADTKFS------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF 389 (448)
T ss_pred cccceEEecchhhhheec-ccceee------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence 888899999887666541 111110 0111223456788888 346799999999999999999999
Q ss_pred cccCC-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 137 DLSFK-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 137 ~~~~~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
.+-.+ ...++..+..+.+++.-|++.||.+||.++.|+-.||+..
T Consensus 390 adlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 390 ADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 65332 2355566778899999999999999999999999998754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-23 Score=151.36 Aligned_cols=157 Identities=18% Similarity=0.213 Sum_probs=118.3
Q ss_pred ccccCCCeeeeccc--------CCccEEEEecCCCCChhhhc-CC--cc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 7 NKLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQ-GK--EE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 7 ~~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~-~~--~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
.-++|.|++..+++ =+.+|+++|.+. .+|..++ .. .. |+++||.|||+ .+|.|||+
T Consensus 107 cfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDI 182 (449)
T KOG0664|consen 107 SSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDI 182 (449)
T ss_pred HhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccC
Confidence 45689999999988 245688899887 4888888 22 22 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcccccc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLS 139 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~ 139 (188)
||.|.++++|..+|++|||+++.-. .......+....|.+|.+|| ++.+.||||.||++.|++..+..|...
T Consensus 183 KPGNLLVNSNCvLKICDFGLARvee-~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 183 KPGNLLVNSNCILKICDFGLARTWD-QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred CCccEEeccCceEEecccccccccc-hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 9999999999999999999998532 12222222345677899998 799999999999999999998888654
Q ss_pred CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 140 FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 140 ~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
.+ ..+++-+.+++ .-||++++....|+.+
T Consensus 262 ~P----iqQL~lItdLL---------GTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 262 GP----IEQLQMIIDLL---------GTPSQEAMKYACEGAK 290 (449)
T ss_pred Ch----HHHHHHHHHHh---------CCCcHHHHHHHhhhhH
Confidence 32 34444444443 2466666665555543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-21 Score=155.78 Aligned_cols=154 Identities=19% Similarity=0.157 Sum_probs=120.1
Q ss_pred eeeeccc---CCccEEEEecCCCCChhhhcCCcc---------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEcc
Q 039565 14 LVELIGK---QKNNALELGFRGNPELVDQQGKEE---------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNE 75 (188)
Q Consensus 14 iv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~---------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~ 75 (188)
+++++.. .+++|||||.+. .+|.+.+++.+ |+..||..|-. .+|+|+||||.|||+++
T Consensus 496 clrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEecc
Confidence 4445444 789999999998 59999995444 99999999998 99999999999999987
Q ss_pred C-CceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC--------
Q 039565 76 K-VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF-------- 140 (188)
Q Consensus 76 ~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~-------- 140 (188)
+ ..+||+|||.+.... ....+.+..+-+|.||| ++...|+||.||++||+.||+..|....
T Consensus 572 ~k~iLKLCDfGSA~~~~----eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFAS----ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred CcceeeeccCccccccc----cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 6 578999999886432 22334455667899999 6889999999999999999986331100
Q ss_pred ---------------------------------------------------------------CCCcCHHHHHHHHHHHH
Q 039565 141 ---------------------------------------------------------------KGEFDIISVEKAVEIAM 157 (188)
Q Consensus 141 ---------------------------------------------------------------~~~~~~~~~~~~~~l~~ 157 (188)
...-.......+.+++.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 01112345667889999
Q ss_pred HccCcCCCCCCCHHHHHH
Q 039565 158 ASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 158 ~cl~~~p~~Rps~~~i~~ 175 (188)
.|+..||++|.|..|.++
T Consensus 728 kml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALK 745 (752)
T ss_pred HHhccChhhcCCHHHHhc
Confidence 999999999999998775
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-21 Score=142.96 Aligned_cols=159 Identities=18% Similarity=0.242 Sum_probs=115.1
Q ss_pred ccCCCeeeeccc----CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 9 LTGPLLVELIGK----QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 9 l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
-.|.||+.-+++ .+.+.+++||++.|+|.+-+.-.+ |+++|+.|+|+ ..++|||||.+|||+
T Consensus 78 s~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLi 154 (378)
T KOG1345|consen 78 SPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILI 154 (378)
T ss_pred ccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEE
Confidence 359999999988 667789999999999999993333 99999999999 999999999999999
Q ss_pred ccC--CceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 74 NEK--VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 74 ~~~--~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
-.. -++|++|||.++-.+ .. .....-...|.+|| ..+..|+|.||++++.+++|.+||...-
T Consensus 155 f~~df~rvKlcDFG~t~k~g---~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 155 FDADFYRVKLCDFGLTRKVG---TT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred ecCCccEEEeeecccccccC---ce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 543 489999999876422 11 11112223455555 3678999999999999999999985221
Q ss_pred CCC----------------cC---HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 KGE----------------FD---IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~~~----------------~~---~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... .+ ...++++..+-..-+..++++|=...+..+
T Consensus 230 ~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 230 IMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred ccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 111 11 123445666666778888888844444433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.8e-20 Score=134.98 Aligned_cols=129 Identities=30% Similarity=0.389 Sum_probs=105.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C-C--cc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G-K--EE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~-~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++|+|++++++. ....++++|++++++|.+++ . . .. +++.++.+||+ .+++|+|+++.
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ 127 (225)
T smart00221 51 LKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPE 127 (225)
T ss_pred HHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHH
Confidence 456789999999988 67899999999999999998 2 2 12 89999999999 89999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC-------CCccchHHHHHHHHHHHhCCccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-------TEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-------~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|++++.++.++++|||.+....... ........+...|++||. +.++|+|+||++++++++|+.||+.
T Consensus 128 ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 128 NILLGMDGLVKLADFGLARFIHRDL-AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred HEEEcCCCCEEEeeCceeeEecCcc-cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 9999999999999999887653221 112233455666777773 4689999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=156.65 Aligned_cols=165 Identities=21% Similarity=0.286 Sum_probs=130.5
Q ss_pred ccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 7 NKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 7 ~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
.+++|||++..+.. .....-.||||++ +|..++ .. .. |++.|+.|+|+ .|+.|||+|++|+
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enl 451 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENL 451 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccE
Confidence 45889999877766 2222233999998 999998 32 22 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCC--cceeeecccccccCCCC-------CCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGT--HMSTTIAGTAGFLNTEL-------TEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~--~~~~~~~~~~~~~~pe~-------~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
+++.+|.+|++|||.+..+...... .......|+..|+|||. ....||||.|+++..|.+|+.||......
T Consensus 452 l~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 452 LVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred EEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 9999999999999998876544444 45556889999999992 45689999999999999999888533221
Q ss_pred C--------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 E--------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ~--------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. .....+.+...++..+++.+|.+|-|+++|++
T Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 532 DNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1 11123445678888999999999999999986
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=145.08 Aligned_cols=175 Identities=23% Similarity=0.268 Sum_probs=133.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-------------cHHHHHHHHhcCCCCCc-EEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-------------VCCPGLEYLHQGLKHPI-IQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-------------~i~~~l~~Lh~~~~~~i-~h~dl~~ 68 (188)
|+.+.|.|+.+++|. +...+.|.+||+-|+|.+.+.... +++.||.|+|. ..+ .|+.++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence 568999999999999 888899999999999999993322 99999999998 444 9999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------------CCCccchHHHHHHHHHHHhCCcc
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------------LTEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------------~~~~~di~s~G~~l~~~~~g~~p 135 (188)
.|.+++..-.+|++|||+.................-..-|.+|| .+.++|+||||++++|+++...|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987542100000011111112345555 36779999999999999999988
Q ss_pred ccccCCCCc--------------------C-H-HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 136 VDLSFKGEF--------------------D-I-ISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 136 ~~~~~~~~~--------------------~-~-~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
|+.....+. . . .....+..++..||..+|..||++++|...++.....
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 865222111 0 1 2233688999999999999999999999988877654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.6e-20 Score=146.57 Aligned_cols=125 Identities=22% Similarity=0.310 Sum_probs=104.3
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecC-CCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFR-GNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~-~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+|++=.|+||++++++ ++.+|+++|.- ++-+|.+++...+ |++.|+++||+ .+|+|||+|-
T Consensus 622 ~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikd 698 (772)
T KOG1152|consen 622 TLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKD 698 (772)
T ss_pred HhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccc---cCceeccccc
Confidence 3444559999999999 88888999975 4569999993333 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccc
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
+|+.++.+|.+|+.|||.+.... ...-..+.||..|.||| ....-|||++|+++|.++-...||
T Consensus 699 envivd~~g~~klidfgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 699 ENVIVDSNGFVKLIDFGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred ccEEEecCCeEEEeeccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99999999999999999876432 12345688999999999 477889999999999888766665
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.2e-18 Score=134.26 Aligned_cols=62 Identities=26% Similarity=0.415 Sum_probs=51.7
Q ss_pred cCCCeeeeccc-------CCccEEEEecCCCCChhhhcCC--c-c-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 10 TGPLLVELIGK-------QKNNALELGFRGNPELVDQQGK--E-E-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 10 ~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~~~--~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
.-.+||++++. +.+.++|+|+... +|..++.. . + |++.||.|||. +.+|||-||||
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKP 216 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKP 216 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCc
Confidence 34568999887 7899999999974 88888822 1 1 99999999998 48999999999
Q ss_pred CcEEEc
Q 039565 69 TNILLN 74 (188)
Q Consensus 69 ~nill~ 74 (188)
+|||+.
T Consensus 217 ENvLl~ 222 (590)
T KOG1290|consen 217 ENVLLC 222 (590)
T ss_pred ceeeee
Confidence 999984
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.7e-18 Score=130.65 Aligned_cols=159 Identities=21% Similarity=0.195 Sum_probs=116.8
Q ss_pred ccCCCeeeeccc------------------------------CCccEEEEecCCCCChhhhc-CCcc----------cHH
Q 039565 9 LTGPLLVELIGK------------------------------QKNNALELGFRGNPELVDQQ-GKEE----------VCC 47 (188)
Q Consensus 9 l~Hpniv~~~~~------------------------------~~~~~lv~e~~~~~~L~~~~-~~~~----------~i~ 47 (188)
-+|||||++.+. +..+|+||.-.+. +|.+++ .+.. |++
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHH
Confidence 469999999876 4566899988874 899999 3332 999
Q ss_pred HHHHHHhcCCCCCcEEeCCCCCcEEEc--cC--CceEEecccCcccccCCCCC----cceeeecccccccCCCC------
Q 039565 48 PGLEYLHQGLKHPIIQRDMKSTNILLN--EK--VQAKLADFGQSRISPVEGGT----HMSTTIAGTAGFLNTEL------ 113 (188)
Q Consensus 48 ~~l~~Lh~~~~~~i~h~dl~~~nill~--~~--~~~kl~d~~~~~~~~~~~~~----~~~~~~~~~~~~~~pe~------ 113 (188)
+|+.|||. ++|.|||+|++||++. ++ ..+.++|||++-.-...+-+ .-....-|....|+||+
T Consensus 352 Eav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 99999999 9999999999999994 33 35789999976432111000 00112334456788883
Q ss_pred ------CCccchHHHHHHHHHHHhCCcccccc-------------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 039565 114 ------TEKSDVDSFEIVILEIITGILTVDLS-------------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMN 171 (188)
Q Consensus 114 ------~~~~di~s~G~~l~~~~~g~~p~~~~-------------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ 171 (188)
=.++|.|+.|.+.||++....||-.+ .....+..++..+.+++...++.||.+|++.+
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 25799999999999999998888431 11223445666788999999999999999854
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.1e-18 Score=132.47 Aligned_cols=162 Identities=19% Similarity=0.216 Sum_probs=123.8
Q ss_pred CCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccC-C
Q 039565 11 GPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEK-V 77 (188)
Q Consensus 11 Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~-~ 77 (188)
+.||+++.++ .++..+|+||.+..+..++..... .+..||.++|. .||+|||+||.|++.+.. +
T Consensus 94 ~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~ 170 (418)
T KOG1167|consen 94 SDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQ 170 (418)
T ss_pred chhhhcchhhhccCCeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccC
Confidence 6788899888 889999999999988888884444 88999999999 999999999999999865 6
Q ss_pred ceEEecccCccccc---------C-------C--------------------------CCCcceeeecccccccCCC---
Q 039565 78 QAKLADFGQSRISP---------V-------E--------------------------GGTHMSTTIAGTAGFLNTE--- 112 (188)
Q Consensus 78 ~~kl~d~~~~~~~~---------~-------~--------------------------~~~~~~~~~~~~~~~~~pe--- 112 (188)
+-.|.|||++.... . . ..........||++|.+||
T Consensus 171 rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~ 250 (418)
T KOG1167|consen 171 RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF 250 (418)
T ss_pred CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh
Confidence 77899999986210 0 0 0001112356899999999
Q ss_pred ----CCCccchHHHHHHHHHHHhCCcccc----------------------------cc--CCC----------------
Q 039565 113 ----LTEKSDVDSFEIVILEIITGILTVD----------------------------LS--FKG---------------- 142 (188)
Q Consensus 113 ----~~~~~di~s~G~~l~~~~~g~~p~~----------------------------~~--~~~---------------- 142 (188)
-+++.|+||.|+++..++++..||= .. +++
T Consensus 251 k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s 330 (418)
T KOG1167|consen 251 RCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFET 330 (418)
T ss_pred hccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhc
Confidence 4788999999999999999987650 00 000
Q ss_pred -----------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 -----------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 -----------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
......+..+.+++.+|+..||.+|.|+++.++
T Consensus 331 ~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 331 LHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 001112336789999999999999999999876
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.5e-16 Score=124.51 Aligned_cols=103 Identities=17% Similarity=0.196 Sum_probs=77.3
Q ss_pred cccccCCCeee-ecccCCccEEEEecCCCCChhhhcCCc-c----cHHHHHHHHhcCCCCCcEEeCC-CCCcEEEccCCc
Q 039565 6 RNKLTGPLLVE-LIGKQKNNALELGFRGNPELVDQQGKE-E----VCCPGLEYLHQGLKHPIIQRDM-KSTNILLNEKVQ 78 (188)
Q Consensus 6 l~~l~Hpniv~-~~~~~~~~~lv~e~~~~~~L~~~~~~~-~----~i~~~l~~Lh~~~~~~i~h~dl-~~~nill~~~~~ 78 (188)
|.+++|+|++. +++. ...+++|||+++++|....... . +++.||.|||+ .+|+|||| ||+||+++.++.
T Consensus 75 L~~L~h~~iv~~l~~~-~~~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 75 LKTVRGIGVVPQLLAT-GKDGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred HHhccCCCCCcEEEEc-CCcEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCC
Confidence 56789999885 4443 4679999999999997432211 1 89999999999 99999999 999999999999
Q ss_pred eEEecccCcccccCCCCCcc------eeeecccccccCCC
Q 039565 79 AKLADFGQSRISPVEGGTHM------STTIAGTAGFLNTE 112 (188)
Q Consensus 79 ~kl~d~~~~~~~~~~~~~~~------~~~~~~~~~~~~pe 112 (188)
++|+|||+++.......... .....++..|.+||
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe 190 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD 190 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence 99999999986542221111 12345566677777
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.9e-16 Score=128.83 Aligned_cols=161 Identities=25% Similarity=0.235 Sum_probs=129.4
Q ss_pred ccc-CCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 8 KLT-GPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 8 ~l~-Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
.++ ||.++++.-. +...++++++..+|.|...+.+.. .++-|++++|. .+++|+|+|++||
T Consensus 52 ~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~eni 128 (612)
T KOG0603|consen 52 FVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENV 128 (612)
T ss_pred hccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccce
Confidence 344 8899998655 889999999999999998883333 78899999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC----CCCccchHHHHHHHHHHHhCCcccccc-------C
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE----LTEKSDVDSFEIVILEIITGILTVDLS-------F 140 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe----~~~~~di~s~G~~l~~~~~g~~p~~~~-------~ 140 (188)
+++.+|++++.|||+++...... ..+|+..||+|| ....+|.||||++.+++++|..||... .
T Consensus 129 lld~~Ghi~~tdfglske~v~~~------~~cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~ 202 (612)
T KOG0603|consen 129 LLLLEGHIKLTDFGLSKEAVKEK------IACGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKA 202 (612)
T ss_pred eecccCccccCCchhhhHhHhhh------hcccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhh
Confidence 99999999999999988643111 117899999999 467899999999999999999999761 1
Q ss_pred CCCcCHHHHHHHHHHHHHccCcCCCCCCCH--HHHHHHH
Q 039565 141 KGEFDIISVEKAVEIAMASVSSKVNRRPLM--NQVVMVR 177 (188)
Q Consensus 141 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~--~~i~~~l 177 (188)
....+......+.+++......+|.+|.-. +.+.+..
T Consensus 203 ~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 203 ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 233556667778888888888899888743 3444433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1e-14 Score=112.04 Aligned_cols=167 Identities=26% Similarity=0.361 Sum_probs=127.2
Q ss_pred cccccCC-Ceeeeccc---CCccEEEEecCCCCChhhhc-CC-----cc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGP-LLVELIGK---QKNNALELGFRGNPELVDQQ-GK-----EE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hp-niv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~-----~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.++.|+ +++++.+. ....+++++++.++++..++ .. .. |++.++.|+|. .+++|||+
T Consensus 51 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~ 127 (384)
T COG0515 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDI 127 (384)
T ss_pred HHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCC
Confidence 4567777 79999888 44469999999999999777 22 22 99999999999 89999999
Q ss_pred CCCcEEEccCC-ceEEecccCcccccCCCCCc----ceeeecccccccCCC---------CCCccchHHHHHHHHHHHhC
Q 039565 67 KSTNILLNEKV-QAKLADFGQSRISPVEGGTH----MSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 67 ~~~nill~~~~-~~kl~d~~~~~~~~~~~~~~----~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g 132 (188)
||+|++++..+ .+++.|||.+.......... ......|+..|++|| .....|+||+|++++++++|
T Consensus 128 kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~ 207 (384)
T COG0515 128 KPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTG 207 (384)
T ss_pred CHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhC
Confidence 99999999988 79999999987543222211 234567888888887 24578999999999999999
Q ss_pred CccccccCCC----C---------cC-----HHH------HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 133 ILTVDLSFKG----E---------FD-----IIS------VEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 133 ~~p~~~~~~~----~---------~~-----~~~------~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..|+...... . .+ ... ...+.+++..|+..+|..|.+..+...
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 208 LPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred CCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 9886544320 0 00 001 146788899999999999998776654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.1e-16 Score=135.37 Aligned_cols=166 Identities=19% Similarity=0.162 Sum_probs=121.1
Q ss_pred cccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCcEE
Q 039565 8 KLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTNIL 72 (188)
Q Consensus 8 ~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~nil 72 (188)
..+|||++.+.-+ ..-.|+|-+|..+ +|.+.+...+ |++.|+..+|. .+|.|||||.+|||
T Consensus 77 l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENIL 152 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENIL 152 (1431)
T ss_pred hhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEE
Confidence 3578998888766 6667788888875 8999884444 99999999999 99999999999999
Q ss_pred EccCCceEEecccCcccccCCCCCcce-----eeecccccccCCC-----------------CCCccchHHHHHHHHHHH
Q 039565 73 LNEKVQAKLADFGQSRISPVEGGTHMS-----TTIAGTAGFLNTE-----------------LTEKSDVDSFEIVILEII 130 (188)
Q Consensus 73 l~~~~~~kl~d~~~~~~~~~~~~~~~~-----~~~~~~~~~~~pe-----------------~~~~~di~s~G~~l~~~~ 130 (188)
++.=.++.|+||...+-.-.+...... .+...-.+|.||| .+++=||+|+||++.|++
T Consensus 153 iTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf 232 (1431)
T KOG1240|consen 153 ITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELF 232 (1431)
T ss_pred EeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHH
Confidence 999999999999876532111111000 0111112466666 467789999999999997
Q ss_pred -hCCcccccc------CCCCcCH------HHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 039565 131 -TGILTVDLS------FKGEFDI------ISVEKAVEIAMASVSSKVNRRPLMNQVVMVR 177 (188)
Q Consensus 131 -~g~~p~~~~------~~~~~~~------~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l 177 (188)
.|+++|+-. ....... .+...+.+++..|++.||.+|-++++.++.-
T Consensus 233 ~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 233 LEGRPLFTLSQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred hcCCCcccHHHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 568888531 1111111 2233678999999999999999999998763
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.4e-16 Score=114.24 Aligned_cols=113 Identities=15% Similarity=0.190 Sum_probs=83.6
Q ss_pred CcccccCCCeeeeccc-----------CCccEEEEecCCCCChhhhcCCc----ccHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 5 NRNKLTGPLLVELIGK-----------QKNNALELGFRGNPELVDQQGKE----EVCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~-----------~~~~~lv~e~~~~~~L~~~~~~~----~~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
.+.+++||+|..+..+ ....+++|||++|.+|.++.... .+++.++..+|+ .+++|||++|.
T Consensus 88 ~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~---~gi~H~Dikp~ 164 (232)
T PRK10359 88 QTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQ---HGMVSGDPHKG 164 (232)
T ss_pred HHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHH---cCCccCCCChH
Confidence 3577889998888766 13578999999999998876221 199999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCCCCccchHHHHHHHHHH
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTELTEKSDVDSFEIVILEI 129 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~di~s~G~~l~~~ 129 (188)
|++++.++ +++.|||.......... ... ..+-..+..++|+||||+++.-.
T Consensus 165 Nili~~~g-i~liDfg~~~~~~e~~a---~d~-----~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 165 NFIVSKNG-LRIIDLSGKRCTAQRKA---KDR-----IDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred HEEEeCCC-EEEEECCCcccccchhh---HHH-----HHHHhHhcccccccceeEeehHH
Confidence 99999888 99999997764321111 110 00111145689999999986643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.2e-16 Score=123.29 Aligned_cols=144 Identities=19% Similarity=0.273 Sum_probs=107.3
Q ss_pred CccEEEEecCCCCChhhhc-CCcc--------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccC
Q 039565 22 KNNALELGFRGNPELVDQQ-GKEE--------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQ 86 (188)
Q Consensus 22 ~~~~lv~e~~~~~~L~~~~-~~~~--------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~ 86 (188)
..+++.|++|...+|.+|+ ++.. |++.|++| ++.+|+|+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 4688999999999999999 3332 77777777 6889999999999999999999999998
Q ss_pred cccccCCC----CCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccc------cccCCCCcCHH--
Q 039565 87 SRISPVEG----GTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTV------DLSFKGEFDII-- 147 (188)
Q Consensus 87 ~~~~~~~~----~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~------~~~~~~~~~~~-- 147 (188)
........ .........|+..||+|| ++.++||||+|++++|++. -...+ .....+.+++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFL 482 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHh
Confidence 76543222 112334578999999999 7999999999999999987 22222 22222223321
Q ss_pred -HHHHHHHHHHHccCcCCCCCCCHH
Q 039565 148 -SVEKAVEIAMASVSSKVNRRPLMN 171 (188)
Q Consensus 148 -~~~~~~~l~~~cl~~~p~~Rps~~ 171 (188)
.-..-..++.+++...|.+||++.
T Consensus 483 ~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 483 QDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hcCcHHHHHHHHhcCCCcccCchHH
Confidence 112345889999999999999543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=9e-15 Score=106.71 Aligned_cols=127 Identities=13% Similarity=0.083 Sum_probs=92.7
Q ss_pred ccccc-CCCeeeecccCCccEEEEecCCCCChhhhcCCcc-----cHHHHHHHHhcCCCCCcEEeCC-CCCcEEEccCCc
Q 039565 6 RNKLT-GPLLVELIGKQKNNALELGFRGNPELVDQQGKEE-----VCCPGLEYLHQGLKHPIIQRDM-KSTNILLNEKVQ 78 (188)
Q Consensus 6 l~~l~-Hpniv~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~i~~~l~~Lh~~~~~~i~h~dl-~~~nill~~~~~ 78 (188)
|.++. |+++++++++ +..+++|||+.+.+|........ |++.++.++|+ .+|+|+|+ ||.||+++.++.
T Consensus 55 L~~L~~~~~vP~ll~~-~~~~lvmeyI~G~~L~~~~~~~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~ 130 (218)
T PRK12274 55 LRQLDGLPRTPRLLHW-DGRHLDRSYLAGAAMYQRPPRGDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGS 130 (218)
T ss_pred HHhcCCCCCCCEEEEE-cCEEEEEeeecCccHHhhhhhhhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCC
Confidence 45664 4778888887 34699999999999977652212 88999999999 99999999 799999999999
Q ss_pred eEEecccCcccccCCCCCc----c----e----eeecccccccCCC-------CC-CccchHHHHHHHHHHHhCCcccc
Q 039565 79 AKLADFGQSRISPVEGGTH----M----S----TTIAGTAGFLNTE-------LT-EKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 79 ~kl~d~~~~~~~~~~~~~~----~----~----~~~~~~~~~~~pe-------~~-~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
++|+|||++.... ..... . . .-...++.+++|+ .+ .+.+.++-|.-+|.++|+..+.-
T Consensus 131 i~LIDFG~A~~~~-~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 131 PAVIDFQLAVRGN-PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred EEEEECCCceecC-CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 9999999998543 22210 0 0 0122455666665 22 34455577999999999987653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.1e-15 Score=112.51 Aligned_cols=135 Identities=19% Similarity=0.140 Sum_probs=88.2
Q ss_pred ccEEEEecCCCCChhhhc------CCcc-------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEec
Q 039565 23 NNALELGFRGNPELVDQQ------GKEE-------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLAD 83 (188)
Q Consensus 23 ~~~lv~e~~~~~~L~~~~------~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d 83 (188)
+.+++|.-+. ++|..++ .+.. |+...+++||+ .|++|+|++|+|++++.+|.+.|+|
T Consensus 113 n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~~~nfll~~~G~v~Lg~ 188 (288)
T PF14531_consen 113 NRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIKPENFLLDQDGGVFLGD 188 (288)
T ss_dssp SEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEE-TTS-EEE--
T ss_pred hhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccceeeEEEcCCCCEEEcC
Confidence 3456666665 6887775 1111 88899999999 9999999999999999999999999
Q ss_pred ccCcccccCCCCCcceeeecccccccCCC--------------CCCccchHHHHHHHHHHHhCCccccccCC--------
Q 039565 84 FGQSRISPVEGGTHMSTTIAGTAGFLNTE--------------LTEKSDVDSFEIVILEIITGILTVDLSFK-------- 141 (188)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-------- 141 (188)
|+...... .. ... ...+..+.+|| ++.+.|.|++|+++|.+.++..||+....
T Consensus 189 F~~~~r~g---~~-~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~~f 263 (288)
T PF14531_consen 189 FSSLVRAG---TR-YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEWDF 263 (288)
T ss_dssp GGGEEETT---EE-EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGGGG
T ss_pred hHHHeecC---ce-eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccccc
Confidence 97654321 11 111 12223444454 46778999999999999999999974322
Q ss_pred CCcCHHHHHHHHHHHHHccCcCCCCC
Q 039565 142 GEFDIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 142 ~~~~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
.... ..++.+..++...|+.+|.+|
T Consensus 264 ~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 264 SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 2233 788999999999999999987
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3e-13 Score=106.06 Aligned_cols=167 Identities=20% Similarity=0.270 Sum_probs=118.8
Q ss_pred CCeeeeccc----CCccEEEEecCCCCChhhhc-CCc-c------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 12 PLLVELIGK----QKNNALELGFRGNPELVDQQ-GKE-E------------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 12 pniv~~~~~----~~~~~lv~e~~~~~~L~~~~-~~~-~------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
+++.++++. ....++||+.+. .+|.++. ... . |++.+|+++|+ .|++|||+||.|+++
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~G-~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~ 155 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLLG-PSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVV 155 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEeccC-ccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeee
Confidence 355666555 446789988886 5999977 222 1 99999999999 999999999999999
Q ss_pred ccC-----CceEEecccCcc--cccCCCCC---cc---eeeecccccccCCC------CCCccchHHHHHHHHHHHhCCc
Q 039565 74 NEK-----VQAKLADFGQSR--ISPVEGGT---HM---STTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGIL 134 (188)
Q Consensus 74 ~~~-----~~~kl~d~~~~~--~~~~~~~~---~~---~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~ 134 (188)
+.. ..+.+.|||+++ .+...... .. ...+.||..|.++. .+.+.|+||++.++.++..|.+
T Consensus 156 g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~L 235 (322)
T KOG1164|consen 156 GQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSL 235 (322)
T ss_pred cCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCC
Confidence 865 358999999998 32211111 11 22356888888765 6899999999999999999999
Q ss_pred cccccCCCC----------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 135 TVDLSFKGE----------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 135 p~~~~~~~~----------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
||....... .....+..+.++...+-..+...+|....+...|++...
T Consensus 236 PW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 236 PWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred CCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 984322110 001123455566666666888899998888887765543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-14 Score=122.78 Aligned_cols=121 Identities=22% Similarity=0.285 Sum_probs=97.1
Q ss_pred cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCC------------C-CCcceeeecccccccCC
Q 039565 45 VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVE------------G-GTHMSTTIAGTAGFLNT 111 (188)
Q Consensus 45 ~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~------------~-~~~~~~~~~~~~~~~~p 111 (188)
+++.|++|+|+ .+|+|||+||+|.+++.-|+.|+.|||+++..... . ..-.....+|++.|.+|
T Consensus 151 dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 151 DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence 88899999999 99999999999999999999999999998742100 0 00112346899999999
Q ss_pred C------CCCccchHHHHHHHHHHHhCCccccccCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCC
Q 039565 112 E------LTEKSDVDSFEIVILEIITGILTVDLSFK--------------GEFDIISVEKAVEIAMASVSSKVNRRP 168 (188)
Q Consensus 112 e------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rp 168 (188)
| |...+|.|++|+++|+.+.|..||....+ .|-+.....+..+++.+.++.+|..|-
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 9 78899999999999999999999865522 223444566788888899999998886
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.5e-14 Score=109.13 Aligned_cols=173 Identities=17% Similarity=0.196 Sum_probs=117.5
Q ss_pred CCCCcccccCCCeeeeccc--------CCccEEEEecCCCCChhhhcCC---cc-------------cHHHHHHHHhcCC
Q 039565 2 YFPNRNKLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQGK---EE-------------VCCPGLEYLHQGL 57 (188)
Q Consensus 2 ~~~~l~~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~~~---~~-------------~i~~~l~~Lh~~~ 57 (188)
.|.++-.+.|.|+|++..+ .....++.||+..|++..++++ .. |+..||.|||+ +
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 3667788899999999888 3345799999999999999922 22 99999999996 4
Q ss_pred CCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCC--CcceeeecccccccCCC------CCCccchHHHHHHHHHH
Q 039565 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGG--THMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEI 129 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~ 129 (188)
...++|+++.-..+++..+|.+|+..-.-......... ........+.++|.+|+ .+..+|||+||.+..+|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 57899999999999999999888753221111100000 01111234556777777 35679999999999998
Q ss_pred HhCCccc-cccCCCCcCHHHH--------HHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 130 ITGILTV-DLSFKGEFDIISV--------EKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 130 ~~g~~p~-~~~~~~~~~~~~~--------~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+..-- .....-+...... ..-...+..|++-.|+.||+|.+++.
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhc
Confidence 7765321 1111101000000 01235677899999999999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.8e-14 Score=118.19 Aligned_cols=162 Identities=22% Similarity=0.301 Sum_probs=129.2
Q ss_pred CCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-------------cHHHHHHHHh-cCCCCCcEEeCCCCCcEE
Q 039565 11 GPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-------------VCCPGLEYLH-QGLKHPIIQRDMKSTNIL 72 (188)
Q Consensus 11 Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-------------~i~~~l~~Lh-~~~~~~i~h~dl~~~nil 72 (188)
|+|++++++. .+..+++++|.+++++.+.+ .... |+..++.|+| . .++.|+|++|+|.+
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSL 156 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccch
Confidence 9999999999 88899999999999988887 3321 9999999999 7 99999999999999
Q ss_pred EccCC-ceEEecccCcccccC-CCCCcceeeecc-cccccCCCC-------CCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 73 LNEKV-QAKLADFGQSRISPV-EGGTHMSTTIAG-TAGFLNTEL-------TEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 73 l~~~~-~~kl~d~~~~~~~~~-~~~~~~~~~~~~-~~~~~~pe~-------~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
++.++ ..+.+|||++..+.. .+.........| ++.|.+||. .+..|+||.|+++..+++|..|++.....
T Consensus 157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 99999 999999999987654 333334445677 889999993 56789999999999999999887543221
Q ss_pred C----------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 E----------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ~----------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. .-........++...++..+|..|.+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 237 DGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 1 11123445667788888899999999877643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.2e-13 Score=99.07 Aligned_cols=80 Identities=15% Similarity=0.146 Sum_probs=58.8
Q ss_pred cccccCCCeeeeccc-CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHH-hcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK-QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYL-HQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~L-h~~~~~~i~h~dl~~~ni 71 (188)
+.++.++++.....+ ....++||||++++++.... .... |++.+|.++ |+ .+++|||+||.||
T Consensus 73 l~~l~~~~v~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NI 149 (190)
T cd05147 73 LKRLVTAGIPCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNL 149 (190)
T ss_pred HHHHHHCCCCCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHE
Confidence 444555554332222 23458999999987775543 2211 899999999 67 8999999999999
Q ss_pred EEccCCceEEecccCccc
Q 039565 72 LLNEKVQAKLADFGQSRI 89 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~ 89 (188)
+++ ++.++++|||++..
T Consensus 150 li~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 150 LYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred EEE-CCcEEEEEcccccc
Confidence 998 47899999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.6e-13 Score=98.16 Aligned_cols=75 Identities=17% Similarity=0.172 Sum_probs=59.0
Q ss_pred cCCCeeeeccc--CC----c-cEEEEec--CCCCChhhhcCCcc---------cHHHHH-HHHhcCCCCCcEEeCCCCCc
Q 039565 10 TGPLLVELIGK--QK----N-NALELGF--RGNPELVDQQGKEE---------VCCPGL-EYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 10 ~Hpniv~~~~~--~~----~-~~lv~e~--~~~~~L~~~~~~~~---------~i~~~l-~~Lh~~~~~~i~h~dl~~~n 70 (188)
+||||++++|+ .+ . ..+|+|| +.+++|.+++.+.. +++.++ +|||+ .+|+|||+||+|
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~---~~IvhrDlKp~N 135 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLD---NRIVTMELKPQN 135 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHH---CCEeecCCCHHH
Confidence 68999999999 22 2 2378999 55789999993221 666666 89999 999999999999
Q ss_pred EEEcc----CCceEEecccCc
Q 039565 71 ILLNE----KVQAKLADFGQS 87 (188)
Q Consensus 71 ill~~----~~~~kl~d~~~~ 87 (188)
|+++. ++.++|+|++.+
T Consensus 136 ILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 136 ILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEeccCCCCCcEEEEECCCC
Confidence 99974 347999995544
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.3e-12 Score=107.61 Aligned_cols=125 Identities=13% Similarity=0.114 Sum_probs=93.1
Q ss_pred CCCcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 3 FPNRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 3 ~~~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+|+.++||||++++.. ....|+|+|-+. .|..++++.+ |++.||.|||+. .+++|+++....
T Consensus 60 ~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~S 135 (690)
T KOG1243|consen 60 VKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELGKEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDS 135 (690)
T ss_pred HHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhHHHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeee
Confidence 357899999999999998 778899999986 5777774443 999999999962 899999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCCCC----ccchHHHHHHHHHHHhCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTELTE----KSDVDSFEIVILEIITGI 133 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~----~~di~s~G~~l~~~~~g~ 133 (188)
++++..|.+||++|........... ......--..+..|+.-. ..|.|.||+++++++.|.
T Consensus 136 VfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 136 VFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSEWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred EEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccccchhhhhHHHHHHHHhCcc
Confidence 9999999999999987643221110 011111112234444222 369999999999999993
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.9e-13 Score=96.82 Aligned_cols=83 Identities=19% Similarity=0.147 Sum_probs=61.8
Q ss_pred CcccccCCCeeeeccc-CCccEEEEecCCCCChhhh-cCC--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 5 NRNKLTGPLLVELIGK-QKNNALELGFRGNPELVDQ-QGK--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~-~~~~~lv~e~~~~~~L~~~-~~~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
.+.++.|+++.....+ ....++||||++++++... +.. .. |++.++.++|+ ..+++|+|+||.||
T Consensus 72 ~l~~l~~~~i~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NI 149 (190)
T cd05145 72 NLKRLYEAGVPVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNI 149 (190)
T ss_pred HHHHHHhCCCCCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhE
Confidence 3556667776433333 2345899999998754433 321 11 99999999997 27999999999999
Q ss_pred EEccCCceEEecccCcccc
Q 039565 72 LLNEKVQAKLADFGQSRIS 90 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~ 90 (188)
+++ ++.++++|||++...
T Consensus 150 ll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred EEE-CCCEEEEEcccceec
Confidence 999 789999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.4e-11 Score=106.72 Aligned_cols=156 Identities=20% Similarity=0.141 Sum_probs=106.1
Q ss_pred CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEcc-------CCceEE
Q 039565 21 QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNE-------KVQAKL 81 (188)
Q Consensus 21 ~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~-------~~~~kl 81 (188)
.+..+|++||.+.|+|.+++.... |++.-++.||. .+|||+||||+|.++.. +..++|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence 788899999999999999994322 99999999999 99999999999999953 346899
Q ss_pred ecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcc-c-ccc-------CCCCcCH
Q 039565 82 ADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILT-V-DLS-------FKGEFDI 146 (188)
Q Consensus 82 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p-~-~~~-------~~~~~~~ 146 (188)
+|||.+.-+..-.....-....++-.+-.+| ++-..|.|.+..+++-|+-|+.. + +.. ++..+..
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~~~~~~~Ry~~~ 922 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWMVKTNFPRYWKR 922 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcceeccccchhhhhH
Confidence 9999886433221111222223333333333 68899999999999999998731 1 111 1122222
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 147 ISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 147 ~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
+.-.++++ ..|+.+-..=|...+|...|++...
T Consensus 923 ~~W~~~F~---~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 923 DMWNKFFD---LLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred HHHHHHHH---HHhCcCcccchhHHHHHHHHHHHHH
Confidence 33334444 4555666666777788777776543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.2e-11 Score=93.27 Aligned_cols=124 Identities=21% Similarity=0.326 Sum_probs=97.1
Q ss_pred CCCeeeeccc---CCccEEEEecCCCCChhhhc----CCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 11 GPLLVELIGK---QKNNALELGFRGNPELVDQQ----GKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 11 Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~----~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
-+.|.+.+-+ +.+..||+|... .+|++.. ++.. |+..-++|+|+ +..|+||+||+|.||.
T Consensus 83 ~~GIP~vYYFGqeG~~NiLVidLLG-PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIG 158 (449)
T KOG1165|consen 83 TEGIPQVYYFGQEGKYNILVIDLLG-PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIG 158 (449)
T ss_pred CCCCCceeeeccccchhhhhhhhhC-cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeec
Confidence 3556666555 677789999986 4777766 3333 99999999999 9999999999999998
Q ss_pred cCC-----ceEEecccCcccccCCCCCc-----ceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 75 EKV-----QAKLADFGQSRISPVEGGTH-----MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 75 ~~~-----~~kl~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
..+ .+.++|||+++.+..+.... ......||..||+-. -+.+.|.=|+|-++...+.|.+||..
T Consensus 159 rp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 159 RPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred CCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 654 47899999999776443321 223568999998754 68899999999999999999999954
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.5e-12 Score=105.27 Aligned_cols=80 Identities=16% Similarity=0.237 Sum_probs=67.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc---cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE---VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQ 78 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~---~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~ 78 (188)
+.+++|++++....+ ....+++|||+++++|.+++.. .. +++.+|.+||+ .+++|||+||.||++ .++.
T Consensus 390 l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~ 465 (535)
T PRK09605 390 LSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDR 465 (535)
T ss_pred HHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCc
Confidence 456789998765444 6678999999999999998832 22 99999999999 999999999999999 6778
Q ss_pred eEEecccCccc
Q 039565 79 AKLADFGQSRI 89 (188)
Q Consensus 79 ~kl~d~~~~~~ 89 (188)
++++|||+++.
T Consensus 466 ~~liDFGla~~ 476 (535)
T PRK09605 466 LYLIDFGLGKY 476 (535)
T ss_pred EEEEeCccccc
Confidence 99999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.3e-11 Score=92.85 Aligned_cols=81 Identities=17% Similarity=0.184 Sum_probs=64.9
Q ss_pred cccccCCCe--eeeccc----CC---ccEEEEecCCC-CChhhhcCCcc-------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLL--VELIGK----QK---NNALELGFRGN-PELVDQQGKEE-------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpni--v~~~~~----~~---~~~lv~e~~~~-~~L~~~~~~~~-------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++|++| ++.++. .. ..++|+|++++ .+|.+++.... +++.++.+||+ .+|+|+|+||
T Consensus 94 l~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~---~GI~HrDlkp 170 (239)
T PRK01723 94 LAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHD---AGVYHADLNA 170 (239)
T ss_pred HHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHH---CCCCCCCCCc
Confidence 456777774 555554 11 23599999997 68988873322 89999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCccc
Q 039565 69 TNILLNEKVQAKLADFGQSRI 89 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~ 89 (188)
.||+++.++.++++|||.+..
T Consensus 171 ~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 171 HNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred hhEEEcCCCCEEEEECCCccc
Confidence 999999988999999998775
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=2e-11 Score=89.84 Aligned_cols=80 Identities=19% Similarity=0.178 Sum_probs=65.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c----c---cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E----E---VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~----~---~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+.++.|+++.....+ ....+++|||+++++|.+++.. . . +++.+|.++|+ .+++|+|++|.||+++
T Consensus 53 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~ 129 (211)
T PRK14879 53 MSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS 129 (211)
T ss_pred HHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE
Confidence 345667776544333 6778999999999999999822 1 1 89999999999 9999999999999999
Q ss_pred cCCceEEecccCccc
Q 039565 75 EKVQAKLADFGQSRI 89 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~ 89 (188)
++.++++|||.+..
T Consensus 130 -~~~~~liDf~~a~~ 143 (211)
T PRK14879 130 -GGKIYLIDFGLAEF 143 (211)
T ss_pred -CCCEEEEECCcccC
Confidence 78899999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.4e-11 Score=88.70 Aligned_cols=79 Identities=18% Similarity=0.231 Sum_probs=64.9
Q ss_pred ccccCCC--eeeeccc-CCccEEEEecCCCCChhhhcCCc--c---cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCc
Q 039565 7 NKLTGPL--LVELIGK-QKNNALELGFRGNPELVDQQGKE--E---VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQ 78 (188)
Q Consensus 7 ~~l~Hpn--iv~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~---~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~ 78 (188)
.+++|++ ++.++.. ....+++|||+++++|.+++... . +++.+|.++|+ .+++|+|++|.|++++ ++.
T Consensus 52 ~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~ 127 (199)
T TIGR03724 52 SRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGNDELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDK 127 (199)
T ss_pred HHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCc
Confidence 3456665 3444445 67779999999999999988332 2 99999999999 9999999999999999 789
Q ss_pred eEEecccCccc
Q 039565 79 AKLADFGQSRI 89 (188)
Q Consensus 79 ~kl~d~~~~~~ 89 (188)
+++.|||.+..
T Consensus 128 ~~liDfg~a~~ 138 (199)
T TIGR03724 128 LYLIDFGLGKY 138 (199)
T ss_pred EEEEECCCCcC
Confidence 99999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4e-11 Score=88.30 Aligned_cols=152 Identities=20% Similarity=0.199 Sum_probs=108.3
Q ss_pred CCccEEEEecCCCCChhhhcCC----cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccC---CceEEecc
Q 039565 21 QKNNALELGFRGNPELVDQQGK----EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEK---VQAKLADF 84 (188)
Q Consensus 21 ~~~~~lv~e~~~~~~L~~~~~~----~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~---~~~kl~d~ 84 (188)
.....+||+... .+|++.... .. |++.-++|+|. ++.+|||+||+|.+..-+ ..+-+.||
T Consensus 83 ~~ynvlVMdLLG-PsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 83 KDYNVLVMDLLG-PSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred cccceeeeeccC-ccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEec
Confidence 566789999986 588887722 22 99999999999 999999999999999765 35679999
Q ss_pred cCcccccCCCCC-----cceeeecccccccCC------CCCCccchHHHHHHHHHHHhCCccccccCCCC----------
Q 039565 85 GQSRISPVEGGT-----HMSTTIAGTAGFLNT------ELTEKSDVDSFEIVILEIITGILTVDLSFKGE---------- 143 (188)
Q Consensus 85 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~p------e~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~---------- 143 (188)
|+++.+....+. ......+||..|.+- |.+.+.|+=|+|.++.....|.+||..-....
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 999876432221 122346777777653 36889999999999999999999996533221
Q ss_pred ----cCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 144 ----FDI-----ISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 144 ----~~~-----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
.+. ..+.++.-.+.-|-...=++-|...-+-+.
T Consensus 239 kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrql 280 (341)
T KOG1163|consen 239 KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQL 280 (341)
T ss_pred hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence 111 123356667777877777777775444443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.1e-11 Score=86.36 Aligned_cols=67 Identities=18% Similarity=0.222 Sum_probs=57.6
Q ss_pred CCccEEEEecCCCCChhhhcC-Ccc-----cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccc
Q 039565 21 QKNNALELGFRGNPELVDQQG-KEE-----VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRIS 90 (188)
Q Consensus 21 ~~~~~lv~e~~~~~~L~~~~~-~~~-----~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~ 90 (188)
....+++|||+++++|..... ... +++.++.++|+ .+++|+|++|.||+++.++.++++|||.+...
T Consensus 103 ~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 103 WNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred cCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 345689999999999887764 211 99999999999 99999999999999999999999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.7e-11 Score=88.28 Aligned_cols=64 Identities=22% Similarity=0.253 Sum_probs=54.4
Q ss_pred ccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCC-cEEeCCCCCcEEEccCCceEEecccCccc
Q 039565 23 NNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHP-IIQRDMKSTNILLNEKVQAKLADFGQSRI 89 (188)
Q Consensus 23 ~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~-i~h~dl~~~nill~~~~~~kl~d~~~~~~ 89 (188)
..++||||+++.+|.... .... |++.++.+||+ .+ ++|+|+||+||+++ ++.++++|||.+..
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 458999999998887655 2221 89999999999 88 99999999999999 78999999998764
Q ss_pred c
Q 039565 90 S 90 (188)
Q Consensus 90 ~ 90 (188)
.
T Consensus 198 ~ 198 (237)
T smart00090 198 L 198 (237)
T ss_pred c
Confidence 3
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.1e-09 Score=74.11 Aligned_cols=83 Identities=16% Similarity=0.125 Sum_probs=64.3
Q ss_pred ccccC--CCeeeeccc---CCccEEEEecCCCCChhhh-----cCCcccHHHHHHHHhcCCCCCcEEeCCCCCcEEEccC
Q 039565 7 NKLTG--PLLVELIGK---QKNNALELGFRGNPELVDQ-----QGKEEVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEK 76 (188)
Q Consensus 7 ~~l~H--pniv~~~~~---~~~~~lv~e~~~~~~L~~~-----~~~~~~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~ 76 (188)
.+++| +++++++.. .+..++++||+.++++..+ .....+++.+++++|.....+++|+|++|.|++++..
T Consensus 46 ~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 46 QLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred HHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 34444 477777766 5679999999998877643 1112289999999998433479999999999999998
Q ss_pred CceEEecccCccc
Q 039565 77 VQAKLADFGQSRI 89 (188)
Q Consensus 77 ~~~kl~d~~~~~~ 89 (188)
+.+++.||+.+..
T Consensus 126 ~~~~l~Df~~~~~ 138 (155)
T cd05120 126 KILGIIDWEYAGY 138 (155)
T ss_pred cEEEEEecccccC
Confidence 8999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.2e-08 Score=72.26 Aligned_cols=66 Identities=20% Similarity=0.223 Sum_probs=52.7
Q ss_pred CccEEEEecCCCC-----ChhhhcCCcc------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccc
Q 039565 22 KNNALELGFRGNP-----ELVDQQGKEE------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRIS 90 (188)
Q Consensus 22 ~~~~lv~e~~~~~-----~L~~~~~~~~------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~ 90 (188)
...+++|||++++ .|........ +++.++.++|.. .+++|+|++|+||+++ ++.++++|||.+...
T Consensus 88 ~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 88 NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 3568999999984 4444332111 899999999973 7999999999999999 889999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.6e-08 Score=80.67 Aligned_cols=166 Identities=19% Similarity=0.116 Sum_probs=117.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHH----HHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCP----GLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~----~l~~Lh~~~~~~i~h~d 65 (188)
...=.|+|.++.+.. .+..++-+|.+. .+|..+. .... +... |+..+|+ ..++|-|
T Consensus 172 ~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~ 247 (524)
T KOG0601|consen 172 HKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDD 247 (524)
T ss_pred cccCccccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---Ccccccc
Confidence 333458888886555 888899999998 5787777 2221 5555 9999999 9999999
Q ss_pred CCCCcEEEccC-CceEEecccCcccccCCC---CCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccc
Q 039565 66 MKSTNILLNEK-VQAKLADFGQSRISPVEG---GTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 66 l~~~nill~~~-~~~kl~d~~~~~~~~~~~---~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
++|.|+++..+ ..+++.||++...+.... .........+...|++|| .+..+|++++|-++.+...+..+.
T Consensus 248 ~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 248 LKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred cchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccc
Confidence 99999999999 888999999876543221 111122225666788888 578899999999999887776332
Q ss_pred ccc------------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 137 DLS------------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 137 ~~~------------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... .+.++-......+..++.++++.+|-.|++.+.+..
T Consensus 328 ~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 328 SVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111 112222233456667899999999999999765543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=8.3e-08 Score=68.51 Aligned_cols=72 Identities=18% Similarity=0.238 Sum_probs=58.6
Q ss_pred eeeeccc-CCccEEEEecCCCCChhhhc-CCcc----cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCc
Q 039565 14 LVELIGK-QKNNALELGFRGNPELVDQQ-GKEE----VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS 87 (188)
Q Consensus 14 iv~~~~~-~~~~~lv~e~~~~~~L~~~~-~~~~----~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~ 87 (188)
++.++.+ +....++|||+++..|.+.+ .... .+-.-+.-||. .+|+|+|+.++||+++... +-+.|||++
T Consensus 63 ~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 63 VPIVYDVDPDNGLIVMEYIEGELLKDALEEARPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CCeEEEEcCCCCEEEEEEeCChhHHHHHHhcchHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcc
Confidence 3455556 78889999999999999888 3323 55566778999 9999999999999998875 788899998
Q ss_pred cc
Q 039565 88 RI 89 (188)
Q Consensus 88 ~~ 89 (188)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 74
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.1e-08 Score=85.14 Aligned_cols=129 Identities=19% Similarity=0.215 Sum_probs=90.6
Q ss_pred cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCC-------CCcceeeecccccccCCC-----
Q 039565 45 VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEG-------GTHMSTTIAGTAGFLNTE----- 112 (188)
Q Consensus 45 ~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~-------~~~~~~~~~~~~~~~~pe----- 112 (188)
+++.|+.|+|.. .+++|+++.|++|.++.++.+|+..|+.+....... .............|.+||
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 778999999984 799999999999999999999999998765432110 001111112233567777
Q ss_pred -CCCccchHHHHHHHHHHHh-CCccccccC---------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 113 -LTEKSDVDSFEIVILEIIT-GILTVDLSF---------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 113 -~~~~~di~s~G~~l~~~~~-g~~p~~~~~---------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+.++|++|+|+++|.+.. |...++... ........+.++.+-+...+..++..||++..+..
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 4788999999999999884 443322110 01123455678888888999999999997766543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.61 E-value=9.9e-08 Score=67.62 Aligned_cols=70 Identities=23% Similarity=0.209 Sum_probs=54.7
Q ss_pred eeeccc-CCccEEEEecCCCCChhhhcC----CcccHHHHHHHHhcCCCCC-----cEEeCCCCCcEEEccCCceEEecc
Q 039565 15 VELIGK-QKNNALELGFRGNPELVDQQG----KEEVCCPGLEYLHQGLKHP-----IIQRDMKSTNILLNEKVQAKLADF 84 (188)
Q Consensus 15 v~~~~~-~~~~~lv~e~~~~~~L~~~~~----~~~~i~~~l~~Lh~~~~~~-----i~h~dl~~~nill~~~~~~kl~d~ 84 (188)
.+++.. ....++||||+++.++..... ...+++.+++.||. .+ ++|+|++|.||+++ ++.+++.||
T Consensus 56 P~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf 131 (170)
T cd05151 56 PKLYYFDPETGVLITEFIEGSELLTEDFSDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDW 131 (170)
T ss_pred CceEEEeCCCCeEEEEecCCCccccccccCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEec
Confidence 445555 556789999999988875321 11289999999998 55 59999999999999 668999999
Q ss_pred cCcc
Q 039565 85 GQSR 88 (188)
Q Consensus 85 ~~~~ 88 (188)
+.+.
T Consensus 132 ~~a~ 135 (170)
T cd05151 132 EYAG 135 (170)
T ss_pred cccc
Confidence 9765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.4e-08 Score=85.01 Aligned_cols=158 Identities=18% Similarity=0.179 Sum_probs=114.6
Q ss_pred CCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEcc
Q 039565 11 GPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNE 75 (188)
Q Consensus 11 Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~ 75 (188)
||-++....- .....|+++|..+++|..-+++.+ .+..+++|||. ..+.|+|++|.|++...
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~ 939 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAY 939 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcc
Confidence 4555544333 788999999999889988873333 77889999998 66899999999999999
Q ss_pred CCceEEecccCcccccCC----CC--------------------C-----cceeeecccccccCCC------CCCccchH
Q 039565 76 KVQAKLADFGQSRISPVE----GG--------------------T-----HMSTTIAGTAGFLNTE------LTEKSDVD 120 (188)
Q Consensus 76 ~~~~kl~d~~~~~~~~~~----~~--------------------~-----~~~~~~~~~~~~~~pe------~~~~~di~ 120 (188)
++..++.+|+........ +. . .......+++.|.+|| ....+|.|
T Consensus 940 ~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~ 1019 (1205)
T KOG0606|consen 940 DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWW 1019 (1205)
T ss_pred cCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhh
Confidence 999999998732211000 00 0 0012356888899998 46789999
Q ss_pred HHHHHHHHHHhCCccccccCCC--------------CcCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 039565 121 SFEIVILEIITGILTVDLSFKG--------------EFDIISVEKAVEIAMASVSSKVNRRPLMN 171 (188)
Q Consensus 121 s~G~~l~~~~~g~~p~~~~~~~--------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ 171 (188)
+.|+++++.++|..||+..... +.+........+++...+..+|.+|-.+.
T Consensus 1020 ~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999998754332 23334555677888888888888887653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.8e-07 Score=76.37 Aligned_cols=67 Identities=15% Similarity=0.149 Sum_probs=53.9
Q ss_pred CCccEEEEecCCCCChhhhcC--Ccc--------cHHH-HHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCccc
Q 039565 21 QKNNALELGFRGNPELVDQQG--KEE--------VCCP-GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89 (188)
Q Consensus 21 ~~~~~lv~e~~~~~~L~~~~~--~~~--------~i~~-~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~ 89 (188)
....+++|||++|++|.++.. ..+ +++. .+..+|. .+++|+|++|.||+++.++.+++.|||++..
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 567899999999999988762 111 2233 3566787 8999999999999999999999999999875
Q ss_pred c
Q 039565 90 S 90 (188)
Q Consensus 90 ~ 90 (188)
.
T Consensus 307 l 307 (437)
T TIGR01982 307 L 307 (437)
T ss_pred C
Confidence 4
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.54 E-value=9.4e-07 Score=72.01 Aligned_cols=155 Identities=13% Similarity=0.152 Sum_probs=110.3
Q ss_pred cccccCCCeeeeccc-------CCccEEEEecCCC-CChhhhc-CCcc--------------------------cHHHHH
Q 039565 6 RNKLTGPLLVELIGK-------QKNNALELGFRGN-PELVDQQ-GKEE--------------------------VCCPGL 50 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-------~~~~~lv~e~~~~-~~L~~~~-~~~~--------------------------~i~~~l 50 (188)
.+++.|+|||++.++ +..+.+|++|.+. ++|.+.. .... |+..||
T Consensus 327 wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL 406 (655)
T KOG3741|consen 327 WKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAAL 406 (655)
T ss_pred HHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHH
Confidence 467899999999888 7788999999874 4776665 2211 999999
Q ss_pred HHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCCCCccchHHHHHHHHHHH
Q 039565 51 EYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTELTEKSDVDSFEIVILEII 130 (188)
Q Consensus 51 ~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~di~s~G~~l~~~~ 130 (188)
.++|+ .|..-+-|.+.+|+++.+.+++++..|........... . -|-..+-|.-.||.++..+.
T Consensus 407 ~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~----~---------le~~Qq~D~~~lG~ll~aLA 470 (655)
T KOG3741|consen 407 YSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTE----P---------LESQQQNDLRDLGLLLLALA 470 (655)
T ss_pred HHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCCCCc----c---------hhHHhhhhHHHHHHHHHHHh
Confidence 99999 89999999999999999989999877766543311100 0 11245679999999999999
Q ss_pred hCCcccc-----ccC-CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 039565 131 TGILTVD-----LSF-KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVR 177 (188)
Q Consensus 131 ~g~~p~~-----~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l 177 (188)
+|..--. ... ........+..+.+++.-....+++. -++.+++.++
T Consensus 471 t~~~ns~~~d~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 471 TGTENSNRTDSTQSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred hcccccccccchHHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 9964211 111 12233345566777887777777775 5666666554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.2e-07 Score=66.84 Aligned_cols=65 Identities=18% Similarity=0.282 Sum_probs=49.4
Q ss_pred CccEEEEecCCCCCh-----hhhc-CC------cccHHHHHHHH-hcCCCCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 22 KNNALELGFRGNPEL-----VDQQ-GK------EEVCCPGLEYL-HQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 22 ~~~~lv~e~~~~~~L-----~~~~-~~------~~~i~~~l~~L-h~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
...+++|||+.+..+ .+.. .. ..+++.+|..+ |. .+++|+|+++.||++.. +.+.++||+.+.
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~~NIL~~~-~~v~iIDF~qav 172 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSEYNMLWHD-GKVWFIDVSQSV 172 (197)
T ss_pred cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEC-CcEEEEECCCce
Confidence 567899999986422 2222 11 11888999988 77 89999999999999974 678999999876
Q ss_pred cc
Q 039565 89 IS 90 (188)
Q Consensus 89 ~~ 90 (188)
..
T Consensus 173 ~~ 174 (197)
T cd05146 173 EP 174 (197)
T ss_pred eC
Confidence 43
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.1e-05 Score=64.65 Aligned_cols=133 Identities=14% Similarity=0.174 Sum_probs=94.7
Q ss_pred cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------C
Q 039565 45 VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------L 113 (188)
Q Consensus 45 ~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~ 113 (188)
.++.|.+-||. .|.+-+|++++|+|+++.+.+.+.|-....+. .......+..|...|.+|| -
T Consensus 125 nlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r 198 (637)
T COG4248 125 NLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFER 198 (637)
T ss_pred HHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec---cCCceEecccCccccCCHHHhccccccccCC
Confidence 88999999999 89999999999999999999998874332221 1112233456777788887 3
Q ss_pred CCccchHHHHHHHHHHHhC-CccccccC-------------------------------CCCcCH-HHHHHHHHHHHHcc
Q 039565 114 TEKSDVDSFEIVILEIITG-ILTVDLSF-------------------------------KGEFDI-ISVEKAVEIAMASV 160 (188)
Q Consensus 114 ~~~~di~s~G~~l~~~~~g-~~p~~~~~-------------------------------~~~~~~-~~~~~~~~l~~~cl 160 (188)
+...|.|.+|+++++++-| +-||.... +.+.+. .....+..+..+|.
T Consensus 199 ~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF 278 (637)
T COG4248 199 TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAF 278 (637)
T ss_pred CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHh
Confidence 6789999999999999865 65553110 112222 23345667777887
Q ss_pred CcC--CCCCCCHHHHHHHHhhccCc
Q 039565 161 SSK--VNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 161 ~~~--p~~Rps~~~i~~~l~~~~~~ 183 (188)
... +.-|||++..+..|..+.++
T Consensus 279 ~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 279 TESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred cccCCCCCCCCHHHHHHHHHHHHHh
Confidence 643 56899999998888776554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.8e-07 Score=73.75 Aligned_cols=167 Identities=17% Similarity=0.105 Sum_probs=107.6
Q ss_pred cCCCeeeecc-c--CCccEEEEecCCCCChhhhc---CCc---c------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIG-K--QKNNALELGFRGNPELVDQQ---GKE---E------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~-~--~~~~~lv~e~~~~~~L~~~~---~~~---~------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
.|.++++... | -.+.++-.|||.++++.... ... . |++.++.++|+ ...+|.|++|.||++.
T Consensus 324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~ 400 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILIS 400 (524)
T ss_pred cccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeec
Confidence 4566665433 3 56777999999988776655 111 1 99999999998 9999999999999999
Q ss_pred cC-CceEEecccCcccccCCCCCc-ceeeec-cccccc-CCCCCCccchHHHHHHHHHHHhCCcc-ccc--------cCC
Q 039565 75 EK-VQAKLADFGQSRISPVEGGTH-MSTTIA-GTAGFL-NTELTEKSDVDSFEIVILEIITGILT-VDL--------SFK 141 (188)
Q Consensus 75 ~~-~~~kl~d~~~~~~~~~~~~~~-~~~~~~-~~~~~~-~pe~~~~~di~s~G~~l~~~~~g~~p-~~~--------~~~ 141 (188)
.+ +..++.|++.+..+....... ...... +....+ .-++..+.|++|||..+.+.+++... ... ...
T Consensus 401 ~~~~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~ 480 (524)
T KOG0601|consen 401 NDGFFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDT 480 (524)
T ss_pred cchhhhhccccccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccc
Confidence 86 778899998875322111100 001111 000000 01167889999999999998887632 111 101
Q ss_pred CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 142 GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 142 ~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
...+ .....+..+....+..++..||++.++..+.+-.
T Consensus 481 p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 481 PNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred cCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111 2225666777778899999999998877655443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.4e-06 Score=60.43 Aligned_cols=67 Identities=27% Similarity=0.337 Sum_probs=52.6
Q ss_pred CCccEEEEecCCC-CChhhhc-CCcc-------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCC---ceEEe
Q 039565 21 QKNNALELGFRGN-PELVDQQ-GKEE-------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKV---QAKLA 82 (188)
Q Consensus 21 ~~~~~lv~e~~~~-~~L~~~~-~~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~---~~kl~ 82 (188)
.....+.|||+++ .++.+++ .... .+-+.+.-||. .+++|+||..+||++..++ .+-+.
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lI 158 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILI 158 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEE
Confidence 6778899999986 3777777 2111 55677889999 9999999999999997665 34789
Q ss_pred cccCcccc
Q 039565 83 DFGQSRIS 90 (188)
Q Consensus 83 d~~~~~~~ 90 (188)
|||++...
T Consensus 159 dfgls~~s 166 (229)
T KOG3087|consen 159 DFGLSSVS 166 (229)
T ss_pred eecchhcc
Confidence 99998754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.1e-06 Score=64.74 Aligned_cols=64 Identities=16% Similarity=0.144 Sum_probs=52.7
Q ss_pred ccEEEEecCCCC-ChhhhcCC---cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEcc-------CCceE
Q 039565 23 NNALELGFRGNP-ELVDQQGK---EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNE-------KVQAK 80 (188)
Q Consensus 23 ~~~lv~e~~~~~-~L~~~~~~---~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~-------~~~~k 80 (188)
..++|+|++++. +|.+++.. .. +++..+.-||. .|++|+|+++.||+++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEE
Confidence 478999999975 88888621 11 78899999999 99999999999999975 45789
Q ss_pred EecccCccc
Q 039565 81 LADFGQSRI 89 (188)
Q Consensus 81 l~d~~~~~~ 89 (188)
++||+.+..
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999997753
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.16 E-value=4.3e-06 Score=69.68 Aligned_cols=67 Identities=12% Similarity=0.075 Sum_probs=50.2
Q ss_pred CCccEEEEecCCCCChhhhc--CCcc----cHHH-----HHHHHhcCCCCCcEEeCCCCCcEEEccCC----ceEEeccc
Q 039565 21 QKNNALELGFRGNPELVDQQ--GKEE----VCCP-----GLEYLHQGLKHPIIQRDMKSTNILLNEKV----QAKLADFG 85 (188)
Q Consensus 21 ~~~~~lv~e~~~~~~L~~~~--~~~~----~i~~-----~l~~Lh~~~~~~i~h~dl~~~nill~~~~----~~kl~d~~ 85 (188)
.....++|||++|+.+.++- ...+ .++. -+.-+.. .+++|+|++|.||+++.++ .+++.|||
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFG 309 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFG 309 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecc
Confidence 66788999999999998753 2222 2222 1222344 8999999999999999887 99999999
Q ss_pred Ccccc
Q 039565 86 QSRIS 90 (188)
Q Consensus 86 ~~~~~ 90 (188)
+....
T Consensus 310 ivg~l 314 (537)
T PRK04750 310 IVGSL 314 (537)
T ss_pred eEEEC
Confidence 87654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.4e-06 Score=61.02 Aligned_cols=64 Identities=20% Similarity=0.219 Sum_probs=53.9
Q ss_pred ccEEEEecCCCC-ChhhhcCC-----cc-------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCC---ceEEecccC
Q 039565 23 NNALELGFRGNP-ELVDQQGK-----EE-------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKV---QAKLADFGQ 86 (188)
Q Consensus 23 ~~~lv~e~~~~~-~L~~~~~~-----~~-------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~---~~kl~d~~~ 86 (188)
..++|+|++++. +|.+++.. .. +++..++-||+ .+++|+|+++.|||+..++ .+.++||+.
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~ 167 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDR 167 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchh
Confidence 458999999874 79998843 11 88899999999 9999999999999999886 788999987
Q ss_pred ccc
Q 039565 87 SRI 89 (188)
Q Consensus 87 ~~~ 89 (188)
++.
T Consensus 168 ~~~ 170 (206)
T PF06293_consen 168 MRF 170 (206)
T ss_pred cee
Confidence 664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.02 E-value=8.9e-06 Score=60.06 Aligned_cols=64 Identities=20% Similarity=0.287 Sum_probs=51.9
Q ss_pred CCccEEEEecCCCCChhhhcCCc----ccHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 21 QKNNALELGFRGNPELVDQQGKE----EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 21 ~~~~~lv~e~~~~~~L~~~~~~~----~~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
....+++|||++|..|.+..+-. ..+.+++.-+|. .|+.|+|..|.|++++.++ +++.|++..+
T Consensus 115 ~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 115 TSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 45567899999998887765222 268899999999 9999999999999998654 8899997554
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.95 E-value=1.5e-05 Score=57.83 Aligned_cols=71 Identities=21% Similarity=0.319 Sum_probs=45.6
Q ss_pred eeeecccCCccEEEEecCC--CCChhhhcCCc---c-------cHHHHHHH-HhcCCCCCcEEeCCCCCcEEEccCCceE
Q 039565 14 LVELIGKQKNNALELGFRG--NPELVDQQGKE---E-------VCCPGLEY-LHQGLKHPIIQRDMKSTNILLNEKVQAK 80 (188)
Q Consensus 14 iv~~~~~~~~~~lv~e~~~--~~~L~~~~~~~---~-------~i~~~l~~-Lh~~~~~~i~h~dl~~~nill~~~~~~k 80 (188)
+++.+.+ ....+||||++ +..+..+.+.. . ++...+.. +|. .+++|+|+++.||+++.+ .+.
T Consensus 72 vP~p~~~-~~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 72 VPKPYDY-NRNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp S--EEEE-ETTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEE
T ss_pred CCcEEEE-eCCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEE
Confidence 4445444 35679999998 65555444222 1 66665555 467 899999999999999988 899
Q ss_pred EecccCccc
Q 039565 81 LADFGQSRI 89 (188)
Q Consensus 81 l~d~~~~~~ 89 (188)
+.||+.+..
T Consensus 147 iIDf~qav~ 155 (188)
T PF01163_consen 147 IIDFGQAVD 155 (188)
T ss_dssp E--GTTEEE
T ss_pred EEecCccee
Confidence 999987764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00014 Score=53.53 Aligned_cols=65 Identities=12% Similarity=0.037 Sum_probs=52.6
Q ss_pred CccEEEEecCCC-CChhhhcCC--c---c---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCc--eEEecc
Q 039565 22 KNNALELGFRGN-PELVDQQGK--E---E---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQ--AKLADF 84 (188)
Q Consensus 22 ~~~~lv~e~~~~-~~L~~~~~~--~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~--~kl~d~ 84 (188)
....||+|-+++ -+|.+++.. . + +++..++-||+ .++.|+|+.+.||+++..+. +++.||
T Consensus 98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDl 174 (216)
T PRK09902 98 WRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDL 174 (216)
T ss_pred eEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEh
Confidence 346799997764 489888722 1 1 88999999999 99999999999999986666 899999
Q ss_pred cCccc
Q 039565 85 GQSRI 89 (188)
Q Consensus 85 ~~~~~ 89 (188)
..++.
T Consensus 175 Ek~r~ 179 (216)
T PRK09902 175 EKSRR 179 (216)
T ss_pred hccch
Confidence 87663
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00014 Score=55.21 Aligned_cols=65 Identities=18% Similarity=0.211 Sum_probs=48.5
Q ss_pred CCccEEEEecCCCCChhhhc-CCcc------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 21 QKNNALELGFRGNPELVDQQ-GKEE------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 21 ~~~~~lv~e~~~~~~L~~~~-~~~~------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
.+...++||++++-.|...- +... .++.-+.-+.. .|++|+|+++-||+++++|.+.+.||--+.
T Consensus 179 ~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 179 WNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred cccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCCEEEEeCcccc
Confidence 45678999999986665544 1222 44454554555 899999999999999999999999996443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0007 Score=49.71 Aligned_cols=76 Identities=12% Similarity=0.099 Sum_probs=54.8
Q ss_pred Ceeeeccc-C-----CccEEEEecCCCCChhhhcC--Cc---------ccHHHHHHHHhcCC------------------
Q 039565 13 LLVELIGK-Q-----KNNALELGFRGNPELVDQQG--KE---------EVCCPGLEYLHQGL------------------ 57 (188)
Q Consensus 13 niv~~~~~-~-----~~~~lv~e~~~~~~L~~~~~--~~---------~~i~~~l~~Lh~~~------------------ 57 (188)
++.+++.+ . +..+++|||+++.++...+. .. .+++.+|..||+..
T Consensus 58 ~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~ 137 (223)
T cd05154 58 PVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLER 137 (223)
T ss_pred CCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHH
Confidence 35555555 2 25689999999988877652 11 16777777777421
Q ss_pred -----------------------------------CCCcEEeCCCCCcEEEcc--CCceEEecccCcc
Q 039565 58 -----------------------------------KHPIIQRDMKSTNILLNE--KVQAKLADFGQSR 88 (188)
Q Consensus 58 -----------------------------------~~~i~h~dl~~~nill~~--~~~~kl~d~~~~~ 88 (188)
...++|+|+.+.||+++. ++.+.+.||+.+.
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 138 QVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245799999999999998 5667899998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.014 Score=42.41 Aligned_cols=75 Identities=20% Similarity=0.163 Sum_probs=56.8
Q ss_pred CCeeeecccCCccEEEEecCCCCCh-------hhhcCCc-c-------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccC
Q 039565 12 PLLVELIGKQKNNALELGFRGNPEL-------VDQQGKE-E-------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEK 76 (188)
Q Consensus 12 pniv~~~~~~~~~~lv~e~~~~~~L-------~~~~~~~-~-------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~ 76 (188)
+++++++|..+. .++.||.+.+++ .++.... . +++..+.+++++....+.-+|++++|+.++++
T Consensus 20 ~~~pk~lG~CG~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~ 98 (188)
T PF12260_consen 20 EPFPKLLGSCGR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDD 98 (188)
T ss_pred CCCCCeeeECCC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCC
Confidence 478889887323 568999986644 4444222 2 77888888887655668999999999999999
Q ss_pred CceEEecccCc
Q 039565 77 VQAKLADFGQS 87 (188)
Q Consensus 77 ~~~kl~d~~~~ 87 (188)
+++|+.|..-.
T Consensus 99 ~~lk~iDld~v 109 (188)
T PF12260_consen 99 GRLKLIDLDDV 109 (188)
T ss_pred CcEEEEechhc
Confidence 99999998644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.00057 Score=61.04 Aligned_cols=168 Identities=13% Similarity=0.086 Sum_probs=97.5
Q ss_pred CCcccccCCCeeeeccc------CC-ccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEe
Q 039565 4 PNRNKLTGPLLVELIGK------QK-NNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQR 64 (188)
Q Consensus 4 ~~l~~l~Hpniv~~~~~------~~-~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~ 64 (188)
..+.++.|+|++.++++ .+ ...+..+++..-++...+..-+ +...||+|+|+ ....|.
T Consensus 234 ~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~---~~l~~v 310 (1351)
T KOG1035|consen 234 ESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS---LSLEHV 310 (1351)
T ss_pred HHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH---hcccee
Confidence 34678899999999888 22 2334556777777776662222 78899999998 544443
Q ss_pred CCCCC---cEEEccCCceEEe--cccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHh
Q 039565 65 DMKST---NILLNEKVQAKLA--DFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 65 dl~~~---nill~~~~~~kl~--d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~ 131 (188)
-+... +-..+..+....+ ||+..+......... . ..-+..+.+++ .+...|+|.+|.....+..
T Consensus 311 ~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~ 387 (1351)
T KOG1035|consen 311 VLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-S--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQ 387 (1351)
T ss_pred EEecccccccccCccceeecchhhhcccccCCCcccch-h--hcCccccccccccccccchhhhhhHHHHHHHHHhhhhh
Confidence 33333 2223333444444 666555432111110 1 11112233333 2344699999999999988
Q ss_pred CCcccc-ccCCCCc-CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 039565 132 GILTVD-LSFKGEF-DIISVEKAVEIAMASVSSKVNRRPLMNQVVMVR 177 (188)
Q Consensus 132 g~~p~~-~~~~~~~-~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l 177 (188)
|..+-. ......+ +........+....|+..++++|+++.+++...
T Consensus 388 ~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 388 GEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred cCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 763221 1111111 111111567888899999999999999998753
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.0074 Score=50.53 Aligned_cols=73 Identities=16% Similarity=0.210 Sum_probs=50.9
Q ss_pred eeeeccc-CCccEEEEecCCCCChhhhc--CCcc----cHHHHH-----HHHhcCCCCCcEEeCCCCCcEEEcc----CC
Q 039565 14 LVELIGK-QKNNALELGFRGNPELVDQQ--GKEE----VCCPGL-----EYLHQGLKHPIIQRDMKSTNILLNE----KV 77 (188)
Q Consensus 14 iv~~~~~-~~~~~lv~e~~~~~~L~~~~--~~~~----~i~~~l-----~~Lh~~~~~~i~h~dl~~~nill~~----~~ 77 (188)
|++++-- .....|+|||++|..+.+.- ++.+ +++..+ .-+-. .|.+|+|-.|.||++.. ++
T Consensus 266 VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~---~GffHaDPHPGNilv~~~~~~~~ 342 (538)
T KOG1235|consen 266 VPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFK---TGFFHADPHPGNILVRPNPEGDE 342 (538)
T ss_pred CCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHh---cCCccCCCCCCcEEEecCCCCCc
Confidence 4444444 67889999999998766655 3333 332222 12223 68999999999999984 56
Q ss_pred ceEEecccCccc
Q 039565 78 QAKLADFGQSRI 89 (188)
Q Consensus 78 ~~kl~d~~~~~~ 89 (188)
.+.+.|+|+...
T Consensus 343 ~ivllDhGl~~~ 354 (538)
T KOG1235|consen 343 EIVLLDHGLYAV 354 (538)
T ss_pred cEEEEccccccc
Confidence 889999998764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.01 Score=49.70 Aligned_cols=67 Identities=18% Similarity=0.175 Sum_probs=51.2
Q ss_pred CCccEEEEecCCCCChhhhc--CCcc----cHHHHH-----HHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCccc
Q 039565 21 QKNNALELGFRGNPELVDQQ--GKEE----VCCPGL-----EYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89 (188)
Q Consensus 21 ~~~~~lv~e~~~~~~L~~~~--~~~~----~i~~~l-----~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~ 89 (188)
.....|+|||++|-.+.+.. +..+ .++..+ ..+-. .+.+|+|..|.||++..+|...+.|||....
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh---cCccccCCCccceEEecCCcEEEEcCcceec
Confidence 67889999999998888885 3322 233222 22223 7999999999999999999999999998764
Q ss_pred c
Q 039565 90 S 90 (188)
Q Consensus 90 ~ 90 (188)
.
T Consensus 315 l 315 (517)
T COG0661 315 L 315 (517)
T ss_pred C
Confidence 3
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.0058 Score=50.81 Aligned_cols=130 Identities=18% Similarity=0.134 Sum_probs=77.7
Q ss_pred CCCcccccCCCeeeeccc----CCccEEEEecCCCCChhhhcCCcc-cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCC
Q 039565 3 FPNRNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQGKEE-VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKV 77 (188)
Q Consensus 3 ~~~l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~-~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~ 77 (188)
|+-++.+.|+|....+.+ .....+|+|++. .||.+++.... ...+++ . +++.|- |+
T Consensus 33 ~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~l~~~s~~----~---~~~~~~-----~~------ 93 (725)
T KOG1093|consen 33 FQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGNLKDESLL----A---HGVLHL-----NI------ 93 (725)
T ss_pred hHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcccchhhhc----c---ccccee-----hh------
Confidence 455788999999998888 555789999997 59999882222 111111 1 333321 11
Q ss_pred ceEEecccCcccccCCCCCcceeeecccccccCCCCCCccchHHHHHHHHHHHhCCccccccC--------------C--
Q 039565 78 QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTELTEKSDVDSFEIVILEIITGILTVDLSF--------------K-- 141 (188)
Q Consensus 78 ~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~di~s~G~~l~~~~~g~~p~~~~~--------------~-- 141 (188)
...+| .+.. .. .. -..+++||||+|.++.++.-|...+..-. +
T Consensus 94 -~~~td-~~~t----~~-----~~----------~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~ 152 (725)
T KOG1093|consen 94 -IYITD-HFLT----KY-----PS----------PIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQE 152 (725)
T ss_pred -hhccc-cccc----cC-----CC----------CCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchh
Confidence 11222 0000 00 00 02359999999999999988775332110 0
Q ss_pred -------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 039565 142 -------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQ 172 (188)
Q Consensus 142 -------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~ 172 (188)
..+...+.+...++...|+...|..||...+
T Consensus 153 ~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 153 LLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred HHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 0122345567788888999999999996543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.004 Score=52.81 Aligned_cols=118 Identities=21% Similarity=0.213 Sum_probs=77.2
Q ss_pred cccccCCC-eeeeccc---CCccEEEEecCCCC-Chhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPL-LVELIGK---QKNNALELGFRGNP-ELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpn-iv~~~~~---~~~~~lv~e~~~~~-~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
|-+++||| .++.++- ....++.++++..+ +-..-. .... .-..+++++|+ ..-+|+|
T Consensus 287 LdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d-- 361 (829)
T KOG0576|consen 287 LDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD-- 361 (829)
T ss_pred HHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc--
Confidence 34788999 5555444 67788999999876 222111 0000 44578888987 4446776
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCc
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGIL 134 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~ 134 (188)
||+.++ +..+..+|++....... ....+..+++.|++|| +..+.|.|+.+.--.++..|..
T Consensus 362 --~~l~s~-~~~~~~~~~v~~~L~~~---~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~p 428 (829)
T KOG0576|consen 362 --NILGSE-EEVKLLDFAVPPQLTRT---MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLP 428 (829)
T ss_pred --cccccc-cccccccccCCcccCcc---cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCC
Confidence 666554 56788888876543311 1455677889999999 5678899999876555555554
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.057 Score=40.91 Aligned_cols=66 Identities=21% Similarity=0.272 Sum_probs=46.6
Q ss_pred CccEEEEecCCCC-----ChhhhcCCc--c-----cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCccc
Q 039565 22 KNNALELGFRGNP-----ELVDQQGKE--E-----VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89 (188)
Q Consensus 22 ~~~~lv~e~~~~~-----~L~~~~~~~--~-----~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~ 89 (188)
.+..|+|||++.. .|.+.-... . ++.+.+.-|.. ..+++|+||+.-|||+. ++.+.++|++-+..
T Consensus 139 ~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 139 RNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred cCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence 4567899998643 222222111 1 66677776665 27999999999999999 77899999987764
Q ss_pred c
Q 039565 90 S 90 (188)
Q Consensus 90 ~ 90 (188)
.
T Consensus 216 ~ 216 (268)
T COG1718 216 I 216 (268)
T ss_pred c
Confidence 3
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.18 Score=36.97 Aligned_cols=73 Identities=22% Similarity=0.289 Sum_probs=52.0
Q ss_pred cccCCCeeeeccc---CCccEEEEecCCC------CChhhhcCCcc---cHHHHH----HHHhcCCCCCcEEeCCCCCcE
Q 039565 8 KLTGPLLVELIGK---QKNNALELGFRGN------PELVDQQGKEE---VCCPGL----EYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 8 ~l~Hpniv~~~~~---~~~~~lv~e~~~~------~~L~~~~~~~~---~i~~~l----~~Lh~~~~~~i~h~dl~~~ni 71 (188)
...+.+|.+++|+ +...-+|+|.+.+ -+|.+++.... .+.++| .||-+ ..|+.+|++|.||
T Consensus 73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~---~~Iv~~dl~~~NI 149 (199)
T PF10707_consen 73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLD---HHIVIRDLNPHNI 149 (199)
T ss_pred CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHH---cCCeecCCCcccE
Confidence 4568889999999 6677888887632 27888883333 344444 35666 8999999999999
Q ss_pred EEccCC----ceEEec
Q 039565 72 LLNEKV----QAKLAD 83 (188)
Q Consensus 72 ll~~~~----~~kl~d 83 (188)
++.... .+.++|
T Consensus 150 v~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEecCCCceEEEEEe
Confidence 996432 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.055 Score=40.54 Aligned_cols=96 Identities=15% Similarity=0.110 Sum_probs=55.5
Q ss_pred CCccEEEEecCCCC--ChhhhcCCcccH-HHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCc
Q 039565 21 QKNNALELGFRGNP--ELVDQQGKEEVC-CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH 97 (188)
Q Consensus 21 ~~~~~lv~e~~~~~--~L~~~~~~~~~i-~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~ 97 (188)
....-+|+|.|-.. ....++ -+ ..+|.-.|++ ..+.+|+|.+|+||+-++.|-+|+.|-+.-..
T Consensus 126 ~~~yGvIlE~Cy~~~i~~~N~i----~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------- 192 (308)
T PF07387_consen 126 NYKYGVILERCYKIKINFSNFI----TAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------- 192 (308)
T ss_pred CceeEEEEeeccCcccchhHHH----HHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--------
Confidence 44556788877421 111111 11 3556677742 35789999999999999999999999653210
Q ss_pred ceeeecccccccCCCCCCccchHHHHHHHHHHHhC
Q 039565 98 MSTTIAGTAGFLNTELTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 98 ~~~~~~~~~~~~~pe~~~~~di~s~G~~l~~~~~g 132 (188)
....+.. ..|.+ .++++++-+|=..+.++...
T Consensus 193 ~~V~~vN-~~Y~~--lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 193 NQVNMVN-IEYES--LTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred heeeEEe-eeccc--cChHHHHHHHHHHHHHHHHH
Confidence 0001111 11211 46677777766555555543
|
The function of this family is unknown. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=93.75 E-value=0.072 Score=39.84 Aligned_cols=30 Identities=20% Similarity=0.318 Sum_probs=25.5
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
.+++|+|+.+.|++++.+....+.||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 458999999999999877667899998765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.0064 Score=56.55 Aligned_cols=129 Identities=11% Similarity=-0.016 Sum_probs=89.2
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhc-CCcc--------------cH-HHHHHHHhc--CCCCCcE
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQ-GKEE--------------VC-CPGLEYLHQ--GLKHPII 62 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~-~~~~--------------~i-~~~l~~Lh~--~~~~~i~ 62 (188)
+++..|+++.....- ....+..++|+.+|.+.+.+ +... ++ ..+..-+|+ ......+
T Consensus 1283 ~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v 1362 (2724)
T KOG1826|consen 1283 LREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNV 1362 (2724)
T ss_pred hhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccch
Confidence 455788887766544 66778899999999999998 2221 22 223333332 1124568
Q ss_pred EeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccc
Q 039565 63 QRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 63 h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
|+++++.|.++..+-.++++++|+.++.. ..........+++.|+.++ ++.++|+|..|+-+|....|..+|
T Consensus 1363 ~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1363 SKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99999999999999999999999988321 1112223345666666665 677799999999999888877644
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=93.39 E-value=0.087 Score=41.75 Aligned_cols=63 Identities=16% Similarity=0.208 Sum_probs=46.9
Q ss_pred CCccEEEEecCCCCChhhhc--CCcc----cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccC
Q 039565 21 QKNNALELGFRGNPELVDQQ--GKEE----VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQ 86 (188)
Q Consensus 21 ~~~~~lv~e~~~~~~L~~~~--~~~~----~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~ 86 (188)
.+..++|||++.+..|...- ...+ .+..-+--|-. +|+||||.+-=||++.+++.++++||--
T Consensus 180 ~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~---~GlIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 180 HNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLAN---HGLIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred ccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHH---cCceecccchheeEEecCCCEEEeechH
Confidence 45678999999988876655 2222 33333334555 8999999999999999999999999953
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=92.79 E-value=0.075 Score=39.01 Aligned_cols=31 Identities=23% Similarity=0.406 Sum_probs=21.4
Q ss_pred CCCcEEeCCCCCcEEEc-cCCceEEecccCcc
Q 039565 58 KHPIIQRDMKSTNILLN-EKVQAKLADFGQSR 88 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~-~~~~~kl~d~~~~~ 88 (188)
...++|+|+.+.||+++ .++.+.+.||+.+.
T Consensus 165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp CEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred CcEEEEeccccccceeeeccceeEEEecccce
Confidence 36799999999999999 55666899998664
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.73 E-value=0.098 Score=40.92 Aligned_cols=31 Identities=19% Similarity=0.273 Sum_probs=26.4
Q ss_pred CCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
..+++|+|+.+.|++++.+....+.||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 3589999999999999976666899998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=91.98 E-value=0.14 Score=38.00 Aligned_cols=30 Identities=30% Similarity=0.390 Sum_probs=26.1
Q ss_pred CCcEEeCCCCCcEEEcc-CCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNE-KVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~-~~~~kl~d~~~~~ 88 (188)
.+++|+|+.+.||+++. ++.+.+.||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 46899999999999998 5789999998665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=91.83 E-value=0.14 Score=39.59 Aligned_cols=30 Identities=20% Similarity=0.301 Sum_probs=26.5
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
.+++|+|+.|.|++++.++...+.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 579999999999999998778899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=91.83 E-value=0.15 Score=38.26 Aligned_cols=30 Identities=17% Similarity=0.222 Sum_probs=26.0
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
..++|+|+.|.|++++.+....|.||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 458999999999999997778899998664
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=91.70 E-value=0.16 Score=39.64 Aligned_cols=31 Identities=19% Similarity=0.287 Sum_probs=27.2
Q ss_pred CCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
..+++|+|+.+.|++++.++...+.||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3689999999999999988877899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=91.68 E-value=0.19 Score=38.94 Aligned_cols=31 Identities=26% Similarity=0.307 Sum_probs=27.0
Q ss_pred CCCcEEeCCCCCcEEEccC----CceEEecccCcc
Q 039565 58 KHPIIQRDMKSTNILLNEK----VQAKLADFGQSR 88 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~----~~~kl~d~~~~~ 88 (188)
...+.|+|+.+.||+++.+ +.+.+.||+.+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4678999999999999974 789999998765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=91.49 E-value=0.2 Score=37.37 Aligned_cols=29 Identities=17% Similarity=0.257 Sum_probs=25.2
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
..++|+|+.|.|+++++++ +.+.||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 3568999999999999888 9999998664
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.21 E-value=0.24 Score=35.92 Aligned_cols=29 Identities=14% Similarity=0.229 Sum_probs=25.0
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
....|+|+.|.|+++++++ ++++||+.+.
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 4569999999999998877 8899998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=91.16 E-value=0.2 Score=37.95 Aligned_cols=29 Identities=17% Similarity=0.283 Sum_probs=25.0
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
..++|+|+.|.|++++.++ +.+.||+.+.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 3589999999999999876 7899998765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=89.96 E-value=0.32 Score=37.49 Aligned_cols=31 Identities=19% Similarity=0.536 Sum_probs=25.5
Q ss_pred CCcEEeCCCCCcEEEccCCc-eEEecccCccc
Q 039565 59 HPIIQRDMKSTNILLNEKVQ-AKLADFGQSRI 89 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~-~kl~d~~~~~~ 89 (188)
..++|+|+.+.|++++.++. ..+.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 46899999999999997554 57999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.14 E-value=0.49 Score=37.35 Aligned_cols=31 Identities=10% Similarity=0.324 Sum_probs=27.9
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCccc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~~ 89 (188)
..++|+|..+.|++++......+.||+.+..
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 4689999999999999988899999998764
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=88.78 E-value=0.42 Score=36.76 Aligned_cols=30 Identities=23% Similarity=0.309 Sum_probs=27.0
Q ss_pred CcEEeCCCCCcEEEccCCceEEecccCccc
Q 039565 60 PIIQRDMKSTNILLNEKVQAKLADFGQSRI 89 (188)
Q Consensus 60 ~i~h~dl~~~nill~~~~~~kl~d~~~~~~ 89 (188)
.+.|+|+.+.|++.++.+.+.|+||.-+..
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 589999999999999999999999987653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=88.63 E-value=0.43 Score=37.02 Aligned_cols=29 Identities=24% Similarity=0.361 Sum_probs=24.8
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
.+++|+|+.+.|++++. +.+.+.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999987 567899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=88.47 E-value=0.44 Score=37.79 Aligned_cols=28 Identities=25% Similarity=0.595 Sum_probs=25.1
Q ss_pred cEEeCCCCCcEEEccCCc-eEEecccCcc
Q 039565 61 IIQRDMKSTNILLNEKVQ-AKLADFGQSR 88 (188)
Q Consensus 61 i~h~dl~~~nill~~~~~-~kl~d~~~~~ 88 (188)
++|+|+.|.|++++.+.. ..+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999999874 8899998765
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=88.39 E-value=0.45 Score=34.60 Aligned_cols=30 Identities=23% Similarity=0.326 Sum_probs=24.8
Q ss_pred CCcEEeCCCCCcEEEccCC-----ceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKV-----QAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~-----~~kl~d~~~~~ 88 (188)
..+.|||+.+.|+++..++ .+.+.||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 5789999999999997543 57899998765
|
subfamily of choline kinases |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=87.90 E-value=0.38 Score=35.26 Aligned_cols=30 Identities=30% Similarity=0.441 Sum_probs=20.9
Q ss_pred CCcEEeCCCCCcEEE-ccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILL-NEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill-~~~~~~kl~d~~~~~ 88 (188)
....|+|+.+.||++ +.++.++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 467899999999999 788899999998765
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=85.81 E-value=1.4 Score=36.01 Aligned_cols=30 Identities=17% Similarity=0.340 Sum_probs=25.5
Q ss_pred CCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
...++|||+.+.||++..+ .+++.||..+.
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 3679999999999999876 58899998665
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=85.15 E-value=0.55 Score=36.65 Aligned_cols=30 Identities=10% Similarity=0.294 Sum_probs=27.0
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
.+++|+|+.+.|++++.++...+.||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 579999999999999998889999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=85.13 E-value=0.91 Score=36.18 Aligned_cols=30 Identities=17% Similarity=0.337 Sum_probs=25.8
Q ss_pred CCcEEeCCCCCcEEEcc-CCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNE-KVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~-~~~~kl~d~~~~~ 88 (188)
..+.|+|+++.||+++. ++.+.+.||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 46899999999999986 4679999998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=85.07 E-value=1.9 Score=31.81 Aligned_cols=54 Identities=30% Similarity=0.335 Sum_probs=39.5
Q ss_pred cEEEEecCCCCChhhhc-CCcccHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCc
Q 039565 24 NALELGFRGNPELVDQQ-GKEEVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS 87 (188)
Q Consensus 24 ~~lv~e~~~~~~L~~~~-~~~~~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~ 87 (188)
..+|.||.+... ..- ....++.+-+..+|. .+|+-+|+++.|.. .-+++|||.+
T Consensus 152 ~aIVKD~v~~~~--~~~~~~~~~~~~dl~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 152 RAIVKDFVPDDP--PLQIRDIPQMLRDLKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred EEEEEeecCCcc--ccchhHHHHHHHHHHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 367888887544 111 333388888999998 99999999999976 4477888743
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=82.78 E-value=1.1 Score=41.03 Aligned_cols=31 Identities=29% Similarity=0.504 Sum_probs=25.5
Q ss_pred CCCcEEeCCCCCcEEEccCC--c-eEEecccCcc
Q 039565 58 KHPIIQRDMKSTNILLNEKV--Q-AKLADFGQSR 88 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~--~-~kl~d~~~~~ 88 (188)
..++||+|+++.||+++.++ . ..|.|||-+.
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 35799999999999999775 3 4699998765
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=82.76 E-value=2 Score=34.60 Aligned_cols=30 Identities=20% Similarity=0.304 Sum_probs=24.7
Q ss_pred CCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
...++|||+.+.||+++.++ .++.|+..+.
T Consensus 191 ~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~ 220 (370)
T TIGR01767 191 AETLLHGDLHSGSIFVSEHE-TKVIDPEFAF 220 (370)
T ss_pred cceeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence 36899999999999997764 6788987654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=82.05 E-value=2.2 Score=32.40 Aligned_cols=37 Identities=14% Similarity=0.155 Sum_probs=25.0
Q ss_pred HHHHHHHHhcCCC--CCcEEeCCCCCcEEEccCCceEEec
Q 039565 46 CCPGLEYLHQGLK--HPIIQRDMKSTNILLNEKVQAKLAD 83 (188)
Q Consensus 46 i~~~l~~Lh~~~~--~~i~h~dl~~~nill~~~~~~kl~d 83 (188)
++..+.-+-..++ ...+|+||...|.+...+| +.+-|
T Consensus 172 ~~~~v~elL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fD 210 (286)
T COG3001 172 IVEKIQELLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFD 210 (286)
T ss_pred HHHHHHHHHhcCCCCcceeecccccccccccCCC-Ceeec
Confidence 3444444443332 5789999999999998888 55544
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=80.32 E-value=2.4 Score=34.66 Aligned_cols=30 Identities=13% Similarity=0.302 Sum_probs=25.1
Q ss_pred CCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
....+|||+.|.||+++.+ ..|+.|..++.
T Consensus 226 ~~aLlHGDlHtGSI~v~~~-~~kvIDpEFAf 255 (409)
T PRK12396 226 AQALIHGDLHTGSVFVKND-STKVIDPEFAF 255 (409)
T ss_pred chhhccCcCCCCCEEecCC-ceEEEcccccc
Confidence 4789999999999999986 58888876654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 188 | ||||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-13 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-12 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-05 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-05 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-05 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-05 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-05 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-05 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-05 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-05 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-05 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-05 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-04 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-04 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-04 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-04 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-04 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-04 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-04 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-04 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-04 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-04 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-04 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-04 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-04 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-04 |
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 188 | |||
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-43 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-39 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-37 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-21 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 8e-21 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 8e-20 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 9e-19 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 9e-19 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-18 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-17 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-17 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 5e-17 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 8e-17 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-16 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-16 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-15 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-15 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 5e-14 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 8e-14 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-13 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 4e-13 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 6e-13 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-13 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-12 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-12 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-12 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-12 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-12 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 6e-12 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-11 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-11 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-11 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 5e-11 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-11 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-11 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-10 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-10 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-10 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-10 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-10 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 7e-10 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 8e-10 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-09 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-09 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-09 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-09 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-09 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-09 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-09 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-09 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-09 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-09 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-09 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-09 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-09 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-09 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-09 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 4e-09 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-09 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 6e-09 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-09 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 7e-09 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 8e-09 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 9e-09 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 9e-09 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 9e-09 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-08 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-08 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-08 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-08 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-08 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-08 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-08 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-08 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-08 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-08 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-08 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-08 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-08 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-08 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-08 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-08 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-08 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-08 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-08 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-08 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-08 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-08 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-08 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-08 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-08 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-08 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-08 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-08 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 5e-08 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 5e-08 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 7e-08 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 7e-08 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 7e-08 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 7e-08 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 8e-08 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 8e-08 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 8e-08 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 9e-08 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-07 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-07 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-07 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-07 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-07 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-07 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-07 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-07 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-07 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-07 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-07 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-07 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-07 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-07 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-07 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-07 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-07 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-07 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-07 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-07 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-07 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-07 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-07 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-07 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 5e-07 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-07 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-07 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 6e-07 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 6e-07 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 6e-07 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 7e-07 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 7e-07 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-07 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 9e-07 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 9e-07 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-06 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-06 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-06 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-06 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-06 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-06 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-06 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-06 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-06 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-06 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-06 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-06 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-06 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-06 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-06 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-06 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 3e-06 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-06 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-06 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-06 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-06 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-06 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-06 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-06 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-06 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-06 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-06 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 4e-06 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 5e-06 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-06 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-06 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-06 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 7e-06 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 7e-06 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 7e-06 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 8e-06 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 8e-06 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-05 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-05 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-05 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-05 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-05 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-05 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-05 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-05 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-05 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-05 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-05 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-05 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-05 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-05 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-05 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-05 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 8e-05 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-04 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-04 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-04 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-04 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-04 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-04 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-04 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-04 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-04 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-04 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-04 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-04 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 5e-04 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 5e-04 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-04 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-04 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 8e-04 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 8e-04 |
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-43
Identities = 49/160 (30%), Positives = 71/160 (44%), Gaps = 37/160 (23%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YLH II RD+KS NILL+E K+ DFG S+ TH+ST + GT G+
Sbjct: 151 GLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 109 LNTE------LTEKSDVDSFEIVILEIITG--------------ILT------------- 135
++ E LTEKSDV SF +V+ E++ +
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 136 -VDLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174
VD + + S+ K + A+ ++ RP M V+
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-39
Identities = 52/166 (31%), Positives = 81/166 (48%), Gaps = 34/166 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G+ +LH+ + I RD+KS NILL+E AK++DFG +R S T M++ I GT +
Sbjct: 145 GINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAY 201
Query: 109 LNTE-----LTEKSDVDSFEIVILEIITGILTVDLSFK---------------------- 141
+ E +T KSD+ SF +V+LEIITG+ VD +
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI 261
Query: 142 ----GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183
+ D SVE +A + K N+RP + +V + ++ + S
Sbjct: 262 DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-37
Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 37/162 (22%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YLH II RD+K+ NILL+E+ +A + DFG +++ TH++T + GT G
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGH 201
Query: 109 LNTE------LTEKSDVDSFEIVILEIITGILTVDLSF---------------------- 140
+ E +EK+DV + +++LE+ITG DL+
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261
Query: 141 --------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174
+G + VE+ +++A+ S RP M++VV
Sbjct: 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-21
Identities = 32/142 (22%), Positives = 51/142 (35%), Gaps = 23/142 (16%)
Query: 49 GLEYLHQ-------GLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT 101
GL YLH+ G K I RD+KS N+LL + A +ADFG + +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 102 IAGTAG-----------FLNTELTEKSDVDSFEIVILEIITGILTVDLSFKGE----FDI 146
GT + + D+ + +V+ E+ + D +
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252
Query: 147 ISVEKAVEIAMASVSSKVNRRP 168
I ++E V K +RP
Sbjct: 253 IGQHPSLEDMQEVVVHK-KKRP 273
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-21
Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 9/90 (10%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAG- 107
G+ YLH PI+ R++KS N+L+++K K+ DFG SR+ + S GT
Sbjct: 149 GMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEW 205
Query: 108 -----FLNTELTEKSDVDSFEIVILEIITG 132
+ EKSDV SF +++ E+ T
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATL 235
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-20
Identities = 29/94 (30%), Positives = 42/94 (44%), Gaps = 12/94 (12%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEK-VQAKLADFGQSRISPVEGGTHMSTTIAG 104
C G+ YLH +I RD+K N+LL K+ DFG + T G
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKG 165
Query: 105 TAG------FLNTELTEKSDVDSFEIVILEIITG 132
+A F + +EK DV S+ I++ E+IT
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITR 199
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-19
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 12/93 (12%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT--- 105
G++YLH II RD+KS NI L+E K+ DFG + G+H ++G+
Sbjct: 132 GMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 106 ------AGFLNTELTEKSDVDSFEIVILEIITG 132
+ + +SDV +F IV+ E++TG
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-19
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 19/97 (19%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEK-----VQAKLADFGQSRISPVEGGTHMSTTIA 103
G+EY+ PI+ RD++S NI L V AK+ADFG S+ S H + +
Sbjct: 134 GIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVSGLL 187
Query: 104 GTAGFLNTEL--------TEKSDVDSFEIVILEIITG 132
G ++ E TEK+D SF +++ I+TG
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-18
Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 18/101 (17%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQ--------AKLADFGQSRISPVEGGTH 97
G+ YLH PII RD+KS+NIL+ +KV+ K+ DFG +R T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTK 171
Query: 98 MSTTIAGTAG------FLNTELTEKSDVDSFEIVILEIITG 132
MS AG + ++ SDV S+ +++ E++TG
Sbjct: 172 MSA--AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-17
Identities = 14/93 (15%), Positives = 36/93 (38%), Gaps = 17/93 (18%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA-- 106
G+ +LH L+ I + + S +++++E + A+++ + S
Sbjct: 123 GMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAW 174
Query: 107 -------GFLNTELTEKSDVDSFEIVILEIITG 132
+D+ SF +++ E++T
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTR 207
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-17
Identities = 29/142 (20%), Positives = 53/142 (37%), Gaps = 23/142 (16%)
Query: 49 GLEYLH-----QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH--MSTT 101
GL +LH K I RD+KS NIL+ + +AD G + + T
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 102 IAGTA------------GFLNTELTEKSDVDSFEIVILEIITGILTVDLSFKGEF---DI 146
GT + + +D+ SF +++ E+ ++ + + + D+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 147 ISVEKAVEIAMASVSSKVNRRP 168
+ + + E V K RP
Sbjct: 266 VPSDPSYEDMREIVCIK-KLRP 286
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-17
Identities = 28/142 (19%), Positives = 55/142 (38%), Gaps = 23/142 (16%)
Query: 49 GLEYLH-----QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH--MSTT 101
GL +LH K I RD+KS NIL+ + Q +AD G + + +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 102 IAGTA------------GFLNTELTEKSDVDSFEIVILEIITGILTVDLSFKGE---FDI 146
GT + ++ D+ +F +V+ E+ +++ + + +D+
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236
Query: 147 ISVEKAVEIAMASVSSKVNRRP 168
+ + + E V +RP
Sbjct: 237 VPNDPSFEDMRKVVCVD-QQRP 257
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-16
Identities = 22/105 (20%), Positives = 35/105 (33%), Gaps = 22/105 (20%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMS---TTI 102
G+ YLH I+ +D+KS N+ + + DFG IS V
Sbjct: 139 IVKGMGYLHA---KGILHKDLKSKNVFYDNGK-VVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 103 AGTAGFLNTEL---------------TEKSDVDSFEIVILEIITG 132
G L E+ ++ SDV + + E+
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-15
Identities = 28/141 (19%), Positives = 47/141 (33%), Gaps = 21/141 (14%)
Query: 49 GLEYLHQ-----GLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH--MSTT 101
GL +LH K I RD+KS NIL+ + +AD G + T
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 102 IAGTA------------GFLNTELTEKSDVDSFEIVILEIITGILTVDL--SFKGEFDII 147
GT + E +++D+ + +V EI + ++ + +
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 148 SVEKAVEIAMASVSSKVNRRP 168
M V + RP
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRP 291
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-15
Identities = 31/103 (30%), Positives = 40/103 (38%), Gaps = 21/103 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGT------------ 96
G+ YLH II RD+ S N L+ E +ADFG +R+ E
Sbjct: 120 GMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 97 HMSTTIAGTAG------FLNTELTEKSDVDSFEIVILEIITGI 133
T+ G EK DV SF IV+ EII +
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 5e-14
Identities = 23/109 (21%), Positives = 38/109 (34%), Gaps = 25/109 (22%)
Query: 49 GLEYLHQ------GLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI------SPVEGGT 96
GL YLH K I RD+ S N+L+ ++DFG S
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 97 HMSTTIAGTA---------GFLNTE----LTEKSDVDSFEIVILEIITG 132
+ + + GT G +N ++ D+ + ++ EI
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-14
Identities = 27/94 (28%), Positives = 44/94 (46%), Gaps = 10/94 (10%)
Query: 47 CPGLEYLHQ--GLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAG 104
L+ H+ H ++ RD+K N+ L+ K KL DFG +RI + T + T G
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVG 178
Query: 105 TAGFLNTEL------TEKSDVDSFEIVILEIITG 132
T +++ E EKSD+ S ++ E+
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-13
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 11/90 (12%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKV-QAKLADFGQSRISPVEGGTHMSTTIAGTAG 107
GL++LH PII RD+K NI + K+ D G + + + + GT
Sbjct: 141 GLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPE 195
Query: 108 F-----LNTELTEKSDVDSFEIVILEIITG 132
F + E DV +F + +LE+ T
Sbjct: 196 FMAPEMYEEKYDESVDVYAFGMCMLEMATS 225
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-13
Identities = 26/92 (28%), Positives = 45/92 (48%), Gaps = 11/92 (11%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
C L+++H I+ RD+KS NI L + +L DFG +R+ + ++ GT
Sbjct: 135 CLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTP 189
Query: 107 GFLNTEL------TEKSDVDSFEIVILEIITG 132
+L+ E+ KSD+ + V+ E+ T
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTL 221
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 6e-13
Identities = 28/90 (31%), Positives = 48/90 (53%), Gaps = 12/90 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YL + K I+ RD+K +NIL+N + + KL DFG S + M+ + GT +
Sbjct: 143 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSY 196
Query: 109 LNTEL------TEKSDVDSFEIVILEIITG 132
++ E + +SD+ S + ++E+ G
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-13
Identities = 31/95 (32%), Positives = 43/95 (45%), Gaps = 16/95 (16%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT--- 105
L YL + KH +I RD+K +NILL+E+ Q KL DFG IS AG
Sbjct: 136 ALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDRSAGCAAY 190
Query: 106 --------AGFLNTELTEKSDVDSFEIVILEIITG 132
+ ++DV S I ++E+ TG
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-12
Identities = 23/92 (25%), Positives = 35/92 (38%), Gaps = 11/92 (11%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
L +LH ++ D+K NI L + + KL DFG G G
Sbjct: 167 LLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDP 220
Query: 107 GFLNTEL-----TEKSDVDSFEIVILEIITGI 133
++ EL +DV S + ILE+ +
Sbjct: 221 RYMAPELLQGSYGTAADVFSLGLTILEVACNM 252
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-12
Identities = 22/92 (23%), Positives = 39/92 (42%), Gaps = 11/92 (11%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
C LE++H ++ RD+K N+ + KL D G R T + ++ GT
Sbjct: 146 CSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTP 200
Query: 107 GFLNTEL------TEKSDVDSFEIVILEIITG 132
+++ E KSD+ S ++ E+
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-12
Identities = 27/94 (28%), Positives = 39/94 (41%), Gaps = 15/94 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT--- 105
LE+LH K +I RD+K +N+L+N Q K+ DFG IS AG
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFG---ISGYLVDDVAKDIDAGCKPY 175
Query: 106 -------AGFLNTELTEKSDVDSFEIVILEIITG 132
+ KSD+ S I ++E+
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-12
Identities = 31/94 (32%), Positives = 40/94 (42%), Gaps = 15/94 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT--- 105
L +L + LK II RD+K +NILL+ KL DFG IS + T AG
Sbjct: 137 ALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDSIAKTRDAGCRPY 191
Query: 106 -------AGFLNTELTEKSDVDSFEIVILEIITG 132
+SDV S I + E+ TG
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-12
Identities = 32/128 (25%), Positives = 54/128 (42%), Gaps = 21/128 (16%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
G+++ H I+ RD+K NIL++ K+ DFG ++ T + + GT
Sbjct: 121 LDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTV 176
Query: 107 GFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGEFDIISVEKAVEIAMASV 160
+ + E E +D+ S IV+ E++ G + F G E AV IA+ +
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVG----EPPFNG-------ETAVSIAIKHI 225
Query: 161 SSKVNRRP 168
V
Sbjct: 226 QDSVPNVT 233
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-11
Identities = 28/94 (29%), Positives = 43/94 (45%), Gaps = 13/94 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEK-VQAKLADFGQS-RISPVEGGTHMST--TIAG 104
GLEYLH I+ D+K+ N+LL+ +A L DFG + + P G + T I G
Sbjct: 162 GLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 105 TAGF------LNTELTEKSDVDSFEIVILEIITG 132
T + K D+ S ++L ++ G
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 4e-11
Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
++ GLE+LHQ II RD+K N+LL++ +++D G + + A
Sbjct: 297 QIVS-GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYA 350
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT GF+ EL + VD + + + E+I
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-11
Identities = 25/131 (19%), Positives = 50/131 (38%), Gaps = 32/131 (24%)
Query: 14 LVELIGKQKNNALELGFRGNPELVDQQGKEEVC------CPGLEYLHQGLKHPIIQRDMK 67
L + I K++ L + G++Y+H +I RD+K
Sbjct: 107 LEQWIEKRRGEKL-------DK-------VLALELFEQITKGVDYIHS---KKLINRDLK 149
Query: 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL------TEKSDVDS 121
+NI L + Q K+ DFG + T GT +++ E ++ D+ +
Sbjct: 150 PSNIFLVDTKQVKIGDFG---LVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYA 206
Query: 122 FEIVILEIITG 132
+++ E++
Sbjct: 207 LGLILAELLHV 217
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-11
Identities = 36/125 (28%), Positives = 56/125 (44%), Gaps = 21/125 (16%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMST-TIAGT 105
C L + HQ + II RD+K NI+++ K+ DFG +R G + T + GT
Sbjct: 126 CQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 106 AGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGEFDIISVEKAVEIAMAS 159
A +L+ E + +SDV S V+ E++TG + F G + V +A
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG----EPPFTG-------DSPVSVAYQH 231
Query: 160 VSSKV 164
V
Sbjct: 232 VREDP 236
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 6e-11
Identities = 18/98 (18%), Positives = 35/98 (35%), Gaps = 18/98 (18%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
L+Y+H + R +K+++IL++ + L+ + S + G
Sbjct: 140 ALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNL-SMISHGQRQRVVHDFPKYS 195
Query: 109 LNT------EL--------TEKSDVDSFEIVILEIITG 132
+ E+ KSD+ S I E+ G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 7e-11
Identities = 24/96 (25%), Positives = 45/96 (46%), Gaps = 15/96 (15%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ GLE++H ++ RD+K NILL+E +++D G + + H
Sbjct: 300 EIIL-GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH---ASV 351
Query: 104 GTAGFLNTELTEKSD-----VD--SFEIVILEIITG 132
GT G++ E+ +K D S ++ +++ G
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-10
Identities = 32/123 (26%), Positives = 55/123 (44%), Gaps = 25/123 (20%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ LEYLH II RD+K NILLNE + ++ DFG +++ E + +
Sbjct: 138 EIVS-ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 193
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG---------------ILTVDLSFKG 142
GTA +++ EL + D + +I +++ G I+ ++ F
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 253
Query: 143 EFD 145
+F
Sbjct: 254 KFF 256
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-10
Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 13/94 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS-RISPVEGGTHMS--TTIAGT 105
GLEYLH K+ I RD+K+ NILL E ++ADFG S ++ T T GT
Sbjct: 133 GLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 106 AGFLNTELTE-------KSDVDSFEIVILEIITG 132
++ E+ E K+D+ SF I +E+ TG
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-10
Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 14/93 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKV-QAKLADFGQSRISPVEGGTHMSTTIAGTAG 107
GL+YLH + I+ RD+K N+L+N K++DFG S+ + G + T GT
Sbjct: 134 GLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQ 188
Query: 108 F--------LNTELTEKSDVDSFEIVILEIITG 132
+ + +D+ S I+E+ TG
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-10
Identities = 21/89 (23%), Positives = 31/89 (34%), Gaps = 19/89 (21%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA--- 103
C GLE +H RD+K TNILL ++ Q L D G + +
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 104 ----GTA---------GFLNTELTEKSDV 119
T + + E++DV
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDV 229
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 5e-10
Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 13/95 (13%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+CC GLE LH + I+ RD+K NILL++ +++D G + P
Sbjct: 294 EICC-GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GRV 346
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT G++ E+ + D + ++ E+I G
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 7e-10
Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ L+YLH + ++ RD+K N++L++ K+ DFG + +G T T
Sbjct: 256 EIVS-ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFC 310
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITGIL 134
GT +L E+ E +D VD +V+ E++ G L
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 8e-10
Identities = 23/93 (24%), Positives = 37/93 (39%), Gaps = 19/93 (20%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT--IAG 104
P L YLH ++ D+K NI+L E+ Q KL D G +++ + G
Sbjct: 192 LPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS--------RINSFGYLYG 239
Query: 105 TAGFL-----NTELTEKSDVDSFEIVILEIITG 132
T GF T T +D+ + + +
Sbjct: 240 TPGFQAPEIVRTGPTVATDIYTVGRTLAALTLD 272
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 1e-09
Identities = 27/95 (28%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ GL +L II RD+K N++L+ + K+ADFG + + +G T + T
Sbjct: 450 EIAI-GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFC 503
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT ++ E+ VD +F +++ E++ G
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-09
Identities = 28/96 (29%), Positives = 42/96 (43%), Gaps = 23/96 (23%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL+YLH I RD+K+ N+LL+E + KLADFG + ++ T F
Sbjct: 131 GLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA--------GQLTDTQIKRNTF 179
Query: 109 LNT------------ELTEKSDVDSFEIVILEIITG 132
+ T K+D+ S I +E+ G
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-09
Identities = 16/42 (38%), Positives = 23/42 (54%), Gaps = 3/42 (7%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS 87
L +LH II RD+K+ N+L+ + +LADFG S
Sbjct: 126 MLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-09
Identities = 19/40 (47%), Positives = 23/40 (57%), Gaps = 3/40 (7%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG 85
C LE+LH + +I RD+KS NILL KL DFG
Sbjct: 125 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-09
Identities = 24/92 (26%), Positives = 41/92 (44%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
L+ H RD+K NIL++ A L DFG + + E T + T+ GT
Sbjct: 144 GSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTL 199
Query: 107 GFL------NTELTEKSDVDSFEIVILEIITG 132
++ + T ++D+ + V+ E +TG
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTG 231
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-09
Identities = 22/40 (55%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG 85
GLEYLH I RD+K+ NILLN + AKLADFG
Sbjct: 134 TLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFG 170
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-09
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 13/93 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAG-- 104
G+EYL I RD+ + N L+ EK K++DFG SR G + ++
Sbjct: 223 AAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQV 277
Query: 105 ----TA--GFLNTELTEKSDVDSFEIVILEIIT 131
TA + +SDV SF I++ E +
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-09
Identities = 29/98 (29%), Positives = 40/98 (40%), Gaps = 22/98 (22%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMS--TTIA 103
GL YLH H +I RD+K+ NILL+E KL DFG + + M+ +
Sbjct: 163 ALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFV 211
Query: 104 GT---------AGFLNTELTEKSDVDSFEIVILEIITG 132
GT + K DV S I +E+
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-09
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ LEYLH ++ RD+K N++L++ K+ DFG + +G T T
Sbjct: 113 EIVS-ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFC 166
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT +L E+ E +D VD +V+ E++ G
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-09
Identities = 19/39 (48%), Positives = 25/39 (64%), Gaps = 3/39 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQS 87
GL +LH +H +I RD+K N+LL E + KL DFG S
Sbjct: 141 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-09
Identities = 17/40 (42%), Positives = 22/40 (55%), Gaps = 3/40 (7%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFG 85
L YLH +I RD+KS +ILL + KL+DFG
Sbjct: 150 VLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFG 186
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 2e-09
Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
+EYL + I R++ + N L+ E K+ADFG SR+ + G T+ +
Sbjct: 328 SSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFP 382
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I TA + + KSDV +F +++ EI T
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-09
Identities = 30/98 (30%), Positives = 43/98 (43%), Gaps = 16/98 (16%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ L+YL II RDMK NILL+E + DF + + P E TT+A
Sbjct: 123 ELVM-ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMA 175
Query: 104 GTAGFLNTELTEKSD-------VD--SFEIVILEIITG 132
GT ++ E+ VD S + E++ G
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-09
Identities = 25/126 (19%), Positives = 47/126 (37%), Gaps = 31/126 (24%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
L Y H ++ +D+K NIL + K+ DFG + + + H T AGT
Sbjct: 136 ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHS-TNAAGT 189
Query: 106 AGF-----LNTELTEKSDVDSFEIVIL----------------EIITGILTVDLSFKGEF 144
A + ++T K D+ S V++ E+ + ++ E
Sbjct: 190 ALYMAPEVFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC 248
Query: 145 DIISVE 150
++ +
Sbjct: 249 RPLTPQ 254
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-09
Identities = 21/61 (34%), Positives = 32/61 (52%), Gaps = 6/61 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
+ LH K I+ RD+K NILL++ + KL DFG S ++ G + + GT +
Sbjct: 136 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKL-REVCGTPSY 189
Query: 109 L 109
L
Sbjct: 190 L 190
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 4e-09
Identities = 28/129 (21%), Positives = 48/129 (37%), Gaps = 32/129 (24%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQA--KLADFGQSRISPVEGGTHMSTTIAG 104
C GL+++H+ H I+ D+K NI+ K + K+ DFG + + +
Sbjct: 159 CEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIV-KVTTA 212
Query: 105 TAGFLNTELTEKSDVDSFEI------VIL----------------EIITGILTVDLSFKG 142
TA F E+ ++ V F V+ E + + D F
Sbjct: 213 TAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 271
Query: 143 E-FDIISVE 150
+ F +S E
Sbjct: 272 DAFSSVSPE 280
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 5e-09
Identities = 23/99 (23%), Positives = 42/99 (42%), Gaps = 18/99 (18%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEK-----VQAKLADFGQSR-ISPVEGGTHMSTTI 102
GL +LH I+ RD+K NIL++ ++A ++DFG + ++ + +
Sbjct: 130 GLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 103 AGTAGFL---------NTELTEKSDVDSFEIVILEIITG 132
GT G++ T D+ S V +I+
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-09
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
G+ Y+ + + RD+++ NIL+ E + K+ADFG +R+ +E + +
Sbjct: 290 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFP 344
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I TA L T KSDV SF I++ E+ T
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 6e-09
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
G+ Y+ + + RD+++ NIL+ E + K+ADFG +R+ +E + +
Sbjct: 373 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFP 427
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I TA L T KSDV SF I++ E+ T
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-09
Identities = 22/61 (36%), Positives = 36/61 (59%), Gaps = 6/61 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
+ +LH + I+ RD+K NILL++ +Q +L+DFG S +E G + + GT G+
Sbjct: 212 AVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKL-RELCGTPGY 265
Query: 109 L 109
L
Sbjct: 266 L 266
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 8e-09
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ L +LH II RD+K N+LL+ + KLADFG + G T + T
Sbjct: 132 EIIS-ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFC 185
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT ++ E+ ++ VD + +++ E++ G
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 9e-09
Identities = 17/51 (33%), Positives = 27/51 (52%), Gaps = 5/51 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTH 97
GL + H ++ RD+K N+L+N + KLA+FG +R PV +
Sbjct: 113 GLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 9e-09
Identities = 27/95 (28%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ GL +L II RD+K N++L+ + K+ADFG + + +G T + T
Sbjct: 129 EIAI-GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFC 182
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT ++ E+ VD +F +++ E++ G
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 9e-09
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ L +LH + II RD+K NI+LN + KL DFG + S +G + T
Sbjct: 129 EISM-ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTFC 182
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT ++ E+ +S VD S ++ +++TG
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-08
Identities = 22/51 (43%), Positives = 29/51 (56%), Gaps = 5/51 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTH 97
G+ + HQ H I+ RD+K N+L+N KLADFG +R PV TH
Sbjct: 131 GVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-08
Identities = 15/57 (26%), Positives = 27/57 (47%), Gaps = 4/57 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
+ +HQ H I+ D+K N L+ + + KL DFG + + + + + GT
Sbjct: 120 AVHTIHQ---HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 1e-08
Identities = 21/53 (39%), Positives = 29/53 (54%), Gaps = 5/53 (9%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTH 97
GL + H H ++ RD+K N+L+N + KLADFG +R PV TH
Sbjct: 113 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-08
Identities = 15/57 (26%), Positives = 27/57 (47%), Gaps = 4/57 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
+ +HQ H I+ D+K N L+ + + KL DFG + + + + + GT
Sbjct: 139 AVHTIHQ---HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGT 191
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-08
Identities = 27/129 (20%), Positives = 46/129 (35%), Gaps = 32/129 (24%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQA--KLADFGQSRISPVEGGTHMSTTIAG 104
C GL ++H+ + + D+K NI+ K KL DFG + ++ + G
Sbjct: 265 CKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSV-KVTTG 318
Query: 105 TAGFLNTELTEKSDVDSFEI------VIL----------------EIITGILTVDLSFKG 142
TA F E+ E V + V+ E + + + D +
Sbjct: 319 TAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 377
Query: 143 E-FDIISVE 150
F IS +
Sbjct: 378 SAFSGISED 386
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-08
Identities = 17/43 (39%), Positives = 27/43 (62%), Gaps = 1/43 (2%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89
C ++++H+ K PII RD+K N+LL+ + KL DFG +
Sbjct: 146 CRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-08
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ L++LH II RD+K NILL+E+ KL DFG S+ S + +
Sbjct: 134 ELAL-ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFC 187
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT ++ E+ + D SF +++ E++TG
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-08
Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ GL++LH I+ RD+K NILL++ K+ADFG + + + + T
Sbjct: 126 EIIL-GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFC 179
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT ++ E+ VD SF +++ E++ G
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-08
Identities = 26/51 (50%), Positives = 32/51 (62%), Gaps = 5/51 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTH 97
GLEYLHQ H I+ RD+K N+LL+E KLADFG ++ SP TH
Sbjct: 124 GLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 1e-08
Identities = 19/51 (37%), Positives = 29/51 (56%), Gaps = 5/51 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTH 97
G+ Y H ++ RD+K N+L+N + + K+ADFG +R PV TH
Sbjct: 112 GIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-08
Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 19/101 (18%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI----------SPVEGGT 96
+E+LH ++ RD+K +NI K+ DFG
Sbjct: 128 AEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 97 HMSTTIAGTAGFLNTEL------TEKSDVDSFEIVILEIIT 131
T GT +++ E + K D+ S +++ E++
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-08
Identities = 18/40 (45%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL Y+H ++ I+ RDMK+ N+L+ KLADFG +R
Sbjct: 136 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-08
Identities = 19/51 (37%), Positives = 30/51 (58%), Gaps = 5/51 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTH 97
GL + H+ + I+ RD+K N+L+N++ Q KL DFG +R PV +
Sbjct: 120 GLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-08
Identities = 21/101 (20%), Positives = 40/101 (39%), Gaps = 21/101 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT--- 105
+ +HQ H I+ D+K N L+ + + KL DFG + + + + + G
Sbjct: 167 AVHTIHQ---HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222
Query: 106 --------------AGFLNTELTEKSDVDSFEIVILEIITG 132
G ++++ KSDV S ++ + G
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-08
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 5/51 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTH 97
+ + H KH I RD+K NIL+ + KL DFG +R+ P +
Sbjct: 114 AVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-08
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
G+ ++ Q I RD+++ NIL++ + K+ADFG +R+ +E + +
Sbjct: 294 AEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFP 348
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I TA T KSDV SF I+++EI+T
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-08
Identities = 19/51 (37%), Positives = 27/51 (52%), Gaps = 5/51 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTH 97
G+ + H H II RD+K NIL+++ KL DFG +R +P E
Sbjct: 136 GIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-08
Identities = 18/42 (42%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL++LH + I+ RD+K NIL+ KLADFG +R
Sbjct: 130 LRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-08
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ L YLH+ II RD+K N+LL+ + KL D+G + G T ++T
Sbjct: 118 EISL-ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFC 171
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT ++ E+ D VD + +++ E++ G
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-08
Identities = 24/106 (22%), Positives = 42/106 (39%), Gaps = 21/106 (19%)
Query: 47 CPGLEYLH-QGLKHPIIQRDMKSTNILLNEKVQAKLADFG----------QSRISPVEGG 95
+E+LH +GL H RD+K +NI K+ DFG + +
Sbjct: 174 AEAVEFLHSKGLMH----RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 96 THMSTTIAGTAGFLNTEL------TEKSDVDSFEIVILEIITGILT 135
T GT +++ E + K D+ S +++ E++ T
Sbjct: 230 YATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-08
Identities = 29/95 (30%), Positives = 43/95 (45%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ L YLH I+ RD+K NILL+ + L DFG + + T ++T
Sbjct: 147 EIAS-ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFC 200
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT +L E+ K VD V+ E++ G
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-08
Identities = 19/51 (37%), Positives = 30/51 (58%), Gaps = 5/51 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTH 97
GL Y H+ ++ RD+K N+L+NE+ + KLADFG +R P + +
Sbjct: 112 GLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-08
Identities = 19/42 (45%), Positives = 26/42 (61%), Gaps = 3/42 (7%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL++LH H ++ RD+K NIL+ Q KLADFG +R
Sbjct: 130 LRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-08
Identities = 27/129 (20%), Positives = 51/129 (39%), Gaps = 32/129 (24%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQA--KLADFGQSRISPVEGGTHMSTTIAG 104
C L++LH H I D++ NI+ + + K+ +FGQ+R ++ G + +
Sbjct: 112 CEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNF-RLLFT 165
Query: 105 TAGFLNTELTEKSDVDSFEI------VIL----------------EIITGILTVDLSFKG 142
+ E+ + V S ++ +II I+ + +F
Sbjct: 166 APEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224
Query: 143 E-FDIISVE 150
E F IS+E
Sbjct: 225 EAFKEISIE 233
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-08
Identities = 22/91 (24%), Positives = 42/91 (46%), Gaps = 9/91 (9%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----I 102
G+ YL ++ RD+ + N+L+ K+ DFG +++ E + + I
Sbjct: 127 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 103 AGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
A L+ T +SDV S+ + + E++T
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-08
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ L YLH+ II RD+K N+LL+ + KL D+G + G T ++T
Sbjct: 161 EISL-ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFC 214
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT ++ E+ D VD + +++ E++ G
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 4e-08
Identities = 33/129 (25%), Positives = 46/129 (35%), Gaps = 32/129 (24%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQA--KLADFGQSRISPVEGGTHMSTTIAG 104
C G+ ++HQ I+ D+K NIL + K+ DFG +R + + G
Sbjct: 197 CEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKL-KVNFG 250
Query: 105 TAGFLNTELTEKSDVDSFEI------VIL----------------EIITGILTVDLSFKG 142
T FL E+ V SF VI E + IL +
Sbjct: 251 TPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED 309
Query: 143 E-FDIISVE 150
E F IS E
Sbjct: 310 EEFQDISEE 318
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-08
Identities = 22/66 (33%), Positives = 36/66 (54%), Gaps = 9/66 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEK---VQAKLADFGQSRISPVEGGTHMSTTIA 103
++YLH ++ II RD+K N+LL+ + K+ DFG S+I + + M T+
Sbjct: 249 LLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLM-RTLC 302
Query: 104 GTAGFL 109
GT +L
Sbjct: 303 GTPTYL 308
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-08
Identities = 20/57 (35%), Positives = 32/57 (56%), Gaps = 5/57 (8%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
G +YLH+ + +I RD+K N+ LNE ++ K+ DFG + + VE + GT
Sbjct: 127 GCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKVLCGT 178
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-08
Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 13/97 (13%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ LE+LH K II RD+K NILL+ L DFG S+ V T +
Sbjct: 167 EIVL-ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFC 221
Query: 104 GTAGFLNTELTEKSD------VD--SFEIVILEIITG 132
GT ++ ++ D VD S +++ E++TG
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 7e-08
Identities = 20/92 (21%), Positives = 46/92 (50%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
G++YL + K+ + R++ + N+LL + AK++DFG S+ + + + +
Sbjct: 446 SMGMKYLEE--KN-FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
+ A + + +SDV S+ + + E ++
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-08
Identities = 26/92 (28%), Positives = 47/92 (51%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
C G+EYL + + RD+ + NIL+ + K+ADFG +++ P++ ++
Sbjct: 137 CKGMEYLGS--RR-CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I A + + +SDV SF +V+ E+ T
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 7e-08
Identities = 20/57 (35%), Positives = 30/57 (52%), Gaps = 5/57 (8%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
G+ YLH H I+ RD+ +N+LL + K+ADFG + + H T+ GT
Sbjct: 124 GMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--TLCGT 175
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-08
Identities = 18/65 (27%), Positives = 31/65 (47%), Gaps = 5/65 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTHMSTTIAGTA 106
L Y+H II RD+K NI ++E K+ DFG ++ ++ S + G++
Sbjct: 128 ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 107 GFLNT 111
L +
Sbjct: 185 DNLTS 189
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-08
Identities = 22/57 (38%), Positives = 31/57 (54%), Gaps = 5/57 (8%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
G+EYLH II RD+K +N+L+ E K+ADFG S +G + + GT
Sbjct: 149 GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF--KGSDALLSNTVGT 200
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 8e-08
Identities = 28/92 (30%), Positives = 42/92 (45%), Gaps = 13/92 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
L Y H +I RD+K N+LL + K+ADFG S +P + T + GT +
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDY 173
Query: 109 LNTEL------TEKSDVDSFEIVILEIITGIL 134
L E+ EK D+ S ++ E + G
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 8e-08
Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAG-- 104
+EYL + I RD+ + N L+ E K+ADFG SR+ + G T+ + A
Sbjct: 121 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFP 175
Query: 105 ---TA--GFLNTELTEKSDVDSFEIVILEIIT 131
TA + + KSDV +F +++ EI T
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-08
Identities = 20/57 (35%), Positives = 32/57 (56%), Gaps = 5/57 (8%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
G +YLH+ + +I RD+K N+ LNE ++ K+ DFG + + VE + GT
Sbjct: 153 GCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKVLCGT 204
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-07
Identities = 22/91 (24%), Positives = 42/91 (46%), Gaps = 9/91 (9%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----I 102
G+ YL ++ RD+ + N+L+ K+ DFG +++ E + + I
Sbjct: 127 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 103 AGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
A L+ T +SDV S+ + + E++T
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-07
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 20/94 (21%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAG-- 104
C +EYL + + RD+ + N+L++E AK++DFG ++ S+T
Sbjct: 299 CEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGK 347
Query: 105 -----TA--GFLNTELTEKSDVDSFEIVILEIIT 131
TA + + KSDV SF I++ EI +
Sbjct: 348 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-07
Identities = 22/92 (23%), Positives = 34/92 (36%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
G+ YL I RD+ + N+LL + K+ DFG R P ++
Sbjct: 131 AEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
A A + SD F + + E+ T
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-07
Identities = 21/92 (22%), Positives = 43/92 (46%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
C G++YL + + RD+ + N+L+ + Q K+ DFG ++ + +
Sbjct: 136 CKGMDYLGS--RQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
+ A + ++ SDV SF + + E++T
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-07
Identities = 33/129 (25%), Positives = 51/129 (39%), Gaps = 35/129 (27%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
G+ YLHQ + I+ D+K NILL K+ DFG SR + + I
Sbjct: 141 LEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACEL-REIM 194
Query: 104 GTAGF-----LNTE-LTEKSDVDSFEI-VIL----------------EIITGILTVDLSF 140
GT + LN + +T +D+ + I +I E I V++ +
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWN--IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY 252
Query: 141 KGE-FDIIS 148
E F +S
Sbjct: 253 SEETFSSVS 261
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-07
Identities = 23/91 (25%), Positives = 45/91 (49%), Gaps = 9/91 (9%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----I 102
G+ YL + H ++ R++ + N+LL Q ++ADFG + + P + + + I
Sbjct: 125 AKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 103 AGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
A + T +SDV S+ + + E++T
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-07
Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
C G+EYL K I RD+ + NIL+ + + K+ DFG +++ P +
Sbjct: 124 CKGMEYLGT--KR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I A ++ + SDV SF +V+ E+ T
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-07
Identities = 32/130 (24%), Positives = 51/130 (39%), Gaps = 31/130 (23%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQA--KLADFGQSRI--SPVEGGTHMSTTIAG 104
L YLH I RD+K N L + KL DFG S+ G + TT AG
Sbjct: 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 105 TAGFLNTELTEKSD------VDSFEI-VIL----------------EIITGILTVDLSFK 141
T F+ E+ ++ D++ V+L + I+ +L L F+
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE 296
Query: 142 G-EFDIISVE 150
++++S
Sbjct: 297 NPNYNVLSPL 306
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-07
Identities = 33/131 (25%), Positives = 44/131 (33%), Gaps = 34/131 (25%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEK----VQAKLADFGQSRISPVEGGTHMSTTI 102
G+ YLH I D+K NI+L +K KL DFG + +E G I
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF-KNI 178
Query: 103 AGTAGFLNTELTEKSDVDSFEI------VIL----------------EIITGILTVDLSF 140
GT F+ E+ + E VI E + I +V F
Sbjct: 179 FGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 141 KGE-FDIISVE 150
E F S
Sbjct: 238 DEEFFSHTSEL 248
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-07
Identities = 34/129 (26%), Positives = 45/129 (34%), Gaps = 34/129 (26%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQA----KLADFGQSRISPVEGGTHMSTTI 102
G+ YLH I D+K NI+L +K KL DFG + +E G I
Sbjct: 118 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEF-KNI 171
Query: 103 AGTAGFLNTELTEKSDVDSFEI------VIL----------------EIITGILTVDLSF 140
GT F+ E+ + E VI E +T I V+ F
Sbjct: 172 FGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF 230
Query: 141 KGE-FDIIS 148
E F S
Sbjct: 231 DEEYFSNTS 239
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-07
Identities = 27/92 (29%), Positives = 45/92 (48%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
C G+EYL K I RD+ + NIL+ + + K+ DFG +++ P + +
Sbjct: 155 CKGMEYLGT--KR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I A ++ + SDV SF +V+ E+ T
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-07
Identities = 26/95 (27%), Positives = 46/95 (48%), Gaps = 15/95 (15%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
++ EYLH +I RD+K N+L++++ ++ DFG ++ V+G T T+
Sbjct: 149 QIVL-TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW---TLC 199
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT L E+ VD + ++I E+ G
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 2e-07
Identities = 6/92 (6%), Positives = 16/92 (17%), Gaps = 16/92 (17%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
L ++ N+ + + L D + +
Sbjct: 206 LAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTY 257
Query: 109 L--------NTELTEKSDVDSFEIVILEIITG 132
T + + I +
Sbjct: 258 APREFLNASTATFTHALNAWQLGLSIYRVWCL 289
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-07
Identities = 29/131 (22%), Positives = 45/131 (34%), Gaps = 34/131 (25%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQA----KLADFGQSRISPVEGGTHMSTTI 102
G+ YLH I D+K NI+L ++ K+ DFG + ++ G I
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEF-KNI 177
Query: 103 AGTAGFLNTELTEKSDVDSFEI------VIL----------------EIITGILTVDLSF 140
GT F+ E+ + E VI E + + V+ F
Sbjct: 178 FGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 141 KGE-FDIISVE 150
+ E F S
Sbjct: 237 EDEYFSNTSAL 247
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-07
Identities = 22/62 (35%), Positives = 33/62 (53%), Gaps = 9/62 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
++YLH ++ II RD+K N+LL E K+ DFG S+I + + M T+ GT
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLM-RTLCGT 179
Query: 106 AG 107
Sbjct: 180 PT 181
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-07
Identities = 18/56 (32%), Positives = 32/56 (57%), Gaps = 9/56 (16%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL----NEKVQAKLADFGQSRI--SPVEGGTHM 98
G+ YLH + ++ RD+K NIL+ E+ + K+AD G +R+ SP++ +
Sbjct: 140 GIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-07
Identities = 21/92 (22%), Positives = 46/92 (50%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
G++YL + K+ + RD+ + N+LL + AK++DFG S+ + + + +
Sbjct: 120 SMGMKYLEE--KN-FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
+ A + + +SDV S+ + + E ++
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-07
Identities = 25/92 (27%), Positives = 37/92 (40%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
L YL + RD+ + N+L++ KL DFG SR +E T+ +
Sbjct: 501 STALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP 555
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I A T SDV F + + EI+
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-07
Identities = 23/92 (25%), Positives = 45/92 (48%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
G++YL + + + RD+ + N+LL + AK++DFG S+ + + + T
Sbjct: 127 SMGMKYLEE--SN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
+ A + + KSDV SF +++ E +
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-07
Identities = 25/100 (25%), Positives = 44/100 (44%), Gaps = 16/100 (16%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ ++ +H + + RD+K NIL++ +LADFG +E GT S+
Sbjct: 183 EMVI-AIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAV 237
Query: 104 GTAGFLNTE-LTEKSD--------VD--SFEIVILEIITG 132
GT +++ E L D S + + E++ G
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-07
Identities = 33/131 (25%), Positives = 43/131 (32%), Gaps = 34/131 (25%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQA----KLADFGQSRISPVEGGTHMSTTI 102
G+ YLH I D+K NI+L +K KL DFG + +E G I
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF-KNI 178
Query: 103 AGTAGFLNTELTEKSDVDSFEI------VIL----------------EIITGILTVDLSF 140
GT F+ E+ + E VI E + I V F
Sbjct: 179 FGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 141 KGE-FDIISVE 150
E F S
Sbjct: 238 DEEFFSQTSEL 248
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-07
Identities = 22/64 (34%), Positives = 33/64 (51%), Gaps = 8/64 (12%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQA---KLADFGQSRISPVEGGTHMSTTIAGT 105
+ + HQ ++ R++K N+LL K++ KLADFG + VEG AGT
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGT 176
Query: 106 AGFL 109
G+L
Sbjct: 177 PGYL 180
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 4e-07
Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 15/95 (15%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
EVC LEYLH II RD+K NILL++ K+ DFG ++ V T+ T+
Sbjct: 114 EVCL-ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY---TLC 164
Query: 104 GTAGFLNTELTEKSD----VD--SFEIVILEIITG 132
GT ++ E+ +D SF I+I E++ G
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-07
Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 13/92 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
L Y H + +I RD+K N+L+ K + K+ADFG S +P + T+ GT +
Sbjct: 126 ALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRTMCGTLDY 178
Query: 109 LNTEL------TEKSDVDSFEIVILEIITGIL 134
L E+ EK D+ ++ E + G+
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 4e-07
Identities = 29/95 (30%), Positives = 42/95 (44%), Gaps = 15/95 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
L YLH+ + II RD+K NI+L +++ K+ D G ++ + T GT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGT 186
Query: 106 AGFLNTEL------TEKSDVDSFEIVILEIITGIL 134
+L EL T D SF + E ITG
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-07
Identities = 27/99 (27%), Positives = 42/99 (42%), Gaps = 15/99 (15%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
EV L+ +H I RD+K N+LL++ KLADFG EG T
Sbjct: 176 EVVL-ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAV 230
Query: 104 GTAGFLNTELTEKSD--------VD--SFEIVILEIITG 132
GT +++ E+ + D S + + E++ G
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-07
Identities = 25/92 (27%), Positives = 41/92 (44%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
C G+ YLH +H I RD+ + N+LL+ K+ DFG ++ P +
Sbjct: 144 CEGMAYLHA--QH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
+ A + SDV SF + + E++T
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-07
Identities = 23/94 (24%), Positives = 39/94 (41%), Gaps = 14/94 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
Y+H + I RD+K +NIL+++ + KL+DFG+S GT F
Sbjct: 163 SFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV----DKKIKGSRGTYEF 216
Query: 109 LNTEL--------TEKSDVDSFEIVILEIITGIL 134
+ E K D+ S I + + ++
Sbjct: 217 MPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 6e-07
Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
C G+ YL + +I RD+ + N L+ E K++DFG +R V + S+T
Sbjct: 114 CEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFP 168
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
+ + F + + KSDV SF +++ E+ +
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-07
Identities = 16/57 (28%), Positives = 24/57 (42%), Gaps = 3/57 (5%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
GLEYLH I+ +D+K N+LL K++ G + T G+
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 6e-07
Identities = 20/103 (19%), Positives = 32/103 (31%), Gaps = 20/103 (19%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQA-----------KLADFGQSRISPVEGG 95
+E +H II D+K N +L L D GQS +
Sbjct: 182 LYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 96 THMSTTIAGTAGFLNTEL------TEKSDVDSFEIVILEIITG 132
+ T T+GF E+ + D + ++ G
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-07
Identities = 19/112 (16%), Positives = 35/112 (31%), Gaps = 35/112 (31%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNE-------------------KVQAKLADFGQS 87
GL Y+H ++ D+K +NI ++ KV K+ D G
Sbjct: 125 GRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 88 RISPVEGGTHMSTTIAGTAGFLNTEL-------TEKSDVDSFEIVILEIITG 132
G + FL E+ K+D+ + + ++
Sbjct: 182 TR------ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 7e-07
Identities = 16/56 (28%), Positives = 26/56 (46%), Gaps = 10/56 (17%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQA-----KLADFGQSRI--SPVEGGTH 97
G+ + H + RD+K N+LL+ + K+ DFG +R P+ TH
Sbjct: 144 GVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 8e-07
Identities = 16/61 (26%), Positives = 30/61 (49%), Gaps = 10/61 (16%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL----NEKVQAKLADFGQSRISPVEGGTHMSTTIAG 104
G+ +L ++ I+ R++K NI+ + + KL DFG +R +E ++ G
Sbjct: 124 GMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQF-VSLYG 177
Query: 105 T 105
T
Sbjct: 178 T 178
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 9e-07
Identities = 25/92 (27%), Positives = 47/92 (51%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
C G+ +L H I RD+ + N L++ + K++DFG +R V ++S+
Sbjct: 114 CEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFP 168
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
+ +A F + + KSDV +F I++ E+ +
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 9e-07
Identities = 17/73 (23%), Positives = 30/73 (41%), Gaps = 3/73 (4%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G++Y+H I+ RD+K N L+N+ K+ DFG +R + I+
Sbjct: 168 GVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 109 LNTELTEKSDVDS 121
+N +
Sbjct: 225 MNLVTFPHTKNLK 237
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-06
Identities = 21/64 (32%), Positives = 30/64 (46%), Gaps = 9/64 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQA---KLADFGQSRISPVEGGTHMSTTIAGT 105
+ Y H + I+ R++K N+LL K + KLADFG + V AGT
Sbjct: 140 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAW-HGFAGT 193
Query: 106 AGFL 109
G+L
Sbjct: 194 PGYL 197
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-06
Identities = 16/61 (26%), Positives = 30/61 (49%), Gaps = 10/61 (16%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL----NEKVQAKLADFGQSRISPVEGGTHMSTTIAG 104
G+ +L ++ I+ R++K NI+ + + KL DFG +R +E ++ G
Sbjct: 124 GMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQF-VSLYG 177
Query: 105 T 105
T
Sbjct: 178 T 178
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-06
Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 11/90 (12%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA----- 103
G+E+L I RD+ + NILL+EK K+ DFG +R + ++ A
Sbjct: 205 GMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI-YKDPDYVRKGDARLPLK 260
Query: 104 GTA--GFLNTELTEKSDVDSFEIVILEIIT 131
A + T +SDV SF +++ EI +
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-06
Identities = 25/92 (27%), Positives = 44/92 (47%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
G++YL + RD+ + NIL+N + K++DFG R+ + +T
Sbjct: 157 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I T+ + T SDV S+ IV+ E+++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-06
Identities = 21/64 (32%), Positives = 30/64 (46%), Gaps = 9/64 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQA---KLADFGQSRISPVEGGTHMSTTIAGT 105
+ Y H + I+ R++K N+LL K + KLADFG + V AGT
Sbjct: 117 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAW-HGFAGT 170
Query: 106 AGFL 109
G+L
Sbjct: 171 PGYL 174
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-06
Identities = 25/127 (19%), Positives = 43/127 (33%), Gaps = 32/127 (25%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
+ Y H+ + RD+K N L + KL DFG + + G M T GT
Sbjct: 118 AVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMM-RTKVGT 171
Query: 106 AGF-----LNTELTEKSDVDSFEIVIL----------------EIITGILTVDLSFKGE- 143
+ L + D S V++ E++ I +F +
Sbjct: 172 PYYVSPQVLEGLYGPECDEWSAG-VMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD 230
Query: 144 FDIISVE 150
+ +S +
Sbjct: 231 WLNVSPQ 237
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-06
Identities = 27/126 (21%), Positives = 43/126 (34%), Gaps = 29/126 (23%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
L Y H + II RD+K +LL KL FG + + ++ GT
Sbjct: 142 ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGT 196
Query: 106 AGFLNTELTEKSD----VDSFEI-VIL---------------EIITGILTVDLSFKG-EF 144
F+ E+ ++ VD + VIL + GI+ ++
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQW 256
Query: 145 DIISVE 150
IS
Sbjct: 257 SHISES 262
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-06
Identities = 36/127 (28%), Positives = 51/127 (40%), Gaps = 32/127 (25%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
G+ Y+H+ H I+ RD+K NILL + K+ DFG S + T M GT
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKM-KDRIGT 186
Query: 106 AGF-----LNTELTEKSDVDSFEIVIL----------------EIITGILTVDLSFKGE- 143
A + L EK DV S VIL +I+ + T +F
Sbjct: 187 AYYIAPEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245
Query: 144 FDIISVE 150
+ IS +
Sbjct: 246 WRTISDD 252
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 1e-06
Identities = 19/68 (27%), Positives = 29/68 (42%), Gaps = 3/68 (4%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G ++H+ II RD+K N LLN+ K+ DFG +R E T++ +
Sbjct: 141 GENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 109 LNTELTEK 116
K
Sbjct: 198 GPHNKNLK 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-06
Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
C +EYL + RD+ + N L+N++ K++DFG SR V + S+
Sbjct: 130 CEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFP 184
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
+ + + ++ + KSD+ +F +++ EI +
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 2e-06
Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
G+ ++ + I RD+++ NIL+++ + K+ADFG +R+ +E + +
Sbjct: 119 AEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFP 173
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I TA T KSDV SF I++ EI+T
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-06
Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 9/64 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
+ YLH+ + I+ RD+K N+L K+ADFG S+I VE M T+ GT
Sbjct: 160 AVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLM-KTVCGT 213
Query: 106 AGFL 109
G+
Sbjct: 214 PGYC 217
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-06
Identities = 25/92 (27%), Positives = 43/92 (46%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
G+ YL + RD+ + N+L++ + K++DFG SR+ + +TT
Sbjct: 161 GAGMRYLSD--LG-YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I TA + SDV SF +V+ E++
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-06
Identities = 23/72 (31%), Positives = 35/72 (48%), Gaps = 8/72 (11%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
++YLH G ++ RDMK +NILLN + K+ADFG SR + ++
Sbjct: 121 VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 109 LNTE-----LTE 115
N + LT+
Sbjct: 178 ENFDDDQPILTD 189
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-06
Identities = 17/65 (26%), Positives = 31/65 (47%), Gaps = 9/65 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQA----KLADFGQSRISPVEGGTHMSTTIAG 104
+EYLH ++ RD+K +NIL ++ ++ DFG ++ + + T
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGLLMTPCY 182
Query: 105 TAGFL 109
TA F+
Sbjct: 183 TANFV 187
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-06
Identities = 17/74 (22%), Positives = 31/74 (41%), Gaps = 18/74 (24%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEK-------------VQAKLADFGQSRISPVEGG 95
G+ +LH II RD+K NIL++ ++ ++DFG +
Sbjct: 127 GVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 96 THMST--TIAGTAG 107
+ + +GT+G
Sbjct: 184 SFRTNLNNPSGTSG 197
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-06
Identities = 17/64 (26%), Positives = 31/64 (48%), Gaps = 6/64 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
++ LH +I RD+K +N+L+N K+ DFG +RI ++ ++ G
Sbjct: 124 AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSG 178
Query: 109 LNTE 112
+ E
Sbjct: 179 M-VE 181
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-06
Identities = 19/62 (30%), Positives = 28/62 (45%), Gaps = 5/62 (8%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
E+ ++ +H+ + RD+K NILL+ +LADFG GT S
Sbjct: 170 EIVM-AIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKL-RADGTVRSLVAV 224
Query: 104 GT 105
GT
Sbjct: 225 GT 226
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-06
Identities = 16/48 (33%), Positives = 28/48 (58%), Gaps = 3/48 (6%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGT 96
GL+Y+H ++ RD+K +N+LLN K+ DFG +R++ +
Sbjct: 140 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-06
Identities = 18/53 (33%), Positives = 25/53 (47%), Gaps = 5/53 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT 101
+ YL II RD+K NI++ E KL DFG + + +E G T
Sbjct: 142 AVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA--AYLERGKLFYTF 189
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-06
Identities = 24/92 (26%), Positives = 36/92 (39%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
C + YL + RD+ NIL+ KL DFG SR +E + +
Sbjct: 123 CKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLP 177
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I + T SDV F + + EI++
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-06
Identities = 17/51 (33%), Positives = 23/51 (45%), Gaps = 5/51 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLN-EKVQAKLADFGQSRI-SPVEGGTH 97
L Y+H I RD+K N+LL+ KL DFG ++I E
Sbjct: 153 SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-06
Identities = 18/57 (31%), Positives = 29/57 (50%), Gaps = 3/57 (5%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
G+ YLH I RD+K N+LL+E+ K++DFG + + + + GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-06
Identities = 15/64 (23%), Positives = 30/64 (46%), Gaps = 8/64 (12%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
+ ++H ++ RD+K N+L N+ ++ K+ DFG +R+ P + T T
Sbjct: 118 AVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK--TPCFT 172
Query: 106 AGFL 109
+
Sbjct: 173 LHYA 176
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 4e-06
Identities = 14/75 (18%), Positives = 28/75 (37%), Gaps = 9/75 (12%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
L LH + ++ ++ +I+L+++ L F V G + + GF
Sbjct: 218 LLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHL----VRDGA--RVVSSVSRGF 268
Query: 109 LNTELTEKSDVDSFE 123
EL + S+
Sbjct: 269 EPPELEARRATISYH 283
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 4e-06
Identities = 14/96 (14%), Positives = 30/96 (31%), Gaps = 13/96 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI----SPVEGGTHMST---- 100
L LH + ++ ++ +I+L+++ L F + G +
Sbjct: 223 LLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETT 279
Query: 101 --TIAGTAGFLNTELTEKSDVDSFEIVILEIITGIL 134
+ T +T D + + I I L
Sbjct: 280 AERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 4e-06
Identities = 25/92 (27%), Positives = 37/92 (40%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
L YL + RD+ + N+L++ KL DFG SR +E T+ +
Sbjct: 126 STALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP 180
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I A T SDV F + + EI+
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-06
Identities = 18/57 (31%), Positives = 29/57 (50%), Gaps = 3/57 (5%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
G+ YLH I RD+K N+LL+E+ K++DFG + + + + GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-06
Identities = 13/46 (28%), Positives = 21/46 (45%), Gaps = 3/46 (6%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEG 94
GL LH+ ++ RD+ NILL + + DF +R +
Sbjct: 146 GLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-06
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 10/92 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT----- 101
G++YL + RD+ + NIL+N + K++DFG SR+ + +T+
Sbjct: 157 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 102 IAGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
I TA + T SDV SF IV+ E++T
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-06
Identities = 17/40 (42%), Positives = 24/40 (60%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL Y+H II RD+K N+ +NE + K+ DFG +R
Sbjct: 140 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-06
Identities = 15/40 (37%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL+Y+H ++ RD+K N+ +NE + K+ DFG +R
Sbjct: 138 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-06
Identities = 17/40 (42%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
GL+Y+H II RD+K +N+ +NE + K+ DFG +R
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 7e-06
Identities = 15/46 (32%), Positives = 25/46 (54%), Gaps = 3/46 (6%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEG 94
G+++LH II RD+K +NI++ K+ DFG +R +
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-06
Identities = 17/53 (32%), Positives = 27/53 (50%), Gaps = 5/53 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT 101
++Y HQ I+ RD+K+ N+LL+ + K+ADFG S G +
Sbjct: 126 AVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAF 173
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-06
Identities = 15/40 (37%), Positives = 24/40 (60%), Gaps = 3/40 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88
G+++LH II RD+K +NI++ K+ DFG +R
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-06
Identities = 20/53 (37%), Positives = 32/53 (60%), Gaps = 5/53 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT 101
+EY H +H I+ RD+K N+LL++ + K+ADFG S I + G + T+
Sbjct: 120 AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTS 167
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-05
Identities = 36/127 (28%), Positives = 48/127 (37%), Gaps = 32/127 (25%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQA---KLADFGQSRISPVEGGTHMSTTIAGT 105
G+ YLH+ H I+ RD+K NILL K K+ DFG S + GT
Sbjct: 158 GICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKL-RDRLGT 211
Query: 106 AGF-----LNTELTEKSDVDSFEIVIL----------------EIITGILTVDLSFKGE- 143
A + L + EK DV S VI+ +II + F
Sbjct: 212 AYYIAPEVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270
Query: 144 FDIISVE 150
+ IS E
Sbjct: 271 WKNISDE 277
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-05
Identities = 15/42 (35%), Positives = 22/42 (52%), Gaps = 4/42 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLN-EKVQAKLADFGQSRI 89
L Y+H I RD+K N+LL+ + KL DFG ++
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-05
Identities = 17/51 (33%), Positives = 24/51 (47%), Gaps = 3/51 (5%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEK-VQAKLADFGQSRI-SPVEGGTH 97
+ LH + RD+K N+L+NE KL DFG ++ SP E
Sbjct: 141 SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 1e-05
Identities = 18/64 (28%), Positives = 33/64 (51%), Gaps = 10/64 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
++YLH ++ I+ RD+K N+L E + + DFG S++ + +T GT
Sbjct: 118 AVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGT 170
Query: 106 AGFL 109
G++
Sbjct: 171 PGYV 174
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-05
Identities = 32/127 (25%), Positives = 51/127 (40%), Gaps = 32/127 (25%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQA---KLADFGQSRISPVEGGTHMSTTIAGT 105
G+ Y+H+ + I+ RD+K N+LL K + ++ DFG S E M GT
Sbjct: 138 GITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKM-KDKIGT 191
Query: 106 AGF-----LNTELTEKSDVDSFEIVIL----------------EIITGILTVDLSFKGE- 143
A + L+ EK DV S VIL +I+ + +F+
Sbjct: 192 AYYIAPEVLHGTYDEKCDVWSTG-VILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 250
Query: 144 FDIISVE 150
+ +S
Sbjct: 251 WKKVSES 257
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-05
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 8/88 (9%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR-ISPVEGGTHMSTTIAGT 105
C +EYL + + RD+ + N+L++E AK++DFG ++ S + + + T
Sbjct: 127 CEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWT 181
Query: 106 A--GFLNTELTEKSDVDSFEIVILEIIT 131
A + + KSDV SF I++ EI +
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-05
Identities = 37/128 (28%), Positives = 52/128 (40%), Gaps = 34/128 (26%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQA---KLADFGQSRISPVEGGTHMSTTIAGT 105
G+ Y+H+ H I+ RD+K NILL K + K+ DFG S + T M GT
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKM-KDRIGT 186
Query: 106 AGF-----LNTELTEKSDVDSFEI-VIL----------------EIITGILTVDLSFKGE 143
A + L EK DV S VIL +I+ + T +F
Sbjct: 187 AYYIAPEVLRGTYDEKCDVWS--AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244
Query: 144 -FDIISVE 150
+ IS +
Sbjct: 245 QWRTISDD 252
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-05
Identities = 19/53 (35%), Positives = 33/53 (62%), Gaps = 5/53 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT 101
G++Y H +H ++ RD+K N+LL+ + AK+ADFG S + + G + T+
Sbjct: 128 GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTS 175
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-05
Identities = 18/53 (33%), Positives = 32/53 (60%), Gaps = 5/53 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT 101
++Y H +H ++ RD+K N+LL+ + AK+ADFG S + + G + T+
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTS 170
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-05
Identities = 35/127 (27%), Positives = 50/127 (39%), Gaps = 32/127 (25%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
G+ YLH+ H I+ RD+K N+LL + K+ DFG S + E M GT
Sbjct: 148 GVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKM-KERLGT 201
Query: 106 AGF-----LNTELTEKSDVDSFEIVIL----------------EIITGILTVDLSFKGE- 143
A + L + EK DV S VIL EI+ + +F
Sbjct: 202 AYYIAPEVLRKKYDEKCDVWSIG-VILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE 260
Query: 144 FDIISVE 150
+ +S
Sbjct: 261 WKNVSEG 267
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-05
Identities = 28/93 (30%), Positives = 44/93 (47%), Gaps = 15/93 (16%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G+EYL + + RD+ + N +L+E K+ADFG +R + + S A
Sbjct: 136 GMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARL 190
Query: 109 ---------LNTEL-TEKSDVDSFEIVILEIIT 131
L T T KSDV SF +++ E++T
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-05
Identities = 15/51 (29%), Positives = 25/51 (49%), Gaps = 5/51 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLN-EKVQAKLADFGQSR-ISPVEGGTH 97
+ ++H I RD+K N+L+N + KL DFG ++ + P E
Sbjct: 153 AVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA 200
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-05
Identities = 16/54 (29%), Positives = 27/54 (50%), Gaps = 4/54 (7%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLN-EKVQAKLADFGQSRISPVEGGTHMSTT 101
GL+Y+H ++ RD+K N+ +N E + K+ DFG +RI +
Sbjct: 132 GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-05
Identities = 17/62 (27%), Positives = 25/62 (40%), Gaps = 9/62 (14%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
++YLH I RD+K N+L KL DFG ++ + TT T
Sbjct: 174 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSL-TTPCYTP 227
Query: 107 GF 108
+
Sbjct: 228 YY 229
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-05
Identities = 27/94 (28%), Positives = 41/94 (43%), Gaps = 19/94 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G+EYL ++ I RD+ + N +L E + +ADFG SR + G A
Sbjct: 149 GMEYLSS--RN-FIHRDLAARNCMLAEDMTVCVADFGLSR--KIY---SGDYYRQGCASK 200
Query: 109 L-----------NTELTEKSDVDSFEIVILEIIT 131
L + T SDV +F + + EI+T
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-05
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 14/90 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAG---- 104
G++YL Q K I RD+ + NIL+ E AK+ADFG SR ++ T+
Sbjct: 154 GMDYLSQ--KQ-FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLPVR 206
Query: 105 -TA--GFLNTELTEKSDVDSFEIVILEIIT 131
A + T SDV S+ +++ EI++
Sbjct: 207 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 1e-04
Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 11/91 (12%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR------ISPVEGGTHMSTTI 102
G+++L K + RD+ + N +L+EK K+ADFG +R V T +
Sbjct: 204 GMKFLAS--KK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 103 AGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
A + T KSDV SF +++ E++T
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 1e-04
Identities = 29/94 (30%), Positives = 42/94 (44%), Gaps = 19/94 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G+EYL K I RD+ + N+L+ E K+ADFG +R + T G
Sbjct: 203 GMEYLAS--KK-CIHRDLAARNVLVTEDNVMKIADFGLARD--IHHI---DYYKKTTNGR 254
Query: 109 L-----------NTELTEKSDVDSFEIVILEIIT 131
L + T +SDV SF +++ EI T
Sbjct: 255 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 1e-04
Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 11/90 (12%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT-----IA 103
G+ +L K+ I RD+ + NILL K+ DFG +R ++ +
Sbjct: 157 GMAFLAS--KN-CIHRDLAARNILLTHGRITKICDFGLARDI-KNDSNYVVKGNARLPVK 212
Query: 104 GTA--GFLNTELTEKSDVDSFEIVILEIIT 131
A N T +SDV S+ I + E+ +
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 2e-04
Identities = 23/94 (24%), Positives = 40/94 (42%), Gaps = 19/94 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G+EYL ++ + RD+ + N +L + + +ADFG S+ + G
Sbjct: 159 GMEYLSN--RN-FLHRDLAARNCMLRDDMTVCVADFGLSK--KIY---SGDYYRQGRIAK 210
Query: 109 L-----------NTELTEKSDVDSFEIVILEIIT 131
+ + T KSDV +F + + EI T
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 2e-04
Identities = 12/41 (29%), Positives = 23/41 (56%), Gaps = 4/41 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLN-EKVQAKLADFGQSR 88
L+Y H I+ RD+K N++++ E + +L D+G +
Sbjct: 142 ALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 2e-04
Identities = 18/69 (26%), Positives = 26/69 (37%), Gaps = 11/69 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRI-----SPVEGGTHMST 100
L++LH I RD+K NIL N+ K+ DF T
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 101 TIAGTAGFL 109
T G+A ++
Sbjct: 180 TPCGSAEYM 188
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 2e-04
Identities = 16/63 (25%), Positives = 25/63 (39%), Gaps = 10/63 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
+++LH H I RD+K N+L + KL DFG ++ T T
Sbjct: 140 AIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQ--TPCYT 192
Query: 106 AGF 108
+
Sbjct: 193 PYY 195
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 2e-04
Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 11/91 (12%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR------ISPVEGGTHMSTTI 102
G++YL K + RD+ + N +L+EK K+ADFG +R V T +
Sbjct: 140 GMKYLAS--KK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 103 AGTA--GFLNTELTEKSDVDSFEIVILEIIT 131
A + T KSDV SF +++ E++T
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 3e-04
Identities = 26/97 (26%), Positives = 42/97 (43%), Gaps = 25/97 (25%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT---IAGT 105
G+E+L + I RD+ + NILL+EK K+ DFG +R + +
Sbjct: 160 GMEFLAS--RK-CIHRDLAARNILLSEKNVVKICDFGLARD--------IYKDPDYVRKG 208
Query: 106 AGFL-----------NTELTEKSDVDSFEIVILEIIT 131
L + T +SDV SF +++ EI +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 3e-04
Identities = 12/44 (27%), Positives = 22/44 (50%), Gaps = 4/44 (9%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLN-EKVQAKLADFGQSRISP 91
+ + H ++ RD+K NIL++ + + KL DFG +
Sbjct: 161 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 3e-04
Identities = 25/94 (26%), Positives = 39/94 (41%), Gaps = 19/94 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G+ YL+ + + RD+ + N ++ E K+ DFG +R + G G
Sbjct: 150 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYET---DYYRKGGKGL 201
Query: 109 L-----------NTELTEKSDVDSFEIVILEIIT 131
L + T SDV SF +V+ EI T
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 4e-04
Identities = 28/94 (29%), Positives = 43/94 (45%), Gaps = 19/94 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G+EYL + I RD+ + N+L+ E K+ADFG +R + + T G
Sbjct: 169 GMEYLAS--QK-CIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYY---KKTTNGR 220
Query: 109 L-----------NTELTEKSDVDSFEIVILEIIT 131
L + T +SDV SF +++ EI T
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 5e-04
Identities = 26/94 (27%), Positives = 41/94 (43%), Gaps = 19/94 (20%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G+ +L K+ I RD+ + N+LL AK+ DFG +R + S I
Sbjct: 176 GMAFLAS--KN-CIHRDVAARNVLLTNGHVAKIGDFGLARD--IMND---SNYIVKGNAR 227
Query: 109 L-----------NTELTEKSDVDSFEIVILEIIT 131
L + T +SDV S+ I++ EI +
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 5e-04
Identities = 15/58 (25%), Positives = 26/58 (44%), Gaps = 8/58 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLN-EKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
+++ H ++ RD+K NIL++ + AKL DFG + + GT
Sbjct: 151 AIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDF-DGT 201
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 5e-04
Identities = 23/90 (25%), Positives = 40/90 (44%), Gaps = 11/90 (12%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT-----IA 103
G+E+L K + RD+ + N+L+ K+ DFG +R + ++ +
Sbjct: 184 GMEFLEF--KS-CVHRDLAARNVLVTHGKVVKICDFGLAR-DIMSDSNYVVRGNARLPVK 239
Query: 104 GTA--GFLNTELTEKSDVDSFEIVILEIIT 131
A T KSDV S+ I++ EI +
Sbjct: 240 WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 38.4 bits (90), Expect = 7e-04
Identities = 24/96 (25%), Positives = 37/96 (38%), Gaps = 19/96 (19%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
G+ YL + RD+ + N L+ + K+ DFG SR V G
Sbjct: 143 ASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRD--VYST---DYYRVGGH 194
Query: 107 G-----------FLNTELTEKSDVDSFEIVILEIIT 131
+ + T +SDV SF +++ EI T
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 38.1 bits (89), Expect = 8e-04
Identities = 16/44 (36%), Positives = 21/44 (47%), Gaps = 5/44 (11%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQA--KLADFGQSRIS 90
G+ Y H I RD+K N LL+ K+ DFG S+ S
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 38.0 bits (89), Expect = 8e-04
Identities = 20/96 (20%), Positives = 33/96 (34%), Gaps = 16/96 (16%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQ--------AKLADFGQSRISPVEGGTHM 98
+ +L + +I ++ + NILL + KL+D G S V +
Sbjct: 123 AAAMHFLEE--NT-LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDIL 177
Query: 99 STTIAGTA--GFLNT-ELTEKSDVDSFEIVILEIIT 131
I N L +D SF + EI +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 188 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.98 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.98 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.98 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.98 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.98 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.98 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.98 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.98 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.98 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.98 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.98 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.98 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.8 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.53 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.31 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.07 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.31 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.76 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.53 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 96.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 95.76 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 95.52 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 94.28 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 92.32 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 91.08 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 90.69 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 90.43 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 89.89 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 86.73 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 86.32 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 85.98 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 85.14 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 84.86 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 81.13 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 81.08 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=297.64 Aligned_cols=176 Identities=26% Similarity=0.346 Sum_probs=144.3
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++|||||+++++ .++.++|||||++|+|.+++ .... |+|.||+|||+ .+|+||||||+|
T Consensus 86 l~~l~HpNIV~l~g~~~~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~N 162 (307)
T 3omv_A 86 LRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNN 162 (307)
T ss_dssp HTTCCCTTBCCEEEEECSSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSS
T ss_pred HHhCCCCCEeeEEEEEECCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHH
Confidence 678999999999999 77899999999999999999 3222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
||++.++.+||+|||+++...............||+.||||| ++.++|||||||++|||++|+.||.....
T Consensus 163 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 163 IFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp EEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 999999999999999998654223333345578999999998 46689999999999999999999954211
Q ss_pred -----------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcc
Q 039565 142 -----------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSR 184 (188)
Q Consensus 142 -----------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 184 (188)
...+..++..+.+++..||+.+|++||||++|++.|+.+...-
T Consensus 243 ~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 243 RDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp HHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 1233456778999999999999999999999999998876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=292.39 Aligned_cols=174 Identities=19% Similarity=0.181 Sum_probs=140.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-----------------c---------cHHHHHHHHhc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-----------------E---------VCCPGLEYLHQ 55 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-----------------~---------~i~~~l~~Lh~ 55 (188)
|++++|||||+++|+ .+..++|||||++|+|.+++ ... . |+|.||.|||+
T Consensus 97 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 176 (329)
T 4aoj_A 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176 (329)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 678999999999999 77899999999999999998 211 1 99999999999
Q ss_pred CCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHH
Q 039565 56 GLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEI 129 (188)
Q Consensus 56 ~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~ 129 (188)
.+|+||||||+|||++.++.+||+|||+++...............||+.|+||| ++.++|||||||++|||
T Consensus 177 ---~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~El 253 (329)
T 4aoj_A 177 ---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 253 (329)
T ss_dssp ---TTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---CCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHH
Confidence 999999999999999999999999999998653222222334567899999999 78999999999999999
Q ss_pred Hh-CCcccccc------------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 130 IT-GILTVDLS------------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 130 ~~-g~~p~~~~------------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
+| |+.||... ...+.+..++..+.+++..||+.||++||||++|++.|+.+.+
T Consensus 254 lt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 254 FTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 98 89998542 1233455567889999999999999999999999999988754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=293.98 Aligned_cols=174 Identities=18% Similarity=0.192 Sum_probs=147.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC---------------cc---------cHHHHHHHHhcCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK---------------EE---------VCCPGLEYLHQGL 57 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~---------------~~---------~i~~~l~~Lh~~~ 57 (188)
|++++|||||+++|+ ++..++|||||++|+|.+++ .. .. |++.||.|||+
T Consensus 69 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-- 146 (299)
T 4asz_A 69 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-- 146 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--
T ss_pred HHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--
Confidence 678999999999999 77899999999999999999 21 11 99999999999
Q ss_pred CCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh
Q 039565 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~ 131 (188)
.+|+||||||+|||++.++.+||+|||+++...............||+.|+||| ++.++|||||||++|||+|
T Consensus 147 -~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt 225 (299)
T 4asz_A 147 -QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225 (299)
T ss_dssp -TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred -CCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHc
Confidence 999999999999999999999999999998543222222223356899999999 7999999999999999998
Q ss_pred -CCccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 132 -GILTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 132 -g~~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
|+.||.... ..+.+..++..+.+++..||+.+|++||||++|++.|+++..
T Consensus 226 ~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 226 YGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp TTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 899985421 123445667889999999999999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=290.85 Aligned_cols=172 Identities=18% Similarity=0.248 Sum_probs=146.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc------------------c---------cHHHHHHHHh
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------------------E---------VCCPGLEYLH 54 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------------------~---------~i~~~l~~Lh 54 (188)
|++++|||||+++|+ ++..++|||||++|+|.+++ .+. . |+|.||.|||
T Consensus 83 l~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 162 (308)
T 4gt4_A 83 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS 162 (308)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 568999999999999 77899999999999999998 221 0 9999999999
Q ss_pred cCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHH
Q 039565 55 QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILE 128 (188)
Q Consensus 55 ~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~ 128 (188)
+ .+|+||||||+|||+++++.+||+|||+++...............||+.|+||| ++.++|||||||++||
T Consensus 163 ~---~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~E 239 (308)
T 4gt4_A 163 S---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 239 (308)
T ss_dssp H---TTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred h---CCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHH
Confidence 9 999999999999999999999999999998653222222334567899999999 7999999999999999
Q ss_pred HHh-CCccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 129 IIT-GILTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 129 ~~~-g~~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
|+| |..||.... ..+.+..++..+.+++..||+.+|++||||++|++.|+..
T Consensus 240 l~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 240 VFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 998 888985421 1234456678899999999999999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=285.97 Aligned_cols=173 Identities=21% Similarity=0.250 Sum_probs=143.2
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
-|++++|||||+++++ ++..++|||||++|+|.+++++ .. |++.||+|||+ .+|+||||||+
T Consensus 103 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~ 179 (336)
T 4g3f_A 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKAD 179 (336)
T ss_dssp TTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHH
Confidence 3678999999999999 7889999999999999999922 22 99999999999 99999999999
Q ss_pred cEEEccCC-ceEEecccCcccccCCCCC---cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccccc
Q 039565 70 NILLNEKV-QAKLADFGQSRISPVEGGT---HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLS 139 (188)
Q Consensus 70 nill~~~~-~~kl~d~~~~~~~~~~~~~---~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~ 139 (188)
|||++.+| .+||+|||+++........ .......||+.|+||| ++.++|||||||++|+|++|..||...
T Consensus 180 NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 259 (336)
T 4g3f_A 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 259 (336)
T ss_dssp GEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred HEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 99999887 6999999999865322111 1123457999999999 789999999999999999999999654
Q ss_pred CCC--------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 140 FKG--------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 140 ~~~--------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
... +.+...+..+.+++..||+.||.+|||+.|+++.|...
T Consensus 260 ~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 260 FRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp CCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 322 23345567899999999999999999999999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=279.54 Aligned_cols=163 Identities=22% Similarity=0.358 Sum_probs=136.5
Q ss_pred cccccCCCeeeeccc-------CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCC--cEEe
Q 039565 6 RNKLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHP--IIQR 64 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~--i~h~ 64 (188)
|++++|||||+++++ ....++|||||++|+|.+++.+ .. |++.||+|||+ .+ |+||
T Consensus 79 l~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHR 155 (290)
T 3fpq_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHR 155 (290)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCC
T ss_pred HHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEec
Confidence 578999999999987 2457999999999999999922 22 99999999998 77 9999
Q ss_pred CCCCCcEEEcc-CCceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccccc
Q 039565 65 DMKSTNILLNE-KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 65 dl~~~nill~~-~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||||+|||++. ++.+||+|||+++... .....+..||+.|+||| ++.++|||||||++|+|++|..||..
T Consensus 156 DlKp~NILl~~~~g~vKl~DFGla~~~~----~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 156 DLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CCCGGGEEESSTTSCEEECCTTGGGGCC----TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccChhheeEECCCCCEEEEeCcCCEeCC----CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999985 7899999999997532 12344678999999999 78999999999999999999999954
Q ss_pred cCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFK--------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... ...+...+..+.+++..||+.||++|||++++++
T Consensus 232 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 232 CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 211 1122334567899999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=282.17 Aligned_cols=165 Identities=18% Similarity=0.189 Sum_probs=141.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc--CCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ--GKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~--~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
|++++|||||+++++ .+..|+|||||++|+|.+++ .... |++.||+|||+ .+|+||||||+||
T Consensus 125 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NI 201 (346)
T 4fih_A 125 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSI 201 (346)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHE
Confidence 567899999999999 88999999999999999998 3232 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC-----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF----- 140 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~----- 140 (188)
|++.++.+||+|||+++.... ......+..||+.|+||| ++.++|||||||++|+|++|..||....
T Consensus 202 Ll~~~g~vKl~DFGla~~~~~--~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 279 (346)
T 4fih_A 202 LLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 279 (346)
T ss_dssp EECTTCCEEECCCTTCEECCS--SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred EECCCCCEEEecCcCceecCC--CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 999999999999999986432 222345678999999999 7899999999999999999999995421
Q ss_pred ---------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 ---------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ---------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
........+..+.+++..||+.||++|||++|+++
T Consensus 280 ~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 280 KMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122345678999999999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=287.34 Aligned_cols=175 Identities=21% Similarity=0.205 Sum_probs=145.2
Q ss_pred cccccC-CCeeeeccc----CCccEEEEecCCCCChhhhc-CC-c-----------------c---------cHHHHHHH
Q 039565 6 RNKLTG-PLLVELIGK----QKNNALELGFRGNPELVDQQ-GK-E-----------------E---------VCCPGLEY 52 (188)
Q Consensus 6 l~~l~H-pniv~~~~~----~~~~~lv~e~~~~~~L~~~~-~~-~-----------------~---------~i~~~l~~ 52 (188)
|.+++| ||||+++|+ +...++|||||++|+|.+++ .. . . |+|.||.|
T Consensus 121 l~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~y 200 (353)
T 4ase_A 121 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200 (353)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHh
Confidence 456655 999999997 35689999999999999998 21 0 1 89999999
Q ss_pred HhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHH
Q 039565 53 LHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVI 126 (188)
Q Consensus 53 Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l 126 (188)
||+ .+|+||||||+|||++.++.+||+|||+++...............||+.|+||| ++.++|||||||++
T Consensus 201 LH~---~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 201 LAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277 (353)
T ss_dssp HHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred Hhh---CCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHH
Confidence 999 999999999999999999999999999998654333333344567899999999 79999999999999
Q ss_pred HHHHh-CCccccccC-------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 127 LEIIT-GILTVDLSF-------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 127 ~~~~~-g~~p~~~~~-------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
|||+| |..||.... ....+...+..+.+++..||+.||++||||++|++.|+.+.+.
T Consensus 278 ~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 278 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 99998 899986432 1223445667899999999999999999999999999876543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=279.43 Aligned_cols=178 Identities=19% Similarity=0.191 Sum_probs=138.5
Q ss_pred cccccCCCeeeeccc---C----CccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCC-----CCCcE
Q 039565 6 RNKLTGPLLVELIGK---Q----KNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGL-----KHPII 62 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~----~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~-----~~~i~ 62 (188)
+.+++|||||+++++ + ...++||||+++|+|.+++++.+ |++.||+|||+.. ..+|+
T Consensus 51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~Ii 130 (303)
T 3hmm_A 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEE
T ss_pred HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEe
Confidence 567899999999999 2 25799999999999999993222 9999999999721 13899
Q ss_pred EeCCCCCcEEEccCCceEEecccCcccccCCCCC--cceeeecccccccCCCC------------CCccchHHHHHHHHH
Q 039565 63 QRDMKSTNILLNEKVQAKLADFGQSRISPVEGGT--HMSTTIAGTAGFLNTEL------------TEKSDVDSFEIVILE 128 (188)
Q Consensus 63 h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~--~~~~~~~~~~~~~~pe~------------~~~~di~s~G~~l~~ 128 (188)
||||||+|||++.++.+||+|||+++........ .......||+.|+|||. +.++|||||||++||
T Consensus 131 HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~E 210 (303)
T 3hmm_A 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210 (303)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHH
T ss_pred eccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHH
Confidence 9999999999999999999999999865422221 12234679999999992 347999999999999
Q ss_pred HHhCCccccccC----------------------------CCCc-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 129 IITGILTVDLSF----------------------------KGEF-----DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 129 ~~~g~~p~~~~~----------------------------~~~~-----~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|++|..|+.... .... +...+..+.+++..||+.||++||||.+|++
T Consensus 211 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 211 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 999976542110 0111 1245567899999999999999999999999
Q ss_pred HHhhccCc
Q 039565 176 VREQGSGS 183 (188)
Q Consensus 176 ~l~~~~~~ 183 (188)
.|+++.++
T Consensus 291 ~L~~l~~~ 298 (303)
T 3hmm_A 291 TLSQLSQQ 298 (303)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHHH
Confidence 99988654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=282.91 Aligned_cols=166 Identities=25% Similarity=0.378 Sum_probs=142.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++|||||+++++ .++.++|||||++|+|.+++.+ .. |++.||+|||+ .+|+||||||+|
T Consensus 86 l~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeN 162 (311)
T 4aw0_A 86 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPEN 162 (311)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHH
Confidence 578899999999999 7889999999999999999922 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
||++.++.+||+|||+++............+.+||+.|+||| ++.++|+||+||++|+|++|..||.....
T Consensus 163 ILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~ 242 (311)
T 4aw0_A 163 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI 242 (311)
T ss_dssp EEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred eEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999998754333333455678999999999 78899999999999999999999964321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~ 174 (188)
..++...+..+.+++..||+.||++|||++|++
T Consensus 243 ~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 243 FAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 224445567899999999999999999998863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=284.22 Aligned_cols=165 Identities=20% Similarity=0.293 Sum_probs=140.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc--CCcc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ--GKEE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~--~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
|++++|||||+++++ ++..|+|||||++|+|.+++ ++.. |++.||.|||+ .+|+||||||
T Consensus 77 l~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp 153 (350)
T 4b9d_A 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKS 153 (350)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCG
T ss_pred HHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCH
Confidence 567899999999999 88899999999999999999 2211 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
+|||++.++.+||+|||+++... ..........||+.|+||| ++.++|||||||++|+|++|..||.....
T Consensus 154 ~NILl~~~g~vKl~DFGla~~~~--~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~ 231 (350)
T 4b9d_A 154 QNIFLTKDGTVQLGDFGIARVLN--STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK 231 (350)
T ss_dssp GGEEECTTCCEEECSTTEESCCC--HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HHEEECCCCCEEEcccccceeec--CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 99999999999999999998542 1112234567999999999 78899999999999999999999964321
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+...+..+.+++..||+.||++|||++++++
T Consensus 232 ~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 232 NLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1233445678999999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=283.73 Aligned_cols=165 Identities=18% Similarity=0.183 Sum_probs=141.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc--CCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ--GKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~--~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
|++++|||||+++++ .+.+|+|||||++|+|.+++ .... |++.||+|||+ .+|+||||||+||
T Consensus 202 l~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NI 278 (423)
T 4fie_A 202 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSI 278 (423)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTE
T ss_pred HHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHE
Confidence 577899999999999 88999999999999999999 3333 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK---- 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~---- 141 (188)
|++.+|.+||+|||+++.... ........+||+.||||| ++.++|||||||++|+|++|..||.....
T Consensus 279 Ll~~~g~vKl~DFGla~~~~~--~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 356 (423)
T 4fie_A 279 LLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 356 (423)
T ss_dssp EECTTCCEEECCCTTCEECCS--SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred EEcCCCCEEEecCccceECCC--CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 999999999999999986432 222345678999999999 78999999999999999999999954211
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+..+.+++..||+.||++|||++|+++
T Consensus 357 ~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 357 KMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122345678899999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=277.29 Aligned_cols=166 Identities=25% Similarity=0.277 Sum_probs=139.8
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
-|++++|||||+++++ ++..++|||||++|+|.+++.+ .. |++.||+|||+ .+|+||||||+
T Consensus 79 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~ 155 (304)
T 3ubd_A 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPE 155 (304)
T ss_dssp CCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGG
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHH
Confidence 3778999999999999 8889999999999999999922 22 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
|||++.++.+||+|||+++.... ......+..||+.|+||| ++.++|+||+||++|+|++|..||.....
T Consensus 156 NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~ 233 (304)
T 3ubd_A 156 NILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233 (304)
T ss_dssp GEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HeEEcCCCCEEecccccceeccC--CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH
Confidence 99999999999999999985421 222344578999999999 78999999999999999999999964321
Q ss_pred ---------CCcCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 039565 142 ---------GEFDIISVEKAVEIAMASVSSKVNRRPL-----MNQVVM 175 (188)
Q Consensus 142 ---------~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~i~~ 175 (188)
...+...+..+.+++..||+.||++||| ++|+++
T Consensus 234 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 234 TMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 2234456678999999999999999998 467765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=270.32 Aligned_cols=168 Identities=21% Similarity=0.302 Sum_probs=132.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++|||||+++++ .+..++||||+ +|+|.+++ ++.. |++.||+|||+ .+|+||||||+|
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~N 142 (275)
T 3hyh_A 67 LRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPEN 142 (275)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTT
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHH
Confidence 567899999999999 78899999999 57999988 3222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------C-CCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------L-TEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~-~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
|+++.++.+||+|||+++... ......+..||+.|+||| + +.++||||+||++|+|++|..||+....
T Consensus 143 ILl~~~~~vkl~DFGla~~~~---~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~ 219 (275)
T 3hyh_A 143 LLLDEHLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV 219 (275)
T ss_dssp EEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eEECCCCCEEEeecCCCeecC---CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 999999999999999997543 222334578999999999 3 5789999999999999999999965321
Q ss_pred ---------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhhc
Q 039565 142 ---------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM--VREQG 180 (188)
Q Consensus 142 ---------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~--~l~~~ 180 (188)
..++...+..+.+++..||+.||++|||++|+++ .++..
T Consensus 220 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 220 LFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 1233445678899999999999999999999998 45443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=258.78 Aligned_cols=164 Identities=19% Similarity=0.283 Sum_probs=125.7
Q ss_pred cccccCCCeeeeccc---CC------------ccEEEEecCCCCChhhhc-CCcc--------------cHHHHHHHHhc
Q 039565 6 RNKLTGPLLVELIGK---QK------------NNALELGFRGNPELVDQQ-GKEE--------------VCCPGLEYLHQ 55 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~------------~~~lv~e~~~~~~L~~~~-~~~~--------------~i~~~l~~Lh~ 55 (188)
|++++|||||+++++ .+ ..+++||||++|+|.+++ .+.. |++.||+|||+
T Consensus 57 l~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~ 136 (299)
T 4g31_A 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS 136 (299)
T ss_dssp HTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH
Confidence 678999999999987 11 268999999999999999 3221 99999999999
Q ss_pred CCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCC----------cceeeecccccccCCC------CCCccch
Q 039565 56 GLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGT----------HMSTTIAGTAGFLNTE------LTEKSDV 119 (188)
Q Consensus 56 ~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~----------~~~~~~~~~~~~~~pe------~~~~~di 119 (188)
.+|+||||||+|||++.++.+||+|||+++........ .......||+.|+||| ++.++||
T Consensus 137 ---~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Di 213 (299)
T 4g31_A 137 ---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213 (299)
T ss_dssp ---TTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHH
T ss_pred ---CcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHH
Confidence 99999999999999999999999999999864321111 1123457999999999 7899999
Q ss_pred HHHHHHHHHHHhCCccccccC----------CCCcCH---HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 120 DSFEIVILEIITGILTVDLSF----------KGEFDI---ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 120 ~s~G~~l~~~~~g~~p~~~~~----------~~~~~~---~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|||||++|+|++ ||.... ...++. .....+.+++..||+.||++|||+.++++
T Consensus 214 wSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 214 FSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 999999999996 553211 112222 23345678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=259.78 Aligned_cols=166 Identities=17% Similarity=0.158 Sum_probs=134.4
Q ss_pred cccccCCCeeeeccc---------CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEe
Q 039565 6 RNKLTGPLLVELIGK---------QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQR 64 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~ 64 (188)
|++++|||||+++++ .+..|+||||++ |+|.+++.+.+ |++.||.|||+ .+|+||
T Consensus 107 l~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHR 182 (398)
T 4b99_A 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHR 182 (398)
T ss_dssp HHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCC
T ss_pred HHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCC
Confidence 567899999999987 256799999997 68999983322 99999999999 999999
Q ss_pred CCCCCcEEEccCCceEEecccCcccccCCC--CCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcc
Q 039565 65 DMKSTNILLNEKVQAKLADFGQSRISPVEG--GTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 65 dl~~~nill~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p 135 (188)
||||+|||++.++.+|++|||+++...... ......+..||+.|+||| ++.++||||+||++|+|++|..|
T Consensus 183 DlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~p 262 (398)
T 4b99_A 183 DLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQL 262 (398)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCS
T ss_pred CcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCC
Confidence 999999999999999999999998643211 122344578999999999 47889999999999999999999
Q ss_pred ccccCCC-------------------------------------CcC-----HHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 039565 136 VDLSFKG-------------------------------------EFD-----IISVEKAVEIAMASVSSKVNRRPLMNQV 173 (188)
Q Consensus 136 ~~~~~~~-------------------------------------~~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i 173 (188)
|...... ..+ ...+..+.+++.+||+.||.+|||++|+
T Consensus 263 F~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 342 (398)
T 4b99_A 263 FPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA 342 (398)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 9532100 000 0124578899999999999999999999
Q ss_pred HH
Q 039565 174 VM 175 (188)
Q Consensus 174 ~~ 175 (188)
++
T Consensus 343 L~ 344 (398)
T 4b99_A 343 LR 344 (398)
T ss_dssp TT
T ss_pred hc
Confidence 87
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=255.17 Aligned_cols=166 Identities=17% Similarity=0.167 Sum_probs=132.8
Q ss_pred ccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 7 NKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
.++ +||||++++++ .++.++||||+++|+|.++++... |++.||+|||+ .+|+||||||+|||+
T Consensus 74 ~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl 150 (361)
T 4f9c_A 74 TVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLY 150 (361)
T ss_dssp HHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred HHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEE
Confidence 344 69999999998 889999999999999999995555 99999999999 999999999999999
Q ss_pred ccC-CceEEecccCcccccCCCC--------------------------CcceeeecccccccCCC-------CCCccch
Q 039565 74 NEK-VQAKLADFGQSRISPVEGG--------------------------THMSTTIAGTAGFLNTE-------LTEKSDV 119 (188)
Q Consensus 74 ~~~-~~~kl~d~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~pe-------~~~~~di 119 (188)
+.+ +.+||+|||+++....... ........||+.|+||| ++.++|+
T Consensus 151 ~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~Di 230 (361)
T 4f9c_A 151 NRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDM 230 (361)
T ss_dssp ETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHH
T ss_pred eCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccch
Confidence 877 7999999999975321110 01123457999999999 5788999
Q ss_pred HHHHHHHHHHHhCCccccccCCCC--------------------------------------------------------
Q 039565 120 DSFEIVILEIITGILTVDLSFKGE-------------------------------------------------------- 143 (188)
Q Consensus 120 ~s~G~~l~~~~~g~~p~~~~~~~~-------------------------------------------------------- 143 (188)
||+||++|+|++|+.||.......
T Consensus 231 WSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~ 310 (361)
T 4f9c_A 231 WSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTS 310 (361)
T ss_dssp HHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----------
T ss_pred hhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccc
Confidence 999999999999999984322100
Q ss_pred ----------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 ----------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 ----------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.....+..+.+++.+||+.||++|||++|+++
T Consensus 311 ~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 311 DIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp -----------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00012346789999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=270.47 Aligned_cols=163 Identities=19% Similarity=0.213 Sum_probs=138.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
++.++|||||++++. .+.+|+||||++||+|..++.+ .. |++.||+|||+ .+|+||||||+|
T Consensus 246 l~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeN 322 (689)
T 3v5w_A 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPAN 322 (689)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGG
T ss_pred HhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHH
Confidence 356789999999998 8899999999999999999922 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
||++.+|.+||+|||+++.... ....+.+||+.|+||| ++.++|+||+||++|+|++|..||.....
T Consensus 323 ILld~~G~vKL~DFGlA~~~~~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~ 398 (689)
T 3v5w_A 323 ILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398 (689)
T ss_dssp EEECTTSCEEECCCTTCEECSS----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC
T ss_pred eEEeCCCCEEecccceeeecCC----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9999999999999999986431 1234578999999999 57889999999999999999999964322
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPL-----MNQVVM 175 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~i~~ 175 (188)
..++...+..+.+++..||+.||.+|++ +++|++
T Consensus 399 ~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 399 KHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1233445678999999999999999998 677765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=263.05 Aligned_cols=164 Identities=21% Similarity=0.259 Sum_probs=139.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|++++|||||+++++ ....+++||||++|+|.+++ ++.. |++.||.|||+ .+|+||||||+
T Consensus 208 l~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~ 284 (573)
T 3uto_A 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPE 284 (573)
T ss_dssp HHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChh
Confidence 577899999999999 88999999999999999998 3332 99999999999 99999999999
Q ss_pred cEEEccC--CceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 70 NILLNEK--VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 70 nill~~~--~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|||++.+ +.+||+|||+++... .........||+.|+||| ++.++||||+||++|+|++|..||.....
T Consensus 285 Nill~~~~~~~vKl~DFG~a~~~~---~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~ 361 (573)
T 3uto_A 285 NIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361 (573)
T ss_dssp GEEESSSSCCCEEECCCSSCEECC---TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred hccccCCCCCCEEEeeccceeEcc---CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 9999854 899999999998643 223345678999999999 67889999999999999999999954221
Q ss_pred ---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+..+.+++..||+.||.+|||++|+++
T Consensus 362 ~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 362 DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111234678899999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=237.65 Aligned_cols=175 Identities=34% Similarity=0.466 Sum_probs=147.3
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc------c---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------E---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
.+.+++||||++++++ .+..++||||+++++|.+++ ... . |++.||.|||+ .+++|||
T Consensus 88 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~d 164 (321)
T 2qkw_B 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRD 164 (321)
T ss_dssp GGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSC
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCC
Confidence 3677899999999999 77889999999999999999 221 1 89999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLS 139 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~ 139 (188)
|||+||+++.++.+||+|||++................|+..|++|| ++.++|+||||+++|++++|..||...
T Consensus 165 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 165 VKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp CCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred CCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 99999999999999999999987543222222334456889999999 689999999999999999999887532
Q ss_pred CC----------------------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 140 FK----------------------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 140 ~~----------------------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
.. ...+...+..+.+++..||+.+|++|||++++++.|+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 21 22456778899999999999999999999999999987654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=238.11 Aligned_cols=174 Identities=31% Similarity=0.479 Sum_probs=146.8
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc------c---------cHHHHHHHHhcCCCC---CcE
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------E---------VCCPGLEYLHQGLKH---PII 62 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------~---------~i~~~l~~Lh~~~~~---~i~ 62 (188)
.+.+++||||++++++ ....++||||+++|+|.+++ ... . |++.||.|||+ . +++
T Consensus 80 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~iv 156 (326)
T 3uim_A 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD---HCDPKII 156 (326)
T ss_dssp GGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH---SSSSCEE
T ss_pred HHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCeE
Confidence 3577899999999999 77889999999999999999 221 1 89999999999 7 999
Q ss_pred EeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccc
Q 039565 63 QRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 63 h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
||||||+||+++.++.++|+|||++.... ...........|++.|+||| ++.++|+||||+++|+|++|..||
T Consensus 157 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 235 (326)
T 3uim_A 157 HRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235 (326)
T ss_dssp CCCCSGGGEEECTTCCEEECCCSSCEECC-SSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSB
T ss_pred eCCCchhhEEECCCCCEEeccCccccccC-cccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcc
Confidence 99999999999999999999999998653 22222334456899999999 588999999999999999999998
Q ss_pred cc------------------------------cCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 137 DL------------------------------SFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 137 ~~------------------------------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
+. ......+...+..+.+++..||+.+|.+|||+++++++|++..-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 236 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp CHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred cccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 41 11123456778899999999999999999999999999986543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=241.18 Aligned_cols=175 Identities=20% Similarity=0.201 Sum_probs=141.4
Q ss_pred CcccccCCCeeeeccc---C----CccEEEEecCCCCChhhhcC--Ccc---------cHHHHHHHHhcCCCC-------
Q 039565 5 NRNKLTGPLLVELIGK---Q----KNNALELGFRGNPELVDQQG--KEE---------VCCPGLEYLHQGLKH------- 59 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~----~~~~lv~e~~~~~~L~~~~~--~~~---------~i~~~l~~Lh~~~~~------- 59 (188)
.+.+++||||++++++ . ...++||||+++|+|.+++. ... |++.||.|||+ .
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~ 147 (322)
T 3soc_A 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHE---DIPGLKDG 147 (322)
T ss_dssp TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTE
T ss_pred HHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHh---hccccccc
Confidence 3678899999999999 2 23699999999999999992 222 99999999998 7
Q ss_pred ---CcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC-----------CCccchHHHHHH
Q 039565 60 ---PIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-----------TEKSDVDSFEIV 125 (188)
Q Consensus 60 ---~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-----------~~~~di~s~G~~ 125 (188)
+++||||||+||+++.++.+||+|||+++...............|++.|+|||. +.++||||||++
T Consensus 148 ~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i 227 (322)
T 3soc_A 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227 (322)
T ss_dssp EECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHH
T ss_pred cCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHH
Confidence 999999999999999999999999999976543332223334678999999992 235699999999
Q ss_pred HHHHHhCCccccccCCCC----------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 039565 126 ILEIITGILTVDLSFKGE----------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMN 171 (188)
Q Consensus 126 l~~~~~g~~p~~~~~~~~----------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~ 171 (188)
+|+|++|..||+...... .....+..+.+++..||+.||++|||++
T Consensus 228 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 307 (322)
T 3soc_A 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307 (322)
T ss_dssp HHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHH
Confidence 999999998886432211 0113345699999999999999999999
Q ss_pred HHHHHHhhccC
Q 039565 172 QVVMVREQGSG 182 (188)
Q Consensus 172 ~i~~~l~~~~~ 182 (188)
++++.|+++.+
T Consensus 308 ell~~L~~l~~ 318 (322)
T 3soc_A 308 CVGERITQMQR 318 (322)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=237.87 Aligned_cols=173 Identities=24% Similarity=0.316 Sum_probs=136.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-----c---------cHHHHHHHHhcCCCCC--cEEeC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-----E---------VCCPGLEYLHQGLKHP--IIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-----~---------~i~~~l~~Lh~~~~~~--i~h~d 65 (188)
+.+++||||++++++ ....++||||+++++|.+++ ... . |++.||+|||+ .+ ++|||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~D 164 (309)
T 3p86_A 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRN 164 (309)
T ss_dssp HHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTT
T ss_pred HHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCC
Confidence 567899999999999 77889999999999999999 322 1 99999999999 88 99999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLS 139 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~ 139 (188)
|||+||+++.++.+||+|||+++... ..........|++.|+||| ++.++|+||||+++|++++|..||...
T Consensus 165 ikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 165 LKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp CCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred CChhhEEEeCCCcEEECCCCCCcccc--ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987532 1112233467889999998 688999999999999999999998643
Q ss_pred C-------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 140 F-------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 140 ~-------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
. ....+...+..+.+++..||+.+|.+|||++++++.|+.+..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 243 NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 2 1223444567899999999999999999999999999887654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=238.75 Aligned_cols=174 Identities=20% Similarity=0.267 Sum_probs=142.1
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++|+||+.+|+|.+++ .... |++.||.|||+ .+++||||||+|
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~N 145 (325)
T 3kex_A 69 IGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARN 145 (325)
T ss_dssp HHTCCCTTBCCEEEEECBSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTT
T ss_pred HhcCCCCCcCeEEEEEcCCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchhe
Confidence 456799999999999 77899999999999999999 3222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCCCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFKGE 143 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~~~ 143 (188)
|+++.++.+||+|||+++...............++..|++|| ++.++|+||||+++|++++ |..||......+
T Consensus 146 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 225 (325)
T 3kex_A 146 VLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225 (325)
T ss_dssp EEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH
T ss_pred EEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH
Confidence 999999999999999998654333333334456777899998 6889999999999999999 999986533211
Q ss_pred ------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 144 ------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 144 ------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
.+...+..+.+++..||+.+|.+|||++++++.|+.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 226 VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp HHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 222334567899999999999999999999999988754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=232.40 Aligned_cols=174 Identities=35% Similarity=0.489 Sum_probs=145.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c-----c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E-----E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~-----~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||++++++ .+..+++|||+++++|.+++.. . . |++.||.|||+ .+++|+|||
T Consensus 84 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlk 160 (307)
T 2nru_A 84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIK 160 (307)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred HHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCC
Confidence 567899999999999 7789999999999999999821 1 1 89999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
|+||+++.++.++|+|||++................|++.|++|| ++.++|+||||+++|++++|..||+.....
T Consensus 161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 999999999999999999987543222222233457889999998 588999999999999999999998653221
Q ss_pred --------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 143 --------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 143 --------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
..+...+..+.+++..||+.+|.+|||++++++.|+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1234566789999999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=235.86 Aligned_cols=174 Identities=24% Similarity=0.260 Sum_probs=141.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC--cc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK--EE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~--~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++||||+++++|.+++.. .. |++.||+|||+ .+++|+||||+
T Consensus 61 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~ 137 (310)
T 3s95_A 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSH 137 (310)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTT
T ss_pred HHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcC
Confidence 567899999999999 7889999999999999999922 21 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCc------------ceeeecccccccCCC------CCCccchHHHHHHHHHHHh
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTH------------MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~------------~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~ 131 (188)
||+++.++.+||+|||++.......... ......|++.|+||| ++.++||||||+++|++++
T Consensus 138 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 217 (310)
T 3s95_A 138 NCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217 (310)
T ss_dssp SEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred eEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhc
Confidence 9999999999999999987543211110 111457889999999 6889999999999999999
Q ss_pred CCccccccCCCC--------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 132 GILTVDLSFKGE--------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 132 g~~p~~~~~~~~--------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
|..|+....... .+...+..+.+++..||+.+|++|||++++++.|+.+..
T Consensus 218 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 218 RVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp TCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 998876533221 122234568899999999999999999999999987753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=242.89 Aligned_cols=174 Identities=20% Similarity=0.207 Sum_probs=143.2
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc------------------c---------cHHHHHHHH
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------------------E---------VCCPGLEYL 53 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------------------~---------~i~~~l~~L 53 (188)
+.++ +||||++++++ .+..++||||+++|+|.+++ ... . |++.||.||
T Consensus 140 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 219 (370)
T 2psq_A 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219 (370)
T ss_dssp HHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 3456 89999999999 77899999999999999998 211 1 999999999
Q ss_pred hcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHH
Q 039565 54 HQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 54 h~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~ 127 (188)
|+ .+++||||||+||+++.++.+||+|||+++...............+++.|+||| ++.++|+||||+++|
T Consensus 220 H~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 296 (370)
T 2psq_A 220 AS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 296 (370)
T ss_dssp HH---TTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred Hh---CCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHH
Confidence 99 999999999999999999999999999987543222222233345677899999 688999999999999
Q ss_pred HHHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 128 EIIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 128 ~~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
+|++ |..||..... ...+...+..+.+++..||+.+|.+|||++++++.|+.+..
T Consensus 297 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 297 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 9999 8888864321 22334456689999999999999999999999999988653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=245.82 Aligned_cols=175 Identities=19% Similarity=0.208 Sum_probs=141.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC----cc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK----EE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~----~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|++++||||++++++ .+..++||||+++|+|.+++.. .. |++.||+|||+ .+++||||||+
T Consensus 166 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~ 242 (377)
T 3cbl_A 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAAR 242 (377)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGG
T ss_pred HHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHH
Confidence 567899999999999 6788999999999999999822 11 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
||+++.++.+||+|||+++...............++..|+||| ++.++|+||||+++|++++ |..||....
T Consensus 243 Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~ 322 (377)
T 3cbl_A 243 NCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ 322 (377)
T ss_dssp GEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH
T ss_pred HEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987532110000111123456799999 5789999999999999998 888885421
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
....+...+..+.+++..||+.+|++|||+++|++.|+.+...
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 323 QTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1223344567889999999999999999999999999987643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=232.94 Aligned_cols=165 Identities=22% Similarity=0.276 Sum_probs=139.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+.+++||||++++++ .+..++||||+++++|.+++.+ .. |++.||.|||+ .+++|||+||+||
T Consensus 71 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Ni 147 (297)
T 3fxz_A 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNI 147 (297)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred HhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHE
Confidence 467899999999998 7889999999999999999822 22 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC-----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF----- 140 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~----- 140 (188)
+++.++.+||+|||++...... ........|++.|+||| ++.++|+||||+++|+|++|..||....
T Consensus 148 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 225 (297)
T 3fxz_A 148 LLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (297)
T ss_dssp EECTTCCEEECCCTTCEECCST--TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred EECCCCCEEEeeCCCceecCCc--ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999998754322 22334567899999999 6889999999999999999999985432
Q ss_pred ---------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 ---------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ---------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+...+..+.+++..||+.||++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11223445677899999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=239.04 Aligned_cols=174 Identities=19% Similarity=0.249 Sum_probs=142.5
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-C-Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-G-KEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~-~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++++||+.+|+|.+++ . ... |++.||.|||+ .+++||||||+|
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~N 147 (327)
T 3poz_A 71 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 147 (327)
T ss_dssp HHHCCBTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChhe
Confidence 567899999999999 67788999999999999998 2 221 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~-- 141 (188)
|+++.++.+||+|||+++...............++..|++|| ++.++|+||||+++|++++ |..||+....
T Consensus 148 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 227 (327)
T 3poz_A 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp EEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH
Confidence 999999999999999988654333322333455677899999 6889999999999999999 9999864322
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
...+...+..+.+++..||+.+|.+|||++++++.|+.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 228 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 12334456689999999999999999999999999987754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=236.77 Aligned_cols=175 Identities=19% Similarity=0.236 Sum_probs=142.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++||||+++++|.+++ .... |++.||.|||+ .+++||||||+
T Consensus 104 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~ 180 (325)
T 3kul_A 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAAR 180 (325)
T ss_dssp HTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGG
T ss_pred HHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcc
Confidence 567899999999999 77889999999999999999 3322 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCC-cceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~- 140 (188)
||+++.++.++|+|||+++........ .......++..|++|| ++.++||||||+++|++++ |..||....
T Consensus 181 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 181 NVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp GEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred eEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999999865322111 1122334566799998 5889999999999999998 999885321
Q ss_pred -----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 141 -----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 141 -----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
....+...+..+.+++..||+.+|++|||+++|++.|+.+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 261 RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1223344567899999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=231.72 Aligned_cols=174 Identities=24% Similarity=0.344 Sum_probs=135.8
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcC-Ccc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQG-KEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~-~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....+++|||+++++|.+++. ... |++.||.|||+ .+++|+||||+|
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~N 150 (289)
T 3og7_A 74 LRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNN 150 (289)
T ss_dssp HTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred HHhCCCCcEEEEEeeccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccce
Confidence 567899999999999 778899999999999999983 222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+++.++.++|+|||++................|++.|++|| ++.++|+||||+++|++++|..||.....
T Consensus 151 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 230 (289)
T 3og7_A 151 IFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230 (289)
T ss_dssp EEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred EEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence 999999999999999987543222222334467889999998 34589999999999999999999864221
Q ss_pred -----------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 142 -----------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 142 -----------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
.......+..+.+++..||+.+|.+|||++++++.|+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 231 RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11223456789999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=228.27 Aligned_cols=175 Identities=23% Similarity=0.305 Sum_probs=142.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC----cc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK----EE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~----~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....+++|||+++++|.+++.. .. |++.||.|||+ .+++|+|+||+
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~ 133 (268)
T 3sxs_A 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAAR 133 (268)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGG
T ss_pred HHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcc
Confidence 567899999999999 6778999999999999999822 11 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
||+++.++.++|+|||.+.... ...........++..|++|| ++.++|+||||+++|++++ |..||+....
T Consensus 134 Nil~~~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (268)
T 3sxs_A 134 NCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS 212 (268)
T ss_dssp GEEECTTCCEEECCTTCEEECC-TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEEECCCCCEEEccCccceecc-hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH
Confidence 9999999999999999987543 12212222344566799998 5889999999999999998 9999864221
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcc
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSR 184 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 184 (188)
...+...+..+.+++..||+.+|.+|||++++++.|+.+.++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 213 EVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp HHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred HHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1122334567899999999999999999999999999987753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=239.20 Aligned_cols=175 Identities=21% Similarity=0.190 Sum_probs=143.1
Q ss_pred cccc-cCCCeeeeccc----CCccEEEEecCCCCChhhhc-CC-------------------------------------
Q 039565 6 RNKL-TGPLLVELIGK----QKNNALELGFRGNPELVDQQ-GK------------------------------------- 42 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~-~~------------------------------------- 42 (188)
+.++ +||||++++++ +...+++|||+++|+|.+++ ..
T Consensus 79 l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (359)
T 3vhe_A 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITS 158 (359)
T ss_dssp HHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------
T ss_pred HHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCc
Confidence 3455 79999999998 44589999999999999998 22
Q ss_pred -------------------------------cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEe
Q 039565 43 -------------------------------EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLA 82 (188)
Q Consensus 43 -------------------------------~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~ 82 (188)
.. |++.||.|||+ .+++||||||+||+++.++.+||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~ 235 (359)
T 3vhe_A 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKIC 235 (359)
T ss_dssp -------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred cccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEE
Confidence 11 89999999999 999999999999999999999999
Q ss_pred cccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-------------C
Q 039565 83 DFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK-------------G 142 (188)
Q Consensus 83 d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~-------------~ 142 (188)
|||++................++..|+||| ++.++||||||+++|+|++ |..||..... .
T Consensus 236 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 315 (359)
T 3vhe_A 236 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 315 (359)
T ss_dssp CCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC
T ss_pred eccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC
Confidence 999997653233323334466788899999 6889999999999999998 9999865332 1
Q ss_pred CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 143 EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 143 ~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
..+...+..+.+++..||+.+|.+|||++++++.|+.+...
T Consensus 316 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 316 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 23334556899999999999999999999999999987643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=245.67 Aligned_cols=173 Identities=22% Similarity=0.258 Sum_probs=143.3
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhcC---C--cc---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQG---K--EE---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~~---~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
|.+++||||++++++ ....++||||+++|+|.+++. . .. |++.||+|||+ .+++|||||
T Consensus 240 l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlk 316 (450)
T 1k9a_A 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLA 316 (450)
T ss_dssp HHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred HHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCC
Confidence 567899999999998 347899999999999999992 1 12 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~ 140 (188)
|+||+++.++.+||+|||+++.... ......++..|+||| ++.++|+||||+++|+|++ |..||....
T Consensus 317 p~Nill~~~~~~kl~DfG~a~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 317 ARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred HhhEEECCCCCEEEeeCCCcccccc-----cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999874321 112235667899998 6889999999999999998 999986432
Q ss_pred CC------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCccee
Q 039565 141 KG------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSRIT 186 (188)
Q Consensus 141 ~~------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~~~ 186 (188)
.. ..+...+..+.+++..||+.+|++|||+.++++.|+.+...++.
T Consensus 392 ~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l~ 449 (450)
T 1k9a_A 392 LKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHELH 449 (450)
T ss_dssp TTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTTT
T ss_pred HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhcc
Confidence 21 23344567899999999999999999999999999998877654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=246.01 Aligned_cols=174 Identities=23% Similarity=0.269 Sum_probs=143.4
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCCc-----c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGKE-----E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-----~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|.+++||||++++++ .+..++||||+++|+|.+++... . |++.||+|||+ .+++||||||+
T Consensus 237 l~~l~h~~iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~ 313 (454)
T 1qcf_A 237 MKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAA 313 (454)
T ss_dssp HTTCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGG
T ss_pred HhhCCCCCEeeEEEEEeCCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHH
Confidence 567899999999999 78899999999999999999321 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
||+++.++.+||+|||+++.... ..........++..|+||| ++.++||||||+++|+|++ |..||....
T Consensus 314 Nill~~~~~~kl~DFG~a~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~ 392 (454)
T 1qcf_A 314 NILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392 (454)
T ss_dssp GEEECTTCCEEECSTTGGGGBCC-HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred HEEECCCCcEEEeeCCCceEcCC-CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875421 1111112234566799998 6889999999999999999 999985421
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
....+...+..+.+++..||+.+|++|||+++|++.|+.+...
T Consensus 393 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 393 EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1222334567899999999999999999999999999988654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=232.40 Aligned_cols=175 Identities=21% Similarity=0.242 Sum_probs=145.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C-Cc-------------------------c---------cH
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G-KE-------------------------E---------VC 46 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~-~~-------------------------~---------~i 46 (188)
+.+++||||++++++ ....+++|||+++++|.+++ . .. . |+
T Consensus 80 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 159 (314)
T 2ivs_A 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159 (314)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHH
T ss_pred HhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHH
Confidence 567899999999998 77899999999999999998 2 11 1 99
Q ss_pred HHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchH
Q 039565 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVD 120 (188)
Q Consensus 47 ~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~ 120 (188)
+.||.|||+ .+++|+||||+||+++.++.++|+|||++................++..|++|| ++.++|+|
T Consensus 160 ~~~l~~lH~---~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 236 (314)
T 2ivs_A 160 SQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVW 236 (314)
T ss_dssp HHHHHHHHH---TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHH
T ss_pred HHHHHHHHH---CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHH
Confidence 999999999 999999999999999999999999999987543222222233345677899999 68899999
Q ss_pred HHHHHHHHHHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 121 SFEIVILEIIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 121 s~G~~l~~~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
|||+++|+|++ |..||..... ...+...+..+.+++..||+.+|++|||++++++.|+++...
T Consensus 237 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 237 SFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99999999999 9888864322 223334567899999999999999999999999999987654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=229.84 Aligned_cols=175 Identities=24% Similarity=0.312 Sum_probs=143.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....+++|||+++++|.+++ .... |++.||.|||+ .+++|+|+||+
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~ 135 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAAR 135 (269)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchh
Confidence 567899999999999 67789999999999999999 3322 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
||+++.++.++|+|||++.... ...........++..|++|| ++.++|+||+|+++|++++ |..||....
T Consensus 136 Nil~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~ 214 (269)
T 4hcu_A 136 NCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 214 (269)
T ss_dssp GEEECGGGCEEECCTTGGGGBC-CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred eEEEcCCCCEEecccccccccc-ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999999987542 11111122344566799998 6889999999999999999 888886432
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcc
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSR 184 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 184 (188)
....+...+..+.+++..||+.+|++|||++++++.|+++.++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 215 EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 12223334677899999999999999999999999999887654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=234.16 Aligned_cols=164 Identities=21% Similarity=0.309 Sum_probs=138.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C--Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G--KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~--~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++||||++++++ .+..++||||+++++|.+++ . ... |++.||.|||+ .+++||||||+|
T Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~N 144 (328)
T 3fe3_A 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAEN 144 (328)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHH
Confidence 567899999999999 78899999999999999998 2 222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------C-CCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------L-TEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~-~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
|+++.++.+||+|||++...... .......|++.|+||| + +.++|+||+|+++|+|++|..||+....
T Consensus 145 Ill~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 221 (328)
T 3fe3_A 145 LLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221 (328)
T ss_dssp EEECTTSCEEECSTTCCGGGSSS---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEcCCCCEEEeeccCceecCCC---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999998754321 2234567899999999 2 4689999999999999999999965431
Q ss_pred ---------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ---------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ---------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+...+..+.+++..||+.||.+|||++++++
T Consensus 222 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 222 LRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1223334667889999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=227.08 Aligned_cols=170 Identities=18% Similarity=0.191 Sum_probs=137.6
Q ss_pred cccCCCeeeeccc-------CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHh--------cCCCCCc
Q 039565 8 KLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLH--------QGLKHPI 61 (188)
Q Consensus 8 ~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh--------~~~~~~i 61 (188)
.++||||++++++ ....+++|||+++|+|.++++... |++.||.||| + .++
T Consensus 58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~i 134 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAI 134 (301)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEE
T ss_pred hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCe
Confidence 3799999999987 345789999999999999994333 9999999999 7 899
Q ss_pred EEeCCCCCcEEEccCCceEEecccCcccccCCCCCc--ceeeecccccccCCCC------------CCccchHHHHHHHH
Q 039565 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH--MSTTIAGTAGFLNTEL------------TEKSDVDSFEIVIL 127 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~--~~~~~~~~~~~~~pe~------------~~~~di~s~G~~l~ 127 (188)
+||||||+||+++.++.+||+|||+++......... ......|++.|+|||. +.++|+||||+++|
T Consensus 135 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~ 214 (301)
T 3q4u_A 135 AHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214 (301)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHH
Confidence 999999999999999999999999987543222111 1223478999999991 14799999999999
Q ss_pred HHHhC----------CccccccCCCC-----------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 039565 128 EIITG----------ILTVDLSFKGE-----------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174 (188)
Q Consensus 128 ~~~~g----------~~p~~~~~~~~-----------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~ 174 (188)
+|++| ..||....... .+...+..+.+++..||+.+|++|||+++++
T Consensus 215 el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 294 (301)
T 3q4u_A 215 EVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294 (301)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 99999 66774322111 1234667899999999999999999999999
Q ss_pred HHHhhc
Q 039565 175 MVREQG 180 (188)
Q Consensus 175 ~~l~~~ 180 (188)
+.|+++
T Consensus 295 ~~L~~i 300 (301)
T 3q4u_A 295 KTLTKI 300 (301)
T ss_dssp HHHHHH
T ss_pred HHHhcc
Confidence 999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=232.50 Aligned_cols=175 Identities=22% Similarity=0.296 Sum_probs=138.2
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||++++++ ....++||||+++++|.+++ ... . |++.||.|||+ .+++|+|||
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dik 141 (295)
T 3ugc_A 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLA 141 (295)
T ss_dssp HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCC
Confidence 567899999999997 46689999999999999999 222 1 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCC-cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+||+++.++.+||+|||++......... .......++..|+||| ++.++||||||+++|++++|..|+....
T Consensus 142 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 221 (295)
T 3ugc_A 142 TRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 221 (295)
T ss_dssp GGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH
T ss_pred HhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh
Confidence 99999999999999999998764322111 1122344666799998 6889999999999999999987764211
Q ss_pred ----------------------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 141 ----------------------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 141 ----------------------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
....+...+..+.+++..||+.+|++|||++++++.|+.+.++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 222 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1112334457899999999999999999999999999987643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=231.18 Aligned_cols=174 Identities=19% Similarity=0.201 Sum_probs=134.1
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..++||||+++++|.+++ .+. . |++.||.|||+ .+++|+||||+|
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~N 146 (281)
T 1mp8_A 70 MRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARN 146 (281)
T ss_dssp HHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred HHhCCCCccceEEEEEccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHH
Confidence 567899999999999 77889999999999999998 222 1 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~-- 141 (188)
|+++.++.+||+|||++..... ..........+++.|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 147 il~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~ 225 (281)
T 1mp8_A 147 VLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225 (281)
T ss_dssp EEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEECCCCCEEECccccccccCc-ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH
Confidence 9999999999999999875431 1111223345667899998 6788999999999999996 8888864322
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
...+...+..+.+++..||+.+|++|||++++++.|+.+...
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 226 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 123334567889999999999999999999999999887543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=231.76 Aligned_cols=174 Identities=18% Similarity=0.241 Sum_probs=139.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..+++|||+++++|.+++.+ .. |++.||.|||+ .+++|||+||+|
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~N 141 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQN 141 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHH
Confidence 567899999999999 7788999999999999999822 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG-- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~-- 142 (188)
|+++.++.+||+|||++.... ...........|++.|++|| ++.++|+||||+++|++++|..||+.....
T Consensus 142 il~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~ 220 (294)
T 4eqm_A 142 ILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220 (294)
T ss_dssp EEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH
T ss_pred EEECCCCCEEEEeCCCccccc-cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999999999999999987543 11112233457899999999 688999999999999999999999653211
Q ss_pred --------------CcCHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHhhccCc
Q 039565 143 --------------EFDIISVEKAVEIAMASVSSKVNRRP-LMNQVVMVREQGSGS 183 (188)
Q Consensus 143 --------------~~~~~~~~~~~~l~~~cl~~~p~~Rp-s~~~i~~~l~~~~~~ 183 (188)
......+..+.+++..|++.+|.+|| +++++.+.|+.....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 221 AIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred HHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 11223457899999999999999999 899999999876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=233.83 Aligned_cols=175 Identities=19% Similarity=0.243 Sum_probs=138.5
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-C-Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-G-KEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~-~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....+++++|+.+|+|.+++ . ... |++.||.|||+ .+++||||||+|
T Consensus 71 l~~l~hp~iv~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~N 147 (327)
T 3lzb_A 71 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 147 (327)
T ss_dssp HTTCCBTTBCCCCEEEESSSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred HHhCCCCCeeEEEEEEecCCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHH
Confidence 567899999999999 67789999999999999999 2 221 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~-- 141 (188)
|+++.++.+||+|||+++...............++..|++|| ++.++|+||||+++|++++ |..||+....
T Consensus 148 Il~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 227 (327)
T 3lzb_A 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp EEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence 999999999999999998653222222233445677899998 6889999999999999999 9999865322
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
...+...+..+.+++..||+.+|.+|||++++++.|+.+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 228 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 123334566799999999999999999999999999887653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=238.84 Aligned_cols=174 Identities=20% Similarity=0.249 Sum_probs=132.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++||||+++++|.+++ .... |++.||.|||+ .+++||||||+
T Consensus 100 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~ 176 (373)
T 2qol_A 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAAR 176 (373)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred HHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcc
Confidence 567899999999999 77889999999999999999 3221 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCC-cceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~ 141 (188)
||+++.++.+||+|||+++........ .......++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 177 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~ 256 (373)
T 2qol_A 177 NILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256 (373)
T ss_dssp GEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred eEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999998764321111 1112234456799998 6889999999999999998 9988853211
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
...+...+..+.+++..||+.+|++||++++|++.|+.+..
T Consensus 257 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 257 QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp HHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 11223455789999999999999999999999999988754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=232.91 Aligned_cols=175 Identities=19% Similarity=0.237 Sum_probs=144.3
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-------------------------c---------cH
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-------------------------E---------VC 46 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-------------------------~---------~i 46 (188)
+.++ +||||++++++ .+..++||||+++|+|.+++ ... . |+
T Consensus 102 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 181 (344)
T 1rjb_A 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181 (344)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence 4566 89999999998 78899999999999999999 221 1 99
Q ss_pred HHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchH
Q 039565 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVD 120 (188)
Q Consensus 47 ~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~ 120 (188)
+.||.|||+ .+++||||||+||+++.++.++|+|||++................++..|+||| ++.++|+|
T Consensus 182 ~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 258 (344)
T 1rjb_A 182 AKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 258 (344)
T ss_dssp HHHHHHHHH---TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHh---CCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHH
Confidence 999999999 999999999999999999999999999987654333222333456777899999 68899999
Q ss_pred HHHHHHHHHHh-CCccccccCC-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 121 SFEIVILEIIT-GILTVDLSFK-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 121 s~G~~l~~~~~-g~~p~~~~~~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
|||+++|+|++ |..||..... ...+...+..+.+++..||+.+|.+|||++++++.|+.+...
T Consensus 259 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 259 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 99999999998 9988865322 122334567899999999999999999999999999887654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=245.45 Aligned_cols=174 Identities=24% Similarity=0.238 Sum_probs=143.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC--Ccc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG--KEE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~--~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
|.+++||||++++++ ....++||||+++|+|.+++. ... |++.||+|||+ .+++||||||
T Consensus 270 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp 346 (495)
T 1opk_A 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAA 346 (495)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSG
T ss_pred HHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence 567899999999999 778999999999999999992 111 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~ 141 (188)
+||+++.++.+||+|||+++.... ..........++..|+||| ++.++||||||+++|+|++ |..||.....
T Consensus 347 ~NIll~~~~~~kl~DFG~a~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 347 RNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp GGEEECGGGCEEECCTTCEECCTT-CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCcEEEeecccceeccC-CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999886431 1111122234566799999 6889999999999999999 8888854321
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
...+...+..+.+++..||+.+|++|||+++|++.|+.+...
T Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 426 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 223344567899999999999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=241.34 Aligned_cols=174 Identities=20% Similarity=0.191 Sum_probs=141.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC---------cc---------cHHHHHHHHhcCCCCCcEE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK---------EE---------VCCPGLEYLHQGLKHPIIQ 63 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~---------~~---------~i~~~l~~Lh~~~~~~i~h 63 (188)
+.+++||||++++++ ....++||||+++|+|.+++ .. .. |++.||.|||+ .+|+|
T Consensus 128 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH 204 (367)
T 3l9p_A 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIH 204 (367)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred HHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeC
Confidence 457899999999999 77889999999999999999 21 11 99999999999 99999
Q ss_pred eCCCCCcEEEccCC---ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CC
Q 039565 64 RDMKSTNILLNEKV---QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GI 133 (188)
Q Consensus 64 ~dl~~~nill~~~~---~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~ 133 (188)
|||||+||+++.++ .+||+|||+++...............+++.|+||| ++.++|+||||+++|+|++ |.
T Consensus 205 rDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~ 284 (367)
T 3l9p_A 205 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 284 (367)
T ss_dssp SCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999554 59999999987432122222233456788899999 6889999999999999998 88
Q ss_pred ccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 134 LTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 134 ~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
.||..... ...+...+..+.+++..||+.+|++|||+++|++.|+....
T Consensus 285 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 285 MPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 88854321 12233455678999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=235.95 Aligned_cols=174 Identities=20% Similarity=0.216 Sum_probs=143.0
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-C-C-----------------cc---------cHHHHHHHH
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G-K-----------------EE---------VCCPGLEYL 53 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~-~-----------------~~---------~i~~~l~~L 53 (188)
+.++ +||||++++++ .+..++||||+++|+|.+++ . . .. |++.||.||
T Consensus 128 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 207 (382)
T 3tt0_A 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207 (382)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 3456 89999999999 77899999999999999998 2 2 11 999999999
Q ss_pred hcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHH
Q 039565 54 HQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 54 h~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~ 127 (188)
|+ .+++||||||+||+++.++.+||+|||+++...............++..|+||| ++.++||||||+++|
T Consensus 208 H~---~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 284 (382)
T 3tt0_A 208 AS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284 (382)
T ss_dssp HH---TTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred Hh---CCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHH
Confidence 99 999999999999999999999999999987653222222333455677899998 688999999999999
Q ss_pred HHHh-CCccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 128 EIIT-GILTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 128 ~~~~-g~~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
++++ |..||.... ....+...+..+.+++..||+.+|++|||++++++.|+.+..
T Consensus 285 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 285 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 9999 888885422 122233456789999999999999999999999999987653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=236.45 Aligned_cols=176 Identities=21% Similarity=0.269 Sum_probs=134.5
Q ss_pred CcccccCCCeeeeccc----CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 5 NRNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
-+.+++||||++++++ .+..++||||+++|+|.+++ .... |++.||.|||+ .+++|||||
T Consensus 143 il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlk 219 (373)
T 3c1x_A 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLA 219 (373)
T ss_dssp TSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCC
T ss_pred HHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccc
Confidence 4678899999999997 45789999999999999999 3221 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCC--CcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccc
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGG--THMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDL 138 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~ 138 (188)
|+||+++.++.+||+|||+++....... ........++..|++|| ++.++|+||||+++|++++ |..||..
T Consensus 220 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~ 299 (373)
T 3c1x_A 220 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299 (373)
T ss_dssp GGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred hheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC
Confidence 9999999999999999999875431111 11122345667899998 6889999999999999999 6677754
Q ss_pred cCCCC------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 139 SFKGE------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 139 ~~~~~------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
....+ .+...+..+.+++..||+.+|++|||++++++.|+.+...
T Consensus 300 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 300 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp SCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 32211 2234567899999999999999999999999999887543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=228.47 Aligned_cols=172 Identities=25% Similarity=0.330 Sum_probs=136.9
Q ss_pred cccccCCCeeeeccc-CCccEEEEecCCCCChhhhc-CCcc--------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK-QKNNALELGFRGNPELVDQQ-GKEE--------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-~~~~~lv~e~~~~~~L~~~~-~~~~--------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ .+..++||||+++++|.+++ .... |++.||.|||+....+++||||||+
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~ 134 (307)
T 2eva_A 55 LSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 134 (307)
T ss_dssp HHHCCCTTBCCEEEBCTTTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGG
T ss_pred HhcCCCCCcCeEEEEEcCCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChh
Confidence 567899999999999 77799999999999999999 3221 8899999999843358999999999
Q ss_pred cEEEccCCc-eEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 70 NILLNEKVQ-AKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~-~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
||+++.++. +||+|||++..... ......|+..|+||| ++.++|+||||+++|+|++|..||+....
T Consensus 135 NIll~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 209 (307)
T 2eva_A 135 NLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP 209 (307)
T ss_dssp GEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS
T ss_pred HEEEeCCCCEEEEccccccccccc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc
Confidence 999998876 79999999864321 122345888999998 68899999999999999999999864321
Q ss_pred -------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 142 -------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 142 -------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
.......+..+.+++..||+.+|++|||++++++.|+.+.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 210 AFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred HHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11223445678999999999999999999999999988754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=242.52 Aligned_cols=174 Identities=22% Similarity=0.239 Sum_probs=139.9
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCC-----cc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGK-----EE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~-----~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|.+++||||++++++ .+..++||||+++|+|.+++.. .. |++.||+|||+ .+++||||||+
T Consensus 233 l~~l~hp~iv~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~ 309 (452)
T 1fmk_A 233 MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAA 309 (452)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred HHhCCCCCEeeEEEEEcCCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChh
Confidence 567899999999999 7788999999999999999932 11 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
||+++.++.+||+|||+++.... ..........++..|+||| ++.++||||||+++|++++ |..||....
T Consensus 310 Nill~~~~~~kl~DfG~a~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 388 (452)
T 1fmk_A 310 NILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388 (452)
T ss_dssp GEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred hEEECCCCCEEECCCccceecCC-CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875431 1111222344667899998 6889999999999999999 888885422
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
....+...+..+.+++..||+.+|++|||+++|++.|+.+...
T Consensus 389 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 389 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1223345567899999999999999999999999999987653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=224.73 Aligned_cols=167 Identities=26% Similarity=0.351 Sum_probs=138.9
Q ss_pred cccccCCCeeeeccc-CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCC--cEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK-QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHP--IIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~--i~h~dl~~~ 69 (188)
+.+++||||++++++ ....+++|||+++++|.+++ .+.. |++.||.|||+ .+ ++|+||||+
T Consensus 77 l~~l~h~~i~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~ 153 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSP 153 (287)
T ss_dssp HTTCCCTTBCCEEEEETTTTEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGG
T ss_pred HHhCCCCCchhhheeecCCCeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcc
Confidence 466899999999999 66668999999999998888 3322 99999999999 88 999999999
Q ss_pred cEEEccCCc-----eEEecccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCccc
Q 039565 70 NILLNEKVQ-----AKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 70 nill~~~~~-----~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
||+++.++. +||+|||+++... .......|++.|++|| ++.++|+||||+++|++++|..||
T Consensus 154 Nil~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 228 (287)
T 4f0f_A 154 NIFLQSLDENAPVCAKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228 (287)
T ss_dssp GEEESCCCTTCSCCEEECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred eEEEeccCCCCceeEEeCCCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence 999987765 9999999987432 1234467888999999 256799999999999999999998
Q ss_pred cccCC---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 137 DLSFK---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 137 ~~~~~---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
+.... ...+...+..+.+++..||+.+|++|||++++++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 229 DEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp TTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 64322 223344567899999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=234.42 Aligned_cols=175 Identities=20% Similarity=0.228 Sum_probs=142.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC------------------------cc-----------cH
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK------------------------EE-----------VC 46 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~------------------------~~-----------~i 46 (188)
+.+++||||++++++ .+..+++|||+++++|.+++ .. .. |+
T Consensus 104 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 567899999999999 78899999999999999998 21 11 99
Q ss_pred HHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchH
Q 039565 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVD 120 (188)
Q Consensus 47 ~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~ 120 (188)
+.||.|||+ .+++||||||+||+++.++.+||+|||++................++..|++|| ++.++|+|
T Consensus 184 ~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 260 (343)
T 1luf_A 184 AAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260 (343)
T ss_dssp HHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHh---CCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccH
Confidence 999999999 999999999999999999999999999987543221112233456778899998 68899999
Q ss_pred HHHHHHHHHHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 121 SFEIVILEIIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 121 s~G~~l~~~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
|||+++|+|++ |..||..... ...+...+..+.+++..||+.+|.+|||++++++.|+++.++
T Consensus 261 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 261 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 99999999999 8888854211 123344567899999999999999999999999999998765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=223.55 Aligned_cols=168 Identities=13% Similarity=0.192 Sum_probs=139.9
Q ss_pred CcccccCCCeeeeccc---C--CccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCC--cEE
Q 039565 5 NRNKLTGPLLVELIGK---Q--KNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHP--IIQ 63 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~--~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~--i~h 63 (188)
.+++++||||++++++ . ...+++|||+++++|.+++ ... . |++.||.|||+ .+ ++|
T Consensus 60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H 136 (271)
T 3kmu_A 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPR 136 (271)
T ss_dssp GGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTT
T ss_pred HHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceec
Confidence 4678899999999998 3 6789999999999999999 322 2 99999999998 88 999
Q ss_pred eCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCC---ccchHHHHHHHHHHHhCCc
Q 039565 64 RDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTE---KSDVDSFEIVILEIITGIL 134 (188)
Q Consensus 64 ~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~---~~di~s~G~~l~~~~~g~~ 134 (188)
+|+||+||+++.++.+++.||+++.... .....+++.|+||| .+. ++|+||||+++|++++|..
T Consensus 137 ~dikp~Nil~~~~~~~~l~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 209 (271)
T 3kmu_A 137 HALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209 (271)
T ss_dssp CCCSGGGEEECTTSCEEEEGGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSC
T ss_pred CCCccceEEEcCCcceeEEeccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999988765322 12245788899999 122 6999999999999999999
Q ss_pred ccccc-------------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 135 TVDLS-------------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 135 p~~~~-------------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
||... .....+...+..+.+++..||+.+|++|||++++++.|+.+.+
T Consensus 210 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 210 PFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp TTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 98532 1223344556789999999999999999999999999998765
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=232.34 Aligned_cols=167 Identities=22% Similarity=0.274 Sum_probs=138.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+++++|.+++... . |++.||.|||+ .+++||||||+|
T Consensus 59 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~N 135 (323)
T 3tki_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPEN 135 (323)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHH
Confidence 456899999999999 77889999999999999999333 2 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKGE 143 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~ 143 (188)
|+++.++.+||+|||++................|++.|+||| .+.++|+||||+++|+|++|..||+......
T Consensus 136 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 215 (323)
T 3tki_A 136 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (323)
T ss_dssp EEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS
T ss_pred EEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 999999999999999997543222222334567899999999 2567999999999999999999996533211
Q ss_pred --------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 --------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 --------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.....+..+.+++..||+.+|.+|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 216 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11234567889999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=232.03 Aligned_cols=165 Identities=20% Similarity=0.258 Sum_probs=138.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..++||||+++|+|..++.+ .. |++.||.|||+ .+|+||||||+|
T Consensus 59 l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~N 135 (337)
T 1o6l_A 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLEN 135 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGG
T ss_pred HHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHH
Confidence 457899999999998 7889999999999999998822 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.+||+|||+++.... .........|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 136 Ill~~~g~vkL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 213 (337)
T 1o6l_A 136 LMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp EEECTTSCEEECCCTTCBCSCC--TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEECCCCCEEEeeccchhhccc--CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999999875321 122344567999999999 58899999999999999999999864321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
..++...+..+.+++..||+.+|++|| +++++++
T Consensus 214 ~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 214 FELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 123334567889999999999999999 8999876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=225.95 Aligned_cols=173 Identities=20% Similarity=0.199 Sum_probs=137.5
Q ss_pred cccCCCeeeeccc---C----CccEEEEecCCCCChhhhc--CCcc---------cHHHHHHHHhcCCCC--------Cc
Q 039565 8 KLTGPLLVELIGK---Q----KNNALELGFRGNPELVDQQ--GKEE---------VCCPGLEYLHQGLKH--------PI 61 (188)
Q Consensus 8 ~l~Hpniv~~~~~---~----~~~~lv~e~~~~~~L~~~~--~~~~---------~i~~~l~~Lh~~~~~--------~i 61 (188)
.++||||++++++ . ...++||||+++|+|.+++ .... |++.||.|||+ . ++
T Consensus 87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~i 163 (337)
T 3mdy_A 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAI 163 (337)
T ss_dssp TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCE
T ss_pred hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCE
Confidence 4689999999988 3 6789999999999999999 2222 99999999998 6 99
Q ss_pred EEeCCCCCcEEEccCCceEEecccCcccccCCCCCc--ceeeecccccccCCC------CCCc------cchHHHHHHHH
Q 039565 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH--MSTTIAGTAGFLNTE------LTEK------SDVDSFEIVIL 127 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~--~~~~~~~~~~~~~pe------~~~~------~di~s~G~~l~ 127 (188)
+||||||+||+++.++.+||+|||++.......... ......|+..|+||| .... +||||||+++|
T Consensus 164 vH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 243 (337)
T 3mdy_A 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243 (337)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHH
T ss_pred EecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHH
Confidence 999999999999999999999999987543221111 122457899999999 2233 89999999999
Q ss_pred HHHhC----------CccccccCCC------------------Cc-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 039565 128 EIITG----------ILTVDLSFKG------------------EF-----DIISVEKAVEIAMASVSSKVNRRPLMNQVV 174 (188)
Q Consensus 128 ~~~~g----------~~p~~~~~~~------------------~~-----~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~ 174 (188)
+|++| ..||...... .. ....+..+.+++..||+.+|.+|||+++++
T Consensus 244 el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 244 EVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 99999 5555432111 11 125677899999999999999999999999
Q ss_pred HHHhhccCc
Q 039565 175 MVREQGSGS 183 (188)
Q Consensus 175 ~~l~~~~~~ 183 (188)
+.|+.+.+.
T Consensus 324 ~~L~~l~~~ 332 (337)
T 3mdy_A 324 KTLAKMSES 332 (337)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHhh
Confidence 999988765
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=231.42 Aligned_cols=175 Identities=23% Similarity=0.248 Sum_probs=134.6
Q ss_pred cccccCCCeeeeccc---CCcc------EEEEecCCCCChhhhc-CC--------cc---------cHHHHHHHHhcCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNN------ALELGFRGNPELVDQQ-GK--------EE---------VCCPGLEYLHQGLK 58 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~------~lv~e~~~~~~L~~~~-~~--------~~---------~i~~~l~~Lh~~~~ 58 (188)
+.+++||||++++++ .... ++++||+++++|.+++ .. .. |++.||.|||+
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--- 155 (323)
T 3qup_A 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--- 155 (323)
T ss_dssp HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---
Confidence 567899999999998 3232 8999999999999998 11 11 99999999999
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT- 131 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~- 131 (188)
.+++||||||+||+++.++.+||+|||+++...............+++.|++|| ++.++|+||||+++|++++
T Consensus 156 ~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~ 235 (323)
T 3qup_A 156 RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235 (323)
T ss_dssp TTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhC
Confidence 999999999999999999999999999987543222222233445667899998 6889999999999999999
Q ss_pred CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 132 GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 132 g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
|..||..... ...+...+..+.+++..||+.+|++|||+.++++.|+++...
T Consensus 236 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 236 GQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp SCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 8898864321 223344567899999999999999999999999999987654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=233.46 Aligned_cols=173 Identities=19% Similarity=0.223 Sum_probs=139.4
Q ss_pred cccccCCCeeeeccc---C----CccEEEEecCCCCChhhhc-CC-c--c---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---Q----KNNALELGFRGNPELVDQQ-GK-E--E---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~----~~~~lv~e~~~~~~L~~~~-~~-~--~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+..++||||++++++ . ...++||||+ +++|.+++ .. . . |++.||.|||+ .+++|||
T Consensus 102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrD 177 (364)
T 3op5_A 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGD 177 (364)
T ss_dssp HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEec
Confidence 467889999999998 1 4479999999 89999999 32 1 1 99999999999 9999999
Q ss_pred CCCCcEEEc--cCCceEEecccCcccccCCCCC-----cceeeecccccccCCC------CCCccchHHHHHHHHHHHhC
Q 039565 66 MKSTNILLN--EKVQAKLADFGQSRISPVEGGT-----HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 66 l~~~nill~--~~~~~kl~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g 132 (188)
|||+||+++ .++.+||+|||+++........ .......|+..|+||| ++.++||||||+++|+|++|
T Consensus 178 lkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g 257 (364)
T 3op5_A 178 IKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTG 257 (364)
T ss_dssp CCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999 8899999999999754321111 1113355899999998 67899999999999999999
Q ss_pred CccccccCCCCc-------------C---------HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 133 ILTVDLSFKGEF-------------D---------IISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 133 ~~p~~~~~~~~~-------------~---------~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
..||........ . ...+..+.+++..||+.+|++||++++|++.|+++..
T Consensus 258 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 258 HLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp CCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 999985432210 0 0114578899999999999999999999999977643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=227.29 Aligned_cols=165 Identities=19% Similarity=0.212 Sum_probs=138.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+.+++||||++++++ .+..+++|||+++++|.+++.+.. |++.||.|||+ .+++|||+||+||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NI 172 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSI 172 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHE
Confidence 567899999999998 788999999999999999984332 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK---- 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~---- 141 (188)
+++.++.+||+|||++...... ........|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~ 250 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred EECCCCcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999998754321 12234567899999998 57899999999999999999999853211
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+..+.+++..||+.+|++|||++++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 KRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112234567899999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=224.05 Aligned_cols=168 Identities=23% Similarity=0.304 Sum_probs=132.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCC---cEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHP---IIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~---i~h~dl~~ 68 (188)
+.+++||||++++++ .+..+++|||+++++|.+++.... |++.||.|||+ .+ ++|+|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp 136 (271)
T 3dtc_A 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKS 136 (271)
T ss_dssp HHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSG
T ss_pred HHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCch
Confidence 456899999999999 778899999999999999983322 99999999999 77 99999999
Q ss_pred CcEEEcc--------CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCc
Q 039565 69 TNILLNE--------KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGIL 134 (188)
Q Consensus 69 ~nill~~--------~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~ 134 (188)
+||+++. ++.++++|||.+...... ......|++.|++|| ++.++|+||||+++|++++|..
T Consensus 137 ~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 212 (271)
T 3dtc_A 137 SNILILQKVENGDLSNKILKITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV 212 (271)
T ss_dssp GGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCC
T ss_pred HHEEEecccccccccCcceEEccCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999986 678999999998754211 122456888999998 6889999999999999999999
Q ss_pred cccccC-------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 135 TVDLSF-------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 135 p~~~~~-------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
||.... ....+...+..+.+++..||+.+|.+|||++++++.|+.+
T Consensus 213 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 213 PFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 986422 1223345567899999999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=228.61 Aligned_cols=174 Identities=16% Similarity=0.171 Sum_probs=136.3
Q ss_pred cccccCCCeeeeccc--------CCccEEEEecCCCCChhhhc--CCcc---------cHHHHHHHHhcCCCC-------
Q 039565 6 RNKLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQ--GKEE---------VCCPGLEYLHQGLKH------- 59 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~--~~~~---------~i~~~l~~Lh~~~~~------- 59 (188)
+..++||||+++++. ....++||||+++|+|.+++ .... |++.||.|||+ .
T Consensus 61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~ 137 (336)
T 3g2f_A 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHY 137 (336)
T ss_dssp STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGC
T ss_pred HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHh---hhcccccc
Confidence 456899999999864 34568999999999999999 2222 99999999998 7
Q ss_pred --CcEEeCCCCCcEEEccCCceEEecccCcccccCCC------CCcceeeecccccccCCCC-------------CCccc
Q 039565 60 --PIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEG------GTHMSTTIAGTAGFLNTEL-------------TEKSD 118 (188)
Q Consensus 60 --~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~------~~~~~~~~~~~~~~~~pe~-------------~~~~d 118 (188)
+++||||||+||+++.++.+||+|||+++...... .........|+..|+|||. +.++|
T Consensus 138 ~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D 217 (336)
T 3g2f_A 138 KPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVD 217 (336)
T ss_dssp BCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHH
T ss_pred ccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccc
Confidence 99999999999999999999999999997543211 1112224568999999992 24689
Q ss_pred hHHHHHHHHHHHhCCccccccCC-------------------------------CC------cCHHHHHHHHHHHHHccC
Q 039565 119 VDSFEIVILEIITGILTVDLSFK-------------------------------GE------FDIISVEKAVEIAMASVS 161 (188)
Q Consensus 119 i~s~G~~l~~~~~g~~p~~~~~~-------------------------------~~------~~~~~~~~~~~l~~~cl~ 161 (188)
|||||+++|+|++|..|+-+... .. .....+..+.+++..||+
T Consensus 218 iwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (336)
T 3g2f_A 218 MYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297 (336)
T ss_dssp HHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSC
T ss_pred hHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhc
Confidence 99999999999999765522111 00 112355679999999999
Q ss_pred cCCCCCCCHHHHHHHHhhccC
Q 039565 162 SKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 162 ~~p~~Rps~~~i~~~l~~~~~ 182 (188)
.+|++|||++++++.|+++..
T Consensus 298 ~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 298 QDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SSGGGSCCHHHHHHHHHHHHH
T ss_pred CChhhCcchHHHHHHHHHHHH
Confidence 999999999999999988653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=226.66 Aligned_cols=173 Identities=21% Similarity=0.213 Sum_probs=139.8
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-C-C--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-G-K--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~-~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..+++|||+++++|.+++ . . .. |++.||.|||+ .+++|+|+||+|
T Consensus 67 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~N 143 (281)
T 3cc6_A 67 MKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRN 143 (281)
T ss_dssp HHHHCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGG
T ss_pred HHhCCCCCcceEEEEEcCCCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccce
Confidence 567899999999999 77789999999999999999 2 1 12 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~-- 141 (188)
|+++.++.++|+|||++..... ..........++..|+||| ++.++|+||||+++|++++ |..||.....
T Consensus 144 il~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~ 222 (281)
T 3cc6_A 144 ILVASPECVKLGDFGLSRYIED-EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222 (281)
T ss_dssp EEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG
T ss_pred EEECCCCcEEeCccCCCccccc-ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH
Confidence 9999999999999999875431 1111223345667899998 6888999999999999998 9999853221
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
...+...+..+.+++..||+.+|++|||++++++.|+.+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 223 VIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 11223345679999999999999999999999999988754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=224.21 Aligned_cols=170 Identities=17% Similarity=0.162 Sum_probs=139.9
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCC------cc---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGK------EE---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~------~~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+.+++||||++++++ ....++||||+++++|.+++.. .. |++.||.|||+ .+++|||
T Consensus 61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~D 137 (319)
T 4euu_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRN 137 (319)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSC
T ss_pred HHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCC
Confidence 567899999999988 3377999999999999999922 12 99999999999 9999999
Q ss_pred CCCCcEEE----ccCCceEEecccCcccccCCCCCcceeeecccccccCCC--------------CCCccchHHHHHHHH
Q 039565 66 MKSTNILL----NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 66 l~~~nill----~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------------~~~~~di~s~G~~l~ 127 (188)
|||+||++ +.++.+||+|||+++..... .......|+..|++|| ++.++|+||||+++|
T Consensus 138 lkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 214 (319)
T 4euu_A 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY 214 (319)
T ss_dssp CSGGGEEEEECTTSCEEEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHH
T ss_pred CCHHHEEEeccCCCCceEEEccCCCceecCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHH
Confidence 99999999 77778999999999764321 1233456888999987 357899999999999
Q ss_pred HHHhCCccccccCC----------------------------------------CCcCHHHHHHHHHHHHHccCcCCCCC
Q 039565 128 EIITGILTVDLSFK----------------------------------------GEFDIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 128 ~~~~g~~p~~~~~~----------------------------------------~~~~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
+|++|..||.+... ..........+.+++..||+.||++|
T Consensus 215 el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 294 (319)
T 4euu_A 215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294 (319)
T ss_dssp HHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTS
T ss_pred HHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhh
Confidence 99999999853211 12345677889999999999999999
Q ss_pred CCHHHHHHHHhhcc
Q 039565 168 PLMNQVVMVREQGS 181 (188)
Q Consensus 168 ps~~~i~~~l~~~~ 181 (188)
||++|+++......
T Consensus 295 ~s~~ell~h~~d~~ 308 (319)
T 4euu_A 295 WGFDQFFAETSDIL 308 (319)
T ss_dssp CCHHHHHHHHHHHT
T ss_pred ccHHHhhhccHHHh
Confidence 99999999876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=227.76 Aligned_cols=175 Identities=20% Similarity=0.219 Sum_probs=143.8
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC--------------------cc---------cHHHHHH
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK--------------------EE---------VCCPGLE 51 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~--------------------~~---------~i~~~l~ 51 (188)
+.++ +||||++++++ .+..+++|||+++|+|.+++ .. .. |++.||.
T Consensus 80 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 4566 89999999998 78899999999999999998 21 11 9999999
Q ss_pred HHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHH
Q 039565 52 YLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIV 125 (188)
Q Consensus 52 ~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~ 125 (188)
|||+ .+++|+||||+||+++.++.+||+|||++................++..|++|| ++.++|+||||++
T Consensus 160 ~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 236 (313)
T 1t46_A 160 FLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (313)
T ss_dssp HHHH---TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHH---CCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHH
Confidence 9999 999999999999999999999999999987654322222233445677899998 6889999999999
Q ss_pred HHHHHh-CCccccccCCC-------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 126 ILEIIT-GILTVDLSFKG-------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 126 l~~~~~-g~~p~~~~~~~-------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
+|+|++ |..||...... ..+...+..+.+++..||+.+|.+|||++++++.|++....
T Consensus 237 l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 999998 88888643221 12234456889999999999999999999999999887543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=245.99 Aligned_cols=173 Identities=21% Similarity=0.238 Sum_probs=139.7
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcC-Ccc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQG-KEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~-~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|.+++||||++++++ .+..++||||+++|+|.+++. +.. |++.||+|||+ .+|+||||||+|
T Consensus 390 l~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~N 466 (613)
T 2ozo_A 390 MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARN 466 (613)
T ss_dssp HTTCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred HHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHH
Confidence 567899999999999 778999999999999999982 221 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCc-ceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTH-MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
|+++.++.+||+|||+++......... ......++..|+||| ++.++||||||+++|+|++ |..||.....
T Consensus 467 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 546 (613)
T 2ozo_A 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546 (613)
T ss_dssp EEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH
T ss_pred EEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 999999999999999998643221111 112234557899998 6889999999999999998 9999864321
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
...+...+..+.+++..||+.+|++||++++|++.|+...
T Consensus 547 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 547 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2234456678999999999999999999999999998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=225.58 Aligned_cols=176 Identities=22% Similarity=0.275 Sum_probs=140.3
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++||||++++++ ....+++|||+++++|.+++ .... |++.||.|||+ .+++|||+||
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp 156 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAA 156 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCch
Confidence 567899999999997 56789999999999999999 3221 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCC--CcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCcccccc
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGG--THMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLS 139 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~ 139 (188)
+||+++.++.+||+|||++........ ........+++.|++|| ++.++|+||||+++|++++ +..||...
T Consensus 157 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 157 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp GGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred heEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 999999999999999999875431111 11222345677899998 6889999999999999999 45566433
Q ss_pred CCCC------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcc
Q 039565 140 FKGE------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSR 184 (188)
Q Consensus 140 ~~~~------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 184 (188)
...+ .+...+..+.+++..||+.+|.+|||++++++.|+.+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 237 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 2211 22334667999999999999999999999999999876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=232.01 Aligned_cols=164 Identities=24% Similarity=0.293 Sum_probs=136.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+++|+|.+++.... |++.||.|||+ .+++||||||+|
T Consensus 69 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~N 145 (361)
T 2yab_A 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPEN 145 (361)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHH
Confidence 567899999999999 778999999999999999993322 99999999999 999999999999
Q ss_pred EEEccCC----ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 71 ILLNEKV----QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 71 ill~~~~----~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+++.++ .+||+|||++..... ........|++.|+||| ++.++|+||||+++|+|++|..||....
T Consensus 146 Ill~~~~~~~~~vkl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 146 IMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp EEESCTTSSSCCEEECCCSSCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred EEEeCCCCCccCEEEEecCCceEcCC---CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998776 799999999876432 12234467999999998 6889999999999999999999996432
Q ss_pred C-----------CCcCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 K-----------GEFDI----ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~-----------~~~~~----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ..++. ..+..+.+++..||..||.+|||++++++
T Consensus 223 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 223 KQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 11221 23567899999999999999999999885
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=236.16 Aligned_cols=165 Identities=19% Similarity=0.201 Sum_probs=137.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+++|+|.+++ .+.. |++.||.|||+ .+|+||||||+|
T Consensus 64 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~N 140 (444)
T 3soa_A 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPEN 140 (444)
T ss_dssp HHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTT
T ss_pred HHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHH
Confidence 567899999999999 78889999999999999988 3222 99999999999 999999999999
Q ss_pred EEEcc---CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILLNE---KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill~~---~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+++. ++.+||+|||++..... .........|++.|+||| ++.++||||+|+++|+|++|..||.....
T Consensus 141 Ill~~~~~~~~vkL~DFG~a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~ 218 (444)
T 3soa_A 141 LLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218 (444)
T ss_dssp EEESBSSTTCCEEECCCSSCBCCCT--TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEEeccCCCCcEEEccCceeEEecC--CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH
Confidence 99984 57899999999975432 222234567999999998 68899999999999999999999854221
Q ss_pred ---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+..+.+++..||+.||++|||+.++++
T Consensus 219 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 219 HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111234678899999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=224.63 Aligned_cols=175 Identities=24% Similarity=0.297 Sum_probs=142.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....+++|||+++++|.+++ ... . |++.||.|||+ .+++|+|+||+
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ 133 (267)
T 3t9t_A 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAAR 133 (267)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGG
T ss_pred HHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchh
Confidence 567899999999998 77899999999999999999 221 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
||+++.++.++++|||++..... ..........++..|++|| ++.++|+||||+++|++++ |..||....
T Consensus 134 Nili~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (267)
T 3t9t_A 134 NCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212 (267)
T ss_dssp GEEECGGGCEEECCTTGGGGBCC-HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred eEEECCCCCEEEccccccccccc-ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH
Confidence 99999999999999999875421 1111112234566799998 6789999999999999999 888886422
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcc
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSR 184 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 184 (188)
....+...+..+.+++..||+.+|++|||++++++.|+++.++.
T Consensus 213 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (267)
T 3t9t_A 213 EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266 (267)
T ss_dssp HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11223344678899999999999999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=230.59 Aligned_cols=163 Identities=23% Similarity=0.346 Sum_probs=137.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C--Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G--KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~--~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||++++++ ....++||||+ +|+|.+++ . ... |++.||.|||+ .+++||||||+|
T Consensus 63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~N 138 (336)
T 3h4j_B 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPEN 138 (336)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTT
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhh
Confidence 567899999999999 77889999999 57888887 2 222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC-------CCccchHHHHHHHHHHHhCCccccccCCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-------TEKSDVDSFEIVILEIITGILTVDLSFKG- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-------~~~~di~s~G~~l~~~~~g~~p~~~~~~~- 142 (188)
|+++.++.+||+|||++.... .........|++.|+|||. +.++|+||||+++|+|++|..||+.....
T Consensus 139 Ill~~~~~~kl~DFG~s~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 215 (336)
T 3h4j_B 139 LLLDDNLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215 (336)
T ss_dssp EEECTTCCEEECCSSCTBTTT---TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT
T ss_pred EEEcCCCCEEEEEeccceecc---CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH
Confidence 999999999999999987543 2222345678999999992 56899999999999999999999754321
Q ss_pred ----------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 ----------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ----------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+...+..+.+++..||+.||.+|||++++++
T Consensus 216 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 216 LFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 133445678999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=226.67 Aligned_cols=173 Identities=22% Similarity=0.270 Sum_probs=141.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....+++|||+++++|.+++.. .. |++.||.|||+ .+++|+|+||+
T Consensus 73 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~ 149 (283)
T 3gen_A 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAAR 149 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGG
T ss_pred HhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccc
Confidence 567889999999999 6788999999999999999933 21 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
||+++.++.++|+|||++..... ..........++..|++|| ++.++|+||||+++|++++ |..||....
T Consensus 150 Nili~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~ 228 (283)
T 3gen_A 150 NCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228 (283)
T ss_dssp GEEECTTSCEEECSTTGGGGBCC-HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEEEcCCCCEEEccccccccccc-cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh
Confidence 99999999999999999875421 1111122334566799998 6889999999999999998 999886421
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
....+...+..+.+++..||+.+|.+|||++++++.|+.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 229 ETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 122233345688999999999999999999999999988754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=228.22 Aligned_cols=176 Identities=17% Similarity=0.175 Sum_probs=143.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-----------c--c---------cHHHHHHHHhcCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-----------E--E---------VCCPGLEYLHQGLKHP 60 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-----------~--~---------~i~~~l~~Lh~~~~~~ 60 (188)
+.+++||||++++++ ....++||||+++++|.+++.. . . |++.||.|||+ .+
T Consensus 82 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ 158 (322)
T 1p4o_A 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NK 158 (322)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred HHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CC
Confidence 567899999999999 7788999999999999999821 0 1 89999999999 99
Q ss_pred cEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CC
Q 039565 61 IIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GI 133 (188)
Q Consensus 61 i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~ 133 (188)
++||||||+||+++.++.+||+|||++................+++.|++|| ++.++|+||||+++|++++ |.
T Consensus 159 i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 238 (322)
T 1p4o_A 159 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238 (322)
T ss_dssp CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999987543222112222345677899998 6889999999999999999 78
Q ss_pred ccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcc
Q 039565 134 LTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSR 184 (188)
Q Consensus 134 ~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 184 (188)
.||..... ...+...+..+.+++..||+.+|++|||++++++.|++.....
T Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 239 QPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred CccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 88854211 1223345567899999999999999999999999999876653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=228.59 Aligned_cols=164 Identities=16% Similarity=0.243 Sum_probs=137.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ .+..+++|||+++++|.+++.. . . |++.||.|||+ .+++||||||+
T Consensus 55 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~ 131 (321)
T 1tki_A 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPE 131 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred HHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHH
Confidence 567899999999999 7889999999999999999932 2 1 99999999999 99999999999
Q ss_pred cEEEcc--CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 70 NILLNE--KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 70 nill~~--~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
||+++. ++.+|++|||++.... .........|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 132 NIl~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 208 (321)
T 1tki_A 132 NIIYQTRRSSTIKIIEFGQARQLK---PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp GEEESSSSCCCEEECCCTTCEECC---TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred HEEEccCCCCCEEEEECCCCeECC---CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH
Confidence 999987 7899999999997643 122334567899999999 57899999999999999999999965321
Q ss_pred C-----------CcCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 G-----------EFDI----ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ~-----------~~~~----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ..+. ..+..+.+++..||..||.+|||++++++
T Consensus 209 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 209 QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1111 23567899999999999999999999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=222.90 Aligned_cols=173 Identities=23% Similarity=0.246 Sum_probs=141.7
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCCc-----c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGKE-----E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-----~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ .+..+++|||+++++|.+++... . |++.||.|||+ .+++|+|+||+
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~ 138 (279)
T 1qpc_A 62 MKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAA 138 (279)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGG
T ss_pred HHhCCCcCcceEEEEEcCCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHh
Confidence 567899999999999 77899999999999999999432 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
||+++.++.++|+|||.+..... ..........++..|++|| ++.++|+||||+++|+|++ |..||.....
T Consensus 139 Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 217 (279)
T 1qpc_A 139 NILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217 (279)
T ss_dssp GEEECTTSCEEECCCTTCEECSS-SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred hEEEcCCCCEEECCCcccccccC-cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH
Confidence 99999999999999999875431 1111122334566799998 5788999999999999999 8888854221
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
...+...+..+.+++..||+.+|++|||++++++.|+++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 218 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 12223445788999999999999999999999999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=224.95 Aligned_cols=165 Identities=20% Similarity=0.250 Sum_probs=134.8
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++||||+++++|.++..... |++.||.|||+ .+++||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 467899999999998 356899999999999998773322 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC---------CCccchHHHHHHHHHHHhCCccccccC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL---------TEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~---------~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+++.++.+||+|||++..... .........|++.|+|||. +.++|+||||+++|+|++|..||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999876432 1222344678999999992 456899999999999999999986432
Q ss_pred C-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 K-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. .......+..+.+++..||+.||++|||++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 1111234567899999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=228.37 Aligned_cols=164 Identities=22% Similarity=0.271 Sum_probs=136.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+++++|.+++.... |++.||.|||+ .+++||||||+|
T Consensus 68 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~N 144 (326)
T 2y0a_A 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPEN 144 (326)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGG
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHH
Confidence 567899999999998 778999999999999999993322 99999999999 999999999999
Q ss_pred EEEccCC----ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 71 ILLNEKV----QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 71 ill~~~~----~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+++.++ .+||+|||++...... .......|++.|+||| ++.++|+||||+++|+|++|..||....
T Consensus 145 Ill~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 145 IMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp EEESCSSSSSCCEEECCCTTCEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred EEEecCCCCCCCEEEEECCCCeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 9998877 7999999998764311 1233457899999998 6789999999999999999999985432
Q ss_pred C-----------CCcCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 K-----------GEFDI----ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~-----------~~~~~----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ...+. ..+..+.+++..||+.+|++|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 11111 23457889999999999999999999987
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=223.58 Aligned_cols=169 Identities=21% Similarity=0.224 Sum_probs=135.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++||||+++ +|.+++ .... |++.||.|||+ .+++||||||+
T Consensus 73 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~ 148 (311)
T 3niz_A 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQ 148 (311)
T ss_dssp HHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred HHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchH
Confidence 567899999999999 7788999999994 888877 3221 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.+||+|||++...... ........++..|+||| ++.++|+||||+++|+|++|..||......
T Consensus 149 NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 149 NLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp GEEECTTCCEEECCCTTCEETTSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred hEEECCCCCEEEccCcCceecCCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence 999999999999999998764311 12233456788899998 577899999999999999999998643322
Q ss_pred CcC-----------------------------------------HHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhh
Q 039565 143 EFD-----------------------------------------IISVEKAVEIAMASVSSKVNRRPLMNQVVM--VREQ 179 (188)
Q Consensus 143 ~~~-----------------------------------------~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~--~l~~ 179 (188)
+.- ...+..+.+++..||+.||++|||++++++ .+++
T Consensus 227 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 227 DQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp THHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 110 012356789999999999999999999987 4444
Q ss_pred c
Q 039565 180 G 180 (188)
Q Consensus 180 ~ 180 (188)
+
T Consensus 307 ~ 307 (311)
T 3niz_A 307 L 307 (311)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=229.45 Aligned_cols=172 Identities=21% Similarity=0.271 Sum_probs=140.1
Q ss_pred cccccCCCeeeeccc-------CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+..++||||++++++ ....+++|||+ +++|.+++... . |++.||.|||+ .+++||||
T Consensus 102 ~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dl 177 (345)
T 2v62_A 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDI 177 (345)
T ss_dssp HHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred hccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCc
Confidence 456799999999998 35689999999 89999999432 2 99999999999 99999999
Q ss_pred CCCcEEEccCC--ceEEecccCcccccCCCC-----CcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCC
Q 039565 67 KSTNILLNEKV--QAKLADFGQSRISPVEGG-----THMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGI 133 (188)
Q Consensus 67 ~~~nill~~~~--~~kl~d~~~~~~~~~~~~-----~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~ 133 (188)
||+||+++.++ .+||+|||+++....... ........|+..|+||| ++.++|+||||+++|+|++|.
T Consensus 178 kp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~ 257 (345)
T 2v62_A 178 KAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257 (345)
T ss_dssp SGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred CHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999877 999999999975432111 11123457889999998 688999999999999999999
Q ss_pred ccccccCCCC-------------cCH---------HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 134 LTVDLSFKGE-------------FDI---------ISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 134 ~p~~~~~~~~-------------~~~---------~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
.||....... .+. ..+..+.+++..||+.+|++|||+++|++.|++..
T Consensus 258 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 258 LPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp CTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred CCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 9996532211 111 23347899999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=231.97 Aligned_cols=164 Identities=22% Similarity=0.293 Sum_probs=137.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+.+|+|..++.+. . |++.||.|||+ .+|+||||||+|
T Consensus 69 l~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~N 145 (384)
T 4fr4_A 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDN 145 (384)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHH
Confidence 567899999999998 77899999999999999999322 2 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+++.++.+||+|||++.... .........|++.|+||| ++.++|+|||||++|+|++|..||.....
T Consensus 146 Ill~~~g~vkL~DFG~a~~~~---~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 222 (384)
T 4fr4_A 146 ILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222 (384)
T ss_dssp EEECTTSCEEECCCTTCEECC---TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred eEECCCCCEEEeccceeeecc---CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999998643 122344567999999998 36689999999999999999999964322
Q ss_pred C--------------CcCHHHHHHHHHHHHHccCcCCCCCCC-HHHHHH
Q 039565 142 G--------------EFDIISVEKAVEIAMASVSSKVNRRPL-MNQVVM 175 (188)
Q Consensus 142 ~--------------~~~~~~~~~~~~l~~~cl~~~p~~Rps-~~~i~~ 175 (188)
. .++...+..+.+++..||+.+|.+||+ ++++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 223 TSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp SCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1 233344578899999999999999998 777664
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=231.92 Aligned_cols=175 Identities=19% Similarity=0.255 Sum_probs=142.9
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-----------------c---------cHHHHHHHHhc
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-----------------E---------VCCPGLEYLHQ 55 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-----------------~---------~i~~~l~~Lh~ 55 (188)
+.++ +||||++++++ ....++||||+++|+|.+++... . |++.||.|||+
T Consensus 103 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 4566 89999999999 77899999999999999998211 1 99999999999
Q ss_pred CCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHH
Q 039565 56 GLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEI 129 (188)
Q Consensus 56 ~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~ 129 (188)
.+++|+||||+||+++.++.++|+|||++................++..|+||| ++.++|+||||+++|+|
T Consensus 183 ---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 259 (333)
T 2i1m_A 183 ---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259 (333)
T ss_dssp ---TTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ---CCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 999999999999999999999999999987543222222233345677899998 68899999999999999
Q ss_pred Hh-CCccccccCCC-------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 130 IT-GILTVDLSFKG-------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 130 ~~-g~~p~~~~~~~-------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
++ |..||...... ..+...+..+.+++..||+.+|.+|||++++++.|+.....
T Consensus 260 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 260 FSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp TTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 98 88888643221 12233456789999999999999999999999999876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=223.09 Aligned_cols=173 Identities=21% Similarity=0.247 Sum_probs=143.0
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcC-Ccc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQG-KEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~-~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..++||||+++++|.+++. ... |++.||.|||+ .+++|+||+|+|
T Consensus 64 l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~N 140 (287)
T 1u59_A 64 MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARN 140 (287)
T ss_dssp HHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HHhCCCCCEeEEEEEecCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchhe
Confidence 567899999999999 778999999999999999982 221 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCC-cceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~- 141 (188)
|+++.++.++|+|||++......... .......++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 141 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 220 (287)
T 1u59_A 141 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 220 (287)
T ss_dssp EEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred EEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999998765322211 1122234577899998 5789999999999999998 9999864321
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
...+...+..+.+++..||+.+|++||+++++++.|+++.
T Consensus 221 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 221 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2234455678999999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=228.50 Aligned_cols=174 Identities=18% Similarity=0.229 Sum_probs=141.3
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGKE--E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++||||+++++|.+++.+. . |++.||.|||+ .+++|+||||+
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~ 163 (318)
T 3lxp_A 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAAR 163 (318)
T ss_dssp HHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGG
T ss_pred HHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchh
Confidence 567899999999998 35678999999999999999332 2 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCC-cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~-- 140 (188)
||+++.++.++|+|||++......... .......++..|++|| ++.++|+||||+++|++++|..||....
T Consensus 164 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~ 243 (318)
T 3lxp_A 164 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 243 (318)
T ss_dssp GEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH
T ss_pred eEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh
Confidence 999999999999999998865322211 1223345777899998 5778999999999999999998875321
Q ss_pred -------------------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 141 -------------------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 141 -------------------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
....+...+..+.+++..||+.+|++|||++++++.|+.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 244 FLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 112233455689999999999999999999999999988754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=225.14 Aligned_cols=171 Identities=16% Similarity=0.193 Sum_probs=140.3
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhcC--Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQG--KEE-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~--~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.++ +||||++++++ ....++||||+ +++|.+++. ... |++.||.|||+ .+++||||||
T Consensus 58 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp 133 (330)
T 2izr_A 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKP 133 (330)
T ss_dssp HHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred HHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCH
Confidence 4566 89999999999 77889999999 899999983 222 99999999999 9999999999
Q ss_pred CcEEEccCCc-----eEEecccCcccccCCCCCc-----ceeeecccccccCCC------CCCccchHHHHHHHHHHHhC
Q 039565 69 TNILLNEKVQ-----AKLADFGQSRISPVEGGTH-----MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 69 ~nill~~~~~-----~kl~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g 132 (188)
+||+++.++. +||+|||+++......... ......|++.|+||| ++.++|+||||+++|+|++|
T Consensus 134 ~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 213 (330)
T 2izr_A 134 ENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213 (330)
T ss_dssp GGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred HHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcC
Confidence 9999998876 9999999998643222111 123567899999998 67899999999999999999
Q ss_pred CccccccCCCCc--------------CHH-----HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 133 ILTVDLSFKGEF--------------DII-----SVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 133 ~~p~~~~~~~~~--------------~~~-----~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
..||........ +.. .+ .+.+++..||+.+|.+||++++|++.|+.+.
T Consensus 214 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 214 SLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp SCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 999976433221 111 22 8899999999999999999999999997664
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=233.02 Aligned_cols=161 Identities=21% Similarity=0.275 Sum_probs=131.8
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+||||++++++ .+..++||||+++|+|..++.+ .. |++.||+|||+ .+|+||||||+||+++
T Consensus 82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~ 158 (353)
T 3txo_A 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLD 158 (353)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEEC
T ss_pred CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEEC
Confidence 79999999999 7889999999999999999822 22 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-------
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------- 141 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------- 141 (188)
.++.+||+|||+++... ..........|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 159 ~~g~ikL~DFG~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i 236 (353)
T 3txo_A 159 HEGHCKLADFGMCKEGI--CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236 (353)
T ss_dssp TTSCEEECCCTTCBCSC--C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCEEEccccceeecc--cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999987432 1222344568999999999 79999999999999999999999965321
Q ss_pred ----CCcCHHHHHHHHHHHHHccCcCCCCCCCH------HHHHH
Q 039565 142 ----GEFDIISVEKAVEIAMASVSSKVNRRPLM------NQVVM 175 (188)
Q Consensus 142 ----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~------~~i~~ 175 (188)
..++...+..+.+++..||+.+|++||++ +++++
T Consensus 237 ~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 237 LNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 12333456778999999999999999998 67765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=226.51 Aligned_cols=175 Identities=21% Similarity=0.196 Sum_probs=142.9
Q ss_pred cccc-cCCCeeeeccc----CCccEEEEecCCCCChhhhc-CCc------------------c---------cHHHHHHH
Q 039565 6 RNKL-TGPLLVELIGK----QKNNALELGFRGNPELVDQQ-GKE------------------E---------VCCPGLEY 52 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~-~~~------------------~---------~i~~~l~~ 52 (188)
+.++ +||||++++++ ....++++||+++++|.+++ ... . |++.||.|
T Consensus 84 l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 163 (316)
T 2xir_A 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163 (316)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHH
Confidence 3455 69999999998 44589999999999999999 221 1 89999999
Q ss_pred HhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHH
Q 039565 53 LHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVI 126 (188)
Q Consensus 53 Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l 126 (188)
||+ .+++|+||||+||+++.++.+||+|||++................++..|+||| ++.++|+||||+++
T Consensus 164 lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 240 (316)
T 2xir_A 164 LAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240 (316)
T ss_dssp HHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHh---CCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHH
Confidence 999 999999999999999999999999999987543222222333456778899998 68899999999999
Q ss_pred HHHHh-CCccccccCC-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 127 LEIIT-GILTVDLSFK-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 127 ~~~~~-g~~p~~~~~~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
|++++ |..||..... ...+...+..+.+++..||+.+|.+|||++++++.|+.+...
T Consensus 241 ~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 241 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp HHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 99998 9999864322 112233456899999999999999999999999999887654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=226.48 Aligned_cols=169 Identities=18% Similarity=0.167 Sum_probs=136.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ .+..++||||+++++|.+++ ... . |++.||.|||+ .+++||||||+
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~ 142 (289)
T 4fvq_A 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAK 142 (289)
T ss_dssp HHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGG
T ss_pred HHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcc
Confidence 567899999999999 77889999999999999999 222 1 99999999999 99999999999
Q ss_pred cEEEccCCc--------eEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCC-
Q 039565 70 NILLNEKVQ--------AKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGI- 133 (188)
Q Consensus 70 nill~~~~~--------~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~- 133 (188)
||+++.++. ++++|||++.... ......++..|+||| ++.++|+||||+++|+|++|.
T Consensus 143 NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 216 (289)
T 4fvq_A 143 NILLIREEDRKTGNPPFIKLSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD 216 (289)
T ss_dssp GEEEEECCBGGGTBCCEEEECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEEEecCCcccccccceeeeccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCC
Confidence 999998876 9999999886432 122345778899998 577899999999999999965
Q ss_pred ccccccC----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 134 LTVDLSF----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 134 ~p~~~~~----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
.|+.... ....+...+..+.+++..||+.+|++|||++++++.|+++..+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 217 KPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred CCccccchHHHHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 4443211 1111222345688999999999999999999999999988654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=224.36 Aligned_cols=173 Identities=23% Similarity=0.246 Sum_probs=137.6
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhcCC-----cc---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQGK-----EE---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~~~-----~~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||++++++ ....++++||+++++|.+++.. .. |++.||.|||+ .+++|+|+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk 144 (278)
T 1byg_A 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLA 144 (278)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCC
Confidence 567899999999997 4578999999999999999822 11 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~ 140 (188)
|+||+++.++.++|+|||++..... ......++..|++|| ++.++|+||||+++|++++ |..||....
T Consensus 145 p~Nil~~~~~~~~l~Dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 145 ARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp GGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred cceEEEeCCCcEEEeeccccccccc-----cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999998874321 112235677899998 6889999999999999998 998886432
Q ss_pred C------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCccee
Q 039565 141 K------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSRIT 186 (188)
Q Consensus 141 ~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~~~ 186 (188)
. ...+...+..+.+++..||+.+|++|||+.++++.|+.+...++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~~ 277 (278)
T 1byg_A 220 LKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELH 277 (278)
T ss_dssp GGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC-
T ss_pred HHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhcc
Confidence 1 122334567899999999999999999999999999998876654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=223.67 Aligned_cols=173 Identities=24% Similarity=0.249 Sum_probs=142.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C-Ccc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G-KEE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~-~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++||||++++++ ....++||||+++++|.+++ . ... |++.||.|||+ .+++|+|+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp 139 (288)
T 3kfa_A 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAA 139 (288)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSG
T ss_pred HHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCc
Confidence 567899999999999 77889999999999999999 2 111 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~ 141 (188)
+||+++.++.++|+|||.+.... ...........++..|++|| ++.++|+||||+++|++++ |..||.....
T Consensus 140 ~Nil~~~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~ 218 (288)
T 3kfa_A 140 RNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218 (288)
T ss_dssp GGEEECGGGCEEECCCCGGGTSC-SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred ceEEEcCCCCEEEccCccceecc-CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987543 22222233345677899998 6889999999999999999 8888854321
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
...+...+..+.+++..||+.+|.+|||++++++.|+.+..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 219 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 22333456789999999999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=226.87 Aligned_cols=174 Identities=20% Similarity=0.207 Sum_probs=142.2
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc------------------c---------cHHHHHHHH
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------------------E---------VCCPGLEYL 53 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------------------~---------~i~~~l~~L 53 (188)
+.++ +||||++++++ .+..++||||+++++|.+++ ... . |++.||.||
T Consensus 94 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 173 (334)
T 2pvf_A 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173 (334)
T ss_dssp HHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 3456 89999999998 77899999999999999998 221 1 999999999
Q ss_pred hcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHH
Q 039565 54 HQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 54 h~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~ 127 (188)
|+ .+++|+||||+||+++.++.+||+|||++................+++.|++|| ++.++|+||||+++|
T Consensus 174 H~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 250 (334)
T 2pvf_A 174 AS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250 (334)
T ss_dssp HH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred Hh---CCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHH
Confidence 99 999999999999999999999999999987543222212223345677899999 588999999999999
Q ss_pred HHHh-CCccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 128 EIIT-GILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 128 ~~~~-g~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
++++ |..||..... ...+...+..+.+++..||+.+|.+|||++++++.|+.+..
T Consensus 251 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 251 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999 8888854221 12233455688999999999999999999999999988754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=225.75 Aligned_cols=175 Identities=21% Similarity=0.239 Sum_probs=135.2
Q ss_pred cccccCCCeeeeccc---C-----CccEEEEecCCCCChhhhc--CC----c---c---------cHHHHHHHHhcCCCC
Q 039565 6 RNKLTGPLLVELIGK---Q-----KNNALELGFRGNPELVDQQ--GK----E---E---------VCCPGLEYLHQGLKH 59 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~-----~~~~lv~e~~~~~~L~~~~--~~----~---~---------~i~~~l~~Lh~~~~~ 59 (188)
+.+++||||++++++ . ...++++||+++++|.+++ .. . . |++.||.|||+ .
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~ 166 (313)
T 3brb_A 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---R 166 (313)
T ss_dssp HHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---C
Confidence 567899999999998 2 2459999999999999998 11 1 1 99999999999 9
Q ss_pred CcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-C
Q 039565 60 PIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-G 132 (188)
Q Consensus 60 ~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g 132 (188)
+++|+||||+||+++.++.+||+|||++................+++.|++|| ++.++|+||||+++|+|++ |
T Consensus 167 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 246 (313)
T 3brb_A 167 NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 246 (313)
T ss_dssp TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcC
Confidence 99999999999999999999999999987543222222223345677899988 5789999999999999999 8
Q ss_pred CccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 133 ILTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 133 ~~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
..||..... ...+...+..+.+++..||+.+|.+|||++++++.|+.+..+
T Consensus 247 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 247 MTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 888854322 123334557899999999999999999999999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=222.94 Aligned_cols=174 Identities=20% Similarity=0.228 Sum_probs=141.7
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+.+++||||++++++ .+..++++||+++++|.+++ ... . |++.||.|||+ .+++|+||||+||
T Consensus 72 l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Ni 148 (291)
T 1xbb_A 72 MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNV 148 (291)
T ss_dssp HHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGE
T ss_pred HHhCCCCCEEEEEEEECCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceE
Confidence 567899999999999 78889999999999999999 222 2 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCc-ceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC---
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTH-MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF--- 140 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~--- 140 (188)
+++.++.++|+|||++.......... ......++..|++|| ++.++|+||||+++|++++ |..||....
T Consensus 149 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 228 (291)
T 1xbb_A 149 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228 (291)
T ss_dssp EEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred EEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999987643222111 112234567799998 5778999999999999999 999986432
Q ss_pred ---------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 141 ---------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 141 ---------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
....+...+..+.+++..||+.+|.+|||++++++.|+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 229 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 122334456789999999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=231.90 Aligned_cols=161 Identities=20% Similarity=0.258 Sum_probs=134.0
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+||||++++++ ....++||||+++|+|..++.+ .. |++.||.|||+ .+|+||||||+||+++
T Consensus 111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~ 187 (396)
T 4dc2_A 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLD 187 (396)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEEC
T ss_pred CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEC
Confidence 89999999998 7889999999999999998822 22 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-------
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------- 141 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------- 141 (188)
.++.+||+|||+++... ..........||+.|+||| ++.++|+|||||++|+|++|..||+....
T Consensus 188 ~~g~ikL~DFGla~~~~--~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~ 265 (396)
T 4dc2_A 188 SEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265 (396)
T ss_dssp TTSCEEECCCTTCBCCC--CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C
T ss_pred CCCCEEEeecceeeecc--cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh
Confidence 99999999999987532 1222345578999999999 68899999999999999999999953211
Q ss_pred -------------CCcCHHHHHHHHHHHHHccCcCCCCCCCH------HHHHH
Q 039565 142 -------------GEFDIISVEKAVEIAMASVSSKVNRRPLM------NQVVM 175 (188)
Q Consensus 142 -------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~------~~i~~ 175 (188)
..++...+..+.+++..||+.||.+||++ ++|++
T Consensus 266 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 266 TEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 11233345678999999999999999985 56654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=223.38 Aligned_cols=172 Identities=14% Similarity=0.147 Sum_probs=139.7
Q ss_pred ccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhcC--Cc--c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 7 NKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQG--KE--E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~--~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
.++ +|+|+++++++ ....+++|||+ +++|.+++. .. . |++.||.|||+ .+++||||||+
T Consensus 60 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~ 135 (298)
T 1csn_A 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPD 135 (298)
T ss_dssp HHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGG
T ss_pred HHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHH
Confidence 445 79999999988 77889999999 899999992 22 2 99999999999 99999999999
Q ss_pred cEEEccCCc-----eEEecccCcccccCCCCC-----cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCC
Q 039565 70 NILLNEKVQ-----AKLADFGQSRISPVEGGT-----HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGI 133 (188)
Q Consensus 70 nill~~~~~-----~kl~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~ 133 (188)
||+++.++. ++|+|||++......... .......|+..|+||| ++.++|+||||+++|+|++|.
T Consensus 136 NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 215 (298)
T 1csn_A 136 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215 (298)
T ss_dssp GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCC
Confidence 999987765 999999999865422221 1233467889999998 578899999999999999999
Q ss_pred ccccccCCCCc--------------C-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 134 LTVDLSFKGEF--------------D-----IISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 134 ~p~~~~~~~~~--------------~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
.||........ + ...+..+.+++..||+.+|++|||+++|++.|+++..
T Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 216 LPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp CTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 99976432210 0 1234578999999999999999999999999987654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=225.34 Aligned_cols=173 Identities=17% Similarity=0.196 Sum_probs=139.5
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhc-CC---cc---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQ-GK---EE---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~-~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||++++++ ....+++|||+++++|.+++ .. .. |++.||.|||+ .+++|+|+|
T Consensus 77 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dik 153 (302)
T 4e5w_A 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLA 153 (302)
T ss_dssp HHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCS
T ss_pred HHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCc
Confidence 567899999999998 26689999999999999998 22 11 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCC-cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+||+++.++.++|+|||++......... .......++..|++|| ++.++|+||||+++|++++|..|+....
T Consensus 154 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 233 (302)
T 4e5w_A 154 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233 (302)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred hheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh
Confidence 99999999999999999998765322211 1223356777899999 5778999999999999999987653211
Q ss_pred ---------------------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 141 ---------------------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 141 ---------------------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
....+...+..+.+++..||+.+|.+|||++++++.|+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 234 ALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11122344567899999999999999999999999998763
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=246.20 Aligned_cols=173 Identities=20% Similarity=0.243 Sum_probs=140.1
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
|.+++||||++++++ .+..++||||+++|+|.+++ ... . |++.||.|||+ .+|+||||||+||
T Consensus 424 l~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NI 500 (635)
T 4fl3_A 424 MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNV 500 (635)
T ss_dssp HHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhE
Confidence 567899999999999 77789999999999999999 222 1 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCC-cceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC---
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF--- 140 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~--- 140 (188)
+++.++.+||+|||+++........ .......++..|+||| ++.++||||||+++|+|++ |..||....
T Consensus 501 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~ 580 (635)
T 4fl3_A 501 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 580 (635)
T ss_dssp EEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred EEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999998765322111 1222345667899998 6889999999999999998 999985422
Q ss_pred ---------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 141 ---------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 141 ---------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
....+...+..+.+++..||+.+|++||++++|++.|+...
T Consensus 581 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 581 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12234456678999999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=228.82 Aligned_cols=164 Identities=21% Similarity=0.270 Sum_probs=135.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+++|+|.+++ .+.. |++.||.|||+ .+++||||||+|
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~N 158 (362)
T 2bdw_A 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPEN 158 (362)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGG
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHH
Confidence 467899999999998 77889999999999999988 3222 99999999999 999999999999
Q ss_pred EEEccC---CceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILLNEK---VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill~~~---~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+++.+ +.+||+|||++.... .........|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 159 Ill~~~~~~~~~kl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 235 (362)
T 2bdw_A 159 LLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235 (362)
T ss_dssp EEESCSSTTCCEEECCCTTCBCCT---TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEecCCCCCCEEEeecCcceEec---CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 999865 459999999987543 112233467899999998 68899999999999999999999854221
Q ss_pred ---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+..+.+++..||+.||++|||++++++
T Consensus 236 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 236 HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111234678899999999999999999999886
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=227.23 Aligned_cols=174 Identities=22% Similarity=0.255 Sum_probs=136.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++||||+++++|.+++ ... . |++.||.|||+ .+++|+||||+
T Consensus 100 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~ 176 (333)
T 1mqb_A 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAAR 176 (333)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred HHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChh
Confidence 567899999999999 77889999999999999999 221 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCC-cceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~- 140 (188)
||+++.++.+||+|||++......... .......++..|++|| ++.++|+||||+++|++++ |..||....
T Consensus 177 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 256 (333)
T 1mqb_A 177 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256 (333)
T ss_dssp GEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred eEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999998754321111 1112234566799998 5788999999999999998 999885321
Q ss_pred -----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 141 -----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 141 -----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
....+...+..+.+++..||+.+|++||+++++++.|+++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 257 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 112233456789999999999999999999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=221.83 Aligned_cols=175 Identities=21% Similarity=0.231 Sum_probs=138.4
Q ss_pred cccccCCCeeeeccc---CC-ccEEEEecCCCCChhhhcCC-cc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QK-NNALELGFRGNPELVDQQGK-EE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~-~~~lv~e~~~~~~L~~~~~~-~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||++++++ .+ ..++++||+.+++|.+++.. .. |++.||.|||+ .+++|+|+||
T Consensus 76 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp 152 (298)
T 3pls_A 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAA 152 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred HHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCc
Confidence 567899999999998 33 34899999999999999922 21 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCC--CCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcc-cccc
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEG--GTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILT-VDLS 139 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p-~~~~ 139 (188)
+||+++.++.++|+|||+++...... .........++..|++|| ++.++|+||||+++|++++|..| +...
T Consensus 153 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~ 232 (298)
T 3pls_A 153 RNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232 (298)
T ss_dssp GGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC
Confidence 99999999999999999987542111 111223346677899988 57889999999999999996544 4321
Q ss_pred CC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 140 FK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 140 ~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
.. ...+...+..+.+++..||+.+|.+|||++++++.|+++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 233 DPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11 122334456899999999999999999999999999887543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=236.53 Aligned_cols=164 Identities=20% Similarity=0.309 Sum_probs=138.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
++.++||||++++++ ....++||||+++|+|.+++.+.+ |++.||.|||+ .+++||||||+|
T Consensus 70 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~N 146 (476)
T 2y94_A 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPEN 146 (476)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGG
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHH
Confidence 567899999999999 788999999999999999993322 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~- 142 (188)
|+++.++.+||+|||++..... ........|++.|+||| .+.++|+||||+++|+|++|..||+.....
T Consensus 147 Ill~~~~~vkL~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 223 (476)
T 2y94_A 147 VLLDAHMNAKIADFGLSNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223 (476)
T ss_dssp EEECTTCCEEECCCSSCEECCT---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH
T ss_pred EEEecCCCeEEEeccchhhccc---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH
Confidence 9999999999999999886431 12234457899999999 256899999999999999999999754221
Q ss_pred ----------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 ----------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ----------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+...+..+.+++..||+.||.+|||++++++
T Consensus 224 ~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 224 LFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 122234567899999999999999999999997
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=230.07 Aligned_cols=168 Identities=14% Similarity=0.163 Sum_probs=134.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC--cc-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK--EE-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~--~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++||||++++++ .+..++||||+++++|.+++ .. .. |++.||.|||+ .+|+||||||
T Consensus 80 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp 156 (389)
T 3gni_B 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKA 156 (389)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred HHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 567899999999998 78899999999999999998 22 11 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCC-----CcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCcc
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGG-----THMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~-----~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p 135 (188)
+||+++.++.+|++|||.+........ ........|+..|+||| ++.++|+|||||++|+|++|..|
T Consensus 157 ~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 236 (389)
T 3gni_B 157 SHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236 (389)
T ss_dssp GGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred HHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999999999998764321111 11122346788899998 46789999999999999999999
Q ss_pred ccccCCCC---------------------------------------------------------cCHHHHHHHHHHHHH
Q 039565 136 VDLSFKGE---------------------------------------------------------FDIISVEKAVEIAMA 158 (188)
Q Consensus 136 ~~~~~~~~---------------------------------------------------------~~~~~~~~~~~l~~~ 158 (188)
|....... .....+..+.+++..
T Consensus 237 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 316 (389)
T 3gni_B 237 FKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316 (389)
T ss_dssp TTTCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHH
T ss_pred CCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHH
Confidence 86432111 111234568899999
Q ss_pred ccCcCCCCCCCHHHHHHH
Q 039565 159 SVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 159 cl~~~p~~Rps~~~i~~~ 176 (188)
||+.||++|||++++++.
T Consensus 317 ~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 317 CLQRNPDARPSASTLLNH 334 (389)
T ss_dssp HTCSCTTTSCCHHHHTTS
T ss_pred HhhcCcccCCCHHHHhcC
Confidence 999999999999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=226.07 Aligned_cols=162 Identities=25% Similarity=0.384 Sum_probs=136.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc--c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE--E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
++.++||||++++++ ....++||||+++|+|.+++ ... . |++.||.|||+ .+++||||||+|
T Consensus 60 l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~N 136 (318)
T 1fot_A 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPEN 136 (318)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGG
T ss_pred HhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhe
Confidence 456899999999999 77899999999999999999 222 2 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.+||+|||+++.... ......|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 137 Ill~~~g~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 211 (318)
T 1fot_A 137 ILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211 (318)
T ss_dssp EEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EEEcCCCCEEEeecCcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999875421 233467899999998 68899999999999999999999854321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
..++...+..+.+++..|++.+|.+|| +++++++
T Consensus 212 ~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 212 YEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 122334456889999999999999999 8888875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=243.51 Aligned_cols=174 Identities=22% Similarity=0.239 Sum_probs=142.8
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCC-----cc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGK-----EE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~-----~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|.+++||||++++++ .+..++||||+++|+|.+++.. .. |++.||.|||+ .+++||||||+
T Consensus 316 l~~l~hpniv~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~ 392 (535)
T 2h8h_A 316 MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAA 392 (535)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred HHhCCCCCEeeEEEEEeeccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHh
Confidence 567899999999999 7789999999999999999932 11 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
||+++.++.+||+|||+++.... ..........++..|++|| ++.++||||||+++|+|++ |..||....
T Consensus 393 NIll~~~~~~kl~DFG~a~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~ 471 (535)
T 2h8h_A 393 NILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471 (535)
T ss_dssp GEEECGGGCEEECCTTSTTTCCC-HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH
T ss_pred hEEEcCCCcEEEcccccceecCC-CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875421 1001112234566799998 6889999999999999999 888885422
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
....+...+..+.+++..||+.+|++|||+++|++.|+.+...
T Consensus 472 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 472 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1122344567899999999999999999999999999987653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=229.27 Aligned_cols=165 Identities=20% Similarity=0.283 Sum_probs=137.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Cc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KE-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|.+++||||++++++ ....++||||+++++|.+++. .. . |++.||.|||+ .+++||||||+
T Consensus 102 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~ 178 (387)
T 1kob_A 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPE 178 (387)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred HHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchH
Confidence 567899999999999 788999999999999999993 22 1 99999999999 99999999999
Q ss_pred cEEEcc--CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 70 NILLNE--KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 70 nill~~--~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
||+++. .+.+||+|||++..... ........|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 179 NIll~~~~~~~vkL~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 255 (387)
T 1kob_A 179 NIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255 (387)
T ss_dssp GEEESSTTCCCEEECCCTTCEECCT---TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred HeEEecCCCCceEEEecccceecCC---CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH
Confidence 999974 46799999999876431 22234457899999999 57889999999999999999999864321
Q ss_pred ---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 ---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 ---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
.......+..+.+++..||+.||++|||++++++.
T Consensus 256 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 256 LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11112346688999999999999999999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=230.83 Aligned_cols=162 Identities=17% Similarity=0.225 Sum_probs=128.7
Q ss_pred cccCCCeeeeccc-------CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 8 KLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 8 ~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
..+||||++++++ ....++||||+++|+|.+++ .+. . |++.||.|||+ .+|+||||
T Consensus 111 ~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDl 187 (400)
T 1nxk_A 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 187 (400)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred hcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCc
Confidence 4589999999987 34578999999999999999 322 1 99999999999 99999999
Q ss_pred CCCcEEEcc---CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 67 KSTNILLNE---KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 67 ~~~nill~~---~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
||+||+++. ++.+||+|||+++... .........|++.|++|| ++.++|||||||++|+|++|..||.
T Consensus 188 kp~Nill~~~~~~~~~kl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 264 (400)
T 1nxk_A 188 KPENLLYTSKRPNAILKLTDFGFAKETT---SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_dssp CGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcceEEEecCCCCccEEEEecccccccC---CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 999999997 7889999999987543 112234567899999999 5789999999999999999999996
Q ss_pred ccCCCCc---------------C----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LSFKGEF---------------D----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~~~~~~---------------~----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....... + ...+..+.+++..||+.||++|||++++++
T Consensus 265 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 265 SNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 5332110 1 234567899999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=228.87 Aligned_cols=174 Identities=17% Similarity=0.168 Sum_probs=143.2
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCCc------c---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGKE------E---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~------~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+.+++||||++++++ ....++||||+++|+|.+++... . |++.||.|||+ .+++|||
T Consensus 61 l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~D 137 (396)
T 4eut_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRN 137 (396)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred HHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECC
Confidence 567899999999998 33679999999999999999331 1 99999999999 9999999
Q ss_pred CCCCcEEE----ccCCceEEecccCcccccCCCCCcceeeecccccccCCCC--------------CCccchHHHHHHHH
Q 039565 66 MKSTNILL----NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL--------------TEKSDVDSFEIVIL 127 (188)
Q Consensus 66 l~~~nill----~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~--------------~~~~di~s~G~~l~ 127 (188)
|||+||++ +.++.+||+|||+++... .........|+..|++||. +.++|+||||+++|
T Consensus 138 lkp~NIll~~~~~~~~~~kL~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~ 214 (396)
T 4eut_A 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY 214 (396)
T ss_dssp CCGGGEEEEECTTSCEEEEECCGGGCEECC---CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHH
T ss_pred cCHHHEEEeecCCCceeEEEecCCCceEcc---CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHH
Confidence 99999999 677789999999987543 1222334568899999982 45799999999999
Q ss_pred HHHhCCccccccCC----------------------------------------CCcCHHHHHHHHHHHHHccCcCCCCC
Q 039565 128 EIITGILTVDLSFK----------------------------------------GEFDIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 128 ~~~~g~~p~~~~~~----------------------------------------~~~~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
+|++|..||.+... ..........+.+++..||+.||++|
T Consensus 215 el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R 294 (396)
T 4eut_A 215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294 (396)
T ss_dssp HHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTS
T ss_pred HHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhh
Confidence 99999999853211 11335677889999999999999999
Q ss_pred CCHHHHHHHHhhccCcce
Q 039565 168 PLMNQVVMVREQGSGSRI 185 (188)
Q Consensus 168 ps~~~i~~~l~~~~~~~~ 185 (188)
|+++++++.++.+....+
T Consensus 295 ~s~~e~l~~l~~il~~~~ 312 (396)
T 4eut_A 295 WGFDQFFAETSDILHRMV 312 (396)
T ss_dssp CCHHHHHHHHHHHHTCEE
T ss_pred ccHHHHHHHHHHHhhceE
Confidence 999999999988776643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=222.62 Aligned_cols=149 Identities=18% Similarity=0.266 Sum_probs=118.9
Q ss_pred cEEEEecCCCCChhhhc-CCcc--------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 24 NALELGFRGNPELVDQQ-GKEE--------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 24 ~~lv~e~~~~~~L~~~~-~~~~--------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
.+++|||+++++|.+++ .... |++.||.|||+ .+++|||+||+||+++.++.+||+|||+++
T Consensus 136 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 212 (332)
T 3qd2_B 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 212 (332)
T ss_dssp EEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCccc
Confidence 79999999999999999 3211 89999999999 999999999999999999999999999988
Q ss_pred cccCCCCC----------cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC-------CCCc-
Q 039565 89 ISPVEGGT----------HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF-------KGEF- 144 (188)
Q Consensus 89 ~~~~~~~~----------~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~-------~~~~- 144 (188)
........ .......|++.|+||| ++.++|+||||+++|+|++|..|+.... ....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~ 292 (332)
T 3qd2_B 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFP 292 (332)
T ss_dssp ECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCC
T ss_pred ccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCC
Confidence 65422111 1123356899999998 6889999999999999999987653210 1111
Q ss_pred --CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 145 --DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 145 --~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+.+++..||+.+|++|||++++++
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 2344567889999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=221.92 Aligned_cols=177 Identities=19% Similarity=0.199 Sum_probs=140.2
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCC-c---c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGK-E---E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++++||+++++|.+++.. . . |++.||.|||+ .+++|+|+||+|
T Consensus 75 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~N 151 (291)
T 1u46_A 75 MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARN 151 (291)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGG
T ss_pred HHhCCCCCcccEEEEEccCCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchhe
Confidence 457889999999999 6678999999999999999822 1 1 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCc-ceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTH-MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
|+++.++.++|+|||++.......... ......++..|++|| ++.++|+||||+++|++++ |..||....
T Consensus 152 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 231 (291)
T 1u46_A 152 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 231 (291)
T ss_dssp EEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred EEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH
Confidence 999999999999999987653222111 122345667899998 5778999999999999999 999885321
Q ss_pred -----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcce
Q 039565 141 -----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSRI 185 (188)
Q Consensus 141 -----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~~ 185 (188)
....+...+..+.+++..||+.+|++|||++++++.|+++.++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 232 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 112233456789999999999999999999999999998877643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=225.71 Aligned_cols=173 Identities=25% Similarity=0.300 Sum_probs=140.5
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc------------------c---------cHHHHHHHH
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------------------E---------VCCPGLEYL 53 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------------------~---------~i~~~l~~L 53 (188)
+.++ +||||++++++ .+..+++|||+++++|.+++ ... . |++.||.||
T Consensus 79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 4567 89999999999 78899999999999999999 322 1 999999999
Q ss_pred hcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHH
Q 039565 54 HQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 54 h~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~ 127 (188)
|+ .+++||||||+||+++.++.+||+|||+++... .........++..|++|| ++.++|+||||+++|
T Consensus 159 H~---~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (327)
T 1fvr_A 159 SQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232 (327)
T ss_dssp HH---TTEECSCCSGGGEEECGGGCEEECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred Hh---CCccCCCCccceEEEcCCCeEEEcccCcCcccc---ccccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence 99 999999999999999999999999999986322 111122345667899998 588999999999999
Q ss_pred HHHh-CCccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcc
Q 039565 128 EIIT-GILTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSR 184 (188)
Q Consensus 128 ~~~~-g~~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 184 (188)
+|++ |..||.... ....+...+..+.+++..||+.+|.+|||++++++.|+.+...+
T Consensus 233 ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 233 EIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 9998 999885422 12233345678999999999999999999999999998765543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=227.60 Aligned_cols=156 Identities=21% Similarity=0.266 Sum_probs=130.5
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+||||++++++ ....++||||+++|+|..++.+ .. |++.||.|||+ .+++||||||+||+++
T Consensus 68 ~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 144 (345)
T 3a8x_A 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLD 144 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEEC
T ss_pred CCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEC
Confidence 89999999998 7889999999999999999822 22 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-------
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------- 141 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------- 141 (188)
.++.+||+|||+++.... .........|++.|+||| ++.++|+|||||++|+|++|..||.....
T Consensus 145 ~~g~~kL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 222 (345)
T 3a8x_A 145 SEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222 (345)
T ss_dssp TTSCEEECCGGGCBCSCC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------
T ss_pred CCCCEEEEeccccccccC--CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc
Confidence 999999999999875321 122344568999999999 58899999999999999999999964211
Q ss_pred -------------CCcCHHHHHHHHHHHHHccCcCCCCCCCH
Q 039565 142 -------------GEFDIISVEKAVEIAMASVSSKVNRRPLM 170 (188)
Q Consensus 142 -------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~ 170 (188)
..++...+..+.+++..||+.+|.+||++
T Consensus 223 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 223 TEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11223345678899999999999999995
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=229.02 Aligned_cols=164 Identities=23% Similarity=0.333 Sum_probs=129.5
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCC-cc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGK-EE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
|.+++||||++++++ .+..++||||+++|+|.+++.. .. |++.||.|||+ .+++||||||+||
T Consensus 194 l~~l~hpniv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NI 270 (419)
T 3i6u_A 194 LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENV 270 (419)
T ss_dssp HHHCCCTTBCCCCEEEESSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred HHhCCCCCEeeEEEEEecCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhE
Confidence 567899999999999 7778999999999999999832 22 99999999999 9999999999999
Q ss_pred EEccCC---ceEEecccCcccccCCCCCcceeeecccccccCCCC---------CCccchHHHHHHHHHHHhCCcccccc
Q 039565 72 LLNEKV---QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL---------TEKSDVDSFEIVILEIITGILTVDLS 139 (188)
Q Consensus 72 ll~~~~---~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~---------~~~~di~s~G~~l~~~~~g~~p~~~~ 139 (188)
+++.++ .+||+|||+++... .........|++.|+|||. +.++|+||||+++|+|++|..||...
T Consensus 271 ll~~~~~~~~~kl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 271 LLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp EESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred EEecCCCcceEEEeecccceecC---CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 997544 59999999998643 2222345678999999993 34799999999999999999999653
Q ss_pred CCCC------------cCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 140 FKGE------------FDI----ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 140 ~~~~------------~~~----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.... ... ..+..+.+++..||+.+|++|||++++++
T Consensus 348 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 348 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 3221 111 23568899999999999999999999987
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=223.02 Aligned_cols=177 Identities=22% Similarity=0.183 Sum_probs=139.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC----------------------------------------
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---------------------------------------- 42 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---------------------------------------- 42 (188)
+.+++||||++++++ .+..++||||+++|+|.+++..
T Consensus 82 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (345)
T 3hko_A 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL 161 (345)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEEC
T ss_pred HHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 567899999999999 7788999999999999998831
Q ss_pred -c-----------ccHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCC--ceEEecccCcccccCCCC--Ccceeeecccc
Q 039565 43 -E-----------EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKV--QAKLADFGQSRISPVEGG--THMSTTIAGTA 106 (188)
Q Consensus 43 -~-----------~~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~--~~kl~d~~~~~~~~~~~~--~~~~~~~~~~~ 106 (188)
. .|++.||.|||+ .+++|+||||+||+++.++ .+||+|||++........ ........|++
T Consensus 162 ~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 238 (345)
T 3hko_A 162 DFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCG
T ss_pred cccccHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCc
Confidence 0 089999999999 9999999999999998766 899999999875432211 11234567889
Q ss_pred cccCCC--------CCCccchHHHHHHHHHHHhCCccccccCC---------------CCcCHHHHHHHHHHHHHccCcC
Q 039565 107 GFLNTE--------LTEKSDVDSFEIVILEIITGILTVDLSFK---------------GEFDIISVEKAVEIAMASVSSK 163 (188)
Q Consensus 107 ~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~~~~~---------------~~~~~~~~~~~~~l~~~cl~~~ 163 (188)
.|+||| ++.++|+||||+++|+|++|..||..... .......+..+.+++..||+.+
T Consensus 239 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp GGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSC
T ss_pred cccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCC
Confidence 999998 46799999999999999999999854221 1111124678899999999999
Q ss_pred CCCCCCHHHHHH--HHhhccCcce
Q 039565 164 VNRRPLMNQVVM--VREQGSGSRI 185 (188)
Q Consensus 164 p~~Rps~~~i~~--~l~~~~~~~~ 185 (188)
|.+|||+.++++ .+++..+.-.
T Consensus 319 p~~Rps~~~~l~hp~~~~~~~~~~ 342 (345)
T 3hko_A 319 VDERFDAMRALQHPWISQFSDKIY 342 (345)
T ss_dssp TTTSCCHHHHHHSHHHHTTSSCSS
T ss_pred hhHCCCHHHHhcChhhccChHhhE
Confidence 999999999998 5666655443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=229.03 Aligned_cols=165 Identities=20% Similarity=0.238 Sum_probs=134.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC------cc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK------EE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~------~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ ....++||||+++++|.+++ .. .. |++.||.|||+ .+++||||
T Consensus 80 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDl 156 (351)
T 3c0i_A 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDV 156 (351)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccC
Confidence 467899999999998 78899999999999998877 21 11 99999999999 99999999
Q ss_pred CCCcEEEccCCc---eEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 67 KSTNILLNEKVQ---AKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 67 ~~~nill~~~~~---~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
||+||+++.++. +||+|||++..... .........|++.|+||| ++.++|+||||+++|+|++|..||.
T Consensus 157 kp~NIl~~~~~~~~~vkl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 157 KPHCVLLASKENSAPVKLGGFGVAIQLGE--SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp SGGGEEECSSSTTCCEEECCCTTCEECCT--TSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ChHHeEEecCCCCCcEEEecCcceeEecC--CCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 999999986554 99999999876432 222234467899999999 6889999999999999999999986
Q ss_pred ccCC----------CCcCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LSFK----------GEFDI----ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~~~----------~~~~~----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.... ...+. ..+..+.+++..||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 235 GTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CcHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 4211 01111 23567899999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=226.37 Aligned_cols=175 Identities=19% Similarity=0.247 Sum_probs=140.1
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCC--c--c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGK--E--E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~--~--~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||++++++ ....++||||+++++|.+++.. . . |++.||.|||+ .+++|+|||
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dik 154 (327)
T 3lxl_A 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLA 154 (327)
T ss_dssp HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCS
T ss_pred HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCC
Confidence 567899999999887 4568899999999999999822 1 1 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCC-cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+||+++.++.++|+|||++......... .......++..|++|| ++.++|+||||+++|++++|..||....
T Consensus 155 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 155 ARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp GGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred hhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999998865322211 1122345777899999 5789999999999999999998874321
Q ss_pred C---------------------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 141 K---------------------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 141 ~---------------------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
. ...+...+..+.+++..||+.+|.+|||++++++.|+.+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 235 AEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred chhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1 112233456789999999999999999999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=224.76 Aligned_cols=165 Identities=16% Similarity=0.209 Sum_probs=137.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCC-ChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNP-ELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~-~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++||||+..| +|..++.+. . |++.||.|||+ .+++||||||+
T Consensus 83 l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~ 159 (335)
T 3dls_A 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDE 159 (335)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGG
T ss_pred HHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHH
Confidence 567899999999999 77889999999776 999999322 2 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
||+++.++.+||+|||++..... ........|++.|+||| .+.++|+||||+++|++++|..||.....
T Consensus 160 NIll~~~~~~kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 236 (335)
T 3dls_A 160 NIVIAEDFTIKLIDFGSAAYLER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET 236 (335)
T ss_dssp GEEECTTSCEEECCCTTCEECCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG
T ss_pred HEEEcCCCcEEEeecccceECCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH
Confidence 99999999999999999875431 12234467899999999 26678999999999999999999864221
Q ss_pred ----CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 ----GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 ----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
...+...+..+.+++..||+.+|++|||++++++.
T Consensus 237 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223356789999999999999999999999984
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=218.35 Aligned_cols=165 Identities=23% Similarity=0.303 Sum_probs=124.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++++||+++++|.+++ .... |++.||.|||+ .+++|+|++|+
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~ 141 (278)
T 3cok_A 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLS 141 (278)
T ss_dssp HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGG
T ss_pred HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHH
Confidence 467899999999999 77889999999999999998 3211 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG- 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~- 142 (188)
||+++.++.++|+|||.+....... .......|++.|++|| ++.++|+||||+++|++++|..||+.....
T Consensus 142 Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 219 (278)
T 3cok_A 142 NLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219 (278)
T ss_dssp GEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-
T ss_pred HEEEcCCCCEEEEeecceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH
Confidence 9999999999999999987543111 1223456888999999 477999999999999999999998653221
Q ss_pred ----------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 ----------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ----------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+...+..+.+++..||+.+|++|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 220 TLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 123345678899999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=231.63 Aligned_cols=161 Identities=21% Similarity=0.240 Sum_probs=134.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+..++||||+++++. .+..++||||+++|+|..++.+ .. |++.||+|||+ .+|+||||||+|
T Consensus 93 l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~N 169 (373)
T 2r5t_A 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPEN 169 (373)
T ss_dssp BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHH
Confidence 467899999999988 7889999999999999999822 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.+||+|||+++.... .........|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 170 Ill~~~g~ikL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~ 247 (373)
T 2r5t_A 170 ILLDSQGHIVLTDFGLCKENIE--HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247 (373)
T ss_dssp EEECTTSCEEECCCCBCGGGBC--CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH
T ss_pred EEECCCCCEEEeeCcccccccc--CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 9999999999999999875321 122344568999999999 68899999999999999999999854321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLMN 171 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~ 171 (188)
..++...+..+.+++..||+.+|.+||++.
T Consensus 248 ~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 248 YDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 122333456789999999999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=228.29 Aligned_cols=162 Identities=19% Similarity=0.231 Sum_probs=137.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+++|+|.+++.+ .. |++.||.|||+ .+++||||||+|
T Consensus 95 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~N 171 (350)
T 1rdq_E 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPEN 171 (350)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccce
Confidence 567899999999998 7788999999999999999922 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.+||+|||+++.... ......|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 172 Ill~~~g~~kL~DFg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 246 (350)
T 1rdq_E 172 LLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp EEECTTSCEEECCCTTCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEECCCCCEEEcccccceeccC-----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH
Confidence 9999999999999999875431 123457899999998 58899999999999999999999864321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPL-----MNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~i~~ 175 (188)
..++...+..+.+++..||+.+|.+||+ +++|++
T Consensus 247 ~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1233345678899999999999999998 888775
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=225.56 Aligned_cols=164 Identities=22% Similarity=0.269 Sum_probs=128.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+++++|.+++.... |++.||.|||+ .+++||||||+|
T Consensus 102 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~N 178 (349)
T 2w4o_A 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPEN 178 (349)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred HHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCccc
Confidence 567899999999998 778899999999999999993322 99999999999 999999999999
Q ss_pred EEEcc---CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILLNE---KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill~~---~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+++. ++.+||+|||+++... .........|++.|++|| ++.++|+||||+++|+|++|..||.....
T Consensus 179 Ill~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 179 LLYATPAPDAPLKIADFGLSKIVE---HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp EEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred EEEecCCCCCCEEEccCccccccC---cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 99975 7899999999987542 112233467889999998 68899999999999999999999854321
Q ss_pred C----------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 G----------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ~----------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ......+..+.+++..||+.||++|||++++++
T Consensus 256 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 256 DQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 111234567899999999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=218.29 Aligned_cols=167 Identities=22% Similarity=0.274 Sum_probs=137.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..++++||+++++|.+++... . |++.||.|||+ .+++|+|++|+|
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~N 135 (276)
T 2yex_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPEN 135 (276)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred HHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHH
Confidence 456899999999999 77889999999999999999432 2 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKGE 143 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~ 143 (188)
|+++.++.++++|||.+................|+..|++|| .+.++|+||||+++|++++|..||+......
T Consensus 136 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 215 (276)
T 2yex_A 136 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (276)
T ss_dssp EEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS
T ss_pred EEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 999999999999999987543222222233457888999999 2457999999999999999999996543221
Q ss_pred --------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 --------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 --------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.....+..+.+++..||+.+|.+|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 216 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 11234567889999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=220.71 Aligned_cols=165 Identities=20% Similarity=0.217 Sum_probs=131.0
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
-+.+++||||++++++ .+..+++|||+++ +|.+++ .... |++.||.|||+ .+++||||||
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp 128 (288)
T 1ob3_A 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKP 128 (288)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCG
T ss_pred HHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCH
Confidence 3678899999999999 7789999999985 898888 3211 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
+||+++.++.+||+|||++...... ........+++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 129 ~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (288)
T 1ob3_A 129 QNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (288)
T ss_dssp GGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHEEEcCCCCEEEeECccccccCcc--ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999998754311 11223456788899998 57889999999999999999998853210
Q ss_pred C----------------------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 G----------------------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ~----------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ......+..+.+++..||+.||++|||++++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 207 ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 000123567789999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=224.68 Aligned_cols=165 Identities=24% Similarity=0.268 Sum_probs=133.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..++||||+++++|.+++.+ .. |++.||.|||+ .+++||||||+|
T Consensus 75 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~N 151 (327)
T 3a62_A 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPEN 151 (327)
T ss_dssp HHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTT
T ss_pred HHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHH
Confidence 567899999999998 7889999999999999999822 12 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.+||+|||+++..... ........|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 152 ill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 229 (327)
T 3a62_A 152 IMLNHQGHVKLTDFGLCKESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229 (327)
T ss_dssp EEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred eEECCCCcEEEEeCCcccccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 99999999999999998743211 11233457889999998 68899999999999999999999964321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
...+...+..+.+++..||+.+|.+|| +++++++
T Consensus 230 ~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 230 IDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 123334457889999999999999999 7778776
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=233.94 Aligned_cols=167 Identities=19% Similarity=0.247 Sum_probs=137.5
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
-+.+++||||++++++ .+..++||||+++|+|..++.+ .. |++.||+|||+ ..+|+||||||+
T Consensus 201 ~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~ 278 (446)
T 4ejn_A 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLE 278 (446)
T ss_dssp CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGG
T ss_pred HHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHH
Confidence 4677899999999998 7889999999999999998822 22 99999999995 168999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
||+++.++.+||+|||+++... ..........|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 279 NIll~~~~~~kl~DFG~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 356 (446)
T 4ejn_A 279 NLMLDKDGHIKITDFGLCKEGI--KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 356 (446)
T ss_dssp GEEECSSSCEEECCCCCCCTTC--C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HEEECCCCCEEEccCCCceecc--CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH
Confidence 9999999999999999987532 1122234567999999998 68999999999999999999999954321
Q ss_pred ---------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 142 ---------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 142 ---------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
..++...+..+.+++..||+.||.+|| +++++++
T Consensus 357 ~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 357 LFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 123334557889999999999999999 9999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=241.82 Aligned_cols=173 Identities=20% Similarity=0.201 Sum_probs=140.2
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc--CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ--GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~--~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..++||||+++|+|.+++ .... |++.||.|||+ .+++||||||+|
T Consensus 445 l~~l~HpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~N 521 (656)
T 2j0j_A 445 MRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARN 521 (656)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred HHhCCCCCCCeEEEEEecCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHh
Confidence 567899999999999 77899999999999999999 2211 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF--- 140 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~--- 140 (188)
|+++.++.+||+|||+++.... ..........++..|+||| ++.++|+||||+++|+|++ |..||....
T Consensus 522 ILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 600 (656)
T 2j0j_A 522 VLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600 (656)
T ss_dssp EEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred EEEeCCCCEEEEecCCCeecCC-CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 9999999999999999876431 1111222345667899999 6889999999999999997 888886422
Q ss_pred ---------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 141 ---------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 141 ---------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
....+...+..+.+++..||+.+|.+|||++++++.|+.+.+
T Consensus 601 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 601 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 122334456789999999999999999999999999988754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=225.30 Aligned_cols=174 Identities=23% Similarity=0.295 Sum_probs=139.5
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhc-CC-c--c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQ-GK-E--E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~-~~-~--~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||++++++ ....++|+||+++++|.+++ .. . . |++.||.|||+ .+++|+|||
T Consensus 96 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dik 172 (326)
T 2w1i_A 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLA 172 (326)
T ss_dssp HHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred HHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCC
Confidence 567899999999987 34789999999999999999 22 1 1 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCc-ceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTH-MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+||+++.++.++|+|||++.......... ......++..|+||| ++.++|+||||+++|++++|..|+....
T Consensus 173 p~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 252 (326)
T 2w1i_A 173 TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 252 (326)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH
T ss_pred cceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH
Confidence 999999999999999999987653222111 112234566799998 5788999999999999999987765320
Q ss_pred ----------------------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 141 ----------------------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 141 ----------------------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
....+...+..+.+++..||+.+|++|||+.++++.|+++.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 253 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011223345688999999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=223.97 Aligned_cols=164 Identities=21% Similarity=0.233 Sum_probs=133.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC--------cc---------cHHHHHHHHhcCCCCCcEEe
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK--------EE---------VCCPGLEYLHQGLKHPIIQR 64 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~--------~~---------~i~~~l~~Lh~~~~~~i~h~ 64 (188)
+.+++||||++++++ .+..++||||++ ++|.+++ .. .. |++.||.|||+ .+++||
T Consensus 57 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~ 132 (317)
T 2pmi_A 57 MKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHR 132 (317)
T ss_dssp HTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECC
T ss_pred HHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeC
Confidence 567899999999999 778899999999 5999887 11 11 99999999999 999999
Q ss_pred CCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 65 DMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 65 dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
||||+||+++.++.+||+|||++....... .......+++.|+||| ++.++|+||||+++|+|++|..||.
T Consensus 133 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 133 DLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp CCCGGGEEECTTCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCChHHeEEcCCCCEEECcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999987643211 1223456788999998 4778999999999999999999885
Q ss_pred ccCCCC---------------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 039565 138 LSFKGE---------------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQ 172 (188)
Q Consensus 138 ~~~~~~---------------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~ 172 (188)
.....+ .....+..+.+++..||+.||++|||+++
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 290 (317)
T 2pmi_A 211 GTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290 (317)
T ss_dssp CSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHH
Confidence 321100 00123457889999999999999999999
Q ss_pred HHH
Q 039565 173 VVM 175 (188)
Q Consensus 173 i~~ 175 (188)
+++
T Consensus 291 ~l~ 293 (317)
T 2pmi_A 291 ALH 293 (317)
T ss_dssp HTT
T ss_pred HhC
Confidence 986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=222.28 Aligned_cols=172 Identities=19% Similarity=0.200 Sum_probs=139.3
Q ss_pred ccCCCeeeeccc---CC----ccEEEEecCCCCChhhhcCC--cc---------cHHHHHHHHh--------cCCCCCcE
Q 039565 9 LTGPLLVELIGK---QK----NNALELGFRGNPELVDQQGK--EE---------VCCPGLEYLH--------QGLKHPII 62 (188)
Q Consensus 9 l~Hpniv~~~~~---~~----~~~lv~e~~~~~~L~~~~~~--~~---------~i~~~l~~Lh--------~~~~~~i~ 62 (188)
++||||++++++ .. ..++||||+++|+|.+++.+ .. |++.||.||| + .+++
T Consensus 93 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~iv 169 (342)
T 1b6c_B 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIA 169 (342)
T ss_dssp CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEE
T ss_pred cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCee
Confidence 799999999998 22 78999999999999999922 22 9999999999 7 8999
Q ss_pred EeCCCCCcEEEccCCceEEecccCcccccCCCCCc--ceeeecccccccCCCC--C----------CccchHHHHHHHHH
Q 039565 63 QRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH--MSTTIAGTAGFLNTEL--T----------EKSDVDSFEIVILE 128 (188)
Q Consensus 63 h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~--~~~~~~~~~~~~~pe~--~----------~~~di~s~G~~l~~ 128 (188)
|+||||+||+++.++.+||+|||++.......... ......|+..|+|||. . .++|+||||+++|+
T Consensus 170 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e 249 (342)
T 1b6c_B 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249 (342)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHH
T ss_pred eCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHH
Confidence 99999999999999999999999987653222111 1234578899999992 1 47999999999999
Q ss_pred HHhC----------CccccccCC------------------CCcC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 129 IITG----------ILTVDLSFK------------------GEFD-----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 129 ~~~g----------~~p~~~~~~------------------~~~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|++| ..||..... ...+ ...+..+.+++..||+.+|++|||++++++
T Consensus 250 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 250 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999 667643211 1111 256678999999999999999999999999
Q ss_pred HHhhccCc
Q 039565 176 VREQGSGS 183 (188)
Q Consensus 176 ~l~~~~~~ 183 (188)
.|+++.++
T Consensus 330 ~L~~i~~~ 337 (342)
T 1b6c_B 330 TLSQLSQQ 337 (342)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHH
Confidence 99988765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=228.89 Aligned_cols=160 Identities=21% Similarity=0.321 Sum_probs=134.6
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+||||++++++ .+..++||||+++|+|.+++.+ .. |++.||.|||+ .+++||||||+||+++
T Consensus 76 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 152 (345)
T 1xjd_A 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLD 152 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEEC
T ss_pred CCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEEC
Confidence 89999999998 7889999999999999999822 22 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-------
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------- 141 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------- 141 (188)
.++.+||+|||+++.... .........|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 153 ~~g~vkL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 230 (345)
T 1xjd_A 153 KDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230 (345)
T ss_dssp TTSCEEECCCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCEEEeEChhhhhccc--CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 999999999999875321 122344568999999999 58899999999999999999999964321
Q ss_pred ----CCcCHHHHHHHHHHHHHccCcCCCCCCCHH-HHH
Q 039565 142 ----GEFDIISVEKAVEIAMASVSSKVNRRPLMN-QVV 174 (188)
Q Consensus 142 ----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-~i~ 174 (188)
..++...+..+.+++..||+.+|++||++. +|+
T Consensus 231 ~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 231 RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 123334567889999999999999999987 554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=227.62 Aligned_cols=164 Identities=23% Similarity=0.266 Sum_probs=135.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ .+..++||||+++++|.+++ ... . |++.||.|||+ .+++||||||+
T Consensus 140 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~ 216 (373)
T 2x4f_A 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPE 216 (373)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHH
Confidence 567899999999999 77889999999999999888 322 1 99999999999 99999999999
Q ss_pred cEEE--ccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 70 NILL--NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 70 nill--~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
||++ +.++.+||+|||+++.... ........|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 217 NIll~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 293 (373)
T 2x4f_A 217 NILCVNRDAKQIKIIDFGLARRYKP---REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND 293 (373)
T ss_dssp GEEEEETTTTEEEECCCSSCEECCT---TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred HEEEecCCCCcEEEEeCCCceecCC---ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999 4567899999999886431 12233456899999999 57789999999999999999999854321
Q ss_pred ---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+..+.+++..||+.+|.+|||++++++
T Consensus 294 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 294 AETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111234578899999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=216.25 Aligned_cols=173 Identities=16% Similarity=0.178 Sum_probs=138.7
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhcC--Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQG--KEE-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~~--~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++|+|++..++. ....+++|||+ +++|.+++. ... |++.||.|||+ .+++||||||
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp 133 (296)
T 4hgt_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKP 133 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSG
T ss_pred HHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCH
Confidence 456778887776665 77789999999 889999983 222 99999999999 9999999999
Q ss_pred CcEEE---ccCCceEEecccCcccccCCCCC-----cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCc
Q 039565 69 TNILL---NEKVQAKLADFGQSRISPVEGGT-----HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGIL 134 (188)
Q Consensus 69 ~nill---~~~~~~kl~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~ 134 (188)
+||++ +.++.+||+|||++......... .......|+..|++|| ++.++|+||||+++|++++|..
T Consensus 134 ~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 213 (296)
T 4hgt_A 134 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 213 (296)
T ss_dssp GGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred HHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCC
Confidence 99999 78899999999998865422211 1223467889999998 5778999999999999999999
Q ss_pred cccccCCCCc--------------C-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 135 TVDLSFKGEF--------------D-----IISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 135 p~~~~~~~~~--------------~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
||........ + ...+..+.+++..||+.+|++|||++++++.|+++..
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 214 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp TTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred CCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 9975432211 1 1125678999999999999999999999999987654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=218.26 Aligned_cols=163 Identities=25% Similarity=0.358 Sum_probs=133.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....+++|||+++++|.+++.+ .. |++.||.|||+ .+++|+|++|+|
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~N 139 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPEN 139 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGG
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHh
Confidence 467889999999999 7778999999999999998822 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++|+|||++.... ........|+..|++|| .+.++|+||||+++|++++|..||.....
T Consensus 140 ili~~~~~~~l~Dfg~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 215 (279)
T 3fdn_A 140 LLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215 (279)
T ss_dssp EEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EEEcCCCCEEEEeccccccCC----cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH
Confidence 999999999999999875432 11233456888999998 57899999999999999999999864321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+...+..+.+++..||+.+|.+|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 216 YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1223334567889999999999999999999997
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=231.24 Aligned_cols=166 Identities=20% Similarity=0.251 Sum_probs=137.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC--Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG--KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~--~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+..++||||++++++ ....++||||+++|+|.+++. ... |++.||.|||+ .+|+||||||+||
T Consensus 123 l~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NI 199 (410)
T 3v8s_A 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNM 199 (410)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHe
Confidence 456899999999998 778999999999999999982 222 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC----------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE----------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe----------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
+++.++.+||+|||+++... ...........|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 200 Ll~~~g~ikL~DFG~a~~~~-~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 278 (410)
T 3v8s_A 200 LLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278 (410)
T ss_dssp EECTTSCEEECCCTTCEECC-TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eECCCCCEEEeccceeEeec-cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence 99999999999999997543 11212234568999999999 35789999999999999999999964321
Q ss_pred C-------------CcC--HHHHHHHHHHHHHccCcCCCC--CCCHHHHHH
Q 039565 142 G-------------EFD--IISVEKAVEIAMASVSSKVNR--RPLMNQVVM 175 (188)
Q Consensus 142 ~-------------~~~--~~~~~~~~~l~~~cl~~~p~~--Rps~~~i~~ 175 (188)
. .++ ...+..+.+++..||+.+|.+ ||++++|++
T Consensus 279 ~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 279 VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred hhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1 111 134577899999999999988 999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=219.35 Aligned_cols=163 Identities=22% Similarity=0.359 Sum_probs=134.3
Q ss_pred cccccCCCeeeeccc-------CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCC--cEEe
Q 039565 6 RNKLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHP--IIQR 64 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~--i~h~ 64 (188)
+.+++||||++++++ ....++||||+++++|.+++.. .. |++.||.|||+ .+ ++|+
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~ 155 (290)
T 1t4h_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHR 155 (290)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCS
T ss_pred HHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEEC
Confidence 567899999999987 3457999999999999999922 22 99999999999 78 9999
Q ss_pred CCCCCcEEEc-cCCceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccccc
Q 039565 65 DMKSTNILLN-EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 65 dl~~~nill~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||||+||+++ .++.++|+|||++.... ........|++.|++|| ++.++|+||||+++|+|++|..||..
T Consensus 156 dikp~Nil~~~~~~~~kl~Dfg~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 156 DLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CCCGGGEEESSTTSCEEECCTTGGGGCC----TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCHHHEEEECCCCCEEEeeCCCccccc----ccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998 78899999999986432 11233456888999998 68899999999999999999999864
Q ss_pred cCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFK--------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... ...+...+..+.+++..||+.+|.+|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 232 CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 221 1122233467999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=224.89 Aligned_cols=174 Identities=19% Similarity=0.185 Sum_probs=138.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc---------c---------cHHHHHHHHhcCCCCCcEE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE---------E---------VCCPGLEYLHQGLKHPIIQ 63 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~---------~---------~i~~~l~~Lh~~~~~~i~h 63 (188)
+.+++||||++++++ ....+++|||+++++|.+++ ... . |++.||.|||+ .+++|
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H 163 (327)
T 2yfx_A 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIH 163 (327)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred HhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeec
Confidence 457899999999999 67889999999999999999 221 1 99999999999 99999
Q ss_pred eCCCCCcEEEcc---CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CC
Q 039565 64 RDMKSTNILLNE---KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GI 133 (188)
Q Consensus 64 ~dl~~~nill~~---~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~ 133 (188)
+||||+||+++. +..++|+|||++................++..|++|| ++.++|+||||+++|++++ |.
T Consensus 164 ~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 243 (327)
T 2yfx_A 164 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 243 (327)
T ss_dssp SCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999984 4469999999887543222222233456778899998 6889999999999999998 88
Q ss_pred ccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 134 LTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 134 ~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
.||..... ...+...+..+.+++..||+.+|.+|||++++++.|+....
T Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 244 MPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 88854321 12223445678999999999999999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=225.28 Aligned_cols=164 Identities=20% Similarity=0.272 Sum_probs=125.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C--Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G--KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~--~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+++|+|.+++ . ... |++.||.|||+ .+++||||||+|
T Consensus 70 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~N 146 (361)
T 3uc3_A 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLEN 146 (361)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGG
T ss_pred HHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHH
Confidence 567899999999999 78899999999999999998 2 222 99999999999 999999999999
Q ss_pred EEEccCCc--eEEecccCcccccCCCCCcceeeecccccccCCC------CC-CccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILLNEKVQ--AKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LT-EKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~-~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+++.++. +||+|||+++... .........|++.|+||| +. .++|+||||+++|+|++|..||.....
T Consensus 147 ill~~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 147 TLLDGSPAPRLKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp EEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred EEEcCCCCceEEEeecCcccccc---ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 99987665 9999999987432 112233457899999999 23 348999999999999999999965322
Q ss_pred CC---------------c--CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 GE---------------F--DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ~~---------------~--~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.. . ....+..+.+++.+||+.+|++|||++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 224 PRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 11 1 1123567889999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=221.20 Aligned_cols=176 Identities=18% Similarity=0.190 Sum_probs=135.8
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-c---c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-E---E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
.+.+++||||++++++ ....++++||+++++|.+++.. . . |++.||.|||+ .+++|+||||
T Consensus 82 ~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp 158 (319)
T 2y4i_B 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKS 158 (319)
T ss_dssp GGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCS
T ss_pred HHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCh
Confidence 4667899999999999 7788999999999999999932 2 1 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCC---CCcceeeecccccccCCC---------------CCCccchHHHHHHHHHHH
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEG---GTHMSTTIAGTAGFLNTE---------------LTEKSDVDSFEIVILEII 130 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~~~~~~~pe---------------~~~~~di~s~G~~l~~~~ 130 (188)
+||+++ ++.++|+|||++....... .........|+..|++|| ++.++|+||||+++|+++
T Consensus 159 ~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~ 237 (319)
T 2y4i_B 159 KNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237 (319)
T ss_dssp TTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHH
T ss_pred hhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHH
Confidence 999998 6799999999876532111 111222345788899988 256799999999999999
Q ss_pred hCCccccccCCC-------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcc
Q 039565 131 TGILTVDLSFKG-------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSR 184 (188)
Q Consensus 131 ~g~~p~~~~~~~-------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 184 (188)
+|..||...... ......+..+.+++..||..+|++|||++++++.|+.+....
T Consensus 238 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 238 AREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred hCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 999998643211 011123457889999999999999999999999999887664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=226.58 Aligned_cols=161 Identities=19% Similarity=0.271 Sum_probs=134.6
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+||||++++++ .+..++||||+++|+|.+++.+ .. |++.||.|||+ .+|+||||||+||+++
T Consensus 79 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~ 155 (353)
T 2i0e_A 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLD 155 (353)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEEC
T ss_pred CCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEc
Confidence 79999999998 7889999999999999999822 22 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-------
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------- 141 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------- 141 (188)
.++.+||+|||+++.... .........|++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 156 ~~g~vkL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i 233 (353)
T 2i0e_A 156 SEGHIKIADFGMCKENIW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233 (353)
T ss_dssp TTSCEEECCCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCcEEEEeCCccccccc--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 999999999999875321 122344567999999999 68899999999999999999999964321
Q ss_pred ----CCcCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 039565 142 ----GEFDIISVEKAVEIAMASVSSKVNRRPL-----MNQVVM 175 (188)
Q Consensus 142 ----~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~i~~ 175 (188)
..++...+..+.+++..||+.+|.+||+ +++|++
T Consensus 234 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 234 MEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1233445678899999999999999995 567664
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=221.03 Aligned_cols=164 Identities=24% Similarity=0.280 Sum_probs=136.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....+++|||+++++|.+++ .... |++.||.|||+ .+++|+||||+|
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~N 145 (321)
T 2a2a_A 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPEN 145 (321)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHH
Confidence 567899999999999 77889999999999999999 3322 99999999999 999999999999
Q ss_pred EEEccCC----ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 71 ILLNEKV----QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 71 ill~~~~----~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+++.++ .++|+|||++...... .......|++.|+||| ++.++|+||||+++|+|++|..||....
T Consensus 146 Il~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 146 IMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp EEESCTTSSSCCEEECCCTTCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred EEEecCCCCcCCEEEccCccceecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence 9999887 7999999998754321 1223456888999998 5789999999999999999999985432
Q ss_pred CC-----------CcC----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 KG-----------EFD----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~~-----------~~~----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.. ..+ ...+..+.+++..||+.+|++|||++++++
T Consensus 223 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 223 KQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 111 123457899999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=221.45 Aligned_cols=174 Identities=16% Similarity=0.144 Sum_probs=135.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..++++||+++++|.+++.. .. |++.||.|||+ .+++|+||+|+|
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~N 164 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPEN 164 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHH
Confidence 567899999999999 7889999999999999999822 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++|+|||++..... ..........++..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (309)
T 2h34_A 165 ILVSADDFAYLVDFGIASATTD-EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243 (309)
T ss_dssp EEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH
T ss_pred EEEcCCCCEEEecCccCccccc-cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH
Confidence 9999999999999999875431 1112223456888999999 57899999999999999999999854211
Q ss_pred -----------CCcCHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHhhccCc
Q 039565 142 -----------GEFDIISVEKAVEIAMASVSSKVNRRP-LMNQVVMVREQGSGS 183 (188)
Q Consensus 142 -----------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-s~~~i~~~l~~~~~~ 183 (188)
...+...+..+.+++..||+.+|++|| +++++++.|+.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 244 GAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp HHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred HHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 112233456788999999999999999 999999999877554
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=220.22 Aligned_cols=165 Identities=19% Similarity=0.219 Sum_probs=130.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+++++|..++. ... |++.||.|||+ .+++|+|+||+|
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~N 132 (311)
T 4agu_A 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPEN 132 (311)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhh
Confidence 567899999999999 778899999999999998872 222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKGE 143 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~ 143 (188)
|+++.++.++|+|||.+..... .........++..|++|| ++.++|+||||+++|++++|..||......+
T Consensus 133 il~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 210 (311)
T 4agu_A 133 ILITKHSVIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210 (311)
T ss_dssp EEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEeeCCCchhccC--cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999875431 112233456788899998 5789999999999999999999885432110
Q ss_pred c------------------------------------------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 F------------------------------------------DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 ~------------------------------------------~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ....+..+.+++..||+.+|.+|||++++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 211 QLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0123445889999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=225.24 Aligned_cols=164 Identities=20% Similarity=0.306 Sum_probs=119.7
Q ss_pred cccc-CCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 7 NKLT-GPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 7 ~~l~-Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
.++. ||||++++++ ....++||||+++|+|.+++ .... |++.||.|||+ .+++||||||+|
T Consensus 60 ~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~N 136 (325)
T 3kn6_A 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPEN 136 (325)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGG
T ss_pred HHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHH
Confidence 4455 9999999999 77889999999999999999 3222 99999999999 999999999999
Q ss_pred EEEccCC---ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILLNEKV---QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill~~~~---~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+++.++ .+||+|||++..... .........|+..|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 137 Ill~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 137 LLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp EEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred EEEecCCCcccEEEeccccceecCC--CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 9998765 799999999875431 222234456789999999 57789999999999999999999964321
Q ss_pred C------------------CcC----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 G------------------EFD----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ~------------------~~~----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ..+ ...+..+.+++..||+.||.+|||++++++
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 215 SLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ---CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 1 011 124568899999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=218.96 Aligned_cols=164 Identities=16% Similarity=0.163 Sum_probs=130.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C-Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G-KEE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~-~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++||||+++ ++.+.+ . ... |++.||.|||+ .+++|||+||+
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~ 130 (292)
T 3o0g_A 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQ 130 (292)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGG
T ss_pred HhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHH
Confidence 567899999999999 7889999999985 555555 2 222 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
||+++.++.+||+|||++..... .........++..|+||| ++.++|+||||+++|+|++|..|+-....
T Consensus 131 Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~ 208 (292)
T 3o0g_A 131 NLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_dssp GEEECTTSCEEECCCTTCEECCS--CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred HEEEcCCCCEEEeecccceecCC--ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH
Confidence 99999999999999999975431 122233456788899998 58899999999999999988876421110
Q ss_pred ----------------------------------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ----------------------------------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ----------------------------------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+..+.+++..||+.||++|||++++++
T Consensus 209 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0011124567789999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=227.46 Aligned_cols=167 Identities=25% Similarity=0.259 Sum_probs=130.6
Q ss_pred ccccc-CCCeeeeccc-----CCccEEEEecCCCCChhhhc--CCcc---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLT-GPLLVELIGK-----QKNNALELGFRGNPELVDQQ--GKEE---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~-Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~--~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.++. ||||++++++ ....++||||++ ++|..++ .... |++.||.|||+ .+|+||||||
T Consensus 62 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp 137 (388)
T 3oz6_A 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKP 137 (388)
T ss_dssp HHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred HHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCH
Confidence 34565 9999999998 336799999998 5899888 2222 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCC-------------------CCcceeeecccccccCCC-------CCCccchHHH
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEG-------------------GTHMSTTIAGTAGFLNTE-------LTEKSDVDSF 122 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~pe-------~~~~~di~s~ 122 (188)
+||+++.++.+||+|||+++...... .........||+.|+||| ++.++||||+
T Consensus 138 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 217 (388)
T 3oz6_A 138 SNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217 (388)
T ss_dssp GGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred HHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHH
Confidence 99999999999999999997542110 111223457899999998 5788999999
Q ss_pred HHHHHHHHhCCccccccCCCC-----------------------c-----------------------C-----------
Q 039565 123 EIVILEIITGILTVDLSFKGE-----------------------F-----------------------D----------- 145 (188)
Q Consensus 123 G~~l~~~~~g~~p~~~~~~~~-----------------------~-----------------------~----------- 145 (188)
||++|+|++|..||......+ + +
T Consensus 218 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (388)
T 3oz6_A 218 GCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297 (388)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccc
Confidence 999999999999985422100 0 0
Q ss_pred -HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 146 -IISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 146 -~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
...+..+.+++..||+.||++|||++++++.
T Consensus 298 ~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 298 KADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp TCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 0124568899999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=224.27 Aligned_cols=161 Identities=20% Similarity=0.267 Sum_probs=132.6
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+||||++++++ ....++||||+++|+|.+++ .... |++.||.|||+ .+++||||||+||++.
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~ 150 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYV 150 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEES
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEe
Confidence 79999999999 77889999999999999998 3322 99999999999 9999999999999985
Q ss_pred cC----CceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC-
Q 039565 75 EK----VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE- 143 (188)
Q Consensus 75 ~~----~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~- 143 (188)
.. +.+||+|||++....... .......|++.|+||| ++.++|+||||+++|+|++|..||.......
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 228 (342)
T 2qr7_A 151 DESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP 228 (342)
T ss_dssp SSSCSGGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH
T ss_pred cCCCCcCeEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH
Confidence 43 359999999988643221 2234567899999999 5789999999999999999999996432111
Q ss_pred -----------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 -----------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 -----------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.....+..+.+++..||+.||++|||+.++++
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 229 EEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11234667899999999999999999999886
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=217.07 Aligned_cols=164 Identities=24% Similarity=0.341 Sum_probs=130.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC------cc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK------EE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~------~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ ....++||||+++++|.+++ .. .. |++.||.|||+ .+++|+||
T Consensus 74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~di 150 (285)
T 3is5_A 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDL 150 (285)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCC
T ss_pred HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCC
Confidence 567899999999999 77889999999999999988 11 11 99999999999 99999999
Q ss_pred CCCcEEEc---cCCceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccccc
Q 039565 67 KSTNILLN---EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 67 ~~~nill~---~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+||+++ .++.++|+|||++..... ........|+..|++|| ++.++|+||||+++|+|++|..||..
T Consensus 151 kp~NIl~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 151 KPENILFQDTSPHSPIKIIDFGLAELFKS---DEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp SGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEEecCCCCCCEEEEeeecceecCC---cccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 99999994 457899999999875431 12233456888999998 67899999999999999999999864
Q ss_pred cCCCC-----------cC---HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKGE-----------FD---IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~~-----------~~---~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+ .. ...+..+.+++..||+.+|++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 228 TSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp SSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 32111 10 113567889999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=220.52 Aligned_cols=173 Identities=18% Similarity=0.237 Sum_probs=132.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-----c--c---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-----E--E---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-----~--~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ .+..+++|||+++++|.+++.. . . |++.||.|||+ .+++|+||
T Consensus 86 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl 162 (310)
T 2wqm_A 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDI 162 (310)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCC
T ss_pred HHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCC
Confidence 567899999999998 7889999999999999998821 1 1 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
+|+||+++.++.++|+|||++..... .........++..|++|| ++.++|+||||+++|++++|..||....
T Consensus 163 ~p~NIl~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 163 KPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp CGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cHHHEEEcCCCCEEEEeccceeeecC--CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999875431 111223456888899998 5788999999999999999999885422
Q ss_pred CC---------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 141 KG---------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 141 ~~---------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
.. ......+..+.+++..||+.||.+|||++++++.|+++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 241 MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11 11123456799999999999999999999999999887643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=229.10 Aligned_cols=163 Identities=18% Similarity=0.208 Sum_probs=127.7
Q ss_pred cccccCCCeeeeccc---C------CccEEEEecCCCCChhhhc-CCcc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---Q------KNNALELGFRGNPELVDQQ-GKEE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~------~~~~lv~e~~~~~~L~~~~-~~~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ . ...++||||+++ +|...+ .... |++.||.|||+ .+|+||||
T Consensus 115 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDl 190 (464)
T 3ttj_A 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDL 190 (464)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCC
T ss_pred HHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCC
Confidence 567899999999998 2 345999999986 566665 3333 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+||+++.++.+||+|||+++... .........|++.|+||| ++.++||||+||++|+|++|+.||....
T Consensus 191 kp~NIll~~~~~~kl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 191 KPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp CGGGEEECTTSCEEECCCCCC--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ChHhEEEeCCCCEEEEEEEeeeecC---CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997543 222334567899999998 6889999999999999999999986432
Q ss_pred CC------------------------------------C-----------------cCHHHHHHHHHHHHHccCcCCCCC
Q 039565 141 KG------------------------------------E-----------------FDIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 141 ~~------------------------------------~-----------------~~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
.. . ........+.+++..||+.||++|
T Consensus 268 ~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 347 (464)
T 3ttj_A 268 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347 (464)
T ss_dssp HHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhC
Confidence 00 0 001125678999999999999999
Q ss_pred CCHHHHHH
Q 039565 168 PLMNQVVM 175 (188)
Q Consensus 168 ps~~~i~~ 175 (188)
||++++++
T Consensus 348 ~ta~e~L~ 355 (464)
T 3ttj_A 348 ISVDDALQ 355 (464)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=220.01 Aligned_cols=159 Identities=20% Similarity=0.221 Sum_probs=128.1
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhc-C-C--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G-K--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~-~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
+||||++++++ ....++||||+. ++|.+++ . . .. |++.||+|||+ .+++||||||+||++
T Consensus 115 ~h~~iv~l~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll 190 (311)
T 3p1a_A 115 QHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFL 190 (311)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEE
T ss_pred CCCcEEEEEEEEEeCCEEEEEEeccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEE
Confidence 89999999999 788999999994 6898887 2 1 22 99999999999 999999999999999
Q ss_pred ccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCcccccc------CCC
Q 039565 74 NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDLS------FKG 142 (188)
Q Consensus 74 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~~------~~~ 142 (188)
+.++.+||+|||++.... .........|++.|+||| ++.++||||||+++|++++|..++... ...
T Consensus 191 ~~~~~~kl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 267 (311)
T 3p1a_A 191 GPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG 267 (311)
T ss_dssp CGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTT
T ss_pred CCCCCEEEccceeeeecc---cCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhcc
Confidence 999999999999987543 122233456889999999 688999999999999999996544211 111
Q ss_pred ----CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 ----EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ----~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+.+...+..+.+++..||+.+|++|||++++++
T Consensus 268 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 268 YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 112234578999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=217.14 Aligned_cols=172 Identities=22% Similarity=0.263 Sum_probs=139.4
Q ss_pred cccccCCCeeeeccc-------------------CCccEEEEecCCCCChhhhc-CC----cc---------cHHHHHHH
Q 039565 6 RNKLTGPLLVELIGK-------------------QKNNALELGFRGNPELVDQQ-GK----EE---------VCCPGLEY 52 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-------------------~~~~~lv~e~~~~~~L~~~~-~~----~~---------~i~~~l~~ 52 (188)
+.+++||||++++++ ....+++|||+++++|.+++ .. .. |++.||.|
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 137 (284)
T 2a19_B 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDY 137 (284)
T ss_dssp HHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 567899999999886 12368999999999999999 22 11 99999999
Q ss_pred HhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHH
Q 039565 53 LHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVI 126 (188)
Q Consensus 53 Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l 126 (188)
||+ .+++|+||||+||+++.++.++|+|||++...... .......+++.|++|| ++.++|+||||+++
T Consensus 138 lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (284)
T 2a19_B 138 IHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 211 (284)
T ss_dssp HHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHH
T ss_pred HHh---CCeeeccCCHHHEEEcCCCCEEECcchhheecccc---ccccccCCcccccChhhhccCCCcchhhhHHHHHHH
Confidence 999 99999999999999999999999999998754321 1223456888999998 68899999999999
Q ss_pred HHHHhCCcccccc-------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 127 LEIITGILTVDLS-------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 127 ~~~~~g~~p~~~~-------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
|+|++|..|+... .....+...+..+.+++..||+.+|.+|||++++++.|+....+
T Consensus 212 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 212 AELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHSCCSSHHHHHHHHHHHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHHhcCCcchhHHHHHHHhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 9999998776321 11122233456788999999999999999999999999887654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=223.86 Aligned_cols=160 Identities=25% Similarity=0.259 Sum_probs=132.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc--CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ--GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~--~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++||||+. |+|.+++ .+.. |++.||.|||+ .+++||||||+
T Consensus 108 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~ 183 (348)
T 1u5q_A 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAG 183 (348)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGG
T ss_pred HHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHH
Confidence 567899999999998 788999999998 6887777 2211 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+++.++.+||+|||++..... .....|++.|+||| ++.++|+||||+++|+|++|..||....
T Consensus 184 NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 184 NILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp GEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred HEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999875431 23456888999998 4678999999999999999999885321
Q ss_pred -------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 -------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 -------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
........+..+.+++..||+.+|++|||++++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 258 AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11112334567889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=231.35 Aligned_cols=164 Identities=25% Similarity=0.302 Sum_probs=135.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+++|+|.+++ .. .. |++.||.|||+ .+++||||||+|
T Consensus 90 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~N 166 (494)
T 3lij_A 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPEN 166 (494)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhh
Confidence 567899999999999 77889999999999999888 22 22 99999999999 999999999999
Q ss_pred EEEccC---CceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 71 ILLNEK---VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 71 ill~~~---~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
|+++.. +.+||+|||++..... ........|++.|+||| ++.++||||+|+++|+|++|..||......
T Consensus 167 il~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 243 (494)
T 3lij_A 167 LLLESKEKDALIKIVDFGLSAVFEN---QKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ 243 (494)
T ss_dssp EEESCSSTTCCEEECCCTTCEECBT---TBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEeCCCCCCcEEEEECCCCeECCC---CccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999764 4599999999876431 12234467899999998 688999999999999999999998643211
Q ss_pred ---------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 ---------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ---------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
......+..+.+++..||+.+|.+|||++++++
T Consensus 244 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 244 EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 111234567899999999999999999999886
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=234.73 Aligned_cols=164 Identities=23% Similarity=0.276 Sum_probs=138.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
|.+++||||+++++. ....++||||+++|+|..++ ... . |++.||.|||+ .+|+||||||
T Consensus 238 L~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKP 314 (576)
T 2acx_A 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKP 314 (576)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred HHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCch
Confidence 567899999999988 78899999999999999998 221 1 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
+||+++.++.+||+|||+++.... ........|++.|+||| ++.++|+|||||++|+|++|..||......
T Consensus 315 eNILld~~g~vKL~DFGla~~~~~---~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~ 391 (576)
T 2acx_A 315 ENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391 (576)
T ss_dssp GGEEECTTSCEEECCCTTCEECCT---TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC
T ss_pred heEEEeCCCCeEEEecccceeccc---CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc
Confidence 999999999999999999976431 12234468999999999 688999999999999999999999764321
Q ss_pred ---------------CcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 143 ---------------EFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 143 ---------------~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
.++...+..+.+++..||+.||.+|| +++++++
T Consensus 392 ~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 392 IKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred hhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 23334456889999999999999999 7888875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=213.27 Aligned_cols=173 Identities=16% Similarity=0.179 Sum_probs=137.8
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhcC--Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQG--KEE-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~~--~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++|++++..+.. ....+++|||+ +++|.+++. ... |++.||.|||+ .+++|+||||
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp 133 (296)
T 3uzp_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKP 133 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCG
T ss_pred HHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCH
Confidence 456788887666555 77789999999 789999983 222 99999999999 9999999999
Q ss_pred CcEEEc---cCCceEEecccCcccccCCCCC-----cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCc
Q 039565 69 TNILLN---EKVQAKLADFGQSRISPVEGGT-----HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGIL 134 (188)
Q Consensus 69 ~nill~---~~~~~kl~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~ 134 (188)
+||+++ .++.+||+|||++......... .......|+..|+||| ++.++|+||||+++|++++|..
T Consensus 134 ~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 213 (296)
T 3uzp_A 134 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 213 (296)
T ss_dssp GGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred HHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 999994 7889999999998765422211 1123467889999998 5788999999999999999999
Q ss_pred cccccCCCC--------------cC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 135 TVDLSFKGE--------------FD-----IISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 135 p~~~~~~~~--------------~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
||....... .+ ...+..+.+++..||+.+|.+|||++++++.|+++..
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 214 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp TTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 997532211 01 1234678999999999999999999999999987653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=228.03 Aligned_cols=166 Identities=20% Similarity=0.185 Sum_probs=126.6
Q ss_pred cccccCCCeeeeccc--------CCccEEEEecCCCCChhhhc-CCc--c---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQ-GKE--E---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~-~~~--~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
|.+++||||++++++ ....++||||+. ++|..++ ... . |++.||.|||+ .+|+|||
T Consensus 106 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrD 181 (458)
T 3rp9_A 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRD 181 (458)
T ss_dssp HHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCC
T ss_pred HHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCC
Confidence 567899999999988 256899999986 6899988 322 1 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCC-------------------------cceeeecccccccCCC-------C
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGT-------------------------HMSTTIAGTAGFLNTE-------L 113 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~pe-------~ 113 (188)
|||+|||++.++.+||+|||+++........ .......||+.|+||| +
T Consensus 182 lKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 261 (458)
T 3rp9_A 182 LKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY 261 (458)
T ss_dssp CCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCC
T ss_pred CChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCC
Confidence 9999999999999999999999864321110 1223457899999999 5
Q ss_pred CCccchHHHHHHHHHHHh-----------CCccccccCCC----------C-----------------------------
Q 039565 114 TEKSDVDSFEIVILEIIT-----------GILTVDLSFKG----------E----------------------------- 143 (188)
Q Consensus 114 ~~~~di~s~G~~l~~~~~-----------g~~p~~~~~~~----------~----------------------------- 143 (188)
+.++|||||||++|+|++ |..+|.....- .
T Consensus 262 ~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~ 341 (458)
T 3rp9_A 262 TEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341 (458)
T ss_dssp CTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHT
T ss_pred CcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhh
Confidence 788999999999999998 44444221100 0
Q ss_pred -----------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 -----------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 -----------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.....+..+.+++..||+.||++|||++++++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 342 LEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp SSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00112557889999999999999999999998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=219.82 Aligned_cols=175 Identities=21% Similarity=0.241 Sum_probs=140.0
Q ss_pred cccccCCCeeeeccc-------CCccEEEEecCCCCChhhhcCC----cc------------cHHHHHHHHhcCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQGK----EE------------VCCPGLEYLHQGLKHPII 62 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~~~----~~------------~i~~~l~~Lh~~~~~~i~ 62 (188)
+.+++||||++++++ ....++++||+++++|.+++.. .. |++.||.|||+ .+++
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~iv 156 (317)
T 2buj_A 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYA 156 (317)
T ss_dssp HHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred HhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 467899999999998 2477899999999999998822 11 99999999999 9999
Q ss_pred EeCCCCCcEEEccCCceEEecccCcccccCCCCCc-------ceeeecccccccCCC---------CCCccchHHHHHHH
Q 039565 63 QRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH-------MSTTIAGTAGFLNTE---------LTEKSDVDSFEIVI 126 (188)
Q Consensus 63 h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~-------~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l 126 (188)
|+||||+||+++.++.++|+|||.+.......... ......|+..|++|| ++.++|+||||+++
T Consensus 157 H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 236 (317)
T 2buj_A 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236 (317)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999876432110000 011245688899999 36789999999999
Q ss_pred HHHHhCCccccccC--------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 127 LEIITGILTVDLSF--------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 127 ~~~~~g~~p~~~~~--------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
|++++|..||+... ........+..+.+++..||+.+|.+|||++++++.|+.+.+.
T Consensus 237 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 237 YAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred HHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 99999999985311 1111223456899999999999999999999999999988765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=223.09 Aligned_cols=167 Identities=22% Similarity=0.255 Sum_probs=135.9
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhcC---Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQG---KEE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~---~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.++ +||||++++++ ....++||||+++++|.+++. ... |++.||.|||+ .+++||||||+
T Consensus 112 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~ 188 (355)
T 1vzo_A 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLE 188 (355)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGG
T ss_pred HHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHH
Confidence 3445 69999999988 778899999999999999982 222 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
||+++.++.+||+|||+++.... ..........|++.|++|| ++.++|+||||+++|+|++|..||.....
T Consensus 189 NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 267 (355)
T 1vzo_A 189 NILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267 (355)
T ss_dssp GEEECTTSCEEESCSSEEEECCG-GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred HEEECCCCcEEEeeCCCCeeccc-CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc
Confidence 99999999999999999875421 1122233467899999998 35789999999999999999999964322
Q ss_pred C---------------CcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 039565 142 G---------------EFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVMV 176 (188)
Q Consensus 142 ~---------------~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~~ 176 (188)
. ..+...+..+.+++..||+.||.+|| +++++++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 268 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred cchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1 22333456788999999999999999 99999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=230.15 Aligned_cols=166 Identities=21% Similarity=0.247 Sum_probs=136.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-cc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-EE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+..++||||++++++ ....++||||+++|+|.+++.+ .. |++.||.|||+ .+|+||||||+
T Consensus 128 l~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~ 204 (437)
T 4aw2_A 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPD 204 (437)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGG
T ss_pred HHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHH
Confidence 456799999999998 7889999999999999999932 22 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+++.++.+||+|||+++... ...........||+.|+||| ++.++|+|||||++|+|++|..||..
T Consensus 205 NILl~~~g~vkL~DFGla~~~~-~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 205 NILMDMNGHIRLADFGSCLKLM-EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp GEEECTTSCEEECCCTTCEECC-TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred HeeEcCCCCEEEcchhhhhhcc-cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999997543 22222333467999999998 36789999999999999999999964
Q ss_pred cCCC-------------CcC---HHHHHHHHHHHHHccCcCCCC--CCCHHHHHH
Q 039565 139 SFKG-------------EFD---IISVEKAVEIAMASVSSKVNR--RPLMNQVVM 175 (188)
Q Consensus 139 ~~~~-------------~~~---~~~~~~~~~l~~~cl~~~p~~--Rps~~~i~~ 175 (188)
.... .++ ...+..+.+++..|+..+|++ ||+++++++
T Consensus 284 ~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 284 ESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp SSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 3211 111 124678899999999888888 999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=213.05 Aligned_cols=164 Identities=18% Similarity=0.205 Sum_probs=136.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C--Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G--KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~--~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+++++|.+++ . ... |++.||.|||+ .+++|+|+||+|
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~N 136 (277)
T 3f3z_A 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPEN 136 (277)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHH
Confidence 567899999999999 77889999999999999988 2 122 99999999999 999999999999
Q ss_pred EEE---ccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 71 ILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 71 ill---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
|++ +.++.++++|||.+..... ........|++.|++|| ++.++|+||||+++|++++|..||......
T Consensus 137 il~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 213 (277)
T 3f3z_A 137 FLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDS 213 (277)
T ss_dssp EEESSSSTTCCEEECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEecCCCCCcEEEEecccceeccC---ccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHH
Confidence 999 7788999999999875431 12233456888999998 688999999999999999999998653211
Q ss_pred -----------CcCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 -----------EFDI----ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 -----------~~~~----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+. ..+..+.+++..||+.+|++|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 214 EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122 23568899999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=220.64 Aligned_cols=170 Identities=19% Similarity=0.203 Sum_probs=131.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++||||++ ++|.+++ ... . |++.||.|||+ .+++||||||+
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~ 129 (324)
T 3mtl_A 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQ 129 (324)
T ss_dssp HSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGG
T ss_pred HHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHH
Confidence 567899999999999 788899999998 5888888 221 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.+||+|||++..... .........++..|+||| ++.++|+||||+++|+|++|..||......
T Consensus 130 NIl~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 207 (324)
T 3mtl_A 130 NLLINERGELKLADFGLARAKSI--PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE 207 (324)
T ss_dssp GEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HEEECCCCCEEEccCcccccccC--CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999875321 112233456788899998 477899999999999999999998543210
Q ss_pred C----------------c-------------------------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhh
Q 039565 143 E----------------F-------------------------DIISVEKAVEIAMASVSSKVNRRPLMNQVVM--VREQ 179 (188)
Q Consensus 143 ~----------------~-------------------------~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~--~l~~ 179 (188)
+ + ....+..+.+++..||+.||.+|||++++++ .+.+
T Consensus 208 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 208 EQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 0 0 0112456789999999999999999999987 4444
Q ss_pred cc
Q 039565 180 GS 181 (188)
Q Consensus 180 ~~ 181 (188)
..
T Consensus 288 ~~ 289 (324)
T 3mtl_A 288 LG 289 (324)
T ss_dssp GC
T ss_pred cc
Confidence 43
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=221.92 Aligned_cols=173 Identities=17% Similarity=0.139 Sum_probs=139.2
Q ss_pred ccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC-----cc------------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 7 NKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK-----EE------------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 7 ~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~-----~~------------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
....|+||+++++. .+..++||||+++|+|.+++.. .. |++.||+|||+ .+|+||||
T Consensus 122 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDi 198 (365)
T 3e7e_A 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDI 198 (365)
T ss_dssp CGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCC
T ss_pred hhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCC
Confidence 34559999999998 7889999999999999999921 11 99999999999 99999999
Q ss_pred CCCcEEEcc-----------CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHH
Q 039565 67 KSTNILLNE-----------KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEI 129 (188)
Q Consensus 67 ~~~nill~~-----------~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~ 129 (188)
||+||+++. ++.+||+|||+++...............||..|+||| ++.++|+||||+++|+|
T Consensus 199 Kp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 278 (365)
T 3e7e_A 199 KPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCM 278 (365)
T ss_dssp SGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHH
T ss_pred CHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHH
Confidence 999999998 8999999999997543233333445567999999999 68899999999999999
Q ss_pred HhCCccccccCCCC------c-CHHHHHHHHHHHHHccCcCCCCC-CCHHHHHHHHhhccC
Q 039565 130 ITGILTVDLSFKGE------F-DIISVEKAVEIAMASVSSKVNRR-PLMNQVVMVREQGSG 182 (188)
Q Consensus 130 ~~g~~p~~~~~~~~------~-~~~~~~~~~~l~~~cl~~~p~~R-ps~~~i~~~l~~~~~ 182 (188)
++|..||....... + .......+.+++..|++.+|.+| |+++++.+.|+...+
T Consensus 279 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 279 LFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp HHSSCCCEEEETTEEEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred HhCCCccccCCCCceeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 99998885432211 0 11235677889999999999998 568888877766543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=216.21 Aligned_cols=165 Identities=22% Similarity=0.276 Sum_probs=135.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc---c-----------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE---E-----------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~---~-----------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||++++++ ....++++||+++++|.+++ ... . |++.||.|||+ .+++|+||+
T Consensus 73 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~ 149 (295)
T 2clq_A 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIK 149 (295)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred HHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCC
Confidence 467899999999998 77889999999999999998 221 1 89999999999 999999999
Q ss_pred CCcEEEcc-CCceEEecccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 68 STNILLNE-KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 68 ~~nill~~-~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|+||+++. ++.++|+|||.+..... .........|+..|++|| ++.++|+||||+++|+|++|..||..
T Consensus 150 p~Nil~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 150 GDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp GGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred hhhEEEECCCCCEEEeecccccccCC--CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 99999987 88999999999875431 112233456888999998 46789999999999999999999853
Q ss_pred cC--------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SF--------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~--------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.. ....+...+..+.+++..||+.+|++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 228 LGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp GSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 21 12233445678899999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=222.33 Aligned_cols=172 Identities=22% Similarity=0.296 Sum_probs=128.5
Q ss_pred CcccccCCCeeeeccc---CC----ccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 5 NRNKLTGPLLVELIGK---QK----NNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~----~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
.+.+++||||++++++ .. ..++||||+++++|.+++.. .. |++.||.|||+ .+++|+|
T Consensus 65 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~d 141 (311)
T 3ork_A 65 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRD 141 (311)
T ss_dssp TCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCC
T ss_pred HHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCC
Confidence 4678899999999988 22 23999999999999999822 22 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCC-cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|||+||+++.++.+||+|||++......... .......|++.|++|| ++.++|+||||+++|+|++|..||..
T Consensus 142 lkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp CCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998754322111 1223456899999999 67889999999999999999999964
Q ss_pred cCCCC----------cC-----HHHHHHHHHHHHHccCcCCCCCCCHHH-HHHHHhh
Q 039565 139 SFKGE----------FD-----IISVEKAVEIAMASVSSKVNRRPLMNQ-VVMVREQ 179 (188)
Q Consensus 139 ~~~~~----------~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~-i~~~l~~ 179 (188)
....+ .+ ...+..+.+++..||+.||++||+..+ +.+.+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 222 DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp SSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 32211 11 113567899999999999999997554 4445543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=216.19 Aligned_cols=162 Identities=20% Similarity=0.217 Sum_probs=131.3
Q ss_pred ccccCCCeeeeccc---CC-----ccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEe
Q 039565 7 NKLTGPLLVELIGK---QK-----NNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQR 64 (188)
Q Consensus 7 ~~l~Hpniv~~~~~---~~-----~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~ 64 (188)
..++||||++++++ .. ..++++||+. ++|.+++ ... . |++.||+|||+ .+++||
T Consensus 69 ~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~ 144 (308)
T 3g33_A 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHR 144 (308)
T ss_dssp HHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred hhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccC
Confidence 34569999999998 22 4789999998 5999998 221 1 99999999999 999999
Q ss_pred CCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 65 DMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 65 dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||||+||+++.++.+||+|||+++... .........|++.|+||| ++.++|+||||+++|+|++|..||..
T Consensus 145 Dlkp~Nil~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 145 DLKPENILVTSGGTVKLADFGLARIYS---YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp CCCTTTEEECTTSCEEECSCSCTTTST---TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred CCCHHHEEEcCCCCEEEeeCccccccC---CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987543 122234467889999998 68899999999999999999998853
Q ss_pred cCCCC--------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKGE--------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~~--------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+ .....+..+.+++..||+.||++|||+.++++
T Consensus 222 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 222 NSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 22100 00123467789999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=213.28 Aligned_cols=164 Identities=21% Similarity=0.269 Sum_probs=134.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....+++|||+++++|.+++ .. .. |++.||.|||+ .+++|+|+||+|
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~N 135 (284)
T 3kk8_A 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPEN 135 (284)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGG
T ss_pred HHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHH
Confidence 467899999999998 77789999999999998888 22 22 99999999999 999999999999
Q ss_pred EEEccCCc---eEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILLNEKVQ---AKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill~~~~~---~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+++.++. ++|+|||.+.... .........|++.|++|| ++.++|+||||+++|++++|..||.....
T Consensus 136 il~~~~~~~~~~kl~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 212 (284)
T 3kk8_A 136 LLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 212 (284)
T ss_dssp EEESSSSTTCCEEECCCTTCEECC---SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEecCCCCCcEEEeeceeeEEcc---cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch
Confidence 99986654 9999999987543 122233457888999998 58899999999999999999999843221
Q ss_pred ---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+..+.+++..||+.+|++|||++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 213 HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111234567899999999999999999999988
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=225.83 Aligned_cols=165 Identities=20% Similarity=0.271 Sum_probs=129.2
Q ss_pred ccccc--CCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLT--GPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~--Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
|.+++ ||||++++++ .+..++||| +.+++|.+++ .... |++.||.|||+ .+|+||||||
T Consensus 108 l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp 183 (390)
T 2zmd_A 108 LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKP 183 (390)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCG
T ss_pred HHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCH
Confidence 34555 5999999988 778899999 5678999998 2222 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------------CCCccchHHHHHHHHHHHh
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------------LTEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------------~~~~~di~s~G~~l~~~~~ 131 (188)
+||+++ ++.+||+|||+++...............|++.|+||| ++.++|||||||++|+|++
T Consensus 184 ~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~ 262 (390)
T 2zmd_A 184 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262 (390)
T ss_dssp GGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH
T ss_pred HHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH
Confidence 999995 5789999999998653222222234567999999998 3457999999999999999
Q ss_pred CCccccccCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 132 GILTVDLSFK--------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 132 g~~p~~~~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|..||..... ...+...+..+.+++..||+.+|.+|||++++++
T Consensus 263 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 263 GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp SSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 9999964321 1222233567899999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=216.11 Aligned_cols=163 Identities=25% Similarity=0.329 Sum_probs=136.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..+++|||+++++|.+++.. .. |++.||.|||+ .+++|+||+|+|
T Consensus 68 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~N 144 (284)
T 2vgo_A 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPEN 144 (284)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGG
T ss_pred HhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHH
Confidence 467889999999999 7788999999999999999822 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++|+|||++..... .......|+..|++|| ++.++|+||||+++|++++|..||+....
T Consensus 145 il~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 220 (284)
T 2vgo_A 145 LLMGYKGELKIADFGWSVHAPS----LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET 220 (284)
T ss_dssp EEECTTCCEEECCCTTCEECSS----SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EEEcCCCCEEEecccccccCcc----cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH
Confidence 9999999999999998864321 1123456888899998 57899999999999999999999864321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+...+..+.+++..||+.+|.+|||++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 221 HRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1233344578899999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=224.18 Aligned_cols=173 Identities=18% Similarity=0.202 Sum_probs=137.6
Q ss_pred cccccCCCeeee---------------ccc----CCccEEEEecCCCCChhhhc-CC--cc-----------cHHHHHHH
Q 039565 6 RNKLTGPLLVEL---------------IGK----QKNNALELGFRGNPELVDQQ-GK--EE-----------VCCPGLEY 52 (188)
Q Consensus 6 l~~l~Hpniv~~---------------~~~----~~~~~lv~e~~~~~~L~~~~-~~--~~-----------~i~~~l~~ 52 (188)
+.+++||||+++ +++ ....++||||+ +++|.+++ .. .. |++.||.|
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~ 174 (352)
T 2jii_A 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEF 174 (352)
T ss_dssp HHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHH
Confidence 456788888873 333 46779999999 89999999 32 11 99999999
Q ss_pred HhcCCCCCcEEeCCCCCcEEEccCC--ceEEecccCcccccCCCC-----CcceeeecccccccCCC------CCCccch
Q 039565 53 LHQGLKHPIIQRDMKSTNILLNEKV--QAKLADFGQSRISPVEGG-----THMSTTIAGTAGFLNTE------LTEKSDV 119 (188)
Q Consensus 53 Lh~~~~~~i~h~dl~~~nill~~~~--~~kl~d~~~~~~~~~~~~-----~~~~~~~~~~~~~~~pe------~~~~~di 119 (188)
||+ .+++||||||+||+++.++ .++|+|||+++....... ........|++.|+||| ++.++|+
T Consensus 175 LH~---~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 251 (352)
T 2jii_A 175 LHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDL 251 (352)
T ss_dssp HHH---TTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred HHh---CCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhH
Confidence 999 9999999999999999988 899999999875432111 11123347888999998 5789999
Q ss_pred HHHHHHHHHHHhCCccccccCCCCcC----------------------HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 039565 120 DSFEIVILEIITGILTVDLSFKGEFD----------------------IISVEKAVEIAMASVSSKVNRRPLMNQVVMVR 177 (188)
Q Consensus 120 ~s~G~~l~~~~~g~~p~~~~~~~~~~----------------------~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l 177 (188)
||||+++|+|++|..||......... ...+..+.+++..||+.+|++|||++++++.|
T Consensus 252 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 252 QSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 99999999999999999764321100 01257899999999999999999999999999
Q ss_pred hhccC
Q 039565 178 EQGSG 182 (188)
Q Consensus 178 ~~~~~ 182 (188)
+++..
T Consensus 332 ~~~~~ 336 (352)
T 2jii_A 332 EALLQ 336 (352)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=222.33 Aligned_cols=166 Identities=20% Similarity=0.259 Sum_probs=128.8
Q ss_pred cccccC--CCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTG--PLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~H--pniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++| |||++++++ ....++||| +.+++|.+++ .... |++.||.|||+ .+|+||||||
T Consensus 61 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp 136 (343)
T 3dbq_A 61 LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKP 136 (343)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCG
T ss_pred HHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCc
Confidence 455666 999999999 778899999 5568999999 2222 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC-----------------CCccchHHHHHHHHHHHh
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-----------------TEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-----------------~~~~di~s~G~~l~~~~~ 131 (188)
+||+++ ++.+||+|||++................|++.|+|||. +.++||||||+++|+|++
T Consensus 137 ~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 215 (343)
T 3dbq_A 137 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215 (343)
T ss_dssp GGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH
T ss_pred ceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 999997 57899999999986542222223345678999999982 457999999999999999
Q ss_pred CCccccccC--------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 132 GILTVDLSF--------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 132 g~~p~~~~~--------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
|..||.... ....+...+..+.+++..||+.+|.+|||++++++.
T Consensus 216 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 216 GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp SSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 999986422 122333344678999999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=217.29 Aligned_cols=166 Identities=22% Similarity=0.291 Sum_probs=138.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+.+++||||++++++ ....++||||+++++|.+++.... |++.||.|||+ .+++|+||+|+||
T Consensus 74 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Ni 150 (303)
T 3a7i_A 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANV 150 (303)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheE
Confidence 467899999999998 788899999999999999994332 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC-----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF----- 140 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~----- 140 (188)
+++.++.++|+|||.+...... ........|+..|++|| ++.++|+||||+++|++++|..||....
T Consensus 151 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 228 (303)
T 3a7i_A 151 LLSEHGEVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL 228 (303)
T ss_dssp EECTTSCEEECCCTTCEECBTT--BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred EECCCCCEEEeecccceecCcc--ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH
Confidence 9999999999999998754321 11233456888899998 5789999999999999999999986421
Q ss_pred -------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 141 -------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 141 -------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
....+...+..+.+++..||+.+|.+|||++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 229 FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 112223345678999999999999999999999873
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=228.06 Aligned_cols=164 Identities=23% Similarity=0.257 Sum_probs=134.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc---CCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ---GKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~---~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++|+||+.+++|.+++ .... |++.||.|||+ .+|+||||||+|
T Consensus 75 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~N 151 (486)
T 3mwu_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPEN 151 (486)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred HHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHH
Confidence 567899999999999 77889999999999999888 2222 99999999999 999999999999
Q ss_pred EEEc---cCCceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 71 ILLN---EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 71 ill~---~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
|+++ .++.+||+|||++..... ........|++.|+||| ++.++||||+|+++|+|++|..||.....
T Consensus 152 il~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 228 (486)
T 3mwu_A 152 ILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (486)
T ss_dssp EEESSSSTTCCEEECSCSCTTTBCC---C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEecCCCCCCEEEEECCcCeECCC---CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9995 456799999999875431 12233457899999999 67899999999999999999999854321
Q ss_pred --------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 --------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 --------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+.....+..+.+++..||+.+|.+|||+.++++
T Consensus 229 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111234567899999999999999999999998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=217.18 Aligned_cols=164 Identities=23% Similarity=0.339 Sum_probs=134.1
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
+.+++||||++++++ .+..++||||+++++|.+++... . |++.||.|||+ .+++|+||||+||
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NI 145 (322)
T 2ycf_A 69 LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENV 145 (322)
T ss_dssp HHHCCCTTBCCEEEEEESSSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred HHhCCCCCCceEeeEEcCCceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHE
Confidence 567899999999999 66789999999999999988322 2 99999999999 9999999999999
Q ss_pred EEccCCc---eEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCcccccc
Q 039565 72 LLNEKVQ---AKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLS 139 (188)
Q Consensus 72 ll~~~~~---~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~ 139 (188)
+++.++. +||+|||++.... .........|+..|++|| ++.++|+||||+++|++++|..||...
T Consensus 146 l~~~~~~~~~~kl~Dfg~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 146 LLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp EESSSSSSCCEEECCCTTCEECC---CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred EEecCCCCCeEEEccCccceecc---cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9987654 9999999987542 112223456888999998 467899999999999999999999654
Q ss_pred CCCC------------cC----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 140 FKGE------------FD----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 140 ~~~~------------~~----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.... .. ...+..+.+++..||+.+|++|||++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 223 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 3221 11 123567899999999999999999999885
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=231.02 Aligned_cols=164 Identities=21% Similarity=0.246 Sum_probs=137.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++|+||+.+++|.+++ .+.. |++.||.|||+ .+++||||||+|
T Consensus 80 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~N 156 (484)
T 3nyv_A 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPEN 156 (484)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHH
Confidence 567899999999999 77889999999999999988 3322 99999999999 999999999999
Q ss_pred EEE---ccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 71 ILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 71 ill---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
|++ +.++.+||+|||++...... .......|++.|+||| ++.++|+||+|+++|+|++|..||.....
T Consensus 157 il~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 233 (484)
T 3nyv_A 157 LLLESKSKDANIRIIDFGLSTHFEAS---KKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEY 233 (484)
T ss_dssp EEESSSSTTCCEEECCTTHHHHBCCC---CSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEecCCCCCcEEEEeeeeeEEcccc---cccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHH
Confidence 999 45788999999998754311 1233457899999998 78999999999999999999999964321
Q ss_pred --------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 --------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 --------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+.....+..+.+++..||+.+|.+|||++++++
T Consensus 234 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 234 DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1111235678899999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=227.02 Aligned_cols=171 Identities=20% Similarity=0.205 Sum_probs=130.5
Q ss_pred cccccCCCeeeeccc---C-----CccEEEEecCCCCChhhhc-CCc--c---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---Q-----KNNALELGFRGNPELVDQQ-GKE--E---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~-----~~~~lv~e~~~~~~L~~~~-~~~--~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
|.+++||||++++++ . ...++||||++ ++|.+++ ... . |++.||.|||+ .+|+|||
T Consensus 79 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrD 154 (432)
T 3n9x_A 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRD 154 (432)
T ss_dssp HHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred HHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCC
Confidence 567899999999998 2 56899999998 5999998 322 2 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCC--------------------cceeeecccccccCCC-------CCCccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGT--------------------HMSTTIAGTAGFLNTE-------LTEKSD 118 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~pe-------~~~~~d 118 (188)
|||+||+++.++.+||+|||+++........ .......||..|+||| ++.++|
T Consensus 155 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~D 234 (432)
T 3n9x_A 155 LKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSID 234 (432)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHH
T ss_pred CCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccc
Confidence 9999999999999999999999864322111 1224567899999999 578899
Q ss_pred hHHHHHHHHHHHhCCccccc-----------cCCC---------------------------------------------
Q 039565 119 VDSFEIVILEIITGILTVDL-----------SFKG--------------------------------------------- 142 (188)
Q Consensus 119 i~s~G~~l~~~~~g~~p~~~-----------~~~~--------------------------------------------- 142 (188)
+||+||++|+|++|..|+.. ...-
T Consensus 235 iwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~ 314 (432)
T 3n9x_A 235 IWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIK 314 (432)
T ss_dssp HHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred cchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHH
Confidence 99999999999986544321 1000
Q ss_pred ---------CcC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhhc
Q 039565 143 ---------EFD-----IISVEKAVEIAMASVSSKVNRRPLMNQVVM--VREQG 180 (188)
Q Consensus 143 ---------~~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~--~l~~~ 180 (188)
..+ ...+..+.+++..||+.||++|||++++++ .+++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 315 YIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 000 113567889999999999999999999987 34444
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=226.08 Aligned_cols=164 Identities=21% Similarity=0.299 Sum_probs=133.5
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCC-CcEEeCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKH-PIIQRDMKS 68 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~-~i~h~dl~~ 68 (188)
.+.+++||||++++++ ....++||||+++++|.+++.+ .. |++.||.|||+ . +++|+||||
T Consensus 84 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp 160 (360)
T 3eqc_A 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKP 160 (360)
T ss_dssp GGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSG
T ss_pred HHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccH
Confidence 3677899999999998 7889999999999999999922 22 99999999998 6 899999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
+||+++.++.++|+|||++..... .......|+..|++|| ++.++|+||||+++|+|++|..||......
T Consensus 161 ~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 236 (360)
T 3eqc_A 161 SNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236 (360)
T ss_dssp GGEEECTTCCEEECCCCCCHHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH
T ss_pred HHEEECCCCCEEEEECCCCccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999998864321 1223456888999998 578899999999999999999998542210
Q ss_pred C-------------------------------------------------------cCHHHHHHHHHHHHHccCcCCCCC
Q 039565 143 E-------------------------------------------------------FDIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 143 ~-------------------------------------------------------~~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
+ .....+..+.+++..||+.+|++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 316 (360)
T 3eqc_A 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316 (360)
T ss_dssp HHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTS
T ss_pred HHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhC
Confidence 0 001134578899999999999999
Q ss_pred CCHHHHHH
Q 039565 168 PLMNQVVM 175 (188)
Q Consensus 168 ps~~~i~~ 175 (188)
||++++++
T Consensus 317 pt~~ell~ 324 (360)
T 3eqc_A 317 ADLKQLMV 324 (360)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=221.41 Aligned_cols=165 Identities=21% Similarity=0.313 Sum_probs=137.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..+++|||+++++|.+++.. .. |++.||.|||+ .+++|+||||+|
T Consensus 95 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~N 171 (335)
T 2owb_A 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGN 171 (335)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGG
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchh
Confidence 467899999999999 7788999999999999998822 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++|+|||++....... .......|+..|++|| ++.++|+||||+++|+|++|..||.....
T Consensus 172 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 249 (335)
T 2owb_A 172 LFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249 (335)
T ss_dssp EEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EEEcCCCCEEEeeccCceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 999999999999999987543211 2233456888999998 57899999999999999999999865321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+......+.+++..||+.||++|||++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 250 YLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122334567889999999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=216.95 Aligned_cols=165 Identities=21% Similarity=0.313 Sum_probs=137.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ .+..+++|||+++++|.+++.+ .. |++.||.|||+ .+++|+|++|+|
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~N 145 (294)
T 2rku_A 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGN 145 (294)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGG
T ss_pred HHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHh
Confidence 467899999999999 7778999999999999998822 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.++|+|||.+....... .......|+..|++|| ++.++|+||||+++|++++|..||+....
T Consensus 146 il~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 223 (294)
T 2rku_A 146 LFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223 (294)
T ss_dssp EEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EEEcCCCCEEEEeccCceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999987543221 1233456888899998 57899999999999999999999865321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+...+..+.+++..||+.+|++|||++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 224 YLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp HHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1223344567899999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=231.86 Aligned_cols=165 Identities=19% Similarity=0.247 Sum_probs=137.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c-----------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E-----------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~-----------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ ....++||||+++|+|..++ ... . |++.||.|||+ .+|+||||
T Consensus 239 L~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDL 315 (543)
T 3c4z_A 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDL 315 (543)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred HHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCC
Confidence 567899999999988 77899999999999999988 321 1 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+||+++.++.+||+|||+++.... .........||+.|+||| ++.++|+|||||++|+|++|..||....
T Consensus 316 KP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 316 KPENVLLDDDGNVRISDLGLAVELKA--GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECCT--TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred ChHHEEEeCCCCEEEeecceeeeccC--CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 99999999999999999999986432 112233468999999999 6889999999999999999999996542
Q ss_pred C---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHH
Q 039565 141 K---------------GEFDIISVEKAVEIAMASVSSKVNRRPLM-----NQVVM 175 (188)
Q Consensus 141 ~---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~-----~~i~~ 175 (188)
. ..++...+..+.+++..||+.+|++||++ ++|++
T Consensus 394 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 394 EKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 2 11333456688999999999999999975 66654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=216.94 Aligned_cols=164 Identities=16% Similarity=0.191 Sum_probs=133.3
Q ss_pred ccccc-CCCeeeeccc-----CCccEEEEecCCCCChhhhcCCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLT-GPLLVELIGK-----QKNNALELGFRGNPELVDQQGKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~-Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++ ||||++++++ ....+++|||+.+++|..+++... |++.||.|||+ .+++||||||+|
T Consensus 84 l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~N 160 (330)
T 3nsz_A 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHN 160 (330)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHH
Confidence 44565 9999999998 456789999999999999984443 99999999999 999999999999
Q ss_pred EEEccCC-ceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 71 ILLNEKV-QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 71 ill~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
|+++.++ .++|+|||+++..... .......++..|++|| ++.++|+||||+++|+|++|..||......
T Consensus 161 il~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 237 (330)
T 3nsz_A 161 VMIDHEHRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237 (330)
T ss_dssp EEEETTTTEEEECCCTTCEECCTT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred EEEcCCCCEEEEEeCCCceEcCCC---CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch
Confidence 9999776 8999999999754321 1233456788899987 578899999999999999999988432110
Q ss_pred -------------------------------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 039565 143 -------------------------------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQV 173 (188)
Q Consensus 143 -------------------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i 173 (188)
+.....+..+.+++..||+.||++|||++++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~ 317 (330)
T 3nsz_A 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317 (330)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 0011146788999999999999999999999
Q ss_pred HH
Q 039565 174 VM 175 (188)
Q Consensus 174 ~~ 175 (188)
++
T Consensus 318 l~ 319 (330)
T 3nsz_A 318 ME 319 (330)
T ss_dssp HT
T ss_pred hc
Confidence 87
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=229.16 Aligned_cols=164 Identities=27% Similarity=0.350 Sum_probs=136.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C--Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G--KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~--~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+++|+|.+++ . ... |++.||.|||+ .+++||||||+|
T Consensus 100 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~N 176 (504)
T 3q5i_A 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPEN 176 (504)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHH
Confidence 467899999999999 77889999999999999988 2 222 99999999999 999999999999
Q ss_pred EEEccCC---ceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 71 ILLNEKV---QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 71 ill~~~~---~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
|+++.++ .+||+|||++..... ........|++.|+||| ++.++|+||+|+++|+|++|..||......
T Consensus 177 il~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 253 (504)
T 3q5i_A 177 ILLENKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253 (504)
T ss_dssp EEESSTTCCSSEEECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEecCCCCccEEEEECCCCEEcCC---CCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9998775 699999999976431 12234457899999998 688999999999999999999999653221
Q ss_pred C-----------cC----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 E-----------FD----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ~-----------~~----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+ .+ ...+..+.+++..||+.+|.+|||++++++
T Consensus 254 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 254 DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1 11 123567899999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=228.11 Aligned_cols=165 Identities=19% Similarity=0.170 Sum_probs=134.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC----cc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK----EE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~----~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ .+..++||||+++|+|.+++.+ .. |++.||+|||+ .+|+||||||+
T Consensus 115 l~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~ 191 (412)
T 2vd5_A 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPD 191 (412)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGG
T ss_pred HHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHH
Confidence 456789999999988 7788999999999999999922 22 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------------CCCccchHHHHHHHHHHHhCCccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
||+++.++.+||+|||+++.... ..........||+.|+||| ++.++|+|||||++|+|++|..||
T Consensus 192 NILld~~g~vkL~DFGla~~~~~-~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 270 (412)
T 2vd5_A 192 NILLDRCGHIRLADFGSCLKLRA-DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270 (412)
T ss_dssp GEEECTTSCEEECCCTTCEECCT-TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred HeeecCCCCEEEeechhheeccC-CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence 99999999999999999976432 2222233467999999998 367899999999999999999999
Q ss_pred cccCCC-------------Cc---CHHHHHHHHHHHHHccCcCCCCC---CCHHHHHH
Q 039565 137 DLSFKG-------------EF---DIISVEKAVEIAMASVSSKVNRR---PLMNQVVM 175 (188)
Q Consensus 137 ~~~~~~-------------~~---~~~~~~~~~~l~~~cl~~~p~~R---ps~~~i~~ 175 (188)
...... .. +...+..+.+++..||. +|.+| |+++++++
T Consensus 271 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 271 YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 643211 11 12345688999999999 99998 58999876
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=220.28 Aligned_cols=159 Identities=22% Similarity=0.260 Sum_probs=129.2
Q ss_pred cccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 8 KLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 8 ~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
.++||||++++++ .+..++||||+ +++|.+++ ... . |++.||.|||+ .+|+||||||+|
T Consensus 92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~N 167 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPEN 167 (360)
T ss_dssp STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCccc
Confidence 3469999999998 78899999999 78999999 221 1 99999999999 999999999999
Q ss_pred EEEcc-------------------------CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccch
Q 039565 71 ILLNE-------------------------KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDV 119 (188)
Q Consensus 71 ill~~-------------------------~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di 119 (188)
|+++. ++.+||+|||++..... ......|++.|+||| ++.++||
T Consensus 168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di 242 (360)
T 3llt_A 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDM 242 (360)
T ss_dssp EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccch
Confidence 99975 78899999999875321 123456888999998 6889999
Q ss_pred HHHHHHHHHHHhCCccccccCCC-----------CcCHH-----------------------------------------
Q 039565 120 DSFEIVILEIITGILTVDLSFKG-----------EFDII----------------------------------------- 147 (188)
Q Consensus 120 ~s~G~~l~~~~~g~~p~~~~~~~-----------~~~~~----------------------------------------- 147 (188)
|||||++|+|++|..||...... ..+..
T Consensus 243 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 322 (360)
T 3llt_A 243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322 (360)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc
Confidence 99999999999999998542210 00000
Q ss_pred -----HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 148 -----SVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 148 -----~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+.+++..||+.||.+|||++++++
T Consensus 323 ~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0145779999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=219.10 Aligned_cols=165 Identities=22% Similarity=0.261 Sum_probs=133.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....++||||+++ +|..++ .... |++.||.|||+ .+++||||||+
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 141 (346)
T 1ua2_A 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPN 141 (346)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGG
T ss_pred HhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHH
Confidence 467889999999998 7889999999995 888888 3221 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
||+++.++.+||+|||++...... ........+++.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 142 Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~ 219 (346)
T 1ua2_A 142 NLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 219 (346)
T ss_dssp GEEECTTCCEEECCCGGGSTTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEEcCCCCEEEEecccceeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence 999999999999999998754321 12233456888999998 46689999999999999999988753211
Q ss_pred ---------------CCc------------------C-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 ---------------GEF------------------D-----IISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 ---------------~~~------------------~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
..+ + ...+..+.+++..||+.||++|||++++++.
T Consensus 220 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 220 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0 1234678999999999999999999999873
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=216.69 Aligned_cols=168 Identities=24% Similarity=0.309 Sum_probs=133.4
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC--------c---c---------cHHHHHHHHhcCCCCCc
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK--------E---E---------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~--------~---~---------~i~~~l~~Lh~~~~~~i 61 (188)
.+.+++||||++++++ .+..+++|||+++++|.+++.. . . |++.||.|||+ .++
T Consensus 66 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i 142 (303)
T 2vwi_A 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQ 142 (303)
T ss_dssp CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred HHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCC
Confidence 4677899999999998 7889999999999999998831 1 1 99999999999 999
Q ss_pred EEeCCCCCcEEEccCCceEEecccCcccccCCCC---CcceeeecccccccCCC-------CCCccchHHHHHHHHHHHh
Q 039565 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGG---THMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~---~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~ 131 (188)
+|+||+|+||+++.++.++|+|||.+........ ........|++.|++|| ++.++|+||||+++|++++
T Consensus 143 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 222 (303)
T 2vwi_A 143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222 (303)
T ss_dssp CCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999998875432111 11223456888999998 5889999999999999999
Q ss_pred CCccccccCCC---------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 132 GILTVDLSFKG---------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 132 g~~p~~~~~~~---------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|..||...... +.....+..+.+++..||+.+|.+|||++++++
T Consensus 223 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 223 GAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 99998642110 011123457889999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=214.94 Aligned_cols=164 Identities=20% Similarity=0.233 Sum_probs=129.3
Q ss_pred ccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 9 LTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 9 l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
.+||||++++++ .+..++||||+++++|.+++ .. .. |++.||.|||+ .+++||||||+||++
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~ 144 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILC 144 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEE
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEE
Confidence 479999999999 78899999999999999999 22 22 99999999999 999999999999999
Q ss_pred ccCCc---eEEecccCcccccCCCC-----CcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCc
Q 039565 74 NEKVQ---AKLADFGQSRISPVEGG-----THMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGIL 134 (188)
Q Consensus 74 ~~~~~---~kl~d~~~~~~~~~~~~-----~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~ 134 (188)
+.++. +||+|||++........ ........|+..|+||| ++.++|+||||+++|+|++|..
T Consensus 145 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~ 224 (316)
T 2ac3_A 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224 (316)
T ss_dssp SCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCC
Confidence 88765 99999999875431111 11122346889999998 4678999999999999999999
Q ss_pred cccccCCC--------------------------CcCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 135 TVDLSFKG--------------------------EFDI----ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 135 p~~~~~~~--------------------------~~~~----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
||...... ..+. ..+..+.+++..||+.||.+|||++++++
T Consensus 225 pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 225 PFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp SCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 99654221 1111 13457889999999999999999999988
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=213.53 Aligned_cols=169 Identities=20% Similarity=0.299 Sum_probs=130.9
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC---Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG---KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~---~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++++||+++++|.+++. ... |++.||.|||+ .+++|+|++|+|
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~N 141 (276)
T 2h6d_A 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPEN 141 (276)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGG
T ss_pred HhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhh
Confidence 567889999999999 788899999999999999982 222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC-------CCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-------TEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-------~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
|+++.++.++++|||++..... ........+++.|++||. +.++|+||||+++|++++|..||+....
T Consensus 142 il~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 218 (276)
T 2h6d_A 142 VLLDAHMNAKIADFGLSNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218 (276)
T ss_dssp EEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEECCCCCEEEeecccccccCC---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 9999999999999999875431 112234567888999992 4689999999999999999999865321
Q ss_pred ---------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhhc
Q 039565 142 ---------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV--REQG 180 (188)
Q Consensus 142 ---------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~--l~~~ 180 (188)
...+...+..+.+++..||+.+|.+|||++++++. +++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 219 LFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 11222345678999999999999999999999983 4443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=214.77 Aligned_cols=165 Identities=23% Similarity=0.273 Sum_probs=137.0
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC--Cc--c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG--KE--E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~--~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ ....+++|||+++++|.+++. .. . |++.||.|||+ .+++|+|++|+
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~ 154 (314)
T 3com_A 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAG 154 (314)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGG
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHH
Confidence 467899999999998 778899999999999999982 21 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
||+++.++.++|+|||.+..... .........|+..|++|| ++.++|+||||+++|++++|..||.....
T Consensus 155 Nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 232 (314)
T 3com_A 155 NILLNTEGHAKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232 (314)
T ss_dssp GEEECTTCCEEECCCTTCEECBT--TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred HEEECCCCCEEEeecccchhhhh--hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 99999999999999999875431 111233456888899998 58899999999999999999999864211
Q ss_pred ------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+...+..+.+++..||+.+|.+|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 233 AIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1122334678999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=220.30 Aligned_cols=163 Identities=21% Similarity=0.300 Sum_probs=134.1
Q ss_pred ccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhcC-C--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 7 NKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQG-K--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
.++ +||||++++++ ....++||||+++++|.+++. . .. |++.||.|||+ .+++|+|+||.|
T Consensus 154 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~N 230 (365)
T 2y7j_A 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPEN 230 (365)
T ss_dssp HHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred HHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHH
Confidence 345 79999999998 788899999999999999982 2 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|+++.++.++++|||++..... ........|++.|++|| ++.++|+||||+++|+|++|..||..
T Consensus 231 Il~~~~~~ikl~DfG~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 231 ILLDDNMQIRLSDFGFSCHLEP---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp EEECTTCCEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEECCCCCEEEEecCcccccCC---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999875431 12233467889999998 45689999999999999999999854
Q ss_pred cCC-----------CCcCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFK-----------GEFDI----ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~-----------~~~~~----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... ...+. ..+..+.+++..||+.+|++|||++++++
T Consensus 308 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 308 RRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 321 01111 12456899999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-34 Score=220.13 Aligned_cols=169 Identities=21% Similarity=0.288 Sum_probs=137.1
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCC-------cc---------cHHHHHHHHhcCCCCC----
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGK-------EE---------VCCPGLEYLHQGLKHP---- 60 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-------~~---------~i~~~l~~Lh~~~~~~---- 60 (188)
+.+++||||++++++ ....+++|||+++++|.+++.. .. |++.||.|||+ .+
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~ 135 (279)
T 2w5a_A 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGH 135 (279)
T ss_dssp HHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC----
T ss_pred HHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCC
Confidence 567899999999986 5678999999999999999821 11 99999999999 77
Q ss_pred -cEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCC
Q 039565 61 -IIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGI 133 (188)
Q Consensus 61 -i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~ 133 (188)
++|+||+|+||+++.++.++|+|||.+..... .........|+..|++|| ++.++|+||||+++|++++|.
T Consensus 136 ~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 213 (279)
T 2w5a_A 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213 (279)
T ss_dssp --CCCCCSGGGEEECSSSCEEECCCCHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred eeEEeccchhhEEEcCCCCEEEecCchheeecc--ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999875431 111223456888999998 578899999999999999999
Q ss_pred ccccccCC------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhh
Q 039565 134 LTVDLSFK------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179 (188)
Q Consensus 134 ~p~~~~~~------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~ 179 (188)
.||..... ...+...+..+.+++..||+.+|++|||++++++.+..
T Consensus 214 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 214 PPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 99864321 12333456789999999999999999999999987644
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-33 Score=214.89 Aligned_cols=163 Identities=21% Similarity=0.286 Sum_probs=135.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C--Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G--KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~--~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....+++|||+++++|.+++ . ... |++.||.|||+ .+++|+|++|+|
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~N 136 (304)
T 2jam_A 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPEN 136 (304)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGG
T ss_pred HHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHH
Confidence 567899999999998 77889999999999999988 2 222 99999999999 999999999999
Q ss_pred EEE---ccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILL---NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|++ +.++.++++|||++.... ........|++.|++|| ++.++|+||||+++|++++|..||.....
T Consensus 137 Il~~~~~~~~~~kl~Dfg~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 212 (304)
T 2jam_A 137 LLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE 212 (304)
T ss_dssp CEESSSSTTCCEEBCSCSTTCCCC----CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EEEecCCCCCCEEEccCCcceecC----CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 999 678899999999986432 11223456888999999 57789999999999999999999854321
Q ss_pred ---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+..+.+++..||+.+|++|||++++++
T Consensus 213 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 213 SKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122234578999999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-33 Score=219.41 Aligned_cols=164 Identities=16% Similarity=0.194 Sum_probs=127.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||++ ++|.+++ .... |++.||.|||+ .+++||||||+|
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~N 162 (329)
T 3gbz_A 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQN 162 (329)
T ss_dssp GGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred HHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHH
Confidence 577899999999999 788999999998 5999998 2222 99999999999 999999999999
Q ss_pred EEEc-----cCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 71 ILLN-----EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 71 ill~-----~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|+++ ..+.+||+|||++...... ........++..|+||| ++.++||||||+++|+|++|..||..
T Consensus 163 Ill~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 163 LLLSVSDASETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp EEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEecCCCCccceEEECcCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 9994 4456999999998754311 12233456788899998 57889999999999999999998853
Q ss_pred cCCCC-----------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKGE-----------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~~-----------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+ .....+..+.+++..||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 241 DSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 22100 00013467889999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.4e-34 Score=221.19 Aligned_cols=165 Identities=22% Similarity=0.247 Sum_probs=130.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....++||||+++++|..+. .... |++.||.|||+ .+++|+||||+|
T Consensus 78 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~N 154 (331)
T 4aaa_A 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPEN 154 (331)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred HhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChhe
Confidence 567899999999999 77889999999999998886 2222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKGE 143 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~ 143 (188)
|+++.++.++|+|||++...... ........++..|++|| ++.++|+||||+++|+|++|..||......+
T Consensus 155 il~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 232 (331)
T 4aaa_A 155 ILVSQSGVVKLCDFGFARTLAAP--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID 232 (331)
T ss_dssp EEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCcEEEEeCCCceeecCC--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 99999999999999998754321 12233456788899998 4778999999999999999999885432100
Q ss_pred -------------------------------------c-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 -------------------------------------F-----DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 -------------------------------------~-----~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ....+..+.+++..||+.||.+|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 233 QLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0123567899999999999999999999886
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7e-33 Score=213.21 Aligned_cols=166 Identities=17% Similarity=0.209 Sum_probs=133.0
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhc-C--Ccc-----------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQ-G--KEE-----------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~-~--~~~-----------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ ....+++|||++++ |.+++ . ... |++.||.|||+ .+++|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl 135 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDI 135 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCC
Confidence 567899999999997 45789999999975 66666 1 111 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC--------CCccchHHHHHHHHHHHhCCccccc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL--------TEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~--------~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+||+++.++.++++|||.+................|+..|++||. +.++|+||||+++|++++|..||+.
T Consensus 136 kp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 136 KPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999876432222233345668899999981 4579999999999999999999864
Q ss_pred cCC-----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFK-----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~-----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... ...+...+..+.+++..||+.||.+|||++++++
T Consensus 216 ~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 216 DNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp SSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred chHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 321 1122234567889999999999999999999997
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-33 Score=236.91 Aligned_cols=161 Identities=19% Similarity=0.273 Sum_probs=136.1
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN 74 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~ 74 (188)
+||||++++++ .+..++||||+++|+|..++.+ .. |++.||+|||+ .+|+||||||+|||++
T Consensus 400 ~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~ 476 (674)
T 3pfq_A 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLD 476 (674)
T ss_dssp CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEEC
T ss_pred CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEc
Confidence 79999999988 6788999999999999999922 22 99999999999 9999999999999999
Q ss_pred cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-------
Q 039565 75 EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK------- 141 (188)
Q Consensus 75 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~------- 141 (188)
.++.+||+|||+++.... .........||+.|+||| ++.++|+||||+++|+|++|..||.....
T Consensus 477 ~~g~ikL~DFGla~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i 554 (674)
T 3pfq_A 477 SEGHIKIADFGMCKENIW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554 (674)
T ss_dssp SSSCEEECCCTTCEECCC--TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCcEEEeecceeecccc--CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 999999999999875321 122345578999999999 68899999999999999999999965321
Q ss_pred ----CCcCHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHH
Q 039565 142 ----GEFDIISVEKAVEIAMASVSSKVNRRPLM-----NQVVM 175 (188)
Q Consensus 142 ----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~-----~~i~~ 175 (188)
..++...+..+.+++..||+.||++||++ ++|++
T Consensus 555 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 555 MEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 22444566789999999999999999997 66654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-33 Score=220.45 Aligned_cols=163 Identities=19% Similarity=0.241 Sum_probs=125.2
Q ss_pred cccccCCCeeeeccc---C------CccEEEEecCCCCChhhhc-CCcc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---Q------KNNALELGFRGNPELVDQQ-GKEE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~------~~~~lv~e~~~~~~L~~~~-~~~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+++++||||++++++ . ...++||||+++ +|.+++ .... |++.||.|||+ .+++||||
T Consensus 78 l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dl 153 (371)
T 2xrw_A 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDL 153 (371)
T ss_dssp HHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred HHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhhccCHHHHHHHHHHHHHHHHHHHH---CCeecccC
Confidence 467899999999998 2 267999999984 788877 3333 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
||+||+++.++.+||+|||+++... .........|+..|+||| ++.++|+||||+++|+|++|..||....
T Consensus 154 kp~NIl~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 154 KPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp CGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHHEEEcCCCCEEEEEeecccccc---cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987542 112233467888999998 6889999999999999999999985421
Q ss_pred CC-----------------------------------------------------CcCHHHHHHHHHHHHHccCcCCCCC
Q 039565 141 KG-----------------------------------------------------EFDIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 141 ~~-----------------------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
.. +.....+..+.+++..||+.||++|
T Consensus 231 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 310 (371)
T 2xrw_A 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310 (371)
T ss_dssp HHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhC
Confidence 10 0011235678999999999999999
Q ss_pred CCHHHHHH
Q 039565 168 PLMNQVVM 175 (188)
Q Consensus 168 ps~~~i~~ 175 (188)
||++++++
T Consensus 311 ~t~~e~l~ 318 (371)
T 2xrw_A 311 ISVDEALQ 318 (371)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhC
Confidence 99999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=218.18 Aligned_cols=166 Identities=22% Similarity=0.225 Sum_probs=134.4
Q ss_pred cccccCCCeeeeccc---C------CccEEEEecCCCCChhhhc--CCcc---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---Q------KNNALELGFRGNPELVDQQ--GKEE---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~------~~~~lv~e~~~~~~L~~~~--~~~~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+.+++||||++++++ . ...++||||+ +++|.+++ .... |++.||.|||+ .+++|||
T Consensus 78 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~D 153 (367)
T 1cm8_A 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRD 153 (367)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred HHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccC
Confidence 567899999999998 2 3459999999 67999998 2222 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|||+||+++.++.+||+|||+++.... ......++..|+||| ++.++|+||+||++|+|++|..||..
T Consensus 154 lkp~NIll~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 154 LKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCHHHEEEcCCCCEEEEeeeccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999875431 123456788999998 57899999999999999999999864
Q ss_pred cCCCC------------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH-
Q 039565 139 SFKGE------------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM- 175 (188)
Q Consensus 139 ~~~~~------------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~- 175 (188)
....+ .....+..+.+++..||+.||.+|||++++++
T Consensus 229 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 229 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 32100 00122456889999999999999999999988
Q ss_pred -HHhhc
Q 039565 176 -VREQG 180 (188)
Q Consensus 176 -~l~~~ 180 (188)
.+++.
T Consensus 309 p~f~~~ 314 (367)
T 1cm8_A 309 PYFESL 314 (367)
T ss_dssp GGGTTT
T ss_pred hHHHhh
Confidence 34443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-33 Score=213.08 Aligned_cols=170 Identities=24% Similarity=0.265 Sum_probs=135.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+.+++||||++++++ ....+++|||+++++|.+++.. .. |++.||.|||+ .+++|+|++|+|
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~N 138 (283)
T 3bhy_A 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPEN 138 (283)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred HHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHH
Confidence 567889999999998 7788999999999999999822 22 99999999999 999999999999
Q ss_pred EEEccCC----ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 71 ILLNEKV----QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 71 ill~~~~----~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+++.++ .++|+|||.+..... ........+++.|++|| ++.++|+||||+++|++++|..||....
T Consensus 139 il~~~~~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 139 IMLLDKNVPNPRIKLIDFGIAHKIEA---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp EEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred EEEecCCCCCCceEEEecccceeccC---CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 9998876 799999999875431 11223456888899998 5789999999999999999999986432
Q ss_pred CC-----------CcCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhhcc
Q 039565 141 KG-----------EFDI----ISVEKAVEIAMASVSSKVNRRPLMNQVVM--VREQGS 181 (188)
Q Consensus 141 ~~-----------~~~~----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~--~l~~~~ 181 (188)
.. ..+. ..+..+.+++..||+.+|++|||++++++ .++...
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 216 KQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred hHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 11 1111 23457899999999999999999999997 455443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.9e-33 Score=215.23 Aligned_cols=160 Identities=24% Similarity=0.266 Sum_probs=130.3
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc--c------------cHHHHHHHHhcCCCCCcEEeCCCCCcEE
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE--E------------VCCPGLEYLHQGLKHPIIQRDMKSTNIL 72 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~------------~i~~~l~~Lh~~~~~~i~h~dl~~~nil 72 (188)
+||||++++++ ....++||||+++|+|.+++... . |++.||+|||+ .+++||||||+||+
T Consensus 87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl 163 (327)
T 3lm5_A 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNIL 163 (327)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEE
Confidence 57999999999 77889999999999999998221 1 99999999999 99999999999999
Q ss_pred Ecc---CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 73 LNE---KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 73 l~~---~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
++. ++.+||+|||++.... .........|++.|++|| ++.++|+||||+++|+|++|..||.....
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 240 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIG---HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE 240 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EecCCCCCcEEEeeCccccccC---CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH
Confidence 987 7899999999987543 111233457889999998 57899999999999999999999854221
Q ss_pred -------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 -------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 -------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+.....+..+.+++..||+.+|.+|||++++++
T Consensus 241 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 241 TYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1122234567899999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-33 Score=222.05 Aligned_cols=145 Identities=11% Similarity=0.003 Sum_probs=119.4
Q ss_pred CccEEEEecCCCCChhhhcCCc-------------------ccHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEe
Q 039565 22 KNNALELGFRGNPELVDQQGKE-------------------EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLA 82 (188)
Q Consensus 22 ~~~~lv~e~~~~~~L~~~~~~~-------------------~~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~ 82 (188)
.+.++||||++ ++|.+++... .|++.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 161 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~ 236 (371)
T 3q60_A 161 ANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLG 236 (371)
T ss_dssp EEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEECTTSCEEEC
T ss_pred eeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCccCcCCHHHEEECCCCCEEEE
Confidence 34799999999 8999998321 189999999999 999999999999999999999999
Q ss_pred cccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCccccccCCC------------
Q 039565 83 DFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTVDLSFKG------------ 142 (188)
Q Consensus 83 d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~------------ 142 (188)
|||+++... . ......+++.|+||| ++.++|+||||+++|+|++|..||......
T Consensus 237 DFG~a~~~~---~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~ 311 (371)
T 3q60_A 237 DVSALWKVG---T--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311 (371)
T ss_dssp CGGGEEETT---C--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTS
T ss_pred ecceeeecC---C--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhh
Confidence 999987542 1 122445668899998 577899999999999999999999655211
Q ss_pred --------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 --------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 --------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
......+..+.+++..||+.||++|||++++++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011244678999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-33 Score=213.75 Aligned_cols=157 Identities=17% Similarity=0.250 Sum_probs=127.7
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-------c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-------E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-------~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+||||++++++ .+..++||||+++++|.+++... . |++.||.|||+ .+++|+||||+|
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~N 145 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSN 145 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHH
Confidence 89999999999 78899999999999999999221 1 99999999999 999999999999
Q ss_pred EEEccC-------------------CceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHH
Q 039565 71 ILLNEK-------------------VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEI 124 (188)
Q Consensus 71 ill~~~-------------------~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~ 124 (188)
|+++.+ ..++++|||.+..... .....|+..|++|| ++.++||||||+
T Consensus 146 Il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 219 (289)
T 1x8b_A 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALAL 219 (289)
T ss_dssp EEEC--------------------CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHH
T ss_pred EEEcCCCCCcccccccccccccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHH
Confidence 999844 4789999999875431 12235888899998 235899999999
Q ss_pred HHHHHHhCCcccccc---------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 125 VILEIITGILTVDLS---------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 125 ~l~~~~~g~~p~~~~---------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
++|++++|..++... .....+...+..+.+++..||+.+|++|||++++++
T Consensus 220 il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 220 TVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHHTTCCCCCSSSHHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCCCcchhHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 999999998654321 112233345678999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=215.89 Aligned_cols=166 Identities=18% Similarity=0.221 Sum_probs=133.7
Q ss_pred cccccCCCeeeeccc---C-----CccEEEEecCCCCChhhhc--CCcc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---Q-----KNNALELGFRGNPELVDQQ--GKEE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~-----~~~~lv~e~~~~~~L~~~~--~~~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ . ...++++||+. ++|.+++ .... |++.||.|||+ .+++||||
T Consensus 79 l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 154 (364)
T 3qyz_A 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDL 154 (364)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred HHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCC
Confidence 567899999999998 1 46799999998 5899988 2222 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCC-CcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+||+++.++.+||+|||++........ ........|++.|++|| ++.++|+||||+++|+|++|..||..
T Consensus 155 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 155 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999875432111 11123457889999998 58889999999999999999999864
Q ss_pred cCCCCc------------------------------------------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKGEF------------------------------------------DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~~~------------------------------------------~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+. ....+..+.+++..||+.||++|||++++++
T Consensus 235 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 235 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp SSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 321110 0112457889999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-33 Score=222.93 Aligned_cols=162 Identities=12% Similarity=0.015 Sum_probs=128.3
Q ss_pred CCcccccCCCeeeec-------cc---CC-----------------ccEEEEecCCCCChhhhcCC-----c-------c
Q 039565 4 PNRNKLTGPLLVELI-------GK---QK-----------------NNALELGFRGNPELVDQQGK-----E-------E 44 (188)
Q Consensus 4 ~~l~~l~Hpniv~~~-------~~---~~-----------------~~~lv~e~~~~~~L~~~~~~-----~-------~ 44 (188)
..+++++||||++++ ++ .+ ..+++|||+ +|+|.+++.. . .
T Consensus 128 ~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~ 206 (377)
T 3byv_A 128 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHH 206 (377)
T ss_dssp GGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHH
T ss_pred HhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHH
Confidence 356778999999998 33 11 378999999 5799999821 1 1
Q ss_pred -------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----
Q 039565 45 -------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE----- 112 (188)
Q Consensus 45 -------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe----- 112 (188)
|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++... .......| ..|+|||
T Consensus 207 ~~~~i~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 207 ARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp HHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhccc
Confidence 99999999999 999999999999999999999999999987422 12334566 8899987
Q ss_pred ------------CCCccchHHHHHHHHHHHhCCccccccCCCC-------cCHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 039565 113 ------------LTEKSDVDSFEIVILEIITGILTVDLSFKGE-------FDIISVEKAVEIAMASVSSKVNRRPLMNQV 173 (188)
Q Consensus 113 ------------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i 173 (188)
++.++|+||||+++|+|++|..||....... .....+..+.+++..||+.||++|||+.++
T Consensus 278 ~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 278 ATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp TSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred ccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 3568999999999999999999996533211 112345789999999999999999999999
Q ss_pred HH
Q 039565 174 VM 175 (188)
Q Consensus 174 ~~ 175 (188)
++
T Consensus 358 l~ 359 (377)
T 3byv_A 358 ME 359 (377)
T ss_dssp HT
T ss_pred hh
Confidence 86
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=216.35 Aligned_cols=166 Identities=20% Similarity=0.196 Sum_probs=130.7
Q ss_pred cccccCCCeeeeccc-----------CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCc
Q 039565 6 RNKLTGPLLVELIGK-----------QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----------~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i 61 (188)
+.+++||||++++++ ....++||||+++ +|.+.+ .... |++.||.|||+ .++
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i 145 (351)
T 3mi9_A 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKI 145 (351)
T ss_dssp HHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred HHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCe
Confidence 467899999999998 1357899999995 777776 3221 99999999999 999
Q ss_pred EEeCCCCCcEEEccCCceEEecccCcccccCCCC--CcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhC
Q 039565 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGG--THMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g 132 (188)
+||||||+||+++.++.+||+|||+++....... ........|++.|+||| ++.++|+||||+++|+|++|
T Consensus 146 vH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 225 (351)
T 3mi9_A 146 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225 (351)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred eCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999876432211 12223456788999998 57899999999999999999
Q ss_pred CccccccCCC---------------C-cCH---------------------------HHHHHHHHHHHHccCcCCCCCCC
Q 039565 133 ILTVDLSFKG---------------E-FDI---------------------------ISVEKAVEIAMASVSSKVNRRPL 169 (188)
Q Consensus 133 ~~p~~~~~~~---------------~-~~~---------------------------~~~~~~~~l~~~cl~~~p~~Rps 169 (188)
..||...... + .+. .....+.+++..||+.||++|||
T Consensus 226 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 305 (351)
T 3mi9_A 226 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305 (351)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC
Confidence 9988542210 0 000 01345889999999999999999
Q ss_pred HHHHHH
Q 039565 170 MNQVVM 175 (188)
Q Consensus 170 ~~~i~~ 175 (188)
++++++
T Consensus 306 ~~e~l~ 311 (351)
T 3mi9_A 306 SDDALN 311 (351)
T ss_dssp HHHHHT
T ss_pred HHHHhC
Confidence 999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-33 Score=220.62 Aligned_cols=170 Identities=19% Similarity=0.174 Sum_probs=131.4
Q ss_pred cccccCCCeeeeccc---CC------ccEEEEecCCCCChhhhc---C-Ccc-----------cHHHHHHHHhcCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QK------NNALELGFRGNPELVDQQ---G-KEE-----------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~------~~~lv~e~~~~~~L~~~~---~-~~~-----------~i~~~l~~Lh~~~~~~i 61 (188)
+.+++||||++++++ .. ..++||||++++.+.... . ... |++.||.|||+ .+|
T Consensus 86 l~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i 162 (394)
T 4e7w_A 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGI 162 (394)
T ss_dssp HHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred HHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCc
Confidence 567899999999988 21 278999999964333322 1 111 99999999999 999
Q ss_pred EEeCCCCCcEEEc-cCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCC
Q 039565 62 IQRDMKSTNILLN-EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGI 133 (188)
Q Consensus 62 ~h~dl~~~nill~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~ 133 (188)
+||||||+||+++ .++.+||+|||+++..... .......++..|+||| ++.++|+|||||++|+|++|.
T Consensus 163 vHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 239 (394)
T 4e7w_A 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239 (394)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECCTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999 7899999999999764311 1233456788899998 578899999999999999999
Q ss_pred ccccccCCCC----------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 039565 134 LTVDLSFKGE----------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQV 173 (188)
Q Consensus 134 ~p~~~~~~~~----------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i 173 (188)
.||......+ ++...+..+.+++..||+.+|.+|||+.++
T Consensus 240 ~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (394)
T 4e7w_A 240 PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA 319 (394)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHH
Confidence 9986432100 111234578999999999999999999999
Q ss_pred HHH--Hhhcc
Q 039565 174 VMV--REQGS 181 (188)
Q Consensus 174 ~~~--l~~~~ 181 (188)
++. ++++.
T Consensus 320 l~hp~f~~~~ 329 (394)
T 4e7w_A 320 LCHPFFDELR 329 (394)
T ss_dssp HTSGGGSTTT
T ss_pred hcChhhhhhc
Confidence 873 54443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=211.14 Aligned_cols=164 Identities=19% Similarity=0.203 Sum_probs=134.6
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.++ +||||++++++ ....++||||+++++|.+++.. .. |++.||.|||+ .+++|+||+|+
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~ 153 (298)
T 1phk_A 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPE 153 (298)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGG
T ss_pred HHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcc
Confidence 3455 49999999999 7788999999999999999822 22 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
||+++.++.++|+|||.+..... ........++..|++|| ++.++|+||||+++|++++|..||.
T Consensus 154 Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 230 (298)
T 1phk_A 154 NILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230 (298)
T ss_dssp GEEECTTCCEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eEEEcCCCcEEEecccchhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence 99999999999999999875431 11233456788899988 4678999999999999999999885
Q ss_pred ccCC---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LSFK---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~~~---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.... .......+..+.+++..||+.+|.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 231 HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 3221 1111234667999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=220.68 Aligned_cols=162 Identities=22% Similarity=0.291 Sum_probs=126.4
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+||||+++++. ....+++|||+. |+|.+++ .... |++.||.|||+ .+|+|||||
T Consensus 67 ~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLk 142 (434)
T 2rio_A 67 DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLK 142 (434)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred CCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCC
Confidence 89999999998 678899999997 6999998 2210 89999999999 999999999
Q ss_pred CCcEEEccC-------------CceEEecccCcccccCCCCCc--ceeeecccccccCCC-------------CCCccch
Q 039565 68 STNILLNEK-------------VQAKLADFGQSRISPVEGGTH--MSTTIAGTAGFLNTE-------------LTEKSDV 119 (188)
Q Consensus 68 ~~nill~~~-------------~~~kl~d~~~~~~~~~~~~~~--~~~~~~~~~~~~~pe-------------~~~~~di 119 (188)
|+||+++.+ +.+||+|||+++......... ......|++.|+||| ++.++||
T Consensus 143 p~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 222 (434)
T 2rio_A 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222 (434)
T ss_dssp GGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHH
T ss_pred hHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhh
Confidence 999999754 479999999998653221111 123457899999998 3667999
Q ss_pred HHHHHHHHHHHh-CCccccccCC----------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 120 DSFEIVILEIIT-GILTVDLSFK----------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 120 ~s~G~~l~~~~~-g~~p~~~~~~----------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|||||++|+|++ |..||+.... ...+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 223 wSlG~il~ellt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 223 FSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHHHHHHTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhHHHHHHHHHhCCCCCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 999999999998 8899864321 1123456788999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=214.42 Aligned_cols=164 Identities=18% Similarity=0.258 Sum_probs=135.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhh------cCC--cc------------cHHHHHHHHhcCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQ------QGK--EE------------VCCPGLEYLHQGLKHPII 62 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~------~~~--~~------------~i~~~l~~Lh~~~~~~i~ 62 (188)
+.+++||||++++++ .+..++||||+++++|.++ +.. .. |++.||.|||+ ..+++
T Consensus 97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~ 174 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNIC 174 (348)
T ss_dssp HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEE
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEe
Confidence 567899999999999 7889999999999999998 632 11 99999999996 27999
Q ss_pred EeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC-------CC-ccchHHHHHHHHHHHhCCc
Q 039565 63 QRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-------TE-KSDVDSFEIVILEIITGIL 134 (188)
Q Consensus 63 h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-------~~-~~di~s~G~~l~~~~~g~~ 134 (188)
|+|++|+||+++.++.++|+|||.+...... ......++..|++||. +. ++|+||||+++|++++|..
T Consensus 175 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 250 (348)
T 2pml_X 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250 (348)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999998754311 3344578889999992 13 8999999999999999999
Q ss_pred cccccCC------------CCcC-------------------HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 135 TVDLSFK------------GEFD-------------------IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 135 p~~~~~~------------~~~~-------------------~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
||..... ...+ ...+..+.+++..||+.+|.+|||++++++
T Consensus 251 pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 251 PFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9864322 1111 335678899999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=217.02 Aligned_cols=163 Identities=18% Similarity=0.156 Sum_probs=124.7
Q ss_pred cccccCCCeeeeccc--------CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEe
Q 039565 6 RNKLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQR 64 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~ 64 (188)
+.+++||||++++++ ....++||||++ |+|.+++ .... |++.||.|||+ .+++|+
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~ 158 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHR 158 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCC
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEec
Confidence 567899999999988 235799999999 5888887 3321 99999999999 999999
Q ss_pred CCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 65 DMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 65 dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
||||+||+++.++.+||+|||++.... .........++..|++|| ++.++|+||||+++|++++|..||.
T Consensus 159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 159 DLHPGNILLADNNDITICDFNLAREDT---ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp CCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCChHHEEEcCCCCEEEEecCcccccc---cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 999999999999999999999987432 112233456788899988 5778999999999999999999986
Q ss_pred ccCCCC-------------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 039565 138 LSFKGE-------------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174 (188)
Q Consensus 138 ~~~~~~-------------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~ 174 (188)
.....+ .....+..+.+++..||+.+|++|||+++++
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 532100 0011245688999999999999999999998
Q ss_pred H
Q 039565 175 M 175 (188)
Q Consensus 175 ~ 175 (188)
+
T Consensus 316 ~ 316 (362)
T 3pg1_A 316 R 316 (362)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-33 Score=222.92 Aligned_cols=166 Identities=19% Similarity=0.203 Sum_probs=125.4
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcC--C----------cc---------cHHHHHHHHhcCCCC
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQG--K----------EE---------VCCPGLEYLHQGLKH 59 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~--~----------~~---------~i~~~l~~Lh~~~~~ 59 (188)
|.+++||||++++++ ....++||||+. ++|.+++. . .. |++.||.|||+ .
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~ 147 (405)
T 3rgf_A 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---N 147 (405)
T ss_dssp HHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---T
T ss_pred HHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence 567899999999988 567899999998 47777662 0 11 99999999999 9
Q ss_pred CcEEeCCCCCcEEE----ccCCceEEecccCcccccCCCC-CcceeeecccccccCCC-------CCCccchHHHHHHHH
Q 039565 60 PIIQRDMKSTNILL----NEKVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 60 ~i~h~dl~~~nill----~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~ 127 (188)
+|+||||||+||++ +.++.+||+|||+++....... ........|++.|+||| ++.++|||||||++|
T Consensus 148 ~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 227 (405)
T 3rgf_A 148 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 227 (405)
T ss_dssp TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHH
T ss_pred CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHH
Confidence 99999999999999 6778999999999986432111 12233467899999998 567899999999999
Q ss_pred HHHhCCccccccCCCC-----cCHH-----------------------------------------------------HH
Q 039565 128 EIITGILTVDLSFKGE-----FDII-----------------------------------------------------SV 149 (188)
Q Consensus 128 ~~~~g~~p~~~~~~~~-----~~~~-----------------------------------------------------~~ 149 (188)
+|++|..||....... .... ..
T Consensus 228 ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (405)
T 3rgf_A 228 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307 (405)
T ss_dssp HHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTT
T ss_pred HHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCC
Confidence 9999999995332110 0000 03
Q ss_pred HHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 150 EKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 150 ~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+.+++..||+.||.+|||++++++
T Consensus 308 ~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 308 SKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp SHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhc
Confidence 56789999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=216.20 Aligned_cols=161 Identities=19% Similarity=0.228 Sum_probs=128.7
Q ss_pred cccccCCCeeeeccc---CCc------cEEEEecCCCCChhhhc-CCcc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QKN------NALELGFRGNPELVDQQ-GKEE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~------~~lv~e~~~~~~L~~~~-~~~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ ... .+++|||+. ++|..++ .... |++.||.|||+ .+++||||
T Consensus 95 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 170 (371)
T 4exu_A 95 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDL 170 (371)
T ss_dssp HHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred HHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCc
Confidence 467899999999998 333 399999998 6898888 3333 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcccccc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLS 139 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~ 139 (188)
||+||+++.++.+||+|||+++.... ......+++.|+||| ++.++|+||||+++|+|++|..||...
T Consensus 171 kp~NIll~~~~~~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 171 KPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp CGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CHHHeEECCCCCEEEEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999875321 123456788899988 578899999999999999999999643
Q ss_pred CCCC------------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 140 FKGE------------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 140 ~~~~------------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+ .....+..+.+++..||+.+|++|||++++++
T Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 246 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 2100 00112567899999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-33 Score=214.54 Aligned_cols=165 Identities=19% Similarity=0.197 Sum_probs=131.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC--Cc--c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG--KE--E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~--~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++++ .+..++++||+++++|..++. .. . |++.||.|||+ .+++|+||+|+
T Consensus 70 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~ 146 (302)
T 2j7t_A 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAG 146 (302)
T ss_dssp HHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGG
T ss_pred HhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHH
Confidence 467899999999998 778999999999999999872 11 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+++.++.++|+|||++..... .........|+..|++|| ++.++|+||||+++|+|++|..||..
T Consensus 147 Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 224 (302)
T 2j7t_A 147 NVLMTLEGDIRLADFGVSAKNLK--TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224 (302)
T ss_dssp GEEECTTSCEEECCCHHHHHHHH--HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HEEECCCCCEEEEECCCCccccc--cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 99999999999999998653210 001122346788899887 46789999999999999999998864
Q ss_pred cCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFK--------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... ...+...+..+.+++..||+.+|.+|||++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 225 LNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 221 1123345668899999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=215.49 Aligned_cols=169 Identities=17% Similarity=0.159 Sum_probs=131.0
Q ss_pred cccccCCCeeeeccc---CC-------ccEEEEecCCCCChhhhc----CCcc------------cHHHHHHHHh--cCC
Q 039565 6 RNKLTGPLLVELIGK---QK-------NNALELGFRGNPELVDQQ----GKEE------------VCCPGLEYLH--QGL 57 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~-------~~~lv~e~~~~~~L~~~~----~~~~------------~i~~~l~~Lh--~~~ 57 (188)
+..++||||++++++ .. ..+++|||+++ +|...+ .... |++.||.||| +
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-- 149 (360)
T 3e3p_A 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-- 149 (360)
T ss_dssp HHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT--
T ss_pred HHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC--
Confidence 456799999999988 11 27899999996 544333 1211 9999999999 8
Q ss_pred CCCcEEeCCCCCcEEEcc-CCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHH
Q 039565 58 KHPIIQRDMKSTNILLNE-KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEI 129 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~-~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~ 129 (188)
.+++||||||+||+++. ++.+||+|||++..... ........|+..|+||| ++.++|+||||+++|+|
T Consensus 150 -~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el 225 (360)
T 3e3p_A 150 -VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM 225 (360)
T ss_dssp -TCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred -CCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999997 89999999999875431 12233456788899998 57889999999999999
Q ss_pred HhCCccccccCCCC-------------------------------------------cCHHHHHHHHHHHHHccCcCCCC
Q 039565 130 ITGILTVDLSFKGE-------------------------------------------FDIISVEKAVEIAMASVSSKVNR 166 (188)
Q Consensus 130 ~~g~~p~~~~~~~~-------------------------------------------~~~~~~~~~~~l~~~cl~~~p~~ 166 (188)
++|..||....... .....+..+.+++..||+.||.+
T Consensus 226 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 305 (360)
T 3e3p_A 226 MLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305 (360)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGG
T ss_pred HhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccc
Confidence 99999986432110 00113568999999999999999
Q ss_pred CCCHHHHHH--HHhhcc
Q 039565 167 RPLMNQVVM--VREQGS 181 (188)
Q Consensus 167 Rps~~~i~~--~l~~~~ 181 (188)
|||++++++ .+++..
T Consensus 306 Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 306 RMKPYEALCHPYFDELH 322 (360)
T ss_dssp SCCHHHHTTSGGGGGGG
T ss_pred cCCHHHHhcCccccccC
Confidence 999999987 344443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-33 Score=211.76 Aligned_cols=163 Identities=21% Similarity=0.237 Sum_probs=125.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC----Cc-c-----------cHHHHHHHHhcCCCC-CcEEeC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG----KE-E-----------VCCPGLEYLHQGLKH-PIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~----~~-~-----------~i~~~l~~Lh~~~~~-~i~h~d 65 (188)
+..++||||++++++ ....+++|||++ |+|.+++. .. . |++.||.|||+ . +++|+|
T Consensus 60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~d 135 (290)
T 3fme_A 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRD 135 (290)
T ss_dssp HTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCC
T ss_pred HHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCC
Confidence 456899999999998 778999999998 58877661 11 1 99999999999 7 999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC----------CCCccchHHHHHHHHHHHhCCcc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE----------LTEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe----------~~~~~di~s~G~~l~~~~~g~~p 135 (188)
+||+||+++.++.+||+|||++..... ........|++.|++|| ++.++|+||||+++|++++|..|
T Consensus 136 lkp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (290)
T 3fme_A 136 VKPSNVLINALGQVKMCDFGISGYLVD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212 (290)
T ss_dssp CSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred CCHHHEEECCCCCEEEeecCCcccccc---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999875431 11223346888899988 35689999999999999999999
Q ss_pred ccccCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 136 VDLSFK--------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 136 ~~~~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|+.... .......+..+.+++..||+.+|++|||++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 213 YDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 864211 1111234567899999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=213.07 Aligned_cols=165 Identities=25% Similarity=0.274 Sum_probs=128.9
Q ss_pred cccc-cCCCeeeeccc---------CCccEEEEecCCCCChhhhc-CCc--c-----------cHHHHHHHHhcCCCCCc
Q 039565 6 RNKL-TGPLLVELIGK---------QKNNALELGFRGNPELVDQQ-GKE--E-----------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~-~~~--~-----------~i~~~l~~Lh~~~~~~i 61 (188)
+.++ +||||++++++ ....+++|||+++++|.+++ ... . |++.||.|||+ .++
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i 150 (326)
T 2x7f_A 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKV 150 (326)
T ss_dssp HHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred HHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCc
Confidence 3455 79999999998 24679999999999999998 221 1 99999999999 999
Q ss_pred EEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHH
Q 039565 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEII 130 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~ 130 (188)
+|+||+|+||+++.++.++|+|||++..... .........|+..|++|| ++.++|+||||+++|+++
T Consensus 151 vH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 228 (326)
T 2x7f_A 151 IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228 (326)
T ss_dssp CCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHH
T ss_pred cccCCcHHHEEEcCCCCEEEeeCcCceecCc--CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHH
Confidence 9999999999999999999999999875421 111233456888899987 467899999999999999
Q ss_pred hCCccccccCC-------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 131 TGILTVDLSFK-------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 131 ~g~~p~~~~~~-------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+|..||..... .......+..+.+++..||..+|.+|||++++++
T Consensus 229 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 229 EGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 99999854211 1112234568899999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=217.97 Aligned_cols=165 Identities=22% Similarity=0.300 Sum_probs=127.1
Q ss_pred ccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 7 NKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
.++ +||||++++++ ....+++|||+. |+|.+++ .... |++.||.|||+ .+|+||||||+
T Consensus 72 ~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~ 147 (432)
T 3p23_A 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPH 147 (432)
T ss_dssp HHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTT
T ss_pred HhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHH
Confidence 445 79999999998 778899999997 5999998 2221 99999999999 99999999999
Q ss_pred cEEEcc-----CCceEEecccCcccccCCCC-CcceeeecccccccCCCC---------CCccchHHHHHHHHHHHh-CC
Q 039565 70 NILLNE-----KVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTEL---------TEKSDVDSFEIVILEIIT-GI 133 (188)
Q Consensus 70 nill~~-----~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe~---------~~~~di~s~G~~l~~~~~-g~ 133 (188)
||+++. ...++|+|||+++....... ........|++.|+|||. +.++|||||||++|++++ |.
T Consensus 148 NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~ 227 (432)
T 3p23_A 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227 (432)
T ss_dssp SEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSC
T ss_pred HEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCC
Confidence 999953 23578999999876432211 122334679999999992 447999999999999999 88
Q ss_pred ccccccCCC--------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 134 LTVDLSFKG--------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 134 ~p~~~~~~~--------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.||...... .........+.+++..||+.+|.+|||++++++
T Consensus 228 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 228 HPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp BTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 888543211 112345566889999999999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-33 Score=215.96 Aligned_cols=163 Identities=18% Similarity=0.234 Sum_probs=118.2
Q ss_pred cccccCCCeeeeccc-------CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEe
Q 039565 6 RNKLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQR 64 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~ 64 (188)
+..+.||||++++++ ....++||||+++|+|.+++ .+. . |++.||.|||+ .+++||
T Consensus 76 ~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~ 152 (336)
T 3fhr_A 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHR 152 (336)
T ss_dssp HHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred HHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 345789999999998 23378999999999999999 332 1 99999999999 999999
Q ss_pred CCCCCcEEEcc---CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcc
Q 039565 65 DMKSTNILLNE---KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 65 dl~~~nill~~---~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p 135 (188)
||||+||+++. ++.+||+|||++.... ........+++.|++|| ++.++|+||||+++|++++|..|
T Consensus 153 dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (336)
T 3fhr_A 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETT----QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228 (336)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCC
T ss_pred CCCHHHEEEEecCCCceEEEeccccceecc----ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999986 4559999999987542 11223456788999999 36689999999999999999999
Q ss_pred ccccCCCCc-------------------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 136 VDLSFKGEF-------------------DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 136 ~~~~~~~~~-------------------~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|........ ....+..+.+++..||+.+|++|||++++++
T Consensus 229 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 229 FYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp C---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 854322111 1234668899999999999999999999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=218.03 Aligned_cols=163 Identities=17% Similarity=0.135 Sum_probs=129.3
Q ss_pred cccccCCCeeeeccc---CC--------------------------------------ccEEEEecCCCCChhhhcC---
Q 039565 6 RNKLTGPLLVELIGK---QK--------------------------------------NNALELGFRGNPELVDQQG--- 41 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~--------------------------------------~~~lv~e~~~~~~L~~~~~--- 41 (188)
+++++||||++++++ .. ..++||||++ ++|.+.+.
T Consensus 54 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 132 (383)
T 3eb0_A 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI 132 (383)
T ss_dssp HTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHH
T ss_pred HHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH
Confidence 567899999999887 11 2789999999 57766651
Q ss_pred --Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEc-cCCceEEecccCcccccCCCCCcceeeeccccc
Q 039565 42 --KEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNILLN-EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAG 107 (188)
Q Consensus 42 --~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~ 107 (188)
... |++.||.|||+ .+++||||||+||+++ .++.+||+|||+++.... ........++..
T Consensus 133 ~~~~~l~~~~~~~i~~qi~~aL~~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~ 206 (383)
T 3eb0_A 133 RSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRF 206 (383)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSS
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCC
Confidence 111 99999999999 9999999999999998 578999999999975431 122334567888
Q ss_pred ccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCCC-------------------------------------
Q 039565 108 FLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKGE------------------------------------- 143 (188)
Q Consensus 108 ~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~------------------------------------- 143 (188)
|+||| ++.++|+||+||++|+|++|..||......+
T Consensus 207 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (383)
T 3eb0_A 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDW 286 (383)
T ss_dssp CCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCH
T ss_pred ccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccH
Confidence 99998 5788999999999999999999986432110
Q ss_pred ---cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 ---FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 ---~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+...+..+.+++..||+.+|++|||+.++++
T Consensus 287 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 287 RKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11123456889999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=214.18 Aligned_cols=173 Identities=20% Similarity=0.201 Sum_probs=121.7
Q ss_pred ccccc-CCCeeeeccc-----------CCccEEEEecCCCCChhhhcC----Cc--c---------cHHHHHHHHhcCCC
Q 039565 6 RNKLT-GPLLVELIGK-----------QKNNALELGFRGNPELVDQQG----KE--E---------VCCPGLEYLHQGLK 58 (188)
Q Consensus 6 l~~l~-Hpniv~~~~~-----------~~~~~lv~e~~~~~~L~~~~~----~~--~---------~i~~~l~~Lh~~~~ 58 (188)
+.++. ||||++++++ ....++++||+. |+|.+++. .. . |++.||.|||+
T Consensus 79 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--- 154 (337)
T 3ll6_A 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR--- 154 (337)
T ss_dssp HHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---
Confidence 34564 9999999876 234789999997 68988872 11 1 99999999999
Q ss_pred CC--cEEeCCCCCcEEEccCCceEEecccCcccccCCCCC----------cceeeecccccccCCCC---------CCcc
Q 039565 59 HP--IIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGT----------HMSTTIAGTAGFLNTEL---------TEKS 117 (188)
Q Consensus 59 ~~--i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~----------~~~~~~~~~~~~~~pe~---------~~~~ 117 (188)
.+ ++|+||||+||+++.++.+||+|||++......... .......+++.|++||. +.++
T Consensus 155 ~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~ 234 (337)
T 3ll6_A 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234 (337)
T ss_dssp SSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHH
T ss_pred CCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHH
Confidence 88 999999999999999999999999998764322111 11123568889999992 4589
Q ss_pred chHHHHHHHHHHHhCCccccccCCCC---------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 118 DVDSFEIVILEIITGILTVDLSFKGE---------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 118 di~s~G~~l~~~~~g~~p~~~~~~~~---------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
|+||||+++|+|++|..||....... ........+.+++..||+.+|.+|||++++++.|+.+..
T Consensus 235 Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 235 DIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp HHHHHHHHHHHHHHSSCCC------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCcchhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999986432211 111233457899999999999999999999999987654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=214.83 Aligned_cols=158 Identities=20% Similarity=0.245 Sum_probs=128.4
Q ss_pred ccCCCeeeeccc-------CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCC-CcEEeCC
Q 039565 9 LTGPLLVELIGK-------QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKH-PIIQRDM 66 (188)
Q Consensus 9 l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~-~i~h~dl 66 (188)
.+||||+++++. ....++||||+. ++|.+++ ... . |++.||.|||+ . +++||||
T Consensus 98 ~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDi 173 (397)
T 1wak_A 98 PNREMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDI 173 (397)
T ss_dssp GGGGGBCCEEEEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCC
T ss_pred CCcceeeeeecceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCC
Confidence 358999999987 357899999995 5666655 221 1 99999999999 8 9999999
Q ss_pred CCCcEEEccCC-------------------------------------------------ceEEecccCcccccCCCCCc
Q 039565 67 KSTNILLNEKV-------------------------------------------------QAKLADFGQSRISPVEGGTH 97 (188)
Q Consensus 67 ~~~nill~~~~-------------------------------------------------~~kl~d~~~~~~~~~~~~~~ 97 (188)
||+||+++.++ .+||+|||.+.....
T Consensus 174 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----- 248 (397)
T 1wak_A 174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----- 248 (397)
T ss_dssp SGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----
T ss_pred CHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----
Confidence 99999998765 799999999875431
Q ss_pred ceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC----------------------------
Q 039565 98 MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE---------------------------- 143 (188)
Q Consensus 98 ~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~---------------------------- 143 (188)
......|+..|+||| ++.++|||||||++|+|++|..||+.....+
T Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 328 (397)
T 1wak_A 249 HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328 (397)
T ss_dssp CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTT
T ss_pred cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccc
Confidence 123346888999998 6889999999999999999999996533221
Q ss_pred -------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 -------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 -------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+...+..+.+++..||+.||++|||++++++
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp GGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 23455677889999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-32 Score=219.96 Aligned_cols=171 Identities=17% Similarity=0.207 Sum_probs=134.4
Q ss_pred ccccCCC-eeeeccc---CCccEEEEecCCCCChhhhcC--Ccc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 7 NKLTGPL-LVELIGK---QKNNALELGFRGNPELVDQQG--KEE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 7 ~~l~Hpn-iv~~~~~---~~~~~lv~e~~~~~~L~~~~~--~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
..++|++ +..+..+ ....+++|||+ +++|.+++. ... |++.||.|||+ .+|+||||||+
T Consensus 57 ~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~ 132 (483)
T 3sv0_A 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPD 132 (483)
T ss_dssp HHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred HHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcc
Confidence 4556644 4344333 77889999999 789999983 222 99999999999 99999999999
Q ss_pred cEEE---ccCCceEEecccCcccccCCCCC-----cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcc
Q 039565 70 NILL---NEKVQAKLADFGQSRISPVEGGT-----HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILT 135 (188)
Q Consensus 70 nill---~~~~~~kl~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p 135 (188)
||++ +.++.+||+|||+++........ .......|+..|++|| ++.++||||||+++|+|++|..|
T Consensus 133 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~P 212 (483)
T 3sv0_A 133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (483)
T ss_dssp GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999 57889999999999865422221 1122567899999998 57889999999999999999999
Q ss_pred ccccCCCCcC-------------------HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 136 VDLSFKGEFD-------------------IISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 136 ~~~~~~~~~~-------------------~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
|......... ...+..+.+++..||+.+|++||++++|++.|+.+.
T Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 213 WQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp TSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 9764332210 112357899999999999999999999999998764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=208.31 Aligned_cols=167 Identities=25% Similarity=0.348 Sum_probs=127.0
Q ss_pred cccccCCCeeeeccc----------------CCccEEEEecCCCCChhhhcC-Cc-c-----------cHHHHHHHHhcC
Q 039565 6 RNKLTGPLLVELIGK----------------QKNNALELGFRGNPELVDQQG-KE-E-----------VCCPGLEYLHQG 56 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----------------~~~~~lv~e~~~~~~L~~~~~-~~-~-----------~i~~~l~~Lh~~ 56 (188)
+.+++||||++++++ ....+++|||+++++|.+++. .. . |++.||+|||+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~- 134 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS- 134 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH-
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh-
Confidence 567899999999875 246789999999999999992 22 1 99999999999
Q ss_pred CCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCC------------CCcceeeecccccccCCC-------CCCcc
Q 039565 57 LKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEG------------GTHMSTTIAGTAGFLNTE-------LTEKS 117 (188)
Q Consensus 57 ~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~------------~~~~~~~~~~~~~~~~pe-------~~~~~ 117 (188)
.+++|+|+||+||+++.++.++|+|||.+....... .........|+..|++|| ++.++
T Consensus 135 --~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 212 (303)
T 1zy4_A 135 --QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI 212 (303)
T ss_dssp --TTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHH
T ss_pred --CCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchh
Confidence 999999999999999999999999999987542110 011223456888899998 57789
Q ss_pred chHHHHHHHHHHHhCCccc-------------cccCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 118 DVDSFEIVILEIITGILTV-------------DLSFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 118 di~s~G~~l~~~~~g~~p~-------------~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|+||||+++|+|+++..+. ....+...+...+..+.+++..||+.||.+|||++++++
T Consensus 213 Di~slG~il~~l~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 213 DMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHHHHHHSCCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHHHHhccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 9999999999999843211 011223344455667899999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=217.41 Aligned_cols=160 Identities=18% Similarity=0.182 Sum_probs=130.3
Q ss_pred ccccCCCeeeeccc---CCccEEEEecCCCCChhhhc--CCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 7 NKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ--GKE---E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 7 ~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~--~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
...+|+||+++++. ....+++|||+. ++|.+++ ... . |++.||+|||+ .+|+||||||+
T Consensus 154 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~ 229 (429)
T 3kvw_A 154 DKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPE 229 (429)
T ss_dssp CTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGG
T ss_pred cccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHH
Confidence 34578999999998 788999999997 6899888 221 1 99999999999 99999999999
Q ss_pred cEEEccCCc--eEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 70 NILLNEKVQ--AKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 70 nill~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
||+++.++. +||+|||++.... .......|++.|+||| ++.++|||||||++|+|++|..||.....
T Consensus 230 NILl~~~~~~~vkL~DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 230 NILLKQQGRSGIKVIDFGSSCYEH-----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp GEEESSTTSCCEEECCCTTCEETT-----CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HeEEccCCCcceEEeecccceecC-----CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 999999887 9999999986432 1223457888999999 78999999999999999999988854221
Q ss_pred CC----------------------------------------------------------------------cCHHHHHH
Q 039565 142 GE----------------------------------------------------------------------FDIISVEK 151 (188)
Q Consensus 142 ~~----------------------------------------------------------------------~~~~~~~~ 151 (188)
.+ ........
T Consensus 305 ~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 384 (429)
T 3kvw_A 305 GDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384 (429)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHH
T ss_pred HHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHH
Confidence 00 00001356
Q ss_pred HHHHHHHccCcCCCCCCCHHHHHH
Q 039565 152 AVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 152 ~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
+.+++..||+.||++|||++++++
T Consensus 385 ~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 385 FLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHCCCChhhCCCHHHHhC
Confidence 889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=211.33 Aligned_cols=161 Identities=20% Similarity=0.237 Sum_probs=129.3
Q ss_pred cccccCCCeeeeccc---CC------ccEEEEecCCCCChhhhc-CCcc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---QK------NNALELGFRGNPELVDQQ-GKEE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~------~~~lv~e~~~~~~L~~~~-~~~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ .. ..+++|||+. ++|.+++ .... |++.||.|||+ .+++|+||
T Consensus 77 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dl 152 (353)
T 3coi_A 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDL 152 (353)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSC
T ss_pred HHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCC
Confidence 567899999999998 22 3499999998 6898888 3333 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcccccc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLS 139 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~ 139 (188)
||+||+++.++.+||+|||++..... ......++..|++|| ++.++|+||||+++|+|++|..||...
T Consensus 153 kp~NIl~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 153 KPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp CGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred CHHHEeECCCCcEEEeecccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999875321 123456788899988 578899999999999999999998643
Q ss_pred CC------------------------------------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 140 FK------------------------------------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 140 ~~------------------------------------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.. .......+..+.+++..||+.||++|||++++++
T Consensus 228 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 21 0011234567899999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-33 Score=221.88 Aligned_cols=169 Identities=20% Similarity=0.163 Sum_probs=130.4
Q ss_pred cccccCCCeeeeccc---------CCccEEEEecCCCCChhhhcC-----Ccc-----------cHHHHHHHHhcCCCCC
Q 039565 6 RNKLTGPLLVELIGK---------QKNNALELGFRGNPELVDQQG-----KEE-----------VCCPGLEYLHQGLKHP 60 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~~-----~~~-----------~i~~~l~~Lh~~~~~~ 60 (188)
|.+++||||++++++ ....++||||+++ +|...+. ... |++.||.|||+ .+
T Consensus 101 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ 176 (420)
T 1j1b_A 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FG 176 (420)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TT
T ss_pred HHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CC
Confidence 567899999999877 1236799999995 5655441 111 99999999999 99
Q ss_pred cEEeCCCCCcEEEccC-CceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhC
Q 039565 61 IIQRDMKSTNILLNEK-VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 61 i~h~dl~~~nill~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g 132 (188)
|+||||||+||+++.+ +.+||+|||+++..... .......|+..|+||| ++.++|||||||++|+|++|
T Consensus 177 ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G 253 (420)
T 1j1b_A 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253 (420)
T ss_dssp EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccCCChhhEEEeCCCCeEEeccchhhhhcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhC
Confidence 9999999999999965 57899999999854311 1233457888999998 57789999999999999999
Q ss_pred CccccccCCCC----------------------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 039565 133 ILTVDLSFKGE----------------------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQ 172 (188)
Q Consensus 133 ~~p~~~~~~~~----------------------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~ 172 (188)
..||......+ ++...+..+.+++.+||+.||.+|||+.+
T Consensus 254 ~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e 333 (420)
T 1j1b_A 254 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 333 (420)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHH
Confidence 99985432100 11123467899999999999999999999
Q ss_pred HHH--HHhhcc
Q 039565 173 VVM--VREQGS 181 (188)
Q Consensus 173 i~~--~l~~~~ 181 (188)
+++ .++++.
T Consensus 334 ~l~hp~f~~~~ 344 (420)
T 1j1b_A 334 ACAHSFFDELR 344 (420)
T ss_dssp HHTSGGGGGGG
T ss_pred HhCCHhhcccc
Confidence 986 444443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=215.37 Aligned_cols=161 Identities=20% Similarity=0.257 Sum_probs=119.4
Q ss_pred cccccCCCeeeeccc---C------CccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---Q------KNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~------~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+.+++||||++++++ . ...++++|++ +++|.+++.... |++.||.|||+ .+++|||
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~D 157 (367)
T 2fst_X 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRD 157 (367)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCC
T ss_pred HHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCC
Confidence 567899999999998 1 5579999999 479998883322 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|||+||+++.++.+||+|||+++.... ......|+..|+||| ++.++|+|||||++|+|++|..||..
T Consensus 158 lkp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 158 LKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp CCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCHhhEEECCCCCEEEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999875321 123457888999998 57889999999999999999999854
Q ss_pred cCCCC-------------------------------------cC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKGE-------------------------------------FD-----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~~-------------------------------------~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+ .+ ...+..+.+++..||+.||.+|||++++++
T Consensus 233 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 32100 00 011346789999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=210.42 Aligned_cols=161 Identities=22% Similarity=0.233 Sum_probs=131.0
Q ss_pred cccCCCeeeeccc--------CCccEEEEecCCCCChhhhc-C-C---cc---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 8 KLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQ-G-K---EE---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 8 ~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~-~-~---~~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
+++||||++++++ ....++++||++ |+|.+++ . . .. |++.||.|||+ .+++|+|
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~d 145 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRD 145 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCC
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecc
Confidence 4589999999987 356789999998 6999998 2 1 11 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLS 139 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~ 139 (188)
+||+||+++.++.++|+|||++.... .........++..|++|| ++.++|+||||+++|++++|..||...
T Consensus 146 lkp~Nili~~~~~~kl~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 146 LKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp CCGGGEEECTTCCEEECSCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCHHHeEEcCCCCEEEecCccccccc---CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999987532 112233456788899998 688999999999999999999988542
Q ss_pred CCC--------------------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 140 FKG--------------------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 140 ~~~--------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... ......+..+.+++..||+.+|.+|||+.++++
T Consensus 223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 223 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 210 011224567789999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=211.57 Aligned_cols=163 Identities=21% Similarity=0.259 Sum_probs=120.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC------Ccc-----------cHHHHHHHHhcCCCC-CcEEe
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG------KEE-----------VCCPGLEYLHQGLKH-PIIQR 64 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~------~~~-----------~i~~~l~~Lh~~~~~-~i~h~ 64 (188)
+..++||||++++++ .+..+++|||+++ +|.+++. ... |++.||.|||+ . +++|+
T Consensus 75 ~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~ 150 (327)
T 3aln_A 75 MRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHR 150 (327)
T ss_dssp HSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCS
T ss_pred HHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeEC
Confidence 456789999999998 7788999999995 7777662 111 99999999999 7 99999
Q ss_pred CCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC----------CCCccchHHHHHHHHHHHhCCc
Q 039565 65 DMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE----------LTEKSDVDSFEIVILEIITGIL 134 (188)
Q Consensus 65 dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe----------~~~~~di~s~G~~l~~~~~g~~ 134 (188)
||||+||+++.++.+||+|||++..... ........|+..|++|| ++.++|+||||+++|+|++|..
T Consensus 151 dlkp~NIll~~~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (327)
T 3aln_A 151 DIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227 (327)
T ss_dssp CCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCC
T ss_pred CCCHHHEEEcCCCCEEEccCCCceeccc---ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999875431 11222346888899998 3578999999999999999999
Q ss_pred cccccCC-----------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 135 TVDLSFK-----------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 135 p~~~~~~-----------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
||..... .......+..+.+++..||+.+|.+|||++++++
T Consensus 228 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 228 PYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 9864211 0011235678999999999999999999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=214.02 Aligned_cols=166 Identities=14% Similarity=0.134 Sum_probs=131.3
Q ss_pred cccccCCCeeeeccc--------CCccEEEEecCCCCChhhhc--CCcc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQ--GKEE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~--~~~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+.+++||||++++++ ....++++||+. ++|.+++ .... |++.||.|||+ .+++||||
T Consensus 63 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dl 138 (353)
T 2b9h_A 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDL 138 (353)
T ss_dssp HHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred HHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCC
Confidence 567899999999988 266899999998 5899988 2222 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCC--------cceeeecccccccCCC-------CCCccchHHHHHHHHHHHh
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGT--------HMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~--------~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~ 131 (188)
||+||+++.++.+||+|||++......... .......|+..|+||| ++.++|+||||+++|+|++
T Consensus 139 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 218 (353)
T 2b9h_A 139 KPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218 (353)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHh
Confidence 999999999999999999998754321111 0112346788999998 4678999999999999999
Q ss_pred CCccccccCCC-----------------C--------------------------cCHHHHHHHHHHHHHccCcCCCCCC
Q 039565 132 GILTVDLSFKG-----------------E--------------------------FDIISVEKAVEIAMASVSSKVNRRP 168 (188)
Q Consensus 132 g~~p~~~~~~~-----------------~--------------------------~~~~~~~~~~~l~~~cl~~~p~~Rp 168 (188)
|..||...... . .....+..+.+++..||+.||++||
T Consensus 219 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 298 (353)
T 2b9h_A 219 RRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI 298 (353)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCC
Confidence 99998543200 0 0012345788999999999999999
Q ss_pred CHHHHHH
Q 039565 169 LMNQVVM 175 (188)
Q Consensus 169 s~~~i~~ 175 (188)
|++++++
T Consensus 299 t~~ell~ 305 (353)
T 2b9h_A 299 TAKEALE 305 (353)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999987
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=205.36 Aligned_cols=151 Identities=8% Similarity=0.059 Sum_probs=126.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc----------cHHHHHHHHhcCCCCCcEEeCCCCCcEE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE----------VCCPGLEYLHQGLKHPIIQRDMKSTNIL 72 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~----------~i~~~l~~Lh~~~~~~i~h~dl~~~nil 72 (188)
+.+++||||++++++ .+..++||||+++++|.+++++.. |++.||.|||+ .+++||||||+||+
T Consensus 85 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIl 161 (286)
T 3uqc_A 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVR 161 (286)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEE
T ss_pred HhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEE
Confidence 567899999999999 778999999999999999994322 99999999999 99999999999999
Q ss_pred EccCCceEEecccCcccccCCCCCcceeeecccccccCCCCCCccchHHHHHHHHHHHhCCccccccCCCC---------
Q 039565 73 LNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTELTEKSDVDSFEIVILEIITGILTVDLSFKGE--------- 143 (188)
Q Consensus 73 l~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~--------- 143 (188)
++.++.+++++++. ++ .++.++|+||||+++|+|++|..||.......
T Consensus 162 l~~~g~~kl~~~~~----------------------~~-~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 218 (286)
T 3uqc_A 162 VSIDGDVVLAYPAT----------------------MP-DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT 218 (286)
T ss_dssp EETTSCEEECSCCC----------------------CT-TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT
T ss_pred EcCCCCEEEEeccc----------------------cC-CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh
Confidence 99999999874331 12 26789999999999999999999996533211
Q ss_pred ---------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 144 ---------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 144 ---------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
.....+..+.+++..||+.||++| |++++++.|++....
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 112346689999999999999999 999999999987654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=208.96 Aligned_cols=166 Identities=17% Similarity=0.192 Sum_probs=130.0
Q ss_pred cccccCCCeeeeccc-----------------CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCC
Q 039565 6 RNKLTGPLLVELIGK-----------------QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGL 57 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----------------~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~ 57 (188)
+.+++||||++++++ ....+++|||++ |+|.+++.+.. |++.||+|||+
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-- 138 (320)
T 2i6l_A 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHS-- 138 (320)
T ss_dssp HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--
T ss_pred HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHh--
Confidence 567899999999876 256789999998 69999984332 99999999999
Q ss_pred CCCcEEeCCCCCcEEEc-cCCceEEecccCcccccCCCC-CcceeeecccccccCCC-------CCCccchHHHHHHHHH
Q 039565 58 KHPIIQRDMKSTNILLN-EKVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILE 128 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~-~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~ 128 (188)
.+++|+||||+||+++ .++.+||+|||++........ ........++..|++|| ++.++|+||||+++|+
T Consensus 139 -~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~e 217 (320)
T 2i6l_A 139 -ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 217 (320)
T ss_dssp -TTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHH
T ss_pred -CCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHH
Confidence 9999999999999997 567899999999875431111 11223345677888888 5678999999999999
Q ss_pred HHhCCccccccCCCC-----------------------------------------cCHHHHHHHHHHHHHccCcCCCCC
Q 039565 129 IITGILTVDLSFKGE-----------------------------------------FDIISVEKAVEIAMASVSSKVNRR 167 (188)
Q Consensus 129 ~~~g~~p~~~~~~~~-----------------------------------------~~~~~~~~~~~l~~~cl~~~p~~R 167 (188)
+++|..||......+ .....+..+.+++..||+.+|++|
T Consensus 218 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (320)
T 2i6l_A 218 MLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297 (320)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGS
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCcccc
Confidence 999999986432100 001135678899999999999999
Q ss_pred CCHHHHHH
Q 039565 168 PLMNQVVM 175 (188)
Q Consensus 168 ps~~~i~~ 175 (188)
||++++++
T Consensus 298 pt~~ell~ 305 (320)
T 2i6l_A 298 LTAEEALS 305 (320)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhC
Confidence 99999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=204.77 Aligned_cols=169 Identities=22% Similarity=0.267 Sum_probs=135.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C--Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G--KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~--~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++||||++++++ ....++++||+++++|.+++ . ... |++.||.|||+ .+++|+|++|+|
T Consensus 75 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~N 151 (287)
T 2wei_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPEN 151 (287)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred HHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhh
Confidence 567899999999998 77889999999999998888 2 222 99999999999 999999999999
Q ss_pred EEEccC---CceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 71 ILLNEK---VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 71 ill~~~---~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
|+++.+ +.+||+|||++...... .......++..|++|| ++.++|+||||+++|++++|..||......
T Consensus 152 Ilv~~~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (287)
T 2wei_A 152 ILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (287)
T ss_dssp EEESCSSTTCCEEECSTTGGGTBCCC---SSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEecCCCcccEEEeccCcceeecCC---CccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999764 46999999998754311 1223345778899988 688999999999999999999998542210
Q ss_pred -------------CcC--HHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhhc
Q 039565 143 -------------EFD--IISVEKAVEIAMASVSSKVNRRPLMNQVVM--VREQG 180 (188)
Q Consensus 143 -------------~~~--~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~--~l~~~ 180 (188)
..+ ...+..+.+++..||+.+|++|||++++++ .+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 111 234567899999999999999999999998 44443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=211.77 Aligned_cols=158 Identities=19% Similarity=0.246 Sum_probs=127.5
Q ss_pred ccCCCeeeeccc---C----CccEEEEecCCCCChhhhc-C-C-c--c---------cHHHHHHHHhcCCCC-CcEEeCC
Q 039565 9 LTGPLLVELIGK---Q----KNNALELGFRGNPELVDQQ-G-K-E--E---------VCCPGLEYLHQGLKH-PIIQRDM 66 (188)
Q Consensus 9 l~Hpniv~~~~~---~----~~~~lv~e~~~~~~L~~~~-~-~-~--~---------~i~~~l~~Lh~~~~~-~i~h~dl 66 (188)
+.||||++++++ . ...++++||+ +++|.+++ . . . . |++.||.|||+ . +++||||
T Consensus 83 ~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Di 158 (373)
T 1q8y_A 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDI 158 (373)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCC
T ss_pred cccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCC
Confidence 359999999998 2 2689999999 78999998 2 1 1 1 99999999999 8 9999999
Q ss_pred CCCcEEEcc------CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCc
Q 039565 67 KSTNILLNE------KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGIL 134 (188)
Q Consensus 67 ~~~nill~~------~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~ 134 (188)
||+||+++. .+.+||+|||++..... ......|+..|+||| ++.++|+||||+++|+|++|..
T Consensus 159 kp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 233 (373)
T 1q8y_A 159 KPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233 (373)
T ss_dssp SGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ChHHeEEeccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 999999953 34799999999875431 122346788999998 6889999999999999999999
Q ss_pred cccccCCC-----------------------------------------------------------CcCHHHHHHHHHH
Q 039565 135 TVDLSFKG-----------------------------------------------------------EFDIISVEKAVEI 155 (188)
Q Consensus 135 p~~~~~~~-----------------------------------------------------------~~~~~~~~~~~~l 155 (188)
||+..... ..+...+..+.++
T Consensus 234 pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 313 (373)
T 1q8y_A 234 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313 (373)
T ss_dssp CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHH
Confidence 99643211 1234567789999
Q ss_pred HHHccCcCCCCCCCHHHHHH
Q 039565 156 AMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 156 ~~~cl~~~p~~Rps~~~i~~ 175 (188)
+..||+.||++|||++++++
T Consensus 314 i~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 314 LSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHhccCccccCCHHHHhh
Confidence 99999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=204.87 Aligned_cols=162 Identities=15% Similarity=0.215 Sum_probs=130.3
Q ss_pred cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCCCcEE
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKSTNIL 72 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nil 72 (188)
.|+++++++++ .+..++||||+ +++|.+++ ... . |++.||.|||+ .+++||||||+||+
T Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil 150 (339)
T 1z57_A 75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENIL 150 (339)
T ss_dssp CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEE
T ss_pred CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEE
Confidence 45568999888 78899999999 68999998 222 1 99999999999 99999999999999
Q ss_pred Ecc-------------------CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHH
Q 039565 73 LNE-------------------KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 73 l~~-------------------~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~ 127 (188)
++. ++.+||+|||++..... ......|+..|+||| ++.++|+||||+++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (339)
T 1z57_A 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILI 225 (339)
T ss_dssp ESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHH
T ss_pred EeccccccccCCccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHH
Confidence 987 66799999999875321 123456888999998 688999999999999
Q ss_pred HHHhCCccccccCCCC-------------------------------------------------------cCHHHHHHH
Q 039565 128 EIITGILTVDLSFKGE-------------------------------------------------------FDIISVEKA 152 (188)
Q Consensus 128 ~~~~g~~p~~~~~~~~-------------------------------------------------------~~~~~~~~~ 152 (188)
++++|..||......+ .....+..+
T Consensus 226 el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 305 (339)
T 1z57_A 226 EYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305 (339)
T ss_dssp HHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHH
Confidence 9999999885432110 112345678
Q ss_pred HHHHHHccCcCCCCCCCHHHHHHH--Hhhc
Q 039565 153 VEIAMASVSSKVNRRPLMNQVVMV--REQG 180 (188)
Q Consensus 153 ~~l~~~cl~~~p~~Rps~~~i~~~--l~~~ 180 (188)
.+++..||+.||.+|||++++++. ++.+
T Consensus 306 ~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 306 FDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred HHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 899999999999999999999863 4443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=208.96 Aligned_cols=159 Identities=21% Similarity=0.289 Sum_probs=129.8
Q ss_pred cCCCeeeeccc---CCccEEEEec-CCCCChhhhcC-C--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 10 TGPLLVELIGK---QKNNALELGF-RGNPELVDQQG-K--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~-~~~~~L~~~~~-~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
+||||++++++ .+..++++|+ +.+++|.+++. + .. |++.||.|||+ .+++|+|+||+||++
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILI 172 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEE
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEE
Confidence 89999999998 7788999999 78899999982 2 22 99999999999 999999999999999
Q ss_pred c-cCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcccccc-----C
Q 039565 74 N-EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLS-----F 140 (188)
Q Consensus 74 ~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~-----~ 140 (188)
+ .++.++|+|||++..... .......|+..|++|| .+.++|+||||+++|++++|..||... .
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 248 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEA 248 (312)
T ss_dssp ETTTTEEEECCCSSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHT
T ss_pred eCCCCeEEEEEcchhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhh
Confidence 9 788999999999875431 1223456888999998 234799999999999999999998542 1
Q ss_pred CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+...+..+.+++..||+.+|++|||++++++
T Consensus 249 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 249 ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11233345668899999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-32 Score=208.12 Aligned_cols=165 Identities=21% Similarity=0.271 Sum_probs=125.7
Q ss_pred ccccc--CCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLT--GPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~--Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.+++ ||||++++++ ....+++|| +.+++|.+++ .... |++.||.|||+ .+++|+||||
T Consensus 80 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp 155 (313)
T 3cek_A 80 LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKP 155 (313)
T ss_dssp HHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCG
T ss_pred HHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCc
Confidence 34555 5999999998 778899999 5668999998 3222 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC-----------------CCccchHHHHHHHHHHHh
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-----------------TEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-----------------~~~~di~s~G~~l~~~~~ 131 (188)
+||++++ +.+||+|||++................|++.|+|||. +.++|+||||+++|+|++
T Consensus 156 ~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~ 234 (313)
T 3cek_A 156 ANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234 (313)
T ss_dssp GGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHH
T ss_pred ccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHh
Confidence 9999965 7999999999876532222222334568889999882 347999999999999999
Q ss_pred CCccccccCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 132 GILTVDLSFK--------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 132 g~~p~~~~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
|..||..... ...+...+..+.+++..||+.+|.+|||++++++
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 235 GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp SSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 9999864321 1222333567899999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=210.08 Aligned_cols=159 Identities=18% Similarity=0.222 Sum_probs=130.9
Q ss_pred cCCCeeeeccc---CCccEEEEecCCC-CChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 10 TGPLLVELIGK---QKNNALELGFRGN-PELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 10 ~Hpniv~~~~~---~~~~~lv~e~~~~-~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
.||||++++++ .+..++++|++.+ ++|.+++.. .. |++.||.|||+ .+++||||||+||++
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll 182 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILI 182 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEE
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEE
Confidence 36999999999 7788999999976 899999822 12 99999999999 999999999999999
Q ss_pred c-cCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC-----
Q 039565 74 N-EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF----- 140 (188)
Q Consensus 74 ~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~----- 140 (188)
+ .++.+||+|||++..... .......|+..|++|| .+.++|+||||+++|++++|..||....
T Consensus 183 ~~~~~~~kL~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 258 (320)
T 3a99_A 183 DLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 258 (320)
T ss_dssp ETTTTEEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC
T ss_pred eCCCCCEEEeeCcccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcc
Confidence 9 678999999999875431 1223456888999999 2567899999999999999999985321
Q ss_pred CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+...+..+.+++..||+.+|++|||++++++
T Consensus 259 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 259 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122334568899999999999999999999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=224.02 Aligned_cols=165 Identities=18% Similarity=0.252 Sum_probs=132.3
Q ss_pred cccccCCCeeeeccc---CCc-----cEEEEecCCCCChhhhc-CCcc---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK---QKN-----NALELGFRGNPELVDQQ-GKEE---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~-----~~lv~e~~~~~~L~~~~-~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+.+++||||++++++ .+. .++||||+++++|.+++ .... |++.||.|||+ .+|+|||||
T Consensus 133 l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlk 209 (681)
T 2pzi_A 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLK 209 (681)
T ss_dssp GGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred HHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccC
Confidence 678899999999998 222 69999999999999988 3333 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
|+||+++.+ .+||+|||+++.... .....|++.|++|| .+.++||||||+++|+|++|..|+......
T Consensus 210 p~NIll~~~-~~kl~DFG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~ 282 (681)
T 2pzi_A 210 PENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD 282 (681)
T ss_dssp GGGEEECSS-CEEECCCTTCEETTC------CSCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS
T ss_pred hHHeEEeCC-cEEEEecccchhccc------CCccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc
Confidence 999999985 899999999875431 13456899999999 577899999999999999999887654332
Q ss_pred CcC-----HHHHHHHHHHHHHccCcCCCCCCC-HHHHHHHHhhc
Q 039565 143 EFD-----IISVEKAVEIAMASVSSKVNRRPL-MNQVVMVREQG 180 (188)
Q Consensus 143 ~~~-----~~~~~~~~~l~~~cl~~~p~~Rps-~~~i~~~l~~~ 180 (188)
..+ ......+.+++..||+.+|.+||+ ++++.+.|.+.
T Consensus 283 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 283 GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 211 233567899999999999999995 66677666543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-31 Score=219.89 Aligned_cols=172 Identities=23% Similarity=0.222 Sum_probs=135.2
Q ss_pred cccccCCCeeeeccc---------CCccEEEEecCCCCChhhhc-CCc-----c---------cHHHHHHHHhcCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---------QKNNALELGFRGNPELVDQQ-GKE-----E---------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~-~~~-----~---------~i~~~l~~Lh~~~~~~i 61 (188)
+.+++||||++++++ ....++||||+++|+|.+++ ... . |++.||.|||+ .++
T Consensus 66 L~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gI 142 (676)
T 3qa8_A 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRI 142 (676)
T ss_dssp HHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTB
T ss_pred HHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCC
Confidence 567899999999887 45678999999999999999 321 1 99999999999 999
Q ss_pred EEeCCCCCcEEEccCCc---eEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhC
Q 039565 62 IQRDMKSTNILLNEKVQ---AKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~---~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g 132 (188)
+|||+||+||+++.++. ++|+|||.+...... .......|+..|++|| ++.++|+||||+++|++++|
T Consensus 143 VHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG 219 (676)
T 3qa8_A 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219 (676)
T ss_dssp CCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSS
T ss_pred ccCCCCHHHeEeecCCCceeEEEcccccccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHC
Confidence 99999999999997654 899999998764321 2233467889999999 57899999999999999999
Q ss_pred Ccccccc-----------------------------------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHH-----
Q 039565 133 ILTVDLS-----------------------------------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQ----- 172 (188)
Q Consensus 133 ~~p~~~~-----------------------------------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~----- 172 (188)
..||.+. .........+..+.+++..||..||++|||+++
T Consensus 220 ~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp 299 (676)
T 3qa8_A 220 FRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVG 299 (676)
T ss_dssp CSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCT
T ss_pred CCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCH
Confidence 9998532 011233456789999999999999999999977
Q ss_pred HHHHHhhccCc
Q 039565 173 VVMVREQGSGS 183 (188)
Q Consensus 173 i~~~l~~~~~~ 183 (188)
.++.++.+...
T Consensus 300 ~F~~l~~iL~~ 310 (676)
T 3qa8_A 300 CFQALDSILSL 310 (676)
T ss_dssp THHHHHHHHCC
T ss_pred HHHHHHHHHhc
Confidence 45555555443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=206.50 Aligned_cols=163 Identities=23% Similarity=0.309 Sum_probs=123.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC--Cc--c---------cHHHHHHHHhcCCCC-CcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG--KE--E---------VCCPGLEYLHQGLKH-PIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~--~~--~---------~i~~~l~~Lh~~~~~-~i~h~dl~~ 68 (188)
+..++||||++++++ .+..+++|||+. +.+..+.. .. . |++.||.|||+ . +++|+||+|
T Consensus 78 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp 153 (318)
T 2dyl_A 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKP 153 (318)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCG
T ss_pred HHhcCCCceeeEEEEEecCCcEEEEEeccC-CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCH
Confidence 456789999999998 778899999993 45555442 11 1 99999999998 6 999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
+||+++.++.+||+|||++..... ........++..|++|| ++.++|+||||+++|+|++|..||.
T Consensus 154 ~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 154 SNILLDERGQIKLCDFGISGRLVD---DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp GGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred HHEEECCCCCEEEEECCCchhccC---CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 999999999999999999865431 11223456788899888 3568999999999999999999986
Q ss_pred ccCC-------------CCc--CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LSFK-------------GEF--DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~~~-------------~~~--~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.... ... ....+..+.+++..||+.+|.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 231 NCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp TCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 4211 001 1124567899999999999999999999886
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=203.22 Aligned_cols=148 Identities=18% Similarity=0.251 Sum_probs=121.5
Q ss_pred ccccCCCeeeeccc-------CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 7 NKLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 7 ~~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
...+||||++++++ ....++||||+++++|.+++ ... . |++.||.|||+ .+++|+|
T Consensus 66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~d 142 (299)
T 3m2w_A 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRD 142 (299)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence 44689999999987 34578999999999999999 221 1 99999999999 9999999
Q ss_pred CCCCcEEEcc---CCceEEecccCcccccCCCCCcceeeecccccccCCCCCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 66 MKSTNILLNE---KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTELTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 66 l~~~nill~~---~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
|||+||+++. ++.++|+|||++..... ..++.++|+||||+++|+|++|..||......
T Consensus 143 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 204 (299)
T 3m2w_A 143 VKPENLLYTSKRPNAILKLTDFGFAKETTG------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 204 (299)
T ss_dssp CSGGGEEESSSSTTCCEEECCCTTCEECTT------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred CCHHHEEEecCCCCCcEEEecccccccccc------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcch
Confidence 9999999998 78899999998864320 12567899999999999999999998532110
Q ss_pred ---------------CcC----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 ---------------EFD----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ---------------~~~----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+ ...+..+.+++..||+.+|++|||++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 205 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ---CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111 124678999999999999999999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-31 Score=208.20 Aligned_cols=158 Identities=18% Similarity=0.174 Sum_probs=125.3
Q ss_pred CCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE
Q 039565 11 GPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKSTNILL 73 (188)
Q Consensus 11 Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill 73 (188)
|++|+++.+. ....++||||++ ++|.+++ ... . |++.||.|||+ ...+|+||||||+||++
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll 192 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILL 192 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEE
T ss_pred ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEE
Confidence 4458888887 788999999997 5999998 221 1 99999999994 12789999999999999
Q ss_pred c--cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC--
Q 039565 74 N--EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE-- 143 (188)
Q Consensus 74 ~--~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~-- 143 (188)
+ .++.+||+|||+++.... ......|++.|+||| ++.++|||||||++|+|++|..||......+
T Consensus 193 ~~~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 267 (382)
T 2vx3_A 193 CNPKRSAIKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM 267 (382)
T ss_dssp SSTTSCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ecCCCCcEEEEeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5 467899999999875431 123456888899998 6889999999999999999999886321100
Q ss_pred -------------------------------------------------------------------------cCHHHHH
Q 039565 144 -------------------------------------------------------------------------FDIISVE 150 (188)
Q Consensus 144 -------------------------------------------------------------------------~~~~~~~ 150 (188)
.......
T Consensus 268 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (382)
T 2vx3_A 268 NKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYL 347 (382)
T ss_dssp HHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHH
T ss_pred HHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhH
Confidence 0112335
Q ss_pred HHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 151 KAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 151 ~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.+.+++..||+.||++|||++++++
T Consensus 348 ~~~dli~~mL~~dP~~Rpta~e~L~ 372 (382)
T 2vx3_A 348 KFKDLILRMLDYDPKTRIQPYYALQ 372 (382)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHhcCCChhhCCCHHHHhc
Confidence 7899999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-31 Score=205.93 Aligned_cols=154 Identities=19% Similarity=0.292 Sum_probs=123.5
Q ss_pred Ceeeeccc---CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCCCCcEEE--
Q 039565 13 LLVELIGK---QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMKSTNILL-- 73 (188)
Q Consensus 13 niv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nill-- 73 (188)
+++.+.++ ....+++|||+. ++|.+++ ... . |++.||.|||+ .+++||||||+||++
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~ 158 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVN 158 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESC
T ss_pred eEEEeeeeeeeCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEec
Confidence 37887776 788999999995 5676666 221 1 99999999999 999999999999999
Q ss_pred -----------------ccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHH
Q 039565 74 -----------------NEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEII 130 (188)
Q Consensus 74 -----------------~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~ 130 (188)
+.++.+||+|||++..... ......|+..|+||| ++.++|+||||+++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 233 (355)
T 2eu9_A 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233 (355)
T ss_dssp CCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHH
Confidence 5678999999999875321 123456888999998 688999999999999999
Q ss_pred hCCccccccCCCC-------------------------------------------------------cCHHHHHHHHHH
Q 039565 131 TGILTVDLSFKGE-------------------------------------------------------FDIISVEKAVEI 155 (188)
Q Consensus 131 ~g~~p~~~~~~~~-------------------------------------------------------~~~~~~~~~~~l 155 (188)
+|..||......+ ........+.++
T Consensus 234 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 313 (355)
T 2eu9_A 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313 (355)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHH
Confidence 9999986432110 011234578899
Q ss_pred HHHccCcCCCCCCCHHHHHH
Q 039565 156 AMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 156 ~~~cl~~~p~~Rps~~~i~~ 175 (188)
+..||+.||++|||++++++
T Consensus 314 i~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 314 MRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHhcCChhhCcCHHHHhc
Confidence 99999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=192.27 Aligned_cols=143 Identities=14% Similarity=0.019 Sum_probs=111.9
Q ss_pred ccEEEEecCCCCChhhhcC------Ccc-------------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEec
Q 039565 23 NNALELGFRGNPELVDQQG------KEE-------------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLAD 83 (188)
Q Consensus 23 ~~~lv~e~~~~~~L~~~~~------~~~-------------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d 83 (188)
..+++|+.+ +++|.++++ ... |++.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcccceEEEecCCeEEEEe
Confidence 345666655 478988882 111 99999999999 9999999999999999999999999
Q ss_pred ccCcccccCCCCCcceeeecccccccCCCC----------------CCccchHHHHHHHHHHHhCCccccccCCCCc---
Q 039565 84 FGQSRISPVEGGTHMSTTIAGTAGFLNTEL----------------TEKSDVDSFEIVILEIITGILTVDLSFKGEF--- 144 (188)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~----------------~~~~di~s~G~~l~~~~~g~~p~~~~~~~~~--- 144 (188)
||+++.... ......| +.|+|||. +.++|||||||++|+|++|..||........
T Consensus 255 FG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~ 328 (413)
T 3dzo_A 255 FEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW 328 (413)
T ss_dssp GGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG
T ss_pred ccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH
Confidence 999875321 1334566 88999982 2489999999999999999999965422110
Q ss_pred ----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 145 ----DIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 145 ----~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+..+.+++..||+.+|++|||+.++++
T Consensus 329 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 329 IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1134578999999999999999999877654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=183.20 Aligned_cols=138 Identities=14% Similarity=0.036 Sum_probs=110.1
Q ss_pred CccEEEEecCCCCChhhhc-CC-cc---------cHHHHHHHHh-cCCCCCcEEeCCCCCcEEEccCC------------
Q 039565 22 KNNALELGFRGNPELVDQQ-GK-EE---------VCCPGLEYLH-QGLKHPIIQRDMKSTNILLNEKV------------ 77 (188)
Q Consensus 22 ~~~~lv~e~~~~~~L~~~~-~~-~~---------~i~~~l~~Lh-~~~~~~i~h~dl~~~nill~~~~------------ 77 (188)
...++||||+++|++.+.+ +. .. |++.||.||| + .+|+||||||+||+++.++
T Consensus 135 ~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~ 211 (336)
T 2vuw_A 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKS 211 (336)
T ss_dssp TCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEE
T ss_pred CeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCcc
Confidence 6789999999999766666 32 22 9999999999 8 9999999999999999887
Q ss_pred --------ceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHH-HHHHHhCCcccccc----
Q 039565 78 --------QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIV-ILEIITGILTVDLS---- 139 (188)
Q Consensus 78 --------~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~-l~~~~~g~~p~~~~---- 139 (188)
.+||+|||+++.... ....||+.|+||| .+.++||||++++ .+++++|..||...
T Consensus 212 ~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~ 284 (336)
T 2vuw_A 212 STIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLH 284 (336)
T ss_dssp EEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH
T ss_pred ccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhh
Confidence 899999999986431 1347899999999 3668999998766 67778898888531
Q ss_pred -----------CC----CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 039565 140 -----------FK----GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174 (188)
Q Consensus 140 -----------~~----~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~ 174 (188)
.. .......+..+.+++..||+.+ |+++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 285 YLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 11 1122357788999999999966 999888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-28 Score=203.56 Aligned_cols=123 Identities=15% Similarity=0.127 Sum_probs=91.0
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEE
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTNIL 72 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nil 72 (188)
|+++ .|+||++++++ +...||||||++|++|.+++.+.+ |++.||+|+|+ .+|+||||||+|||
T Consensus 295 l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~---~GIIHRDIKPeNIL 371 (569)
T 4azs_A 295 LTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEK---QGFWHDDVRPWNVM 371 (569)
T ss_dssp HHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHH---TTCEESCCCGGGEE
T ss_pred HHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHH---CCceeccCchHhEE
Confidence 4556 79999999999 788999999999999999993322 99999999999 99999999999999
Q ss_pred EccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCC
Q 039565 73 LNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGI 133 (188)
Q Consensus 73 l~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~ 133 (188)
++.+|.+||+|||+++..... .....+..||+.|++|| ....+|+||+|+..+.+.++.
T Consensus 372 L~~dg~vKL~DFGlAr~~~~~--~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 372 VDARQHARLIDFGSIVTTPQD--CSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC-----------------CCCCTTH
T ss_pred ECCCCCEEEeecccCeeCCCC--CccccCceechhhccHHHhCCCCCCcccccccccchhhhcccc
Confidence 999999999999999864321 12234567999999998 456799999999887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.8e-21 Score=158.91 Aligned_cols=126 Identities=12% Similarity=0.127 Sum_probs=101.2
Q ss_pred cccccCCCee--eeccc-CCccEEEEecCCCCChhhhcCCcc----cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCc
Q 039565 6 RNKLTGPLLV--ELIGK-QKNNALELGFRGNPELVDQQGKEE----VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQ 78 (188)
Q Consensus 6 l~~l~Hpniv--~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~----~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~ 78 (188)
+++++||||+ ++++. .+..++||||+++++|.+++.... |++.||.|||+ .+|+||||||+||+++. .
T Consensus 393 l~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~ 467 (540)
T 3en9_A 393 LALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--D 467 (540)
T ss_dssp HHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTTCTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--S
T ss_pred HHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--e
Confidence 5678999999 55666 788899999999999999995422 99999999999 99999999999999999 9
Q ss_pred eEEecccCcccccCCCCCc-----ceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCccc
Q 039565 79 AKLADFGQSRISPVEGGTH-----MSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 79 ~kl~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
+||+|||+++......... ......||+.|++|| ++..+|+||...-..+-+.++.++
T Consensus 468 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 468 LYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9999999998653111111 123568999999999 466789999887777766655444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=6.3e-15 Score=112.38 Aligned_cols=71 Identities=18% Similarity=0.186 Sum_probs=60.7
Q ss_pred eeeccc--CCccEEEEecCCCCChhhhcCCcc------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccC
Q 039565 15 VELIGK--QKNNALELGFRGNPELVDQQGKEE------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQ 86 (188)
Q Consensus 15 v~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~ 86 (188)
+++.++ .+..++||||+++++|.+ +.... |++.||.|||+ .+++|||+||+||+++ ++.++|+|||+
T Consensus 164 ~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 164 LAVPKVYAWEGNAVLMELIDAKELYR-VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp SSSCCEEEEETTEEEEECCCCEEGGG-CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred CCcCeEEeccceEEEEEecCCCcHHH-cchhhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 455555 566799999999999999 52222 99999999999 9999999999999999 99999999999
Q ss_pred cccc
Q 039565 87 SRIS 90 (188)
Q Consensus 87 ~~~~ 90 (188)
++..
T Consensus 239 a~~~ 242 (282)
T 1zar_A 239 SVEV 242 (282)
T ss_dssp CEET
T ss_pred CeEC
Confidence 8753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=1e-12 Score=98.78 Aligned_cols=79 Identities=16% Similarity=0.225 Sum_probs=60.5
Q ss_pred cccccCCCe--eeecccCCccEEEEecCCC-C----ChhhhcCCc---c------cHHHHHHHHh-cCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLL--VELIGKQKNNALELGFRGN-P----ELVDQQGKE---E------VCCPGLEYLH-QGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpni--v~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~---~------~i~~~l~~Lh-~~~~~~i~h~dl~~ 68 (188)
|.+++|+++ +++++ ....++||||+.+ | +|.++.... . |++.||.||| + .+++|||+||
T Consensus 124 l~~l~~~~i~~p~~~~-~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~givHrDlkp 199 (258)
T 1zth_A 124 LERAKEAGVSVPQPYT-YMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQE---AELVHADLSE 199 (258)
T ss_dssp HHHHHHTTCCCCCEEE-EETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHT---SCEECSSCST
T ss_pred HHHHHhCCCCCCeEEE-cCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCH
Confidence 455666653 22332 3467899999942 3 777766221 1 9999999999 8 9999999999
Q ss_pred CcEEEccCCceEEecccCcccc
Q 039565 69 TNILLNEKVQAKLADFGQSRIS 90 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~ 90 (188)
.||+++. .++|+|||++...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 8999999998753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.07 E-value=3e-11 Score=95.55 Aligned_cols=76 Identities=16% Similarity=0.180 Sum_probs=59.8
Q ss_pred CCCeeeeccc---------CCccEEEEecCCCCChhhhcCCcc------cHHHHHHHHhcCCCCCcEEeCCCCCcEEEcc
Q 039565 11 GPLLVELIGK---------QKNNALELGFRGNPELVDQQGKEE------VCCPGLEYLHQGLKHPIIQRDMKSTNILLNE 75 (188)
Q Consensus 11 Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~~~~~------~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~ 75 (188)
|+|+.+++.. ....++||||+++++|..+..... |++.+|.+||. .+++||||||.|||++.
T Consensus 164 ~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 164 FAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIRE 240 (397)
T ss_dssp HHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEE
T ss_pred HHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeC
Confidence 6666666433 234579999999989887663222 99999999999 99999999999999987
Q ss_pred CC----------ceEEecccCccc
Q 039565 76 KV----------QAKLADFGQSRI 89 (188)
Q Consensus 76 ~~----------~~kl~d~~~~~~ 89 (188)
++ .+.+.||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 378999986653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=7.7e-07 Score=66.33 Aligned_cols=78 Identities=10% Similarity=0.122 Sum_probs=59.9
Q ss_pred CCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------cHHHHHHHHhcC------------------------
Q 039565 11 GPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------VCCPGLEYLHQG------------------------ 56 (188)
Q Consensus 11 Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------~i~~~l~~Lh~~------------------------ 56 (188)
+.++++++++ ....+++||+++|.+|.+.+ .... +++.++..||+-
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhc
Confidence 4567777766 66789999999999998875 1111 888999999971
Q ss_pred --------------------------------CCCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 57 --------------------------------LKHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 57 --------------------------------~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
....++|+|+++.||+++.+....+.||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876566799998664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.22 E-value=1.3e-06 Score=64.66 Aligned_cols=74 Identities=15% Similarity=0.147 Sum_probs=54.5
Q ss_pred eeeeccc---CCccEEEEecCCCCChhhhcCCc-----ccHHHHHHHHhcCC----------------------------
Q 039565 14 LVELIGK---QKNNALELGFRGNPELVDQQGKE-----EVCCPGLEYLHQGL---------------------------- 57 (188)
Q Consensus 14 iv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-----~~i~~~l~~Lh~~~---------------------------- 57 (188)
+.++++. ++..+++|||+++.+|. +-... .+++..+..||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~-~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL-SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ 155 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT-TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC-cCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence 4556666 55679999999998885 22111 17788888888621
Q ss_pred ---------------------------CCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 58 ---------------------------KHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 58 ---------------------------~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
..+++|+|++|.||+++.++..++.||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999877667799998765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.76 E-value=3.9e-05 Score=59.80 Aligned_cols=78 Identities=13% Similarity=0.125 Sum_probs=56.5
Q ss_pred CCeeeeccc---C---CccEEEEecCCCCChhhh-cCCc---------ccHHHHHHHHhcCC------------------
Q 039565 12 PLLVELIGK---Q---KNNALELGFRGNPELVDQ-QGKE---------EVCCPGLEYLHQGL------------------ 57 (188)
Q Consensus 12 pniv~~~~~---~---~~~~lv~e~~~~~~L~~~-~~~~---------~~i~~~l~~Lh~~~------------------ 57 (188)
.++++++.. . ...++||||+++.++.+. +... .+++.+|+.||...
T Consensus 98 vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3dxp_A 98 VPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQR 177 (359)
T ss_dssp SCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHH
T ss_pred CCCCcEEEECCCCCccCCeEEEEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHH
Confidence 446666666 2 347899999998877532 2221 17889999999621
Q ss_pred -------------------------------------CCCcEEeCCCCCcEEEccCCc--eEEecccCccc
Q 039565 58 -------------------------------------KHPIIQRDMKSTNILLNEKVQ--AKLADFGQSRI 89 (188)
Q Consensus 58 -------------------------------------~~~i~h~dl~~~nill~~~~~--~kl~d~~~~~~ 89 (188)
...++|+|+++.||+++.++. +.+.||+.+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 178 QIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256899999999999987653 68999998763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.53 E-value=4.5e-05 Score=58.06 Aligned_cols=78 Identities=22% Similarity=0.282 Sum_probs=46.1
Q ss_pred CCcEEeCCCCCcEEEcc--CCceEEecccCcccccCC-------CC---C--cceeeecccccccC-CCC----CCccch
Q 039565 59 HPIIQRDMKSTNILLNE--KVQAKLADFGQSRISPVE-------GG---T--HMSTTIAGTAGFLN-TEL----TEKSDV 119 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~--~~~~kl~d~~~~~~~~~~-------~~---~--~~~~~~~~~~~~~~-pe~----~~~~di 119 (188)
..++|+|+++.||+++. ...+.+.||+.+...... .. . .....+........ |+. .-..+.
T Consensus 191 ~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~ 270 (304)
T 3sg8_A 191 PCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKY 270 (304)
T ss_dssp CEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHH
T ss_pred ceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHH
Confidence 35799999999999998 456789999877542100 00 0 00000000001111 111 112578
Q ss_pred HHHHHHHHHHHhCCccc
Q 039565 120 DSFEIVILEIITGILTV 136 (188)
Q Consensus 120 ~s~G~~l~~~~~g~~p~ 136 (188)
|+++.++|.+.+|..++
T Consensus 271 ~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 271 WSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHcCCHHH
Confidence 99999999999998665
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0032 Score=46.66 Aligned_cols=29 Identities=17% Similarity=0.286 Sum_probs=25.1
Q ss_pred CcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 60 PIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 60 ~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
.++|+|+.+.||+++.++...|.||+.+.
T Consensus 194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 37899999999999987777899998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=95.76 E-value=0.014 Score=44.37 Aligned_cols=31 Identities=26% Similarity=0.489 Sum_probs=24.9
Q ss_pred CCcEEeCCCCCcEEEcc---CCc-eEEecccCccc
Q 039565 59 HPIIQRDMKSTNILLNE---KVQ-AKLADFGQSRI 89 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~---~~~-~kl~d~~~~~~ 89 (188)
..++|+|+.+.|++++. ++. ..+.||+.+..
T Consensus 190 ~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 190 PRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred CeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 35699999999999987 355 48999987653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=94.28 E-value=0.038 Score=42.04 Aligned_cols=31 Identities=23% Similarity=0.275 Sum_probs=27.5
Q ss_pred CCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
...++|+|+++.||+++.++.+.+.||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 3789999999999999877889999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=92.32 E-value=0.058 Score=42.75 Aligned_cols=30 Identities=13% Similarity=0.293 Sum_probs=26.4
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCccc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~~ 89 (188)
..++|+|+++.||+++.++ +.+.||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 6799999999999998776 99999987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=91.08 E-value=0.72 Score=33.44 Aligned_cols=115 Identities=13% Similarity=0.089 Sum_probs=62.0
Q ss_pred cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCCC-----CCccch
Q 039565 45 VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL-----TEKSDV 119 (188)
Q Consensus 45 ~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~-----~~~~di 119 (188)
|.+.+|.-+-.. ..-..+=..|..|++..+|.+.+.+ ..+. ... ..+.+|+. +.+.-|
T Consensus 57 Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------~~~-----~~~~~pe~~~~~~te~~~I 119 (229)
T 2yle_A 57 QCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------AGE-----PPPVAGKLGYSQCMETEVI 119 (229)
T ss_dssp HHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C--------------------------CCSSSSSCHHHHH
T ss_pred HHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc---------ccc-----cCCCChhhccccchHHHHH
Confidence 666666554210 0111122345788888888877653 1110 000 11234443 567779
Q ss_pred HHHHHHHHHHHhCCccccccCCCCcCHHHHHHHHHHHHHccCc-------------------------CCCCCCCHHHHH
Q 039565 120 DSFEIVILEIITGILTVDLSFKGEFDIISVEKAVEIAMASVSS-------------------------KVNRRPLMNQVV 174 (188)
Q Consensus 120 ~s~G~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~l~~~cl~~-------------------------~p~~Rps~~~i~ 174 (188)
+|+|+++|.-+.-..|-+.. ...++.+-+++..|... .+..|++.++|+
T Consensus 120 ysLG~tLY~ALDygL~e~eE------~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi 193 (229)
T 2yle_A 120 ESLGIIIYKALDYGLKENEE------RELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVM 193 (229)
T ss_dssp HHHHHHHHHHHTTTCCTTEE------ECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHH
T ss_pred HHHHHHHHHHhhcCCCcccc------hhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHH
Confidence 99999999987654443322 22334444555555433 346889999999
Q ss_pred HHHhhccC
Q 039565 175 MVREQGSG 182 (188)
Q Consensus 175 ~~l~~~~~ 182 (188)
+..+.-..
T Consensus 194 ~~C~~hl~ 201 (229)
T 2yle_A 194 KLCAAHLP 201 (229)
T ss_dssp HHHHTTSS
T ss_pred HHHHhhcc
Confidence 88765544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=90.69 E-value=0.079 Score=40.09 Aligned_cols=30 Identities=20% Similarity=0.235 Sum_probs=25.6
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
.+++|+|+.+.||+++.+....+.||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 478999999999999887666899998664
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=90.43 E-value=0.093 Score=40.36 Aligned_cols=30 Identities=13% Similarity=0.199 Sum_probs=25.4
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
..++|+|+.+.||+++++..+.+.||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 678999999999999964457899998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=89.89 E-value=0.13 Score=39.22 Aligned_cols=31 Identities=19% Similarity=0.456 Sum_probs=26.5
Q ss_pred CCcEEeCCCCCcEEEccC----CceEEecccCccc
Q 039565 59 HPIIQRDMKSTNILLNEK----VQAKLADFGQSRI 89 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~----~~~kl~d~~~~~~ 89 (188)
..++|+|+.+.||+++.+ +.+.+.||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 578999999999999874 6789999987754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=86.73 E-value=0.26 Score=37.33 Aligned_cols=28 Identities=21% Similarity=0.312 Sum_probs=24.2
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
..++|+|+++.||+++ + .+.+.||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 5689999999999999 4 88999997665
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=86.32 E-value=0.32 Score=37.97 Aligned_cols=29 Identities=21% Similarity=0.331 Sum_probs=24.8
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
..++|+|+.+.||+++.+ .+.+.||..+.
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 678999999999999876 48899997665
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=85.98 E-value=0.26 Score=37.80 Aligned_cols=30 Identities=13% Similarity=0.312 Sum_probs=26.5
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
..++|+|+.+.|++++.++.+.+.||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 578999999999999987889999997665
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=85.14 E-value=0.35 Score=37.37 Aligned_cols=29 Identities=28% Similarity=0.397 Sum_probs=23.6
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
..++|+|+.+.||+++.++ +.+.||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 4689999999999998654 8899997665
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=84.86 E-value=0.4 Score=35.90 Aligned_cols=29 Identities=17% Similarity=0.126 Sum_probs=24.2
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
..++|+|+.+.|++ ..++.+.+.||..+.
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 45899999999999 556678999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=81.13 E-value=0.62 Score=37.04 Aligned_cols=18 Identities=28% Similarity=0.433 Sum_probs=15.2
Q ss_pred CCcEEeCCCCCcEEEccC
Q 039565 59 HPIIQRDMKSTNILLNEK 76 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~ 76 (188)
..++|+|+.+.||+++.+
T Consensus 249 ~v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 249 VTFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEEECSCCCGGGEEEEC-
T ss_pred eEEEeCCCCCCeEEeeCC
Confidence 357999999999999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 188 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-21 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-17 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-17 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-17 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-17 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-17 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-16 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-16 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-16 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-16 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-16 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-16 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-15 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-15 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-15 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-15 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-15 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-14 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-14 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-14 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-14 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-14 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-14 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-13 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-13 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-13 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-13 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-12 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-12 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-12 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-12 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-11 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-11 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-11 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-11 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-11 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-10 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-10 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-10 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-10 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-10 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-09 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-09 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-09 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-09 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-09 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-09 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-09 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-08 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-08 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-08 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-08 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-07 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-07 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-07 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-06 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-06 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-06 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-05 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-05 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.8 bits (212), Expect = 4e-21
Identities = 38/160 (23%), Positives = 67/160 (41%), Gaps = 29/160 (18%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
G++YLH II RD+KS NI L+E + K+ DFG + + G+H ++G+
Sbjct: 113 TAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 106 AGFLNTE---------LTEKSDVDSFEIVILEIITG---------------ILTVDLSFK 141
++ E + +SDV +F IV+ E++TG ++
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229
Query: 142 GEFDIIS--VEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179
+ S + + + K + RPL Q++ E
Sbjct: 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.8 bits (186), Expect = 1e-17
Identities = 30/152 (19%), Positives = 59/152 (38%), Gaps = 23/152 (15%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
G+ ++ + I RD+++ NIL+++ + K+ADFG +R+ +
Sbjct: 118 IAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFP 173
Query: 106 AGFL------NTELTEKSDVDSFEIVILEIITG-------------ILTVDLSFKGEFDI 146
+ T KSDV SF I++ EI+T I ++ ++
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233
Query: 147 ISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178
E+ ++ + RP + + V E
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.9 bits (186), Expect = 2e-17
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 12/90 (13%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YL + KH I+ RD+K +NIL+N + + KL DFG S M+ + GT +
Sbjct: 116 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSY 169
Query: 109 LNTEL------TEKSDVDSFEIVILEIITG 132
++ E + +SD+ S + ++E+ G
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.0 bits (184), Expect = 3e-17
Identities = 30/149 (20%), Positives = 53/149 (35%), Gaps = 25/149 (16%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLN-EKVQAKLADFGQSRISPVEGGTHMSTTIAG 104
GL++LH PII RD+K NI + K+ D G + + + + G
Sbjct: 121 ILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIG 175
Query: 105 TAGF-----LNTELTEKSDVDSFEIVILEIITGIL--------------TVDLSFKGEFD 145
T F + E DV +F + +LE+ T FD
Sbjct: 176 TPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235
Query: 146 IISVEKAVEIAMASVSSKVNRRPLMNQVV 174
+++ + EI + + R + ++
Sbjct: 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.1 bits (184), Expect = 3e-17
Identities = 29/148 (19%), Positives = 54/148 (36%), Gaps = 23/148 (15%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
G+ Y+ + + RD+++ NIL+ E + K+ADFG +R+ +
Sbjct: 122 IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFP 177
Query: 106 AGF------LNTELTEKSDVDSFEIVILEIITG-------------ILTVDLSFKGEFDI 146
+ L T KSDV SF I++ E+ T + V+ ++
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 237
Query: 147 ISVEKAVEIAMASVSSKVNRRPLMNQVV 174
E ++ + RP +
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQ 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 74.9 bits (183), Expect = 5e-17
Identities = 28/150 (18%), Positives = 50/150 (33%), Gaps = 22/150 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
G+ YL + + RD+ + N L+ E + K+ADFG SR A +
Sbjct: 152 GMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRW 208
Query: 109 ------LNTELTEKSDVDSFEIVILEIITGIL----------TVDLSFKGEFDIIS---V 149
T +SDV ++ +V+ EI + L + G
Sbjct: 209 MPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCP 268
Query: 150 EKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179
+ + S RP + + ++
Sbjct: 269 LELYNLMRLCWSKLPADRPSFCSIHRILQR 298
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.5 bits (180), Expect = 1e-16
Identities = 29/98 (29%), Positives = 45/98 (45%), Gaps = 10/98 (10%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
G+ YLH I RD+K N+LL+E+ K++DFG + + + + GT
Sbjct: 113 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 107 GFLNTEL-------TEKSDVDSFEIVILEIITGILTVD 137
++ EL E DV S IV+ ++ G L D
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 73.2 bits (179), Expect = 2e-16
Identities = 31/153 (20%), Positives = 59/153 (38%), Gaps = 25/153 (16%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAG- 107
G++YL + RD+ + NIL+N + K++DFG SR + T+ G
Sbjct: 140 GMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 108 --------FLNTELTEKSDVDSFEIVILEIITG-------------ILTVDLSFKGEFDI 146
+ T SDV S+ IV+ E+++ I ++ ++ +
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256
Query: 147 ISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179
++ + N RP Q+V ++
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (177), Expect = 3e-16
Identities = 27/146 (18%), Positives = 50/146 (34%), Gaps = 23/146 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAG- 107
G+E+L + RD+ + N+L+ K+ DFG +R + +
Sbjct: 176 GMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKW 232
Query: 108 -----FLNTELTEKSDVDSFEIVILEIITG--------------ILTVDLSFKGEFDIIS 148
T KSDV S+ I++ EI + + FK + +
Sbjct: 233 MAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA 292
Query: 149 VEKAVEIAMASVSSKVNRRPLMNQVV 174
E+ I + + +RP +
Sbjct: 293 TEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.6 bits (175), Expect = 4e-16
Identities = 29/148 (19%), Positives = 55/148 (37%), Gaps = 23/148 (15%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
C +EYL + RD+ + N L+N++ K++DFG SR + S
Sbjct: 109 VCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFP 164
Query: 106 AGFLNTE------LTEKSDVDSFEIVILEIITG-------------ILTVDLSFKGEFDI 146
+ E + KSD+ +F +++ EI + + +
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 224
Query: 147 ISVEKAVEIAMASVSSKVNRRPLMNQVV 174
++ EK I + K + RP ++
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILL 252
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.9 bits (176), Expect = 4e-16
Identities = 34/146 (23%), Positives = 62/146 (42%), Gaps = 22/146 (15%)
Query: 49 GLEYLHQ--GLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
L+ H+ H ++ RD+K N+ L+ K KL DFG +RI + T + GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTP 178
Query: 107 GFLNTEL------TEKSDVDSFEIVILEIITGIL---------TVDLSFKGEFDIISV-- 149
+++ E EKSD+ S ++ E+ + +G+F I
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 150 -EKAVEIAMASVSSKVNRRPLMNQVV 174
++ EI ++ K RP + +++
Sbjct: 239 SDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (175), Expect = 5e-16
Identities = 34/190 (17%), Positives = 65/190 (34%), Gaps = 29/190 (15%)
Query: 11 GPLLVELIGKQKNNALELGFRGNPELVDQQGKEEVCCP------GLEYLHQGLKHPIIQR 64
L + ++N + D E + C G+E+L I R
Sbjct: 102 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHR 158
Query: 65 DMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAG------FLNTELTEKSD 118
D+ + NILL+EK K+ DFG +R + + T +SD
Sbjct: 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 218
Query: 119 VDSFEIVILEIITGILTVDLSFKGEFDIISV--------------EKAVEIAMASVSSKV 164
V SF +++ EI + + K + + + + + +
Sbjct: 219 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 278
Query: 165 NRRPLMNQVV 174
++RP +++V
Sbjct: 279 SQRPTFSELV 288
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.8 bits (170), Expect = 4e-15
Identities = 24/147 (16%), Positives = 53/147 (36%), Gaps = 22/147 (14%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
G+ YL ++ RD+ + N+L+ K+ DFG +++ E + +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 107 GFLNTE------LTEKSDVDSFEIVILEIITG-------------ILTVDLSFKGEFDII 147
++ E T +SDV S+ + + E++T ++ + I
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 237
Query: 148 SVEKAVEIAMASVSSKVNRRPLMNQVV 174
I + + RP +++
Sbjct: 238 CTIDVYMIMVKCWMIDADSRPKFRELI 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.3 bits (169), Expect = 4e-15
Identities = 27/149 (18%), Positives = 57/149 (38%), Gaps = 20/149 (13%)
Query: 45 VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAG 104
+C E + + +I RD+ + N L+ E K++DFG +R + ST
Sbjct: 106 MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKF 164
Query: 105 TAGFLNTE------LTEKSDVDSFEIVILEIITG-------------ILTVDLSFKGEFD 145
+ + E + KSDV SF +++ E+ + + + F+
Sbjct: 165 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 224
Query: 146 IISVEKAVEIAMASVSSKVNRRPLMNQVV 174
++ +I + RP ++++
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.4 bits (169), Expect = 5e-15
Identities = 34/152 (22%), Positives = 60/152 (39%), Gaps = 25/152 (16%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
G++YL Q I RD+ + NIL+ E AK+ADFG SR V T
Sbjct: 137 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPV 190
Query: 107 GFLNTE------LTEKSDVDSFEIVILEIITG-------------ILTVDLSFKGEFDII 147
++ E T SDV S+ +++ EI++ + ++ E +
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 250
Query: 148 SVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179
++ ++ K RP Q+++ +
Sbjct: 251 CDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (168), Expect = 5e-15
Identities = 30/150 (20%), Positives = 58/150 (38%), Gaps = 20/150 (13%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR-ISPVEGGTHMSTTIAGTAGF 108
+ + RD+ + NIL+N + K++DFG SR + T+ ++ +
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 109 LNTEL------TEKSDVDSFEIVILEIITG-------------ILTVDLSFKGEFDIISV 149
E T SDV SF IV+ E++T + ++ F+ +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239
Query: 150 EKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179
++ M + RRP +V + ++
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.8 bits (168), Expect = 6e-15
Identities = 37/149 (24%), Positives = 62/149 (41%), Gaps = 32/149 (21%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
L Y H +I RD+K N+LL + K+ADFG S +P + TT+ GT
Sbjct: 116 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTL 168
Query: 107 GFLNTEL------TEKSDVDSFEIVILEIITG---------------ILTVDLSFKGEFD 145
+L E+ EK D+ S ++ E + G I V+ +F
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 228
Query: 146 IISVEKAVEIAMASVSSKVNRRPLMNQVV 174
E A ++ + ++RP++ +V+
Sbjct: 229 ----EGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (165), Expect = 2e-14
Identities = 29/154 (18%), Positives = 54/154 (35%), Gaps = 23/154 (14%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
G+ +L I RD+ + NILL K+ DFG +R + +
Sbjct: 154 VAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 106 AGFL------NTELTEKSDVDSFEIVILEIITG--------------ILTVDLSFKGEFD 145
++ N T +SDV S+ I + E+ + + F+
Sbjct: 211 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 270
Query: 146 IISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQ 179
+ + +I + +RP Q+V + E+
Sbjct: 271 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.1 bits (163), Expect = 3e-14
Identities = 31/148 (20%), Positives = 55/148 (37%), Gaps = 23/148 (15%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
+EYL + I RD+ + N L+ E K+ADFG SR+
Sbjct: 124 ISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 179
Query: 106 AGFL------NTELTEKSDVDSFEIVILEIITGILT-------------VDLSFKGEFDI 146
+ + + KSDV +F +++ EI T ++ ++ ++ E
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 239
Query: 147 ISVEKAVEIAMASVSSKVNRRPLMNQVV 174
EK E+ A + RP ++
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.2 bits (161), Expect = 5e-14
Identities = 32/148 (21%), Positives = 57/148 (38%), Gaps = 19/148 (12%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
C +EYL + + RD+ + N+L++E AK++DFG ++ + + TA
Sbjct: 113 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVKWTA 168
Query: 107 --GFLNTELTEKSDVDSFEIVILEIITG-------------ILTVDLSFKGEFDIISVEK 151
+ + KSDV SF I++ EI + + V+ +K +
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228
Query: 152 AVEIAMASVSSKVNRRPLMNQVVMVREQ 179
E+ RP Q+ E
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.9 bits (160), Expect = 6e-14
Identities = 24/149 (16%), Positives = 53/149 (35%), Gaps = 23/149 (15%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR-ISPVEGGTHMSTTIAG 104
G++YL + + RD+ + N+LL + AK++DFG S+ + + +
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 105 TAGFL------NTELTEKSDVDSFEIVILEIITG-------------ILTVDLSFKGEFD 145
+ + + +SDV S+ + + E ++ + ++ + E
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 234
Query: 146 IISVEKAVEIAMASVSSKVNRRPLMNQVV 174
+ + K RP V
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVE 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.8 bits (160), Expect = 7e-14
Identities = 28/97 (28%), Positives = 39/97 (40%), Gaps = 16/97 (16%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
L YLH + II RD+K+ NIL KLADFG S + GT
Sbjct: 120 LDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTP 174
Query: 107 GFLNTEL-----------TEKSDVDSFEIVILEIITG 132
++ E+ K+DV S I ++E+
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 211
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 9e-14
Identities = 29/151 (19%), Positives = 55/151 (36%), Gaps = 21/151 (13%)
Query: 45 VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGG--THMSTTI 102
+ + + RD+ + N +L+EK K+ADFG +R + H T
Sbjct: 135 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 103 AGTAGFLNTEL------TEKSDVDSFEIVILEIITG-------------ILTVDLSFKGE 143
++ E T KSDV SF +++ E++T + + +
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 254
Query: 144 FDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174
+ E+ + K RP +++V
Sbjct: 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 285
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 65.4 bits (159), Expect = 1e-13
Identities = 30/93 (32%), Positives = 42/93 (45%), Gaps = 18/93 (19%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGF 108
GL YLH H +I RD+K+ NILL+E KL DFG + I + + GT +
Sbjct: 127 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYW 177
Query: 109 LNTEL---------TEKSDVDSFEIVILEIITG 132
+ E+ K DV S I +E+
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.5 bits (156), Expect = 3e-13
Identities = 30/148 (20%), Positives = 56/148 (37%), Gaps = 22/148 (14%)
Query: 47 CPGLEYLHQGL-----KHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGT--HMS 99
GL +LH + K I RD+KS NIL+ + +AD G + T
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169
Query: 100 TTIAGTAGFLNTEL------------TEKSDVDSFEIVILEIITGILTVDLSFKGE---F 144
GT ++ E+ +++D+ + +V EI + + +
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229
Query: 145 DIISVEKAVEIAMASVSSKVNRRPLMNQ 172
D++ + +VE V + R + N+
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNR 257
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.9 bits (155), Expect = 4e-13
Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
+ L II RD+K NILLNE + ++ DFG +++ E + + GTA ++
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 110 NTEL------TEKSDVDSFEIVILEIITG 132
+ EL + SD+ + +I +++ G
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAG 206
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.9 bits (155), Expect = 4e-13
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 11/93 (11%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
C LE+LH + +I RD+KS NILL KL DFG + +T+ GT
Sbjct: 125 CLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGT 179
Query: 106 AGFLNTE------LTEKSDVDSFEIVILEIITG 132
++ E K D+ S I+ +E+I G
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (149), Expect = 2e-12
Identities = 23/92 (25%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMS--TTIAGTAG 107
L L+ ++ I+ RDMK+ N+L+ KLADFG +R + + + T T
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 108 FLNTEL-------TEKSDVDSFEIVILEIITG 132
+ EL D+ ++ E+ T
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (148), Expect = 3e-12
Identities = 28/147 (19%), Positives = 54/147 (36%), Gaps = 23/147 (15%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSR-ISPVEGGTHMSTTIAGTAG 107
G++YL + + RD+ + N+LL + AK++DFG S+ + E T
Sbjct: 119 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 108 FLNTE------LTEKSDVDSFEIVILEIITG-------------ILTVDLSFKGEFDIIS 148
+ E + KSDV SF +++ E + ++ +
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 235
Query: 149 VEKAVEIAMASVSSKVNRRPLMNQVVM 175
+ ++ + V RP V +
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVEL 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (146), Expect = 5e-12
Identities = 26/147 (17%), Positives = 49/147 (33%), Gaps = 23/147 (15%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
L YL + RD+ + N+L++ KL DFG SR + + ++
Sbjct: 118 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPI 173
Query: 107 GFLNTE------LTEKSDVDSFEIVILEIITG-------------ILTVDLSFKGEFDII 147
++ E T SDV F + + EI+ I ++ +
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233
Query: 148 SVEKAVEIAMASVSSKVNRRPLMNQVV 174
+ + +RRP ++
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELK 260
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.3 bits (145), Expect = 9e-12
Identities = 29/116 (25%), Positives = 49/116 (42%), Gaps = 16/116 (13%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
GL++LH H ++ RD+K NIL+ Q KLADFG +RI T++ T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVT 178
Query: 106 AGFL------NTELTEKSDVDSFEIVILEIITGILTVDLSFKGEFDIISVEKAVEI 155
+ + D+ S + E+ F+G D+ + K +++
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR----KPLFRGSSDVDQLGKILDV 230
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 60.1 bits (145), Expect = 1e-11
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 11/89 (12%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
L II RD+K NILL++ K+ DFG ++ P ++ T+ GT ++
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYI 168
Query: 110 NTE------LTEKSDVDSFEIVILEIITG 132
E + D SF I+I E++ G
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAG 197
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.5 bits (143), Expect = 2e-11
Identities = 36/196 (18%), Positives = 71/196 (36%), Gaps = 28/196 (14%)
Query: 9 LTGPLLVELIGKQKNNALELGFRGNPELVDQQGKEEV------CCPGLEYLHQGLKHPII 62
+ L E + ++ LE + + +Q +++ G+EYL I
Sbjct: 101 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCI 157
Query: 63 QRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEK 116
RD+ + N+L+ E K+ADFG +R +T ++ E T +
Sbjct: 158 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 217
Query: 117 SDVDSFEIVILEIITG-------------ILTVDLSFKGEFDIISVEKAVEIAMASVSSK 163
SDV SF +++ EI T + + + + + +
Sbjct: 218 SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAV 277
Query: 164 VNRRPLMNQVVMVREQ 179
++RP Q+V ++
Sbjct: 278 PSQRPTFKQLVEDLDR 293
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.7 bits (141), Expect = 2e-11
Identities = 26/113 (23%), Positives = 45/113 (39%), Gaps = 13/113 (11%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
L+ L +H I+ RD+K N+LL+E KLADFG ++ T T +
Sbjct: 110 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYR 167
Query: 110 NTEL-------TEKSDVDSFEIVILEIITGILTVDLSFKGEFDIISVEKAVEI 155
EL D+ + ++ E++ G+ D+ + + E
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELLLR----VPFLPGDSDLDQLTRIFET 216
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.3 bits (140), Expect = 4e-11
Identities = 20/89 (22%), Positives = 38/89 (42%), Gaps = 8/89 (8%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
+ L ++ RD+K N++L++ K+ DFG + +G T T GT +L
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYL 172
Query: 110 ------NTELTEKSDVDSFEIVILEIITG 132
+ + D +V+ E++ G
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (138), Expect = 6e-11
Identities = 26/152 (17%), Positives = 43/152 (28%), Gaps = 28/152 (18%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH-MSTTIAG 104
G+ YL I RD+ + N+LL + K+ DFG R P + M
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 105 TAGFL------NTELTEKSDVDSFEIVILEIITG----------------ILTVDLSFKG 142
+ + SD F + + E+ T I
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236
Query: 143 EFDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174
D + + + + K RP +
Sbjct: 237 PEDC--PQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 57.0 bits (137), Expect = 1e-10
Identities = 24/98 (24%), Positives = 41/98 (41%), Gaps = 18/98 (18%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
+ LH K I+ RD+K NILL++ + KL DFG S + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVCGTP 173
Query: 107 GFLNTEL------------TEKSDVDSFEIVILEIITG 132
+L E+ ++ D+ S +++ ++ G
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 56.4 bits (135), Expect = 2e-10
Identities = 15/103 (14%), Positives = 37/103 (35%), Gaps = 19/103 (18%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKV-----QAKLADFGQSRISPVEGGT---- 96
++ +H+ ++ RD+K N L+ + DFG +
Sbjct: 110 MLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166
Query: 97 -HMSTTIAGTAGFLNTEL------TEKSDVDSFEIVILEIITG 132
++GTA +++ + + D+++ V + + G
Sbjct: 167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 209
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.3 bits (135), Expect = 2e-10
Identities = 19/89 (21%), Positives = 36/89 (40%), Gaps = 6/89 (6%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
GLE++H ++ RD+K NILL+E +++D G + + T A
Sbjct: 117 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMA 173
Query: 107 G---FLNTELTEKSDVDSFEIVILEIITG 132
+D S ++ +++ G
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRG 202
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (133), Expect = 4e-10
Identities = 18/94 (19%), Positives = 38/94 (40%), Gaps = 14/94 (14%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEK--VQAKLADFGQSRISPVEGGTHMSTTIAG 104
C L++LH H I D++ NI+ + K+ +FGQ+R +
Sbjct: 112 CEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFT 165
Query: 105 TAGFLNTEL------TEKSDVDSFEIVILEIITG 132
+ E+ + +D+ S ++ +++G
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (132), Expect = 5e-10
Identities = 26/92 (28%), Positives = 44/92 (47%), Gaps = 11/92 (11%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
GL++LH I+ RD+K NILL++ K+ADFG + + + T GT
Sbjct: 113 ILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTP 167
Query: 107 GFLNTEL------TEKSDVDSFEIVILEIITG 132
++ E+ D SF +++ E++ G
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (129), Expect = 1e-09
Identities = 20/88 (22%), Positives = 36/88 (40%), Gaps = 5/88 (5%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRI--SPVEGGTHMSTTIAGTAG 107
L+ L ++ RD+K N+L+N + KLA+FG +R PV + T+
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 108 FL---NTELTEKSDVDSFEIVILEIITG 132
+ + D+ S + E+
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANA 198
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 53.9 bits (129), Expect = 1e-09
Identities = 20/91 (21%), Positives = 40/91 (43%), Gaps = 8/91 (8%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKV--QAKLADFGQSRISPVEGGTHMSTTIAG 104
C GL ++H ++ + D+K NI+ K + KL DFG + + ++T A
Sbjct: 134 CKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190
Query: 105 TAG---FLNTELTEKSDVDSFEIVILEIITG 132
A + +D+ S ++ +++G
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.3 bits (127), Expect = 2e-09
Identities = 24/144 (16%), Positives = 46/144 (31%), Gaps = 19/144 (13%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
+ + + + RD+ + N ++ E K+ DFG +R ++
Sbjct: 143 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 110 NTEL------TEKSDVDSFEIVILEIITGIL----------TVDLSFKGEFDIIS---VE 150
+ E T SDV SF +V+ EI T + +G +
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD 262
Query: 151 KAVEIAMASVSSKVNRRPLMNQVV 174
E+ RP +++
Sbjct: 263 MLFELMRMCWQYNPKMRPSFLEII 286
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 53.0 bits (126), Expect = 2e-09
Identities = 18/88 (20%), Positives = 37/88 (42%), Gaps = 5/88 (5%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTT-----IAG 104
L + ++ RD+K N+L+N + + K+ADFG +R + + A
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 105 TAGFLNTELTEKSDVDSFEIVILEIITG 132
+ + + D+ S + E++ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 52.9 bits (126), Expect = 3e-09
Identities = 18/95 (18%), Positives = 34/95 (35%), Gaps = 14/95 (14%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILL-NEKVQAKLADFGQSRISPVEGGTHMSTTIAG 104
L+Y H I+ RD+K N+++ +E + +L D+G +
Sbjct: 138 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVA 191
Query: 105 TAGFLNTEL-------TEKSDVDSFEIVILEIITG 132
+ F EL D+ S ++ +I
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.2 bits (124), Expect = 5e-09
Identities = 24/95 (25%), Positives = 39/95 (41%), Gaps = 9/95 (9%)
Query: 45 VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAG 104
L+ L H ++ RD+K N+L+N + KLADFG +R V T
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVV 164
Query: 105 TAGFLNTEL-------TEKSDVDSFEIVILEIITG 132
T + E+ + D+ S + E++T
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 52.1 bits (124), Expect = 6e-09
Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGT-HMSTTI 102
EV + L+ ++ II RD+K NI+++ K+ DFG +R G + + +
Sbjct: 115 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174
Query: 103 AGTAGFLNTE------LTEKSDVDSFEIVILEIITG 132
GTA +L+ E + +SDV S V+ E++TG
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 210
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.0 bits (121), Expect = 1e-08
Identities = 23/94 (24%), Positives = 44/94 (46%), Gaps = 11/94 (11%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMS-TTIAGT 105
GL+Y+H ++ RD+K +N+LLN K+ DFG +R++ + T T
Sbjct: 119 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 106 AGFLNTEL-------TEKSDVDSFEIVILEIITG 132
+ E+ T+ D+ S ++ E+++
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (118), Expect = 3e-08
Identities = 24/144 (16%), Positives = 53/144 (36%), Gaps = 28/144 (19%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLN-EKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
+ + H ++ RD+K NIL++ + + KL DFG + + T GT
Sbjct: 120 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGT 172
Query: 106 AGFLNTEL-------TEKSDVDSFEIVILEIITG---------ILTVDLSFKGEFDIISV 149
+ E + V S I++ +++ G I+ + F+
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS---- 228
Query: 150 EKAVEIAMASVSSKVNRRPLMNQV 173
+ + ++ + + RP ++
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 49.8 bits (118), Expect = 3e-08
Identities = 22/93 (23%), Positives = 41/93 (44%), Gaps = 14/93 (15%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
EYLH +I RD+K N+L++++ ++ DFG ++ + T+ GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGT 201
Query: 106 AGFLNTEL------TEKSDVDSFEIVILEIITG 132
L E+ + D + ++I E+ G
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (115), Expect = 9e-08
Identities = 26/114 (22%), Positives = 45/114 (39%), Gaps = 16/114 (14%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEK-VQAKLADFGQSRISPVEGGTHMSTTIAGTAG 107
L Y+H I RD+K N+LL+ KL DFG ++ + G + I
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYY 188
Query: 108 FLNTEL------TEKSDVDSFEIVILEIITGILTVDLSFKGEFDIISVEKAVEI 155
+ T DV S V+ E++ G F G+ + + + +++
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG----QPIFPGDSGVDQLVEIIKV 238
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.9 bits (113), Expect = 1e-07
Identities = 22/98 (22%), Positives = 38/98 (38%), Gaps = 17/98 (17%)
Query: 49 GLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLA---DFGQSRISPVEGGT-----HMST 100
+EY+H I RD+K N L+ + L DFG ++ +
Sbjct: 115 RIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 101 TIAGTAGF------LNTELTEKSDVDSFEIVILEIITG 132
+ GTA + L E + + D++S V++ G
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 209
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.3 bits (112), Expect = 2e-07
Identities = 17/93 (18%), Positives = 36/93 (38%), Gaps = 9/93 (9%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGT 105
++YLH + L+E + ++DFG S++ E + +T GT
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 172
Query: 106 AGFL------NTELTEKSDVDSFEIVILEIITG 132
G++ ++ D S ++ ++ G
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 205
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 46.6 bits (110), Expect = 5e-07
Identities = 19/92 (20%), Positives = 41/92 (44%), Gaps = 8/92 (8%)
Query: 46 CCPGLEYLHQGLKHPIIQRDMKSTNILL--NEKVQAKLADFGQSRISPVEGGTHMSTTIA 103
C GL+++H+ H I+ D+K NI+ + K+ DFG + + ++T A
Sbjct: 136 ACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA 192
Query: 104 GTAG---FLNTELTEKSDVDSFEIVILEIITG 132
A + +D+ + ++ +++G
Sbjct: 193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (107), Expect = 1e-06
Identities = 21/99 (21%), Positives = 40/99 (40%), Gaps = 13/99 (13%)
Query: 44 EVCCPGLEYLHQGLKHPIIQRDMKSTNILLNE----KVQAKLADFGQSRISPVEGGTHMS 99
E L ++ I D+K NI+L + K + K+ DFG + +
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEF 173
Query: 100 TTIAGTAGFLNTEL------TEKSDVDSFEIVILEIITG 132
I GT F+ E+ ++D+ S ++ +++G
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (107), Expect = 1e-06
Identities = 21/95 (22%), Positives = 39/95 (41%), Gaps = 15/95 (15%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLN---EKVQAKLADFGQSRISPVEGGTHMSTTIA 103
++YLH I RD+K N+L KL DFG ++ + + TT
Sbjct: 121 GEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---SHNSLTTPC 174
Query: 104 GTAGFLNTEL------TEKSDVDSFEIVILEIITG 132
T ++ E+ + D+ S +++ ++ G
Sbjct: 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 209
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (105), Expect = 1e-06
Identities = 21/90 (23%), Positives = 33/90 (36%), Gaps = 7/90 (7%)
Query: 50 LEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFL 109
+ L K II RD+K NILL+ L DFG S+ +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 110 NTEL-------TEKSDVDSFEIVILEIITG 132
+ + D S +++ E++TG
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 44.0 bits (103), Expect = 2e-06
Identities = 23/132 (17%), Positives = 48/132 (36%), Gaps = 9/132 (6%)
Query: 2 YFPNRNKLTGPLLVELIGKQKNN-ALELGFRGNPELVDQQGKEEVC---CPGLEYLHQGL 57
F KL G + ++ + N +EL V + +EV + +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH-- 121
Query: 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSR-ISPVEGGTHMSTTIAGTAGFLNTELTEK 116
I+ D+ N+L++E+ + DF QS + + + + + +
Sbjct: 122 -RGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTE 179
Query: 117 SDVDSFEIVILE 128
D++S IL+
Sbjct: 180 KDINSAIDRILQ 191
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 1e-05
Identities = 24/92 (26%), Positives = 39/92 (42%), Gaps = 12/92 (13%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
G+++LH II RD+K +NI++ K+ DFG +R G + M T T
Sbjct: 129 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTR 182
Query: 107 G------FLNTELTEKSDVDSFEIVILEIITG 132
L E D+ S ++ E++
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 4e-05
Identities = 24/88 (27%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTA 106
GL+Y+H II RD+K +N+ +NE + K+ DFG +R + E +++T
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAP 187
Query: 107 GFL--NTELTEKSDVDSFEIVILEIITG 132
+ + D+ S ++ E++TG
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTG 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 40.0 bits (92), Expect = 8e-05
Identities = 25/138 (18%), Positives = 52/138 (37%), Gaps = 9/138 (6%)
Query: 2 YFPNRNKLTGPLLVELIGKQKNNALELGFRGNPELVDQQGKEEVCCPGLEYLHQGLKHPI 61
N + ++ E++G+ ++ L+ + + GL+Y+H+ + I
Sbjct: 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGI 147
Query: 62 IQRDMKSTNILLN-EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTEL------T 114
I D+K N+L+ L + + T T + + E+
Sbjct: 148 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWG 207
Query: 115 EKSDVDSFEIVILEIITG 132
+D+ S +I E+ITG
Sbjct: 208 CGADIWSTACLIFELITG 225
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 188 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.55 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.22 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.65 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 90.67 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 88.19 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 81.7 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=282.64 Aligned_cols=175 Identities=25% Similarity=0.359 Sum_probs=142.6
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|.+++|||||+++++ .+..++||||+++|+|.+++ .... |++.||+|||+ .+|+||||||+|
T Consensus 58 l~~l~HpnIv~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~N 134 (276)
T d1uwha_ 58 LRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNN 134 (276)
T ss_dssp HTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred HHhCCCCCEeeeeEEEeccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHH
Confidence 678999999999999 77889999999999999998 3322 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+++.++.+||+|||+++...............||+.|+||| ++.++|||||||++|||++|..||.....
T Consensus 135 iLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 135 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp EEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 999999999999999998654333333344568999999998 36689999999999999999999854211
Q ss_pred -----------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 142 -----------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 142 -----------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
...+...+..+.+++..||+.+|++||||++|++.|+.+.++
T Consensus 215 ~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 215 RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 112334567899999999999999999999999999987643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-44 Score=275.10 Aligned_cols=175 Identities=21% Similarity=0.232 Sum_probs=136.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|++++|||||+++++ ++..++||||+++|+|.+++ ...+ |++.||.|||+ .+++||||||+
T Consensus 81 l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~ 157 (299)
T d1jpaa_ 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAAR 157 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred HHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccc
Confidence 578999999999999 78899999999999999988 3222 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCc---ceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCcccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTH---MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLS 139 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~---~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~ 139 (188)
|||++.++.+||+|||+++......... ......|++.|+||| ++.++|||||||++|||++ |..||...
T Consensus 158 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 158 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp GEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 9999999999999999998653222111 112245788999998 6889999999999999998 88888532
Q ss_pred C------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 140 F------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 140 ~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
. ..+.+...+..+.+++.+||+.+|++||||++|++.|+++.++
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 238 TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1 1223445667899999999999999999999999999887543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=271.06 Aligned_cols=167 Identities=22% Similarity=0.274 Sum_probs=140.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++||||++++++ ++..++||||+++|+|.+++.+. . |++.||.|||+ .+|+||||||+|
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~N 133 (271)
T d1nvra_ 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPEN 133 (271)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGG
T ss_pred HHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHH
Confidence 577899999999999 88889999999999999999332 2 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCCC
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKGE 143 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~ 143 (188)
|+++.++.+||+|||+++...............||+.|+||| .+.++||||+||++|+|++|..||+......
T Consensus 134 ILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 213 (271)
T d1nvra_ 134 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213 (271)
T ss_dssp EEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS
T ss_pred EEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH
Confidence 999999999999999998654222223344568999999999 2567999999999999999999996543221
Q ss_pred --------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 144 --------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 144 --------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.....+..+.+++.+||+.||++|||++|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 214 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11234567889999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=271.11 Aligned_cols=173 Identities=24% Similarity=0.308 Sum_probs=135.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++|+ ++..++||||+++|+|.+++ .... |+|.||.|||+ .+|+||||||+
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~ 130 (263)
T d1sm2a_ 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAAR 130 (263)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGG
T ss_pred HHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchh
Confidence 578999999999998 78899999999999999998 3222 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhC-Ccccccc---
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITG-ILTVDLS--- 139 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g-~~p~~~~--- 139 (188)
||+++.++.+||+|||+++.... ..........|+..|+||| ++.++||||||+++|||+++ ..|+...
T Consensus 131 Nill~~~~~~Kl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~ 209 (263)
T d1sm2a_ 131 NCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209 (263)
T ss_dssp GEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH
T ss_pred heeecCCCCeEecccchheeccC-CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH
Confidence 99999999999999999976432 2222233457889999998 68899999999999999995 4555321
Q ss_pred ---------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 140 ---------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 140 ---------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
.....+...+..+.+++..||+.+|++||||++|++.|+++.+
T Consensus 210 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 210 EVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1122344456789999999999999999999999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=270.10 Aligned_cols=172 Identities=22% Similarity=0.278 Sum_probs=144.4
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++|||||+++++ .+..++||||+++|+|.+++ ... . |++.||.|||+ .+|+||||||+|
T Consensus 63 l~~l~HpnIv~l~g~~~~~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~N 139 (285)
T d1u59a_ 63 MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARN 139 (285)
T ss_dssp HHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HHhCCCCCEeeEeeeeccCeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhh
Confidence 567999999999999 77899999999999999987 222 2 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCC-cceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGT-HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
|+++.++.+||+|||+++........ .......|++.|+||| ++.++|||||||++|||++ |..||....
T Consensus 140 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 140 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp EEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred eeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999865422221 1122356888999999 6889999999999999998 899986422
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
..+.+...+..+.+++..||+.+|++||||.+|++.|+..
T Consensus 220 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 220 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2234455677899999999999999999999999988754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=274.36 Aligned_cols=170 Identities=21% Similarity=0.263 Sum_probs=144.0
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-------------------------c---------cH
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-------------------------E---------VC 46 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-------------------------~---------~i 46 (188)
|.++ +|||||+++++ .+..++||||+++|+|.+++ .+. . |+
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 173 (325)
T d1rjba_ 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173 (325)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence 4566 89999999999 78899999999999999998 321 1 99
Q ss_pred HHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchH
Q 039565 47 CPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVD 120 (188)
Q Consensus 47 ~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~ 120 (188)
+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...............||+.|+||| ++.++|||
T Consensus 174 ~~gl~yLH~---~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Diw 250 (325)
T d1rjba_ 174 AKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250 (325)
T ss_dssp HHHHHHHHH---TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHh---CCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceecc
Confidence 999999999 999999999999999999999999999998654333333334567899999999 78999999
Q ss_pred HHHHHHHHHHh-CCccccccC-------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 039565 121 SFEIVILEIIT-GILTVDLSF-------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVRE 178 (188)
Q Consensus 121 s~G~~l~~~~~-g~~p~~~~~-------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~ 178 (188)
||||++|||++ |..||.... ..+.+...+..+.+++..||+.+|++|||+++|+++|.
T Consensus 251 S~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred chhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 99999999997 899985422 12234456778999999999999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-43 Score=269.91 Aligned_cols=174 Identities=24% Similarity=0.245 Sum_probs=144.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC-cc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK-EE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~-~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
|++++|||||+++++ .+..+++|||+++|+|..++ .. .. |++.||.|||+ .+|+||||||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp 143 (287)
T d1opja_ 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAA 143 (287)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred HHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCcccc
Confidence 678999999999998 78899999999999999998 22 11 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccccc---
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLS--- 139 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~--- 139 (188)
+|||++.++.+||+|||+++.... ..........|+..|+||| ++.++|||||||++|+|++|..|+...
T Consensus 144 ~NILl~~~~~~Kl~DFG~a~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~ 222 (287)
T d1opja_ 144 RNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222 (287)
T ss_dssp GGEEECGGGCEEECCCCCTTTCCS-SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CeEEECCCCcEEEccccceeecCC-CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH
Confidence 999999999999999999986432 2222233456788899999 688999999999999999977554221
Q ss_pred ----------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 140 ----------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 140 ----------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
...+.+...+..+.+++..||+.||++|||+++|++.|+.+...
T Consensus 223 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 223 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 12234445677899999999999999999999999999886543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=268.62 Aligned_cols=172 Identities=20% Similarity=0.240 Sum_probs=143.0
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
|++++|||||+++++ .+..++||||+++|+|.+++ .... |++.||.|||+ .+|+||||||+||
T Consensus 62 l~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Ni 138 (277)
T d1xbba_ 62 MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNV 138 (277)
T ss_dssp HHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGE
T ss_pred HHhCCCCCCceEEEEeccCCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhh
Confidence 578999999999999 77889999999999999999 2222 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCc-ceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCcccccc----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTH-MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLS---- 139 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~---- 139 (188)
+++.++.+|++|||+++......... ......||+.|+||| ++.++|||||||++|||++ |..||...
T Consensus 139 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~ 218 (277)
T d1xbba_ 139 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218 (277)
T ss_dssp EEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred cccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH
Confidence 99999999999999998653222221 223457888999999 6889999999999999997 89998532
Q ss_pred --------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 140 --------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 140 --------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
...+.+...+..+.+++.+||+.+|++|||+++|++.|+..
T Consensus 219 ~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 219 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 12234455678899999999999999999999999988764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-44 Score=267.93 Aligned_cols=163 Identities=26% Similarity=0.363 Sum_probs=140.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC---Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG---KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~---~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++|||||+++++ .+..++||||+++|+|.+++. ... |++.||.|||+ .+|+||||||+|
T Consensus 60 l~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~N 136 (263)
T d2j4za1 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPEN 136 (263)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred HHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeecccc
Confidence 567899999999999 778999999999999999982 222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.++.+||+|||+++... ........||+.|+||| ++.++|||||||++|+|++|..||.....
T Consensus 137 ill~~~~~~kl~DFG~a~~~~----~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 212 (263)
T d2j4za1 137 LLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 212 (263)
T ss_dssp EEECTTSCEEECCCCSCSCCC----CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ceecCCCCEeecccceeeecC----CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999997542 12234567999999999 68999999999999999999999964321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...+...++.+.+++.+||+.||++|||++|+++
T Consensus 213 ~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 213 YKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1234445678999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=267.02 Aligned_cols=172 Identities=23% Similarity=0.249 Sum_probs=142.6
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCCc-----c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGKE-----E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-----~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|++++|||||+++++ .+..++||||+++|+|.+++... . |++.||.|||+ .+|+||||||+
T Consensus 62 l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~ 138 (272)
T d1qpca_ 62 MKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAA 138 (272)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGG
T ss_pred HHhCCCCCEeEEEeeeccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchh
Confidence 678999999999999 77889999999999999988222 1 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCc-ccccc---
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGIL-TVDLS--- 139 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~-p~~~~--- 139 (188)
||+++.++.+||+|||+++... ...........|+..|+||| ++.++|||||||++|||++|.. |+...
T Consensus 139 NIll~~~~~~Kl~DFGla~~~~-~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~ 217 (272)
T d1qpca_ 139 NILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217 (272)
T ss_dssp GEEECTTSCEEECCCTTCEECS-SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred heeeecccceeeccccceEEcc-CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998653 22222233457888999999 6889999999999999999654 44321
Q ss_pred ---------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 140 ---------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 140 ---------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
.....+...+..+.+++..||+.+|++||||++|+++|+...
T Consensus 218 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 218 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 122233456678999999999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=265.21 Aligned_cols=165 Identities=22% Similarity=0.260 Sum_probs=141.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc--CCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ--GKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTNI 71 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~--~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ni 71 (188)
|++++|||||+++++ .+..++||||+++|+|.+++ .... |++.||.|||+ .+|+||||||+||
T Consensus 71 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NI 147 (293)
T d1yhwa1 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNI 147 (293)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred HHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHe
Confidence 567899999999998 88899999999999999988 2222 99999999999 9999999999999
Q ss_pred EEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC-----
Q 039565 72 LLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF----- 140 (188)
Q Consensus 72 ll~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~----- 140 (188)
+++.++.+||+|||+++.... .........||+.|+||| ++.++|||||||++|+|++|..||....
T Consensus 148 Ll~~~~~vkl~DFG~a~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 225 (293)
T d1yhwa1 148 LLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (293)
T ss_dssp EECTTCCEEECCCTTCEECCS--TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred EECCCCcEeeccchhheeecc--ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH
Confidence 999999999999999986432 222344567999999999 6889999999999999999999985322
Q ss_pred ---------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 ---------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ---------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+...+..+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12233445678999999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-43 Score=263.99 Aligned_cols=163 Identities=22% Similarity=0.359 Sum_probs=136.1
Q ss_pred cccccCCCeeeeccc-------CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCC--cEEe
Q 039565 6 RNKLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHP--IIQR 64 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~--i~h~ 64 (188)
|++++|||||+++++ ....++||||+++|+|.+++.+ .. |++.||.|||+ .+ |+||
T Consensus 62 l~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHr 138 (270)
T d1t4ha_ 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHR 138 (270)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCS
T ss_pred HHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeC
Confidence 678999999999987 3457899999999999999922 22 99999999998 77 9999
Q ss_pred CCCCCcEEEc-cCCceEEecccCcccccCCCCCcceeeecccccccCCC-----CCCccchHHHHHHHHHHHhCCccccc
Q 039565 65 DMKSTNILLN-EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 65 dl~~~nill~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||||+||+++ .++.+||+|||+++... ........||+.|+||| ++.++|||||||++|+|++|..||..
T Consensus 139 DiKp~NILl~~~~~~~Kl~DFGla~~~~----~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 139 DLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp CCCGGGEEESSTTSCEEECCTTGGGGCC----TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcChhhceeeCCCCCEEEeecCcceecc----CCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 9999999997 47899999999997532 12234568999999999 78999999999999999999999954
Q ss_pred cCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFK--------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... ...+...+..+.+++.+||+.||++|||++|+++
T Consensus 215 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 215 CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 221 1122334567899999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=263.10 Aligned_cols=174 Identities=22% Similarity=0.256 Sum_probs=136.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++|||||+++|+ .+..++++||+.++++.+++ .... |++.||.|||+ .+|+||||||+
T Consensus 63 l~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~ 139 (283)
T d1mqba_ 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAAR 139 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred HHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccc
Confidence 567899999999999 78889999999999999887 2222 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCC-CcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccc----
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDL---- 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~---- 138 (188)
|||++.++.+||+|||+++....... ........||..|+||| ++.++||||||+++|||+++..|+..
T Consensus 140 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~ 219 (283)
T d1mqba_ 140 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 219 (283)
T ss_dssp GEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred eEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH
Confidence 99999999999999999986432211 11223456788999999 68899999999999999997654421
Q ss_pred ---------cCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 139 ---------SFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 139 ---------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
....+.+...+..+.+++..||+.+|++||||++|++.|+.+.+
T Consensus 220 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 220 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 12223444566789999999999999999999999999987644
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=266.89 Aligned_cols=168 Identities=21% Similarity=0.293 Sum_probs=127.3
Q ss_pred cccccCCCeeeeccc-----CCccEEEEecCCCCChhhhcCC-------cc---------cHHHHHHHHhcCC--CCCcE
Q 039565 6 RNKLTGPLLVELIGK-----QKNNALELGFRGNPELVDQQGK-------EE---------VCCPGLEYLHQGL--KHPII 62 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-------~~---------~i~~~l~~Lh~~~--~~~i~ 62 (188)
|++++|||||+++++ ....++||||+++|+|.+++.+ .. |++.||.|||+.. ..+|+
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~Ii 136 (269)
T d2java1 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 136 (269)
T ss_dssp TTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC------
T ss_pred HHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEE
Confidence 678999999999997 4567999999999999998821 11 9999999999811 12499
Q ss_pred EeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccc
Q 039565 63 QRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 63 h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
||||||+||+++.++.+||+|||+++.... .........||+.|+||| ++.++|||||||++|+|++|..||
T Consensus 137 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 137 HRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp ---CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred eCcCchhhcCcCCCCcEEEeeccceeeccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCC
Confidence 999999999999999999999999986432 222334578999999999 688999999999999999999998
Q ss_pred cccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 137 DLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 137 ~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.... ....+...+..+.+++.+||+.||++|||++|+++
T Consensus 215 ~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 215 TAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 6422 12234456678999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-43 Score=266.88 Aligned_cols=165 Identities=22% Similarity=0.215 Sum_probs=138.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C-Cc--c---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G-KE--E---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~-~~--~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|++++|||||+++++ ++..++||||+++|+|.+++ + .. . |++.||.|||+ .+|+||||||+
T Consensus 63 l~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~ 139 (288)
T d2jfla1 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAG 139 (288)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGG
T ss_pred HHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChh
Confidence 567899999999999 88899999999999999987 2 22 2 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-----------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-----------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-----------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||+++.++.+||+|||+++.... .........||+.|+||| ++.++|||||||++|+|++|..||..
T Consensus 140 NIll~~~~~~Kl~DFG~a~~~~~--~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 140 NILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp GEEECTTSCEEECCCTTCEECHH--HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred heeECCCCCEEEEechhhhccCC--CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence 99999999999999999874321 111233567999999998 36789999999999999999999964
Q ss_pred cCC--------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFK--------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~--------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
... ...+...+..+.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 218 LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 321 1223455778999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=262.90 Aligned_cols=173 Identities=20% Similarity=0.211 Sum_probs=135.5
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc--CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ--GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~--~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++||||++++++ .+..++||||+++|+|..++ .... |++.||.|||+ .+++||||||+|
T Consensus 62 l~~l~HpnIv~l~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~N 138 (273)
T d1mp8a_ 62 MRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARN 138 (273)
T ss_dssp HHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred HHhCCCCCEeeEEEEEecCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhh
Confidence 678999999999999 78899999999999999987 2222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~-- 141 (188)
|+++.++.+|++|||+++... ...........||+.|+||| ++.++|||||||++|||++ |..||.....
T Consensus 139 Ill~~~~~~Kl~DfG~a~~~~-~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~ 217 (273)
T d1mp8a_ 139 VLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217 (273)
T ss_dssp EEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred eeecCCCcEEEccchhheecc-CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999997543 12222333456788999998 6889999999999999997 7888854321
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
.+.+...+..+.+++..||+.||++|||+++|++.|+.+.+
T Consensus 218 ~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 218 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 23444567789999999999999999999999999987643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=257.68 Aligned_cols=171 Identities=22% Similarity=0.271 Sum_probs=143.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+.+++||||++++|+ ++..++||||+++|+|..++ .... |++.||+|||+ .+|+||||||+
T Consensus 53 ~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~ 129 (258)
T d1k2pa_ 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAAR 129 (258)
T ss_dssp HHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGG
T ss_pred HHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccce
Confidence 568899999999999 78899999999999999997 2222 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccC--
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSF-- 140 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~-- 140 (188)
||+++.++.+||+|||+++.... ..........++..|+||| ++.++||||||+++|||++ |..||....
T Consensus 130 Nill~~~~~~kl~DfG~a~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 130 NCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp GEEECTTCCEEECCCSSCCBCSS-SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred eEEEcCCCcEEECcchhheeccC-CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 99999999999999999975432 2222333467888999999 6889999999999999998 788885321
Q ss_pred ----------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 141 ----------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 141 ----------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
....+...+..+.+++..||+.+|++|||+++|++.|..+
T Consensus 209 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 209 ETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2233445567899999999999999999999999998653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=268.27 Aligned_cols=166 Identities=24% Similarity=0.372 Sum_probs=137.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC---Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG---KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~---~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++||||++++++ .+..++||||+++|+|.+++. ... |++.||.|||+ .+|+||||||+|
T Consensus 62 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~N 138 (288)
T d1uu3a_ 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPEN 138 (288)
T ss_dssp HHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred HHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccc
Confidence 567899999999999 778899999999999999882 222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC----
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF---- 140 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~---- 140 (188)
|+++.++.+|++|||+++...............||+.|+||| ++.++||||+||++|+|++|..||....
T Consensus 139 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 218 (288)
T d1uu3a_ 139 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218 (288)
T ss_dssp EEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH
Confidence 999999999999999998654333333344567999999999 6889999999999999999999996432
Q ss_pred -------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 039565 141 -------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVV 174 (188)
Q Consensus 141 -------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~ 174 (188)
...++...+..+.+++..||+.||++|||++|++
T Consensus 219 ~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 219 FQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp HHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred HHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 1224445677899999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=267.26 Aligned_cols=170 Identities=22% Similarity=0.318 Sum_probs=138.4
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
-|++++|||||+++++ +.+.++||||+++|+|.+++.+ .. |++.||.|||+ +.+|+||||||+
T Consensus 57 il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~ 134 (322)
T d1s9ja_ 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 134 (322)
T ss_dssp GGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHH
Confidence 3678999999999999 7889999999999999999922 22 99999999997 148999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFKGE 143 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~~ 143 (188)
|||++.++.+||+|||+++.... .......||+.|+||| ++.++||||+||++|+|++|+.||......+
T Consensus 135 NILl~~~~~vkl~DFGla~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 135 NILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp GEEECTTCCEEECCCCCCHHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred HeeECCCCCEEEeeCCCccccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999999999999999985421 1233568999999999 7999999999999999999999985432110
Q ss_pred c-------------------------------------------------------CHHHHHHHHHHHHHccCcCCCCCC
Q 039565 144 F-------------------------------------------------------DIISVEKAVEIAMASVSSKVNRRP 168 (188)
Q Consensus 144 ~-------------------------------------------------------~~~~~~~~~~l~~~cl~~~p~~Rp 168 (188)
. ....+..+.+++.+||+.||++||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ 290 (322)
T d1s9ja_ 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290 (322)
T ss_dssp HHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCc
Confidence 0 001235788999999999999999
Q ss_pred CHHHHHH--HHhhc
Q 039565 169 LMNQVVM--VREQG 180 (188)
Q Consensus 169 s~~~i~~--~l~~~ 180 (188)
|++|+++ .+.+.
T Consensus 291 ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 291 DLKQLMVHAFIKRS 304 (322)
T ss_dssp CHHHHHTSHHHHHH
T ss_pred CHHHHhhCHhhCcC
Confidence 9999987 35443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-41 Score=261.08 Aligned_cols=164 Identities=21% Similarity=0.261 Sum_probs=128.6
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++|||||+++++ ++..++||||+++|+|.+++ .+.. |++.||.|||+ .+|+|||+||+|
T Consensus 61 l~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~N 137 (307)
T d1a06a_ 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPEN 137 (307)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccc
Confidence 578899999999999 78899999999999999999 3322 99999999999 999999999999
Q ss_pred EEEc---cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC-
Q 039565 71 ILLN---EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF- 140 (188)
Q Consensus 71 ill~---~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~- 140 (188)
|++. .++.+||+|||+++... .........||+.|+||| ++.++|||||||++|+|++|..||....
T Consensus 138 il~~~~~~~~~vkl~DFG~a~~~~---~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 138 LLYYSLDEDSKIMISDFGLSKMED---PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp EEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeecccCCCceEEEeccceeEEcc---CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH
Confidence 9995 46889999999997542 222334567999999999 7899999999999999999999995421
Q ss_pred --------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 --------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 --------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
........+..+.+++..||+.||++|||++|+++
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 215 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11222345678999999999999999999999988
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-42 Score=263.52 Aligned_cols=173 Identities=18% Similarity=0.245 Sum_probs=142.4
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
+++++|||||+++++ .+..++++||+.+|+|.+++ .+. . |++.||.|||+ .+|+||||||+|
T Consensus 65 l~~l~HpnIv~l~g~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~N 141 (317)
T d1xkka_ 65 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 141 (317)
T ss_dssp HHHCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred HHhCCCCCEeeEEEEEecCCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhc
Confidence 567899999999999 77889999999999999888 222 2 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~~~-- 141 (188)
|+++.++.+||+|||+++...............||+.|+||| ++.++|||||||++|||++ |..||+....
T Consensus 142 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~ 221 (317)
T d1xkka_ 142 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221 (317)
T ss_dssp EEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred ceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 999999999999999998654333333344457899999999 6899999999999999998 7888864321
Q ss_pred ----------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 142 ----------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 142 ----------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
.+.+...+..+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus 222 ~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 222 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 2334456678999999999999999999999999987764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-42 Score=262.55 Aligned_cols=161 Identities=24% Similarity=0.244 Sum_probs=136.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++|||||+++++ ++..++|||||.+|+|..++ .+.. |++.||.|||+ .+|+||||||+|
T Consensus 69 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~N 145 (309)
T d1u5ra_ 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGN 145 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGG
T ss_pred HHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcce
Confidence 678999999999999 78899999999999998776 2222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC---------CCCccchHHHHHHHHHHHhCCccccccC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE---------LTEKSDVDSFEIVILEIITGILTVDLSF- 140 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe---------~~~~~di~s~G~~l~~~~~g~~p~~~~~- 140 (188)
|+++.++.+||+|||++.... ......||+.|+||| ++.++|||||||++|+|++|..||....
T Consensus 146 ILl~~~~~~Kl~DFG~a~~~~------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 146 ILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp EEEETTTEEEECCCTTCBSSS------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EEECCCCCEEEeecccccccC------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 999999999999999987542 123457999999998 4678999999999999999999985321
Q ss_pred ------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 ------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
....+...+..+.+++..||+.||.+|||++++++
T Consensus 220 ~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11122345678999999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=258.70 Aligned_cols=173 Identities=21% Similarity=0.232 Sum_probs=138.5
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhcCC-----cc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQGK-----EE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~~~-----~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++|||||+++++ .+..++||||+++|+|..++.. .. |++.||+|||+ .+++||||||+
T Consensus 66 l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~ 142 (285)
T d1fmka3 66 MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAA 142 (285)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred HHhcccCCEeEEEEEEecCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccce
Confidence 678999999999999 7789999999999999988821 11 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccc-cc----
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTV-DL---- 138 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~-~~---- 138 (188)
||+++.++.+||+|||+++... ...........|++.|+||| ++.++||||||+++|+|++|..|+ ..
T Consensus 143 NIll~~~~~~kl~DfGla~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~ 221 (285)
T d1fmka3 143 NILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221 (285)
T ss_dssp GEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred EEEECCCCcEEEcccchhhhcc-CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999997643 12222233457889999999 789999999999999999966443 21
Q ss_pred --------cCCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 139 --------SFKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 139 --------~~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
....+.+...++++.+++.+||+.+|++|||+++|+++|+....
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 222 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 11233455667789999999999999999999999999987654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=256.62 Aligned_cols=172 Identities=19% Similarity=0.194 Sum_probs=140.6
Q ss_pred cccccCCCeeeeccc--CCccEEEEecCCCCChhhhc-CCc---c---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK--QKNNALELGFRGNPELVDQQ-GKE---E---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--~~~~~lv~e~~~~~~L~~~~-~~~---~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|.+++||||++++|+ .+..++||||+++|++.+++ .+. . |++.||.|||+ .+|+||||||+|
T Consensus 65 l~~l~H~nIv~~~g~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~N 141 (273)
T d1u46a_ 65 MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARN 141 (273)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGG
T ss_pred HHhCCCCCEEEEEEEEeecchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHH
Confidence 678899999999999 77789999999999999887 222 1 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCc-ceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCcccccc---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTH-MSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLS--- 139 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~--- 139 (188)
|+++.++.+||+|||+++......... ......++..|+||| ++.++||||||+++|||++ |..||...
T Consensus 142 Ill~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221 (273)
T ss_dssp EEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred hccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH
Confidence 999999999999999998653222221 122345777899999 6888999999999999998 89988422
Q ss_pred ----------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 140 ----------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 140 ----------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
...+.+...+..+.+++..||+.||++||||++|++.|++.
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 222 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 12233445567899999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=258.35 Aligned_cols=170 Identities=21% Similarity=0.184 Sum_probs=135.5
Q ss_pred cCCCeeeeccc----CCccEEEEecCCCCChhhhc-CC-c-----------------c---------cHHHHHHHHhcCC
Q 039565 10 TGPLLVELIGK----QKNNALELGFRGNPELVDQQ-GK-E-----------------E---------VCCPGLEYLHQGL 57 (188)
Q Consensus 10 ~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~-~~-~-----------------~---------~i~~~l~~Lh~~~ 57 (188)
+||||++++++ ....+++|||+++|+|.+++ .+ . . |++.||.|||+
T Consensus 75 ~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-- 152 (299)
T d1ywna1 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-- 152 (299)
T ss_dssp CCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--
T ss_pred CCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--
Confidence 68999999888 55689999999999999998 21 1 1 99999999999
Q ss_pred CCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh
Q 039565 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT 131 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~ 131 (188)
.+|+||||||+||+++.++.+||+|||+++...............||+.|+||| ++.++|||||||++|+|++
T Consensus 153 -~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 153 -RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp -TTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred -CCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHh
Confidence 999999999999999999999999999998654333333344567899999999 7899999999999999998
Q ss_pred CC-ccccccC-------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 132 GI-LTVDLSF-------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 132 g~-~p~~~~~-------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
+. .||.... ....+...+..+.+++.+||+.||++|||+++|+++|+++.+
T Consensus 232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 232 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp TSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 75 5664322 122334456789999999999999999999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-41 Score=258.53 Aligned_cols=176 Identities=20% Similarity=0.252 Sum_probs=144.2
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
|++++||||++++|+ +...++||||+++|+|.+++ .... |++.||.|||+ .+|+||||||
T Consensus 82 l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~ 158 (311)
T d1r0pa_ 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAA 158 (311)
T ss_dssp HHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred HHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccH
Confidence 578999999999998 45789999999999999988 2222 99999999999 9999999999
Q ss_pred CcEEEccCCceEEecccCcccccCCCCC--cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 69 TNILLNEKVQAKLADFGQSRISPVEGGT--HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 69 ~nill~~~~~~kl~d~~~~~~~~~~~~~--~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
+||++++++.+||+|||+++........ .......|+..|++|| ++.++||||||+++|||++|..||....
T Consensus 159 ~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 159 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp GGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred HhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999999864322111 1222356888999999 7889999999999999999877664321
Q ss_pred -------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcc
Q 039565 141 -------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSR 184 (188)
Q Consensus 141 -------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 184 (188)
....+...+..+.+++..||+.||++||||.||++.|+++..+.
T Consensus 239 ~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 239 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp ----CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 11233345678999999999999999999999999999886553
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=255.70 Aligned_cols=170 Identities=24% Similarity=0.285 Sum_probs=136.7
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhc-CCc----c---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQ-GKE----E---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~-~~~----~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+++++||||++++|+ .+..++||||+++|+|.+++ .+. . |++.||.|||+ .+++|||||
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlk 130 (262)
T d1byga_ 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLA 130 (262)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred HHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---Cceeccccc
Confidence 678899999999997 35689999999999999998 221 1 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHh-CCcccccc-
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIIT-GILTVDLS- 139 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~-g~~p~~~~- 139 (188)
|+||+++.++.+|++|||+++.... ......++..|+||| ++.++||||||+++|||++ |..||...
T Consensus 131 p~Nil~~~~~~~kl~dfg~s~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~ 205 (262)
T d1byga_ 131 ARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205 (262)
T ss_dssp GGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred hHhheecCCCCEeecccccceecCC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC
Confidence 9999999999999999999875321 122345677899998 7899999999999999998 67776432
Q ss_pred -----------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 140 -----------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 140 -----------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
...+.+...+..+.+++.+||+.||++||||.+|+++|++++..
T Consensus 206 ~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 206 LKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp GGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 12334455667899999999999999999999999999987654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-41 Score=258.83 Aligned_cols=175 Identities=19% Similarity=0.187 Sum_probs=144.0
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc--------------------------c---------c
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE--------------------------E---------V 45 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~--------------------------~---------~ 45 (188)
.|++++||||++++++ ....++++||+++|+|.+++ ... . |
T Consensus 69 il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 148 (301)
T d1lufa_ 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 148 (301)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred HHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHH
Confidence 3678999999999998 78999999999999999988 211 0 9
Q ss_pred HHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccch
Q 039565 46 CCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDV 119 (188)
Q Consensus 46 i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di 119 (188)
++.||+|||+ .+++||||||+||+++.++.+||+|||+++...............++..|+||| ++.++||
T Consensus 149 i~~gl~ylH~---~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDV 225 (301)
T d1lufa_ 149 VAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225 (301)
T ss_dssp HHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHhhhccc---CCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhh
Confidence 9999999999 999999999999999999999999999997553222222334566888999999 7899999
Q ss_pred HHHHHHHHHHHhCC-ccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccC
Q 039565 120 DSFEIVILEIITGI-LTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSG 182 (188)
Q Consensus 120 ~s~G~~l~~~~~g~-~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~ 182 (188)
|||||++|||++|. .||.... ..+.+...+..+.+++..||+.+|++||||.+|+++|+++.+
T Consensus 226 wS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 226 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 99999999999986 4564221 122344566789999999999999999999999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=255.28 Aligned_cols=172 Identities=20% Similarity=0.234 Sum_probs=144.4
Q ss_pred ccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc------------------c---------cHHHHHHHHh
Q 039565 7 NKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------------------E---------VCCPGLEYLH 54 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------------------~---------~i~~~l~~Lh 54 (188)
.++ +|||||+++++ +...++||||+++|+|.+++ .+. . |++.||.|||
T Consensus 73 ~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH 152 (299)
T d1fgka_ 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 152 (299)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh
Confidence 345 79999999999 77899999999999999999 221 1 9999999999
Q ss_pred cCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHH
Q 039565 55 QGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILE 128 (188)
Q Consensus 55 ~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~ 128 (188)
+ .+++||||||+||+++.++.+||+|||+++...............+++.|+||| ++.++||||||+++|+
T Consensus 153 ~---~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~e 229 (299)
T d1fgka_ 153 S---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 229 (299)
T ss_dssp H---TTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred h---CCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHH
Confidence 9 999999999999999999999999999998654333333344567888999998 7899999999999999
Q ss_pred HHh-CCcccccc------------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 129 IIT-GILTVDLS------------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 129 ~~~-g~~p~~~~------------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
|++ |..||... ...+.+...+..+.+++.+||+.+|++|||+++|++.|+++.
T Consensus 230 ll~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 230 IFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 998 67777432 122334455678999999999999999999999999998763
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-40 Score=259.06 Aligned_cols=164 Identities=20% Similarity=0.292 Sum_probs=139.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|++++|||||+++++ ++..++||||+++|+|.+++ .+. . |++.||.|||+ .+|+||||||+
T Consensus 80 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~ 156 (352)
T d1koba_ 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPE 156 (352)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccc
Confidence 578899999999999 78889999999999999887 322 1 99999999999 99999999999
Q ss_pred cEEEc--cCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC-
Q 039565 70 NILLN--EKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF- 140 (188)
Q Consensus 70 nill~--~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~- 140 (188)
|||++ .++.+||+|||++.... .........|++.|+||| ++.++||||+||++|+|++|..||....
T Consensus 157 NILl~~~~~~~vkL~DFGla~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 233 (352)
T d1koba_ 157 NIMCETKKASSVKIIDFGLATKLN---PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 233 (352)
T ss_dssp GEEESSTTCCCEEECCCTTCEECC---TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred cccccccCCCeEEEeecccceecC---CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 99998 56899999999998653 223345568899999998 6889999999999999999999995421
Q ss_pred --------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 --------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 --------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
........+..+.+++..||+.||.+|||++++++
T Consensus 234 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 234 LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12222345678899999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-40 Score=258.36 Aligned_cols=165 Identities=20% Similarity=0.248 Sum_probs=139.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|++++|||||+++++ .+..++||||+++|+|.+++ ++.+ |++.||.|||+ .+++||||||+
T Consensus 77 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~ 153 (350)
T d1koaa2 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPE 153 (350)
T ss_dssp HHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechh
Confidence 578899999999999 88999999999999999988 3322 99999999999 99999999999
Q ss_pred cEEEcc--CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 70 NILLNE--KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 70 nill~~--~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
||+++. ++.+||+|||+++... .........||+.|+||| ++.++|||||||++|+|++|..||.....
T Consensus 154 NIll~~~~~~~vkL~DFG~a~~~~---~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 230 (350)
T d1koaa2 154 NIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 230 (350)
T ss_dssp GEEESSTTSCCEEECCCTTCEECC---TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HeeeccCCCCeEEEeecchheecc---cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 999964 5789999999998643 223345678999999999 57899999999999999999999964321
Q ss_pred ---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 142 ---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 142 ---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
.......+..+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 231 DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112346788999999999999999999999883
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=258.00 Aligned_cols=165 Identities=20% Similarity=0.260 Sum_probs=140.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++||||++++++ .+..++||||+++|+|..++.+ .. |++.||+|||+ .+|+||||||+|
T Consensus 59 l~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~N 135 (337)
T d1o6la_ 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLEN 135 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGG
T ss_pred HHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHH
Confidence 577899999999998 7889999999999999999922 22 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
|+++.+|.+||+|||+++... ..........||+.|+||| ++.++|+||+||++|+|++|..||.....
T Consensus 136 ILl~~~g~vkl~DFG~a~~~~--~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 213 (337)
T d1o6la_ 136 LMLDKDGHIKITDFGLCKEGI--SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp EEECTTSCEEECCCTTCBCSC--CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred eEecCCCCEEEeecccccccc--cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH
Confidence 999999999999999998543 2222345678999999999 68999999999999999999999854321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRPL-----MNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~i~~ 175 (188)
..++...+..+.+++.+||+.||.+||+ ++++++
T Consensus 214 ~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 214 FELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 2234456678899999999999999995 788876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-40 Score=260.00 Aligned_cols=163 Identities=19% Similarity=0.218 Sum_probs=138.1
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCC---cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGK---EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~---~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
++.++|||||+++++ .+..++||||+++|+|.+++.+ .. |++.||.|||+ .+++||||||+|
T Consensus 61 l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~N 137 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPAN 137 (364)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccce
Confidence 456789999999998 7889999999999999999822 11 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~- 142 (188)
||++.++.+||+|||+++.... .......||+.|+||| ++.++|||||||++|+|++|..||......
T Consensus 138 ILl~~~g~iKl~DFGla~~~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 213 (364)
T d1omwa3 138 ILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213 (364)
T ss_dssp EEECSSSCEEECCCTTCEECSS----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred eEEcCCCcEEEeeeceeeecCC----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999985431 1234467999999999 578999999999999999999999643221
Q ss_pred -------------CcCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 039565 143 -------------EFDIISVEKAVEIAMASVSSKVNRRPL-----MNQVVM 175 (188)
Q Consensus 143 -------------~~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~i~~ 175 (188)
..+...+..+.+++..||+.||++||| ++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 214 KHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 123345678999999999999999999 688875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=255.78 Aligned_cols=179 Identities=18% Similarity=0.188 Sum_probs=140.0
Q ss_pred CcccccCCCeeeeccc---C----CccEEEEecCCCCChhhhcC--Ccc---------cHHHHHHHHhcCC-----CCCc
Q 039565 5 NRNKLTGPLLVELIGK---Q----KNNALELGFRGNPELVDQQG--KEE---------VCCPGLEYLHQGL-----KHPI 61 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~----~~~~lv~e~~~~~~L~~~~~--~~~---------~i~~~l~~Lh~~~-----~~~i 61 (188)
.+.+++||||++++++ . ...++||||+++|+|.++++ ... |++.||.|+|+.. ..+|
T Consensus 50 ~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~I 129 (303)
T d1vjya_ 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129 (303)
T ss_dssp TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEE
T ss_pred HHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCe
Confidence 4567899999999999 1 25789999999999999993 222 9999999999621 2599
Q ss_pred EEeCCCCCcEEEccCCceEEecccCcccccCCCCCc--ceeeecccccccCCCC------------CCccchHHHHHHHH
Q 039565 62 IQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTH--MSTTIAGTAGFLNTEL------------TEKSDVDSFEIVIL 127 (188)
Q Consensus 62 ~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~--~~~~~~~~~~~~~pe~------------~~~~di~s~G~~l~ 127 (188)
+||||||+||+++.++.+||+|||+++......... ......||+.|+|||. +.++|||||||++|
T Consensus 130 vHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~ 209 (303)
T d1vjya_ 130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209 (303)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred eccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHH
Confidence 999999999999999999999999998654222211 2234679999999982 44789999999999
Q ss_pred HHHhCCccccccC----------------------------CCCc-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 039565 128 EIITGILTVDLSF----------------------------KGEF-----DIISVEKAVEIAMASVSSKVNRRPLMNQVV 174 (188)
Q Consensus 128 ~~~~g~~p~~~~~----------------------------~~~~-----~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~ 174 (188)
||++|..|+.... .... +...+..+.+++.+||+.||++|||+.||+
T Consensus 210 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~ 289 (303)
T d1vjya_ 210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289 (303)
T ss_dssp HHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred HHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 9999986652110 0011 123556799999999999999999999999
Q ss_pred HHHhhccCc
Q 039565 175 MVREQGSGS 183 (188)
Q Consensus 175 ~~l~~~~~~ 183 (188)
+.|+++.++
T Consensus 290 ~~L~~i~~~ 298 (303)
T d1vjya_ 290 KTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999987754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=254.40 Aligned_cols=176 Identities=17% Similarity=0.159 Sum_probs=146.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCc-------------c---------cHHHHHHHHhcCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKE-------------E---------VCCPGLEYLHQGLKHP 60 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-------------~---------~i~~~l~~Lh~~~~~~ 60 (188)
+.+++||||++++++ .+..++||||+++|+|.+++... . |++.||.|||+ .+
T Consensus 77 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ 153 (308)
T d1p4oa_ 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NK 153 (308)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred HHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CC
Confidence 678999999999999 78899999999999999987211 0 99999999999 99
Q ss_pred cEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCC-
Q 039565 61 IIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGI- 133 (188)
Q Consensus 61 i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~- 133 (188)
|+||||||+|||++.++.+||+|||+++...............+++.|++|| ++.++|+||||+++|||++|.
T Consensus 154 ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~ 233 (308)
T d1p4oa_ 154 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233 (308)
T ss_dssp CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCC
Confidence 9999999999999999999999999998654333333334457889999998 688999999999999999985
Q ss_pred ccccccC------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCcc
Q 039565 134 LTVDLSF------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGSR 184 (188)
Q Consensus 134 ~p~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 184 (188)
.||.... ..+.+...+..+.+++..||+.+|++|||+++|+++|++..+..
T Consensus 234 ~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 234 QPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 6664211 12233455678999999999999999999999999999887654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=255.18 Aligned_cols=172 Identities=24% Similarity=0.285 Sum_probs=140.9
Q ss_pred cccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc------------------c---------cHHHHHHHH
Q 039565 6 RNKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE------------------E---------VCCPGLEYL 53 (188)
Q Consensus 6 l~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~------------------~---------~i~~~l~~L 53 (188)
|+++ +|||||+++++ .+..++||||+++|+|.+++ .+. . |++.||.||
T Consensus 64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l 143 (309)
T d1fvra_ 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143 (309)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence 4566 79999999999 78899999999999999998 321 0 999999999
Q ss_pred hcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHH
Q 039565 54 HQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVIL 127 (188)
Q Consensus 54 h~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~ 127 (188)
|+ .+++|||+||+||+++.++.+||+|||+++... .........|+..|++|| ++.++||||||+++|
T Consensus 144 H~---~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ 217 (309)
T d1fvra_ 144 SQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217 (309)
T ss_dssp HH---TTEECSCCSGGGEEECGGGCEEECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred hc---CCccccccccceEEEcCCCceEEcccccccccc---ccccccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence 99 999999999999999999999999999987532 112223456888999999 688999999999999
Q ss_pred HHHhCC-cccccc------------CCCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhccCc
Q 039565 128 EIITGI-LTVDLS------------FKGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGSGS 183 (188)
Q Consensus 128 ~~~~g~-~p~~~~------------~~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~~~ 183 (188)
+|++|. .||... ...+.+...+..+.+++.+||+.+|++||||++|++.|+++.+.
T Consensus 218 ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 218 EIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 999976 456321 12233445678899999999999999999999999999886543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=253.50 Aligned_cols=172 Identities=20% Similarity=0.212 Sum_probs=142.0
Q ss_pred ccc-cCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCc--------------------c---------cHHHHHHH
Q 039565 7 NKL-TGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE--------------------E---------VCCPGLEY 52 (188)
Q Consensus 7 ~~l-~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~--------------------~---------~i~~~l~~ 52 (188)
+++ +|||||+++++ ....+++|||+++|+|.+++ ... . |++.||.|
T Consensus 81 ~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~ 160 (311)
T d1t46a_ 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160 (311)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred HhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 345 69999999999 77899999999999999998 211 0 99999999
Q ss_pred HhcCCCCCcEEeCCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHH
Q 039565 53 LHQGLKHPIIQRDMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVI 126 (188)
Q Consensus 53 Lh~~~~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l 126 (188)
||+ .+++||||||+||+++.++.++++|||.++...............|++.|+||| ++.++||||||+++
T Consensus 161 LH~---~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l 237 (311)
T d1t46a_ 161 LAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237 (311)
T ss_dssp HHH---TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHh---CCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHH
Confidence 999 999999999999999999999999999998654333333344567899999999 68999999999999
Q ss_pred HHHHhC-CccccccC-------------CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 127 LEIITG-ILTVDLSF-------------KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 127 ~~~~~g-~~p~~~~~-------------~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
|+|+++ ..|+.... ....+...+..+.+++.+||+.||++||||++|+++|++..
T Consensus 238 ~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 999985 45443221 12233445678999999999999999999999999998653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=253.04 Aligned_cols=164 Identities=22% Similarity=0.249 Sum_probs=137.2
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CC--cc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GK--EE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++|||||+++++ .++.++||||+++|+|.+++ .+ .. |++.||.|||+ .+++|||+||+|
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~N 143 (293)
T d1jksa_ 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPEN 143 (293)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhh---cceeecccccce
Confidence 567899999999999 88899999999999999998 22 22 99999999999 999999999999
Q ss_pred EEEccCC----ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 71 ILLNEKV----QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 71 ill~~~~----~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
|+++.++ .+|++|||++.... .........|++.|+||| ++.++|||||||++|+|++|..||....
T Consensus 144 ill~~~~~~~~~vkl~DfG~a~~~~---~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 144 IMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp EEESCSSSSSCCEEECCCTTCEECT---TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEecCCCcccceEecchhhhhhcC---CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 9998766 59999999987643 122334567889999999 6899999999999999999999996432
Q ss_pred C-----------CCcC----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 K-----------GEFD----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 ~-----------~~~~----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ...+ ...+..+.+++.+||+.||++|||++++++
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1112 123567889999999999999999999987
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-40 Score=253.31 Aligned_cols=162 Identities=25% Similarity=0.388 Sum_probs=139.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++||||++++++ ++..++||||+++|+|..++ .... |++.||.|||+ .+|+||||||+|
T Consensus 58 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~N 134 (316)
T d1fota_ 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPEN 134 (316)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGG
T ss_pred HHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchh
Confidence 567899999999999 88899999999999999998 2222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccC----
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSF---- 140 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~---- 140 (188)
|+++.++.+||+|||+++.... ......||+.|+||| ++.++||||+||++|+|++|..||....
T Consensus 135 ILl~~~g~vkL~DFG~a~~~~~-----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 209 (316)
T d1fota_ 135 ILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209 (316)
T ss_dssp EEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred eeEcCCCCEEEecCccceEecc-----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH
Confidence 9999999999999999986431 233568999999999 6889999999999999999999996432
Q ss_pred -------CCCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 141 -------KGEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 141 -------~~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
....+...+..+.+++.+||+.+|.+|+ |++++++
T Consensus 210 ~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 210 YEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1223445567899999999999999996 8999886
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.8e-40 Score=248.15 Aligned_cols=164 Identities=20% Similarity=0.214 Sum_probs=137.8
Q ss_pred ccccc-CCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLT-GPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~-Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
+++++ ||||++++++ +++.++||||+++|+|.+++ .+.. |++.||+|||+ .+++||||||+
T Consensus 63 l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~ 139 (277)
T d1phka_ 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPE 139 (277)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGG
T ss_pred HHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccc
Confidence 44565 9999999999 88889999999999999999 2222 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
||+++.++.+||+|||+++.... ........||+.|++|| ++.++||||+||++|+|++|..||.
T Consensus 140 Nill~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~ 216 (277)
T d1phka_ 140 NILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216 (277)
T ss_dssp GEEECTTCCEEECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eEEEcCCCCeEEccchheeEccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC
Confidence 99999999999999999986432 22234467889999988 3678999999999999999999996
Q ss_pred ccCC---------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LSFK---------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~~~---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.... .......++.+.+++.+||+.+|++|||++++++
T Consensus 217 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 217 HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 4321 1122356678999999999999999999999876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=252.14 Aligned_cols=162 Identities=19% Similarity=0.242 Sum_probs=134.8
Q ss_pred cccCCCeeeeccc-------CCccEEEEecCCCCChhhhc-CCc--c-----------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 8 KLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQ-GKE--E-----------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 8 ~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~-~~~--~-----------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
..+|||||+++++ ....++|||||++|+|.+++ ++. . |++.||+|||+ .+|+||||
T Consensus 61 ~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDi 137 (335)
T d2ozaa1 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 137 (335)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred hcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccc
Confidence 3479999999987 35689999999999999999 432 1 99999999999 99999999
Q ss_pred CCCcEEEcc---CCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccc
Q 039565 67 KSTNILLNE---KVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVD 137 (188)
Q Consensus 67 ~~~nill~~---~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~ 137 (188)
||+||+++. .+.+|++|||+++.... ........|++.|+||| ++.++|||||||++|+|++|..||.
T Consensus 138 Kp~NIll~~~~~~~~~Kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~ 214 (335)
T d2ozaa1 138 KPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 214 (335)
T ss_dssp SGGGEEESCSSTTCCEEECCCTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred cccccccccccccccccccccceeeeccC---CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCC
Confidence 999999986 45799999999986432 22334568999999999 5789999999999999999999995
Q ss_pred ccCCC---------------CcC----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 138 LSFKG---------------EFD----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 138 ~~~~~---------------~~~----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..... .++ ...+..+.+++..||+.||++|||++++++
T Consensus 215 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 215 SNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 43211 111 234678999999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=249.77 Aligned_cols=165 Identities=22% Similarity=0.230 Sum_probs=135.5
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|.+++|||||+++++ .++.++||||+.++++..+..... |++.||+|||+ .+++||||||+|
T Consensus 54 l~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~N 130 (299)
T d1ua2a_ 54 LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNN 130 (299)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred HHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcce
Confidence 567899999999999 888999999999887777663222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC-
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG- 142 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~- 142 (188)
|+++.++.+||+|||+++..... ........||+.|+||| ++.++|||||||++|+|++|..||......
T Consensus 131 Ili~~~~~~KL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~ 208 (299)
T d1ua2a_ 131 LLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 208 (299)
T ss_dssp EEECTTCCEEECCCGGGSTTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEecCCCccccccCccccccCCC--cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH
Confidence 99999999999999999754322 22233457899999999 477899999999999999999888532100
Q ss_pred ---------------------------------CcC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 143 ---------------------------------EFD-----IISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 143 ---------------------------------~~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
..+ ...++.+.+++.+||+.||++|||++|+++
T Consensus 209 ~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 209 QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 123467899999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-39 Score=246.60 Aligned_cols=174 Identities=21% Similarity=0.280 Sum_probs=135.1
Q ss_pred cccccCCCeeeeccc---C----CccEEEEecCCCCChhhhc-C--Ccc---------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK---Q----KNNALELGFRGNPELVDQQ-G--KEE---------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~----~~~~lv~e~~~~~~L~~~~-~--~~~---------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
+++++||||++++++ . ...++||||+++++|..++ . ... |++.||.|||+ .+++||||
T Consensus 61 l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDi 137 (277)
T d1o6ya_ 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDV 137 (277)
T ss_dssp HHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred HHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccc
Confidence 567899999999998 2 2378999999999999988 2 222 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCC-CCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCcccccc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEG-GTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLS 139 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~ 139 (188)
||+||+++.++..+++|||.+....... .........||+.|+||| ++.++|||||||++|+|++|..||...
T Consensus 138 KP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 138 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp SGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 9999999999999999999876532221 122334567999999999 688999999999999999999999643
Q ss_pred CC---------------CCcCHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHhhccC
Q 039565 140 FK---------------GEFDIISVEKAVEIAMASVSSKVNRRP-LMNQVVMVREQGSG 182 (188)
Q Consensus 140 ~~---------------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-s~~~i~~~l~~~~~ 182 (188)
.. .......+..+.+++.+||+.||.+|| |++++++.|.++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 218 SPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp SHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 21 111223467899999999999999999 89999999887643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-39 Score=249.15 Aligned_cols=164 Identities=16% Similarity=0.248 Sum_probs=137.8
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcC-Cc-c-----------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG-KE-E-----------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~-~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|.+++||||++++++ +++.|+|||||++|+|.+++. +. . |++.||.|||+ .+|+||||||+
T Consensus 55 l~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~ 131 (321)
T d1tkia_ 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPE 131 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCccccccc
Confidence 578899999999998 889999999999999999993 22 2 99999999999 99999999999
Q ss_pred cEEEccC--CceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 70 NILLNEK--VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 70 nill~~~--~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
||+++.+ ..+|++|||++.... .........+++.|++|| ++.++||||+||++|+|++|..||.....
T Consensus 132 NIll~~~~~~~ikl~DFG~~~~~~---~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~ 208 (321)
T d1tkia_ 132 NIIYQTRRSSTIKIIEFGQARQLK---PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp GEEESSSSCCCEEECCCTTCEECC---TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ceeecCCCceEEEEcccchhhccc---cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence 9999854 578999999987542 223345567889999998 68899999999999999999999965432
Q ss_pred C-----------CcCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 G-----------EFDI----ISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ~-----------~~~~----~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
. ..+. ..+..+.+++..||..||++|||++++++
T Consensus 209 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 209 QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1222 23567899999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=252.00 Aligned_cols=163 Identities=21% Similarity=0.317 Sum_probs=137.8
Q ss_pred cccCCCeeeeccc---CCccEEEEecCCCCChhhhcC---Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCcEE
Q 039565 8 KLTGPLLVELIGK---QKNNALELGFRGNPELVDQQG---KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTNIL 72 (188)
Q Consensus 8 ~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~---~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~nil 72 (188)
.++|||||+++++ ++..++||||+++|+|.+++. ... |++.||.|||+ .+++|||+||+|||
T Consensus 59 ~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL 135 (320)
T d1xjda_ 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNIL 135 (320)
T ss_dssp HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEE
T ss_pred hCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCccccee
Confidence 5899999999999 888999999999999999992 222 99999999999 99999999999999
Q ss_pred EccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC-----
Q 039565 73 LNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK----- 141 (188)
Q Consensus 73 l~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~----- 141 (188)
++.++.+|++|||+++.... .........||+.|+||| ++.++|||||||++|+|++|..||.....
T Consensus 136 ~~~~~~~kl~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 213 (320)
T d1xjda_ 136 LDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213 (320)
T ss_dssp ECTTSCEEECCCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ecCCCceeccccchhhhccc--ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999985432 222334567999999999 68899999999999999999999964321
Q ss_pred ------CCcCHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 039565 142 ------GEFDIISVEKAVEIAMASVSSKVNRRPLMN-QVVM 175 (188)
Q Consensus 142 ------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~-~i~~ 175 (188)
..++...+..+.+++.+||+.||.+|||+. ++++
T Consensus 214 ~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 214 SIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 223344567899999999999999999985 6653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-38 Score=248.85 Aligned_cols=162 Identities=19% Similarity=0.231 Sum_probs=138.4
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-C--Ccc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-G--KEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~--~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++|||||+++++ ....++|+||+.+|+|..++ . ... |++.||.|||+ .+|+||||||+|
T Consensus 95 l~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~N 171 (350)
T d1rdqe_ 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPEN 171 (350)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHH
Confidence 578899999999998 77889999999999999998 2 222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC---
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK--- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~--- 141 (188)
||++.++.+||+|||+++.... ......||+.|+||| ++.++|||||||++|+|++|..||.....
T Consensus 172 ILl~~~g~ikL~DFG~a~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 246 (350)
T d1rdqe_ 172 LLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp EEECTTSCEEECCCTTCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccCCCCCEEeeeceeeeeccc-----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH
Confidence 9999999999999999986431 233567999999999 68899999999999999999999964321
Q ss_pred --------CCcCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 039565 142 --------GEFDIISVEKAVEIAMASVSSKVNRRP-----LMNQVVM 175 (188)
Q Consensus 142 --------~~~~~~~~~~~~~l~~~cl~~~p~~Rp-----s~~~i~~ 175 (188)
...+...+..+.+++..||+.||.+|+ |++++++
T Consensus 247 ~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 247 YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 123344567899999999999999994 8999886
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=240.71 Aligned_cols=162 Identities=18% Similarity=0.227 Sum_probs=132.8
Q ss_pred cccc--CCCeeeeccc---CCccEEEEecCCC-CChhhhc-CC--cc---------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 7 NKLT--GPLLVELIGK---QKNNALELGFRGN-PELVDQQ-GK--EE---------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 7 ~~l~--Hpniv~~~~~---~~~~~lv~e~~~~-~~L~~~~-~~--~~---------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
++++ |||||+++++ ++..++||||+.+ +++.+++ .+ .. |++.||.|||+ .+|+||||||
T Consensus 62 ~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp 138 (273)
T d1xwsa_ 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKD 138 (273)
T ss_dssp HHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSG
T ss_pred HHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcc
Confidence 3454 9999999999 7888999999975 5777777 22 22 99999999999 9999999999
Q ss_pred CcEEEccC-CceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccC
Q 039565 69 TNILLNEK-VQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSF 140 (188)
Q Consensus 69 ~nill~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~ 140 (188)
+||+++.+ +.+|++|||+++.... .......||+.|+||| .+.++||||+||++|+|++|..||....
T Consensus 139 ~NIll~~~~~~vkl~DFG~a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (273)
T d1xwsa_ 139 ENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214 (273)
T ss_dssp GGEEEETTTTEEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred cceEEecCCCeEEECccccceeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch
Confidence 99999854 7899999999975421 1234567999999999 3567899999999999999999996421
Q ss_pred -----CCCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 141 -----KGEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 141 -----~~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
...++...+..+.+++.+||+.||++|||++|+++
T Consensus 215 ~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 12233445678999999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-38 Score=239.76 Aligned_cols=173 Identities=20% Similarity=0.177 Sum_probs=137.7
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhc-CCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQ-GKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|++++|||||+++++ ..+.++||||+.++.+.... .... |++.||.|||+ .+|+||||||+
T Consensus 55 l~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpe 131 (298)
T d1gz8a_ 55 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQ 131 (298)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred HHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCch
Confidence 578999999999999 88899999999865444333 2222 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||+++.++.+|++|||.++.... .........|++.|++|| .+.++|+||+||++|+|++|..||......
T Consensus 132 NIl~~~~~~~kl~DFG~a~~~~~--~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~ 209 (298)
T d1gz8a_ 132 NLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209 (298)
T ss_dssp GEEECTTSCEEECSTTHHHHHCC--CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred heeecccCcceeccCCcceeccC--CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH
Confidence 99999999999999999975432 222344567889999998 478899999999999999999998532100
Q ss_pred --------------C--------------------------cCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--Hhhc
Q 039565 143 --------------E--------------------------FDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV--REQG 180 (188)
Q Consensus 143 --------------~--------------------------~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~--l~~~ 180 (188)
+ .....+..+.+++.+||+.||++|||++|+++. |+++
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0 001224578899999999999999999999984 6665
Q ss_pred cCc
Q 039565 181 SGS 183 (188)
Q Consensus 181 ~~~ 183 (188)
.+.
T Consensus 290 ~~p 292 (298)
T d1gz8a_ 290 TKP 292 (298)
T ss_dssp CCC
T ss_pred CCC
Confidence 543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=238.66 Aligned_cols=164 Identities=21% Similarity=0.210 Sum_probs=132.9
Q ss_pred cccccCCCeeeeccc--------CCccEEEEecCCCCChhhhc-CCc-c-----------cHHHHHHHHhcCCCCCcEEe
Q 039565 6 RNKLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQ-GKE-E-----------VCCPGLEYLHQGLKHPIIQR 64 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~-~~~-~-----------~i~~~l~~Lh~~~~~~i~h~ 64 (188)
|+.++||||++++++ ....++++||++++++.... ... . |++.||+|||+ .+|+||
T Consensus 64 l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHr 140 (305)
T d1blxa_ 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHR 140 (305)
T ss_dssp HHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCC
T ss_pred HhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEec
Confidence 344589999999987 24678999999987765554 221 1 99999999999 999999
Q ss_pred CCCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 65 DMKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 65 dl~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
||||+|||++..+.+|++|||+++... .........||+.|+||| ++.++||||+||++|+|++|..||..
T Consensus 141 DiKp~NILi~~~~~~kl~dfg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 141 DLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp CCCGGGEEECTTCCEEECSCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCccEEEEcCCCCeeecchhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence 999999999999999999999987532 223345678999999999 78999999999999999999999854
Q ss_pred cCCC--------------------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 139 SFKG--------------------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 139 ~~~~--------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.... ......++.+.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 218 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 3110 011123457889999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.4e-37 Score=234.52 Aligned_cols=166 Identities=19% Similarity=0.184 Sum_probs=131.9
Q ss_pred CcccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 5 NRNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
-|++++||||+++++. .+..++++|++.++.+..+..... |++.||+|||+ .+|+||||||+
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~ 129 (286)
T d1ob3a_ 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQ 129 (286)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred HHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCc
Confidence 4678999999999999 888999999999877777663222 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC-
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK- 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~- 141 (188)
||+++.++.+|++|||.+...... ........+++.|++|| ++.++|+||+||++|+|++|..||.....
T Consensus 130 NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~ 207 (286)
T d1ob3a_ 130 NLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (286)
T ss_dssp GEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred eeeEcCCCCEEecccccceecccC--ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH
Confidence 999999999999999998764321 12233456788899887 58899999999999999999999853210
Q ss_pred ---------------------------------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ---------------------------------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ---------------------------------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+..+.+++.+||+.||++|||++|+++
T Consensus 208 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011123467889999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-36 Score=235.48 Aligned_cols=173 Identities=19% Similarity=0.147 Sum_probs=133.5
Q ss_pred cccccCCCeeeeccc---------CCccEEEEecCCCCChhhhc----CCcc-----------cHHHHHHHHhcCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---------QKNNALELGFRGNPELVDQQ----GKEE-----------VCCPGLEYLHQGLKHPI 61 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~----~~~~-----------~i~~~l~~Lh~~~~~~i 61 (188)
|++++||||++++++ ..+.++||||++++.+.... .... |++.||+|||+ .+|
T Consensus 67 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~I 143 (350)
T d1q5ka_ 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGI 143 (350)
T ss_dssp HHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTE
T ss_pred HHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCC
Confidence 567899999999887 22468999999976433332 1211 99999999999 999
Q ss_pred EEeCCCCCcEEEccCC-ceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCC
Q 039565 62 IQRDMKSTNILLNEKV-QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGI 133 (188)
Q Consensus 62 ~h~dl~~~nill~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~ 133 (188)
+||||||+|||++.++ .+||+|||++..... ........|+..|++|| ++.++||||+||++|+|++|.
T Consensus 144 iHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~ 220 (350)
T d1q5ka_ 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220 (350)
T ss_dssp ECCCCCGGGEEECTTTCCEEECCCTTCEECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTS
T ss_pred cccCCCcceEEEecCCCceeEecccchhhccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCC
Confidence 9999999999999775 899999999875431 12234467888899987 688999999999999999999
Q ss_pred ccccccCCC----------------------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 039565 134 LTVDLSFKG----------------------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQV 173 (188)
Q Consensus 134 ~p~~~~~~~----------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i 173 (188)
.||...... ......+..+.+++.+||+.||++|||++|+
T Consensus 221 ~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 300 (350)
T d1q5ka_ 221 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300 (350)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 998532110 0111235578899999999999999999999
Q ss_pred HH--HHhhccCcc
Q 039565 174 VM--VREQGSGSR 184 (188)
Q Consensus 174 ~~--~l~~~~~~~ 184 (188)
++ .|+++.+..
T Consensus 301 L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 301 CAHSFFDELRDPN 313 (350)
T ss_dssp HTSGGGGGGGCTT
T ss_pred hcCHhhccccCCC
Confidence 97 466655443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-36 Score=232.40 Aligned_cols=166 Identities=22% Similarity=0.257 Sum_probs=137.2
Q ss_pred cccccC-CCeeeeccc---CCccEEEEecCCCCChhhhc---CCcc---------cHHHHHHHHhcCCCCCcEEeCCCCC
Q 039565 6 RNKLTG-PLLVELIGK---QKNNALELGFRGNPELVDQQ---GKEE---------VCCPGLEYLHQGLKHPIIQRDMKST 69 (188)
Q Consensus 6 l~~l~H-pniv~~~~~---~~~~~lv~e~~~~~~L~~~~---~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~ 69 (188)
|.+++| |||++++++ ....++++||+.+|+|.+++ .... |++.||.|||+ .+++||||||+
T Consensus 82 l~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~ 158 (322)
T d1vzoa_ 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLE 158 (322)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGG
T ss_pred HHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCcc
Confidence 567767 899999988 88999999999999999998 2222 99999999999 99999999999
Q ss_pred cEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC--------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 70 NILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE--------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 70 nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe--------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
||+++.++.+||+|||+++.+. ...........|++.|++|| ++.++|||||||++|+|++|..||.....
T Consensus 159 Nill~~~~~vkL~DFG~a~~~~-~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~ 237 (322)
T d1vzoa_ 159 NILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237 (322)
T ss_dssp GEEECTTSCEEESCSSEEEECC-GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred ceeecCCCCEEEeeccchhhhc-ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999987543 12222334567888899887 46789999999999999999999965432
Q ss_pred CC---------------cCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 039565 142 GE---------------FDIISVEKAVEIAMASVSSKVNRRPL-----MNQVVM 175 (188)
Q Consensus 142 ~~---------------~~~~~~~~~~~l~~~cl~~~p~~Rps-----~~~i~~ 175 (188)
.+ .+...+..+.+++..||+.||++||| ++|+++
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 238 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 22 23345678999999999999999994 788876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-35 Score=230.84 Aligned_cols=168 Identities=18% Similarity=0.219 Sum_probs=133.0
Q ss_pred cccccCCCeeeeccc-------CCccEEEEecCCCCChhhhc--CCcc---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK-------QKNNALELGFRGNPELVDQQ--GKEE---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-------~~~~~lv~e~~~~~~L~~~~--~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
|.+++||||++++++ ....+++++|+.+|+|.+++ +... |++.||+|||+ .+|+|||||
T Consensus 60 l~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIK 136 (345)
T d1pmea_ 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLK 136 (345)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCC
T ss_pred HHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCC
Confidence 567899999999988 12345666777789999999 3333 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCC-CcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcccccc
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGG-THMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLS 139 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~ 139 (188)
|+||+++.++.+||+|||++........ ........|++.|+||| ++.++|+||+||++|+|++|..||+..
T Consensus 137 p~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 137 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 9999999999999999999875432211 12234467889999998 477899999999999999999998543
Q ss_pred CCC-------------------------------------CcC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 140 FKG-------------------------------------EFD-----IISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 140 ~~~-------------------------------------~~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
... ..+ ...+.++.+++.+||+.||.+|||++++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 217 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 210 000 0123468899999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-35 Score=229.56 Aligned_cols=167 Identities=23% Similarity=0.222 Sum_probs=134.5
Q ss_pred cccccCCCeeeeccc---------CCccEEEEecCCCCChhhhc--CCcc---------cHHHHHHHHhcCCCCCcEEeC
Q 039565 6 RNKLTGPLLVELIGK---------QKNNALELGFRGNPELVDQQ--GKEE---------VCCPGLEYLHQGLKHPIIQRD 65 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~--~~~~---------~i~~~l~~Lh~~~~~~i~h~d 65 (188)
|++++|||||+++++ ....++||||++ .+|..++ .... |++.||.|||+ .+|+|||
T Consensus 71 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrD 146 (346)
T d1cm8a_ 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRD 146 (346)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred HHhcCCCCeeEEEEEeccCccccccceEEEEEeccc-ccHHHHHHhccccHHHHHHHHHHHHHHHHHHHh---CCCcccc
Confidence 567899999999998 225699999994 5777777 2333 99999999999 9999999
Q ss_pred CCCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccc
Q 039565 66 MKSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDL 138 (188)
Q Consensus 66 l~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~ 138 (188)
|||+||+++.++.+|++|||+++.... ......|++.|+||| ++.++||||+||++|+|++|..||..
T Consensus 147 iKp~NIL~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 147 LKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCcchhhcccccccccccccceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 999999999999999999999975431 223457889999999 47899999999999999999999854
Q ss_pred cCCC------------------------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 039565 139 SFKG------------------------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 139 ~~~~------------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~ 176 (188)
.... ......+..+.+++.+||+.||.+|||++++++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 3110 0011224567899999999999999999999984
Q ss_pred --Hhhcc
Q 039565 177 --REQGS 181 (188)
Q Consensus 177 --l~~~~ 181 (188)
|+++.
T Consensus 302 p~f~~~~ 308 (346)
T d1cm8a_ 302 PYFESLH 308 (346)
T ss_dssp GGGTTTC
T ss_pred hhhCcCC
Confidence 55443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-35 Score=228.20 Aligned_cols=167 Identities=19% Similarity=0.148 Sum_probs=130.4
Q ss_pred cccccCCCeeeeccc-----------CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcE
Q 039565 6 RNKLTGPLLVELIGK-----------QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPII 62 (188)
Q Consensus 6 l~~l~Hpniv~~~~~-----------~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~ 62 (188)
|.+++||||++++++ ..+.+++|||+.++.+..+..... |++.||.|||+ .+|+
T Consensus 63 l~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~---~~iv 139 (318)
T d3blha1 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKIL 139 (318)
T ss_dssp HHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred HHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhcc---CCEE
Confidence 578999999999887 346799999999877766552222 99999999999 9999
Q ss_pred EeCCCCCcEEEccCCceEEecccCcccccCCCC--CcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCC
Q 039565 63 QRDMKSTNILLNEKVQAKLADFGQSRISPVEGG--THMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGI 133 (188)
Q Consensus 63 h~dl~~~nill~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~ 133 (188)
||||||+||+++.++.+|++|||++........ ........||+.|+||| ++.++||||+||++|+|++|+
T Consensus 140 HrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~ 219 (318)
T d3blha1 140 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219 (318)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCC
Confidence 999999999999999999999999975432211 11223356899999999 578999999999999999999
Q ss_pred ccccccCCCC------------------------------------cC-------HHHHHHHHHHHHHccCcCCCCCCCH
Q 039565 134 LTVDLSFKGE------------------------------------FD-------IISVEKAVEIAMASVSSKVNRRPLM 170 (188)
Q Consensus 134 ~p~~~~~~~~------------------------------------~~-------~~~~~~~~~l~~~cl~~~p~~Rps~ 170 (188)
.||+.....+ .. ......+.+++.+||+.||++|||+
T Consensus 220 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa 299 (318)
T d3blha1 220 PIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299 (318)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH
Confidence 9985321000 00 0113356789999999999999999
Q ss_pred HHHHH
Q 039565 171 NQVVM 175 (188)
Q Consensus 171 ~~i~~ 175 (188)
+|+++
T Consensus 300 ~elL~ 304 (318)
T d3blha1 300 DDALN 304 (318)
T ss_dssp HHHHH
T ss_pred HHHHc
Confidence 99987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.3e-35 Score=225.86 Aligned_cols=164 Identities=16% Similarity=0.191 Sum_probs=132.5
Q ss_pred ccccc-CCCeeeeccc-----CCccEEEEecCCCCChhhhcCCcc---------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLT-GPLLVELIGK-----QKNNALELGFRGNPELVDQQGKEE---------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~-Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|.+++ ||||++++++ ....++||||+++++|..+.+... |++.||.|||+ .+|+||||||+|
T Consensus 83 l~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~N 159 (328)
T d3bqca1 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHN 159 (328)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccc
Confidence 45664 9999999987 456899999999999988875544 99999999999 999999999999
Q ss_pred EEEccCC-ceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCCC
Q 039565 71 ILLNEKV-QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFKG 142 (188)
Q Consensus 71 ill~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~~ 142 (188)
||++.++ .+|++|||++...... .......+|..|+||| ++.++|+||+||++|++++|..||......
T Consensus 160 ILi~~~~~~vkl~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~ 236 (328)
T d3bqca1 160 VMIDHEHRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236 (328)
T ss_dssp EEEETTTTEEEECCGGGCEECCTT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred eEEcCCCCeeeecccccceeccCC---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh
Confidence 9998655 6899999999754311 2234456888899998 578899999999999999999887432110
Q ss_pred -------------------------------------------------CcCHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 039565 143 -------------------------------------------------EFDIISVEKAVEIAMASVSSKVNRRPLMNQV 173 (188)
Q Consensus 143 -------------------------------------------------~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i 173 (188)
......+..+.+++.+||+.||++|||++|+
T Consensus 237 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~ 316 (328)
T d3bqca1 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316 (328)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 0111234568899999999999999999999
Q ss_pred HH
Q 039565 174 VM 175 (188)
Q Consensus 174 ~~ 175 (188)
++
T Consensus 317 L~ 318 (328)
T d3bqca1 317 ME 318 (328)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-35 Score=222.67 Aligned_cols=171 Identities=17% Similarity=0.182 Sum_probs=131.0
Q ss_pred cccccCCCeeeeccc----CCccEEEEecCCCCChhhhc--CCcc-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTGPLLVELIGK----QKNNALELGFRGNPELVDQQ--GKEE-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~Hpniv~~~~~----~~~~~lv~e~~~~~~L~~~~--~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+++++|+|++..++. ....++||||+. +++...+ .... |++.||+|||+ .+|+||||||
T Consensus 56 ~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp 131 (299)
T d1ckia_ 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKP 131 (299)
T ss_dssp HHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCG
T ss_pred HHHccCCCcccEEEEEEecCCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCH
Confidence 456777776555444 778889999996 4666655 2222 99999999999 9999999999
Q ss_pred CcEEEcc---CCceEEecccCcccccCCCCC-----cceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCc
Q 039565 69 TNILLNE---KVQAKLADFGQSRISPVEGGT-----HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGIL 134 (188)
Q Consensus 69 ~nill~~---~~~~kl~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~ 134 (188)
+||+++. +..++++|||+++........ .......||+.|+||| ++.++|||||||++|+|++|..
T Consensus 132 ~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~ 211 (299)
T d1ckia_ 132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 211 (299)
T ss_dssp GGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred hhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCC
Confidence 9999864 457999999999865422211 1233467999999998 7899999999999999999999
Q ss_pred cccccCCCCc-------------------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhc
Q 039565 135 TVDLSFKGEF-------------------DIISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQG 180 (188)
Q Consensus 135 p~~~~~~~~~-------------------~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~ 180 (188)
||........ ....+..+.+++..||+.+|++||+++++.+.|+..
T Consensus 212 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 212 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp TTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 9965433221 012345688999999999999999999998888765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-35 Score=221.80 Aligned_cols=165 Identities=16% Similarity=0.117 Sum_probs=131.3
Q ss_pred cccccCCCeeeeccc---CCccEEEEecCCCCChhhhcCCcc------------cHHHHHHHHhcCCCCCcEEeCCCCCc
Q 039565 6 RNKLTGPLLVELIGK---QKNNALELGFRGNPELVDQQGKEE------------VCCPGLEYLHQGLKHPIIQRDMKSTN 70 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~~n 70 (188)
|++++||||++++++ ..+.+++++++.+++|..++.... |++.||+|||+ .+|+||||||+|
T Consensus 55 l~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~N 131 (292)
T d1unla_ 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQN 131 (292)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred HHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcc
Confidence 578899999999999 888899999999988888872222 99999999999 999999999999
Q ss_pred EEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCccccccCC--
Q 039565 71 ILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLSFK-- 141 (188)
Q Consensus 71 ill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~~~-- 141 (188)
|+++.++.+|++|||.++....... ......++..|.+|| ++.++||||+||++|+|++|..||-....
T Consensus 132 Ili~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 209 (292)
T d1unla_ 132 LLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_dssp EEECTTCCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred cccccCCceeeeecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH
Confidence 9999999999999999986532211 222334556667765 57889999999999999999987521100
Q ss_pred ---------------------------------------CCcCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 039565 142 ---------------------------------------GEFDIISVEKAVEIAMASVSSKVNRRPLMNQVVM 175 (188)
Q Consensus 142 ---------------------------------------~~~~~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~ 175 (188)
.......+..+.+++.+||+.||++|||++|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011233457889999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-34 Score=219.11 Aligned_cols=172 Identities=15% Similarity=0.162 Sum_probs=136.5
Q ss_pred cccccC-CCeeeeccc---CCccEEEEecCCCCChhhhc-CCc-c-----------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 6 RNKLTG-PLLVELIGK---QKNNALELGFRGNPELVDQQ-GKE-E-----------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 6 l~~l~H-pniv~~~~~---~~~~~lv~e~~~~~~L~~~~-~~~-~-----------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+..++| +|+++++++ ....++||||+. ++|.+++ ... . |++.||+|||+ .+|+||||||
T Consensus 54 ~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp 129 (293)
T d1csna_ 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKP 129 (293)
T ss_dssp HHHTTTCTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCG
T ss_pred HHHhcCCCCCCEEEEEeecCCccEEEEEecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCc
Confidence 445655 888888888 888899999995 7999888 222 1 99999999999 9999999999
Q ss_pred CcEEEcc-----CCceEEecccCcccccCCCCC-----cceeeecccccccCCC------CCCccchHHHHHHHHHHHhC
Q 039565 69 TNILLNE-----KVQAKLADFGQSRISPVEGGT-----HMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITG 132 (188)
Q Consensus 69 ~nill~~-----~~~~kl~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g 132 (188)
+||+++. .+.++++|||+++........ .......||+.|+||| ++.++|+||||+++|+|++|
T Consensus 130 ~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg 209 (293)
T d1csna_ 130 DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 209 (293)
T ss_dssp GGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhC
Confidence 9999974 568999999999865422111 1233467999999999 68899999999999999999
Q ss_pred CccccccCCCCc--------------C-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhhcc
Q 039565 133 ILTVDLSFKGEF--------------D-----IISVEKAVEIAMASVSSKVNRRPLMNQVVMVREQGS 181 (188)
Q Consensus 133 ~~p~~~~~~~~~--------------~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~~l~~~~ 181 (188)
..||........ + ...++.+.+++..|+..+|++||+++.+.+.|+++.
T Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 210 SLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp SCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 999975433221 0 113357889999999999999999999988887654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-34 Score=222.82 Aligned_cols=164 Identities=18% Similarity=0.192 Sum_probs=126.0
Q ss_pred cccccCCCeeeeccc---------CCccEEEEecCCCCChhhhcCCcc---------cHHHHHHHHhcCCCCCcEEeCCC
Q 039565 6 RNKLTGPLLVELIGK---------QKNNALELGFRGNPELVDQQGKEE---------VCCPGLEYLHQGLKHPIIQRDMK 67 (188)
Q Consensus 6 l~~l~Hpniv~~~~~---------~~~~~lv~e~~~~~~L~~~~~~~~---------~i~~~l~~Lh~~~~~~i~h~dl~ 67 (188)
+++++||||++++++ ..+.+++|||+.++.+..+..... |++.||.|||+ .+|+|||+|
T Consensus 70 l~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlK 146 (355)
T d2b1pa1 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLK 146 (355)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCC
T ss_pred HHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCC
Confidence 467899999999998 257799999998765555444444 99999999999 999999999
Q ss_pred CCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccccccCC
Q 039565 68 STNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTVDLSFK 141 (188)
Q Consensus 68 ~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~~~~~~ 141 (188)
|+||+++.++..+++|||+++... .........+|..|+||| ++.++||||+||++|+|++|..||.....
T Consensus 147 P~Nil~~~~~~~kl~df~~~~~~~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 147 PSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_dssp GGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccccccceeeechhhhhccc---cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence 999999999999999999887543 222334557888999999 68899999999999999999998842110
Q ss_pred -----------------------------------------------------CCcCHHHHHHHHHHHHHccCcCCCCCC
Q 039565 142 -----------------------------------------------------GEFDIISVEKAVEIAMASVSSKVNRRP 168 (188)
Q Consensus 142 -----------------------------------------------------~~~~~~~~~~~~~l~~~cl~~~p~~Rp 168 (188)
.......+..+.+++.+||..||++||
T Consensus 224 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 303 (355)
T d2b1pa1 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc
Confidence 001123466789999999999999999
Q ss_pred CHHHHHH
Q 039565 169 LMNQVVM 175 (188)
Q Consensus 169 s~~~i~~ 175 (188)
|++|+++
T Consensus 304 ta~elL~ 310 (355)
T d2b1pa1 304 SVDDALQ 310 (355)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-34 Score=224.04 Aligned_cols=167 Identities=20% Similarity=0.236 Sum_probs=130.5
Q ss_pred cccccCCCeeeeccc--------CCccEEEEecCCCCChhhhcCCcc-----------cHHHHHHHHhcCCCCCcEEeCC
Q 039565 6 RNKLTGPLLVELIGK--------QKNNALELGFRGNPELVDQQGKEE-----------VCCPGLEYLHQGLKHPIIQRDM 66 (188)
Q Consensus 6 l~~l~Hpniv~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~-----------~i~~~l~~Lh~~~~~~i~h~dl 66 (188)
|.+++|||||+++++ ....+++++|+.+|+|.+++.... |++.||+|||+ .+|+||||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDi 147 (348)
T d2gfsa1 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDL 147 (348)
T ss_dssp HHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCC
T ss_pred HHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHh---CCCccccc
Confidence 568899999999987 234577788888999999993333 99999999999 99999999
Q ss_pred CCCcEEEccCCceEEecccCcccccCCCCCcceeeecccccccCCC-------CCCccchHHHHHHHHHHHhCCcccccc
Q 039565 67 KSTNILLNEKVQAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE-------LTEKSDVDSFEIVILEIITGILTVDLS 139 (188)
Q Consensus 67 ~~~nill~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe-------~~~~~di~s~G~~l~~~~~g~~p~~~~ 139 (188)
||+||+++.++.+|++|||.+.... .......|+..|++|| .+.++|+||+||++|+|++|..||...
T Consensus 148 Kp~NILi~~~~~~kl~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 148 KPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp CGGGEEECTTCCEEECCC----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCccccccccccccccccchhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999886432 2234456788889888 478999999999999999999998532
Q ss_pred CCC-------------------------------------CcC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH--
Q 039565 140 FKG-------------------------------------EFD-----IISVEKAVEIAMASVSSKVNRRPLMNQVVM-- 175 (188)
Q Consensus 140 ~~~-------------------------------------~~~-----~~~~~~~~~l~~~cl~~~p~~Rps~~~i~~-- 175 (188)
... ..+ ...+..+.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp 302 (348)
T d2gfsa1 223 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302 (348)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCH
Confidence 100 000 112456789999999999999999999997
Q ss_pred HHhhc
Q 039565 176 VREQG 180 (188)
Q Consensus 176 ~l~~~ 180 (188)
.|.+.
T Consensus 303 ~f~~~ 307 (348)
T d2gfsa1 303 YFAQY 307 (348)
T ss_dssp GGTTT
T ss_pred hhCCC
Confidence 45443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=2e-28 Score=191.10 Aligned_cols=161 Identities=19% Similarity=0.200 Sum_probs=121.7
Q ss_pred ccCCCeeeeccc-----CCccEEEEecCCCCChhhh-c--CCcc------------cHHHHHHHHhcCCCCCcEEeCCCC
Q 039565 9 LTGPLLVELIGK-----QKNNALELGFRGNPELVDQ-Q--GKEE------------VCCPGLEYLHQGLKHPIIQRDMKS 68 (188)
Q Consensus 9 l~Hpniv~~~~~-----~~~~~lv~e~~~~~~L~~~-~--~~~~------------~i~~~l~~Lh~~~~~~i~h~dl~~ 68 (188)
+.|+||++++++ ....+++++++..+..... . .... |++.||.|||+ ..+|+||||||
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp 154 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKP 154 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSG
T ss_pred cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCCh
Confidence 458899999887 4556677777654432222 2 2111 99999999996 27899999999
Q ss_pred CcEEEccCC------ceEEecccCcccccCCCCCcceeeecccccccCCC------CCCccchHHHHHHHHHHHhCCccc
Q 039565 69 TNILLNEKV------QAKLADFGQSRISPVEGGTHMSTTIAGTAGFLNTE------LTEKSDVDSFEIVILEIITGILTV 136 (188)
Q Consensus 69 ~nill~~~~------~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~pe------~~~~~di~s~G~~l~~~~~g~~p~ 136 (188)
+||+++.++ .++++|||.+..... ......|++.|+||| ++.++|+||+||++++|++|..||
T Consensus 155 ~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF 229 (362)
T d1q8ya_ 155 ENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229 (362)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred hHeeeeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCC
Confidence 999998654 489999999875321 223457889999999 689999999999999999999988
Q ss_pred cccCC-----------------------------------------------------------CCcCHHHHHHHHHHHH
Q 039565 137 DLSFK-----------------------------------------------------------GEFDIISVEKAVEIAM 157 (188)
Q Consensus 137 ~~~~~-----------------------------------------------------------~~~~~~~~~~~~~l~~ 157 (188)
.+... .......+..+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 309 (362)
T d1q8ya_ 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309 (362)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHH
Confidence 53211 0122455678999999
Q ss_pred HccCcCCCCCCCHHHHHHH
Q 039565 158 ASVSSKVNRRPLMNQVVMV 176 (188)
Q Consensus 158 ~cl~~~p~~Rps~~~i~~~ 176 (188)
.|+..||.+|||++|+++.
T Consensus 310 ~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 310 PMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp GGGCSSTTTCBCHHHHHTC
T ss_pred HHCCCChhHCcCHHHHhcC
Confidence 9999999999999999873
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.55 E-value=3.4e-16 Score=111.08 Aligned_cols=115 Identities=17% Similarity=0.207 Sum_probs=77.8
Q ss_pred CcccccCCCeeeecccCCccEEEEecCCCCChhhhcCCcc-----cHHHHHHHHhcCCCCCcEEeCCCCCcEEEccCCce
Q 039565 5 NRNKLTGPLLVELIGKQKNNALELGFRGNPELVDQQGKEE-----VCCPGLEYLHQGLKHPIIQRDMKSTNILLNEKVQA 79 (188)
Q Consensus 5 ~l~~l~Hpniv~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~i~~~l~~Lh~~~~~~i~h~dl~~~nill~~~~~~ 79 (188)
.+.++.|++++..++.. ..+++|||+++..+...-.... |++.|+.|||+ .+++|||+||+||+++++ .+
T Consensus 67 ~l~~l~~~~v~~~~~~~-~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 67 ALQKLQGLAVPKVYAWE-GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp HHHHTTTSSSCCEEEEE-TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EE
T ss_pred HHHHccCCCcceEEEec-CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CE
Confidence 35667888888887762 2379999999876655442221 99999999999 999999999999999965 48
Q ss_pred EEecccCcccccCCCCCcceee-ecccccccCCCCCCccchHHHHH
Q 039565 80 KLADFGQSRISPVEGGTHMSTT-IAGTAGFLNTELTEKSDVDSFEI 124 (188)
Q Consensus 80 kl~d~~~~~~~~~~~~~~~~~~-~~~~~~~~~pe~~~~~di~s~G~ 124 (188)
+++|||.++....+........ ......|....++.++|+||..-
T Consensus 142 ~liDFG~a~~~~~~~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp EECCCTTCEETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred EEEECCCcccCCCCCcHHHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 8999999875432211110000 00001122233678889999653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.22 E-value=0.0033 Score=44.53 Aligned_cols=29 Identities=21% Similarity=0.392 Sum_probs=24.7
Q ss_pred CcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 60 PIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 60 ~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
.++|+|+.+.||+++.++...+.||+.+.
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEEeeccCcceeecCCceEEEeechhcc
Confidence 37899999999999987667799998765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.65 E-value=0.0089 Score=43.57 Aligned_cols=31 Identities=19% Similarity=0.221 Sum_probs=27.3
Q ss_pred CCCcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
..+++|+|+.+.|++++.+....+.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3579999999999999988777899998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=90.67 E-value=0.045 Score=38.09 Aligned_cols=29 Identities=17% Similarity=0.217 Sum_probs=24.7
Q ss_pred CcEEeCCCCCcEEEccCCceEEecccCcc
Q 039565 60 PIIQRDMKSTNILLNEKVQAKLADFGQSR 88 (188)
Q Consensus 60 ~i~h~dl~~~nill~~~~~~kl~d~~~~~ 88 (188)
.++|+|+.|.||+++.+....+.||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 37999999999999987667899998664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=88.19 E-value=0.11 Score=39.09 Aligned_cols=30 Identities=20% Similarity=0.273 Sum_probs=25.3
Q ss_pred CCcEEeCCCCCcEEEccCCceEEecccCccc
Q 039565 59 HPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89 (188)
Q Consensus 59 ~~i~h~dl~~~nill~~~~~~kl~d~~~~~~ 89 (188)
..++|+|+.+.|||++.+. +++.||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 4689999999999998764 89999987653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=81.70 E-value=0.27 Score=35.61 Aligned_cols=30 Identities=20% Similarity=0.285 Sum_probs=23.7
Q ss_pred CCCcEEeCCCCCcEEEccCCceEEecccCccc
Q 039565 58 KHPIIQRDMKSTNILLNEKVQAKLADFGQSRI 89 (188)
Q Consensus 58 ~~~i~h~dl~~~nill~~~~~~kl~d~~~~~~ 89 (188)
..+++|+|+.+.|++++++ ..+.||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 3578999999999999753 45789987653
|